data_2lgo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lgo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.872 -0.418 . . . . 73.129999999999995 109.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.3 tp -145.92 102.02 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.784 0.326 . . . . 72.129999999999995 111.019 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' H ' ' HB ' ' A' ' 99' ' ' THR . 50.1 mm-40 -113.62 140.68 48.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.99 -0.744 . . . . 65.329999999999998 108.99 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 9.1 ptpp? -128.32 111.92 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 71.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -123.41 110.0 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 74.450000000000003 109.878 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 9.9 p -71.37 128.06 34.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.842 0.353 . . . . 74.030000000000001 111.314 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 97' ' ' LEU . 3.0 mm? -86.96 -38.08 16.97 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.592 -0.522 . . . . 73.129999999999995 109.592 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.1 m -141.6 112.7 6.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.966 -0.561 . . . . 74.030000000000001 110.187 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.15 146.09 62.81 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.51 2.14 . . . . 71.120000000000005 111.638 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.62 -164.64 28.23 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.271 -0.49 . . . . 71.150000000000006 112.717 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.79 -40.89 63.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.092 0.472 . . . . 72.409999999999997 110.996 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 -30.78 2.48 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.734 -0.667 . . . . 51.130000000000003 112.657 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.6 -24.5 8.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.032 0.444 . . . . 74.230000000000004 110.43 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.432 ' HG1' ' HB3' ' A' ' 92' ' ' LEU . 15.2 p -75.05 139.58 42.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.552 -0.749 . . . . 54.219999999999999 110.436 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -126.41 113.72 23.29 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.504 -0.316 . . . . 71.519999999999996 110.896 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.64 130.95 14.17 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.429 2.086 . . . . 72.230000000000004 111.451 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.47 149.28 44.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.43 -0.35 . . . . 75.109999999999999 110.815 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.32 164.5 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.111 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.24 34.48 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.156 -0.474 . . . . 73.239999999999995 112.73 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -101.44 146.7 27.27 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 75.150000000000006 111.597 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -77.42 110.85 12.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.299 -0.864 . . . . 63.310000000000002 109.282 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.9 m -106.4 148.76 10.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.945 0.403 . . . . 72.019999999999996 111.662 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.9 m -102.53 108.19 19.4 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 115.02 -0.991 . . . . 54.210000000000001 110.515 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.507 HG22 ' HE1' ' A' ' 72' ' ' PHE . 33.1 m -119.21 178.36 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 114.64 -1.164 . . . . 54.299999999999997 111.931 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 13.8 t-160 -157.51 147.32 20.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.199 -1.037 . . . . 71.409999999999997 108.199 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.6 m-85 -132.99 157.39 45.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.822 0.283 . . . . 74.140000000000001 111.383 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.822 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 45.0 m-20 -136.0 122.32 20.52 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.693 -0.685 . . . . 72.430000000000007 109.863 170.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.29 129.79 10.32 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.664 -0.574 . . . . 64.230000000000004 111.664 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -149.0 143.77 26.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 75.299999999999997 110.825 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 147.5 40.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.943 -0.391 . . . . 75.120000000000005 109.943 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.32 -22.49 49.66 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.894 2.396 . . . . 75.109999999999999 112.067 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.32 -34.27 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.5 -0.773 . . . . 72.329999999999998 110.797 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.59 -38.45 2.19 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.059 -0.816 . . . . 62.229999999999997 111.059 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.95 123.12 16.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.508 -0.346 . . . . 73.120000000000005 110.328 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -75.65 144.19 41.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.506 . . . . 72.329999999999998 110.917 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -72.93 -45.22 59.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.521 -0.548 . . . . 73.530000000000001 109.521 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -166.7 131.3 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 72.129999999999995 109.459 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -78.74 85.6 4.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.239 0.542 . . . . 74.510000000000005 109.865 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -72.66 -14.0 61.49 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.438 0.637 . . . . 73.299999999999997 110.086 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.691 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 13.1 ptt-85 -64.46 -35.96 82.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.42 -0.809 . . . . 75.5 110.678 171.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -69.17 -18.2 63.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.098 0.475 . . . . 52.329999999999998 110.057 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -82.32 -14.2 55.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.989 -0.551 . . . . 75.439999999999998 110.574 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.81 32.82 59.27 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.816 -0.629 . . . . 63.329999999999998 113.578 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -106.47 109.57 63.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.755 0.278 . . . . 75.340000000000003 110.98 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -90.5 125.68 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.948 2.432 . . . . 73.209999999999994 112.054 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.77 162.63 14.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.33 -0.618 . . . . 71.25 109.33 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.95 137.35 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.414 -0.178 . . . . 75.030000000000001 110.767 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.507 ' HE1' HG22 ' A' ' 48' ' ' VAL . 35.1 p90 -159.27 155.28 26.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.213 -0.195 . . . . 73.400000000000006 110.616 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.6 m -72.09 113.8 9.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.431 -0.35 . . . . 75.200000000000003 110.687 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 87' ' ' VAL . 55.8 tp -61.97 133.56 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.7 -0.482 . . . . 75.129999999999995 109.7 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.75 68.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 70.140000000000001 112.803 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.39 11.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 74.430000000000007 110.525 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.91 31.68 3.33 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.475 -0.393 . . . . 71.230000000000004 112.631 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -63.74 -43.54 96.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 110.593 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.675 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 26.8 m -128.75 177.73 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 62.130000000000003 110.147 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.3 pt -68.92 152.77 9.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.687 0.279 . . . . 75.420000000000002 110.389 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 5.6 tmtm? -56.25 -29.02 60.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.073 -0.512 . . . . 74.329999999999998 109.94 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.44 -54.43 36.09 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.133 -0.556 . . . . 74.310000000000002 112.057 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.675 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 26.0 m0 -68.75 -38.17 79.93 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.52 -0.178 . . . . 71.340000000000003 110.52 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -54.51 -49.3 70.51 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.215 0.531 . . . . 72.430000000000007 110.389 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -65.03 -41.32 95.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 74.129999999999995 110.267 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.04 43.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.924 -0.58 . . . . 70.400000000000006 112.492 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.478 ' HA ' ' SD ' ' A' ' 90' ' ' MET . 6.6 p -71.03 -31.81 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.685 0.279 . . . . 63.539999999999999 111.068 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.59 -30.66 67.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 72.340000000000003 111.659 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 -15.65 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.93 0.344 . . . . 73.040000000000006 111.93 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 87' ' ' VAL . 16.5 ptm -91.01 -175.39 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.581 0.229 . . . . 71.329999999999998 110.828 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -126.51 175.23 8.06 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 75.530000000000001 111.14 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.781 ' HA ' HD11 ' A' ' 127' ' ' LEU . 7.2 tt -73.84 137.58 43.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.698 0.285 . . . . 74.120000000000005 110.26 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.489 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.25 10.58 85.9 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.652 -0.579 . . . . 72.25 111.652 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.86 149.65 30.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.607 -0.296 . . . . 71.340000000000003 110.63 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . 13.9 ptmt -140.43 133.45 29.35 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.498 -0.556 . . . . 74.540000000000006 109.498 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -131.43 156.71 45.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.693 -0.685 . . . . 55.240000000000002 111.037 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.563 ' HB2' HD21 ' A' ' 31' ' ' LEU . 8.7 tt -90.73 107.2 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.061 -1.089 . . . . 64.409999999999997 108.061 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -111.46 114.43 27.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.85 -0.426 . . . . 65.010000000000005 109.85 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.473 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 22.3 m -76.88 118.44 19.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.5 -0.318 . . . . 72.409999999999997 110.805 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 105' ' ' ALA . 40.0 mm -101.75 110.84 63.05 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 120.675 0.274 . . . . 60.109999999999999 110.414 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.548 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.3 Cg_endo -62.46 143.44 93.24 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.634 2.222 . . . . 73.230000000000004 111.889 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -54.26 -32.58 56.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.691 -0.686 . . . . 75.519999999999996 111.982 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.32 -23.34 65.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.074 0.398 . . . . 73.140000000000001 112.074 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.3 mt -96.12 -28.25 14.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.671 0.272 . . . . 73.129999999999995 111.549 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 100' ' ' ILE . . . -110.06 -174.34 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 75.530000000000001 111.127 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -70.12 -7.44 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.621 . . . . 75.329999999999998 111.08 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.33 -28.84 51.52 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 113.089 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 7.6 tm-20 -64.28 -49.85 70.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.365 -0.605 . . . . 70.209999999999994 109.365 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -27.32 58.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.491 -0.777 . . . . 75.25 110.48 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 80.14 -82.83 1.43 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.616 -0.72 . . . . 74.310000000000002 111.77 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.571 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 58.8 m-85 89.33 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.209 1.404 . . . . 75.400000000000006 111.986 -175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 59.4 Cg_endo -89.0 152.67 5.8 Favored 'Trans proline' 0 C--N 1.366 1.482 0 CA-C-N 121.693 1.64 . . . . 74.049999999999997 111.665 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.33 -7.78 13.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.557 2.171 . . . . 75.519999999999996 112.369 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.95 -31.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 109.938 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.89 101.92 48.68 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.812 -0.631 . . . . 64.329999999999998 109.899 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 Cg_endo -67.08 119.64 6.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.241 1.961 . . . . 73.409999999999997 111.388 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.34 133.96 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.683 2.922 . . . . 75.400000000000006 113.42 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 54.0 mtmt 73.0 31.68 1.45 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.645 0.778 . . . . 73.319999999999993 111.124 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -93.77 123.86 37.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.878 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 101' ' ' PRO . 74.0 m -73.69 127.64 33.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.257 -0.646 . . . . 71.230000000000004 109.257 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.498 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -120.88 137.09 54.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.547 -0.538 . . . . 74.120000000000005 109.547 -170.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.498 ' N ' HD13 ' A' ' 121' ' ' LEU . 88.7 t -98.51 131.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.691 0.281 . . . . 74.230000000000004 110.424 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.29 123.04 41.22 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.947 -0.39 . . . . 55.210000000000001 109.947 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.822 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 51.0 mt-10 -75.34 115.34 14.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.553 -0.906 . . . . 75.120000000000005 108.553 171.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 m -95.74 137.17 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.653 0.595 . . . . 55.229999999999997 109.413 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.726 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 36.3 tt0 -136.61 117.71 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.589 -0.522 . . . . 75.209999999999994 109.589 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 92' ' ' LEU . 3.1 tm? -99.87 106.3 18.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.72 -0.845 . . . . 72.310000000000002 108.72 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 49' ' ' HIS . 3.6 mm? -78.2 -45.83 22.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.41 -0.589 . . . . 73.209999999999994 109.41 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -170.81 -173.61 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.528 -0.76 . . . . 73.019999999999996 109.92 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.114 -0.946 . . . . 71.349999999999994 108.669 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.589 ' H ' ' HB3' ' A' ' 101' ' ' PRO . 8.8 mm-40 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.393 -0.595 . . . . 73.129999999999995 109.393 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -144.4 102.41 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.945 0.402 . . . . 72.129999999999995 110.397 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 48.8 mt-10 -142.72 130.59 21.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 65.329999999999998 110.122 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -133.2 101.42 5.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.767 -0.827 . . . . 71.0 108.767 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -108.71 110.33 21.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 74.450000000000003 109.763 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.59 114.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.189 0.518 . . . . 74.030000000000001 110.336 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.7 mt -88.88 -33.02 17.47 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.843 -0.617 . . . . 73.129999999999995 110.117 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 44.7 m -145.49 120.58 5.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.523 -0.762 . . . . 74.030000000000001 109.397 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 146.44 51.99 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.608 2.205 . . . . 71.120000000000005 112.427 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -99.91 -172.06 30.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.069 -0.514 . . . . 71.150000000000006 112.431 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.422 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 78.2 m-20 -63.85 -36.88 85.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.034 0.445 . . . . 72.409999999999997 110.397 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.35 -30.29 2.18 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.774 -0.648 . . . . 51.130000000000003 113.039 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 m -82.25 -35.65 13.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.148 0.499 . . . . 74.230000000000004 110.07 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 12.3 p -84.83 115.57 22.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.585 -0.734 . . . . 54.219999999999999 109.476 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 8.3 mtmp? -124.39 132.23 24.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 71.519999999999996 111.063 -171.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.18 166.73 20.39 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.549 2.166 . . . . 72.230000000000004 110.997 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -165.21 166.38 18.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.404 -0.221 . . . . 75.109999999999999 110.404 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.39 141.66 52.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.337 -0.392 . . . . 74.420000000000002 110.936 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.59 20.3 41.3 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.068 -0.515 . . . . 73.239999999999995 111.877 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -130.61 138.16 49.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.695 0.398 . . . . 75.150000000000006 110.869 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -79.6 106.07 11.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.491 -0.929 . . . . 63.310000000000002 108.491 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 130' ' ' VAL . 28.2 m -106.49 146.19 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.365 . . . . 72.019999999999996 111.254 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.1 m -96.35 108.07 20.53 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.613 -0.721 . . . . 54.210000000000001 109.926 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.73 HG12 HD21 ' A' ' 127' ' ' LEU . 18.4 m -124.45 178.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.519 0.676 . . . . 54.299999999999997 111.234 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 15.4 t-80 -151.6 140.63 21.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.947 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 86.0 m-85 -126.5 144.01 51.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.595 -0.891 . . . . 74.140000000000001 108.595 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 8.9 t70 -136.15 110.71 8.59 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.469 -0.567 . . . . 72.430000000000007 109.469 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.46 137.4 30.88 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.938 -0.574 . . . . 64.230000000000004 112.154 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -148.01 137.16 22.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.002 0.43 . . . . 75.299999999999997 110.519 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 88.9 m-85 -78.53 146.8 70.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 75.120000000000005 110.168 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 30.5 Cg_exo -62.92 -10.39 20.12 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.97 2.446 . . . . 75.109999999999999 113.289 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -87.16 -4.94 59.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.675 0.274 . . . . 72.329999999999998 110.916 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.17 -24.58 15.79 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.742 -0.543 . . . . 62.229999999999997 111.742 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.675 ' HZ2' ' HB2' ' A' ' 58' ' ' LYS . 4.8 ttmp? -59.09 148.63 30.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.204 0.602 . . . . 73.120000000000005 110.896 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -94.88 143.62 26.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.025 -0.361 . . . . 72.329999999999998 110.025 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -86.47 -55.66 3.78 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.957 0.408 . . . . 73.530000000000001 110.558 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -138.67 131.41 29.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.348 -0.387 . . . . 72.129999999999995 110.323 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -76.19 85.12 3.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 74.510000000000005 109.95 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.0 p -90.33 -46.91 8.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.441 . . . . 73.299999999999997 109.95 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.3 ptt180 -60.64 -31.61 70.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.987 -0.551 . . . . 75.5 110.137 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -70.68 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 52.329999999999998 111.378 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -93.17 -2.27 55.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.907 0.384 . . . . 75.439999999999998 110.234 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.18 39.2 69.83 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.71 -0.677 . . . . 63.329999999999998 113.768 174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -141.81 122.63 8.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.796 0.298 . . . . 75.340000000000003 110.582 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.81 177.66 6.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.795 2.33 . . . . 73.209999999999994 111.861 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -135.02 129.92 34.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 71.25 109.848 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -100.45 141.91 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.293 -0.262 . . . . 75.030000000000001 110.293 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.52 ' HZ ' HG13 ' A' ' 87' ' ' VAL . 11.6 p90 -154.34 158.17 39.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.726 0.298 . . . . 73.400000000000006 110.265 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -83.69 109.43 17.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 110.033 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.72 142.06 56.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.447 -0.342 . . . . 75.129999999999995 110.435 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.21 26.9 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.891 -0.484 . . . . 70.140000000000001 111.891 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.81 168.95 18.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.696 0.398 . . . . 74.430000000000007 109.966 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.42 28.48 1.48 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.397 -0.43 . . . . 71.230000000000004 113.304 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.04 -34.84 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.292 0.568 . . . . 75.439999999999998 109.767 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.13 165.27 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.233 -0.894 . . . . 62.130000000000003 110.421 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 pt -80.66 164.63 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 75.420000000000002 110.526 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -55.9 -28.54 57.2 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.201 0.445 . . . . 74.329999999999998 112.201 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.52 -59.5 9.74 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 120.432 -0.889 . . . . 74.310000000000002 111.681 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.464 ' O ' HG12 ' A' ' 87' ' ' VAL . 27.0 m0 -66.0 -37.02 84.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.665 -0.268 . . . . 71.340000000000003 110.287 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.57 -55.01 39.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.936 -0.575 . . . . 72.430000000000007 110.842 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.83 -42.56 90.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 110.453 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.52 -48.68 69.01 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.014 -0.612 . . . . 70.400000000000006 112.682 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.52 HG13 ' HZ ' ' A' ' 72' ' ' PHE . 14.2 p -75.21 -32.94 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.826 0.346 . . . . 63.539999999999999 111.077 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.36 68.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.514 -0.312 . . . . 72.340000000000003 111.649 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 t -86.23 -4.46 59.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.215 0.45 . . . . 73.040000000000006 112.215 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 19.4 ptm -106.81 176.0 5.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.669 0.271 . . . . 71.329999999999998 110.889 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.1 p -118.65 174.55 6.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.764 0.316 . . . . 75.530000000000001 111.306 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 130' ' ' VAL . 7.6 tt -73.16 138.34 45.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 111.134 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.484 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.34 34.8 44.52 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.737 -0.665 . . . . 72.25 111.926 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 33.7 tt0 -134.52 153.71 51.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.945 0.402 . . . . 71.340000000000003 111.694 -169.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -131.41 122.36 26.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 74.540000000000006 109.845 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.76 141.57 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 55.240000000000002 110.62 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.407 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.7 tt -90.89 113.75 26.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.951 -0.759 . . . . 64.409999999999997 108.951 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -114.37 121.2 42.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.841 0.353 . . . . 65.010000000000005 110.389 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 31.2 m -78.67 116.06 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 72.409999999999997 110.294 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.7 mm -89.87 113.29 56.43 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 116.385 -0.371 . . . . 60.109999999999999 110.853 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 25' ' ' GLN . 73.5 Cg_endo -75.75 155.0 39.45 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.547 2.165 . . . . 73.230000000000004 111.556 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -54.17 -30.83 50.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.959 -0.564 . . . . 75.519999999999996 112.075 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.02 -26.8 64.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.729 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.4 mt -96.19 11.74 33.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.359 0.124 . . . . 73.129999999999995 111.286 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 -178.2 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 75.530000000000001 110.466 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -69.72 -8.27 46.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 75.329999999999998 110.783 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.83 -20.39 32.82 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.065 -0.516 . . . . 75.140000000000001 112.817 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -58.17 -51.95 67.58 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.562 -0.533 . . . . 70.209999999999994 109.562 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -84.33 -53.82 5.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.45 -0.795 . . . . 75.25 110.77 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.96 146.17 12.69 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.097 -0.501 . . . . 74.310000000000002 112.158 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.684 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -139.06 -55.41 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 122.369 0.268 . . . . 75.400000000000006 110.854 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.684 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 13.4 Cg_exo -70.01 128.34 15.66 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.942 1.761 . . . . 74.049999999999997 110.631 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.58 -27.67 26.29 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.82 2.347 . . . . 75.519999999999996 113.342 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.2 t -73.87 -35.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 74.310000000000002 110.56 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.54 106.17 17.35 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 64.329999999999998 109.549 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.493 ' O ' ' HB1' ' A' ' 119' ' ' ALA . 95.3 Cg_endo -79.66 163.38 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.406 2.071 . . . . 73.409999999999997 112.364 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.11 143.9 91.71 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.212 1.941 . . . . 75.400000000000006 111.17 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 65.92 28.19 10.7 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.24 0.338 . . . . 73.319999999999993 111.276 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 116' ' ' PRO . . . -76.34 148.96 37.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.18 0.514 . . . . 74.120000000000005 112.067 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.3 m -108.9 131.33 55.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.439 -0.8 . . . . 71.230000000000004 109.379 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -138.48 147.27 43.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.208 -0.664 . . . . 74.120000000000005 109.208 -175.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.541 ' N ' HD13 ' A' ' 121' ' ' LEU . 94.7 t -105.03 144.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.388 . . . . 74.230000000000004 110.98 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -133.01 125.6 30.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.021 0.439 . . . . 55.210000000000001 110.715 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 58.5 mt-10 -76.4 114.85 15.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.23 -0.656 . . . . 75.120000000000005 109.23 170.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.3 m -95.87 133.55 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 55.229999999999997 108.765 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 45.5 tt0 -139.02 116.64 11.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.39 -0.368 . . . . 75.209999999999994 110.265 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.73 HD21 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -96.04 111.71 23.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.557 -0.905 . . . . 72.310000000000002 108.557 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.05 -50.82 7.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.921 0.391 . . . . 73.209999999999994 110.065 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -167.1 178.82 5.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 73.019999999999996 109.905 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.599 HG21 HD13 ' A' ' 92' ' ' LEU . 46.6 t . . . . . 0 C--O 1.251 1.142 0 N-CA-C 108.843 -0.799 . . . . 71.349999999999994 108.843 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 . . . . . 0 C--O 1.232 0.174 0 N-CA-C 108.635 -0.876 . . . . 73.129999999999995 108.635 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 102.04 8.42 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.039 0.447 . . . . 72.129999999999995 111.02 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.27 130.1 56.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 65.329999999999998 109.993 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.669 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -140.88 117.18 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.549 -0.751 . . . . 71.0 109.209 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.55 118.09 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.481 -0.327 . . . . 74.450000000000003 110.542 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.02 134.0 27.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 74.030000000000001 110.374 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.87 -18.45 13.69 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.409 -0.36 . . . . 73.129999999999995 110.688 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 88.2 m -142.71 110.63 5.7 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.148 -0.316 . . . . 74.030000000000001 110.148 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.23 126.13 10.83 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.766 2.311 . . . . 71.120000000000005 111.053 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.2 -171.29 47.3 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.236 -0.507 . . . . 71.150000000000006 113.177 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.467 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -57.61 -34.76 69.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.603 0.361 . . . . 72.409999999999997 111.346 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.524 ' HA2' HG22 ' A' ' 91' ' ' THR . . . 76.08 -25.59 1.54 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.281 -0.485 . . . . 51.130000000000003 113.474 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 35' ' ' ASP . 34.1 m -75.12 -21.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.872 0.368 . . . . 74.230000000000004 111.471 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -81.07 128.92 34.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 54.219999999999999 111.222 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -100.09 110.24 58.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.47 . . . . 71.519999999999996 109.988 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.24 134.15 13.99 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 72.230000000000004 111.161 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -127.96 141.72 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 75.109999999999999 110.371 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 162.13 29.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.01 -0.541 . . . . 74.420000000000002 111.776 -176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.95 77.17 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.562 -0.744 . . . . 73.239999999999995 112.981 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.4 170.73 15.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.075 0.464 . . . . 75.150000000000006 111.719 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -78.64 142.75 36.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 63.310000000000002 111.495 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.15 141.94 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.845 -0.616 . . . . 72.019999999999996 110.112 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.3 m -93.68 108.12 19.9 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.764 -0.653 . . . . 54.210000000000001 110.277 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.506 HG11 HD21 ' A' ' 127' ' ' LEU . 20.4 m -123.78 178.33 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.995 -1.002 . . . . 54.299999999999997 111.325 -172.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.559 ' HB3' HD23 ' A' ' 128' ' ' LEU . 8.9 t-80 -157.83 143.35 17.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.391 -0.822 . . . . 71.409999999999997 109.136 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 49.2 p90 -141.49 150.21 41.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.49 0.186 . . . . 74.140000000000001 110.953 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.19 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.063 -0.517 . . . . 72.430000000000007 110.292 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.28 148.44 17.05 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 116.323 -0.399 . . . . 64.230000000000004 112.484 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.54 143.25 17.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.881 -0.414 . . . . 75.299999999999997 109.881 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.91 140.21 27.66 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 75.120000000000005 110.401 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.82 -13.3 21.72 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.721 2.281 . . . . 75.109999999999999 111.432 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.57 -25.71 39.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.044 -0.98 . . . . 72.329999999999998 110.883 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.31 23.73 12.31 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.278 -0.729 . . . . 62.229999999999997 111.278 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HZ2' ' HB3' ' A' ' 58' ' ' LYS . 7.1 ttpm? -149.16 147.12 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.933 -0.395 . . . . 73.120000000000005 109.933 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.05 136.62 53.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.128 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -65.25 -54.28 31.66 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.326 -0.397 . . . . 73.530000000000001 110.002 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.23 160.65 43.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.621 -0.718 . . . . 72.129999999999995 109.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 64' ' ' ARG . 39.5 m -117.41 121.57 41.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.379 -0.373 . . . . 74.510000000000005 110.457 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.6 m -70.35 -29.25 65.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 73.299999999999997 109.88 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.485 HH12 ' HD2' ' A' ' 95' ' ' LYS . 8.8 ptm180 -59.85 -31.03 69.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 75.5 111.336 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.2 m -57.05 -30.25 64.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.451 -0.34 . . . . 52.329999999999998 110.655 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 5.4 mmp_? -81.09 -10.55 59.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.158 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.31 48.66 84.16 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 112.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 20.5 tptm -112.61 115.23 49.31 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 122.826 -0.22 . . . . 75.340000000000003 110.481 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 4.1 Cg_exo -81.26 167.62 17.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.15 2.566 . . . . 73.209999999999994 111.928 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.437 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 97.1 m-85 -136.2 158.97 43.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 71.25 110.087 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 97.6 mt-30 -143.57 135.87 26.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.874 -0.417 . . . . 75.030000000000001 109.874 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' HE1' HG12 ' A' ' 48' ' ' VAL . 11.6 p90 -150.54 160.42 43.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 121.057 -0.257 . . . . 73.400000000000006 110.623 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.46 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 15.2 m -85.42 104.66 15.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 75.200000000000003 110.271 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.72 HD11 ' HB1' ' A' ' 88' ' ' ALA . 51.0 tp -55.89 137.09 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 75.129999999999995 111.046 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.02 -30.45 5.48 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.091 -0.576 . . . . 70.140000000000001 112.626 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.05 178.27 7.65 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.279 . . . . 74.430000000000007 111.095 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.48 53.9 4.78 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.883 -0.487 . . . . 71.230000000000004 111.883 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' A' ' 73' ' ' THR . 5.7 mm-40 -90.71 -44.93 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.043 0.449 . . . . 75.439999999999998 110.552 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.5 m -136.82 177.89 5.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.678 -0.692 . . . . 62.130000000000003 110.089 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.479 HD13 ' O ' ' A' ' 104' ' ' LEU . 18.0 pt -68.19 140.97 18.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 109.95 -0.389 . . . . 75.420000000000002 109.95 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.598 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 61.6 mmtt -63.71 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.617 0.599 . . . . 74.329999999999998 112.617 -173.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -56.98 22.26 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.43 -0.89 . . . . 74.310000000000002 111.017 171.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -69.15 -40.17 78.36 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.271 -0.27 . . . . 71.340000000000003 110.271 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.598 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 12.4 t70 -51.75 -55.19 21.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.746 -0.661 . . . . 72.430000000000007 110.528 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.99 -42.17 70.0 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.077 -0.51 . . . . 74.129999999999995 110.685 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.31 -49.97 48.79 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.045 -0.598 . . . . 70.400000000000006 112.073 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.538 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.7 p -75.93 -31.93 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.692 0.282 . . . . 63.539999999999999 110.942 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 74' ' ' LEU . . . -59.74 -35.29 74.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.692 0.282 . . . . 72.340000000000003 111.735 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 t -87.73 6.56 34.37 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.269 0.47 . . . . 73.040000000000006 112.269 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 13.8 ptp -112.01 177.89 4.5 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.046 -0.408 . . . . 71.329999999999998 110.552 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' HA2' ' A' ' 36' ' ' GLY . 42.5 p -121.1 178.82 4.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.852 0.358 . . . . 75.530000000000001 111.708 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.808 ' HA ' HD11 ' A' ' 127' ' ' LEU . 7.8 tt -61.99 129.97 43.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.703 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.69 17.25 77.8 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.781 -0.645 . . . . 72.25 112.457 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 32' ' ' THR . 14.6 tt0 -106.98 136.35 46.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 71.340000000000003 110.313 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.485 ' HD2' HH12 ' A' ' 64' ' ' ARG . 28.3 ttpp -131.7 126.76 35.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.988 -0.551 . . . . 74.540000000000006 110.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.87 142.12 50.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 55.240000000000002 110.892 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 tt -90.79 117.23 29.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.395 -0.965 . . . . 64.409999999999997 108.395 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.37 122.44 38.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.5 . . . . 65.010000000000005 109.649 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 54.1 m -81.89 106.51 13.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.66 -0.496 . . . . 72.409999999999997 109.66 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.0 mm -85.64 112.3 43.64 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 115.978 -0.555 . . . . 60.109999999999999 110.236 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 120' ' ' THR . 38.2 Cg_endo -66.4 159.33 50.81 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.205 1.937 . . . . 73.230000000000004 111.075 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.524 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 38.4 p90 -54.41 -31.5 55.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 75.519999999999996 111.348 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.47 -30.04 70.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.515 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 80' ' ' ILE . 88.0 mt -105.38 13.13 30.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.327 -0.397 . . . . 73.129999999999995 111.544 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.15 176.17 10.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.075 0.464 . . . . 75.530000000000001 111.435 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -68.47 -14.98 63.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.559 -0.746 . . . . 75.329999999999998 110.617 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.91 -16.42 47.02 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.926 -0.579 . . . . 75.140000000000001 113.045 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 35.0 tt0 -56.2 -55.23 35.66 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.074 0.464 . . . . 70.209999999999994 110.327 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -98.81 -35.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.831 . . . . 75.25 110.52 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.67 161.98 10.99 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.805 -0.634 . . . . 74.310000000000002 112.399 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.696 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.7 m-85 -135.39 -57.18 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 122.23 0.212 . . . . 75.400000000000006 110.486 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 68.7 Cg_endo -91.25 142.41 2.99 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.003 1.802 . . . . 74.049999999999997 111.854 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.05 -18.69 17.88 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.771 2.314 . . . . 75.519999999999996 112.737 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.61 -36.88 77.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.017 -0.538 . . . . 74.310000000000002 110.201 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.4 mm -110.16 99.11 38.3 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 109.304 -0.628 . . . . 64.329999999999998 109.304 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 159.79 51.96 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.626 2.217 . . . . 73.409999999999997 112.513 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.71 147.25 89.75 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.233 1.955 . . . . 75.400000000000006 111.665 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 7.0 mtmp? 69.69 22.85 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.069 0.548 . . . . 73.319999999999993 110.629 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.56 131.62 35.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.114 0.483 . . . . 74.120000000000005 111.31 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -97.98 127.99 44.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.182 -0.673 . . . . 71.230000000000004 109.182 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -129.44 143.6 50.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.789 -0.448 . . . . 74.120000000000005 109.789 -171.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.544 ' N ' HD12 ' A' ' 121' ' ' LEU . 46.9 t -98.3 131.82 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.117 -0.327 . . . . 74.230000000000004 110.117 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.55 132.17 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.656 0.265 . . . . 55.210000000000001 111.153 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 30.9 mt-10 -82.44 112.29 19.24 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.12 -0.696 . . . . 75.120000000000005 109.12 170.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.494 HG23 ' HE3' ' A' ' 90' ' ' MET . 11.1 m -97.06 135.45 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.097 -0.705 . . . . 55.229999999999997 109.097 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.443 ' OE2' ' HD3' ' A' ' 95' ' ' LYS . 45.2 tt0 -141.3 121.46 13.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.319 -0.401 . . . . 75.209999999999994 110.427 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.808 HD11 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -93.54 113.95 26.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.613 -0.884 . . . . 72.310000000000002 108.613 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 49' ' ' HIS . 3.9 mm? -87.78 -50.72 6.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.804 0.335 . . . . 73.209999999999994 110.125 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.22 -173.41 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 73.019999999999996 110.094 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.768 -0.634 . . . . 71.349999999999994 109.532 173.562 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.232 0.141 0 N-CA-C 108.649 -0.871 . . . . 73.129999999999995 108.649 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 55.0 tp -145.83 102.8 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.418 0.525 . . . . 72.129999999999995 112.418 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -111.93 132.43 54.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.067 -0.716 . . . . 65.329999999999998 109.067 165.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -129.95 101.27 5.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.508 -0.923 . . . . 71.0 108.508 176.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -123.03 113.74 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 74.450000000000003 110.736 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 6.5 p -64.38 114.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 74.030000000000001 110.863 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.18 -49.75 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.445 -0.576 . . . . 73.129999999999995 109.445 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -112.4 113.54 51.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.369 -0.832 . . . . 74.030000000000001 109.423 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.79 140.86 52.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.634 2.223 . . . . 71.120000000000005 112.438 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -98.53 -169.38 31.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.39 -0.433 . . . . 71.150000000000006 112.66 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.42 -46.07 67.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.781 0.324 . . . . 72.409999999999997 110.434 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 91' ' ' THR . . . 95.2 -20.74 47.85 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.093 -0.503 . . . . 51.130000000000003 113.931 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -103.24 -0.86 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 117.687 0.743 . . . . 74.230000000000004 112.634 -172.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.3 p -85.07 142.18 29.73 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.713 0.292 . . . . 54.219999999999999 110.568 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -113.43 119.57 41.6 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.387 -0.369 . . . . 71.519999999999996 110.025 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 14.4 Cg_exo -69.56 143.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.18 . . . . 72.230000000000004 111.582 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.54 141.82 23.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.826 0.346 . . . . 75.109999999999999 110.52 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.752 -0.658 . . . . 74.420000000000002 111.71 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.98 19.56 57.37 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.628 -0.715 . . . . 73.239999999999995 113.058 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.47 161.73 36.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.077 0.439 . . . . 75.150000000000006 110.813 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.6 tppp? -81.63 117.12 21.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.836 -0.62 . . . . 63.310000000000002 109.636 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.403 HG12 HD23 ' A' ' 74' ' ' LEU . 27.5 m -110.35 151.38 12.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 120.901 0.382 . . . . 72.019999999999996 110.539 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -117.01 108.18 15.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.562 -0.745 . . . . 54.210000000000001 110.169 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.01 178.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.589 -0.732 . . . . 54.299999999999997 110.494 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 63.7 t60 -149.24 146.48 27.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.09 -0.707 . . . . 71.409999999999997 109.09 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -126.59 152.53 46.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.701 -0.481 . . . . 74.140000000000001 109.701 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.72 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 35.7 m-20 -135.6 112.74 10.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.498 -0.927 . . . . 72.430000000000007 108.498 172.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.95 111.13 3.33 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.936 -0.575 . . . . 64.230000000000004 112.609 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 53' ' ' ARG . 22.3 ttt180 -122.38 137.49 54.84 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.32 0.581 . . . . 75.299999999999997 111.019 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -89.23 151.91 47.17 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 109.886 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.64 -17.63 36.27 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.177 2.585 . . . . 75.109999999999999 114.006 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.94 -14.74 53.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.853 0.359 . . . . 72.329999999999998 110.606 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.36 -1.02 37.35 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.219 -0.515 . . . . 62.229999999999997 112.425 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HZ1' ' HB2' ' A' ' 58' ' ' LYS . 3.7 ttmp? -94.43 157.23 16.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.544 -0.539 . . . . 73.120000000000005 109.544 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.73 -0.471 . . . . 72.329999999999998 109.73 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.23 -46.97 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.530000000000001 111.324 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.01 131.28 45.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.355 -0.384 . . . . 72.129999999999995 110.959 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 m -104.92 85.63 2.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 74.510000000000005 109.375 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -56.95 -28.86 62.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.059 -0.518 . . . . 73.299999999999997 110.835 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -53.91 -31.76 51.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.749 -0.66 . . . . 75.5 111.311 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -59.1 -37.32 76.88 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.886 0.374 . . . . 52.329999999999998 110.728 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -80.29 -11.54 59.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.992 -0.549 . . . . 75.439999999999998 110.564 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.41 18.99 59.42 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.132 -0.485 . . . . 63.329999999999998 112.106 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -82.14 119.13 74.34 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 122.363 0.265 . . . . 75.340000000000003 110.375 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.55 162.5 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.046 2.497 . . . . 73.209999999999994 112.352 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -122.69 117.0 24.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.37 -0.604 . . . . 71.25 109.37 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.559 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 92.2 mt-30 -107.06 140.96 39.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.573 -0.285 . . . . 75.030000000000001 110.468 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -156.89 167.6 29.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.479 -0.328 . . . . 73.400000000000006 110.23 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 m -82.07 108.93 15.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 110.294 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.403 HD23 HG12 ' A' ' 46' ' ' VAL . 45.1 tp -62.1 111.03 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.702 -0.481 . . . . 75.129999999999995 109.702 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.14 -24.56 5.64 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.214 -0.755 . . . . 70.140000000000001 111.214 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.63 145.2 47.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.4 -0.222 . . . . 74.430000000000007 110.4 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.41 43.61 2.33 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.429 -0.35 . . . . 71.230000000000004 113.064 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -82.54 -47.61 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 75.439999999999998 110.198 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.06 162.56 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.75 . . . . 62.130000000000003 110.949 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.435 HG12 ' CE3' ' A' ' 83' ' ' TRP . 35.4 pt -80.07 159.02 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.573 -0.528 . . . . 75.420000000000002 109.573 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 55.4 mmtt -60.41 -21.14 61.88 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.418 0.155 . . . . 74.329999999999998 111.418 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -47.97 88.19 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.599 -0.81 . . . . 74.310000000000002 111.574 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.435 ' CE3' HG12 ' A' ' 80' ' ' ILE . 18.1 m0 -79.76 -29.28 40.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.589 0.233 . . . . 71.340000000000003 110.401 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.567 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 6.6 t70 -58.0 -55.05 39.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.616 0.722 . . . . 72.430000000000007 109.792 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -67.68 -35.86 79.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.496 -0.774 . . . . 74.129999999999995 109.861 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.9 -49.35 58.99 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.766 -0.652 . . . . 70.400000000000006 112.434 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 12.2 p -75.24 -32.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 63.539999999999999 110.274 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -30.08 71.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.33 -0.396 . . . . 72.340000000000003 112.015 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -90.4 -14.86 32.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.116 0.413 . . . . 73.040000000000006 112.116 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.877 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.8 ptp -93.92 -179.77 5.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.691 0.281 . . . . 71.329999999999998 110.879 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.426 HG22 ' HA2' ' A' ' 36' ' ' GLY . 16.7 p -138.83 178.95 6.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.197 -0.456 . . . . 75.530000000000001 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.683 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -58.81 124.5 20.01 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.886 0.474 . . . . 74.120000000000005 110.694 -176.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.68 37.63 57.57 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.398 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.611 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.9 tt0 -124.2 126.62 46.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 71.340000000000003 110.975 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' HZ3' ' HB2' ' A' ' 126' ' ' GLU . 24.5 ttmm -114.9 115.06 26.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.803 -0.635 . . . . 74.540000000000006 109.549 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -113.52 145.42 41.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 110.638 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 28' ' ' LYS . 9.4 tt -90.63 105.4 17.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.04 -1.096 . . . . 64.409999999999997 108.04 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -112.13 126.39 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.337 -0.392 . . . . 65.010000000000005 110.423 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 26' ' ' LEU . 7.9 m -85.12 118.16 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.446 -0.343 . . . . 72.409999999999997 110.639 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.8 mm -99.05 108.57 50.19 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 110.387 -0.227 . . . . 60.109999999999999 110.387 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.99 140.94 39.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.097 2.531 . . . . 73.230000000000004 111.275 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.97 -29.56 57.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.454 -0.339 . . . . 75.519999999999996 111.836 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.2 -30.07 70.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.514 . . . . 73.140000000000001 111.644 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.88 9.06 43.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 73.129999999999995 111.777 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.26 178.95 8.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.145 0.498 . . . . 75.530000000000001 111.658 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -73.61 -2.47 23.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.495 -0.775 . . . . 75.329999999999998 111.332 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.31 -14.25 56.35 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.189 -0.459 . . . . 75.140000000000001 112.085 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 8.4 tm-20 -66.77 -49.42 65.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.413 -0.588 . . . . 70.209999999999994 109.413 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 117' ' ' PRO . 40.4 ttm180 -67.86 -52.08 40.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 75.25 110.695 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.61 172.29 3.84 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.101 -0.571 . . . . 74.310000000000002 111.952 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.687 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 88.5 m-85 -147.17 -63.64 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.782 0.291 . . . . 75.400000000000006 111.298 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 2.3 Cg_endo -84.23 141.36 9.14 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.213 1.942 . . . . 74.049999999999997 111.988 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.63 -21.93 57.89 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.692 2.261 . . . . 75.519999999999996 111.747 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.77 -35.34 63.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.772 -0.649 . . . . 74.310000000000002 110.115 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.02 92.95 46.66 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 64.329999999999998 109.218 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -52.02 147.24 27.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.038 2.492 . . . . 73.409999999999997 112.673 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 21.1 Cg_endo -59.83 153.43 56.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.727 2.285 . . . . 75.400000000000006 111.435 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 19.4 mtmm 59.1 53.11 5.69 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.393 0.616 . . . . 73.319999999999993 110.431 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.53 132.38 54.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.325 -0.852 . . . . 74.120000000000005 111.123 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.6 m -83.05 130.48 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.38 -0.6 . . . . 71.230000000000004 109.38 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.564 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -123.06 143.39 49.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.672 -0.492 . . . . 74.120000000000005 109.672 -173.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.564 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.2 t -100.53 116.13 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 74.230000000000004 109.832 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -109.06 116.58 32.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.096 -0.335 . . . . 55.210000000000001 110.096 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.8 mt-10 -78.58 106.86 10.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.181 -1.044 . . . . 75.120000000000005 108.181 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 13.4 m -97.59 149.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.047 -0.979 . . . . 55.229999999999997 110.112 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 63.8 tt0 -147.22 131.6 17.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.76 -0.2 . . . . 75.209999999999994 110.795 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.877 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 3.2 tm? -103.08 112.97 26.07 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.865 -0.42 . . . . 72.310000000000002 109.865 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -90.86 -41.48 11.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 110.324 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.43 139.1 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 73.019999999999996 109.932 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 119.37 -0.348 . . . . 71.349999999999994 110.401 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 73.129999999999995 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 5.9 tt -145.7 102.39 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.509 -0.552 . . . . 72.129999999999995 109.509 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.73 149.82 42.71 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.981 -0.554 . . . . 65.329999999999998 110.185 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 18.4 ptpt -127.98 103.7 7.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.637 -0.71 . . . . 71.0 109.448 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 66.8 mttm -109.1 110.39 21.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.825 -0.435 . . . . 74.450000000000003 109.825 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -71.87 97.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.486 0.66 . . . . 74.030000000000001 110.134 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.708 HD21 ' HD3' ' A' ' 95' ' ' LYS . 33.9 tp -76.94 -29.2 55.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 109.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 32.1 m -145.51 115.82 4.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 74.030000000000001 109.74 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.3 128.74 13.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.065 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.69 -159.81 22.05 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.177 -0.535 . . . . 71.150000000000006 112.44 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.46 -37.44 87.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.088 0.471 . . . . 72.409999999999997 110.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.21 -29.84 3.81 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.952 -0.567 . . . . 51.130000000000003 112.134 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.26 -34.12 7.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.737 0.303 . . . . 74.230000000000004 110.711 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 p -71.77 94.07 1.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.295 0.569 . . . . 54.219999999999999 110.983 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -88.06 125.91 62.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.494 -0.775 . . . . 71.519999999999996 110.452 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 90' ' ' MET . 86.3 Cg_endo -78.07 176.4 10.02 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.62 2.213 . . . . 72.230000000000004 111.547 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.97 167.25 14.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 109.905 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 156.24 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.345 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.71 73.64 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.15 -0.548 . . . . 73.239999999999995 112.562 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.742 ' HZ3' ' HB3' ' A' ' 44' ' ' LYS . 4.3 mmmp? -116.19 130.02 56.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.683 0.278 . . . . 75.150000000000006 110.738 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.83 104.01 3.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.68 -0.859 . . . . 63.310000000000002 108.68 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 34.1 m -105.86 142.54 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.157 0.503 . . . . 72.019999999999996 110.951 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.8 m -99.27 120.32 39.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.112 -0.949 . . . . 54.210000000000001 109.27 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG12 HG22 ' A' ' 87' ' ' VAL . 32.6 m -136.68 177.97 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.569 0.699 . . . . 54.299999999999997 112.454 -172.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 7.3 m170 -137.59 152.62 49.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.504 -1.226 . . . . 71.409999999999997 109.098 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -128.0 142.85 51.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 74.140000000000001 109.534 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.774 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 24.0 m-20 -135.4 119.73 17.87 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.017 -0.734 . . . . 72.430000000000007 109.017 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -82.68 114.32 3.82 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.214 -0.448 . . . . 64.230000000000004 112.295 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.501 HH11 HD13 ' A' ' 97' ' ' LEU . 42.1 ttm180 -130.8 148.5 52.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.428 0.633 . . . . 75.299999999999997 111.364 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -90.12 156.37 46.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.224 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.38 2.3 1.26 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.946 2.43 . . . . 75.109999999999999 112.861 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.76 -29.9 25.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.236 0.541 . . . . 72.329999999999998 110.517 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.85 -25.47 8.43 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.706 -0.679 . . . . 62.229999999999997 111.882 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -84.61 157.32 21.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.825 -0.435 . . . . 73.120000000000005 109.825 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 13.9 pt20 -141.84 -175.28 4.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.715 0.293 . . . . 72.329999999999998 110.905 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -86.06 -64.86 1.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 73.530000000000001 110.108 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -144.91 156.66 44.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.009 -0.367 . . . . 72.129999999999995 110.009 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.3 p -87.26 91.53 8.75 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.359 -0.608 . . . . 74.510000000000005 109.359 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.4 m -64.33 -27.39 68.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.829 -0.623 . . . . 73.299999999999997 111.155 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.24 69.4 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.434 -0.348 . . . . 75.5 110.424 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -73.8 -6.23 45.75 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.001 -0.545 . . . . 52.329999999999998 111.593 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.69 -2.82 31.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.084 0.468 . . . . 75.439999999999998 110.759 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.25 8.57 65.88 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 63.329999999999998 113.953 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.585 ' HD2' ' HD2' ' A' ' 69' ' ' PRO . 52.5 tptt -122.89 121.58 27.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 117.051 0.426 . . . . 75.340000000000003 109.971 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.585 ' HD2' ' HD2' ' A' ' 68' ' ' LYS . 68.1 Cg_endo -85.27 160.06 11.27 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.658 2.239 . . . . 73.209999999999994 112.276 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -114.33 158.14 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.127 -0.694 . . . . 71.25 109.127 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 85.7 mt-30 -134.77 139.48 45.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.574 0.226 . . . . 75.030000000000001 110.825 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.536 ' HE1' HG21 ' A' ' 48' ' ' VAL . 33.5 p90 -156.16 151.88 27.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.508 -0.553 . . . . 73.400000000000006 109.508 173.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.5 m -73.66 109.03 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 75.200000000000003 110.905 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.8 135.31 57.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.057 -0.519 . . . . 75.129999999999995 110.209 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.83 -11.52 71.91 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.119 -0.562 . . . . 70.140000000000001 112.135 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.13 160.95 14.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.202 -0.296 . . . . 74.430000000000007 110.202 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.65 2.62 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 121.2 -0.524 . . . . 71.230000000000004 112.756 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -85.75 -25.46 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 75.439999999999998 110.304 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.48 168.21 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.76 -0.655 . . . . 62.130000000000003 109.722 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 105' ' ' ALA . 14.4 pt -72.91 154.7 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.997 -0.372 . . . . 75.420000000000002 109.997 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 4.5 tmtm? -60.09 -28.42 67.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.475 -0.33 . . . . 74.329999999999998 110.756 -172.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.88 -54.55 36.55 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.923 -0.656 . . . . 74.310000000000002 112.003 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.442 ' O ' HG12 ' A' ' 87' ' ' VAL . 48.2 m0 -66.48 -41.25 89.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.025 -0.361 . . . . 71.340000000000003 110.025 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.11 -50.95 60.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.474 -0.785 . . . . 72.430000000000007 110.886 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -66.54 -46.34 76.46 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.347 -0.388 . . . . 74.129999999999995 110.307 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.38 -48.39 54.48 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.606 -0.724 . . . . 70.400000000000006 112.834 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 48' ' ' VAL . 12.3 p -75.55 -33.2 26.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 63.539999999999999 111.139 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.23 -25.95 65.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.706 0.261 . . . . 72.340000000000003 111.706 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.7 t -89.54 17.58 6.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 73.040000000000006 112.89 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.743 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 12.3 ptp -125.37 178.15 5.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.901 -0.499 . . . . 71.329999999999998 111.412 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -116.65 177.31 4.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.294 -0.412 . . . . 75.530000000000001 110.477 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.783 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -69.45 129.71 40.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.091 -0.337 . . . . 74.120000000000005 110.091 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.406 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 88.82 6.11 73.04 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.326 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' THR . 19.6 tt0 -100.18 133.76 44.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.340000000000003 111.022 -175.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.708 ' HD3' HD21 ' A' ' 31' ' ' LEU . 50.0 tttm -117.67 117.52 29.58 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -122.65 137.72 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.216 0.531 . . . . 55.240000000000002 111.275 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 7.8 tt -90.78 106.29 18.41 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.972 -1.121 . . . . 64.409999999999997 107.972 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -115.25 124.82 52.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.113 -0.329 . . . . 65.010000000000005 110.113 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.511 ' HB ' ' HA ' ' A' ' 26' ' ' LEU . 4.3 m -80.36 111.75 17.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 72.409999999999997 110.546 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 105' ' ' ALA . 32.6 mm -93.58 113.22 59.71 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.618 -0.264 . . . . 60.109999999999999 110.449 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 120' ' ' THR . 43.8 Cg_endo -67.31 151.63 80.41 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.758 2.305 . . . . 73.230000000000004 111.783 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -55.99 -31.79 63.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.074 -0.512 . . . . 75.519999999999996 111.972 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.539 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 4.1 pt20 -65.52 -27.62 68.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.409 . . . . 73.140000000000001 110.954 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 91.9 mt -109.07 22.86 15.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 73.129999999999995 110.096 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 100' ' ' ILE . . . -149.18 176.61 10.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.887 -0.597 . . . . 75.530000000000001 111.406 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -76.65 -11.77 59.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 75.329999999999998 110.282 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.69 31.32 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.835 -0.62 . . . . 75.140000000000001 113.377 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.57 -49.32 76.77 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.408 -0.59 . . . . 70.209999999999994 109.408 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -91.92 -26.22 18.54 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.548 -0.751 . . . . 75.25 110.55 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 82.0 -66.25 3.9 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.745 -0.662 . . . . 74.310000000000002 111.584 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 50.5 m-85 94.56 -74.36 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.324 1.45 . . . . 75.400000000000006 111.567 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 110' ' ' GLY . 95.4 Cg_endo -81.15 139.2 11.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 CA-C-N 121.332 1.512 . . . . 74.049999999999997 110.84 174.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.11 -11.36 15.43 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.79 2.327 . . . . 75.519999999999996 112.457 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.72 -31.79 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.138 0.494 . . . . 74.310000000000002 110.026 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.9 mm -100.76 120.71 54.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.687 -0.688 . . . . 64.329999999999998 109.711 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 58.3 Cg_endo -70.97 151.09 61.89 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.354 2.036 . . . . 73.409999999999997 112.173 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 39.0 Cg_endo -66.43 141.0 59.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.294 1.996 . . . . 75.400000000000006 111.739 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.763 ' HB2' ' HZ2' ' A' ' 118' ' ' LYS . 8.6 mtmp? 71.49 26.51 3.21 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.006 -0.543 . . . . 73.319999999999993 111.126 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 116' ' ' PRO . . . -84.77 142.53 29.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 74.120000000000005 111.365 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 101' ' ' PRO . 91.7 m -95.21 137.34 34.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.695 -0.684 . . . . 71.230000000000004 109.419 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -128.57 139.98 52.02 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.78 -0.452 . . . . 74.120000000000005 109.78 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.518 ' N ' HD13 ' A' ' 121' ' ' LEU . 99.3 t -98.54 122.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.715 0.293 . . . . 74.230000000000004 110.32 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -113.6 120.09 39.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.836 0.35 . . . . 55.210000000000001 110.194 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.774 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 22.2 mt-10 -81.49 110.99 17.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.641 -0.874 . . . . 75.120000000000005 108.641 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.483 ' O ' ' HE1' ' A' ' 90' ' ' MET . 4.0 m -99.84 139.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.739 -0.664 . . . . 55.229999999999997 109.483 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.4 tt0 -131.79 119.02 20.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.506 -0.316 . . . . 75.209999999999994 110.31 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -87.76 113.78 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 72.310000000000002 109.688 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.73 -43.09 9.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.364 -0.38 . . . . 73.209999999999994 110.693 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.47 142.13 24.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.542 -0.299 . . . . 73.019999999999996 110.886 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.423 ' OXT' ' NZ ' ' A' ' 44' ' ' LYS . 66.4 t . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.602 -0.713 . . . . 71.349999999999994 110.411 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.597 0.237 . . . . 73.129999999999995 110.506 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.0 tp -106.23 101.84 11.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.974 -0.75 . . . . 72.129999999999995 108.974 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -147.67 106.11 3.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.802 -0.636 . . . . 65.329999999999998 110.388 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.97 144.91 43.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.932 0.396 . . . . 71.0 110.065 175.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -140.3 113.17 8.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 74.450000000000003 109.543 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.67 128.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.783 0.325 . . . . 74.030000000000001 110.661 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 97' ' ' LEU . 2.7 mm? -91.99 -42.78 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.268 0.556 . . . . 73.129999999999995 109.751 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 110.9 6.92 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.683 -0.689 . . . . 74.030000000000001 110.565 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.62 137.96 44.02 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.583 2.189 . . . . 71.120000000000005 111.698 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.26 -143.68 10.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.082 -0.58 . . . . 71.150000000000006 112.43 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.8 -37.42 81.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 72.409999999999997 110.535 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.84 -30.51 1.29 Allowed Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.704 -0.68 . . . . 51.130000000000003 113.751 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.85 -9.86 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 74.230000000000004 111.015 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -87.25 115.84 24.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.824 -0.626 . . . . 54.219999999999999 110.791 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.788 ' HB3' ' HZ1' ' A' ' 39' ' ' LYS . 9.1 mtpm? -92.43 114.44 62.37 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 110.317 -0.253 . . . . 71.519999999999996 110.317 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.21 108.18 1.92 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.754 2.303 . . . . 72.230000000000004 112.183 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.26 120.96 34.13 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.036 -0.529 . . . . 75.109999999999999 109.692 173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.36 154.18 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 74.420000000000002 111.021 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.37 -28.08 8.93 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.043 -0.526 . . . . 73.239999999999995 112.023 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -86.04 159.21 19.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.159 0.504 . . . . 75.150000000000006 111.264 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -77.89 112.24 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.479 -0.782 . . . . 63.310000000000002 109.101 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.46 152.52 8.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.059 0.456 . . . . 72.019999999999996 111.384 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.2 m -106.5 110.83 23.16 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.072 -0.967 . . . . 54.210000000000001 110.014 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.412 HG22 ' HE1' ' A' ' 72' ' ' PHE . 25.7 m -119.3 178.28 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.336 -0.847 . . . . 54.299999999999997 111.181 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 22.8 t-80 -157.09 142.47 17.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.732 -0.84 . . . . 71.409999999999997 108.732 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.2 m-85 -126.95 153.18 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 74.140000000000001 110.165 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 16.8 t70 -136.67 109.49 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.539 -0.541 . . . . 72.430000000000007 109.539 174.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.8 147.27 32.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.356 -0.45 . . . . 64.230000000000004 113.587 -172.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.405 ' O ' HD12 ' A' ' 121' ' ' LEU . 25.8 ttm180 -162.14 144.56 11.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.315 0.578 . . . . 75.299999999999997 111.131 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.29 147.74 54.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 109.834 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.77 -17.92 61.73 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.373 2.049 . . . . 75.109999999999999 111.533 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.9 -25.74 62.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.566 -0.743 . . . . 72.329999999999998 110.461 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.58 -39.94 1.89 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.959 -0.564 . . . . 62.229999999999997 111.861 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -56.71 148.44 20.24 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.975 0.51 . . . . 73.120000000000005 111.493 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 19.8 pt20 -130.66 141.53 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.245 -0.65 . . . . 72.329999999999998 109.245 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -80.12 -38.42 31.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.812 0.301 . . . . 73.530000000000001 111.812 -173.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -152.92 133.64 13.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.318 -0.253 . . . . 72.129999999999995 110.318 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 t -81.07 91.14 6.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 74.510000000000005 109.436 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.9 m -67.6 -17.1 64.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.676 -0.693 . . . . 73.299999999999997 110.861 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -31.31 62.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.004 -0.544 . . . . 75.5 110.984 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 t -63.84 -46.22 86.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.769 0.318 . . . . 52.329999999999998 110.616 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -75.87 -12.41 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.533 -0.303 . . . . 75.439999999999998 111.411 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.6 36.53 48.27 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.125 -0.488 . . . . 63.329999999999998 113.823 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.1 tppt? -92.21 113.43 59.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.163 -0.31 . . . . 75.340000000000003 110.163 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.4 Cg_endo -81.91 150.66 16.24 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.245 2.63 . . . . 73.209999999999994 111.894 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -114.28 160.61 18.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.92 -0.77 . . . . 71.25 108.92 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -140.62 146.85 38.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.093 -0.336 . . . . 75.030000000000001 110.093 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . 39.8 p90 -166.98 161.59 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 73.400000000000006 110.289 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 m -74.92 112.78 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.514 -0.312 . . . . 75.200000000000003 110.206 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 88' ' ' ALA . 47.2 tp -67.81 136.5 54.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.574 -0.285 . . . . 75.129999999999995 110.78 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 40.1 32.66 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.303 -0.475 . . . . 70.140000000000001 111.931 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.68 178.34 8.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.39 0.276 . . . . 74.430000000000007 110.31 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.34 46.19 3.59 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.036 -0.602 . . . . 71.230000000000004 112.173 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 9.3 mm-40 -85.04 -47.8 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 75.439999999999998 111.051 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.85 178.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.674 . . . . 62.130000000000003 109.67 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.97 142.92 15.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.172 0.511 . . . . 75.420000000000002 111.035 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -58.14 -30.61 66.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 74.329999999999998 111.862 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.02 -51.04 59.74 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.884 -0.674 . . . . 74.310000000000002 111.616 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -69.14 -47.67 64.45 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.792 -0.204 . . . . 71.340000000000003 110.636 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.27 -54.92 33.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.033 0.444 . . . . 72.430000000000007 111.149 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -72.07 -38.3 69.47 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.1 -0.5 . . . . 74.129999999999995 110.501 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 89' ' ' THR . . . -54.42 -50.11 57.94 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.935 -0.575 . . . . 70.400000000000006 112.215 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.1 p -75.72 -31.12 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 63.539999999999999 110.977 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -62.43 -33.49 74.91 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.741 0.305 . . . . 72.340000000000003 111.746 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 86' ' ' GLY . 11.0 t -79.5 7.41 8.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.461 0.541 . . . . 73.040000000000006 112.461 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 7.7 ptm -116.32 -176.51 2.97 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.196 -0.315 . . . . 71.329999999999998 110.456 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.9 p -118.21 178.81 4.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.775 0.321 . . . . 75.530000000000001 111.637 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.833 ' HA ' HD11 ' A' ' 127' ' ' LEU . 7.3 tt -68.69 135.16 50.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.863 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.423 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 71.96 23.68 77.64 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.633 -0.712 . . . . 72.25 112.299 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -112.46 148.54 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.859 0.361 . . . . 71.340000000000003 111.271 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -130.09 124.68 33.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.638 -0.71 . . . . 74.540000000000006 110.323 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.21 141.29 39.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 55.240000000000002 110.414 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.561 ' HB2' HD22 ' A' ' 31' ' ' LEU . 9.1 tt -92.19 123.95 35.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.119 -0.697 . . . . 64.409999999999997 109.119 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -130.21 134.51 47.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.918 0.389 . . . . 65.010000000000005 110.656 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 51.8 m -83.51 112.68 20.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.004 -0.544 . . . . 72.409999999999997 109.923 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.2 mm -84.84 110.93 31.6 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 116.382 -0.372 . . . . 60.109999999999999 110.607 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 99' ' ' THR . 24.4 Cg_exo -64.22 142.91 81.98 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.117 2.545 . . . . 73.230000000000004 111.565 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.59 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 51.3 p90 -54.39 -39.36 67.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 75.519999999999996 111.799 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -70.2 -13.78 62.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.376 -0.375 . . . . 73.140000000000001 111.829 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.93 16.55 24.16 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.997 0.427 . . . . 73.129999999999995 110.153 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.05 178.65 9.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.654 -0.703 . . . . 75.530000000000001 111.141 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -60.06 -25.09 65.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 75.329999999999998 110.705 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.73 -19.9 30.15 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.634 -0.712 . . . . 75.140000000000001 113.301 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.59 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 43.2 tt0 -56.16 -47.55 78.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 70.209999999999994 110.169 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -107.6 -15.33 14.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.4 -0.818 . . . . 75.25 110.907 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.75 -171.78 6.92 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 116.072 -0.513 . . . . 74.310000000000002 112.63 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.733 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 63.7 m-85 -147.53 -61.39 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.614 0.207 . . . . 75.400000000000006 110.677 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 50.9 Cg_endo -93.17 152.02 2.56 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.247 1.964 . . . . 74.049999999999997 112.037 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.63 -19.73 38.79 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.535 2.157 . . . . 75.519999999999996 111.765 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.98 -35.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.929 -0.578 . . . . 74.310000000000002 110.355 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.3 mm -121.25 80.75 36.72 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 108.538 -0.912 . . . . 64.329999999999998 108.538 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.444 ' O ' ' HB3' ' A' ' 119' ' ' ALA . 83.5 Cg_endo -75.22 169.32 22.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.88 2.387 . . . . 73.409999999999997 112.319 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 71.5 Cg_exo -50.14 148.98 12.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 75.400000000000006 112.228 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.3 mtmt 72.19 17.46 4.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.738 0.649 . . . . 73.319999999999993 111.312 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 116' ' ' PRO . . . -78.06 104.42 8.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 111.43 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.416 HG21 ' HA ' ' A' ' 101' ' ' PRO . 99.8 m -83.71 134.47 34.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.205 -0.665 . . . . 71.230000000000004 109.205 171.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -136.96 147.02 46.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.962 -0.385 . . . . 74.120000000000005 109.962 -170.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.534 ' N ' HD12 ' A' ' 121' ' ' LEU . 60.7 t -98.39 137.33 26.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 110.28 -175.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.44 129.38 31.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.54 -0.3 . . . . 55.210000000000001 110.411 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 59.3 mt-10 -75.15 118.57 18.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.756 -0.831 . . . . 75.120000000000005 108.756 167.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' ' HE1' ' A' ' 90' ' ' MET . 35.7 m -95.59 136.8 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.834 -0.802 . . . . 55.229999999999997 108.834 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 47.8 tt0 -138.59 114.97 10.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.124 -0.489 . . . . 75.209999999999994 109.73 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.833 HD11 ' HA ' ' A' ' 92' ' ' LEU . 2.6 tm? -97.42 111.84 23.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.252 -0.648 . . . . 72.310000000000002 109.252 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.0 -41.26 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.47 -0.332 . . . . 73.209999999999994 110.647 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.77 145.87 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.572 -0.285 . . . . 73.019999999999996 111.038 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.25 1.105 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.059 178.563 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 110.043 -0.355 . . . . 73.129999999999995 110.043 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.88 121.65 35.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.172 -0.677 . . . . 72.129999999999995 109.172 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.718 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 40.3 mt-10 -129.71 108.17 9.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 65.329999999999998 110.344 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 21.1 pttp -109.41 101.53 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.353 -0.61 . . . . 71.0 109.353 173.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.718 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 87.0 mttt -118.91 110.4 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.318 . . . . 74.450000000000003 110.415 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.73 119.21 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.051 -0.351 . . . . 74.030000000000001 110.051 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 ' HD3' ' A' ' 95' ' ' LYS . 32.7 tp -94.86 -30.99 13.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.267 0.556 . . . . 73.129999999999995 109.977 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 57.3 m -147.14 110.85 4.03 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.494 -0.775 . . . . 74.030000000000001 109.44 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 22.5 Cg_exo -65.48 146.35 84.86 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.037 2.492 . . . . 71.120000000000005 112.64 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.36 -158.67 31.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 71.150000000000006 111.987 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB3' HG21 ' A' ' 37' ' ' VAL . 25.0 m-20 -71.27 -56.78 5.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.283 0.563 . . . . 72.409999999999997 110.582 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 -30.23 3.78 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.403 -0.817 . . . . 51.130000000000003 111.889 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 35' ' ' ASP . 30.3 m -78.54 -32.33 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.166 0.508 . . . . 74.230000000000004 110.245 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 6.0 p -71.15 105.93 3.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.341 -0.614 . . . . 54.219999999999999 109.341 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -91.63 109.31 35.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.812 -0.631 . . . . 71.519999999999996 110.928 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 38' ' ' THR . 60.9 Cg_endo -95.85 174.06 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.508 2.805 . . . . 72.230000000000004 111.411 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.74 163.0 40.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 110.812 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.27 166.12 23.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.726 -0.67 . . . . 74.420000000000002 111.609 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.04 86.33 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.969 -0.56 . . . . 73.239999999999995 112.443 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -119.2 155.76 31.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.607 0.241 . . . . 75.150000000000006 110.476 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -81.01 113.41 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.322 -0.622 . . . . 63.310000000000002 109.322 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HB ' HD23 ' A' ' 127' ' ' LEU . 33.9 m -106.61 145.89 13.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.908 0.385 . . . . 72.019999999999996 111.423 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.5 m -98.86 108.47 21.16 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.175 -0.921 . . . . 54.210000000000001 110.117 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -115.44 178.5 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 124.355 1.034 . . . . 54.299999999999997 111.575 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 11.0 t-160 -152.98 136.55 15.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.989 -1.115 . . . . 71.409999999999997 107.989 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -126.85 151.7 48.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.807 0.299 . . . . 74.140000000000001 111.807 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.707 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 33.5 t70 -138.85 118.54 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.998 -0.547 . . . . 72.430000000000007 110.095 169.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.16 138.93 17.12 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.371 -0.442 . . . . 64.230000000000004 112.624 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 28.1 ttm180 -157.51 149.26 22.13 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.341 0.591 . . . . 75.299999999999997 111.751 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -87.58 153.83 53.21 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.713 -0.676 . . . . 75.120000000000005 109.332 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.64 -20.13 56.43 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.708 2.272 . . . . 75.109999999999999 113.412 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.58 3.54 52.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.558 0.218 . . . . 72.329999999999998 111.26 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.07 -31.73 8.31 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.336 -0.459 . . . . 62.229999999999997 112.143 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.45 145.5 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.908 -0.405 . . . . 73.120000000000005 109.908 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 20.2 pt20 -151.64 147.59 26.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.516 176.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -62.23 -38.4 89.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 73.530000000000001 111.307 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.4 156.56 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.265 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 22.9 t -87.41 86.79 7.27 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.493 -0.558 . . . . 74.510000000000005 109.493 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.707 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 14.7 m -60.07 -30.11 68.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 73.299999999999997 110.453 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.563 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 34.8 ptt180 -71.32 -44.46 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 75.5 110.972 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -4.47 34.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.622 0.248 . . . . 52.329999999999998 111.142 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 62' ' ' SER . 27.2 mmt180 -76.63 -12.71 60.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.575 -0.284 . . . . 75.439999999999998 110.869 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.08 77.4 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.959 -0.639 . . . . 63.329999999999998 112.282 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.74 104.39 55.31 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-O 120.562 0.22 . . . . 75.340000000000003 110.783 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.86 166.35 19.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.004 2.469 . . . . 73.209999999999994 110.985 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.74 131.92 21.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.792 -0.447 . . . . 71.25 109.792 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 97.4 mt-30 -113.15 131.95 55.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.558 0.218 . . . . 75.030000000000001 110.501 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.555 ' HZ ' HG13 ' A' ' 87' ' ' VAL . 24.5 p90 -154.37 161.13 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.462 -0.335 . . . . 73.400000000000006 110.484 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 m -77.32 115.95 17.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.447 . . . . 75.200000000000003 110.752 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 127.91 33.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.036 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.93 43.68 7.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.161 -0.542 . . . . 70.140000000000001 112.075 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.69 173.78 14.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.821 0.343 . . . . 74.430000000000007 111.018 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.61 27.64 3.28 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.157 -0.474 . . . . 71.230000000000004 112.678 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 5.6 mm-40 -65.01 -43.78 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.227 0.537 . . . . 75.439999999999998 110.279 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.71 178.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.505 -0.77 . . . . 62.130000000000003 110.195 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.436 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.1 pt -62.49 143.59 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 110.01 -0.367 . . . . 75.420000000000002 110.01 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -58.23 -23.97 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.463 -0.335 . . . . 74.329999999999998 110.823 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.73 -50.45 67.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.948 -0.644 . . . . 74.310000000000002 111.835 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.436 ' H ' HG13 ' A' ' 80' ' ' ILE . 53.2 m0 -69.05 -42.09 76.75 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.153 -0.314 . . . . 71.340000000000003 110.153 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -54.05 -49.94 67.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.721 -0.672 . . . . 72.430000000000007 110.64 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.42 -41.24 80.67 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.316 -0.402 . . . . 74.129999999999995 110.501 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.34 -48.65 53.7 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.425 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.555 HG13 ' HZ ' ' A' ' 72' ' ' PHE . 7.1 p -75.68 -36.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 63.539999999999999 110.993 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.36 70.47 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.945 0.35 . . . . 72.340000000000003 111.945 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.3 t -84.56 -20.39 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.116 0.413 . . . . 73.040000000000006 112.116 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 18.0 ptp -88.82 -174.47 4.52 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 71.329999999999998 111.35 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 p -119.42 178.78 4.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.679 -0.692 . . . . 75.530000000000001 110.285 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.811 ' HA ' HD13 ' A' ' 127' ' ' LEU . 9.2 tt -72.0 132.94 44.97 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.986 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.93 34.87 46.53 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.383 -0.826 . . . . 72.25 112.252 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -125.95 138.18 53.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.965 0.412 . . . . 71.340000000000003 111.627 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.557 ' HD3' HD22 ' A' ' 31' ' ' LEU . 19.2 ttmm -107.6 113.8 27.35 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.446 -0.797 . . . . 74.540000000000006 109.745 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.46 132.59 56.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.42 . . . . 55.240000000000002 110.656 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.53 108.4 19.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.873 -1.158 . . . . 64.409999999999997 107.873 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' HD11 ' A' ' 100' ' ' ILE . 12.3 t80 -116.77 123.53 47.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.151 -0.477 . . . . 65.010000000000005 109.956 -174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.9 m -81.17 106.33 13.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.526 -0.546 . . . . 72.409999999999997 109.526 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 98' ' ' PHE . 47.5 mm -78.25 115.08 48.11 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 115.815 -0.63 . . . . 60.109999999999999 110.777 -175.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 104' ' ' LEU . 22.0 Cg_exo -64.94 141.3 70.21 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.876 2.384 . . . . 73.230000000000004 110.916 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -58.12 -25.65 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.708 0.633 . . . . 75.519999999999996 112.708 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -75.26 -13.68 60.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.794 0.33 . . . . 73.140000000000001 111.405 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 101' ' ' PRO . 88.1 mt -102.05 16.94 24.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.776 0.322 . . . . 73.129999999999995 110.382 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.79 -174.47 4.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.85 -0.614 . . . . 75.530000000000001 110.516 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -76.0 -5.42 46.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 75.329999999999998 110.358 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.49 -21.98 58.32 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.783 -0.644 . . . . 75.140000000000001 113.407 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 7.4 pt-20 -62.23 -42.61 99.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.902 0.382 . . . . 70.209999999999994 110.782 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.486 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 12.5 ttm180 -92.29 -42.51 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 75.25 110.399 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.94 141.4 4.14 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.817 -0.629 . . . . 74.310000000000002 111.629 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.659 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 49.2 m-85 -137.21 -58.16 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.691 0.246 . . . . 75.400000000000006 110.901 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 8.4 Cg_exo -72.98 147.75 43.99 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.974 1.783 . . . . 74.049999999999997 111.185 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.75 -19.2 60.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 75.519999999999996 112.183 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 115' ' ' ILE . 35.1 m -86.31 -17.87 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 74.310000000000002 111.106 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.609 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.2 mm -114.27 102.06 54.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.851 0.357 . . . . 64.329999999999998 110.365 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.57 170.62 19.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.665 2.243 . . . . 73.409999999999997 112.056 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.2 144.92 96.25 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.559 2.173 . . . . 75.400000000000006 111.725 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 61.41 26.9 16.6 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.717 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.45 103.12 7.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 74.120000000000005 111.494 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -73.52 122.62 22.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.538 HD11 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -124.58 144.52 50.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.012 -0.366 . . . . 74.120000000000005 110.012 -167.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.538 ' N ' HD11 ' A' ' 121' ' ' LEU . 85.5 t -98.42 133.1 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.732 0.301 . . . . 74.230000000000004 110.439 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.487 ' CE2' HD12 ' A' ' 121' ' ' LEU . 75.8 m-85 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 55.210000000000001 110.531 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 64.4 mt-10 -74.94 106.51 6.48 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.898 -1.149 . . . . 75.120000000000005 107.898 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.467 ' O ' ' HE1' ' A' ' 90' ' ' MET . 17.8 m -97.23 129.18 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.056 -0.72 . . . . 55.229999999999997 109.056 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.4 tt0 -134.77 120.75 19.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.528 -0.305 . . . . 75.209999999999994 110.412 -170.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.811 HD13 ' HA ' ' A' ' 92' ' ' LEU . 3.3 tm? -97.21 110.21 22.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.368 -0.604 . . . . 72.310000000000002 109.368 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 128' ' ' LEU . 3.7 mm? -86.97 -50.54 6.6 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.46 -0.337 . . . . 73.209999999999994 110.641 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.5 -177.03 6.3 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.635 -0.426 . . . . 73.019999999999996 112.133 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.38 -0.827 . . . . 71.349999999999994 109.425 176.684 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.081 -0.711 . . . . 73.129999999999995 109.081 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.24 111.8 5.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.207 -0.294 . . . . 72.129999999999995 110.207 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.03 108.29 9.98 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.059 -0.349 . . . . 65.329999999999998 110.059 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -114.36 103.87 11.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.083 -0.71 . . . . 71.0 109.083 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.71 110.5 21.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 74.450000000000003 110.028 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 111.69 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 74.030000000000001 110.769 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.86 -42.43 24.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.329 -0.989 . . . . 73.129999999999995 108.329 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -149.83 119.93 3.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.222 -0.899 . . . . 74.030000000000001 109.258 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.45 138.31 24.3 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.631 2.221 . . . . 71.120000000000005 112.259 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -89.7 -167.74 42.67 Favored Glycine 0 C--O 1.236 0.244 0 CA-C-N 116.088 -0.505 . . . . 71.150000000000006 112.625 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.617 ' HB3' HG22 ' A' ' 37' ' ' VAL . 72.4 m-20 -56.34 -44.55 80.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.99 0.424 . . . . 72.409999999999997 111.387 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 80.41 -30.65 2.45 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.919 -0.582 . . . . 51.130000000000003 112.093 -175.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 35' ' ' ASP . 35.6 m -76.81 -25.52 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.958 0.408 . . . . 74.230000000000004 109.996 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 19.5 p -97.86 89.68 4.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 54.219999999999999 109.748 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HA ' HG23 ' A' ' 91' ' ' THR . 58.8 mttp -95.91 149.56 36.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 115.748 -0.66 . . . . 71.519999999999996 111.106 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.88 154.49 23.01 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.715 2.277 . . . . 72.230000000000004 111.594 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -133.59 130.06 37.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.109999999999999 110.065 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.56 122.74 17.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.493 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.62 -4.66 32.71 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.356 -0.449 . . . . 73.239999999999995 112.044 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -109.56 165.92 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 75.150000000000006 110.796 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.56 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.7 tppp? -67.45 149.09 50.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 63.310000000000002 111.179 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 130' ' ' VAL . 16.9 m -140.14 141.89 32.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.903 -0.59 . . . . 72.019999999999996 109.7 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.9 m -115.09 108.42 16.63 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.514 -0.766 . . . . 54.210000000000001 109.497 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.25 178.21 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.818 -0.628 . . . . 54.299999999999997 112.27 -170.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 8.5 t-160 -150.07 147.73 28.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.926 -1.034 . . . . 71.409999999999997 108.329 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.2 153.31 44.85 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.857 0.36 . . . . 74.140000000000001 111.365 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.721 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 36.6 t70 -136.27 109.26 7.66 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.663 -0.866 . . . . 72.430000000000007 108.663 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.54 146.97 33.47 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.461 -0.399 . . . . 64.230000000000004 113.121 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.452 ' NH2' HH21 ' A' ' 64' ' ' ARG . 22.3 ttm180 -160.16 149.05 17.26 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.006 0.431 . . . . 75.299999999999997 111.176 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -90.54 151.03 43.68 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.319 -0.4 . . . . 75.120000000000005 110.313 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.21 -13.08 33.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.792 2.328 . . . . 75.109999999999999 111.819 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.63 -17.44 64.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.589 -0.732 . . . . 72.329999999999998 110.346 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.21 28.84 10.2 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.95 -0.568 . . . . 62.229999999999997 112.374 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -155.21 161.42 41.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.649 -0.501 . . . . 73.120000000000005 109.649 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -142.52 155.83 45.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.684 0.278 . . . . 72.329999999999998 110.535 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.37 -18.63 25.14 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.013 -0.539 . . . . 73.530000000000001 111.467 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -137.38 145.57 43.44 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.015 -0.365 . . . . 72.129999999999995 110.015 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.4 p -102.17 85.61 2.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.422 0.63 . . . . 74.510000000000005 110.173 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.721 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 16.1 m -67.78 -20.68 65.24 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.683 -0.69 . . . . 73.299999999999997 110.317 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.452 HH21 ' NH2' ' A' ' 53' ' ' ARG . 12.8 ptp180 -62.95 -44.38 96.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.403 -0.817 . . . . 75.5 110.732 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -70.85 -16.62 62.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.242 -0.436 . . . . 52.329999999999998 111.213 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.579 ' HD3' ' HA ' ' A' ' 63' ' ' SER . 56.9 mtp180 -82.9 -28.84 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 75.439999999999998 109.882 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.52 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.407 -0.815 . . . . 63.329999999999998 114.238 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -91.1 110.21 40.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.938 0.369 . . . . 75.340000000000003 110.299 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.83 168.55 23.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.818 2.345 . . . . 73.209999999999994 112.22 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -147.4 131.24 17.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.748 -0.464 . . . . 71.25 109.748 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 90.6 mt-30 -107.69 143.92 35.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.699 -0.228 . . . . 75.030000000000001 110.539 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.407 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 39.2 p90 -163.04 170.67 17.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 73.400000000000006 110.254 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.0 m -87.42 117.86 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.43 -0.35 . . . . 75.200000000000003 110.5 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 88' ' ' ALA . 64.4 tp -63.12 138.48 58.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.025 -0.534 . . . . 75.129999999999995 110.812 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 -22.58 37.76 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 116.141 -0.481 . . . . 70.140000000000001 112.133 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.31 178.47 6.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 74.430000000000007 111.597 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.07 24.39 21.94 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.866 -0.606 . . . . 71.230000000000004 112.278 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 72' ' ' PHE . 10.5 mm-40 -61.45 -45.76 92.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.285 0.564 . . . . 75.439999999999998 110.316 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.442 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 31.2 m -127.26 163.79 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.63 -0.713 . . . . 62.130000000000003 109.756 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.7 pt -60.48 141.01 17.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.807 -0.442 . . . . 75.420000000000002 109.807 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.801 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 4.3 mptp? -58.47 -15.54 11.43 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.02 0.378 . . . . 74.329999999999998 112.02 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.1 -56.02 27.57 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.374 -0.917 . . . . 74.310000000000002 111.199 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.442 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 43.7 m0 -69.66 -38.72 77.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.002 -0.369 . . . . 71.340000000000003 110.002 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.801 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 24.4 t70 -54.87 -48.97 72.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.441 -0.8 . . . . 72.430000000000007 110.822 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.421 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 31.2 mm-40 -71.54 -34.59 70.16 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.352 -0.385 . . . . 74.129999999999995 110.111 176.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 89' ' ' THR . . . -52.51 -48.21 55.63 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.0 -0.545 . . . . 70.400000000000006 112.287 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG22 HD21 ' A' ' 127' ' ' LEU . 3.5 p -75.63 -36.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.775 0.321 . . . . 63.539999999999999 110.801 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -64.73 -20.61 66.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.687 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 86' ' ' GLY . 12.6 t -95.53 10.99 34.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.171 0.434 . . . . 73.040000000000006 112.171 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.2 ptp -127.72 177.3 6.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.939 0.399 . . . . 71.329999999999998 111.664 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 39' ' ' LYS . 22.9 p -130.97 178.74 6.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.712 -0.676 . . . . 75.530000000000001 110.725 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.884 ' HA ' HD13 ' A' ' 127' ' ' LEU . 3.8 tt -65.32 130.31 42.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.807 0.336 . . . . 74.120000000000005 110.314 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.49 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.7 26.8 55.68 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.687 -0.688 . . . . 72.25 112.107 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 22.2 tt0 -123.71 141.19 52.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 71.340000000000003 110.534 -176.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 125' ' ' VAL . 29.2 ttpp -138.95 135.75 34.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 74.540000000000006 109.531 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.58 152.03 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.442 . . . . 55.240000000000002 111.693 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -91.18 114.07 26.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.06 -1.089 . . . . 64.409999999999997 108.06 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.433 ' HD1' HD11 ' A' ' 100' ' ' ILE . 7.2 t80 -117.32 121.08 40.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.356 . . . . 65.010000000000005 110.579 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 m -80.92 112.88 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 72.409999999999997 109.76 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.627 HG23 ' HB1' ' A' ' 105' ' ' ALA . 23.7 mm -88.46 110.56 37.61 Favored Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.695 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.19 139.96 62.77 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.769 2.313 . . . . 73.230000000000004 111.358 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -55.95 -28.43 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.241 0.46 . . . . 75.519999999999996 112.241 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.36 -37.28 86.67 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.975 0.417 . . . . 73.140000000000001 110.66 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.2 mt -99.4 18.79 16.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.878 -0.601 . . . . 73.129999999999995 109.987 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.627 ' HB1' HG23 ' A' ' 100' ' ' ILE . . . -136.61 171.47 14.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.671 . . . . 75.530000000000001 111.24 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.428 ' HB2' ' HE1' ' A' ' 111' ' ' TYR . 44.9 p90 -76.86 -10.08 59.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 75.329999999999998 110.191 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -25.21 64.06 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.453 -0.794 . . . . 75.140000000000001 112.911 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 2.5 tm-20 -61.35 -54.53 42.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.982 -0.747 . . . . 70.209999999999994 108.982 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -64.87 -49.27 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.036 -0.984 . . . . 75.25 111.219 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.89 75.7 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.057 -0.592 . . . . 74.310000000000002 111.732 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.715 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m-85 -59.35 -54.0 60.5 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 111.594 0.22 . . . . 75.400000000000006 111.594 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.715 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 76.9 Cg_endo -96.72 148.99 1.06 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.53 2.154 . . . . 74.049999999999997 112.101 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.39 -20.4 39.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.602 2.201 . . . . 75.519999999999996 112.069 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.58 -28.95 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 110.423 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.93 99.0 36.94 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.146 -0.686 . . . . 64.329999999999998 109.146 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.56 140.64 75.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.72 2.28 . . . . 73.409999999999997 112.717 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.83 142.52 93.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.362 2.041 . . . . 75.400000000000006 111.318 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 99.7 mttt 63.48 25.8 14.6 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 73.319999999999993 111.612 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.86 135.75 33.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.948 0.404 . . . . 74.120000000000005 111.028 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.4 m -87.41 140.18 29.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 71.230000000000004 109.663 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.97 165.88 12.61 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.487 0.185 . . . . 74.120000000000005 110.619 -174.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.38 132.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.812 -0.44 . . . . 74.230000000000004 109.812 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -135.42 125.56 26.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.647 0.261 . . . . 55.210000000000001 110.43 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 30.9 tt0 -84.4 110.04 18.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.808 -1.182 . . . . 75.120000000000005 107.808 172.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 15.3 m -99.64 141.4 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.546 -0.752 . . . . 55.229999999999997 110.907 -175.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 46.1 tt0 -131.29 125.65 33.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 75.209999999999994 110.26 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.884 HD13 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -99.94 107.96 20.07 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.798 -0.445 . . . . 72.310000000000002 109.798 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 128' ' ' LEU . 3.2 mm? -85.75 -43.01 13.71 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.292 -0.413 . . . . 73.209999999999994 110.448 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.37 169.45 24.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.286 -0.415 . . . . 73.019999999999996 110.363 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 46' ' ' VAL . 30.0 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.461 0.116 0 N-CA-C 108.487 -0.931 . . . . 73.129999999999995 108.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.9 tp -138.69 102.28 4.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 72.129999999999995 110.16 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.27 164.1 35.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 65.329999999999998 110.229 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -145.65 118.98 8.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 71.0 109.425 173.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -108.91 110.43 21.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.227 -0.657 . . . . 74.450000000000003 109.227 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.64 122.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.894 0.378 . . . . 74.030000000000001 111.316 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 31' ' ' LEU . 2.5 mm? -87.68 -38.89 15.46 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.311 -0.626 . . . . 73.129999999999995 109.311 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -135.4 111.02 10.64 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.324 -0.853 . . . . 74.030000000000001 109.969 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.65 138.65 46.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.495 2.13 . . . . 71.120000000000005 112.228 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.87 -164.78 40.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.244 -0.503 . . . . 71.150000000000006 112.103 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 47.1 m-20 -63.71 -25.79 68.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.728 0.299 . . . . 72.409999999999997 110.966 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.95 -30.26 1.81 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.478 -0.392 . . . . 51.130000000000003 113.092 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -93.43 -23.47 5.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.729 0.299 . . . . 74.230000000000004 110.892 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 7.6 p -76.42 88.47 3.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.165 0.507 . . . . 54.219999999999999 110.705 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -85.88 112.82 47.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 71.519999999999996 111.072 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 114.81 2.5 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.203 2.602 . . . . 72.230000000000004 111.576 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.45 175.13 5.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 110.741 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 157.21 36.01 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.355 -0.384 . . . . 74.420000000000002 110.5 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.69 22.74 68.84 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.068 -0.514 . . . . 73.239999999999995 111.964 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -116.66 136.25 53.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.66 0.267 . . . . 75.150000000000006 110.828 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.77 101.63 10.25 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.738 -0.838 . . . . 63.310000000000002 108.738 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.24 142.02 20.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 121.029 0.443 . . . . 72.019999999999996 111.276 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -105.67 108.47 20.01 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.137 -0.938 . . . . 54.210000000000001 109.301 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.17 172.14 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.164 0.507 . . . . 54.299999999999997 111.021 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 14.5 t-160 -134.03 132.08 39.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.186 -1.042 . . . . 71.409999999999997 108.186 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 29.2 p90 -128.37 145.46 51.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.707 0.289 . . . . 74.140000000000001 111.361 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.827 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 26.0 t70 -137.81 119.76 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 72.430000000000007 109.809 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.55 127.63 8.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.37 -0.443 . . . . 64.230000000000004 112.259 -177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.644 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 20.4 ttm180 -147.11 151.83 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.98 0.419 . . . . 75.299999999999997 111.053 -173.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.31 150.02 42.25 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.839 -0.43 . . . . 75.120000000000005 109.839 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.02 -13.6 28.47 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.518 2.146 . . . . 75.109999999999999 111.656 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.98 -32.46 73.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.264 -0.88 . . . . 72.329999999999998 110.532 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.07 -42.04 1.68 Allowed Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.276 -0.73 . . . . 62.229999999999997 111.276 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -79.87 157.87 26.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.774 0.321 . . . . 73.120000000000005 110.522 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.644 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 13.5 pt20 -125.23 165.19 18.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 110.803 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -86.7 -16.74 35.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.733 0.271 . . . . 73.530000000000001 111.733 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.58 153.75 6.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.215 -0.661 . . . . 72.129999999999995 109.215 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 46.4 m -89.48 97.0 10.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.07 0.462 . . . . 74.510000000000005 110.837 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 50.9 m -93.49 -18.43 22.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.288 0.566 . . . . 73.299999999999997 110.267 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -68.37 -47.48 67.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.78 -0.645 . . . . 75.5 111.013 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 p -68.92 -27.86 66.14 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.76 0.314 . . . . 52.329999999999998 111.785 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 62' ' ' SER . 19.8 mtp180 -75.6 -21.52 57.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.416 -0.356 . . . . 75.439999999999998 110.719 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.19 48.09 65.01 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.881 -0.599 . . . . 63.329999999999998 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 68' ' ' LYS . 1.6 tmtp? -95.95 111.76 57.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.814 -0.809 . . . . 75.340000000000003 108.814 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.64 152.35 7.55 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.802 2.335 . . . . 73.209999999999994 112.635 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -122.18 137.68 54.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.359 -0.608 . . . . 71.25 109.359 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.39 129.24 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.355 . . . . 75.030000000000001 110.168 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -149.46 160.11 43.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 73.400000000000006 110.554 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.3 m -83.45 104.86 13.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 75.200000000000003 109.937 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.83 131.4 49.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 110.001 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.67 -25.78 26.94 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.145 -0.55 . . . . 70.140000000000001 111.98 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.47 171.19 15.47 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.658 0.266 . . . . 74.430000000000007 110.501 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.54 35.77 2.25 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.233 -0.508 . . . . 71.230000000000004 113.233 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -84.88 -38.74 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.214 0.53 . . . . 75.439999999999998 109.844 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.64 157.95 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.409 -0.814 . . . . 62.130000000000003 109.366 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.8 pt -92.26 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.186 -0.301 . . . . 75.420000000000002 110.186 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 9.5 mmtm -51.62 -19.1 1.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.096 0.776 . . . . 74.329999999999998 113.096 -173.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.07 -63.0 4.91 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.446 -0.883 . . . . 74.310000000000002 111.72 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -70.85 -28.42 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 110.234 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.668 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 16.8 t70 -58.44 -51.66 68.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 72.430000000000007 110.087 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.28 -37.56 87.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.968 -0.382 . . . . 74.129999999999995 109.968 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -51.69 40.78 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.736 -0.666 . . . . 70.400000000000006 112.648 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.2 p -75.65 -31.38 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.038 0.447 . . . . 63.539999999999999 111.086 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.76 66.3 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -83.01 -5.48 59.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.003 0.371 . . . . 73.040000000000006 112.003 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.1 ptp -110.45 177.7 4.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.692 0.282 . . . . 71.329999999999998 111.136 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 p -127.66 177.98 6.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.089 -0.505 . . . . 75.530000000000001 110.173 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HA ' HD12 ' A' ' 127' ' ' LEU . 5.1 tt -63.88 130.6 44.78 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.541 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.495 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 83.71 13.0 76.54 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.405 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -102.63 129.2 49.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.042 0.449 . . . . 71.340000000000003 111.382 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -110.64 116.92 32.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.273 -0.876 . . . . 74.540000000000006 108.893 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.33 142.8 50.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.228 0.537 . . . . 55.240000000000002 111.151 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.86 109.6 20.82 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.679 -0.859 . . . . 64.409999999999997 108.679 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 28' ' ' LYS . 12.6 t80 -105.17 134.65 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 65.010000000000005 110.511 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.6 m -93.56 112.82 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 72.409999999999997 110.138 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.566 HG23 ' HB1' ' A' ' 105' ' ' ALA . 26.8 mm -103.12 114.0 65.44 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 116.552 -0.295 . . . . 60.109999999999999 110.569 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.562 ' HD2' HD12 ' A' ' 104' ' ' LEU . 34.3 Cg_exo -59.57 155.1 43.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.52 2.147 . . . . 73.230000000000004 111.659 175.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -54.81 -32.18 59.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.936 0.398 . . . . 75.519999999999996 111.111 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -76.22 -10.01 59.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 73.140000000000001 111.795 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 101' ' ' PRO . 82.3 mt -115.27 19.58 15.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.641 0.258 . . . . 73.129999999999995 110.768 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 100' ' ' ILE . . . -163.46 -172.24 2.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.029 0.443 . . . . 75.530000000000001 110.776 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -76.39 -3.99 39.94 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.91 -0.586 . . . . 75.329999999999998 110.897 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.59 60.22 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 113.093 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.39 -55.84 9.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.835 0.35 . . . . 70.209999999999994 110.431 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.21 -49.81 16.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.813 -0.631 . . . . 75.25 110.987 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.92 80.41 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.348 -0.453 . . . . 74.310000000000002 112.84 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.5 m-85 -77.22 -50.67 2.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 111.819 0.303 . . . . 75.400000000000006 111.819 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 3.5 Cg_exo -77.48 128.47 9.58 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.233 1.955 . . . . 74.049999999999997 111.51 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.4 -11.9 21.65 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.849 2.366 . . . . 75.519999999999996 113.152 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 115' ' ' ILE . 27.6 m -81.4 -17.93 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.992 0.425 . . . . 74.310000000000002 110.684 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 114' ' ' VAL . 49.9 mm -105.32 122.24 43.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 64.329999999999998 109.947 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.95 130.6 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.374 2.049 . . . . 73.409999999999997 112.173 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.26 149.36 81.34 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.822 2.348 . . . . 75.400000000000006 112.044 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm 64.28 27.63 13.83 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.298 0.639 . . . . 73.319999999999993 111.1 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.83 148.9 32.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 74.120000000000005 111.246 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 86.6 m -82.85 132.31 35.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.718 -0.674 . . . . 71.230000000000004 109.843 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -117.69 139.39 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.785 -0.45 . . . . 74.120000000000005 109.785 -173.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.4 t -106.25 138.81 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.536 -0.302 . . . . 74.230000000000004 110.241 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.21 125.24 38.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.074 -0.343 . . . . 55.210000000000001 110.074 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.827 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 35.6 tt0 -75.1 106.84 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.124 -1.435 . . . . 75.120000000000005 107.124 168.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 m -111.71 137.93 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.949 -0.568 . . . . 55.229999999999997 109.868 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.9 tt0 -144.02 126.68 16.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.854 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.3 tm? -79.34 101.69 8.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.310000000000002 108.302 176.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.94 -49.89 18.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 73.209999999999994 109.549 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.74 156.64 20.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 73.019999999999996 111.027 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.901 -0.591 . . . . 71.349999999999994 109.497 175.565 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.423 -0.955 . . . . 73.129999999999995 108.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.3 102.29 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 72.129999999999995 111.923 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -110.42 113.67 26.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 65.329999999999998 109.654 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -113.82 101.35 9.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.629 -0.878 . . . . 71.0 108.629 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.82 118.96 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.644 -0.707 . . . . 74.450000000000003 110.435 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.3 113.08 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.081 -0.509 . . . . 74.030000000000001 109.807 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -76.66 -40.78 48.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.332 -0.618 . . . . 73.129999999999995 109.332 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.3 m -147.08 114.67 4.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.606 -0.724 . . . . 74.030000000000001 109.305 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.44 150.3 87.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.713 2.275 . . . . 71.120000000000005 112.611 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -106.46 -135.29 7.97 Favored Glycine 0 C--O 1.237 0.31 0 CA-C-N 115.968 -0.56 . . . . 71.150000000000006 112.005 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.483 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 31.6 m-20 -73.4 -50.62 20.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 72.409999999999997 111.251 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.83 -25.18 8.91 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.926 -0.654 . . . . 51.130000000000003 112.172 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.64 -24.59 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.019 0.438 . . . . 74.230000000000004 111.157 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.503 ' HG1' ' HB3' ' A' ' 92' ' ' LEU . 14.8 p -79.1 92.97 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.16 0.505 . . . . 54.219999999999999 110.242 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -88.6 128.59 52.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.738 -0.664 . . . . 71.519999999999996 110.938 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.98 122.93 6.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.487 2.124 . . . . 72.230000000000004 112.048 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.44 148.5 22.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.811 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.91 138.16 46.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.420000000000002 109.763 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.29 68.51 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.182 -0.532 . . . . 73.239999999999995 112.085 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -91.66 134.2 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 75.150000000000006 110.982 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.58 ' HZ1' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.24 108.34 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.846 -0.798 . . . . 63.310000000000002 108.846 171.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG13 HG22 ' A' ' 130' ' ' VAL . 27.5 m -106.39 147.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.797 0.332 . . . . 72.019999999999996 110.805 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.1 m -104.62 108.17 19.49 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.787 -0.642 . . . . 54.210000000000001 110.064 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.769 HG13 HD22 ' A' ' 127' ' ' LEU . 15.8 m -125.96 178.23 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.631 -0.713 . . . . 54.299999999999997 110.636 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.81 154.19 36.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.84 -0.8 . . . . 71.409999999999997 108.84 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 36.9 p90 -134.06 158.14 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.429 -0.212 . . . . 74.140000000000001 110.429 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.671 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 1.4 m-20 -134.65 123.37 23.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.131 -0.692 . . . . 72.430000000000007 109.131 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.0 94.46 1.76 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.879 -0.601 . . . . 64.230000000000004 112.908 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HA ' ' HB3' ' A' ' 59' ' ' GLN . 19.3 ttm180 -106.25 137.36 44.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.363 0.602 . . . . 75.299999999999997 110.774 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -78.06 154.73 80.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 75.120000000000005 109.789 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.97 -23.71 29.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.767 2.311 . . . . 75.109999999999999 112.05 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.21 -24.24 40.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.379 -0.828 . . . . 72.329999999999998 111.177 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.13 -2.86 56.71 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.63 -0.714 . . . . 62.229999999999997 111.439 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -110.37 156.31 20.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.976 0.51 . . . . 73.120000000000005 110.042 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 26.0 pt20 -141.23 163.56 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.908 -0.405 . . . . 72.329999999999998 109.908 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.63 -46.63 78.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 111.479 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -170.33 133.21 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.851 -0.425 . . . . 72.129999999999995 109.851 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -69.35 106.67 3.0 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.886 0.374 . . . . 74.510000000000005 110.219 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.3 p -76.46 -26.23 55.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 73.299999999999997 110.776 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -31.39 71.94 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.939 0.4 . . . . 75.5 110.048 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -60.84 -13.59 16.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.695 . . . . 52.329999999999998 111.225 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -78.36 -16.37 57.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.775 0.321 . . . . 75.439999999999998 111.075 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.5 34.33 73.56 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.159 -0.543 . . . . 63.329999999999998 112.344 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HZ1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -132.04 113.65 14.89 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 110.252 -0.277 . . . . 75.340000000000003 110.252 -179.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -95.61 177.2 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.187 2.592 . . . . 73.209999999999994 113.271 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -125.9 142.23 51.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.581 -0.896 . . . . 71.25 108.581 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -112.68 135.29 53.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.522 -0.177 . . . . 75.030000000000001 110.522 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -150.75 161.12 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.774 -0.454 . . . . 73.400000000000006 109.774 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.425 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 56.9 m -86.09 115.95 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.482 0.182 . . . . 75.200000000000003 110.642 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 88' ' ' ALA . 63.6 tp -64.15 138.64 58.55 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.253 -0.431 . . . . 75.129999999999995 110.452 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.38 32.39 31.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.128 -0.558 . . . . 70.140000000000001 111.949 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.15 160.27 43.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.04 -0.355 . . . . 74.430000000000007 110.04 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 29.04 1.51 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.566 -0.349 . . . . 71.230000000000004 113.47 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 73' ' ' THR . 10.9 mm-40 -62.32 -46.65 87.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.502 0.668 . . . . 75.439999999999998 109.568 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.82 178.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.729 -1.123 . . . . 62.130000000000003 109.689 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 105' ' ' ALA . 28.1 pt -68.59 145.53 13.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 123.333 0.396 . . . . 75.420000000000002 110.77 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.49 -20.46 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 111.579 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.05 21.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 74.310000000000002 111.535 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.421 ' H ' HG13 ' A' ' 80' ' ' ILE . 47.8 m0 -68.98 -37.91 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.675 0.274 . . . . 71.340000000000003 110.298 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.93 -55.03 35.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.885 -0.598 . . . . 72.430000000000007 110.499 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.37 -34.74 70.7 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.025 -0.534 . . . . 74.129999999999995 110.513 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.428 ' O ' HG21 ' A' ' 89' ' ' THR . . . -55.02 -49.83 61.23 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.917 -0.583 . . . . 70.400000000000006 112.138 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 90' ' ' MET . 21.6 m -75.8 -31.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.777 0.323 . . . . 63.539999999999999 111.12 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -63.82 -32.0 73.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.609 -0.269 . . . . 72.340000000000003 111.54 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 86' ' ' GLY . 14.0 t -82.27 -10.72 59.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.823 0.305 . . . . 73.040000000000006 111.823 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 16.7 ptp -103.59 -172.05 2.04 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.712 0.292 . . . . 71.329999999999998 110.964 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -133.18 179.01 6.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.216 -0.447 . . . . 75.530000000000001 110.805 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.503 ' HB3' ' HG1' ' A' ' 38' ' ' THR . 3.4 tm? -62.9 138.49 58.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.802 0.334 . . . . 74.120000000000005 110.537 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.406 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.78 24.65 75.7 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.483 -0.78 . . . . 72.25 112.395 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 21.9 tt0 -121.2 135.32 55.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 71.340000000000003 110.792 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -117.87 128.42 54.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.507 -0.77 . . . . 74.540000000000006 109.341 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.13 141.53 44.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.459 . . . . 55.240000000000002 111.331 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.9 115.63 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.633 -0.877 . . . . 64.409999999999997 108.633 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.47 ' HD1' HD12 ' A' ' 100' ' ' ILE . 21.4 t80 -121.26 122.73 40.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 65.010000000000005 110.107 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.57 HG22 HG21 ' A' ' 122' ' ' VAL . 4.2 m -79.59 107.85 12.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.45 . . . . 72.409999999999997 109.784 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.47 HD12 ' HD1' ' A' ' 98' ' ' PHE . 37.2 mm -82.72 110.43 22.46 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 116.222 -0.444 . . . . 60.109999999999999 110.575 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.557 ' HA ' HG21 ' A' ' 120' ' ' THR . 61.3 Cg_endo -72.68 150.29 50.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.41 2.073 . . . . 73.230000000000004 111.88 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -54.32 -27.99 39.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.679 -0.691 . . . . 75.519999999999996 111.975 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.11 -22.14 49.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.328 -0.396 . . . . 73.140000000000001 111.893 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.9 mt -106.35 22.48 15.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.01 0.434 . . . . 73.129999999999995 110.197 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -160.53 -174.99 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.626 . . . . 75.530000000000001 111.053 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -79.85 -3.37 47.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 110.243 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.66 -24.6 48.5 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.898 -0.592 . . . . 75.140000000000001 113.465 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 5.9 tm-20 -65.71 -48.36 72.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.555 -0.535 . . . . 70.209999999999994 109.555 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 1.6 tpm_? -78.38 -56.58 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.62 -0.718 . . . . 75.25 110.974 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.99 162.54 25.86 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.485 -0.646 . . . . 74.310000000000002 111.485 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.591 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 89.2 m-85 -143.15 -58.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.05 0.425 . . . . 75.400000000000006 110.824 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 71.7 Cg_endo -82.98 140.67 10.19 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.585 1.523 . . . . 74.049999999999997 111.499 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.43 -5.89 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.819 2.346 . . . . 75.519999999999996 112.983 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 t -81.24 -29.56 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.472 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -111.35 109.31 56.46 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.969 -0.56 . . . . 64.329999999999998 110.043 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.27 149.96 87.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.715 2.277 . . . . 73.409999999999997 112.014 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.41 153.9 76.29 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.74 2.294 . . . . 75.400000000000006 112.039 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 47.4 mtmt 59.33 32.91 22.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.05 0.452 . . . . 73.319999999999993 110.759 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.77 32.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.953 -0.567 . . . . 74.120000000000005 111.12 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -73.79 124.66 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.3 -0.63 . . . . 71.230000000000004 109.3 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.2 tm? -119.11 144.47 46.6 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.097 -0.705 . . . . 74.120000000000005 109.097 -172.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.57 HG21 HG22 ' A' ' 99' ' ' THR . 63.9 t -98.38 111.19 27.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 110.166 -0.309 . . . . 74.230000000000004 110.166 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.444 ' CE2' HD11 ' A' ' 121' ' ' LEU . 40.1 m-85 -108.75 118.4 36.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.281 0.562 . . . . 55.210000000000001 110.855 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.671 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 43.8 mt-10 -75.45 109.04 8.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.337 -0.986 . . . . 75.120000000000005 108.337 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 m -95.99 149.13 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 123.508 0.505 . . . . 55.229999999999997 109.646 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.51 119.64 8.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 110.193 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.769 HD22 HG13 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -90.67 104.35 16.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.472 -0.566 . . . . 72.310000000000002 109.472 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.0 -43.9 12.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.801 0.334 . . . . 73.209999999999994 110.752 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.487 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -159.39 164.34 34.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.019999999999996 110.465 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.499 HG22 HG13 ' A' ' 46' ' ' VAL . 2.7 p . . . . . 0 C--O 1.245 0.843 0 N-CA-C 109.771 -0.455 . . . . 71.349999999999994 109.771 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 . . . . . 0 C--O 1.232 0.149 0 N-CA-C 108.984 -0.747 . . . . 73.129999999999995 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 60.9 tp -146.18 119.62 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.178 0.436 . . . . 72.129999999999995 112.178 -175.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -101.45 129.52 47.51 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.121 -0.696 . . . . 65.329999999999998 109.121 162.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HZ1' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -125.79 100.71 6.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.745 -1.206 . . . . 71.0 107.745 169.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -119.71 113.29 20.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.945 -0.57 . . . . 74.450000000000003 110.308 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.03 108.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.224 0.535 . . . . 74.030000000000001 110.474 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -82.97 -44.85 14.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.857 -0.61 . . . . 73.129999999999995 109.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.8 m -139.68 110.76 7.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 74.030000000000001 109.45 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.14 133.9 40.2 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.621 2.214 . . . . 71.120000000000005 111.614 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.46 -150.69 23.03 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.166 -0.54 . . . . 71.150000000000006 112.795 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.71 -54.73 40.72 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.707 0.403 . . . . 72.409999999999997 111.254 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.49 ' HA2' HG22 ' A' ' 91' ' ' THR . . . 75.7 -9.11 17.47 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.212 -0.518 . . . . 51.130000000000003 113.037 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.49 -6.7 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.115 0.483 . . . . 74.230000000000004 110.7 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 92' ' ' LEU . 40.8 p -83.96 120.11 25.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.795 -0.639 . . . . 54.219999999999999 110.681 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -126.66 89.67 51.59 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.728 -0.215 . . . . 71.519999999999996 110.637 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.8 -175.68 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.87 2.38 . . . . 72.230000000000004 111.993 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -146.55 174.94 10.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.368 -0.378 . . . . 75.109999999999999 110.268 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 140.36 57.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.196 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.12 -1.37 54.67 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.215 -0.516 . . . . 73.239999999999995 112.515 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -92.02 133.08 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 75.150000000000006 110.925 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -83.77 107.83 16.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.851 -0.796 . . . . 63.310000000000002 108.851 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 35.9 m -107.18 147.67 12.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 116.49 -0.323 . . . . 72.019999999999996 111.534 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 m -100.73 108.17 19.95 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.036 -0.983 . . . . 54.210000000000001 110.728 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.808 HG13 HD21 ' A' ' 127' ' ' LEU . 19.7 m -120.36 178.66 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 114.893 -1.048 . . . . 54.299999999999997 111.365 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.644 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 22.4 t-160 -152.8 146.4 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.697 -1.223 . . . . 71.409999999999997 107.697 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.5 m-85 -126.97 159.45 34.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.901 0.382 . . . . 74.140000000000001 111.965 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.878 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 5.6 m-20 -135.78 157.35 47.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.951 -1.022 . . . . 72.430000000000007 108.509 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -118.6 128.93 7.92 Favored Glycine 0 N--CA 1.461 0.312 0 C-N-CA 121.039 -0.6 . . . . 64.230000000000004 112.597 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.523 HH21 HG22 ' A' ' 122' ' ' VAL . 16.2 ttp180 -138.32 145.53 41.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.934 0.397 . . . . 75.299999999999997 110.752 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.0 155.56 64.19 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 75.120000000000005 109.767 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.33 -17.91 49.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.621 2.214 . . . . 75.109999999999999 112.487 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.8 -23.82 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 72.329999999999998 110.598 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.07 -22.53 18.25 Favored Glycine 0 N--CA 1.454 -0.165 0 N-CA-C 111.177 -0.769 . . . . 62.229999999999997 111.177 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -71.77 141.16 49.73 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.726 0.41 . . . . 73.120000000000005 109.949 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 14.6 pt20 -121.2 135.58 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.122 -0.695 . . . . 72.329999999999998 109.122 172.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -69.87 -29.95 67.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.615 -0.266 . . . . 73.530000000000001 111.394 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.09 134.15 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 72.129999999999995 110.779 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.466 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 13.7 p -79.14 86.69 4.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.452 -0.573 . . . . 74.510000000000005 109.452 171.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 m -65.42 -12.01 48.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.176 0.512 . . . . 73.299999999999997 110.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.644 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 8.8 ptp85 -63.56 -31.73 72.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.566 -0.743 . . . . 75.5 109.934 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 t -73.4 -19.14 61.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.831 -0.622 . . . . 52.329999999999998 110.952 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -75.57 -20.56 58.54 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.422 -0.353 . . . . 75.439999999999998 110.06 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.68 48.72 69.64 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.955 -0.566 . . . . 63.329999999999998 113.72 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 64.6 tttp -130.94 124.27 20.53 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.801 -0.444 . . . . 75.340000000000003 109.801 174.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 Cg_endo -83.65 175.13 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.107 2.538 . . . . 73.209999999999994 112.015 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -146.91 128.73 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 71.25 108.515 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 92.6 mt-30 -106.6 131.54 53.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.464 0.173 . . . . 75.030000000000001 110.654 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.86 158.77 43.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.564 -0.289 . . . . 73.400000000000006 110.471 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.1 m -84.32 124.36 31.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 75.200000000000003 110.386 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 tp -59.38 130.3 46.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.365 -0.379 . . . . 75.129999999999995 110.383 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.18 39.02 72.63 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.989 -0.55 . . . . 70.140000000000001 112.521 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.81 161.97 31.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.995 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.78 18.51 8.94 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 116.021 -0.536 . . . . 71.230000000000004 113.462 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.83 -19.75 54.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.599 . . . . 75.439999999999998 109.814 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.96 159.71 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.446 -0.797 . . . . 62.130000000000003 109.48 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.518 HG13 ' H ' ' A' ' 83' ' ' TRP . 21.3 pt -70.28 151.09 9.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 116.406 -0.361 . . . . 75.420000000000002 110.102 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -56.68 -26.68 57.16 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.827 -0.434 . . . . 74.329999999999998 109.827 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.27 -52.06 53.84 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.052 -0.594 . . . . 74.310000000000002 111.853 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.518 ' H ' HG13 ' A' ' 80' ' ' ILE . 40.8 m0 -69.32 -31.29 69.66 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.325 -0.25 . . . . 71.340000000000003 110.325 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.4 -45.75 80.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.132 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.12 -35.35 76.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 74.129999999999995 109.789 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 89' ' ' THR . . . -56.46 -47.07 86.22 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.876 -0.602 . . . . 70.400000000000006 112.353 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.597 HG23 HD23 ' A' ' 127' ' ' LEU . 7.1 p -75.05 -34.08 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.809 0.338 . . . . 63.539999999999999 110.622 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.75 70.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.483 -0.326 . . . . 72.340000000000003 111.456 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 86' ' ' GLY . 8.9 t -87.01 3.34 46.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.673 0.273 . . . . 73.040000000000006 111.187 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.3 ptm -130.14 175.74 8.66 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 110.81 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.49 HG22 ' HA2' ' A' ' 36' ' ' GLY . 59.5 p -127.34 178.68 5.9 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.296 -0.411 . . . . 75.530000000000001 110.789 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.646 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -69.22 139.38 54.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.634 -0.257 . . . . 74.120000000000005 110.395 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.488 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 77.93 12.57 84.29 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.956 -0.565 . . . . 72.25 112.219 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -112.72 153.75 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.321 0.248 . . . . 71.340000000000003 110.643 -172.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -134.09 127.82 32.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.353 -0.61 . . . . 74.540000000000006 109.353 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.07 146.85 41.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 55.240000000000002 110.914 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 tt -90.8 111.67 23.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.531 -0.915 . . . . 64.409999999999997 108.531 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -117.9 129.0 55.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.802 0.334 . . . . 65.010000000000005 110.147 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.504 HG23 HG21 ' A' ' 122' ' ' VAL . 27.9 m -84.51 131.12 34.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.655 0.264 . . . . 72.409999999999997 111.138 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.68 103.0 44.83 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-O 120.896 0.379 . . . . 60.109999999999999 110.063 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.602 ' HA ' HG21 ' A' ' 120' ' ' THR . 26.9 Cg_exo -62.67 155.09 61.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.598 2.199 . . . . 73.230000000000004 111.927 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -55.07 -23.38 19.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.992 -0.549 . . . . 75.519999999999996 111.415 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -75.63 -6.5 50.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.241 -0.436 . . . . 73.140000000000001 111.972 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.511 HD12 ' HD2' ' A' ' 101' ' ' PRO . 96.7 mt -127.53 14.46 7.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.707 0.262 . . . . 73.129999999999995 111.707 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.34 -175.77 5.01 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.953 0.406 . . . . 75.530000000000001 111.485 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -66.55 -12.33 57.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.515 -0.766 . . . . 75.329999999999998 111.314 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.91 -32.83 19.51 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.35 -0.386 . . . . 75.140000000000001 113.688 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 tp10 -58.08 -49.23 77.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.367 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.26 -47.74 9.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 75.25 110.971 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.77 153.44 13.05 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 112.076 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.695 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 76.1 m-85 -144.41 -57.19 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 122.314 0.246 . . . . 75.400000000000006 110.944 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.695 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 6.8 Cg_exo -73.49 143.1 34.01 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.896 1.731 . . . . 74.049999999999997 111.235 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.48 -27.66 41.38 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.821 2.347 . . . . 75.519999999999996 112.786 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.465 HG21 HG12 ' A' ' 115' ' ' ILE . 33.3 m -78.19 -18.18 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 111.514 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.507 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 49.0 mm -108.19 103.37 50.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.318 -0.401 . . . . 64.329999999999998 110.188 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.52 164.68 31.97 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.568 2.179 . . . . 73.409999999999997 111.668 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.35 142.6 94.98 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.317 2.012 . . . . 75.400000000000006 112.135 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 67.6 mttm 65.97 27.74 10.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.937 -0.574 . . . . 73.319999999999993 111.283 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.73 116.84 26.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.835 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.602 HG21 ' HA ' ' A' ' 101' ' ' PRO . 70.6 m -74.04 138.37 44.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.015 -0.539 . . . . 71.230000000000004 109.75 174.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -129.64 138.95 51.5 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.263 -0.643 . . . . 74.120000000000005 109.263 -175.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG22 HH21 ' A' ' 53' ' ' ARG . 48.1 t -98.6 133.72 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.588 0.232 . . . . 74.230000000000004 110.397 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.54 126.51 44.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.069 0.461 . . . . 55.210000000000001 110.533 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.878 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.0 mt-10 -78.23 118.36 20.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.953 -0.758 . . . . 75.120000000000005 108.953 173.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -95.97 135.57 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.443 -0.577 . . . . 55.229999999999997 109.443 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.9 tt0 -135.16 106.51 6.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.283 -0.417 . . . . 75.209999999999994 110.113 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.808 HD21 HG13 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -87.03 108.27 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.829 -0.804 . . . . 72.310000000000002 108.829 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.24 -50.9 7.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.856 -0.424 . . . . 73.209999999999994 109.856 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -169.9 -173.68 1.63 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.969 -0.56 . . . . 73.019999999999996 110.602 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.243 0.736 0 N-CA-C 109.161 -0.681 . . . . 71.349999999999994 109.161 173.216 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.847 0.356 . . . . 73.129999999999995 110.638 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -142.51 102.03 3.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 72.129999999999995 110.134 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -124.63 102.26 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.262 0.553 . . . . 65.329999999999998 110.047 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -112.74 109.7 19.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.272 -0.876 . . . . 71.0 109.16 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -108.66 110.35 21.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.469 -0.567 . . . . 74.450000000000003 109.469 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.75 106.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.109 -0.33 . . . . 74.030000000000001 110.109 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 97' ' ' LEU . 85.4 mt -87.7 -28.84 21.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 110.154 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 28.5 m -140.83 110.92 6.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.48 -0.782 . . . . 74.030000000000001 109.518 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.81 127.0 22.0 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.486 2.124 . . . . 71.120000000000005 111.249 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.11 -174.35 50.32 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 71.150000000000006 112.922 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD2' HG22 ' A' ' 37' ' ' VAL . 23.0 t70 -60.82 -43.06 98.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 110.543 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.3 9.74 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.934 -0.575 . . . . 51.130000000000003 114.43 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.432 HG22 ' OD2' ' A' ' 35' ' ' ASP . 14.0 m -103.57 -28.0 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.087 0.943 . . . . 74.230000000000004 110.807 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 5.5 p -75.95 88.62 2.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.41 0.624 . . . . 54.219999999999999 109.854 173.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' HZ2' ' HB3' ' A' ' 39' ' ' LYS . 8.5 mtpm? -93.29 114.45 62.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.348 -0.842 . . . . 71.519999999999996 111.068 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HG3' ' HG ' ' A' ' 127' ' ' LEU . 56.1 Cg_endo -70.58 107.77 2.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.412 2.074 . . . . 72.230000000000004 110.974 174.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.08 157.72 15.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 75.109999999999999 110.609 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 157.27 32.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 74.420000000000002 111.057 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.08 76.93 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.004 -0.544 . . . . 73.239999999999995 112.128 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -132.08 141.78 49.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.456 0.303 . . . . 75.150000000000006 110.311 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -71.95 107.61 4.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.736 -0.468 . . . . 63.310000000000002 109.736 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 HG11 HG23 ' A' ' 130' ' ' VAL . 33.6 m -106.42 147.42 11.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 120.887 0.375 . . . . 72.019999999999996 110.903 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.2 m -104.81 108.44 19.93 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.472 -0.786 . . . . 54.210000000000001 109.761 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.648 HG13 HD22 ' A' ' 127' ' ' LEU . 21.3 m -118.78 178.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.482 -0.781 . . . . 54.299999999999997 111.97 -171.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -150.61 137.02 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.866 . . . . 71.409999999999997 109.231 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.623 ' HD1' HG12 ' A' ' 125' ' ' VAL . 56.2 m-85 -126.64 159.4 33.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.71 -0.107 . . . . 74.140000000000001 110.71 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.62 136.35 29.05 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.466 0.479 . . . . 72.430000000000007 109.728 167.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 124.82 7.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.475 -0.393 . . . . 64.230000000000004 112.277 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.404 ' O ' HD11 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -141.01 137.46 32.99 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.327 0.584 . . . . 75.299999999999997 110.974 -170.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.19 148.37 39.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 109.744 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 -18.56 37.0 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.799 2.333 . . . . 75.109999999999999 112.457 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -66.56 -31.3 71.93 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.054 -0.521 . . . . 72.329999999999998 110.783 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.43 -21.07 15.21 Favored Glycine 0 C--N 1.327 0.038 0 N-CA-C 109.992 -1.243 . . . . 62.229999999999997 109.992 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -68.87 154.46 41.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.672 -0.764 . . . . 73.120000000000005 110.101 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -142.23 151.77 42.44 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.778 -0.453 . . . . 72.329999999999998 109.778 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.75 -4.54 36.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.714 0.292 . . . . 73.530000000000001 111.422 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -168.26 144.79 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.141 -0.688 . . . . 72.129999999999995 109.141 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.8 p -109.07 85.34 2.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.62 0.724 . . . . 74.510000000000005 110.292 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.1 m -77.83 -18.26 56.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.539 -0.755 . . . . 73.299999999999997 109.401 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -65.05 -32.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.21 -0.904 . . . . 75.5 109.645 173.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -73.57 -24.26 60.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.342 -0.844 . . . . 52.329999999999998 110.869 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -84.27 -28.64 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 75.439999999999998 110.598 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.25 25.1 59.73 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.086 -0.506 . . . . 63.329999999999998 112.194 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.92 129.15 47.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 122.52 0.328 . . . . 75.340000000000003 110.825 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -87.84 157.05 7.41 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.967 2.444 . . . . 73.209999999999994 112.434 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -134.92 130.13 35.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.888 -0.782 . . . . 71.25 108.888 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -107.85 138.24 44.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.504 0.192 . . . . 75.030000000000001 110.756 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -157.21 163.55 38.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.267 -0.424 . . . . 73.400000000000006 110.051 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.9 m -82.46 110.79 17.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.192 -0.299 . . . . 75.200000000000003 110.192 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 88' ' ' ALA . 48.1 tp -61.82 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.238 -0.437 . . . . 75.129999999999995 110.223 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.14 12.48 Favored Glycine 0 C--O 1.237 0.286 0 N-CA-C 111.488 -0.645 . . . . 70.140000000000001 111.488 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.57 154.19 38.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 74.430000000000007 110.504 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.61 33.89 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.147 -0.479 . . . . 71.230000000000004 112.67 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.89 -23.6 67.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.022 0.439 . . . . 75.439999999999998 110.641 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.93 174.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.139 -0.689 . . . . 62.130000000000003 109.139 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.468 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.6 pt -73.61 140.28 18.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.741 -0.466 . . . . 75.420000000000002 109.741 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 30.3 mmtp -58.45 -16.68 16.1 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.689 0.255 . . . . 74.329999999999998 111.689 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.93 -53.02 46.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.416 -0.897 . . . . 74.310000000000002 111.183 172.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.468 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.1 m0 -67.06 -42.1 85.33 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.114 -0.328 . . . . 71.340000000000003 110.114 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 17.8 t70 -52.59 -55.15 24.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.511 -0.768 . . . . 72.430000000000007 110.671 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -65.6 -40.42 92.65 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.094 -0.503 . . . . 74.129999999999995 110.666 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.69 -53.96 30.24 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.919 -0.582 . . . . 70.400000000000006 112.622 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.94 -30.35 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.544 0.212 . . . . 63.539999999999999 111.369 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -67.2 -30.15 70.01 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.725 0.269 . . . . 72.340000000000003 111.725 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 t -88.46 7.32 33.43 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.001 0.371 . . . . 73.040000000000006 112.001 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 11.9 ptp -121.97 -173.87 2.75 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.168 -0.332 . . . . 71.329999999999998 111.113 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -124.31 175.3 7.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.132 -0.486 . . . . 75.530000000000001 110.732 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 127' ' ' LEU . 7.7 tt -63.33 131.84 49.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 74.120000000000005 110.364 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 8.78 83.7 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.416 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.631 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 14.1 tt0 -102.02 140.92 35.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 71.340000000000003 110.585 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.433 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.9 ttpm? -131.79 136.23 47.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.808 -0.442 . . . . 74.540000000000006 109.808 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.13 150.62 35.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.961 0.41 . . . . 55.240000000000002 111.186 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.444 ' HB2' HD13 ' A' ' 31' ' ' LEU . 9.1 tt -90.67 109.42 20.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.984 -1.117 . . . . 64.409999999999997 107.984 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.402 ' HD1' HD11 ' A' ' 100' ' ' ILE . 7.0 t80 -112.0 117.77 33.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 65.010000000000005 110.109 -174.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 31.9 m -77.22 110.54 12.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.401 -0.363 . . . . 72.409999999999997 110.224 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.402 HD11 ' HD1' ' A' ' 98' ' ' PHE . 42.0 mm -90.48 111.6 48.33 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.127 -0.488 . . . . 60.109999999999999 110.488 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.429 ' HA ' HG23 ' A' ' 120' ' ' THR . 34.3 Cg_exo -59.9 144.46 99.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.396 2.064 . . . . 73.230000000000004 110.908 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 46.5 p90 -54.56 -36.32 64.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 75.519999999999996 110.882 -176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -62.99 -24.15 67.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 73.140000000000001 111.398 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.34 16.91 24.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.285 -0.416 . . . . 73.129999999999995 110.723 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.69 7.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 75.530000000000001 111.169 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -74.43 -11.03 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.893 -0.594 . . . . 75.329999999999998 111.016 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.89 63.45 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.928 -0.578 . . . . 75.140000000000001 112.485 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.529 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 4.7 tm-20 -57.62 -54.81 42.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.072 0.463 . . . . 70.209999999999994 109.996 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -103.67 -24.69 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 75.25 110.086 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.06 -175.22 52.57 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 112.317 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.785 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m-85 -151.04 -59.47 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.877 0.471 . . . . 75.400000000000006 110.119 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 72.8 Cg_endo -95.26 157.6 1.66 Allowed 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.653 2.235 . . . . 74.049999999999997 112.193 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.82 -17.28 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.852 2.368 . . . . 75.519999999999996 112.472 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.74 -32.53 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 74.310000000000002 110.251 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.631 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 mm -109.14 99.56 36.45 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.05 -0.523 . . . . 64.329999999999998 109.619 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.648 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 36.2 Cg_endo -66.08 152.22 81.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.515 2.144 . . . . 73.409999999999997 112.182 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.87 137.13 61.02 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.36 2.04 . . . . 75.400000000000006 111.277 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 64.75 37.5 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.63 0.581 . . . . 73.319999999999993 110.501 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.648 ' HB1' ' HG2' ' A' ' 116' ' ' PRO . . . -92.98 116.33 28.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.607 -0.724 . . . . 74.120000000000005 110.544 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -74.1 133.96 42.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 71.230000000000004 109.389 173.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.457 HD11 ' H ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -124.87 144.3 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 74.120000000000005 109.307 -172.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.457 ' H ' HD11 ' A' ' 121' ' ' LEU . 88.6 t -100.85 128.01 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 109.914 -0.402 . . . . 74.230000000000004 109.914 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -123.02 120.71 34.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.151 0.501 . . . . 55.210000000000001 110.329 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -82.84 111.05 18.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.614 -0.884 . . . . 75.120000000000005 108.614 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.623 HG12 ' HD1' ' A' ' 50' ' ' TYR . 34.2 m -104.81 150.24 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.029 -0.987 . . . . 55.229999999999997 110.614 -173.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.01 128.88 12.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.49 -0.323 . . . . 75.209999999999994 110.439 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.678 HD11 ' HA ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -93.43 118.17 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.929 -0.767 . . . . 72.310000000000002 108.929 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.79 -50.33 5.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.428 0.156 . . . . 73.209999999999994 111.141 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.24 0.543 . . . . 73.019999999999996 111.677 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.599 HG13 HD13 ' A' ' 92' ' ' LEU . 13.3 p . . . . . 0 C--O 1.251 1.167 0 CA-C-N 115.206 -0.906 . . . . 71.349999999999994 108.947 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 . . . . . 0 C--O 1.232 0.139 0 N-CA-C 109.711 -0.477 . . . . 73.129999999999995 109.711 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.8 tp -128.0 118.21 23.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.83 0.348 . . . . 72.129999999999995 110.298 -176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.422 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 43.2 mt-10 -123.72 146.06 48.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 65.329999999999998 111.001 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -141.02 110.67 6.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 71.0 109.459 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.593 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.9 mptt -108.69 110.4 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 74.450000000000003 109.697 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.5 112.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.015 0.436 . . . . 74.030000000000001 110.139 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 97' ' ' LEU . 79.6 mt -92.08 -30.11 16.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.119 -177.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 33.6 m -141.37 110.66 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.982 -0.748 . . . . 74.030000000000001 108.982 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.63 135.65 28.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.271 1.981 . . . . 71.120000000000005 112.043 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.94 -165.0 30.65 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.143 -0.551 . . . . 71.150000000000006 111.747 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.24 -20.71 62.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.63 0.215 . . . . 72.409999999999997 111.165 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.22 -30.32 1.15 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.489 -0.386 . . . . 51.130000000000003 113.481 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.4 -32.85 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 74.230000000000004 110.87 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 1.9 p -80.02 108.17 13.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.498 0.666 . . . . 54.219999999999999 110.61 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HE3' ' OE1' ' A' ' 41' ' ' GLN . 56.5 pttt -94.43 125.91 50.09 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.105 -0.952 . . . . 71.519999999999996 111.426 -173.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.99 106.17 2.12 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.853 2.368 . . . . 72.230000000000004 110.564 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' ' HE3' ' A' ' 39' ' ' LYS . 26.1 mt-30 -88.12 146.06 25.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.379 -0.373 . . . . 75.109999999999999 111.242 -176.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.45 156.77 36.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.857 -0.611 . . . . 74.420000000000002 109.892 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.19 16.6 79.65 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.905 -0.664 . . . . 73.239999999999995 111.68 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -132.94 154.86 50.03 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.737 0.415 . . . . 75.150000000000006 109.982 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.688 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -73.17 127.2 31.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 63.310000000000002 109.944 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.77 150.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 120.818 0.342 . . . . 72.019999999999996 110.642 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 m -111.27 110.53 21.06 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.213 -0.903 . . . . 54.210000000000001 110.698 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.709 HG11 HD22 ' A' ' 127' ' ' LEU . 24.8 m -128.66 177.88 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.719 0.771 . . . . 54.299999999999997 112.914 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.742 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 8.7 m170 -139.68 152.48 46.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.463 -1.244 . . . . 71.409999999999997 108.933 172.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 83' ' ' TRP . 63.6 m-85 -134.91 142.53 46.57 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.542 -0.54 . . . . 74.140000000000001 109.542 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 123' ' ' PHE . 36.5 t0 -137.02 143.76 42.9 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.203 -0.295 . . . . 72.430000000000007 110.203 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.55 140.01 15.22 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.338 -0.458 . . . . 64.230000000000004 112.328 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -157.26 149.31 22.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.375 0.607 . . . . 75.299999999999997 111.781 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.87 153.37 63.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.385 -0.825 . . . . 75.120000000000005 109.595 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.11 -20.28 45.32 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.029 2.486 . . . . 75.109999999999999 113.812 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.87 4.16 45.69 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.77 0.319 . . . . 72.329999999999998 111.004 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.37 26.01 37.69 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.184 -0.531 . . . . 62.229999999999997 112.342 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.04 146.77 39.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.807 -0.442 . . . . 73.120000000000005 109.807 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -160.15 157.49 28.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.977 -0.379 . . . . 72.329999999999998 109.977 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -69.21 -42.38 75.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.323 -0.399 . . . . 73.530000000000001 110.706 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.435 ' CG ' HH21 ' A' ' 66' ' ' ARG . 28.0 t70 -170.0 145.71 2.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.725 -0.671 . . . . 72.129999999999995 109.955 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.3 t -82.79 114.8 21.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.624 -0.509 . . . . 74.510000000000005 109.624 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.6 m -86.67 -28.0 23.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 73.299999999999997 111.783 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -69.61 -31.47 69.62 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.142 -0.349 . . . . 75.5 110.828 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 29.8 p -73.6 -2.92 24.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.285 -0.416 . . . . 52.329999999999998 111.09 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.435 HH21 ' CG ' ' A' ' 61' ' ' ASP . 28.5 mmt180 -75.95 -3.93 38.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.52 -0.309 . . . . 75.439999999999998 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 69' ' ' PRO . . . 72.61 8.36 71.66 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.47 -0.395 . . . . 63.329999999999998 113.045 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 55.8 tptt -91.97 106.82 18.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.549 -0.537 . . . . 75.340000000000003 109.549 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.1 Cg_exo -80.86 139.95 12.53 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.176 2.584 . . . . 73.209999999999994 112.1 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -107.62 142.89 36.86 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.793 -0.817 . . . . 71.25 108.793 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 50.7 mt-30 -134.63 138.26 44.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.32 -0.252 . . . . 75.030000000000001 110.32 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.32 164.26 34.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.774 -0.193 . . . . 73.400000000000006 110.657 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.5 m -78.53 111.42 14.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.839 -0.43 . . . . 75.200000000000003 109.839 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.421 HD13 ' HB1' ' A' ' 88' ' ' ALA . 50.7 tp -61.03 142.61 56.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.41 -0.359 . . . . 75.129999999999995 110.765 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.57 30.51 44.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.192 -0.528 . . . . 70.140000000000001 111.967 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.16 160.7 39.19 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.387 -0.227 . . . . 74.430000000000007 110.387 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.98 42.75 2.12 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 116.39 -0.368 . . . . 71.230000000000004 113.131 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -76.81 -47.43 21.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.973 -0.751 . . . . 75.439999999999998 108.973 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.66 175.53 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.222 -0.899 . . . . 62.130000000000003 109.143 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.499 HG13 ' H ' ' A' ' 83' ' ' TRP . 37.2 pt -64.6 144.6 14.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.902 -0.407 . . . . 75.420000000000002 109.902 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 3.9 tmtm? -58.92 -22.52 59.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.308 -0.405 . . . . 74.329999999999998 109.936 -176.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.32 -52.59 51.75 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.921 -0.657 . . . . 74.310000000000002 111.793 175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.499 ' H ' HG13 ' A' ' 80' ' ' ILE . 51.3 m0 -67.39 -41.87 84.26 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.127 -0.324 . . . . 71.340000000000003 110.127 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.2 t70 -54.47 -45.68 73.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.622 -0.717 . . . . 72.430000000000007 110.236 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -64.37 -44.72 90.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 74.129999999999995 110.319 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 89' ' ' THR . . . -54.75 -49.61 61.05 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.733 -0.667 . . . . 70.400000000000006 112.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.6 -30.34 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.49 0.186 . . . . 63.539999999999999 111.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HB1' HD13 ' A' ' 74' ' ' LEU . . . -72.92 -30.23 63.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.617 0.228 . . . . 72.340000000000003 111.617 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 86' ' ' GLY . 14.7 t -81.32 -4.15 54.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.723 0.296 . . . . 73.040000000000006 111.696 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.737 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 15.2 ptp -112.2 -176.66 2.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.886 0.374 . . . . 71.329999999999998 110.792 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.9 p -121.34 176.2 5.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.458 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 127' ' ' LEU . 6.4 tt -62.64 126.94 29.04 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.981 0.419 . . . . 74.120000000000005 110.71 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.84 65.12 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.648 -0.705 . . . . 72.25 112.772 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 32' ' ' THR . 15.0 tt0 -99.4 143.57 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 71.340000000000003 111.071 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -131.11 120.01 22.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.097 -0.705 . . . . 74.540000000000006 109.097 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.8 147.09 50.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.294 0.569 . . . . 55.240000000000002 111.306 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.593 HD22 ' HD3' ' A' ' 29' ' ' LYS . 10.0 tt -90.44 104.96 17.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.676 -1.231 . . . . 64.409999999999997 107.676 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -103.45 118.4 36.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.992 -0.549 . . . . 65.010000000000005 109.731 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 27.4 m -89.06 106.53 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.318 -0.401 . . . . 72.409999999999997 110.0 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.6 mm -86.44 113.69 53.83 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.949 -0.569 . . . . 60.109999999999999 111.076 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.553 ' HA ' HG23 ' A' ' 120' ' ' THR . 36.3 Cg_endo -66.12 149.93 85.42 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.372 2.048 . . . . 73.230000000000004 110.33 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.512 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 45.9 p90 -54.45 -31.71 56.06 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.356 0.502 . . . . 75.519999999999996 112.356 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.87 -23.78 64.26 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.004 0.372 . . . . 73.140000000000001 112.004 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.03 6.32 46.85 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.556 0.206 . . . . 73.129999999999995 111.556 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.06 -177.71 6.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 75.530000000000001 111.039 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -67.67 -14.3 62.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 75.329999999999998 110.875 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.62 -23.19 35.21 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.405 0.44 . . . . 75.140000000000001 112.63 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 44.9 tt0 -56.76 -44.24 81.57 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.044 0.449 . . . . 70.209999999999994 110.254 174.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 109' ' ' ARG . 20.1 mtp180 -97.92 -18.82 18.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.528 -0.76 . . . . 75.25 110.42 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 67.23 -110.22 3.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.761 -0.654 . . . . 74.310000000000002 112.681 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 31.8 m-85 102.92 -71.33 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.639 1.575 . . . . 75.400000000000006 112.418 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HG2' ' HB ' ' A' ' 115' ' ' ILE . 41.9 Cg_endo -65.84 149.45 86.63 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 121.439 1.426 . . . . 74.049999999999997 111.748 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.92 -31.85 44.97 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.103 2.536 . . . . 75.519999999999996 113.23 -175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 115' ' ' ILE . 27.4 m -83.2 -20.39 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 74.310000000000002 111.586 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 114' ' ' VAL . 49.2 mm -125.15 94.6 43.27 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.486 -0.325 . . . . 64.329999999999998 110.254 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' HB1' ' A' ' 119' ' ' ALA . 94.6 Cg_endo -81.43 169.9 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.811 2.341 . . . . 73.409999999999997 111.402 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.58 148.46 63.87 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.127 1.884 . . . . 75.400000000000006 111.694 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.92 16.38 8.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.144 0.578 . . . . 73.319999999999993 111.818 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 116' ' ' PRO . . . -72.39 112.21 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.120000000000005 111.752 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.7 m -88.15 119.59 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.502 -0.925 . . . . 71.230000000000004 108.502 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -124.59 147.97 48.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.649 0.262 . . . . 74.120000000000005 110.512 -167.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.573 ' N ' HD12 ' A' ' 121' ' ' LEU . 76.0 t -98.52 131.85 44.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.428 -0.351 . . . . 74.230000000000004 110.705 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 97.4 m-85 -130.01 121.94 27.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.388 -0.369 . . . . 55.210000000000001 110.561 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 16.8 mt-10 -77.4 113.95 15.72 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.264 -0.643 . . . . 75.120000000000005 109.264 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 132.93 42.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.617 -0.719 . . . . 55.229999999999997 109.345 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.742 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.6 tt0 -133.32 112.33 11.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 75.209999999999994 110.629 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.737 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -87.62 106.2 17.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.333 -0.618 . . . . 72.310000000000002 109.333 178.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.546 HD23 ' ND1' ' A' ' 49' ' ' HIS . 3.9 mm? -79.24 -50.63 10.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.215 0.531 . . . . 73.209999999999994 109.949 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . . . -168.35 -176.68 2.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 73.019999999999996 109.683 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.708 -0.849 . . . . 71.349999999999994 108.708 175.365 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 110.247 -0.279 . . . . 73.129999999999995 110.247 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 47.8 tp -145.95 101.72 3.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.26 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -116.84 122.99 45.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.706 -0.479 . . . . 65.329999999999998 109.706 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' NZ ' ' OG1' ' A' ' 89' ' ' THR . 61.5 pttt -126.39 119.29 26.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.114 0.483 . . . . 71.0 110.13 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.648 -0.705 . . . . 74.450000000000003 110.214 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -61.45 110.6 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.134 0.493 . . . . 74.030000000000001 109.739 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.55 HD22 ' HE3' ' A' ' 95' ' ' LYS . 34.8 tp -96.04 -25.13 16.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.018 -0.537 . . . . 73.129999999999995 110.072 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 57.1 m -149.0 110.77 3.52 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.893 -0.594 . . . . 74.030000000000001 109.725 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.38 133.84 21.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.039 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -95.24 -151.86 28.73 Favored Glycine 0 C--O 1.236 0.254 0 CA-C-N 116.063 -0.517 . . . . 71.150000000000006 111.823 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.414 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 44.1 m-20 -63.92 -36.14 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.933 0.367 . . . . 72.409999999999997 111.306 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.48 -30.03 2.83 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 112.479 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.81 -25.11 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.799 0.333 . . . . 74.230000000000004 111.484 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.431 ' HG1' ' HB3' ' A' ' 92' ' ' LEU . 7.8 p -80.31 96.47 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 54.219999999999999 110.701 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -97.89 124.32 48.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.555 . . . . 71.519999999999996 111.651 -173.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.12 154.16 41.74 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.902 2.401 . . . . 72.230000000000004 111.401 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.63 174.82 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.565 -0.288 . . . . 75.109999999999999 110.689 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.2 144.19 57.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.353 -0.385 . . . . 74.420000000000002 111.153 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.74 16.22 71.08 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 112.434 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 27.8 mmmt -109.33 121.8 45.97 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.526 0.331 . . . . 75.150000000000006 111.174 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -74.16 106.1 5.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.15 -0.685 . . . . 63.310000000000002 109.15 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.44 142.14 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.21 0.528 . . . . 72.019999999999996 111.689 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 25.5 m -103.65 108.3 19.52 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.132 -0.94 . . . . 54.210000000000001 109.079 175.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.0 178.15 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.944 -0.571 . . . . 54.299999999999997 111.76 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.474 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.8 t-80 -147.59 139.95 24.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.696 -0.684 . . . . 71.409999999999997 109.366 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.4 m-85 -126.46 149.84 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.37 0.419 . . . . 74.140000000000001 110.543 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.721 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 56.9 m-20 -136.11 128.27 29.86 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.607 -0.516 . . . . 72.430000000000007 109.607 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.73 115.52 4.88 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 121.124 -0.56 . . . . 64.230000000000004 112.34 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 26.7 ttp180 -133.32 144.24 49.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.98 0.419 . . . . 75.299999999999997 110.951 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -74.34 144.55 81.48 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.962 -0.755 . . . . 75.120000000000005 108.962 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -39.96 -48.74 3.74 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.658 2.905 . . . . 75.109999999999999 114.045 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.81 -41.4 97.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.325 0.491 . . . . 72.329999999999998 112.325 -173.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.84 -24.43 0.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.515 -0.85 . . . . 62.229999999999997 113.108 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -66.71 112.83 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.813 -0.228 . . . . 73.120000000000005 111.174 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.562 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 12.1 pt20 -102.11 144.03 31.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.016 -0.364 . . . . 72.329999999999998 110.016 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -96.44 -26.81 15.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.437 -0.347 . . . . 73.530000000000001 110.606 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -148.36 138.18 22.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.09 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.2 p -124.28 90.2 3.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.11 0.481 . . . . 74.510000000000005 110.589 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -68.05 -18.27 64.63 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.361 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG2' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -59.42 -35.27 73.69 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.56 . . . . 75.5 110.248 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.484 ' N ' ' HG2' ' A' ' 64' ' ' ARG . 8.1 m -64.87 -28.5 69.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.755 -0.657 . . . . 52.329999999999998 110.309 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -96.01 -16.79 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.838 -0.619 . . . . 75.439999999999998 110.373 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.05 35.39 91.93 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.691 -0.564 . . . . 63.329999999999998 111.691 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 69' ' ' PRO . 12.9 tmtt? -85.95 116.75 66.96 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 110.232 -0.284 . . . . 75.340000000000003 110.232 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.448 ' O ' ' HD3' ' A' ' 68' ' ' LYS . 56.7 Cg_endo -94.18 175.06 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.3 2.666 . . . . 73.209999999999994 112.659 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -149.05 128.75 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.381 -0.6 . . . . 71.25 109.381 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.9 137.09 42.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.562 0.22 . . . . 75.030000000000001 110.891 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.548 ' HZ ' HG22 ' A' ' 87' ' ' VAL . 37.7 p90 -154.64 158.19 39.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.749 -0.463 . . . . 73.400000000000006 109.749 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m -87.21 106.65 18.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.76 0.314 . . . . 75.200000000000003 110.816 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.77 111.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 109.774 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.24 -30.67 2.69 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.058 -0.817 . . . . 70.140000000000001 111.058 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.83 158.27 15.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.882 -0.414 . . . . 74.430000000000007 109.882 176.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 43.27 2.35 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.287 -0.483 . . . . 71.230000000000004 113.185 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.24 -23.74 62.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.044 0.45 . . . . 75.439999999999998 110.39 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.63 168.54 22.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.882 -0.599 . . . . 62.130000000000003 110.254 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.514 HD11 ' O ' ' A' ' 104' ' ' LEU . 12.6 pt -75.48 158.36 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 75.420000000000002 110.352 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 7.0 tmtm? -56.01 -37.41 69.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.79 0.329 . . . . 74.329999999999998 110.472 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.21 -46.33 86.11 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.804 -0.713 . . . . 74.310000000000002 112.158 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -73.1 -38.65 66.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.477 -0.194 . . . . 71.340000000000003 110.477 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.71 78.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.002 0.43 . . . . 72.430000000000007 110.024 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.35 -43.92 89.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.212 -0.449 . . . . 74.129999999999995 109.923 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 89' ' ' THR . . . -52.93 -50.03 52.46 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.85 -0.613 . . . . 70.400000000000006 112.827 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.548 HG22 ' HZ ' ' A' ' 72' ' ' PHE . 18.8 m -75.38 -33.3 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 63.539999999999999 111.328 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.15 -20.77 55.06 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.065 0.394 . . . . 72.340000000000003 112.065 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 86' ' ' GLY . 7.9 t -86.98 0.99 54.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.892 0.33 . . . . 73.040000000000006 111.892 -176.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 19.2 ptp -116.22 -171.18 1.94 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.615 0.245 . . . . 71.329999999999998 111.07 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 p -132.05 178.83 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.195 -0.457 . . . . 75.530000000000001 110.941 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 HG12 ' A' ' 130' ' ' VAL . 3.2 tm? -60.86 128.57 37.14 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 120.783 0.325 . . . . 74.120000000000005 110.753 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.74 87.45 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.62 -0.718 . . . . 72.25 112.592 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.461 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.1 tt0 -102.66 143.74 31.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.708 0.289 . . . . 71.340000000000003 110.705 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.55 ' HE3' HD22 ' A' ' 31' ' ' LEU . 37.9 ttpt -136.86 142.48 42.8 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.012 0.434 . . . . 74.540000000000006 110.175 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.94 151.75 48.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.845 -0.616 . . . . 55.240000000000002 110.901 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.0 tp -90.59 105.37 17.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.385 -1.339 . . . . 64.409999999999997 107.385 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 11.3 t80 -110.44 109.65 20.11 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.048 -0.524 . . . . 65.010000000000005 111.086 -167.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.1 m -73.05 113.13 9.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.616 . . . . 72.409999999999997 110.682 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' A' ' 105' ' ' ALA . 35.2 mm -96.75 111.82 58.53 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.363 -0.38 . . . . 60.109999999999999 110.383 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.438 ' HA ' HG21 ' A' ' 120' ' ' THR . 23.3 Cg_endo -61.85 155.55 53.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.531 2.154 . . . . 73.230000000000004 111.261 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.453 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 9.6 p90 -54.37 -42.16 70.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.837 -0.62 . . . . 75.519999999999996 112.265 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.25 -7.6 56.21 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.787 0.291 . . . . 73.140000000000001 111.787 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.514 ' O ' HD11 ' A' ' 80' ' ' ILE . 56.9 mt -102.84 15.3 29.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 73.129999999999995 110.56 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 100' ' ' ILE . . . -152.83 175.01 13.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 75.530000000000001 110.616 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -66.28 -15.64 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 75.329999999999998 110.65 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -62.0 -16.68 53.34 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.013 -0.54 . . . . 75.140000000000001 112.636 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 102' ' ' TYR . 3.3 tm-20 -60.56 -55.87 28.22 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.102 0.477 . . . . 70.209999999999994 109.748 176.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.55 -31.44 14.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 75.25 111.391 -171.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.96 140.64 1.9 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.194 -0.527 . . . . 74.310000000000002 112.441 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.632 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.3 m-85 -137.54 -55.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 122.333 0.253 . . . . 75.400000000000006 110.681 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 80.5 Cg_endo -88.44 139.75 4.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.87 1.713 . . . . 74.049999999999997 111.299 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.14 -24.88 21.37 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.862 2.374 . . . . 75.519999999999996 113.331 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.615 HG21 HG12 ' A' ' 115' ' ' ILE . 27.2 m -72.88 -26.7 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.643 -0.253 . . . . 74.310000000000002 111.498 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 114' ' ' VAL . 49.1 mm -113.18 101.92 54.1 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.782 -0.451 . . . . 64.329999999999998 109.782 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.12 163.83 34.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.63 2.22 . . . . 73.409999999999997 111.97 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.3 148.7 84.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.295 1.997 . . . . 75.400000000000006 111.709 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt 67.89 19.58 9.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 73.319999999999993 111.087 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.21 27.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 111.082 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.438 HG21 ' HA ' ' A' ' 101' ' ' PRO . 47.1 m -86.96 131.97 33.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.032 -0.729 . . . . 71.230000000000004 109.032 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -132.13 136.88 47.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.811 -0.44 . . . . 74.120000000000005 109.811 -171.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.513 ' N ' HD12 ' A' ' 121' ' ' LEU . 52.1 t -104.38 120.58 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 74.230000000000004 110.208 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 96.2 m-85 -109.31 127.22 54.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.251 -0.431 . . . . 55.210000000000001 110.419 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 29.7 mt-10 -75.15 114.1 13.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.408 -0.96 . . . . 75.120000000000005 108.408 168.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.462 HG21 ' HE2' ' A' ' 90' ' ' MET . 11.4 m -107.55 134.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 55.229999999999997 109.964 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 95' ' ' LYS . 41.7 tt0 -138.86 133.87 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.635 -0.257 . . . . 75.209999999999994 110.796 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.625 HD11 ' HB ' ' A' ' 130' ' ' VAL . 1.7 tm? -98.52 105.92 18.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.296 -0.631 . . . . 72.310000000000002 109.296 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.7 mm? -85.41 -41.98 14.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.418 -0.355 . . . . 73.209999999999994 111.189 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -146.7 140.52 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.652 0.263 . . . . 73.019999999999996 111.201 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.625 ' HB ' HD11 ' A' ' 127' ' ' LEU . 5.0 p . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.428 -0.796 . . . . 71.349999999999994 109.929 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 109.532 -0.544 . . . . 73.129999999999995 109.532 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.64 110.61 5.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.36 . . . . 72.129999999999995 111.65 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.492 ' H ' ' HB ' ' A' ' 99' ' ' THR . 42.9 mm-40 -109.83 113.51 26.3 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.026 -0.731 . . . . 65.329999999999998 109.026 170.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -111.1 101.34 9.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.529 0.681 . . . . 71.0 109.461 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 43.0 tptt -108.96 117.66 34.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.508 -0.769 . . . . 74.450000000000003 110.17 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.99 106.0 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.483 -0.562 . . . . 74.030000000000001 109.483 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.466 HD11 ' HE2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -86.62 -29.66 22.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 73.129999999999995 109.734 -173.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -152.88 110.66 2.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.63 . . . . 74.030000000000001 109.563 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.58 126.7 20.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.876 2.384 . . . . 71.120000000000005 111.978 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.62 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -102.59 -157.63 25.7 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.358 -0.449 . . . . 71.150000000000006 112.6 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.83 -56.64 19.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.601 0.361 . . . . 72.409999999999997 111.26 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.88 -30.05 10.85 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 119.793 -0.449 . . . . 51.130000000000003 114.205 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.21 -9.72 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.102 0.951 . . . . 74.230000000000004 111.494 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.3 m -109.19 111.68 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.874 -0.417 . . . . 54.219999999999999 109.874 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.707 ' HB3' ' HZ3' ' A' ' 39' ' ' LYS . 8.2 mtpm? -106.47 140.08 20.96 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.417 -0.356 . . . . 71.519999999999996 110.786 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.11 160.56 39.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.266 1.977 . . . . 72.230000000000004 110.672 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -141.29 171.46 14.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.633 0.254 . . . . 75.109999999999999 110.738 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.26 156.56 37.08 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.079 -0.51 . . . . 74.420000000000002 111.403 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.9 27.06 67.51 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.009 -0.541 . . . . 73.239999999999995 112.151 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -130.71 128.04 40.06 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.525 -0.176 . . . . 75.150000000000006 110.525 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 17.1 tppt? -73.45 104.91 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.006 -0.739 . . . . 63.310000000000002 109.006 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.3 m -107.26 152.26 8.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.144 0.497 . . . . 72.019999999999996 112.185 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.0 m -100.42 110.17 22.36 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.053 -0.976 . . . . 54.210000000000001 110.393 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG12 ' HE1' ' A' ' 72' ' ' PHE . 30.4 m -121.57 178.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.35 -0.841 . . . . 54.299999999999997 111.889 -172.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 4.6 t-160 -144.32 138.25 27.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.003 -0.74 . . . . 71.409999999999997 109.003 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.421 ' CD1' HG11 ' A' ' 125' ' ' VAL . 94.5 m-85 -126.64 144.21 50.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.572 -0.285 . . . . 74.140000000000001 110.96 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 58.7 m-20 -136.18 144.66 45.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.931 -0.766 . . . . 72.430000000000007 108.931 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.57 128.34 9.15 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.104 -0.569 . . . . 64.230000000000004 112.65 -173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 13.3 ttm180 -139.61 140.72 37.07 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.56 0.695 . . . . 75.299999999999997 111.343 -175.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 60' ' ' PHE . 83.5 m-85 -81.19 157.82 70.39 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.538 -0.755 . . . . 75.120000000000005 109.468 172.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.97 -15.09 36.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.615 2.21 . . . . 75.109999999999999 112.247 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.29 -5.97 58.38 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.079 -0.509 . . . . 72.329999999999998 110.902 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.69 49.34 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.196 -0.526 . . . . 62.229999999999997 112.625 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.72 122.17 19.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 122.296 0.238 . . . . 73.120000000000005 110.885 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 12.8 pt20 -85.23 132.58 34.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.742 -0.466 . . . . 72.329999999999998 109.742 175.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.568 ' HE2' HD13 ' A' ' 121' ' ' LEU . 44.8 p90 -89.34 -19.6 25.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.627 0.251 . . . . 73.530000000000001 110.847 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -156.97 144.31 18.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.614 -0.513 . . . . 72.129999999999995 109.614 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.8 p -124.46 98.7 5.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 74.510000000000005 110.861 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.04 64.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.344 -0.613 . . . . 73.299999999999997 109.344 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.457 HH12 ' CD ' ' A' ' 124' ' ' GLU . 6.9 ptt-85 -60.85 -41.19 95.36 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.603 -0.726 . . . . 75.5 110.807 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 t -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.978 -0.379 . . . . 52.329999999999998 109.978 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.6 mtt180 -85.15 -28.85 25.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.172 0.511 . . . . 75.439999999999998 110.059 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.08 26.27 64.65 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.578 -0.737 . . . . 63.329999999999998 111.712 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.35 116.84 55.91 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 122.234 0.214 . . . . 75.340000000000003 111.309 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.41 -178.63 3.8 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 73.209999999999994 112.074 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -140.86 163.62 32.43 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.951 -0.759 . . . . 71.25 108.951 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -142.07 138.07 31.47 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.55 0.214 . . . . 75.030000000000001 110.621 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.508 ' HZ ' HG23 ' A' ' 87' ' ' VAL . 20.6 p90 -157.29 165.76 34.97 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.964 -0.384 . . . . 73.400000000000006 109.964 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 m -89.15 108.83 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.348 -0.241 . . . . 75.200000000000003 110.348 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.1 135.14 57.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.171 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.55 58.77 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.26 -0.495 . . . . 70.140000000000001 112.405 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.54 171.46 14.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.996 0.427 . . . . 74.430000000000007 110.999 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.12 55.93 4.95 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.745 -0.661 . . . . 71.230000000000004 112.333 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -119.12 -19.01 8.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.614 0.245 . . . . 75.439999999999998 110.495 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -142.77 162.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.497 -0.319 . . . . 62.130000000000003 110.324 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.8 pt -72.31 151.34 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.958 -0.564 . . . . 75.420000000000002 110.366 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 51.3 mmtt -60.47 -15.81 30.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.331 0.493 . . . . 74.329999999999998 112.331 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.69 -60.27 8.78 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.26 -0.972 . . . . 74.310000000000002 111.254 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -67.07 -39.58 86.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.101 -0.333 . . . . 71.340000000000003 110.101 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 20.8 t70 -52.14 -54.95 24.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.513 -0.767 . . . . 72.430000000000007 110.625 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -68.21 -36.75 80.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.044 -0.525 . . . . 74.129999999999995 110.507 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 89' ' ' THR . . . -52.3 -53.43 31.47 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.536 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.508 HG23 ' HZ ' ' A' ' 72' ' ' PHE . 33.4 m -75.59 -30.89 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.734 0.302 . . . . 63.539999999999999 111.091 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.39 -26.23 67.15 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 86' ' ' GLY . 10.9 t -87.99 0.79 55.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.882 0.327 . . . . 73.040000000000006 111.882 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 16.1 ptp -112.4 -174.98 2.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.06 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -121.98 178.98 4.67 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.218 -0.446 . . . . 75.530000000000001 111.072 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -60.56 128.36 36.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.986 -0.552 . . . . 74.120000000000005 110.653 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.26 35.78 63.71 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.577 -0.344 . . . . 72.25 112.427 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.62 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 28.6 tt0 -128.02 150.45 49.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.666 0.27 . . . . 71.340000000000003 110.324 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HB3' ' HZ3' ' A' ' 95' ' ' LYS . 6.8 ttpm? -133.26 138.84 46.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 74.540000000000006 110.678 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.9 145.07 41.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.768 -0.651 . . . . 55.240000000000002 110.645 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 8.6 tt -90.25 105.56 17.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.321 -1.362 . . . . 64.409999999999997 107.321 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.549 ' HD2' HD13 ' A' ' 100' ' ' ILE . 17.7 t80 -111.65 114.05 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 65.010000000000005 110.031 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 16.2 m -75.71 106.75 7.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 72.409999999999997 110.068 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 98' ' ' PHE . 34.5 mm -80.77 114.31 47.17 Favored Pre-proline 0 C--O 1.243 0.744 0 CA-C-N 116.069 -0.514 . . . . 60.109999999999999 110.568 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.652 ' HA ' HG23 ' A' ' 120' ' ' THR . 21.4 Cg_exo -66.31 149.93 84.84 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.825 2.35 . . . . 73.230000000000004 112.007 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.38 -30.46 52.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.755 -0.657 . . . . 75.519999999999996 111.307 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -65.64 -35.95 82.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.066 -0.516 . . . . 73.140000000000001 111.388 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.48 19.96 15.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 73.129999999999995 111.022 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.09 -178.22 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 75.530000000000001 110.995 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.22 -9.93 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.646 -0.707 . . . . 75.329999999999998 110.424 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.92 40.08 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.856 -0.611 . . . . 75.140000000000001 113.742 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 35.9 tt0 -65.97 -41.36 91.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.652 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.51 -14.07 20.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.052 -0.522 . . . . 75.25 111.053 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 66.89 -82.07 0.12 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-N 116.033 -0.53 . . . . 74.310000000000002 113.777 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.708 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 62.9 m-85 97.92 -74.25 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.859 1.663 . . . . 75.400000000000006 111.478 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 11.3 Cg_endo -89.05 143.16 4.77 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.058 1.839 . . . . 74.049999999999997 111.856 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.62 -18.41 40.11 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.862 2.375 . . . . 75.519999999999996 112.422 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.68 -37.39 79.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.031 -0.532 . . . . 74.310000000000002 109.948 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.8 mm -106.8 106.48 58.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.573 -0.74 . . . . 64.329999999999998 109.498 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.44 148.6 92.56 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.457 2.105 . . . . 73.409999999999997 112.365 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.36 144.35 67.51 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.551 2.168 . . . . 75.400000000000006 112.235 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.804 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 44.7 mtpt 63.59 25.72 14.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.402 -0.817 . . . . 73.319999999999993 111.21 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.49 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 74.120000000000005 111.535 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.652 HG23 ' HA ' ' A' ' 101' ' ' PRO . 28.3 m -86.18 131.24 34.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 71.230000000000004 109.072 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.6 HD11 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -123.82 145.73 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.711 -0.478 . . . . 74.120000000000005 109.711 -170.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.6 ' N ' HD11 ' A' ' 121' ' ' LEU . 97.5 t -98.38 119.8 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.78 0.324 . . . . 74.230000000000004 110.33 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 121' ' ' LEU . 57.7 m-85 -116.08 118.61 33.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 55.210000000000001 110.166 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 38.2 mt-10 -83.22 106.99 15.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.831 . . . . 75.120000000000005 109.037 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.421 HG11 ' CD1' ' A' ' 50' ' ' TYR . 28.9 m -102.92 145.32 12.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 55.229999999999997 110.261 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 43.5 tt0 -143.27 130.12 20.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.542 -0.299 . . . . 75.209999999999994 110.484 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -98.82 105.7 17.88 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.922 -0.77 . . . . 72.310000000000002 108.922 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.89 -48.14 10.33 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.894 0.378 . . . . 73.209999999999994 110.289 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -164.94 -173.68 3.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.656 -0.702 . . . . 73.019999999999996 109.823 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.081 -0.961 . . . . 71.349999999999994 109.762 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.695 ' HB2' HG23 ' A' ' 120' ' ' THR . 71.7 mt-30 . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.899 -0.408 . . . . 73.129999999999995 109.899 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -145.76 112.94 6.15 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.816 0.341 . . . . 72.129999999999995 110.96 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 43.6 mt-10 -136.86 135.36 37.8 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.263 -0.643 . . . . 65.329999999999998 109.263 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -132.91 101.12 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.482 0.658 . . . . 71.0 109.668 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -113.34 110.89 21.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.245 -0.889 . . . . 74.450000000000003 110.378 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.13 111.1 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 74.030000000000001 110.445 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.5 mt -85.4 -24.04 27.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 73.129999999999995 110.327 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.1 m -153.35 110.69 2.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.634 -0.712 . . . . 74.030000000000001 109.462 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.83 126.6 13.45 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 71.120000000000005 111.835 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.19 -145.66 15.24 Favored Glycine 0 C--O 1.237 0.296 0 CA-C-N 115.906 -0.588 . . . . 71.150000000000006 112.114 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.464 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.6 m-20 -66.0 -43.92 86.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.787 0.327 . . . . 72.409999999999997 111.501 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.48 -30.14 2.82 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.228 -0.51 . . . . 51.130000000000003 112.333 -175.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 35' ' ' ASP . 33.4 m -89.29 -24.9 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.944 0.402 . . . . 74.230000000000004 110.943 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.4 p -78.03 95.41 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 54.219999999999999 110.524 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -106.41 103.91 48.03 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.577 -0.738 . . . . 71.519999999999996 111.066 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.11 156.62 42.52 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.467 2.111 . . . . 72.230000000000004 111.454 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.76 170.69 14.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.329 . . . . 75.109999999999999 110.74 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.88 156.74 26.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.806 -0.634 . . . . 74.420000000000002 111.047 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.92 25.28 67.29 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 115.889 -0.596 . . . . 73.239999999999995 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -130.01 119.15 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 75.150000000000006 110.748 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -66.34 104.27 1.18 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.159 -0.682 . . . . 63.310000000000002 109.159 172.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 130' ' ' VAL . 29.5 m -106.98 155.56 7.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.301 -0.409 . . . . 72.019999999999996 111.342 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -98.91 108.27 20.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.483 -0.781 . . . . 54.210000000000001 110.646 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.464 HG12 HD21 ' A' ' 127' ' ' LEU . 10.5 m -123.43 178.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 54.299999999999997 111.394 -173.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 65.0 t60 -152.29 133.31 14.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 109.566 170.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -126.79 146.19 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.578 -0.897 . . . . 74.140000000000001 108.578 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 123' ' ' PHE . 0.8 OUTLIER -135.86 152.02 50.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.823 -0.436 . . . . 72.430000000000007 109.823 -177.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.05 129.32 9.78 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.381 -0.438 . . . . 64.230000000000004 113.003 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -147.52 145.94 29.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.2 0.524 . . . . 75.299999999999997 110.302 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -90.22 148.47 39.29 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.306 -0.406 . . . . 75.120000000000005 110.422 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.77 -13.77 28.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.796 2.331 . . . . 75.109999999999999 111.719 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.16 -25.97 64.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.497 -0.774 . . . . 72.329999999999998 110.348 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.89 -14.78 28.99 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.343 -0.844 . . . . 62.229999999999997 111.489 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -103.11 148.67 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.09 0.556 . . . . 73.120000000000005 110.938 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.71 135.07 54.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.589 -0.522 . . . . 72.329999999999998 109.589 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -68.76 -62.34 1.43 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.148 -0.478 . . . . 73.530000000000001 110.783 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -137.51 131.31 31.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.92 -0.77 . . . . 72.129999999999995 108.92 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.534 ' OG ' ' HG3' ' A' ' 64' ' ' ARG . 9.7 t -111.02 134.44 52.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 74.510000000000005 111.108 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.8 m -75.75 -22.98 55.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.103 -0.499 . . . . 73.299999999999997 111.427 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.534 ' HG3' ' OG ' ' A' ' 62' ' ' SER . 6.7 ppt_? -56.82 -30.67 63.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.654 0.264 . . . . 75.5 110.861 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 8.9 m -59.14 -26.53 64.81 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.282 -0.417 . . . . 52.329999999999998 110.99 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -96.2 -16.12 21.64 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.113 -0.494 . . . . 75.439999999999998 110.409 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.95 15.78 69.72 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.804 -0.635 . . . . 63.329999999999998 113.51 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.3 ttpp -88.64 118.99 69.95 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-O 120.742 0.306 . . . . 75.340000000000003 111.009 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -89.27 -173.05 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.459 2.773 . . . . 73.209999999999994 111.753 175.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 81.0 m-85 -137.2 160.31 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 71.25 109.735 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -139.26 131.31 27.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.848 -0.427 . . . . 75.030000000000001 109.848 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -155.89 156.59 34.89 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.786 -0.45 . . . . 73.400000000000006 109.786 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 86.3 m -79.4 114.54 18.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.14 -0.319 . . . . 75.200000000000003 110.14 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.653 HD12 ' HB2' ' A' ' 88' ' ' ALA . 32.6 tp -56.83 123.13 13.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.744 -0.465 . . . . 75.129999999999995 109.744 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.74 -26.46 24.01 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.886 -0.486 . . . . 70.140000000000001 111.886 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.47 5.07 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.004 0.431 . . . . 74.430000000000007 111.231 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.37 16.52 48.78 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.158 -0.544 . . . . 71.230000000000004 113.186 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -56.25 -39.97 73.42 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 110.181 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.451 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 28.3 m -126.43 164.91 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 62.130000000000003 109.177 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.9 pt -67.75 150.05 11.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.123 0.487 . . . . 75.420000000000002 111.482 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 24.8 mmtm -62.8 -17.42 61.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.787 -0.642 . . . . 74.329999999999998 111.845 -175.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.23 20.73 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.349 -0.929 . . . . 74.310000000000002 111.088 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.451 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 18.7 m0 -71.69 -36.54 70.61 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.503 -0.349 . . . . 71.340000000000003 110.216 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.648 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 10.0 t70 -52.82 -55.23 24.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.841 -0.618 . . . . 72.430000000000007 110.39 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.752 ' HA ' HE21 ' A' ' 85' ' ' GLN . 0.0 OUTLIER -72.75 -37.68 67.62 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.156 -0.475 . . . . 74.129999999999995 110.33 -179.098 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.28 -49.79 49.37 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.932 -0.577 . . . . 70.400000000000006 112.038 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.567 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.8 p -75.99 -32.29 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.816 0.341 . . . . 63.539999999999999 111.05 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -60.52 -29.18 68.95 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.8 t -78.69 4.01 14.88 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.932 0.716 . . . . 73.040000000000006 112.932 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.567 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.4 ptp -120.04 -179.47 3.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.203 0.456 . . . . 71.329999999999998 111.442 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.403 HG21 ' HA2' ' A' ' 36' ' ' GLY . 68.7 p -118.88 178.86 4.33 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.963 -0.562 . . . . 75.530000000000001 111.124 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.725 ' HA ' HD13 ' A' ' 127' ' ' LEU . 6.0 tt -67.24 135.87 54.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.072 0.463 . . . . 74.120000000000005 110.704 -176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.537 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.8 17.25 80.04 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.415 -0.812 . . . . 72.25 111.821 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.84 137.51 51.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 71.340000000000003 110.351 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HZ3' ' HB2' ' A' ' 95' ' ' LYS . 4.0 ttmp? -123.83 135.31 53.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.625 -0.716 . . . . 74.540000000000006 109.46 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.91 148.75 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.21 0.529 . . . . 55.240000000000002 111.544 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.0 tt -90.76 114.0 26.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.225 -1.028 . . . . 64.409999999999997 108.225 174.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -119.79 116.6 26.23 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.934 0.397 . . . . 65.010000000000005 110.417 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 18.4 m -75.67 106.44 7.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.085 -0.507 . . . . 72.409999999999997 110.304 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.1 mm -83.69 116.72 66.06 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.29 -0.414 . . . . 60.109999999999999 110.624 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HA ' HG21 ' A' ' 120' ' ' THR . 52.1 Cg_exo -54.63 146.48 53.84 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.015 2.477 . . . . 73.230000000000004 112.066 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -54.22 -39.62 66.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 75.519999999999996 112.081 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -69.93 -25.82 63.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.807 0.337 . . . . 73.140000000000001 111.092 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.26 15.42 15.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.035 0.445 . . . . 73.129999999999995 110.261 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.19 -170.08 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 75.530000000000001 109.827 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.621 ' HE2' HG13 ' A' ' 115' ' ' ILE . 45.0 p90 -81.35 -7.56 59.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.37 . . . . 75.329999999999998 110.59 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.8 -21.32 65.18 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.836 -0.62 . . . . 75.140000000000001 112.934 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.21 -46.13 79.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.369 0.604 . . . . 70.209999999999994 110.402 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -102.86 -36.31 8.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.949 -1.023 . . . . 75.25 111.416 -166.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.19 90.58 0.05 OUTLIER Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.178 -0.534 . . . . 74.310000000000002 112.025 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 95.7 m-85 -82.98 -52.41 0.64 Allowed Pre-proline 0 CA--C 1.537 0.476 0 O-C-N 122.809 -0.23 . . . . 75.400000000000006 110.997 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 96.3 Cg_endo -84.87 143.92 9.57 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.757 1.638 . . . . 74.049999999999997 111.311 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.38 -16.81 30.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.371 . . . . 75.519999999999996 112.631 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.57 -34.74 58.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.074 -0.512 . . . . 74.310000000000002 110.526 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.621 HG13 ' HE2' ' A' ' 106' ' ' TYR . 49.2 mm -103.45 110.39 63.69 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 64.329999999999998 110.327 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.95 155.79 61.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.704 2.269 . . . . 73.409999999999997 111.992 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.34 148.91 88.69 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.239 1.96 . . . . 75.400000000000006 111.283 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.803 ' HZ2' ' HB3' ' A' ' 118' ' ' LYS . 9.2 mtpm? 60.93 23.15 13.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.04 0.536 . . . . 73.319999999999993 111.557 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.89 114.97 27.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.759 0.314 . . . . 74.120000000000005 110.474 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.695 HG23 ' HB2' ' A' ' 25' ' ' GLN . 98.1 m -73.64 133.11 43.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 71.230000000000004 109.118 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.499 HD11 ' N ' ' A' ' 122' ' ' VAL . 1.1 tm? -123.48 142.62 50.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.246 -0.65 . . . . 74.120000000000005 109.246 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.499 ' N ' HD11 ' A' ' 121' ' ' LEU . 67.4 t -98.27 136.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.001 0.429 . . . . 74.230000000000004 110.24 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 49.7 m-85 -123.28 122.18 37.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 55.210000000000001 110.42 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -80.36 107.23 12.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.28 -1.008 . . . . 75.120000000000005 108.28 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.84 150.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.507 -0.77 . . . . 55.229999999999997 111.195 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -150.19 136.33 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.976 -0.557 . . . . 75.209999999999994 110.295 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 92' ' ' LEU . 1.5 tm? -96.81 109.53 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.572 -0.899 . . . . 72.310000000000002 108.572 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.71 -43.5 15.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.913 0.387 . . . . 73.209999999999994 110.426 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -171.23 -178.11 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 73.019999999999996 109.82 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 46' ' ' VAL . 5.2 p . . . . . 0 C--O 1.249 1.069 0 N-CA-C 109.24 -0.652 . . . . 71.349999999999994 109.24 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 108.898 -0.778 . . . . 73.129999999999995 108.898 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.31 105.29 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.641 0.257 . . . . 72.129999999999995 110.368 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.82 122.66 18.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.342 -0.614 . . . . 65.329999999999998 109.342 170.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -120.44 122.63 41.11 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.26 -0.644 . . . . 71.0 109.26 175.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 35.1 ttmt -116.1 110.12 18.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 110.073 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.66 104.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 74.030000000000001 110.533 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.2 tp -88.37 -22.18 23.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 73.129999999999995 110.026 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 m -149.92 110.93 3.32 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.636 -0.711 . . . . 74.030000000000001 109.745 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.69 119.05 6.06 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.754 2.302 . . . . 71.120000000000005 111.588 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -86.65 -176.82 49.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.933 -0.651 . . . . 71.150000000000006 112.735 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.83 -33.02 69.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.65 0.262 . . . . 72.409999999999997 111.305 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.26 -30.29 1.63 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 113.511 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -79.37 -38.09 19.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 74.230000000000004 111.048 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.426 ' HG1' ' HB ' ' A' ' 91' ' ' THR . 25.4 p -66.15 94.0 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.514 . . . . 54.219999999999999 110.715 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -102.09 115.78 64.13 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.479 . . . . 71.519999999999996 110.605 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.95 -173.09 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.684 2.256 . . . . 72.230000000000004 112.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -156.66 164.74 37.81 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.148 -0.478 . . . . 75.109999999999999 110.112 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.98 127.69 33.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.239 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.28 31.63 7.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.772 -0.531 . . . . 73.239999999999995 111.772 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 130.29 49.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.984 -0.376 . . . . 75.150000000000006 109.984 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.11 108.26 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.552 . . . . 63.310000000000002 109.511 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.52 158.68 19.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 116.365 -0.379 . . . . 72.019999999999996 111.128 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.8 m -111.92 115.78 29.54 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.956 -0.565 . . . . 54.210000000000001 110.209 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 127' ' ' LEU . 10.3 m -120.99 177.96 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.184 0.516 . . . . 54.299999999999997 111.684 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -149.83 139.64 21.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.306 -0.861 . . . . 71.409999999999997 108.712 175.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -137.72 156.02 48.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.578 -0.283 . . . . 74.140000000000001 110.81 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -152.98 160.53 43.03 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.014 -0.736 . . . . 72.430000000000007 109.014 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 59' ' ' GLN . . . -132.16 151.17 19.78 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.784 -0.722 . . . . 64.230000000000004 113.271 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -148.77 155.05 40.43 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.849 0.459 . . . . 75.299999999999997 109.886 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -87.1 150.17 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 110.407 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.87 -31.77 90.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.908 2.405 . . . . 75.109999999999999 112.954 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.94 -39.95 83.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.472 -0.331 . . . . 72.329999999999998 110.752 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.4 -26.55 1.99 Allowed Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.711 -0.757 . . . . 62.229999999999997 113.429 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -74.79 164.64 26.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.188 0.494 . . . . 73.120000000000005 110.821 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 63.4 tt0 -134.0 141.15 47.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 72.329999999999998 109.911 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -72.23 -54.17 10.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.158 0.504 . . . . 73.530000000000001 110.261 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -151.77 143.97 23.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.648 -0.705 . . . . 72.129999999999995 109.312 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -91.61 90.96 7.81 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.187 0.518 . . . . 74.510000000000005 111.875 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.4 t -73.83 -23.97 59.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.056 -0.52 . . . . 73.299999999999997 110.225 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -68.7 -34.68 76.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.83 -0.433 . . . . 75.5 109.83 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -73.51 -36.21 65.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.751 -0.659 . . . . 52.329999999999998 110.937 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -76.6 -28.61 56.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.437 -0.347 . . . . 75.439999999999998 110.615 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.54 37.08 94.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.24 -0.505 . . . . 63.329999999999998 112.714 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -79.48 115.67 55.01 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 110.183 -0.302 . . . . 75.340000000000003 110.183 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 169.17 15.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.732 2.288 . . . . 73.209999999999994 111.754 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.413 ' O ' HG22 ' A' ' 48' ' ' VAL . 77.8 t80 -147.62 115.6 6.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.581 -0.526 . . . . 71.25 109.581 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -100.11 127.31 46.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.74 -0.467 . . . . 75.030000000000001 109.74 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -153.65 170.03 21.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 73.400000000000006 110.77 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 104.56 14.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 75.200000000000003 109.856 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.555 HD13 ' HB1' ' A' ' 88' ' ' ALA . 48.4 tp -59.06 138.91 57.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 75.129999999999995 110.772 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.41 25.91 37.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.061 -0.59 . . . . 70.140000000000001 112.103 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . . . -132.27 178.71 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.22 -0.289 . . . . 74.430000000000007 110.22 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.91 39.47 3.12 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 121.235 -0.507 . . . . 71.230000000000004 112.168 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 6.8 mm-40 -74.88 -34.35 62.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.247 0.546 . . . . 75.439999999999998 109.726 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.58 171.65 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.152 -0.931 . . . . 62.130000000000003 109.163 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.7 pt -59.64 141.28 16.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.936 -0.394 . . . . 75.420000000000002 109.936 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 67.2 mmtt -61.59 -16.21 46.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.287 0.477 . . . . 74.329999999999998 112.287 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.05 -52.0 54.98 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.139 -1.029 . . . . 74.310000000000002 110.87 171.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -73.77 -43.65 58.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.53 -0.335 . . . . 71.340000000000003 110.381 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 29.4 t70 -53.5 -54.9 30.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.1 -0.5 . . . . 72.430000000000007 110.442 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.82 -44.6 69.63 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 110.677 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.21 -47.84 54.61 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.993 -0.548 . . . . 70.400000000000006 112.313 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG23 HD21 ' A' ' 127' ' ' LEU . 8.7 p -75.96 -33.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.8 0.334 . . . . 63.539999999999999 110.775 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.555 ' HB1' HD13 ' A' ' 74' ' ' LEU . . . -60.76 -30.46 70.03 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.946 0.35 . . . . 72.340000000000003 111.946 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 86' ' ' GLY . 9.1 t -82.35 -10.19 59.17 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.419 0.526 . . . . 73.040000000000006 112.419 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.9 ptp -102.97 -170.02 1.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.998 -0.438 . . . . 71.329999999999998 111.001 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.426 ' HB ' ' HG1' ' A' ' 38' ' ' THR . 56.1 p -133.69 179.03 6.48 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.58 -0.282 . . . . 75.530000000000001 111.726 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.693 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.1 tt -64.19 137.83 58.14 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.235 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.507 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 75.12 13.64 82.55 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.651 -0.704 . . . . 72.25 111.908 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.629 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.6 tt0 -111.37 134.13 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 71.340000000000003 110.443 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.558 ' HB3' ' HZ2' ' A' ' 95' ' ' LYS . 6.1 ttpm? -133.96 130.43 37.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.612 -0.722 . . . . 74.540000000000006 109.765 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.14 143.88 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.031 0.443 . . . . 55.240000000000002 110.966 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.89 111.03 22.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.061 -1.088 . . . . 64.409999999999997 108.061 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -112.73 137.99 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 65.010000000000005 110.328 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -89.26 106.68 18.6 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.791 -0.448 . . . . 72.409999999999997 109.791 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.96 113.74 60.66 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 116.38 -0.373 . . . . 60.109999999999999 111.034 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.414 ' HA ' HG22 ' A' ' 120' ' ' THR . 72.7 Cg_endo -75.42 159.35 39.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.795 2.33 . . . . 73.230000000000004 111.908 176.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -60.02 -26.46 66.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.04 0.385 . . . . 75.519999999999996 112.04 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.633 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 11.2 pt20 -66.1 -18.68 65.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.694 0.283 . . . . 73.140000000000001 111.236 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 93.9 mt -115.2 14.91 17.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.387 -0.37 . . . . 73.129999999999995 110.948 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.57 175.46 13.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.273 0.559 . . . . 75.530000000000001 111.551 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -72.6 -11.24 60.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.481 -0.781 . . . . 75.329999999999998 110.654 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.18 -15.28 7.09 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.879 -0.601 . . . . 75.140000000000001 113.578 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.6 tt0 -63.59 -55.22 25.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.223 0.535 . . . . 70.209999999999994 110.144 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -97.34 -5.49 36.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.432 -0.804 . . . . 75.25 110.647 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 64.02 -91.22 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.68 -0.691 . . . . 74.310000000000002 113.618 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.719 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 44.0 m-85 98.94 -65.78 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.793 1.637 . . . . 75.400000000000006 111.562 -172.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.719 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 5.1 Cg_exo -75.81 135.55 17.75 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.703 1.602 . . . . 74.049999999999997 111.262 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.5 -14.93 38.04 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.801 2.334 . . . . 75.519999999999996 112.675 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.0 t -75.49 -20.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 110.211 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.26 116.36 64.54 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.845 -0.616 . . . . 64.329999999999998 110.072 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.38 154.07 70.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.619 2.213 . . . . 73.409999999999997 111.946 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.48 126.88 16.97 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.31 2.007 . . . . 75.400000000000006 111.867 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 56.0 mtmt 57.22 49.75 12.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 73.319999999999993 110.713 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.02 148.88 22.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 74.120000000000005 111.348 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 101' ' ' PRO . 94.7 m -100.66 131.48 46.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.591 -0.732 . . . . 71.230000000000004 109.698 175.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.27 161.63 20.09 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.92 0.39 . . . . 74.120000000000005 111.002 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.0 t -98.61 131.51 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.322 -0.621 . . . . 74.230000000000004 109.322 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.95 123.76 23.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 55.210000000000001 111.252 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -85.76 111.08 19.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.047 -0.723 . . . . 75.120000000000005 109.047 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.41 143.72 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 55.229999999999997 109.952 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -147.48 133.15 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 75.209999999999994 110.812 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.0 tm? -102.64 113.16 26.3 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.968 -0.752 . . . . 72.310000000000002 108.968 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 128' ' ' LEU . 3.8 mm? -89.03 -44.43 10.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.566 -0.288 . . . . 73.209999999999994 111.103 -177.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.55 141.66 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.638 -0.255 . . . . 73.019999999999996 111.121 -177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.252 1.199 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.224 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 108.786 -0.82 . . . . 73.129999999999995 108.786 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.32 111.56 5.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.861 0.362 . . . . 72.129999999999995 111.036 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -129.35 139.98 51.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.181 -0.463 . . . . 65.329999999999998 109.873 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' HB3' ' HD1' ' A' ' 98' ' ' PHE . 24.9 pttm -139.0 111.8 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 71.0 109.549 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.23 117.26 20.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 74.450000000000003 109.175 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.11 136.28 26.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.088 0.47 . . . . 74.030000000000001 110.763 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.4 tp -101.42 -28.18 12.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 73.129999999999995 110.198 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -153.87 112.26 2.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.12 -0.696 . . . . 74.030000000000001 109.12 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.11 134.77 47.49 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.581 2.187 . . . . 71.120000000000005 111.824 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.627 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.04 177.81 50.88 Favored Glycine 0 C--O 1.236 0.232 0 C-N-CA 121.271 -0.49 . . . . 71.150000000000006 113.218 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' OD2' HG23 ' A' ' 37' ' ' VAL . 30.6 t70 -64.7 -30.22 71.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.918 0.389 . . . . 72.409999999999997 110.6 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.62 6.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 114.884 0.714 . . . . 51.130000000000003 114.884 168.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.439 HG23 ' OD2' ' A' ' 35' ' ' ASP . 6.4 m -89.75 -23.36 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 117.924 0.862 . . . . 74.230000000000004 112.271 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 92' ' ' LEU . 34.0 p -62.66 125.57 24.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.698 -0.228 . . . . 54.219999999999999 111.063 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -100.07 126.98 34.67 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 120.933 0.397 . . . . 71.519999999999996 111.29 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -90.24 160.18 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.158 2.572 . . . . 72.230000000000004 111.847 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.611 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 19.8 pt20 -157.41 158.84 36.63 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 110.116 -0.327 . . . . 75.109999999999999 110.116 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -74.16 109.67 7.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.257 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.15 -21.22 3.51 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.738 -0.744 . . . . 73.239999999999995 113.143 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.611 ' HE2' ' HG2' ' A' ' 41' ' ' GLN . 50.9 mtmt -84.35 129.95 34.83 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.042 0.448 . . . . 75.150000000000006 110.607 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.49 111.28 7.53 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.286 -1.005 . . . . 63.310000000000002 108.286 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 130' ' ' VAL . 33.4 m -106.0 143.75 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.982 0.42 . . . . 72.019999999999996 110.91 -174.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -100.35 111.39 23.65 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.27 -0.877 . . . . 54.210000000000001 109.509 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG11 HG12 ' A' ' 87' ' ' VAL . 31.0 m -121.5 178.13 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 54.299999999999997 110.614 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 17.1 t-160 -147.27 136.37 22.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.2 -0.667 . . . . 71.409999999999997 109.2 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.473 ' HD1' HG11 ' A' ' 125' ' ' VAL . 78.3 m-85 -126.6 152.37 46.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.769 0.319 . . . . 74.140000000000001 111.086 -176.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -144.95 155.11 43.23 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.73 -0.841 . . . . 72.430000000000007 108.73 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.48 132.34 10.24 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.334 -0.46 . . . . 64.230000000000004 112.899 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ttm-85 -141.58 144.99 34.53 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.366 0.603 . . . . 75.299999999999997 110.902 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.92 147.3 61.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 75.120000000000005 109.555 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.63 -24.81 38.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.135 2.557 . . . . 75.109999999999999 113.491 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -74.33 -34.85 63.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.719 0.295 . . . . 72.329999999999998 110.552 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.78 -12.54 4.51 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 116.117 -0.492 . . . . 62.229999999999997 112.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -75.43 147.06 40.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.228 0.211 . . . . 73.120000000000005 110.568 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.88 127.36 26.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.772 -0.455 . . . . 72.329999999999998 109.772 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -67.54 -36.6 81.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.786 -0.643 . . . . 73.530000000000001 111.574 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -165.6 131.32 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 109.792 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 t -86.18 111.46 20.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.5 . . . . 74.510000000000005 110.728 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 m -79.4 -15.47 57.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 73.299999999999997 111.252 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.426 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 14.2 ptp180 -68.0 -32.18 72.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.535 -0.302 . . . . 75.5 110.764 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 t -67.33 -22.2 65.62 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.096 -0.502 . . . . 52.329999999999998 111.215 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -76.09 -8.97 58.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.706 0.289 . . . . 75.439999999999998 111.151 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.81 8.28 5.52 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 115.263 0.865 . . . . 63.329999999999998 115.263 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -99.3 128.85 30.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 117.669 0.735 . . . . 75.340000000000003 110.065 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -86.74 178.45 3.75 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.801 2.334 . . . . 73.209999999999994 111.912 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -134.45 133.31 40.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.485 -0.561 . . . . 71.25 109.485 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 96.4 mt-30 -106.19 133.59 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.632 -0.258 . . . . 75.030000000000001 110.368 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 25.3 p90 -152.47 154.96 36.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.584 0.231 . . . . 73.400000000000006 110.415 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.452 ' N ' ' HG3' ' A' ' 78' ' ' GLU . 55.6 m -74.62 110.26 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.551 -0.295 . . . . 75.200000000000003 110.34 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 88' ' ' ALA . 53.0 tp -67.2 136.7 55.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.488 -0.324 . . . . 75.129999999999995 110.478 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.89 80.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.266 -0.493 . . . . 70.140000000000001 112.33 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.61 167.41 11.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.177 -0.305 . . . . 74.430000000000007 110.177 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.92 50.43 3.9 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.337 -0.459 . . . . 71.230000000000004 112.484 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 73' ' ' THR . 6.7 mm-40 -79.68 -46.33 17.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 75.439999999999998 109.968 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.66 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.331 -0.85 . . . . 62.130000000000003 109.839 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.7 pt -58.54 142.93 13.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.097 0.475 . . . . 75.420000000000002 111.013 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 37.6 mmtm -55.86 -23.22 29.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.814 -0.63 . . . . 74.329999999999998 111.846 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.37 -51.9 56.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.641 -0.79 . . . . 74.310000000000002 111.635 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -70.38 -38.61 74.75 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.267 -0.271 . . . . 71.340000000000003 110.267 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.9 t70 -52.12 -54.66 27.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.117 -0.492 . . . . 72.430000000000007 110.266 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.34 -43.06 95.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.211 -0.45 . . . . 74.129999999999995 110.636 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 89' ' ' THR . . . -52.66 -48.67 55.65 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.953 -0.567 . . . . 70.400000000000006 112.66 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.489 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.1 m -75.65 -33.83 27.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.927 0.394 . . . . 63.539999999999999 111.176 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -73.81 -13.56 60.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.943 0.349 . . . . 72.340000000000003 111.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -95.58 12.14 30.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 121.267 -0.173 . . . . 73.040000000000006 111.325 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.0 ptp -133.32 -177.19 4.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 111.631 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.5 p -135.93 179.11 6.54 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.7 -0.682 . . . . 75.530000000000001 111.33 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 127' ' ' LEU . 1.5 tm? -51.45 124.62 12.41 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.968 0.507 . . . . 74.120000000000005 111.104 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.81 -1.09 89.09 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.009 -0.541 . . . . 72.25 112.877 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.627 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 11.0 tt0 -88.13 143.14 27.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.011 0.434 . . . . 71.340000000000003 110.787 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -142.45 133.51 25.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.531 -0.759 . . . . 74.540000000000006 109.025 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.13 30.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.421 . . . . 55.240000000000002 111.743 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.5 tt -90.86 110.14 21.36 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.475 -0.935 . . . . 64.409999999999997 108.475 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.455 ' HD1' ' HB3' ' A' ' 28' ' ' LYS . 70.3 t80 -122.25 134.31 54.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.144 0.497 . . . . 65.010000000000005 110.888 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.2 m -79.31 120.81 24.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.837 -0.62 . . . . 72.409999999999997 110.264 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.3 mm -99.03 107.24 42.91 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 110.025 -0.361 . . . . 60.109999999999999 110.025 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.461 ' HA ' HG21 ' A' ' 120' ' ' THR . 28.2 Cg_exo -61.94 145.91 96.62 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.72 2.28 . . . . 73.230000000000004 111.245 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -54.33 -35.49 62.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 75.519999999999996 111.47 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -64.24 -26.42 68.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.318 -0.401 . . . . 73.140000000000001 111.263 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.02 11.83 37.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.508 -0.315 . . . . 73.129999999999995 111.02 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.16 -176.77 5.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 75.530000000000001 111.018 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.44 -11.81 60.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.693 -0.685 . . . . 75.329999999999998 110.782 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.89 -14.9 59.4 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.843 -0.617 . . . . 75.140000000000001 112.315 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.34 -55.64 30.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.897 -0.408 . . . . 70.209999999999994 109.897 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -86.2 -41.88 14.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.59 . . . . 75.25 110.758 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.05 143.2 3.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 74.310000000000002 111.608 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.556 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 95.5 m-85 -142.87 -51.69 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 122.84 -0.212 . . . . 75.400000000000006 110.72 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 111' ' ' TYR . 89.3 Cg_endo -82.07 138.41 10.18 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.582 1.522 . . . . 74.049999999999997 110.789 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.26 -21.36 35.84 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 122.868 2.379 . . . . 75.519999999999996 113.349 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.627 HG21 HG12 ' A' ' 115' ' ' ILE . 35.5 m -75.12 -24.83 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.037 0.446 . . . . 74.310000000000002 110.834 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.627 HG12 HG21 ' A' ' 114' ' ' VAL . 49.0 mm -123.0 88.13 50.9 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 109.173 -0.677 . . . . 64.329999999999998 109.173 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.43 173.59 14.23 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.922 2.415 . . . . 73.409999999999997 112.505 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.42 132.54 24.61 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.576 2.184 . . . . 75.400000000000006 112.84 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 62.43 37.64 13.39 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.437 -0.801 . . . . 73.319999999999993 111.671 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.4 114.74 26.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.120000000000005 110.762 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 101' ' ' PRO . 52.9 m -82.3 136.98 34.94 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 71.230000000000004 109.921 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.573 HD11 ' N ' ' A' ' 122' ' ' VAL . 1.7 tm? -134.25 145.17 48.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.669 -0.493 . . . . 74.120000000000005 109.669 -172.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.573 ' N ' HD11 ' A' ' 121' ' ' LEU . 61.8 t -99.82 120.91 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.229 . . . . 74.230000000000004 110.398 -176.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -110.83 131.99 54.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.123 0.487 . . . . 55.210000000000001 111.109 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.13 117.08 28.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.855 -0.794 . . . . 75.120000000000005 108.855 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.473 HG11 ' HD1' ' A' ' 50' ' ' TYR . 19.2 m -109.4 149.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.695 . . . . 55.229999999999997 110.728 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.0 tt0 -145.03 133.48 21.88 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.837 -0.619 . . . . 75.209999999999994 110.202 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -102.36 116.03 31.78 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 122.702 0.401 . . . . 72.310000000000002 110.192 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 49' ' ' HIS . 3.3 mm? -96.75 -37.66 10.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 111.296 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.9 142.26 20.6 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.837 -0.165 . . . . 73.019999999999996 111.016 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.439 ' HA ' HG11 ' A' ' 46' ' ' VAL . 3.1 p . . . . . 0 C--O 1.251 1.162 0 CA-C-N 116.49 -0.323 . . . . 71.349999999999994 110.745 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.641 0.258 . . . . 73.129999999999995 110.717 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 tp -145.9 137.0 24.66 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.851 0.358 . . . . 72.129999999999995 111.37 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -141.35 140.63 33.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.944 -0.762 . . . . 65.329999999999998 108.944 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.34 119.85 13.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.848 0.356 . . . . 71.0 110.601 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -112.82 125.59 54.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 74.450000000000003 109.776 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 114.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.562 -0.533 . . . . 74.030000000000001 109.562 176.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.7 mt -99.24 -27.01 13.99 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.58 0.229 . . . . 73.129999999999995 111.5 -174.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 7.4 m -153.66 110.64 2.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 110.247 -0.279 . . . . 74.030000000000001 110.247 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.12 124.15 13.01 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.188 . . . . 71.120000000000005 111.619 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -92.36 -174.13 41.84 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.241 -0.504 . . . . 71.150000000000006 113.098 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -44.66 -57.17 3.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.823 0.849 . . . . 72.409999999999997 112.13 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.1 -30.65 9.44 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.013 -0.613 . . . . 51.130000000000003 114.594 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.5 m -90.34 -22.81 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.175 0.988 . . . . 74.230000000000004 111.007 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.409 HG22 HD11 ' A' ' 92' ' ' LEU . 5.2 p -65.14 142.82 58.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 54.219999999999999 110.541 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.19 101.57 16.24 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 71.519999999999996 110.947 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 141.38 26.72 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 72.230000000000004 111.507 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -131.74 160.42 35.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.073 -0.343 . . . . 75.109999999999999 110.073 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 140.83 50.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.358 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.22 64.98 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 73.239999999999995 112.152 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 143.62 33.28 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.779 0.323 . . . . 75.150000000000006 110.162 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 14.1 tppt? -69.89 126.69 30.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.916 -0.584 . . . . 63.310000000000002 110.027 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 130' ' ' VAL . 27.2 m -117.59 141.96 34.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 120.875 0.369 . . . . 72.019999999999996 110.758 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.4 m -99.87 108.53 20.81 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.369 -0.832 . . . . 54.210000000000001 109.749 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.448 HG13 ' HE1' ' A' ' 72' ' ' PHE . 20.9 m -118.26 178.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.27 -0.877 . . . . 54.299999999999997 111.747 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.6 t-160 -155.87 135.97 12.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.393 -0.822 . . . . 71.409999999999997 109.126 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.58 ' HD1' HG12 ' A' ' 125' ' ' VAL . 61.7 m-85 -126.81 155.51 42.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.479 0.18 . . . . 74.140000000000001 110.857 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.72 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 35.4 t70 -136.42 128.19 29.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.994 -0.548 . . . . 72.430000000000007 109.874 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -86.92 100.88 2.61 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.324 -0.465 . . . . 64.230000000000004 112.852 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 53' ' ' ARG . 24.2 ttm-85 -115.95 144.66 43.76 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.927 0.394 . . . . 75.299999999999997 111.126 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -90.67 151.12 43.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 110.085 -0.339 . . . . 75.120000000000005 110.085 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.52 -8.68 21.61 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.892 2.395 . . . . 75.109999999999999 113.473 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.46 -22.11 25.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.69 0.281 . . . . 72.329999999999998 111.162 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.79 10.14 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.313 -0.47 . . . . 62.229999999999997 112.033 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.666 ' HB3' ' HZ3' ' A' ' 58' ' ' LYS . 6.8 ttpm? -97.53 162.89 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.345 -0.613 . . . . 73.120000000000005 109.345 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 19.4 pt20 -147.76 146.94 29.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.378 -0.23 . . . . 72.329999999999998 110.378 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -76.82 -34.01 57.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.276 -0.42 . . . . 73.530000000000001 111.714 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.24 131.71 17.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.989 -0.374 . . . . 72.129999999999995 109.989 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.544 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 11.3 p -81.73 85.6 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.223 0.535 . . . . 74.510000000000005 110.197 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.66 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 20.1 m -81.47 -21.66 38.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.786 -0.643 . . . . 73.299999999999997 109.985 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -66.94 -36.97 83.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.729 -0.669 . . . . 75.5 109.513 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.6 m -71.54 -21.58 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.468 -0.787 . . . . 52.329999999999998 110.877 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -76.0 -26.32 56.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.233 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.21 31.97 50.26 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.579 -0.737 . . . . 63.329999999999998 113.027 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -79.13 119.8 78.43 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.536 0.168 . . . . 75.340000000000003 110.659 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.63 93.92 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.069 2.513 . . . . 73.209999999999994 111.116 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.34 161.4 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.722 -0.672 . . . . 71.25 109.408 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.32 133.7 33.35 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.292 -0.255 . . . . 75.030000000000001 110.797 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.448 ' HE1' HG13 ' A' ' 48' ' ' VAL . 26.9 p90 -150.81 158.08 43.71 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.422 -0.353 . . . . 73.400000000000006 110.199 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.5 m -77.42 113.04 14.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.07 -0.344 . . . . 75.200000000000003 110.07 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 88' ' ' ALA . 38.5 tp -60.39 140.41 57.2 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.441 -0.345 . . . . 75.129999999999995 110.878 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.13 -21.61 33.53 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 116.337 -0.392 . . . . 70.140000000000001 112.351 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . . . -81.66 178.48 8.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 111.022 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.57 24.51 29.05 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.966 -0.561 . . . . 71.230000000000004 112.056 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 9.8 mm-40 -58.35 -41.49 84.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 109.892 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.451 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 34.5 m -123.68 178.23 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 62.130000000000003 109.058 174.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.9 pt -73.4 144.43 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.341 -0.615 . . . . 75.420000000000002 109.341 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.769 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 5.0 mptp? -61.84 -15.79 44.92 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.064 0.394 . . . . 74.329999999999998 112.064 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.96 33.56 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.553 -0.832 . . . . 74.310000000000002 111.044 171.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.451 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 27.4 m0 -72.33 -36.17 68.77 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 120.851 0.357 . . . . 71.340000000000003 110.238 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.769 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 25.7 t70 -57.62 -55.36 35.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.517 -0.765 . . . . 72.430000000000007 110.747 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -72.51 -38.09 68.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.303 -0.408 . . . . 74.129999999999995 110.15 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' O ' HG21 ' A' ' 89' ' ' THR . . . -54.37 -47.93 66.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.88 -0.6 . . . . 70.400000000000006 112.465 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.2 p -76.05 -35.16 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.773 0.32 . . . . 63.539999999999999 110.862 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.97 -29.27 69.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.679 0.252 . . . . 72.340000000000003 111.679 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 86' ' ' GLY . 6.5 t -79.49 9.11 5.2 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.675 0.62 . . . . 73.040000000000006 112.675 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 17.1 ptp -124.86 -168.4 1.81 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.043 -0.411 . . . . 71.329999999999998 110.896 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -128.92 178.69 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.479 -0.328 . . . . 75.530000000000001 111.404 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.805 ' HA ' HD13 ' A' ' 127' ' ' LEU . 9.6 tt -63.28 135.53 57.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 74.120000000000005 111.196 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.65 10.94 85.69 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.907 -0.588 . . . . 72.25 112.633 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.503 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.7 tt0 -106.18 148.81 27.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 71.340000000000003 110.869 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' HB3' ' HZ3' ' A' ' 95' ' ' LYS . 6.7 ttpm? -142.38 137.65 30.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 110.786 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.9 149.78 34.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.02 -0.536 . . . . 55.240000000000002 110.637 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.661 ' HB2' HD11 ' A' ' 31' ' ' LEU . 8.9 tt -90.72 107.51 19.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.494 -0.928 . . . . 64.409999999999997 108.494 175.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -112.0 125.71 54.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 65.010000000000005 110.168 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.6 m -76.2 130.35 38.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 72.409999999999997 110.268 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.3 mm -108.14 98.81 28.28 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.364 -0.38 . . . . 60.109999999999999 110.021 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.04 153.97 73.76 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.572 2.181 . . . . 73.230000000000004 111.694 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.31 -23.57 66.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.719 0.637 . . . . 75.519999999999996 112.719 -171.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.55 -16.77 57.08 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.674 0.249 . . . . 73.140000000000001 111.674 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.51 15.58 25.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 73.129999999999995 110.905 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.11 -175.8 5.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 111.322 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -73.79 -6.22 45.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.373 -0.83 . . . . 75.329999999999998 111.005 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -52.8 -25.11 21.74 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.367 0.417 . . . . 75.140000000000001 113.262 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.04 -46.22 91.58 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.909 0.385 . . . . 70.209999999999994 110.74 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -99.63 -46.64 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 75.25 111.466 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.7 161.65 3.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.58 -0.343 . . . . 74.310000000000002 112.815 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.699 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 87.9 m-85 -135.82 -57.56 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 119.576 -0.25 . . . . 75.400000000000006 110.767 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.699 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 9.5 Cg_exo -71.69 142.95 40.82 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.857 1.705 . . . . 74.049999999999997 111.022 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.36 -19.08 33.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.591 2.194 . . . . 75.519999999999996 112.147 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.451 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 33.9 t -76.09 -24.4 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 110.627 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.06 98.21 18.07 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.148 -0.478 . . . . 64.329999999999998 109.874 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 114' ' ' VAL . 17.9 Cg_exo -67.34 159.9 50.16 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.002 2.468 . . . . 73.409999999999997 112.573 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.81 136.12 44.15 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.588 2.192 . . . . 75.400000000000006 111.43 174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 61.07 34.84 18.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.073 -0.512 . . . . 73.319999999999993 110.871 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.42 122.79 31.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.789 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -73.83 119.11 17.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.625 -0.509 . . . . 71.230000000000004 109.625 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.92 168.78 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.046 0.451 . . . . 74.120000000000005 110.401 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.6 t -133.0 138.21 52.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.426 -0.953 . . . . 74.230000000000004 108.426 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -130.19 122.81 28.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.345 0.593 . . . . 55.210000000000001 110.734 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 31.2 tt0 -76.44 107.03 8.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.559 -1.275 . . . . 75.120000000000005 107.559 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.58 HG12 ' HD1' ' A' ' 50' ' ' TYR . 31.6 m -104.1 144.14 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 55.229999999999997 110.4 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 39.2 tt0 -147.54 128.31 14.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 75.209999999999994 110.633 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 92' ' ' LEU . 2.5 tm? -98.55 106.17 18.41 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.626 -0.879 . . . . 72.310000000000002 108.626 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.8 mm? -78.57 -48.3 15.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 73.209999999999994 111.002 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.62 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.019999999999996 111.195 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 46' ' ' VAL . 2.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-N 115.926 -0.579 . . . . 71.349999999999994 110.203 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.252 -0.277 . . . . 73.129999999999995 110.252 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -131.55 102.03 5.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.326 -0.99 . . . . 72.129999999999995 108.326 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.34 125.57 15.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 65.329999999999998 109.224 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -125.48 126.22 44.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 71.0 110.469 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -109.19 121.01 44.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.696 -0.683 . . . . 74.450000000000003 110.232 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.33 103.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.902 -0.407 . . . . 74.030000000000001 109.902 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.41 -19.66 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.42 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 37.9 m -149.57 110.83 3.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.992 -0.549 . . . . 74.030000000000001 109.712 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.75 130.63 23.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 71.120000000000005 111.824 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.17 -153.28 19.88 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.06 -0.518 . . . . 71.150000000000006 112.545 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.73 -36.9 42.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.161 0.505 . . . . 72.409999999999997 110.28 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.553 ' HA2' HG23 ' A' ' 91' ' ' THR . . . 81.01 -17.72 11.07 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.623 -0.717 . . . . 51.130000000000003 113.329 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 m -89.4 -20.31 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.971 0.36 . . . . 74.230000000000004 111.971 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.4 p -79.95 144.17 33.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.998 0.428 . . . . 54.219999999999999 111.062 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.737 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.58 96.24 49.06 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.958 -0.564 . . . . 71.519999999999996 109.784 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.562 ' HA ' HG22 ' A' ' 130' ' ' VAL . 51.6 Cg_exo -55.94 145.14 75.39 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.009 2.473 . . . . 72.230000000000004 113.188 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.17 146.0 44.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.971 -0.559 . . . . 75.109999999999999 109.939 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.6 166.14 24.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.728 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.07 7.3 70.46 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.221 -0.514 . . . . 73.239999999999995 112.711 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.95 149.88 40.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.943 0.401 . . . . 75.150000000000006 111.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.712 ' HB2' ' HZ2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -78.06 104.09 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.89 -0.782 . . . . 63.310000000000002 108.89 171.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.33 151.63 8.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.276 0.56 . . . . 72.019999999999996 111.661 -173.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.2 m -99.13 108.38 20.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.005 -0.998 . . . . 54.210000000000001 110.015 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.468 HG23 ' CE2' ' A' ' 72' ' ' PHE . 14.7 m -122.57 178.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.924 -0.58 . . . . 54.299999999999997 110.466 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -154.22 149.46 27.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.134 -0.691 . . . . 71.409999999999997 109.134 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -151.33 152.27 32.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.499 0.19 . . . . 74.140000000000001 110.615 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -135.74 134.59 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.157 -0.682 . . . . 72.430000000000007 109.157 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.23 139.71 15.35 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.281 -0.485 . . . . 64.230000000000004 112.818 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.544 HH21 HG23 ' A' ' 122' ' ' VAL . 11.1 ttp180 -142.03 137.15 30.9 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.092 0.472 . . . . 75.299999999999997 110.432 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -79.95 152.83 74.77 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.731 -0.668 . . . . 75.120000000000005 109.939 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.45 -18.68 32.72 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.666 2.244 . . . . 75.109999999999999 111.774 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.28 -38.87 88.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.392 -0.822 . . . . 72.329999999999998 110.367 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.09 -19.25 5.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.015 -0.538 . . . . 62.229999999999997 112.357 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -86.32 142.93 28.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.6 0.2 . . . . 73.120000000000005 110.571 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.2 mt-30 -86.45 155.25 20.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.604 -0.517 . . . . 72.329999999999998 109.604 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -76.16 -62.02 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.483 -0.562 . . . . 73.530000000000001 109.483 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -145.26 132.99 21.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.634 -0.712 . . . . 72.129999999999995 109.265 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 33.1 t -89.54 85.66 6.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 74.510000000000005 109.85 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 99.9 p -65.25 -26.78 68.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.486 . . . . 73.299999999999997 109.928 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 64' ' ' ARG . 5.3 ptp180 -60.35 -44.29 95.69 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.746 -0.661 . . . . 75.5 110.477 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -69.81 -23.44 63.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.061 0.458 . . . . 52.329999999999998 110.199 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 62' ' ' SER . 17.4 mtp180 -75.91 -21.85 56.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.294 -0.632 . . . . 75.439999999999998 109.294 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.07 46.53 7.6 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.404 -0.816 . . . . 63.329999999999998 114.128 170.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -145.8 128.98 8.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.101 0.451 . . . . 75.340000000000003 110.477 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.91 -177.42 2.81 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.24 2.627 . . . . 73.209999999999994 111.914 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.4 152.36 48.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.242 -0.651 . . . . 71.25 109.242 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -134.14 129.58 36.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.356 -0.239 . . . . 75.030000000000001 110.356 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' A' ' 48' ' ' VAL . 12.6 p90 -154.61 169.86 22.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.715 -0.221 . . . . 73.400000000000006 110.543 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.471 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 21.7 m -80.88 119.09 22.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.421 -0.354 . . . . 75.200000000000003 111.204 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 88' ' ' ALA . 56.8 tp -70.21 137.69 51.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.09 -0.505 . . . . 75.129999999999995 110.347 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.17 24.99 64.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.014 -0.612 . . . . 70.140000000000001 112.422 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.67 172.3 11.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.727 0.299 . . . . 74.430000000000007 110.407 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 15.93 8.4 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 113.315 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 73' ' ' THR . 26.6 mm-40 -55.68 -42.99 75.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.269 0.557 . . . . 75.439999999999998 110.314 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.526 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 30.4 m -134.91 176.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 62.130000000000003 109.987 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.9 pt -69.21 150.01 10.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 116.499 -0.318 . . . . 75.420000000000002 110.392 177.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.473 ' HD2' HE21 ' A' ' 85' ' ' GLN . 4.7 tmtm? -58.59 -25.22 62.37 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 110.274 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.62 -52.16 54.21 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.055 -0.593 . . . . 74.310000000000002 111.963 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 49.8 m0 -68.14 -35.12 77.58 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.084 -0.339 . . . . 71.340000000000003 110.084 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.08 -49.37 71.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.105 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.473 HE21 ' HD2' ' A' ' 81' ' ' LYS . 80.3 mt-30 -59.14 -49.18 78.86 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.294 -0.412 . . . . 74.129999999999995 110.237 175.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.24 -50.05 48.05 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.455 -0.793 . . . . 70.400000000000006 113.003 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -75.36 -33.25 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.71 0.291 . . . . 63.539999999999999 111.763 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB3' HD13 ' A' ' 74' ' ' LEU . . . -77.69 -20.8 53.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.366 0.506 . . . . 72.340000000000003 112.366 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.3 t -85.76 -10.27 55.81 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.171 0.434 . . . . 73.040000000000006 112.171 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.9 ptp -107.19 -176.46 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 111.637 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.553 HG23 ' HA2' ' A' ' 36' ' ' GLY . 17.3 p -118.56 178.83 4.32 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.899 -0.591 . . . . 75.530000000000001 110.89 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.791 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.3 tt -67.28 126.42 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.096 0.474 . . . . 74.120000000000005 110.542 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.62 11.97 82.3 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.707 -0.679 . . . . 72.25 112.531 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 19.1 tt0 -100.5 146.48 27.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.841 0.353 . . . . 71.340000000000003 110.618 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.4 ttpm? -137.45 136.92 38.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.848 -0.614 . . . . 74.540000000000006 109.957 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.82 148.11 46.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.313 -0.403 . . . . 55.240000000000002 110.691 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.5 tt -90.75 105.47 17.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.628 -1.249 . . . . 64.409999999999997 107.628 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.86 126.43 50.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 65.010000000000005 110.268 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.3 m -84.89 106.44 16.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.949 -0.759 . . . . 72.409999999999997 108.949 174.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.98 110.77 40.44 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.435 -0.348 . . . . 60.109999999999999 110.77 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.93 140.87 47.01 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.486 2.124 . . . . 73.230000000000004 111.233 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 46.3 p90 -54.5 -35.06 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 75.519999999999996 111.781 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.528 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 13.8 pt20 -61.83 -20.87 64.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 111.543 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.528 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 95.6 mt -113.45 19.0 17.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.535 -0.302 . . . . 73.129999999999995 110.657 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.8 171.54 14.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.665 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -72.12 -17.34 61.98 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.282 -0.872 . . . . 75.329999999999998 110.587 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.89 -15.97 44.76 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.907 -0.588 . . . . 75.140000000000001 112.366 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.734 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 3.6 tm-20 -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.119 -0.326 . . . . 70.209999999999994 110.119 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -78.46 -52.83 7.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.426 -0.583 . . . . 75.25 109.426 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.97 153.36 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.936 -0.575 . . . . 74.310000000000002 113.008 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.541 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 54.2 m-85 -142.49 -59.84 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 122.574 0.35 . . . . 75.400000000000006 110.651 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 75.6 Cg_endo -84.51 151.18 11.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 121.899 1.733 . . . . 74.049999999999997 111.882 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.9 -21.49 64.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.683 2.255 . . . . 75.519999999999996 112.634 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.616 HG21 HG12 ' A' ' 115' ' ' ILE . 33.8 m -71.91 -22.45 21.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.301 -0.408 . . . . 74.310000000000002 110.724 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.616 HG12 HG21 ' A' ' 114' ' ' VAL . 47.1 mm -121.81 87.68 46.69 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 109.165 -0.68 . . . . 64.329999999999998 109.165 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.98 156.34 63.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 73.409999999999997 111.785 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.11 135.85 60.2 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.358 2.038 . . . . 75.400000000000006 112.217 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 98.1 mttt 61.83 35.12 16.73 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.778 -0.647 . . . . 73.319999999999993 111.493 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.29 125.04 34.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.053 -0.521 . . . . 74.120000000000005 111.562 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.6 m -74.09 132.81 42.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.921 -0.581 . . . . 71.230000000000004 109.442 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -129.58 150.41 50.92 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.883 -0.414 . . . . 74.120000000000005 109.883 -171.239 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.567 ' N ' HD12 ' A' ' 121' ' ' LEU . 90.0 t -98.73 131.06 46.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 110.378 -0.23 . . . . 74.230000000000004 110.378 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.448 ' CE2' HD13 ' A' ' 121' ' ' LEU . 56.5 m-85 -130.32 118.76 21.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 55.210000000000001 110.644 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 46.8 mt-10 -77.73 107.8 10.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.759 -0.83 . . . . 75.120000000000005 108.759 171.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.15 147.33 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 123.325 0.391 . . . . 55.229999999999997 110.312 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.96 128.92 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 75.209999999999994 110.703 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.9 tm? -96.14 115.91 28.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.85 -43.41 10.05 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.643 0.258 . . . . 73.209999999999994 110.998 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.39 135.29 17.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.348 -0.387 . . . . 73.019999999999996 110.388 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.562 HG22 ' HA ' ' A' ' 40' ' ' PRO . 2.9 p . . . . . 0 C--O 1.251 1.149 0 CA-C-N 116.23 -0.441 . . . . 71.349999999999994 111.235 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 109.697 -0.483 . . . . 73.310000000000002 109.697 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.62 97.39 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 70.140000000000001 111.691 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -108.14 106.67 16.98 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.814 -1.18 . . . . 75.329999999999998 107.814 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -57.5 102.66 0.1 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.589 -0.732 . . . . 73.230000000000004 111.246 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -67.42 81.92 0.16 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 75.319999999999993 109.74 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -93.05 124.68 37.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.45 -0.574 . . . . 73.329999999999998 109.45 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.549 ' CE1' ' SD ' ' A' ' 9' ' ' MET . 14.1 t-80 -158.26 121.16 3.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.484 -0.325 . . . . 71.439999999999998 110.203 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.75 79.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 73.239999999999995 109.663 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.549 ' SD ' ' CE1' ' A' ' 7' ' ' HIS . 11.0 tpt -83.87 -59.65 2.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 75.209999999999994 110.305 -174.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.2 -167.33 29.63 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.79 -0.641 . . . . 72.519999999999996 112.092 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 p -135.73 110.97 8.99 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 110.05 -0.352 . . . . 74.140000000000001 110.05 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.24 -48.58 70.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.539 . . . . 72.230000000000004 109.546 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -112.54 114.74 27.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.383 -0.826 . . . . 63.329999999999998 109.128 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.16 -35.19 31.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.232 -0.44 . . . . 72.420000000000002 111.477 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 54.04 56.13 7.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.169 -0.678 . . . . 75.299999999999997 109.169 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.7 p 47.37 80.71 0.05 OUTLIER 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.366 -0.834 . . . . 75.230000000000004 110.735 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.58 141.79 56.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.126 -0.943 . . . . 72.329999999999998 111.133 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.01 -152.79 18.09 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.241 -0.743 . . . . 74.25 111.241 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.2 -11.08 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.535 2.156 . . . . 73.400000000000006 112.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.65 -158.37 27.72 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.565 -0.614 . . . . 72.409999999999997 111.565 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.4 m -62.4 131.91 50.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.449 0.299 . . . . 73.519999999999996 110.763 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.1 mmt -68.85 79.03 0.31 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.26 0.553 . . . . 74.010000000000005 110.974 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.4 m -157.87 -161.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.244 -0.889 . . . . 72.25 109.34 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.42 90.14 0.23 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.904 0.383 . . . . 75.019999999999996 110.783 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -92.12 137.77 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 73.129999999999995 109.872 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.3 tp -145.92 102.02 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.784 0.326 . . . . 72.129999999999995 111.019 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' H ' ' HB ' ' A' ' 99' ' ' THR . 50.1 mm-40 -113.62 140.68 48.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.99 -0.744 . . . . 65.329999999999998 108.99 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 9.1 ptpp? -128.32 111.92 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 71.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -123.41 110.0 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 74.450000000000003 109.878 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 9.9 p -71.37 128.06 34.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.842 0.353 . . . . 74.030000000000001 111.314 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 97' ' ' LEU . 3.0 mm? -86.96 -38.08 16.97 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.592 -0.522 . . . . 73.129999999999995 109.592 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.1 m -141.6 112.7 6.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.966 -0.561 . . . . 74.030000000000001 110.187 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.15 146.09 62.81 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.51 2.14 . . . . 71.120000000000005 111.638 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.62 -164.64 28.23 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.271 -0.49 . . . . 71.150000000000006 112.717 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.79 -40.89 63.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.092 0.472 . . . . 72.409999999999997 110.996 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 -30.78 2.48 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.734 -0.667 . . . . 51.130000000000003 112.657 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.6 -24.5 8.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.032 0.444 . . . . 74.230000000000004 110.43 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.432 ' HG1' ' HB3' ' A' ' 92' ' ' LEU . 15.2 p -75.05 139.58 42.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.552 -0.749 . . . . 54.219999999999999 110.436 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -126.41 113.72 23.29 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.504 -0.316 . . . . 71.519999999999996 110.896 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.64 130.95 14.17 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.429 2.086 . . . . 72.230000000000004 111.451 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.47 149.28 44.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.43 -0.35 . . . . 75.109999999999999 110.815 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.32 164.5 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.111 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.24 34.48 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.156 -0.474 . . . . 73.239999999999995 112.73 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -101.44 146.7 27.27 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 75.150000000000006 111.597 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -77.42 110.85 12.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.299 -0.864 . . . . 63.310000000000002 109.282 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.9 m -106.4 148.76 10.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.945 0.403 . . . . 72.019999999999996 111.662 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.9 m -102.53 108.19 19.4 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 115.02 -0.991 . . . . 54.210000000000001 110.515 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.507 HG22 ' HE1' ' A' ' 72' ' ' PHE . 33.1 m -119.21 178.36 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 114.64 -1.164 . . . . 54.299999999999997 111.931 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 13.8 t-160 -157.51 147.32 20.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.199 -1.037 . . . . 71.409999999999997 108.199 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.6 m-85 -132.99 157.39 45.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.822 0.283 . . . . 74.140000000000001 111.383 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.822 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 45.0 m-20 -136.0 122.32 20.52 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.693 -0.685 . . . . 72.430000000000007 109.863 170.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.29 129.79 10.32 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.664 -0.574 . . . . 64.230000000000004 111.664 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -149.0 143.77 26.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 75.299999999999997 110.825 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 147.5 40.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.943 -0.391 . . . . 75.120000000000005 109.943 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.32 -22.49 49.66 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.894 2.396 . . . . 75.109999999999999 112.067 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.32 -34.27 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.5 -0.773 . . . . 72.329999999999998 110.797 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.59 -38.45 2.19 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.059 -0.816 . . . . 62.229999999999997 111.059 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.95 123.12 16.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.508 -0.346 . . . . 73.120000000000005 110.328 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -75.65 144.19 41.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.506 . . . . 72.329999999999998 110.917 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -72.93 -45.22 59.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.521 -0.548 . . . . 73.530000000000001 109.521 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -166.7 131.3 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 72.129999999999995 109.459 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -78.74 85.6 4.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.239 0.542 . . . . 74.510000000000005 109.865 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -72.66 -14.0 61.49 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.438 0.637 . . . . 73.299999999999997 110.086 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.691 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 13.1 ptt-85 -64.46 -35.96 82.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.42 -0.809 . . . . 75.5 110.678 171.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -69.17 -18.2 63.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.098 0.475 . . . . 52.329999999999998 110.057 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -82.32 -14.2 55.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.989 -0.551 . . . . 75.439999999999998 110.574 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.81 32.82 59.27 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.816 -0.629 . . . . 63.329999999999998 113.578 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -106.47 109.57 63.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.755 0.278 . . . . 75.340000000000003 110.98 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -90.5 125.68 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.948 2.432 . . . . 73.209999999999994 112.054 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.77 162.63 14.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.33 -0.618 . . . . 71.25 109.33 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.95 137.35 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.414 -0.178 . . . . 75.030000000000001 110.767 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.507 ' HE1' HG22 ' A' ' 48' ' ' VAL . 35.1 p90 -159.27 155.28 26.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.213 -0.195 . . . . 73.400000000000006 110.616 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.6 m -72.09 113.8 9.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.431 -0.35 . . . . 75.200000000000003 110.687 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.466 HD12 HG13 ' A' ' 87' ' ' VAL . 55.8 tp -61.97 133.56 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.7 -0.482 . . . . 75.129999999999995 109.7 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.75 68.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 70.140000000000001 112.803 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.39 11.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 74.430000000000007 110.525 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.91 31.68 3.33 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.475 -0.393 . . . . 71.230000000000004 112.631 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -63.74 -43.54 96.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 110.593 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.675 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 26.8 m -128.75 177.73 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 62.130000000000003 110.147 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.3 pt -68.92 152.77 9.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.687 0.279 . . . . 75.420000000000002 110.389 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 5.6 tmtm? -56.25 -29.02 60.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.073 -0.512 . . . . 74.329999999999998 109.94 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.44 -54.43 36.09 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.133 -0.556 . . . . 74.310000000000002 112.057 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.675 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 26.0 m0 -68.75 -38.17 79.93 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.52 -0.178 . . . . 71.340000000000003 110.52 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -54.51 -49.3 70.51 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.215 0.531 . . . . 72.430000000000007 110.389 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -65.03 -41.32 95.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 74.129999999999995 110.267 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.04 43.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.924 -0.58 . . . . 70.400000000000006 112.492 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.478 ' HA ' ' SD ' ' A' ' 90' ' ' MET . 6.6 p -71.03 -31.81 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.685 0.279 . . . . 63.539999999999999 111.068 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.59 -30.66 67.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 72.340000000000003 111.659 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 -15.65 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.93 0.344 . . . . 73.040000000000006 111.93 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 87' ' ' VAL . 16.5 ptm -91.01 -175.39 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.581 0.229 . . . . 71.329999999999998 110.828 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -126.51 175.23 8.06 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 75.530000000000001 111.14 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.781 ' HA ' HD11 ' A' ' 127' ' ' LEU . 7.2 tt -73.84 137.58 43.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.698 0.285 . . . . 74.120000000000005 110.26 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.489 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.25 10.58 85.9 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.652 -0.579 . . . . 72.25 111.652 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.86 149.65 30.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.607 -0.296 . . . . 71.340000000000003 110.63 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . 13.9 ptmt -140.43 133.45 29.35 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.498 -0.556 . . . . 74.540000000000006 109.498 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -131.43 156.71 45.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.693 -0.685 . . . . 55.240000000000002 111.037 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.563 ' HB2' HD21 ' A' ' 31' ' ' LEU . 8.7 tt -90.73 107.2 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.061 -1.089 . . . . 64.409999999999997 108.061 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -111.46 114.43 27.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.85 -0.426 . . . . 65.010000000000005 109.85 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.473 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 22.3 m -76.88 118.44 19.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.5 -0.318 . . . . 72.409999999999997 110.805 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 105' ' ' ALA . 40.0 mm -101.75 110.84 63.05 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 120.675 0.274 . . . . 60.109999999999999 110.414 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.548 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.3 Cg_endo -62.46 143.44 93.24 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.634 2.222 . . . . 73.230000000000004 111.889 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -54.26 -32.58 56.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.691 -0.686 . . . . 75.519999999999996 111.982 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.32 -23.34 65.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.074 0.398 . . . . 73.140000000000001 112.074 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.3 mt -96.12 -28.25 14.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.671 0.272 . . . . 73.129999999999995 111.549 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 100' ' ' ILE . . . -110.06 -174.34 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 75.530000000000001 111.127 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -70.12 -7.44 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.621 . . . . 75.329999999999998 111.08 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.33 -28.84 51.52 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 113.089 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 7.6 tm-20 -64.28 -49.85 70.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.365 -0.605 . . . . 70.209999999999994 109.365 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -27.32 58.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.491 -0.777 . . . . 75.25 110.48 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 80.14 -82.83 1.43 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.616 -0.72 . . . . 74.310000000000002 111.77 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.571 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 58.8 m-85 89.33 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.209 1.404 . . . . 75.400000000000006 111.986 -175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 59.4 Cg_endo -89.0 152.67 5.8 Favored 'Trans proline' 0 C--N 1.366 1.482 0 CA-C-N 121.693 1.64 . . . . 74.049999999999997 111.665 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.33 -7.78 13.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.557 2.171 . . . . 75.519999999999996 112.369 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.95 -31.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 109.938 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.89 101.92 48.68 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.812 -0.631 . . . . 64.329999999999998 109.899 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 Cg_endo -67.08 119.64 6.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.241 1.961 . . . . 73.409999999999997 111.388 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.34 133.96 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.683 2.922 . . . . 75.400000000000006 113.42 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 54.0 mtmt 73.0 31.68 1.45 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.645 0.778 . . . . 73.319999999999993 111.124 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -93.77 123.86 37.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.878 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 101' ' ' PRO . 74.0 m -73.69 127.64 33.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.257 -0.646 . . . . 71.230000000000004 109.257 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.498 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -120.88 137.09 54.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.547 -0.538 . . . . 74.120000000000005 109.547 -170.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.498 ' N ' HD13 ' A' ' 121' ' ' LEU . 88.7 t -98.51 131.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.691 0.281 . . . . 74.230000000000004 110.424 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.29 123.04 41.22 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.947 -0.39 . . . . 55.210000000000001 109.947 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.822 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 51.0 mt-10 -75.34 115.34 14.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.553 -0.906 . . . . 75.120000000000005 108.553 171.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 m -95.74 137.17 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.653 0.595 . . . . 55.229999999999997 109.413 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.726 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 36.3 tt0 -136.61 117.71 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.589 -0.522 . . . . 75.209999999999994 109.589 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 92' ' ' LEU . 3.1 tm? -99.87 106.3 18.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.72 -0.845 . . . . 72.310000000000002 108.72 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 49' ' ' HIS . 3.6 mm? -78.2 -45.83 22.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.41 -0.589 . . . . 73.209999999999994 109.41 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -170.81 -173.61 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.528 -0.76 . . . . 73.019999999999996 109.92 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.114 -0.946 . . . . 71.349999999999994 108.669 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.688 0.28 . . . . 73.310000000000002 110.543 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.36 114.63 26.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 70.140000000000001 110.078 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -71.56 95.7 1.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.325 0.583 . . . . 75.329999999999998 111.263 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -77.3 93.31 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 73.230000000000004 109.714 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -137.59 0.95 2.31 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.63 -0.259 . . . . 75.319999999999993 111.667 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -125.27 155.34 40.32 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.884 -0.413 . . . . 73.329999999999998 109.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -153.33 141.6 20.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.744 -0.207 . . . . 71.439999999999998 110.716 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -99.13 -24.89 14.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.351 -0.386 . . . . 73.239999999999995 110.888 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.9 tpp -82.47 131.38 35.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.857 0.361 . . . . 75.209999999999994 111.063 -177.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -179.37 18.6 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.073 -0.811 . . . . 72.519999999999996 111.073 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.3 m -75.33 87.47 2.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.037 0.419 . . . . 74.140000000000001 109.942 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt 56.31 52.39 10.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.012 -0.736 . . . . 72.230000000000004 109.012 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 73.29 -18.7 0.36 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.977 -1.01 . . . . 63.329999999999998 112.097 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.54 160.2 22.63 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.022 0.439 . . . . 72.420000000000002 110.803 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.31 174.07 7.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.803 -0.635 . . . . 75.299999999999997 110.171 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -86.37 166.72 15.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.308 -0.406 . . . . 75.230000000000004 110.569 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -79.58 172.93 13.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.081 -0.509 . . . . 72.329999999999998 109.968 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.44 151.01 39.27 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.029 -0.605 . . . . 74.25 111.735 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.29 152.09 66.38 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.399 2.066 . . . . 73.400000000000006 112.011 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.96 17.09 9.89 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.176 -0.535 . . . . 72.409999999999997 112.166 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -73.11 138.65 45.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.572 0.225 . . . . 73.519999999999996 110.652 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' A' ' 22' ' ' MET . 23.2 ptm -74.05 95.67 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 74.010000000000005 110.433 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 t -176.57 176.27 1.6 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.782 -0.644 . . . . 72.25 110.005 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.25 111.28 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.464 -0.569 . . . . 75.019999999999996 109.464 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.589 ' H ' ' HB3' ' A' ' 101' ' ' PRO . 8.8 mm-40 -91.89 135.48 33.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.393 -0.595 . . . . 73.129999999999995 109.393 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -144.4 102.41 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.945 0.402 . . . . 72.129999999999995 110.397 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.44 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 48.8 mt-10 -142.72 130.59 21.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 65.329999999999998 110.122 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -133.2 101.42 5.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.767 -0.827 . . . . 71.0 108.767 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -108.71 110.33 21.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 74.450000000000003 109.763 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.59 114.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.189 0.518 . . . . 74.030000000000001 110.336 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.7 mt -88.88 -33.02 17.47 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.843 -0.617 . . . . 73.129999999999995 110.117 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 44.7 m -145.49 120.58 5.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.523 -0.762 . . . . 74.030000000000001 109.397 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 146.44 51.99 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.608 2.205 . . . . 71.120000000000005 112.427 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -99.91 -172.06 30.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.069 -0.514 . . . . 71.150000000000006 112.431 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.422 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 78.2 m-20 -63.85 -36.88 85.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.034 0.445 . . . . 72.409999999999997 110.397 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.35 -30.29 2.18 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.774 -0.648 . . . . 51.130000000000003 113.039 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 m -82.25 -35.65 13.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.148 0.499 . . . . 74.230000000000004 110.07 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 12.3 p -84.83 115.57 22.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.585 -0.734 . . . . 54.219999999999999 109.476 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 8.3 mtmp? -124.39 132.23 24.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 71.519999999999996 111.063 -171.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.18 166.73 20.39 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.549 2.166 . . . . 72.230000000000004 110.997 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -165.21 166.38 18.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.404 -0.221 . . . . 75.109999999999999 110.404 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.39 141.66 52.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.337 -0.392 . . . . 74.420000000000002 110.936 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.59 20.3 41.3 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.068 -0.515 . . . . 73.239999999999995 111.877 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -130.61 138.16 49.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.695 0.398 . . . . 75.150000000000006 110.869 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -79.6 106.07 11.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.491 -0.929 . . . . 63.310000000000002 108.491 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 130' ' ' VAL . 28.2 m -106.49 146.19 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.365 . . . . 72.019999999999996 111.254 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.1 m -96.35 108.07 20.53 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.613 -0.721 . . . . 54.210000000000001 109.926 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.73 HG12 HD21 ' A' ' 127' ' ' LEU . 18.4 m -124.45 178.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.519 0.676 . . . . 54.299999999999997 111.234 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 15.4 t-80 -151.6 140.63 21.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.947 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 86.0 m-85 -126.5 144.01 51.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.595 -0.891 . . . . 74.140000000000001 108.595 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 8.9 t70 -136.15 110.71 8.59 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.469 -0.567 . . . . 72.430000000000007 109.469 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.46 137.4 30.88 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.938 -0.574 . . . . 64.230000000000004 112.154 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -148.01 137.16 22.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.002 0.43 . . . . 75.299999999999997 110.519 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 88.9 m-85 -78.53 146.8 70.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 75.120000000000005 110.168 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 30.5 Cg_exo -62.92 -10.39 20.12 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.97 2.446 . . . . 75.109999999999999 113.289 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -87.16 -4.94 59.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.675 0.274 . . . . 72.329999999999998 110.916 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.17 -24.58 15.79 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.742 -0.543 . . . . 62.229999999999997 111.742 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.675 ' HZ2' ' HB2' ' A' ' 58' ' ' LYS . 4.8 ttmp? -59.09 148.63 30.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.204 0.602 . . . . 73.120000000000005 110.896 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -94.88 143.62 26.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.025 -0.361 . . . . 72.329999999999998 110.025 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -86.47 -55.66 3.78 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.957 0.408 . . . . 73.530000000000001 110.558 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -138.67 131.41 29.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.348 -0.387 . . . . 72.129999999999995 110.323 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -76.19 85.12 3.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 74.510000000000005 109.95 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.0 p -90.33 -46.91 8.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.441 . . . . 73.299999999999997 109.95 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.3 ptt180 -60.64 -31.61 70.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.987 -0.551 . . . . 75.5 110.137 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -70.68 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 52.329999999999998 111.378 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -93.17 -2.27 55.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.907 0.384 . . . . 75.439999999999998 110.234 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.18 39.2 69.83 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.71 -0.677 . . . . 63.329999999999998 113.768 174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -141.81 122.63 8.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.796 0.298 . . . . 75.340000000000003 110.582 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.81 177.66 6.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.795 2.33 . . . . 73.209999999999994 111.861 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -135.02 129.92 34.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 71.25 109.848 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -100.45 141.91 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.293 -0.262 . . . . 75.030000000000001 110.293 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.52 ' HZ ' HG13 ' A' ' 87' ' ' VAL . 11.6 p90 -154.34 158.17 39.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.726 0.298 . . . . 73.400000000000006 110.265 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -83.69 109.43 17.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 110.033 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.72 142.06 56.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.447 -0.342 . . . . 75.129999999999995 110.435 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.21 26.9 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.891 -0.484 . . . . 70.140000000000001 111.891 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.81 168.95 18.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.696 0.398 . . . . 74.430000000000007 109.966 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.42 28.48 1.48 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.397 -0.43 . . . . 71.230000000000004 113.304 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.04 -34.84 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.292 0.568 . . . . 75.439999999999998 109.767 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.13 165.27 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.233 -0.894 . . . . 62.130000000000003 110.421 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 pt -80.66 164.63 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 75.420000000000002 110.526 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -55.9 -28.54 57.2 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.201 0.445 . . . . 74.329999999999998 112.201 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.52 -59.5 9.74 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 120.432 -0.889 . . . . 74.310000000000002 111.681 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.464 ' O ' HG12 ' A' ' 87' ' ' VAL . 27.0 m0 -66.0 -37.02 84.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.665 -0.268 . . . . 71.340000000000003 110.287 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.57 -55.01 39.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.936 -0.575 . . . . 72.430000000000007 110.842 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.83 -42.56 90.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 110.453 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.52 -48.68 69.01 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.014 -0.612 . . . . 70.400000000000006 112.682 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.52 HG13 ' HZ ' ' A' ' 72' ' ' PHE . 14.2 p -75.21 -32.94 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.826 0.346 . . . . 63.539999999999999 111.077 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.36 68.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.514 -0.312 . . . . 72.340000000000003 111.649 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 t -86.23 -4.46 59.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.215 0.45 . . . . 73.040000000000006 112.215 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 19.4 ptm -106.81 176.0 5.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.669 0.271 . . . . 71.329999999999998 110.889 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.1 p -118.65 174.55 6.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.764 0.316 . . . . 75.530000000000001 111.306 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 130' ' ' VAL . 7.6 tt -73.16 138.34 45.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 111.134 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.484 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.34 34.8 44.52 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.737 -0.665 . . . . 72.25 111.926 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 33.7 tt0 -134.52 153.71 51.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.945 0.402 . . . . 71.340000000000003 111.694 -169.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -131.41 122.36 26.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 74.540000000000006 109.845 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.76 141.57 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 55.240000000000002 110.62 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.407 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.7 tt -90.89 113.75 26.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.951 -0.759 . . . . 64.409999999999997 108.951 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -114.37 121.2 42.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.841 0.353 . . . . 65.010000000000005 110.389 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 31.2 m -78.67 116.06 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 72.409999999999997 110.294 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.7 mm -89.87 113.29 56.43 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 116.385 -0.371 . . . . 60.109999999999999 110.853 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 25' ' ' GLN . 73.5 Cg_endo -75.75 155.0 39.45 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.547 2.165 . . . . 73.230000000000004 111.556 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -54.17 -30.83 50.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.959 -0.564 . . . . 75.519999999999996 112.075 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.02 -26.8 64.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.729 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.4 mt -96.19 11.74 33.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.359 0.124 . . . . 73.129999999999995 111.286 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 -178.2 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 75.530000000000001 110.466 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -69.72 -8.27 46.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 75.329999999999998 110.783 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.83 -20.39 32.82 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.065 -0.516 . . . . 75.140000000000001 112.817 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -58.17 -51.95 67.58 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.562 -0.533 . . . . 70.209999999999994 109.562 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -84.33 -53.82 5.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.45 -0.795 . . . . 75.25 110.77 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.96 146.17 12.69 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.097 -0.501 . . . . 74.310000000000002 112.158 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.684 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -139.06 -55.41 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 122.369 0.268 . . . . 75.400000000000006 110.854 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.684 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 13.4 Cg_exo -70.01 128.34 15.66 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.942 1.761 . . . . 74.049999999999997 110.631 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.58 -27.67 26.29 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.82 2.347 . . . . 75.519999999999996 113.342 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.2 t -73.87 -35.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 74.310000000000002 110.56 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.54 106.17 17.35 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 64.329999999999998 109.549 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.493 ' O ' ' HB1' ' A' ' 119' ' ' ALA . 95.3 Cg_endo -79.66 163.38 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.406 2.071 . . . . 73.409999999999997 112.364 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.11 143.9 91.71 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.212 1.941 . . . . 75.400000000000006 111.17 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 65.92 28.19 10.7 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.24 0.338 . . . . 73.319999999999993 111.276 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 116' ' ' PRO . . . -76.34 148.96 37.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.18 0.514 . . . . 74.120000000000005 112.067 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.3 m -108.9 131.33 55.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.439 -0.8 . . . . 71.230000000000004 109.379 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.541 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -138.48 147.27 43.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.208 -0.664 . . . . 74.120000000000005 109.208 -175.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.541 ' N ' HD13 ' A' ' 121' ' ' LEU . 94.7 t -105.03 144.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.388 . . . . 74.230000000000004 110.98 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -133.01 125.6 30.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.021 0.439 . . . . 55.210000000000001 110.715 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 58.5 mt-10 -76.4 114.85 15.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.23 -0.656 . . . . 75.120000000000005 109.23 170.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.3 m -95.87 133.55 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 55.229999999999997 108.765 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 45.5 tt0 -139.02 116.64 11.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.39 -0.368 . . . . 75.209999999999994 110.265 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.73 HD21 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -96.04 111.71 23.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.557 -0.905 . . . . 72.310000000000002 108.557 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.05 -50.82 7.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.921 0.391 . . . . 73.209999999999994 110.065 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -167.1 178.82 5.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 73.019999999999996 109.905 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.599 HG21 HD13 ' A' ' 92' ' ' LEU . 46.6 t . . . . . 0 C--O 1.251 1.142 0 N-CA-C 108.843 -0.799 . . . . 71.349999999999994 108.843 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.727 0.298 . . . . 73.310000000000002 110.464 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.86 88.58 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 70.140000000000001 110.181 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.26 106.01 0.21 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.033 -0.53 . . . . 75.329999999999998 110.071 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -69.79 127.08 31.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.447 -0.797 . . . . 73.230000000000004 111.742 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -146.78 130.43 16.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.924 -0.58 . . . . 75.319999999999993 110.108 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -73.45 158.99 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.529 -0.915 . . . . 73.329999999999998 108.529 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.437 ' HD2' ' SD ' ' A' ' 9' ' ' MET . 85.3 t60 -54.73 99.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 71.439999999999998 110.943 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -62.15 111.71 2.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.861 -0.609 . . . . 73.239999999999995 110.676 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.437 ' SD ' ' HD2' ' A' ' 7' ' ' HIS . 94.8 mmm -85.21 145.49 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 75.209999999999994 109.815 176.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.9 95.43 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.125 -0.559 . . . . 72.519999999999996 112.218 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -57.32 100.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.766 0.317 . . . . 74.140000000000001 110.429 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.3 178.4 3.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 111.568 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.23 105.26 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 63.329999999999998 110.804 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 98.74 5.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.48 -0.563 . . . . 72.420000000000002 109.48 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.01 -19.73 43.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.094 -0.503 . . . . 75.299999999999997 110.264 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.6 m -110.48 138.1 47.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.025 -0.534 . . . . 75.230000000000004 109.824 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -83.04 157.93 22.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.931 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.84 165.68 26.81 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.991 -0.549 . . . . 74.25 111.795 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.85 99.19 0.21 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.49 2.126 . . . . 73.400000000000006 112.032 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.11 21.16 9.12 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 112.96 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.1 m -67.1 81.4 0.12 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.797 0.332 . . . . 73.519999999999996 110.866 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 58.13 15.44 3.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.807 -0.633 . . . . 74.010000000000005 111.803 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -150.16 128.86 12.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 72.25 109.273 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.46 127.21 31.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 75.019999999999996 111.688 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -95.88 135.46 37.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.635 -0.876 . . . . 73.129999999999995 108.635 172.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 102.04 8.42 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.039 0.447 . . . . 72.129999999999995 111.02 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.27 130.1 56.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 65.329999999999998 109.993 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.669 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -140.88 117.18 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.549 -0.751 . . . . 71.0 109.209 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.55 118.09 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.481 -0.327 . . . . 74.450000000000003 110.542 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.02 134.0 27.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 74.030000000000001 110.374 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.87 -18.45 13.69 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.409 -0.36 . . . . 73.129999999999995 110.688 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 88.2 m -142.71 110.63 5.7 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.148 -0.316 . . . . 74.030000000000001 110.148 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.23 126.13 10.83 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.766 2.311 . . . . 71.120000000000005 111.053 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.2 -171.29 47.3 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.236 -0.507 . . . . 71.150000000000006 113.177 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.467 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -57.61 -34.76 69.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.603 0.361 . . . . 72.409999999999997 111.346 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.524 ' HA2' HG22 ' A' ' 91' ' ' THR . . . 76.08 -25.59 1.54 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.281 -0.485 . . . . 51.130000000000003 113.474 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 35' ' ' ASP . 34.1 m -75.12 -21.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.872 0.368 . . . . 74.230000000000004 111.471 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -81.07 128.92 34.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 54.219999999999999 111.222 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -100.09 110.24 58.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.47 . . . . 71.519999999999996 109.988 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.24 134.15 13.99 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 72.230000000000004 111.161 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -127.96 141.72 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 75.109999999999999 110.371 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 162.13 29.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.01 -0.541 . . . . 74.420000000000002 111.776 -176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.95 77.17 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.562 -0.744 . . . . 73.239999999999995 112.981 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.4 170.73 15.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.075 0.464 . . . . 75.150000000000006 111.719 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -78.64 142.75 36.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 63.310000000000002 111.495 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.15 141.94 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.845 -0.616 . . . . 72.019999999999996 110.112 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.3 m -93.68 108.12 19.9 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.764 -0.653 . . . . 54.210000000000001 110.277 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.506 HG11 HD21 ' A' ' 127' ' ' LEU . 20.4 m -123.78 178.33 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.995 -1.002 . . . . 54.299999999999997 111.325 -172.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.559 ' HB3' HD23 ' A' ' 128' ' ' LEU . 8.9 t-80 -157.83 143.35 17.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.391 -0.822 . . . . 71.409999999999997 109.136 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 49.2 p90 -141.49 150.21 41.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.49 0.186 . . . . 74.140000000000001 110.953 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.19 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.063 -0.517 . . . . 72.430000000000007 110.292 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.28 148.44 17.05 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 116.323 -0.399 . . . . 64.230000000000004 112.484 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.54 143.25 17.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.881 -0.414 . . . . 75.299999999999997 109.881 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.91 140.21 27.66 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 75.120000000000005 110.401 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.82 -13.3 21.72 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.721 2.281 . . . . 75.109999999999999 111.432 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.57 -25.71 39.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.044 -0.98 . . . . 72.329999999999998 110.883 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.31 23.73 12.31 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.278 -0.729 . . . . 62.229999999999997 111.278 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HZ2' ' HB3' ' A' ' 58' ' ' LYS . 7.1 ttpm? -149.16 147.12 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.933 -0.395 . . . . 73.120000000000005 109.933 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.05 136.62 53.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.128 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -65.25 -54.28 31.66 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.326 -0.397 . . . . 73.530000000000001 110.002 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.23 160.65 43.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.621 -0.718 . . . . 72.129999999999995 109.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 64' ' ' ARG . 39.5 m -117.41 121.57 41.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.379 -0.373 . . . . 74.510000000000005 110.457 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.6 m -70.35 -29.25 65.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 73.299999999999997 109.88 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.485 HH12 ' HD2' ' A' ' 95' ' ' LYS . 8.8 ptm180 -59.85 -31.03 69.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 75.5 111.336 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.2 m -57.05 -30.25 64.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.451 -0.34 . . . . 52.329999999999998 110.655 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 5.4 mmp_? -81.09 -10.55 59.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.158 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.31 48.66 84.16 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 112.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 20.5 tptm -112.61 115.23 49.31 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 122.826 -0.22 . . . . 75.340000000000003 110.481 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 4.1 Cg_exo -81.26 167.62 17.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.15 2.566 . . . . 73.209999999999994 111.928 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.437 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 97.1 m-85 -136.2 158.97 43.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 71.25 110.087 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 97.6 mt-30 -143.57 135.87 26.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.874 -0.417 . . . . 75.030000000000001 109.874 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' HE1' HG12 ' A' ' 48' ' ' VAL . 11.6 p90 -150.54 160.42 43.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 121.057 -0.257 . . . . 73.400000000000006 110.623 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.46 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 15.2 m -85.42 104.66 15.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 75.200000000000003 110.271 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.72 HD11 ' HB1' ' A' ' 88' ' ' ALA . 51.0 tp -55.89 137.09 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 75.129999999999995 111.046 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.02 -30.45 5.48 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.091 -0.576 . . . . 70.140000000000001 112.626 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.05 178.27 7.65 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.279 . . . . 74.430000000000007 111.095 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.48 53.9 4.78 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.883 -0.487 . . . . 71.230000000000004 111.883 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' A' ' 73' ' ' THR . 5.7 mm-40 -90.71 -44.93 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.043 0.449 . . . . 75.439999999999998 110.552 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.5 m -136.82 177.89 5.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.678 -0.692 . . . . 62.130000000000003 110.089 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.479 HD13 ' O ' ' A' ' 104' ' ' LEU . 18.0 pt -68.19 140.97 18.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 109.95 -0.389 . . . . 75.420000000000002 109.95 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.598 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 61.6 mmtt -63.71 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.617 0.599 . . . . 74.329999999999998 112.617 -173.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -56.98 22.26 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.43 -0.89 . . . . 74.310000000000002 111.017 171.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -69.15 -40.17 78.36 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.271 -0.27 . . . . 71.340000000000003 110.271 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.598 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 12.4 t70 -51.75 -55.19 21.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.746 -0.661 . . . . 72.430000000000007 110.528 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.99 -42.17 70.0 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.077 -0.51 . . . . 74.129999999999995 110.685 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.31 -49.97 48.79 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.045 -0.598 . . . . 70.400000000000006 112.073 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.538 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.7 p -75.93 -31.93 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.692 0.282 . . . . 63.539999999999999 110.942 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 74' ' ' LEU . . . -59.74 -35.29 74.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.692 0.282 . . . . 72.340000000000003 111.735 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 t -87.73 6.56 34.37 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.269 0.47 . . . . 73.040000000000006 112.269 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 13.8 ptp -112.01 177.89 4.5 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.046 -0.408 . . . . 71.329999999999998 110.552 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' HA2' ' A' ' 36' ' ' GLY . 42.5 p -121.1 178.82 4.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.852 0.358 . . . . 75.530000000000001 111.708 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.808 ' HA ' HD11 ' A' ' 127' ' ' LEU . 7.8 tt -61.99 129.97 43.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.703 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.69 17.25 77.8 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.781 -0.645 . . . . 72.25 112.457 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 32' ' ' THR . 14.6 tt0 -106.98 136.35 46.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 71.340000000000003 110.313 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.485 ' HD2' HH12 ' A' ' 64' ' ' ARG . 28.3 ttpp -131.7 126.76 35.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.988 -0.551 . . . . 74.540000000000006 110.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.87 142.12 50.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 55.240000000000002 110.892 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 tt -90.79 117.23 29.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.395 -0.965 . . . . 64.409999999999997 108.395 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.37 122.44 38.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.5 . . . . 65.010000000000005 109.649 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 54.1 m -81.89 106.51 13.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.66 -0.496 . . . . 72.409999999999997 109.66 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.0 mm -85.64 112.3 43.64 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 115.978 -0.555 . . . . 60.109999999999999 110.236 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.623 ' HA ' HG22 ' A' ' 120' ' ' THR . 38.2 Cg_endo -66.4 159.33 50.81 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.205 1.937 . . . . 73.230000000000004 111.075 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.524 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 38.4 p90 -54.41 -31.5 55.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 75.519999999999996 111.348 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.47 -30.04 70.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.515 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 80' ' ' ILE . 88.0 mt -105.38 13.13 30.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.327 -0.397 . . . . 73.129999999999995 111.544 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.15 176.17 10.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.075 0.464 . . . . 75.530000000000001 111.435 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -68.47 -14.98 63.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.559 -0.746 . . . . 75.329999999999998 110.617 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.91 -16.42 47.02 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.926 -0.579 . . . . 75.140000000000001 113.045 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 35.0 tt0 -56.2 -55.23 35.66 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.074 0.464 . . . . 70.209999999999994 110.327 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -98.81 -35.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.831 . . . . 75.25 110.52 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.67 161.98 10.99 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.805 -0.634 . . . . 74.310000000000002 112.399 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.696 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.7 m-85 -135.39 -57.18 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 122.23 0.212 . . . . 75.400000000000006 110.486 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.696 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 68.7 Cg_endo -91.25 142.41 2.99 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.003 1.802 . . . . 74.049999999999997 111.854 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.05 -18.69 17.88 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.771 2.314 . . . . 75.519999999999996 112.737 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.61 -36.88 77.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.017 -0.538 . . . . 74.310000000000002 110.201 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.4 mm -110.16 99.11 38.3 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 109.304 -0.628 . . . . 64.329999999999998 109.304 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 159.79 51.96 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.626 2.217 . . . . 73.409999999999997 112.513 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.71 147.25 89.75 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.233 1.955 . . . . 75.400000000000006 111.665 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 7.0 mtmp? 69.69 22.85 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.069 0.548 . . . . 73.319999999999993 110.629 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.56 131.62 35.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.114 0.483 . . . . 74.120000000000005 111.31 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -97.98 127.99 44.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.182 -0.673 . . . . 71.230000000000004 109.182 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -129.44 143.6 50.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.789 -0.448 . . . . 74.120000000000005 109.789 -171.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.544 ' N ' HD12 ' A' ' 121' ' ' LEU . 46.9 t -98.3 131.82 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.117 -0.327 . . . . 74.230000000000004 110.117 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.55 132.17 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.656 0.265 . . . . 55.210000000000001 111.153 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 30.9 mt-10 -82.44 112.29 19.24 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.12 -0.696 . . . . 75.120000000000005 109.12 170.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.494 HG23 ' HE3' ' A' ' 90' ' ' MET . 11.1 m -97.06 135.45 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.097 -0.705 . . . . 55.229999999999997 109.097 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.443 ' OE2' ' HD3' ' A' ' 95' ' ' LYS . 45.2 tt0 -141.3 121.46 13.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.319 -0.401 . . . . 75.209999999999994 110.427 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.808 HD11 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -93.54 113.95 26.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.613 -0.884 . . . . 72.310000000000002 108.613 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 49' ' ' HIS . 3.9 mm? -87.78 -50.72 6.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.804 0.335 . . . . 73.209999999999994 110.125 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.22 -173.41 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 73.019999999999996 110.094 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.768 -0.634 . . . . 71.349999999999994 109.532 173.562 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.048 -0.353 . . . . 73.310000000000002 110.048 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.94 131.68 1.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.278 -0.419 . . . . 70.140000000000001 110.153 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -119.19 95.35 4.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.483 -0.326 . . . . 75.329999999999998 110.309 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -68.89 84.51 0.32 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.743 -0.836 . . . . 73.230000000000004 108.743 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -98.24 160.6 14.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.35 -0.841 . . . . 75.319999999999993 111.454 -171.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -83.81 162.48 20.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 73.329999999999998 110.061 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -96.91 101.57 13.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.281 -0.418 . . . . 71.439999999999998 109.891 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -74.07 141.59 45.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.853 -0.425 . . . . 73.239999999999995 109.853 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp -137.38 -179.91 6.01 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.213 -0.449 . . . . 75.209999999999994 110.4 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.34 124.47 5.31 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.278 -0.729 . . . . 72.519999999999996 111.278 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -77.86 117.42 19.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.825 0.312 . . . . 74.140000000000001 110.367 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' N ' HD13 ' A' ' 12' ' ' LEU . 6.9 mp -54.99 -62.23 1.8 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.385 0.428 . . . . 72.230000000000004 109.858 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -103.15 119.2 38.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 63.329999999999998 109.198 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.11 -177.33 1.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 72.420000000000002 111.399 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -64.29 148.21 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 75.299999999999997 110.809 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 p -84.81 13.29 6.0 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.177 0.513 . . . . 75.230000000000004 111.489 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -145.66 140.07 27.05 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.946 -0.57 . . . . 72.329999999999998 109.97 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.86 -143.04 3.56 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.601 -0.6 . . . . 74.25 111.601 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.5 34.94 0.54 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.182 2.588 . . . . 73.400000000000006 112.284 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.71 70.9 2.95 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.31 -0.471 . . . . 72.409999999999997 112.637 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.2 t -152.48 135.35 15.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.252 -0.647 . . . . 73.519999999999996 109.252 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -81.3 -19.94 41.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.691 0.282 . . . . 74.010000000000005 111.158 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -78.93 166.58 22.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 72.25 110.651 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.24 109.88 1.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.676 -0.693 . . . . 75.019999999999996 111.266 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -92.27 135.0 34.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.649 -0.871 . . . . 73.129999999999995 108.649 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 55.0 tp -145.83 102.8 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.418 0.525 . . . . 72.129999999999995 112.418 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -111.93 132.43 54.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.067 -0.716 . . . . 65.329999999999998 109.067 165.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -129.95 101.27 5.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.508 -0.923 . . . . 71.0 108.508 176.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -123.03 113.74 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 74.450000000000003 110.736 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 6.5 p -64.38 114.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 74.030000000000001 110.863 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.18 -49.75 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.445 -0.576 . . . . 73.129999999999995 109.445 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -112.4 113.54 51.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.369 -0.832 . . . . 74.030000000000001 109.423 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.79 140.86 52.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.634 2.223 . . . . 71.120000000000005 112.438 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -98.53 -169.38 31.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.39 -0.433 . . . . 71.150000000000006 112.66 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.42 -46.07 67.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.781 0.324 . . . . 72.409999999999997 110.434 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 91' ' ' THR . . . 95.2 -20.74 47.85 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.093 -0.503 . . . . 51.130000000000003 113.931 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -103.24 -0.86 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 117.687 0.743 . . . . 74.230000000000004 112.634 -172.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.3 p -85.07 142.18 29.73 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.713 0.292 . . . . 54.219999999999999 110.568 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -113.43 119.57 41.6 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.387 -0.369 . . . . 71.519999999999996 110.025 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 14.4 Cg_exo -69.56 143.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.18 . . . . 72.230000000000004 111.582 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.54 141.82 23.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.826 0.346 . . . . 75.109999999999999 110.52 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.752 -0.658 . . . . 74.420000000000002 111.71 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.98 19.56 57.37 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.628 -0.715 . . . . 73.239999999999995 113.058 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.47 161.73 36.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.077 0.439 . . . . 75.150000000000006 110.813 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.6 tppp? -81.63 117.12 21.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.836 -0.62 . . . . 63.310000000000002 109.636 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.403 HG12 HD23 ' A' ' 74' ' ' LEU . 27.5 m -110.35 151.38 12.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 120.901 0.382 . . . . 72.019999999999996 110.539 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -117.01 108.18 15.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.562 -0.745 . . . . 54.210000000000001 110.169 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.01 178.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.589 -0.732 . . . . 54.299999999999997 110.494 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 63.7 t60 -149.24 146.48 27.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.09 -0.707 . . . . 71.409999999999997 109.09 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -126.59 152.53 46.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.701 -0.481 . . . . 74.140000000000001 109.701 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.72 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 35.7 m-20 -135.6 112.74 10.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.498 -0.927 . . . . 72.430000000000007 108.498 172.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.95 111.13 3.33 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.936 -0.575 . . . . 64.230000000000004 112.609 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 53' ' ' ARG . 22.3 ttt180 -122.38 137.49 54.84 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.32 0.581 . . . . 75.299999999999997 111.019 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -89.23 151.91 47.17 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 109.886 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.64 -17.63 36.27 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.177 2.585 . . . . 75.109999999999999 114.006 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.94 -14.74 53.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.853 0.359 . . . . 72.329999999999998 110.606 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.36 -1.02 37.35 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.219 -0.515 . . . . 62.229999999999997 112.425 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HZ1' ' HB2' ' A' ' 58' ' ' LYS . 3.7 ttmp? -94.43 157.23 16.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.544 -0.539 . . . . 73.120000000000005 109.544 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.73 -0.471 . . . . 72.329999999999998 109.73 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.23 -46.97 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.530000000000001 111.324 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.01 131.28 45.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.355 -0.384 . . . . 72.129999999999995 110.959 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 m -104.92 85.63 2.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 74.510000000000005 109.375 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -56.95 -28.86 62.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.059 -0.518 . . . . 73.299999999999997 110.835 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -53.91 -31.76 51.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.749 -0.66 . . . . 75.5 111.311 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -59.1 -37.32 76.88 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.886 0.374 . . . . 52.329999999999998 110.728 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -80.29 -11.54 59.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.992 -0.549 . . . . 75.439999999999998 110.564 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.41 18.99 59.42 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.132 -0.485 . . . . 63.329999999999998 112.106 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -82.14 119.13 74.34 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 122.363 0.265 . . . . 75.340000000000003 110.375 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.55 162.5 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.046 2.497 . . . . 73.209999999999994 112.352 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -122.69 117.0 24.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.37 -0.604 . . . . 71.25 109.37 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.559 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 92.2 mt-30 -107.06 140.96 39.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.573 -0.285 . . . . 75.030000000000001 110.468 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -156.89 167.6 29.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.479 -0.328 . . . . 73.400000000000006 110.23 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 m -82.07 108.93 15.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 110.294 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.403 HD23 HG12 ' A' ' 46' ' ' VAL . 45.1 tp -62.1 111.03 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.702 -0.481 . . . . 75.129999999999995 109.702 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.14 -24.56 5.64 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.214 -0.755 . . . . 70.140000000000001 111.214 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.63 145.2 47.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.4 -0.222 . . . . 74.430000000000007 110.4 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.41 43.61 2.33 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.429 -0.35 . . . . 71.230000000000004 113.064 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -82.54 -47.61 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 75.439999999999998 110.198 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.06 162.56 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.75 . . . . 62.130000000000003 110.949 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.435 HG12 ' CE3' ' A' ' 83' ' ' TRP . 35.4 pt -80.07 159.02 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.573 -0.528 . . . . 75.420000000000002 109.573 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 55.4 mmtt -60.41 -21.14 61.88 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.418 0.155 . . . . 74.329999999999998 111.418 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -47.97 88.19 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.599 -0.81 . . . . 74.310000000000002 111.574 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.435 ' CE3' HG12 ' A' ' 80' ' ' ILE . 18.1 m0 -79.76 -29.28 40.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.589 0.233 . . . . 71.340000000000003 110.401 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.567 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 6.6 t70 -58.0 -55.05 39.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.616 0.722 . . . . 72.430000000000007 109.792 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -67.68 -35.86 79.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.496 -0.774 . . . . 74.129999999999995 109.861 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.9 -49.35 58.99 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.766 -0.652 . . . . 70.400000000000006 112.434 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 12.2 p -75.24 -32.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 63.539999999999999 110.274 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -30.08 71.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.33 -0.396 . . . . 72.340000000000003 112.015 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -90.4 -14.86 32.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.116 0.413 . . . . 73.040000000000006 112.116 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.877 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.8 ptp -93.92 -179.77 5.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.691 0.281 . . . . 71.329999999999998 110.879 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.426 HG22 ' HA2' ' A' ' 36' ' ' GLY . 16.7 p -138.83 178.95 6.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.197 -0.456 . . . . 75.530000000000001 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.683 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -58.81 124.5 20.01 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.886 0.474 . . . . 74.120000000000005 110.694 -176.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.68 37.63 57.57 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.398 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.611 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.9 tt0 -124.2 126.62 46.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 71.340000000000003 110.975 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' HZ3' ' HB2' ' A' ' 126' ' ' GLU . 24.5 ttmm -114.9 115.06 26.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.803 -0.635 . . . . 74.540000000000006 109.549 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -113.52 145.42 41.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 110.638 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 28' ' ' LYS . 9.4 tt -90.63 105.4 17.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.04 -1.096 . . . . 64.409999999999997 108.04 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -112.13 126.39 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.337 -0.392 . . . . 65.010000000000005 110.423 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 26' ' ' LEU . 7.9 m -85.12 118.16 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.446 -0.343 . . . . 72.409999999999997 110.639 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.8 mm -99.05 108.57 50.19 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 110.387 -0.227 . . . . 60.109999999999999 110.387 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.99 140.94 39.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.097 2.531 . . . . 73.230000000000004 111.275 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.97 -29.56 57.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.454 -0.339 . . . . 75.519999999999996 111.836 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.2 -30.07 70.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.514 . . . . 73.140000000000001 111.644 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.88 9.06 43.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 73.129999999999995 111.777 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.26 178.95 8.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.145 0.498 . . . . 75.530000000000001 111.658 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -73.61 -2.47 23.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.495 -0.775 . . . . 75.329999999999998 111.332 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.31 -14.25 56.35 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.189 -0.459 . . . . 75.140000000000001 112.085 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 8.4 tm-20 -66.77 -49.42 65.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.413 -0.588 . . . . 70.209999999999994 109.413 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 117' ' ' PRO . 40.4 ttm180 -67.86 -52.08 40.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 75.25 110.695 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.61 172.29 3.84 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.101 -0.571 . . . . 74.310000000000002 111.952 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.687 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 88.5 m-85 -147.17 -63.64 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.782 0.291 . . . . 75.400000000000006 111.298 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 2.3 Cg_endo -84.23 141.36 9.14 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.213 1.942 . . . . 74.049999999999997 111.988 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.63 -21.93 57.89 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.692 2.261 . . . . 75.519999999999996 111.747 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.77 -35.34 63.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.772 -0.649 . . . . 74.310000000000002 110.115 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.02 92.95 46.66 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 64.329999999999998 109.218 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -52.02 147.24 27.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.038 2.492 . . . . 73.409999999999997 112.673 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 21.1 Cg_endo -59.83 153.43 56.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.727 2.285 . . . . 75.400000000000006 111.435 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 19.4 mtmm 59.1 53.11 5.69 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.393 0.616 . . . . 73.319999999999993 110.431 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.53 132.38 54.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.325 -0.852 . . . . 74.120000000000005 111.123 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.6 m -83.05 130.48 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.38 -0.6 . . . . 71.230000000000004 109.38 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.564 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -123.06 143.39 49.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.672 -0.492 . . . . 74.120000000000005 109.672 -173.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.564 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.2 t -100.53 116.13 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 74.230000000000004 109.832 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -109.06 116.58 32.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.096 -0.335 . . . . 55.210000000000001 110.096 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.8 mt-10 -78.58 106.86 10.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.181 -1.044 . . . . 75.120000000000005 108.181 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 13.4 m -97.59 149.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.047 -0.979 . . . . 55.229999999999997 110.112 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 63.8 tt0 -147.22 131.6 17.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.76 -0.2 . . . . 75.209999999999994 110.795 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.877 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 3.2 tm? -103.08 112.97 26.07 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.865 -0.42 . . . . 72.310000000000002 109.865 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -90.86 -41.48 11.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 110.324 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.43 139.1 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 73.019999999999996 109.932 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 119.37 -0.348 . . . . 71.349999999999994 110.401 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.709 0.29 . . . . 73.310000000000002 110.383 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.89 -70.68 0.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.522 . . . . 70.140000000000001 109.592 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -94.1 54.37 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.969 0.89 . . . . 75.329999999999998 109.037 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -140.0 81.08 1.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.764 -1.107 . . . . 73.230000000000004 108.856 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -92.26 -76.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 75.319999999999993 110.824 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -66.26 142.36 57.71 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.048 -0.524 . . . . 73.329999999999998 110.353 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.548 ' NE2' ' SD ' ' A' ' 9' ' ' MET . 84.0 t60 -145.93 39.54 1.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.193 0.52 . . . . 71.439999999999998 110.406 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -65.4 86.1 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.013 0.435 . . . . 73.239999999999995 109.959 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.548 ' SD ' ' NE2' ' A' ' 7' ' ' HIS . 16.4 ptm -103.06 4.27 37.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.695 -0.684 . . . . 75.209999999999994 110.108 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.1 -157.54 6.12 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.533 -0.758 . . . . 72.519999999999996 112.401 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -76.97 167.52 21.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.676 0.751 . . . . 74.140000000000001 111.972 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 12' ' ' LEU . 2.1 pt? -158.11 14.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.357 -1.292 . . . . 72.230000000000004 108.339 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -100.48 171.58 7.65 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.862 -1.063 . . . . 63.329999999999998 110.348 -172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.04 37.67 29.28 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.55 0.531 . . . . 72.420000000000002 110.44 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -66.68 -14.33 62.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.711 -0.677 . . . . 75.299999999999997 111.308 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -59.82 87.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.368 0.604 . . . . 75.230000000000004 110.214 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.36 -5.89 49.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.391 -0.822 . . . . 72.329999999999998 111.668 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.2 171.04 26.67 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.719 -0.552 . . . . 74.25 111.719 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.1 125.26 9.68 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.662 2.241 . . . . 73.400000000000006 112.039 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.39 25.01 9.45 Favored Glycine 0 N--CA 1.453 -0.168 0 N-CA-C 111.615 -0.594 . . . . 72.409999999999997 111.615 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -156.84 176.3 12.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.613 -0.514 . . . . 73.519999999999996 109.613 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.28 58.84 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.221 0.534 . . . . 74.010000000000005 110.11 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -76.7 37.81 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.603 -0.726 . . . . 72.25 111.482 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.66 89.04 1.73 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 75.019999999999996 110.015 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -132.28 135.31 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.716 -0.675 . . . . 73.129999999999995 109.497 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 5.9 tt -145.7 102.39 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.509 -0.552 . . . . 72.129999999999995 109.509 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.73 149.82 42.71 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.981 -0.554 . . . . 65.329999999999998 110.185 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 18.4 ptpt -127.98 103.7 7.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.637 -0.71 . . . . 71.0 109.448 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 66.8 mttm -109.1 110.39 21.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.825 -0.435 . . . . 74.450000000000003 109.825 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -71.87 97.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.486 0.66 . . . . 74.030000000000001 110.134 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.708 HD21 ' HD3' ' A' ' 95' ' ' LYS . 33.9 tp -76.94 -29.2 55.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 109.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 32.1 m -145.51 115.82 4.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 74.030000000000001 109.74 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.3 128.74 13.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.065 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.69 -159.81 22.05 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.177 -0.535 . . . . 71.150000000000006 112.44 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.46 -37.44 87.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.088 0.471 . . . . 72.409999999999997 110.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.21 -29.84 3.81 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.952 -0.567 . . . . 51.130000000000003 112.134 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.26 -34.12 7.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.737 0.303 . . . . 74.230000000000004 110.711 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 p -71.77 94.07 1.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.295 0.569 . . . . 54.219999999999999 110.983 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -88.06 125.91 62.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.494 -0.775 . . . . 71.519999999999996 110.452 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 90' ' ' MET . 86.3 Cg_endo -78.07 176.4 10.02 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.62 2.213 . . . . 72.230000000000004 111.547 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.97 167.25 14.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 109.905 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 156.24 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.345 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.71 73.64 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.15 -0.548 . . . . 73.239999999999995 112.562 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.742 ' HZ3' ' HB3' ' A' ' 44' ' ' LYS . 4.3 mmmp? -116.19 130.02 56.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.683 0.278 . . . . 75.150000000000006 110.738 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.83 104.01 3.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.68 -0.859 . . . . 63.310000000000002 108.68 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 34.1 m -105.86 142.54 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.157 0.503 . . . . 72.019999999999996 110.951 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.8 m -99.27 120.32 39.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.112 -0.949 . . . . 54.210000000000001 109.27 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG12 HG22 ' A' ' 87' ' ' VAL . 32.6 m -136.68 177.97 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.569 0.699 . . . . 54.299999999999997 112.454 -172.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 7.3 m170 -137.59 152.62 49.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.504 -1.226 . . . . 71.409999999999997 109.098 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -128.0 142.85 51.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 74.140000000000001 109.534 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.774 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 24.0 m-20 -135.4 119.73 17.87 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.017 -0.734 . . . . 72.430000000000007 109.017 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -82.68 114.32 3.82 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.214 -0.448 . . . . 64.230000000000004 112.295 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.501 HH11 HD13 ' A' ' 97' ' ' LEU . 42.1 ttm180 -130.8 148.5 52.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.428 0.633 . . . . 75.299999999999997 111.364 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -90.12 156.37 46.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.224 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.38 2.3 1.26 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.946 2.43 . . . . 75.109999999999999 112.861 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.76 -29.9 25.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.236 0.541 . . . . 72.329999999999998 110.517 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.85 -25.47 8.43 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.706 -0.679 . . . . 62.229999999999997 111.882 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -84.61 157.32 21.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.825 -0.435 . . . . 73.120000000000005 109.825 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 13.9 pt20 -141.84 -175.28 4.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.715 0.293 . . . . 72.329999999999998 110.905 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -86.06 -64.86 1.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 73.530000000000001 110.108 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -144.91 156.66 44.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.009 -0.367 . . . . 72.129999999999995 110.009 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.3 p -87.26 91.53 8.75 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.359 -0.608 . . . . 74.510000000000005 109.359 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.4 m -64.33 -27.39 68.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.829 -0.623 . . . . 73.299999999999997 111.155 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.24 69.4 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.434 -0.348 . . . . 75.5 110.424 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -73.8 -6.23 45.75 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.001 -0.545 . . . . 52.329999999999998 111.593 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.69 -2.82 31.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.084 0.468 . . . . 75.439999999999998 110.759 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.25 8.57 65.88 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 63.329999999999998 113.953 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.585 ' HD2' ' HD2' ' A' ' 69' ' ' PRO . 52.5 tptt -122.89 121.58 27.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 117.051 0.426 . . . . 75.340000000000003 109.971 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.585 ' HD2' ' HD2' ' A' ' 68' ' ' LYS . 68.1 Cg_endo -85.27 160.06 11.27 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.658 2.239 . . . . 73.209999999999994 112.276 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -114.33 158.14 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.127 -0.694 . . . . 71.25 109.127 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 85.7 mt-30 -134.77 139.48 45.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.574 0.226 . . . . 75.030000000000001 110.825 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.536 ' HE1' HG21 ' A' ' 48' ' ' VAL . 33.5 p90 -156.16 151.88 27.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.508 -0.553 . . . . 73.400000000000006 109.508 173.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.5 m -73.66 109.03 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 75.200000000000003 110.905 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.8 135.31 57.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.057 -0.519 . . . . 75.129999999999995 110.209 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.83 -11.52 71.91 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.119 -0.562 . . . . 70.140000000000001 112.135 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.13 160.95 14.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.202 -0.296 . . . . 74.430000000000007 110.202 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.65 2.62 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 121.2 -0.524 . . . . 71.230000000000004 112.756 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -85.75 -25.46 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 75.439999999999998 110.304 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.48 168.21 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.76 -0.655 . . . . 62.130000000000003 109.722 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 105' ' ' ALA . 14.4 pt -72.91 154.7 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.997 -0.372 . . . . 75.420000000000002 109.997 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 4.5 tmtm? -60.09 -28.42 67.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.475 -0.33 . . . . 74.329999999999998 110.756 -172.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.88 -54.55 36.55 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.923 -0.656 . . . . 74.310000000000002 112.003 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.442 ' O ' HG12 ' A' ' 87' ' ' VAL . 48.2 m0 -66.48 -41.25 89.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.025 -0.361 . . . . 71.340000000000003 110.025 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.11 -50.95 60.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.474 -0.785 . . . . 72.430000000000007 110.886 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -66.54 -46.34 76.46 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.347 -0.388 . . . . 74.129999999999995 110.307 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.38 -48.39 54.48 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.606 -0.724 . . . . 70.400000000000006 112.834 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 48' ' ' VAL . 12.3 p -75.55 -33.2 26.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 63.539999999999999 111.139 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.23 -25.95 65.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.706 0.261 . . . . 72.340000000000003 111.706 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.7 t -89.54 17.58 6.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 73.040000000000006 112.89 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.743 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 12.3 ptp -125.37 178.15 5.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.901 -0.499 . . . . 71.329999999999998 111.412 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -116.65 177.31 4.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.294 -0.412 . . . . 75.530000000000001 110.477 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.783 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -69.45 129.71 40.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.091 -0.337 . . . . 74.120000000000005 110.091 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.406 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 88.82 6.11 73.04 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.326 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' THR . 19.6 tt0 -100.18 133.76 44.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.340000000000003 111.022 -175.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.708 ' HD3' HD21 ' A' ' 31' ' ' LEU . 50.0 tttm -117.67 117.52 29.58 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -122.65 137.72 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.216 0.531 . . . . 55.240000000000002 111.275 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 7.8 tt -90.78 106.29 18.41 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.972 -1.121 . . . . 64.409999999999997 107.972 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -115.25 124.82 52.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.113 -0.329 . . . . 65.010000000000005 110.113 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.511 ' HB ' ' HA ' ' A' ' 26' ' ' LEU . 4.3 m -80.36 111.75 17.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 72.409999999999997 110.546 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 105' ' ' ALA . 32.6 mm -93.58 113.22 59.71 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.618 -0.264 . . . . 60.109999999999999 110.449 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 120' ' ' THR . 43.8 Cg_endo -67.31 151.63 80.41 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.758 2.305 . . . . 73.230000000000004 111.783 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -55.99 -31.79 63.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.074 -0.512 . . . . 75.519999999999996 111.972 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.539 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 4.1 pt20 -65.52 -27.62 68.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.409 . . . . 73.140000000000001 110.954 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 91.9 mt -109.07 22.86 15.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 73.129999999999995 110.096 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 100' ' ' ILE . . . -149.18 176.61 10.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.887 -0.597 . . . . 75.530000000000001 111.406 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -76.65 -11.77 59.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 75.329999999999998 110.282 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.69 31.32 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.835 -0.62 . . . . 75.140000000000001 113.377 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.57 -49.32 76.77 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.408 -0.59 . . . . 70.209999999999994 109.408 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -91.92 -26.22 18.54 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.548 -0.751 . . . . 75.25 110.55 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 82.0 -66.25 3.9 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.745 -0.662 . . . . 74.310000000000002 111.584 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 50.5 m-85 94.56 -74.36 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.324 1.45 . . . . 75.400000000000006 111.567 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 110' ' ' GLY . 95.4 Cg_endo -81.15 139.2 11.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 CA-C-N 121.332 1.512 . . . . 74.049999999999997 110.84 174.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.11 -11.36 15.43 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.79 2.327 . . . . 75.519999999999996 112.457 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.72 -31.79 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.138 0.494 . . . . 74.310000000000002 110.026 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.9 mm -100.76 120.71 54.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.687 -0.688 . . . . 64.329999999999998 109.711 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 58.3 Cg_endo -70.97 151.09 61.89 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.354 2.036 . . . . 73.409999999999997 112.173 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 39.0 Cg_endo -66.43 141.0 59.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.294 1.996 . . . . 75.400000000000006 111.739 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.763 ' HB2' ' HZ2' ' A' ' 118' ' ' LYS . 8.6 mtmp? 71.49 26.51 3.21 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.006 -0.543 . . . . 73.319999999999993 111.126 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 116' ' ' PRO . . . -84.77 142.53 29.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 74.120000000000005 111.365 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 101' ' ' PRO . 91.7 m -95.21 137.34 34.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.695 -0.684 . . . . 71.230000000000004 109.419 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -128.57 139.98 52.02 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.78 -0.452 . . . . 74.120000000000005 109.78 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.518 ' N ' HD13 ' A' ' 121' ' ' LEU . 99.3 t -98.54 122.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.715 0.293 . . . . 74.230000000000004 110.32 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -113.6 120.09 39.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.836 0.35 . . . . 55.210000000000001 110.194 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.774 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 22.2 mt-10 -81.49 110.99 17.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.641 -0.874 . . . . 75.120000000000005 108.641 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.483 ' O ' ' HE1' ' A' ' 90' ' ' MET . 4.0 m -99.84 139.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.739 -0.664 . . . . 55.229999999999997 109.483 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.4 tt0 -131.79 119.02 20.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.506 -0.316 . . . . 75.209999999999994 110.31 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -87.76 113.78 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 72.310000000000002 109.688 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.73 -43.09 9.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.364 -0.38 . . . . 73.209999999999994 110.693 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.47 142.13 24.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.542 -0.299 . . . . 73.019999999999996 110.886 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.423 ' OXT' ' NZ ' ' A' ' 44' ' ' LYS . 66.4 t . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.602 -0.713 . . . . 71.349999999999994 110.411 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.85 0.357 . . . . 73.310000000000002 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.56 134.81 40.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 70.140000000000001 109.823 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 m170 -76.24 75.06 3.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 75.329999999999998 111.028 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.65 -11.86 4.39 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.821 -0.627 . . . . 73.230000000000004 110.446 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -158.24 127.26 5.63 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.979 -0.555 . . . . 75.319999999999993 109.991 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -164.19 137.33 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 110.128 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -144.0 113.12 6.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 71.439999999999998 109.601 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -84.16 128.52 34.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.076 -0.511 . . . . 73.239999999999995 110.44 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ttt -119.41 134.73 55.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.516 -0.55 . . . . 75.209999999999994 109.516 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.47 124.29 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.606 -0.598 . . . . 72.519999999999996 111.606 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 13' ' ' GLU . 12.9 t -71.63 -17.0 62.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.534 0.207 . . . . 74.140000000000001 110.849 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.8 mt 66.71 1.69 2.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.112 0.565 . . . . 72.230000000000004 112.332 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.565 ' H ' HG23 ' A' ' 11' ' ' THR . 40.9 mt-10 -97.75 124.27 42.03 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 110.008 -0.367 . . . . 63.329999999999998 110.008 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.0 101.18 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 72.420000000000002 110.728 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -70.96 -30.48 66.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 75.299999999999997 109.576 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -129.26 117.36 20.58 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.075 -0.966 . . . . 75.230000000000004 109.398 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -75.5 -43.64 48.07 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.612 -0.267 . . . . 72.329999999999998 110.841 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.16 -130.29 1.24 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.594 -0.812 . . . . 74.25 113.072 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.22 134.26 22.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.891 2.394 . . . . 73.400000000000006 113.103 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.16 39.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.765 -0.934 . . . . 72.409999999999997 110.765 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.5 t -101.15 166.36 10.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.814 0.34 . . . . 73.519999999999996 111.024 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.7 ttp -113.94 3.14 15.27 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.439 0.638 . . . . 74.010000000000005 109.601 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -99.45 179.41 4.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.635 -0.711 . . . . 72.25 110.526 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . . . -90.85 122.77 33.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.062 -0.347 . . . . 75.019999999999996 110.062 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -92.18 135.41 34.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 110.506 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.0 tp -106.23 101.84 11.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.974 -0.75 . . . . 72.129999999999995 108.974 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -147.67 106.11 3.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.802 -0.636 . . . . 65.329999999999998 110.388 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.97 144.91 43.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.932 0.396 . . . . 71.0 110.065 175.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -140.3 113.17 8.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 74.450000000000003 109.543 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.67 128.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.783 0.325 . . . . 74.030000000000001 110.661 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 97' ' ' LEU . 2.7 mm? -91.99 -42.78 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.268 0.556 . . . . 73.129999999999995 109.751 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 110.9 6.92 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.683 -0.689 . . . . 74.030000000000001 110.565 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.62 137.96 44.02 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.583 2.189 . . . . 71.120000000000005 111.698 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.26 -143.68 10.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.082 -0.58 . . . . 71.150000000000006 112.43 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.8 -37.42 81.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 72.409999999999997 110.535 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.84 -30.51 1.29 Allowed Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.704 -0.68 . . . . 51.130000000000003 113.751 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.85 -9.86 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 74.230000000000004 111.015 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -87.25 115.84 24.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.824 -0.626 . . . . 54.219999999999999 110.791 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.788 ' HB3' ' HZ1' ' A' ' 39' ' ' LYS . 9.1 mtpm? -92.43 114.44 62.37 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 110.317 -0.253 . . . . 71.519999999999996 110.317 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.21 108.18 1.92 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.754 2.303 . . . . 72.230000000000004 112.183 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.26 120.96 34.13 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.036 -0.529 . . . . 75.109999999999999 109.692 173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.36 154.18 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 74.420000000000002 111.021 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.37 -28.08 8.93 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.043 -0.526 . . . . 73.239999999999995 112.023 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -86.04 159.21 19.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.159 0.504 . . . . 75.150000000000006 111.264 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -77.89 112.24 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.479 -0.782 . . . . 63.310000000000002 109.101 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.46 152.52 8.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.059 0.456 . . . . 72.019999999999996 111.384 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.2 m -106.5 110.83 23.16 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.072 -0.967 . . . . 54.210000000000001 110.014 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.412 HG22 ' HE1' ' A' ' 72' ' ' PHE . 25.7 m -119.3 178.28 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.336 -0.847 . . . . 54.299999999999997 111.181 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 22.8 t-80 -157.09 142.47 17.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.732 -0.84 . . . . 71.409999999999997 108.732 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.2 m-85 -126.95 153.18 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 74.140000000000001 110.165 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 16.8 t70 -136.67 109.49 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.539 -0.541 . . . . 72.430000000000007 109.539 174.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.8 147.27 32.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.356 -0.45 . . . . 64.230000000000004 113.587 -172.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.405 ' O ' HD12 ' A' ' 121' ' ' LEU . 25.8 ttm180 -162.14 144.56 11.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.315 0.578 . . . . 75.299999999999997 111.131 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.29 147.74 54.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 109.834 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.77 -17.92 61.73 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.373 2.049 . . . . 75.109999999999999 111.533 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.9 -25.74 62.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.566 -0.743 . . . . 72.329999999999998 110.461 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.58 -39.94 1.89 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.959 -0.564 . . . . 62.229999999999997 111.861 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -56.71 148.44 20.24 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.975 0.51 . . . . 73.120000000000005 111.493 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 19.8 pt20 -130.66 141.53 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.245 -0.65 . . . . 72.329999999999998 109.245 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -80.12 -38.42 31.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.812 0.301 . . . . 73.530000000000001 111.812 -173.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -152.92 133.64 13.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.318 -0.253 . . . . 72.129999999999995 110.318 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 t -81.07 91.14 6.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 74.510000000000005 109.436 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.9 m -67.6 -17.1 64.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.676 -0.693 . . . . 73.299999999999997 110.861 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -31.31 62.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.004 -0.544 . . . . 75.5 110.984 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 t -63.84 -46.22 86.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.769 0.318 . . . . 52.329999999999998 110.616 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -75.87 -12.41 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.533 -0.303 . . . . 75.439999999999998 111.411 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.6 36.53 48.27 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.125 -0.488 . . . . 63.329999999999998 113.823 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.1 tppt? -92.21 113.43 59.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.163 -0.31 . . . . 75.340000000000003 110.163 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.4 Cg_endo -81.91 150.66 16.24 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.245 2.63 . . . . 73.209999999999994 111.894 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -114.28 160.61 18.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.92 -0.77 . . . . 71.25 108.92 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -140.62 146.85 38.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.093 -0.336 . . . . 75.030000000000001 110.093 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 78' ' ' GLU . 39.8 p90 -166.98 161.59 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 73.400000000000006 110.289 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 m -74.92 112.78 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.514 -0.312 . . . . 75.200000000000003 110.206 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 88' ' ' ALA . 47.2 tp -67.81 136.5 54.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.574 -0.285 . . . . 75.129999999999995 110.78 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 40.1 32.66 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.303 -0.475 . . . . 70.140000000000001 111.931 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.68 178.34 8.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.39 0.276 . . . . 74.430000000000007 110.31 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.34 46.19 3.59 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.036 -0.602 . . . . 71.230000000000004 112.173 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 9.3 mm-40 -85.04 -47.8 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 75.439999999999998 111.051 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.85 178.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.674 . . . . 62.130000000000003 109.67 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.97 142.92 15.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.172 0.511 . . . . 75.420000000000002 111.035 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -58.14 -30.61 66.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 74.329999999999998 111.862 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.02 -51.04 59.74 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.884 -0.674 . . . . 74.310000000000002 111.616 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -69.14 -47.67 64.45 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.792 -0.204 . . . . 71.340000000000003 110.636 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.27 -54.92 33.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.033 0.444 . . . . 72.430000000000007 111.149 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -72.07 -38.3 69.47 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.1 -0.5 . . . . 74.129999999999995 110.501 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 89' ' ' THR . . . -54.42 -50.11 57.94 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.935 -0.575 . . . . 70.400000000000006 112.215 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.1 p -75.72 -31.12 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 63.539999999999999 110.977 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -62.43 -33.49 74.91 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.741 0.305 . . . . 72.340000000000003 111.746 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 86' ' ' GLY . 11.0 t -79.5 7.41 8.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.461 0.541 . . . . 73.040000000000006 112.461 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 7.7 ptm -116.32 -176.51 2.97 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.196 -0.315 . . . . 71.329999999999998 110.456 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.9 p -118.21 178.81 4.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.775 0.321 . . . . 75.530000000000001 111.637 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.833 ' HA ' HD11 ' A' ' 127' ' ' LEU . 7.3 tt -68.69 135.16 50.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.863 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.423 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 71.96 23.68 77.64 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.633 -0.712 . . . . 72.25 112.299 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -112.46 148.54 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.859 0.361 . . . . 71.340000000000003 111.271 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -130.09 124.68 33.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.638 -0.71 . . . . 74.540000000000006 110.323 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.21 141.29 39.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 55.240000000000002 110.414 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.561 ' HB2' HD22 ' A' ' 31' ' ' LEU . 9.1 tt -92.19 123.95 35.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.119 -0.697 . . . . 64.409999999999997 109.119 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -130.21 134.51 47.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.918 0.389 . . . . 65.010000000000005 110.656 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 51.8 m -83.51 112.68 20.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.004 -0.544 . . . . 72.409999999999997 109.923 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.2 mm -84.84 110.93 31.6 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 116.382 -0.372 . . . . 60.109999999999999 110.607 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 99' ' ' THR . 24.4 Cg_exo -64.22 142.91 81.98 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.117 2.545 . . . . 73.230000000000004 111.565 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.59 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 51.3 p90 -54.39 -39.36 67.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 75.519999999999996 111.799 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 13.9 pt20 -70.2 -13.78 62.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.376 -0.375 . . . . 73.140000000000001 111.829 -174.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.93 16.55 24.16 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.997 0.427 . . . . 73.129999999999995 110.153 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.05 178.65 9.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.654 -0.703 . . . . 75.530000000000001 111.141 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -60.06 -25.09 65.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 75.329999999999998 110.705 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.73 -19.9 30.15 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.634 -0.712 . . . . 75.140000000000001 113.301 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.59 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 43.2 tt0 -56.16 -47.55 78.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 70.209999999999994 110.169 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -107.6 -15.33 14.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.4 -0.818 . . . . 75.25 110.907 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.75 -171.78 6.92 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 116.072 -0.513 . . . . 74.310000000000002 112.63 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.733 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 63.7 m-85 -147.53 -61.39 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.614 0.207 . . . . 75.400000000000006 110.677 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 50.9 Cg_endo -93.17 152.02 2.56 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.247 1.964 . . . . 74.049999999999997 112.037 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.63 -19.73 38.79 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.535 2.157 . . . . 75.519999999999996 111.765 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.98 -35.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.929 -0.578 . . . . 74.310000000000002 110.355 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.3 mm -121.25 80.75 36.72 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 108.538 -0.912 . . . . 64.329999999999998 108.538 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' O ' ' HB3' ' A' ' 119' ' ' ALA . 83.5 Cg_endo -75.22 169.32 22.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.88 2.387 . . . . 73.409999999999997 112.319 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 71.5 Cg_exo -50.14 148.98 12.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 75.400000000000006 112.228 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.3 mtmt 72.19 17.46 4.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.738 0.649 . . . . 73.319999999999993 111.312 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 116' ' ' PRO . . . -78.06 104.42 8.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 111.43 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.416 HG21 ' HA ' ' A' ' 101' ' ' PRO . 99.8 m -83.71 134.47 34.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.205 -0.665 . . . . 71.230000000000004 109.205 171.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -136.96 147.02 46.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.962 -0.385 . . . . 74.120000000000005 109.962 -170.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.534 ' N ' HD12 ' A' ' 121' ' ' LEU . 60.7 t -98.39 137.33 26.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 110.28 -175.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.44 129.38 31.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.54 -0.3 . . . . 55.210000000000001 110.411 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 59.3 mt-10 -75.15 118.57 18.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.756 -0.831 . . . . 75.120000000000005 108.756 167.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' ' HE1' ' A' ' 90' ' ' MET . 35.7 m -95.59 136.8 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.834 -0.802 . . . . 55.229999999999997 108.834 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 47.8 tt0 -138.59 114.97 10.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.124 -0.489 . . . . 75.209999999999994 109.73 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.833 HD11 ' HA ' ' A' ' 92' ' ' LEU . 2.6 tm? -97.42 111.84 23.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.252 -0.648 . . . . 72.310000000000002 109.252 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.0 -41.26 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.47 -0.332 . . . . 73.209999999999994 110.647 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.77 145.87 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.572 -0.285 . . . . 73.019999999999996 111.038 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.25 1.105 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.059 178.563 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.758 0.313 . . . . 73.310000000000002 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.08 86.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.175 0.512 . . . . 70.140000000000001 111.771 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -99.38 115.27 28.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.187 -0.672 . . . . 75.329999999999998 109.187 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -61.78 95.95 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.241 0.543 . . . . 73.230000000000004 109.672 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -76.26 147.94 37.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 75.319999999999993 111.69 -172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -60.7 118.21 6.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.424 -0.807 . . . . 73.329999999999998 109.253 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -59.3 110.24 1.04 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.933 0.397 . . . . 71.439999999999998 110.027 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -162.28 147.26 12.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.804 -0.634 . . . . 73.239999999999995 109.516 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm -63.47 91.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 75.209999999999994 110.391 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.43 -169.93 46.03 Favored Glycine 0 C--O 1.235 0.213 0 CA-C-N 115.782 -0.645 . . . . 72.519999999999996 112.049 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 t -166.98 174.46 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.033 0.444 . . . . 74.140000000000001 110.649 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.4 mp -90.53 148.4 22.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 109.604 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.11 156.28 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 63.329999999999998 111.527 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.27 146.72 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.943 -0.571 . . . . 72.420000000000002 110.101 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.7 101.93 0.16 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.415 0.626 . . . . 75.299999999999997 110.437 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -90.06 17.31 7.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.695 -0.684 . . . . 75.230000000000004 110.87 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -119.39 148.5 43.14 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 72.329999999999998 110.298 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' H ' ' HD2' ' A' ' 19' ' ' PRO . . . -109.32 -61.59 0.53 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.18 -0.464 . . . . 74.25 113.508 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 18' ' ' GLY . 71.1 Cg_endo -71.49 24.91 0.23 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.088 2.526 . . . . 73.400000000000006 114.167 -172.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.57 30.58 78.3 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.246 -0.502 . . . . 72.409999999999997 113.234 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -66.4 78.01 0.1 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.698 0.761 . . . . 73.519999999999996 110.462 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.2 ptt? 179.7 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.675 -1.148 . . . . 74.010000000000005 108.856 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.5 m -99.86 175.45 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.563 -0.744 . . . . 72.25 109.858 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.23 98.07 8.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.664 0.269 . . . . 75.019999999999996 110.598 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -108.0 142.89 37.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 73.129999999999995 110.043 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.88 121.65 35.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.172 -0.677 . . . . 72.129999999999995 109.172 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.718 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 40.3 mt-10 -129.71 108.17 9.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 65.329999999999998 110.344 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 21.1 pttp -109.41 101.53 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.353 -0.61 . . . . 71.0 109.353 173.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.718 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 87.0 mttt -118.91 110.4 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.318 . . . . 74.450000000000003 110.415 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.73 119.21 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.051 -0.351 . . . . 74.030000000000001 110.051 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 ' HD3' ' A' ' 95' ' ' LYS . 32.7 tp -94.86 -30.99 13.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.267 0.556 . . . . 73.129999999999995 109.977 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 57.3 m -147.14 110.85 4.03 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.494 -0.775 . . . . 74.030000000000001 109.44 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 22.5 Cg_exo -65.48 146.35 84.86 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.037 2.492 . . . . 71.120000000000005 112.64 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.36 -158.67 31.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 71.150000000000006 111.987 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' HB3' HG21 ' A' ' 37' ' ' VAL . 25.0 m-20 -71.27 -56.78 5.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.283 0.563 . . . . 72.409999999999997 110.582 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 -30.23 3.78 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.403 -0.817 . . . . 51.130000000000003 111.889 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 35' ' ' ASP . 30.3 m -78.54 -32.33 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.166 0.508 . . . . 74.230000000000004 110.245 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 6.0 p -71.15 105.93 3.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.341 -0.614 . . . . 54.219999999999999 109.341 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -91.63 109.31 35.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.812 -0.631 . . . . 71.519999999999996 110.928 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 38' ' ' THR . 60.9 Cg_endo -95.85 174.06 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.508 2.805 . . . . 72.230000000000004 111.411 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.74 163.0 40.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 110.812 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.27 166.12 23.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.726 -0.67 . . . . 74.420000000000002 111.609 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.04 86.33 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.969 -0.56 . . . . 73.239999999999995 112.443 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -119.2 155.76 31.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.607 0.241 . . . . 75.150000000000006 110.476 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -81.01 113.41 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.322 -0.622 . . . . 63.310000000000002 109.322 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HB ' HD23 ' A' ' 127' ' ' LEU . 33.9 m -106.61 145.89 13.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.908 0.385 . . . . 72.019999999999996 111.423 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.5 m -98.86 108.47 21.16 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.175 -0.921 . . . . 54.210000000000001 110.117 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -115.44 178.5 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 124.355 1.034 . . . . 54.299999999999997 111.575 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 11.0 t-160 -152.98 136.55 15.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.989 -1.115 . . . . 71.409999999999997 107.989 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -126.85 151.7 48.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.807 0.299 . . . . 74.140000000000001 111.807 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.707 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 33.5 t70 -138.85 118.54 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.998 -0.547 . . . . 72.430000000000007 110.095 169.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.16 138.93 17.12 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.371 -0.442 . . . . 64.230000000000004 112.624 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 28.1 ttm180 -157.51 149.26 22.13 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.341 0.591 . . . . 75.299999999999997 111.751 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -87.58 153.83 53.21 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.713 -0.676 . . . . 75.120000000000005 109.332 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.64 -20.13 56.43 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.708 2.272 . . . . 75.109999999999999 113.412 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.58 3.54 52.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.558 0.218 . . . . 72.329999999999998 111.26 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.07 -31.73 8.31 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.336 -0.459 . . . . 62.229999999999997 112.143 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.45 145.5 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.908 -0.405 . . . . 73.120000000000005 109.908 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.62 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 20.2 pt20 -151.64 147.59 26.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.516 176.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -62.23 -38.4 89.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 73.530000000000001 111.307 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.4 156.56 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.265 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 22.9 t -87.41 86.79 7.27 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.493 -0.558 . . . . 74.510000000000005 109.493 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.707 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 14.7 m -60.07 -30.11 68.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 73.299999999999997 110.453 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.563 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 34.8 ptt180 -71.32 -44.46 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 75.5 110.972 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -4.47 34.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.622 0.248 . . . . 52.329999999999998 111.142 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 62' ' ' SER . 27.2 mmt180 -76.63 -12.71 60.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.575 -0.284 . . . . 75.439999999999998 110.869 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.08 77.4 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.959 -0.639 . . . . 63.329999999999998 112.282 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.74 104.39 55.31 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-O 120.562 0.22 . . . . 75.340000000000003 110.783 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.86 166.35 19.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.004 2.469 . . . . 73.209999999999994 110.985 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.74 131.92 21.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.792 -0.447 . . . . 71.25 109.792 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 97.4 mt-30 -113.15 131.95 55.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.558 0.218 . . . . 75.030000000000001 110.501 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.555 ' HZ ' HG13 ' A' ' 87' ' ' VAL . 24.5 p90 -154.37 161.13 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.462 -0.335 . . . . 73.400000000000006 110.484 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 m -77.32 115.95 17.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.447 . . . . 75.200000000000003 110.752 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 127.91 33.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.036 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.93 43.68 7.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.161 -0.542 . . . . 70.140000000000001 112.075 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.69 173.78 14.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.821 0.343 . . . . 74.430000000000007 111.018 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.61 27.64 3.28 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.157 -0.474 . . . . 71.230000000000004 112.678 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 5.6 mm-40 -65.01 -43.78 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.227 0.537 . . . . 75.439999999999998 110.279 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.71 178.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.505 -0.77 . . . . 62.130000000000003 110.195 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.436 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.1 pt -62.49 143.59 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 110.01 -0.367 . . . . 75.420000000000002 110.01 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -58.23 -23.97 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.463 -0.335 . . . . 74.329999999999998 110.823 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.73 -50.45 67.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.948 -0.644 . . . . 74.310000000000002 111.835 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.436 ' H ' HG13 ' A' ' 80' ' ' ILE . 53.2 m0 -69.05 -42.09 76.75 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.153 -0.314 . . . . 71.340000000000003 110.153 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -54.05 -49.94 67.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.721 -0.672 . . . . 72.430000000000007 110.64 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.42 -41.24 80.67 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.316 -0.402 . . . . 74.129999999999995 110.501 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.34 -48.65 53.7 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.425 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.555 HG13 ' HZ ' ' A' ' 72' ' ' PHE . 7.1 p -75.68 -36.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 63.539999999999999 110.993 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.36 70.47 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.945 0.35 . . . . 72.340000000000003 111.945 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.3 t -84.56 -20.39 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.116 0.413 . . . . 73.040000000000006 112.116 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 18.0 ptp -88.82 -174.47 4.52 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 71.329999999999998 111.35 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 p -119.42 178.78 4.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.679 -0.692 . . . . 75.530000000000001 110.285 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.811 ' HA ' HD13 ' A' ' 127' ' ' LEU . 9.2 tt -72.0 132.94 44.97 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.986 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.93 34.87 46.53 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.383 -0.826 . . . . 72.25 112.252 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -125.95 138.18 53.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.965 0.412 . . . . 71.340000000000003 111.627 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.557 ' HD3' HD22 ' A' ' 31' ' ' LEU . 19.2 ttmm -107.6 113.8 27.35 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.446 -0.797 . . . . 74.540000000000006 109.745 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.46 132.59 56.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.42 . . . . 55.240000000000002 110.656 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.53 108.4 19.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.873 -1.158 . . . . 64.409999999999997 107.873 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' HD11 ' A' ' 100' ' ' ILE . 12.3 t80 -116.77 123.53 47.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.151 -0.477 . . . . 65.010000000000005 109.956 -174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.9 m -81.17 106.33 13.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.526 -0.546 . . . . 72.409999999999997 109.526 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 98' ' ' PHE . 47.5 mm -78.25 115.08 48.11 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 115.815 -0.63 . . . . 60.109999999999999 110.777 -175.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 104' ' ' LEU . 22.0 Cg_exo -64.94 141.3 70.21 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.876 2.384 . . . . 73.230000000000004 110.916 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -58.12 -25.65 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.708 0.633 . . . . 75.519999999999996 112.708 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -75.26 -13.68 60.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.794 0.33 . . . . 73.140000000000001 111.405 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 101' ' ' PRO . 88.1 mt -102.05 16.94 24.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.776 0.322 . . . . 73.129999999999995 110.382 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.79 -174.47 4.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.85 -0.614 . . . . 75.530000000000001 110.516 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -76.0 -5.42 46.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 75.329999999999998 110.358 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.49 -21.98 58.32 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.783 -0.644 . . . . 75.140000000000001 113.407 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 7.4 pt-20 -62.23 -42.61 99.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.902 0.382 . . . . 70.209999999999994 110.782 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.486 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 12.5 ttm180 -92.29 -42.51 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 75.25 110.399 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.94 141.4 4.14 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.817 -0.629 . . . . 74.310000000000002 111.629 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.659 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 49.2 m-85 -137.21 -58.16 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.691 0.246 . . . . 75.400000000000006 110.901 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 8.4 Cg_exo -72.98 147.75 43.99 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.974 1.783 . . . . 74.049999999999997 111.185 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.75 -19.2 60.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 75.519999999999996 112.183 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 115' ' ' ILE . 35.1 m -86.31 -17.87 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 74.310000000000002 111.106 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.609 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.2 mm -114.27 102.06 54.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.851 0.357 . . . . 64.329999999999998 110.365 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.57 170.62 19.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.665 2.243 . . . . 73.409999999999997 112.056 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.2 144.92 96.25 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.559 2.173 . . . . 75.400000000000006 111.725 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 61.41 26.9 16.6 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.717 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.45 103.12 7.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 74.120000000000005 111.494 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -73.52 122.62 22.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.538 HD11 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -124.58 144.52 50.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.012 -0.366 . . . . 74.120000000000005 110.012 -167.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.538 ' N ' HD11 ' A' ' 121' ' ' LEU . 85.5 t -98.42 133.1 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.732 0.301 . . . . 74.230000000000004 110.439 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.487 ' CE2' HD12 ' A' ' 121' ' ' LEU . 75.8 m-85 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 55.210000000000001 110.531 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 64.4 mt-10 -74.94 106.51 6.48 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.898 -1.149 . . . . 75.120000000000005 107.898 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.467 ' O ' ' HE1' ' A' ' 90' ' ' MET . 17.8 m -97.23 129.18 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.056 -0.72 . . . . 55.229999999999997 109.056 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.4 tt0 -134.77 120.75 19.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.528 -0.305 . . . . 75.209999999999994 110.412 -170.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.811 HD13 ' HA ' ' A' ' 92' ' ' LEU . 3.3 tm? -97.21 110.21 22.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.368 -0.604 . . . . 72.310000000000002 109.368 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 128' ' ' LEU . 3.7 mm? -86.97 -50.54 6.6 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.46 -0.337 . . . . 73.209999999999994 110.641 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.5 -177.03 6.3 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.635 -0.426 . . . . 73.019999999999996 112.133 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.38 -0.827 . . . . 71.349999999999994 109.425 176.684 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.511 0.196 . . . . 73.310000000000002 110.488 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.85 110.27 0.88 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 70.140000000000001 111.516 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -70.93 120.89 17.17 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.934 -0.575 . . . . 75.329999999999998 109.493 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -66.18 100.95 0.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.379 0.609 . . . . 73.230000000000004 110.985 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -91.36 113.24 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.043 -0.981 . . . . 75.319999999999993 109.77 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -74.72 136.96 41.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 73.329999999999998 111.079 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -79.04 128.31 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.346 -0.613 . . . . 71.439999999999998 109.346 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -80.76 39.4 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 -0.288 . . . . 73.239999999999995 110.749 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.3 mtt -117.65 9.0 12.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.053 0.454 . . . . 75.209999999999994 110.208 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.85 153.04 21.34 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.695 -0.684 . . . . 72.519999999999996 112.509 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 109.69 21.04 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.312 -0.255 . . . . 74.140000000000001 110.312 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.38 97.77 5.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 72.230000000000004 109.962 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.61 103.14 11.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.808 -0.633 . . . . 63.329999999999998 109.557 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.18 90.63 3.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 72.420000000000002 111.121 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -86.46 31.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.558 0.694 . . . . 75.299999999999997 109.61 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.1 p -86.1 82.83 7.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.34 -0.845 . . . . 75.230000000000004 111.919 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.17 -71.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 72.329999999999998 110.309 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.93 -170.61 26.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.165 -0.541 . . . . 74.25 111.887 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.21 122.33 10.74 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.603 2.202 . . . . 73.400000000000006 112.028 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.72 -179.37 38.73 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 111.788 -0.525 . . . . 72.409999999999997 111.788 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 m -72.21 77.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.098 0.475 . . . . 73.519999999999996 111.076 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.6 mmm -107.8 108.95 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.881 -0.6 . . . . 74.010000000000005 109.782 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.0 m -62.64 -41.26 98.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 72.25 111.577 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.29 96.75 6.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.929 0.395 . . . . 75.019999999999996 111.462 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -139.26 135.14 33.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.593 -0.731 . . . . 73.129999999999995 109.081 172.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.24 111.8 5.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.207 -0.294 . . . . 72.129999999999995 110.207 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.03 108.29 9.98 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.059 -0.349 . . . . 65.329999999999998 110.059 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -114.36 103.87 11.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.083 -0.71 . . . . 71.0 109.083 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.71 110.5 21.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 74.450000000000003 110.028 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 111.69 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 74.030000000000001 110.769 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.86 -42.43 24.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.329 -0.989 . . . . 73.129999999999995 108.329 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -149.83 119.93 3.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.222 -0.899 . . . . 74.030000000000001 109.258 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.45 138.31 24.3 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.631 2.221 . . . . 71.120000000000005 112.259 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -89.7 -167.74 42.67 Favored Glycine 0 C--O 1.236 0.244 0 CA-C-N 116.088 -0.505 . . . . 71.150000000000006 112.625 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.617 ' HB3' HG22 ' A' ' 37' ' ' VAL . 72.4 m-20 -56.34 -44.55 80.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.99 0.424 . . . . 72.409999999999997 111.387 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 80.41 -30.65 2.45 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.919 -0.582 . . . . 51.130000000000003 112.093 -175.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 35' ' ' ASP . 35.6 m -76.81 -25.52 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.958 0.408 . . . . 74.230000000000004 109.996 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 19.5 p -97.86 89.68 4.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 54.219999999999999 109.748 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HA ' HG23 ' A' ' 91' ' ' THR . 58.8 mttp -95.91 149.56 36.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 115.748 -0.66 . . . . 71.519999999999996 111.106 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.88 154.49 23.01 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.715 2.277 . . . . 72.230000000000004 111.594 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -133.59 130.06 37.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.109999999999999 110.065 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.56 122.74 17.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.493 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.62 -4.66 32.71 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.356 -0.449 . . . . 73.239999999999995 112.044 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -109.56 165.92 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 75.150000000000006 110.796 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.56 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.7 tppp? -67.45 149.09 50.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 63.310000000000002 111.179 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 130' ' ' VAL . 16.9 m -140.14 141.89 32.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.903 -0.59 . . . . 72.019999999999996 109.7 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.9 m -115.09 108.42 16.63 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.514 -0.766 . . . . 54.210000000000001 109.497 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.25 178.21 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.818 -0.628 . . . . 54.299999999999997 112.27 -170.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 8.5 t-160 -150.07 147.73 28.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.926 -1.034 . . . . 71.409999999999997 108.329 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.2 153.31 44.85 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.857 0.36 . . . . 74.140000000000001 111.365 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.721 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 36.6 t70 -136.27 109.26 7.66 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.663 -0.866 . . . . 72.430000000000007 108.663 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.54 146.97 33.47 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.461 -0.399 . . . . 64.230000000000004 113.121 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.452 ' NH2' HH21 ' A' ' 64' ' ' ARG . 22.3 ttm180 -160.16 149.05 17.26 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.006 0.431 . . . . 75.299999999999997 111.176 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -90.54 151.03 43.68 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.319 -0.4 . . . . 75.120000000000005 110.313 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.21 -13.08 33.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.792 2.328 . . . . 75.109999999999999 111.819 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.63 -17.44 64.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.589 -0.732 . . . . 72.329999999999998 110.346 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.21 28.84 10.2 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.95 -0.568 . . . . 62.229999999999997 112.374 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -155.21 161.42 41.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.649 -0.501 . . . . 73.120000000000005 109.649 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -142.52 155.83 45.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.684 0.278 . . . . 72.329999999999998 110.535 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.37 -18.63 25.14 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.013 -0.539 . . . . 73.530000000000001 111.467 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -137.38 145.57 43.44 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.015 -0.365 . . . . 72.129999999999995 110.015 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.4 p -102.17 85.61 2.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.422 0.63 . . . . 74.510000000000005 110.173 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.721 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 16.1 m -67.78 -20.68 65.24 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.683 -0.69 . . . . 73.299999999999997 110.317 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.452 HH21 ' NH2' ' A' ' 53' ' ' ARG . 12.8 ptp180 -62.95 -44.38 96.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.403 -0.817 . . . . 75.5 110.732 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -70.85 -16.62 62.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.242 -0.436 . . . . 52.329999999999998 111.213 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.579 ' HD3' ' HA ' ' A' ' 63' ' ' SER . 56.9 mtp180 -82.9 -28.84 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 75.439999999999998 109.882 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.52 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.407 -0.815 . . . . 63.329999999999998 114.238 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -91.1 110.21 40.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.938 0.369 . . . . 75.340000000000003 110.299 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.83 168.55 23.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.818 2.345 . . . . 73.209999999999994 112.22 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -147.4 131.24 17.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.748 -0.464 . . . . 71.25 109.748 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 90.6 mt-30 -107.69 143.92 35.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.699 -0.228 . . . . 75.030000000000001 110.539 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.407 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 39.2 p90 -163.04 170.67 17.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 73.400000000000006 110.254 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.0 m -87.42 117.86 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.43 -0.35 . . . . 75.200000000000003 110.5 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 88' ' ' ALA . 64.4 tp -63.12 138.48 58.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.025 -0.534 . . . . 75.129999999999995 110.812 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 -22.58 37.76 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 116.141 -0.481 . . . . 70.140000000000001 112.133 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.31 178.47 6.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 74.430000000000007 111.597 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.07 24.39 21.94 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.866 -0.606 . . . . 71.230000000000004 112.278 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 72' ' ' PHE . 10.5 mm-40 -61.45 -45.76 92.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.285 0.564 . . . . 75.439999999999998 110.316 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.442 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 31.2 m -127.26 163.79 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.63 -0.713 . . . . 62.130000000000003 109.756 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.7 pt -60.48 141.01 17.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.807 -0.442 . . . . 75.420000000000002 109.807 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.801 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 4.3 mptp? -58.47 -15.54 11.43 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.02 0.378 . . . . 74.329999999999998 112.02 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.1 -56.02 27.57 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.374 -0.917 . . . . 74.310000000000002 111.199 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.442 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 43.7 m0 -69.66 -38.72 77.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.002 -0.369 . . . . 71.340000000000003 110.002 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.801 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 24.4 t70 -54.87 -48.97 72.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.441 -0.8 . . . . 72.430000000000007 110.822 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 31.2 mm-40 -71.54 -34.59 70.16 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.352 -0.385 . . . . 74.129999999999995 110.111 176.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 89' ' ' THR . . . -52.51 -48.21 55.63 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.0 -0.545 . . . . 70.400000000000006 112.287 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG22 HD21 ' A' ' 127' ' ' LEU . 3.5 p -75.63 -36.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.775 0.321 . . . . 63.539999999999999 110.801 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -64.73 -20.61 66.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.687 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 86' ' ' GLY . 12.6 t -95.53 10.99 34.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.171 0.434 . . . . 73.040000000000006 112.171 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.2 ptp -127.72 177.3 6.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.939 0.399 . . . . 71.329999999999998 111.664 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 39' ' ' LYS . 22.9 p -130.97 178.74 6.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.712 -0.676 . . . . 75.530000000000001 110.725 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.884 ' HA ' HD13 ' A' ' 127' ' ' LEU . 3.8 tt -65.32 130.31 42.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.807 0.336 . . . . 74.120000000000005 110.314 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.49 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.7 26.8 55.68 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.687 -0.688 . . . . 72.25 112.107 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 22.2 tt0 -123.71 141.19 52.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 71.340000000000003 110.534 -176.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 125' ' ' VAL . 29.2 ttpp -138.95 135.75 34.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 74.540000000000006 109.531 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.58 152.03 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.442 . . . . 55.240000000000002 111.693 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -91.18 114.07 26.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.06 -1.089 . . . . 64.409999999999997 108.06 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.433 ' HD1' HD11 ' A' ' 100' ' ' ILE . 7.2 t80 -117.32 121.08 40.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.356 . . . . 65.010000000000005 110.579 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 m -80.92 112.88 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 72.409999999999997 109.76 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.627 HG23 ' HB1' ' A' ' 105' ' ' ALA . 23.7 mm -88.46 110.56 37.61 Favored Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.695 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.19 139.96 62.77 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.769 2.313 . . . . 73.230000000000004 111.358 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -55.95 -28.43 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.241 0.46 . . . . 75.519999999999996 112.241 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.36 -37.28 86.67 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.975 0.417 . . . . 73.140000000000001 110.66 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.2 mt -99.4 18.79 16.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.878 -0.601 . . . . 73.129999999999995 109.987 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.627 ' HB1' HG23 ' A' ' 100' ' ' ILE . . . -136.61 171.47 14.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.671 . . . . 75.530000000000001 111.24 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.428 ' HB2' ' HE1' ' A' ' 111' ' ' TYR . 44.9 p90 -76.86 -10.08 59.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 75.329999999999998 110.191 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -25.21 64.06 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.453 -0.794 . . . . 75.140000000000001 112.911 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 2.5 tm-20 -61.35 -54.53 42.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.982 -0.747 . . . . 70.209999999999994 108.982 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -64.87 -49.27 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.036 -0.984 . . . . 75.25 111.219 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.89 75.7 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.057 -0.592 . . . . 74.310000000000002 111.732 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.715 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m-85 -59.35 -54.0 60.5 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 111.594 0.22 . . . . 75.400000000000006 111.594 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.715 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 76.9 Cg_endo -96.72 148.99 1.06 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.53 2.154 . . . . 74.049999999999997 112.101 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.39 -20.4 39.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.602 2.201 . . . . 75.519999999999996 112.069 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.58 -28.95 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 110.423 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.93 99.0 36.94 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.146 -0.686 . . . . 64.329999999999998 109.146 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.56 140.64 75.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.72 2.28 . . . . 73.409999999999997 112.717 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.83 142.52 93.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.362 2.041 . . . . 75.400000000000006 111.318 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 99.7 mttt 63.48 25.8 14.6 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 73.319999999999993 111.612 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.86 135.75 33.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.948 0.404 . . . . 74.120000000000005 111.028 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.4 m -87.41 140.18 29.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 71.230000000000004 109.663 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.97 165.88 12.61 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.487 0.185 . . . . 74.120000000000005 110.619 -174.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.38 132.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.812 -0.44 . . . . 74.230000000000004 109.812 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -135.42 125.56 26.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.647 0.261 . . . . 55.210000000000001 110.43 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 30.9 tt0 -84.4 110.04 18.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.808 -1.182 . . . . 75.120000000000005 107.808 172.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 15.3 m -99.64 141.4 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.546 -0.752 . . . . 55.229999999999997 110.907 -175.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 46.1 tt0 -131.29 125.65 33.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 75.209999999999994 110.26 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.884 HD13 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -99.94 107.96 20.07 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.798 -0.445 . . . . 72.310000000000002 109.798 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 128' ' ' LEU . 3.2 mm? -85.75 -43.01 13.71 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.292 -0.413 . . . . 73.209999999999994 110.448 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.37 169.45 24.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.286 -0.415 . . . . 73.019999999999996 110.363 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.419 HG12 HG12 ' A' ' 46' ' ' VAL . 30.0 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 tmm? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.937 0.398 . . . . 73.310000000000002 109.952 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.69 171.23 15.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.888 -0.596 . . . . 70.140000000000001 109.96 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -114.32 135.61 53.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 75.329999999999998 110.662 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -87.04 76.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.015 -0.735 . . . . 73.230000000000004 109.015 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -109.7 23.4 14.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 75.319999999999993 111.343 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -85.94 -25.65 25.97 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.473 -0.936 . . . . 73.329999999999998 108.473 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 74.24 7.33 4.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.437 -1.256 . . . . 71.439999999999998 113.512 163.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -79.11 88.57 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.354 -0.61 . . . . 73.239999999999995 109.354 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.4 ttm -55.83 -62.04 1.96 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.08 -0.964 . . . . 75.209999999999994 111.59 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.4 -45.59 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.887 -0.673 . . . . 72.519999999999996 111.693 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -140.62 136.46 32.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 110.092 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.2 tp -165.21 -49.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.801 -0.814 . . . . 72.230000000000004 108.801 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -86.62 48.51 1.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 63.329999999999998 109.485 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.63 63.62 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.57 -0.741 . . . . 72.420000000000002 111.858 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -94.34 110.03 21.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.423 -0.584 . . . . 75.299999999999997 109.423 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.9 m -52.82 117.74 3.16 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.097 -0.502 . . . . 75.230000000000004 111.234 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.47 -26.94 66.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.056 -0.52 . . . . 72.329999999999998 110.756 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 79.89 1.33 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.116 -0.564 . . . . 74.25 112.856 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.44 -31.62 86.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.842 2.361 . . . . 73.400000000000006 112.234 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.86 55.07 4.81 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.795 -0.639 . . . . 72.409999999999997 111.803 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 m -61.29 106.44 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.616 0.246 . . . . 73.519999999999996 110.681 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.8 mtt -76.59 46.56 0.45 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.058 0.456 . . . . 74.010000000000005 111.625 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -152.66 -89.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.326 -0.62 . . . . 72.25 109.326 175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 174.53 143.69 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.051 -0.522 . . . . 75.019999999999996 110.187 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -129.95 134.96 47.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.487 -0.931 . . . . 73.129999999999995 108.487 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.9 tp -138.69 102.28 4.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 72.129999999999995 110.16 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.27 164.1 35.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 65.329999999999998 110.229 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -145.65 118.98 8.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 71.0 109.425 173.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -108.91 110.43 21.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.227 -0.657 . . . . 74.450000000000003 109.227 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.64 122.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.894 0.378 . . . . 74.030000000000001 111.316 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 31' ' ' LEU . 2.5 mm? -87.68 -38.89 15.46 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.311 -0.626 . . . . 73.129999999999995 109.311 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -135.4 111.02 10.64 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.324 -0.853 . . . . 74.030000000000001 109.969 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.65 138.65 46.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.495 2.13 . . . . 71.120000000000005 112.228 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.87 -164.78 40.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.244 -0.503 . . . . 71.150000000000006 112.103 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 47.1 m-20 -63.71 -25.79 68.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.728 0.299 . . . . 72.409999999999997 110.966 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.95 -30.26 1.81 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.478 -0.392 . . . . 51.130000000000003 113.092 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -93.43 -23.47 5.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.729 0.299 . . . . 74.230000000000004 110.892 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 7.6 p -76.42 88.47 3.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.165 0.507 . . . . 54.219999999999999 110.705 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -85.88 112.82 47.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 71.519999999999996 111.072 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 114.81 2.5 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.203 2.602 . . . . 72.230000000000004 111.576 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.45 175.13 5.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 110.741 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 157.21 36.01 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.355 -0.384 . . . . 74.420000000000002 110.5 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.69 22.74 68.84 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.068 -0.514 . . . . 73.239999999999995 111.964 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -116.66 136.25 53.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.66 0.267 . . . . 75.150000000000006 110.828 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.77 101.63 10.25 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.738 -0.838 . . . . 63.310000000000002 108.738 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.24 142.02 20.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 121.029 0.443 . . . . 72.019999999999996 111.276 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -105.67 108.47 20.01 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.137 -0.938 . . . . 54.210000000000001 109.301 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.17 172.14 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.164 0.507 . . . . 54.299999999999997 111.021 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 14.5 t-160 -134.03 132.08 39.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.186 -1.042 . . . . 71.409999999999997 108.186 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 29.2 p90 -128.37 145.46 51.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.707 0.289 . . . . 74.140000000000001 111.361 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.827 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 26.0 t70 -137.81 119.76 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 72.430000000000007 109.809 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.55 127.63 8.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.37 -0.443 . . . . 64.230000000000004 112.259 -177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.644 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 20.4 ttm180 -147.11 151.83 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.98 0.419 . . . . 75.299999999999997 111.053 -173.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.31 150.02 42.25 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.839 -0.43 . . . . 75.120000000000005 109.839 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.02 -13.6 28.47 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.518 2.146 . . . . 75.109999999999999 111.656 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.98 -32.46 73.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.264 -0.88 . . . . 72.329999999999998 110.532 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.07 -42.04 1.68 Allowed Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.276 -0.73 . . . . 62.229999999999997 111.276 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -79.87 157.87 26.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.774 0.321 . . . . 73.120000000000005 110.522 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.644 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 13.5 pt20 -125.23 165.19 18.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 110.803 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -86.7 -16.74 35.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.733 0.271 . . . . 73.530000000000001 111.733 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.58 153.75 6.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.215 -0.661 . . . . 72.129999999999995 109.215 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.496 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 46.4 m -89.48 97.0 10.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.07 0.462 . . . . 74.510000000000005 110.837 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 50.9 m -93.49 -18.43 22.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.288 0.566 . . . . 73.299999999999997 110.267 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -68.37 -47.48 67.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.78 -0.645 . . . . 75.5 111.013 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 p -68.92 -27.86 66.14 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.76 0.314 . . . . 52.329999999999998 111.785 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 62' ' ' SER . 19.8 mtp180 -75.6 -21.52 57.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.416 -0.356 . . . . 75.439999999999998 110.719 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.19 48.09 65.01 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.881 -0.599 . . . . 63.329999999999998 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 68' ' ' LYS . 1.6 tmtp? -95.95 111.76 57.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.814 -0.809 . . . . 75.340000000000003 108.814 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.64 152.35 7.55 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.802 2.335 . . . . 73.209999999999994 112.635 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -122.18 137.68 54.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.359 -0.608 . . . . 71.25 109.359 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.39 129.24 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.355 . . . . 75.030000000000001 110.168 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -149.46 160.11 43.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 73.400000000000006 110.554 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.3 m -83.45 104.86 13.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 75.200000000000003 109.937 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.83 131.4 49.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 110.001 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.67 -25.78 26.94 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.145 -0.55 . . . . 70.140000000000001 111.98 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.47 171.19 15.47 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.658 0.266 . . . . 74.430000000000007 110.501 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.54 35.77 2.25 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.233 -0.508 . . . . 71.230000000000004 113.233 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -84.88 -38.74 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.214 0.53 . . . . 75.439999999999998 109.844 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.64 157.95 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.409 -0.814 . . . . 62.130000000000003 109.366 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.8 pt -92.26 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.186 -0.301 . . . . 75.420000000000002 110.186 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.668 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 9.5 mmtm -51.62 -19.1 1.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.096 0.776 . . . . 74.329999999999998 113.096 -173.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.07 -63.0 4.91 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.446 -0.883 . . . . 74.310000000000002 111.72 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -70.85 -28.42 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 110.234 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.668 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 16.8 t70 -58.44 -51.66 68.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 72.430000000000007 110.087 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.28 -37.56 87.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.968 -0.382 . . . . 74.129999999999995 109.968 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -51.69 40.78 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.736 -0.666 . . . . 70.400000000000006 112.648 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.2 p -75.65 -31.38 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.038 0.447 . . . . 63.539999999999999 111.086 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.76 66.3 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -83.01 -5.48 59.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.003 0.371 . . . . 73.040000000000006 112.003 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.1 ptp -110.45 177.7 4.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.692 0.282 . . . . 71.329999999999998 111.136 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 p -127.66 177.98 6.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.089 -0.505 . . . . 75.530000000000001 110.173 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HA ' HD12 ' A' ' 127' ' ' LEU . 5.1 tt -63.88 130.6 44.78 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.541 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.495 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 83.71 13.0 76.54 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.405 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -102.63 129.2 49.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.042 0.449 . . . . 71.340000000000003 111.382 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -110.64 116.92 32.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.273 -0.876 . . . . 74.540000000000006 108.893 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.33 142.8 50.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.228 0.537 . . . . 55.240000000000002 111.151 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.86 109.6 20.82 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.679 -0.859 . . . . 64.409999999999997 108.679 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 28' ' ' LYS . 12.6 t80 -105.17 134.65 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 65.010000000000005 110.511 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.6 m -93.56 112.82 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 72.409999999999997 110.138 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.566 HG23 ' HB1' ' A' ' 105' ' ' ALA . 26.8 mm -103.12 114.0 65.44 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 116.552 -0.295 . . . . 60.109999999999999 110.569 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.562 ' HD2' HD12 ' A' ' 104' ' ' LEU . 34.3 Cg_exo -59.57 155.1 43.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.52 2.147 . . . . 73.230000000000004 111.659 175.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -54.81 -32.18 59.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.936 0.398 . . . . 75.519999999999996 111.111 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -76.22 -10.01 59.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 73.140000000000001 111.795 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 101' ' ' PRO . 82.3 mt -115.27 19.58 15.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.641 0.258 . . . . 73.129999999999995 110.768 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 100' ' ' ILE . . . -163.46 -172.24 2.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.029 0.443 . . . . 75.530000000000001 110.776 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -76.39 -3.99 39.94 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.91 -0.586 . . . . 75.329999999999998 110.897 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.59 60.22 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 113.093 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.39 -55.84 9.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.835 0.35 . . . . 70.209999999999994 110.431 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.21 -49.81 16.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.813 -0.631 . . . . 75.25 110.987 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.92 80.41 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.348 -0.453 . . . . 74.310000000000002 112.84 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.549 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.5 m-85 -77.22 -50.67 2.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 111.819 0.303 . . . . 75.400000000000006 111.819 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 3.5 Cg_exo -77.48 128.47 9.58 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.233 1.955 . . . . 74.049999999999997 111.51 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.4 -11.9 21.65 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.849 2.366 . . . . 75.519999999999996 113.152 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 115' ' ' ILE . 27.6 m -81.4 -17.93 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.992 0.425 . . . . 74.310000000000002 110.684 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 114' ' ' VAL . 49.9 mm -105.32 122.24 43.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 64.329999999999998 109.947 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.95 130.6 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.374 2.049 . . . . 73.409999999999997 112.173 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.26 149.36 81.34 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.822 2.348 . . . . 75.400000000000006 112.044 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm 64.28 27.63 13.83 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.298 0.639 . . . . 73.319999999999993 111.1 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.83 148.9 32.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 74.120000000000005 111.246 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 86.6 m -82.85 132.31 35.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.718 -0.674 . . . . 71.230000000000004 109.843 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -117.69 139.39 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.785 -0.45 . . . . 74.120000000000005 109.785 -173.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.4 t -106.25 138.81 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.536 -0.302 . . . . 74.230000000000004 110.241 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.21 125.24 38.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.074 -0.343 . . . . 55.210000000000001 110.074 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.827 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 35.6 tt0 -75.1 106.84 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.124 -1.435 . . . . 75.120000000000005 107.124 168.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 m -111.71 137.93 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.949 -0.568 . . . . 55.229999999999997 109.868 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.9 tt0 -144.02 126.68 16.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.854 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.3 tm? -79.34 101.69 8.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.310000000000002 108.302 176.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.94 -49.89 18.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 73.209999999999994 109.549 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.74 156.64 20.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 73.019999999999996 111.027 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.901 -0.591 . . . . 71.349999999999994 109.497 175.565 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.076 -0.342 . . . . 73.310000000000002 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.48 164.6 33.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 70.140000000000001 109.984 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -86.94 140.93 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.921 0.391 . . . . 75.329999999999998 110.628 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -120.11 50.46 1.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.748 -0.834 . . . . 73.230000000000004 108.748 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -71.76 -14.89 62.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.478 -0.783 . . . . 75.319999999999993 110.37 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -107.02 157.54 17.73 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.678 -0.86 . . . . 73.329999999999998 108.678 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -136.65 151.53 49.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.715 0.293 . . . . 71.439999999999998 110.567 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -94.95 142.42 27.5 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.07 -0.514 . . . . 73.239999999999995 111.317 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.96 121.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.185 -0.672 . . . . 75.209999999999994 109.185 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.61 82.6 0.31 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.161 -0.542 . . . . 72.519999999999996 112.62 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -89.77 104.05 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.01 -0.367 . . . . 74.140000000000001 110.01 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.48 113.93 21.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.023 -0.535 . . . . 72.230000000000004 109.651 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.9 134.7 35.07 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.418 -0.355 . . . . 63.329999999999998 110.119 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -110.93 107.95 17.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 72.420000000000002 110.803 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -81.75 168.83 17.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.985 0.421 . . . . 75.299999999999997 110.561 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 p -86.71 151.2 23.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 75.230000000000004 110.671 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 171.77 8.11 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.621 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.62 -157.54 9.1 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.127 -0.488 . . . . 74.25 112.175 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.73 -43.63 12.35 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 73.400000000000006 112.276 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.39 -91.55 0.21 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 72.409999999999997 112.034 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -96.24 151.95 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 73.519999999999996 110.41 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -87.25 -3.69 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.198 -0.455 . . . . 74.010000000000005 110.501 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 p -61.8 169.58 2.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.966 -0.561 . . . . 72.25 111.204 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 92.48 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.019999999999996 111.426 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -93.02 135.92 33.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.423 -0.955 . . . . 73.129999999999995 108.423 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.3 102.29 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 72.129999999999995 111.923 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -110.42 113.67 26.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 65.329999999999998 109.654 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -113.82 101.35 9.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.629 -0.878 . . . . 71.0 108.629 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.82 118.96 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.644 -0.707 . . . . 74.450000000000003 110.435 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.3 113.08 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.081 -0.509 . . . . 74.030000000000001 109.807 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -76.66 -40.78 48.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.332 -0.618 . . . . 73.129999999999995 109.332 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.3 m -147.08 114.67 4.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.606 -0.724 . . . . 74.030000000000001 109.305 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.44 150.3 87.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.713 2.275 . . . . 71.120000000000005 112.611 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -106.46 -135.29 7.97 Favored Glycine 0 C--O 1.237 0.31 0 CA-C-N 115.968 -0.56 . . . . 71.150000000000006 112.005 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.483 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 31.6 m-20 -73.4 -50.62 20.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 72.409999999999997 111.251 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.83 -25.18 8.91 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.926 -0.654 . . . . 51.130000000000003 112.172 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.64 -24.59 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.019 0.438 . . . . 74.230000000000004 111.157 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.503 ' HG1' ' HB3' ' A' ' 92' ' ' LEU . 14.8 p -79.1 92.97 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.16 0.505 . . . . 54.219999999999999 110.242 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -88.6 128.59 52.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.738 -0.664 . . . . 71.519999999999996 110.938 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.98 122.93 6.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.487 2.124 . . . . 72.230000000000004 112.048 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.44 148.5 22.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.811 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.91 138.16 46.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.420000000000002 109.763 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.29 68.51 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.182 -0.532 . . . . 73.239999999999995 112.085 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -91.66 134.2 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 75.150000000000006 110.982 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.58 ' HZ1' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.24 108.34 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.846 -0.798 . . . . 63.310000000000002 108.846 171.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG13 HG22 ' A' ' 130' ' ' VAL . 27.5 m -106.39 147.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.797 0.332 . . . . 72.019999999999996 110.805 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.1 m -104.62 108.17 19.49 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.787 -0.642 . . . . 54.210000000000001 110.064 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.769 HG13 HD22 ' A' ' 127' ' ' LEU . 15.8 m -125.96 178.23 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.631 -0.713 . . . . 54.299999999999997 110.636 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.81 154.19 36.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.84 -0.8 . . . . 71.409999999999997 108.84 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 36.9 p90 -134.06 158.14 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.429 -0.212 . . . . 74.140000000000001 110.429 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.671 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 1.4 m-20 -134.65 123.37 23.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.131 -0.692 . . . . 72.430000000000007 109.131 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.0 94.46 1.76 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.879 -0.601 . . . . 64.230000000000004 112.908 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HA ' ' HB3' ' A' ' 59' ' ' GLN . 19.3 ttm180 -106.25 137.36 44.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.363 0.602 . . . . 75.299999999999997 110.774 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -78.06 154.73 80.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 75.120000000000005 109.789 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.97 -23.71 29.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.767 2.311 . . . . 75.109999999999999 112.05 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.21 -24.24 40.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.379 -0.828 . . . . 72.329999999999998 111.177 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.13 -2.86 56.71 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.63 -0.714 . . . . 62.229999999999997 111.439 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -110.37 156.31 20.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.976 0.51 . . . . 73.120000000000005 110.042 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 26.0 pt20 -141.23 163.56 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.908 -0.405 . . . . 72.329999999999998 109.908 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.63 -46.63 78.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 111.479 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -170.33 133.21 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.851 -0.425 . . . . 72.129999999999995 109.851 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -69.35 106.67 3.0 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.886 0.374 . . . . 74.510000000000005 110.219 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.3 p -76.46 -26.23 55.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 73.299999999999997 110.776 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -31.39 71.94 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.939 0.4 . . . . 75.5 110.048 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -60.84 -13.59 16.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.695 . . . . 52.329999999999998 111.225 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -78.36 -16.37 57.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.775 0.321 . . . . 75.439999999999998 111.075 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.5 34.33 73.56 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.159 -0.543 . . . . 63.329999999999998 112.344 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.609 ' HZ1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -132.04 113.65 14.89 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 110.252 -0.277 . . . . 75.340000000000003 110.252 -179.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -95.61 177.2 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.187 2.592 . . . . 73.209999999999994 113.271 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -125.9 142.23 51.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.581 -0.896 . . . . 71.25 108.581 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -112.68 135.29 53.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.522 -0.177 . . . . 75.030000000000001 110.522 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -150.75 161.12 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.774 -0.454 . . . . 73.400000000000006 109.774 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.425 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 56.9 m -86.09 115.95 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.482 0.182 . . . . 75.200000000000003 110.642 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 88' ' ' ALA . 63.6 tp -64.15 138.64 58.55 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.253 -0.431 . . . . 75.129999999999995 110.452 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.38 32.39 31.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.128 -0.558 . . . . 70.140000000000001 111.949 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.15 160.27 43.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.04 -0.355 . . . . 74.430000000000007 110.04 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 29.04 1.51 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.566 -0.349 . . . . 71.230000000000004 113.47 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 73' ' ' THR . 10.9 mm-40 -62.32 -46.65 87.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.502 0.668 . . . . 75.439999999999998 109.568 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.82 178.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.729 -1.123 . . . . 62.130000000000003 109.689 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 105' ' ' ALA . 28.1 pt -68.59 145.53 13.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 123.333 0.396 . . . . 75.420000000000002 110.77 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.49 -20.46 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 111.579 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.05 21.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 74.310000000000002 111.535 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.421 ' H ' HG13 ' A' ' 80' ' ' ILE . 47.8 m0 -68.98 -37.91 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.675 0.274 . . . . 71.340000000000003 110.298 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.93 -55.03 35.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.885 -0.598 . . . . 72.430000000000007 110.499 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.37 -34.74 70.7 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.025 -0.534 . . . . 74.129999999999995 110.513 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.428 ' O ' HG21 ' A' ' 89' ' ' THR . . . -55.02 -49.83 61.23 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.917 -0.583 . . . . 70.400000000000006 112.138 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 90' ' ' MET . 21.6 m -75.8 -31.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.777 0.323 . . . . 63.539999999999999 111.12 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -63.82 -32.0 73.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.609 -0.269 . . . . 72.340000000000003 111.54 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 86' ' ' GLY . 14.0 t -82.27 -10.72 59.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.823 0.305 . . . . 73.040000000000006 111.823 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 16.7 ptp -103.59 -172.05 2.04 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.712 0.292 . . . . 71.329999999999998 110.964 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -133.18 179.01 6.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.216 -0.447 . . . . 75.530000000000001 110.805 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.503 ' HB3' ' HG1' ' A' ' 38' ' ' THR . 3.4 tm? -62.9 138.49 58.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.802 0.334 . . . . 74.120000000000005 110.537 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.406 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.78 24.65 75.7 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.483 -0.78 . . . . 72.25 112.395 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 21.9 tt0 -121.2 135.32 55.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 71.340000000000003 110.792 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -117.87 128.42 54.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.507 -0.77 . . . . 74.540000000000006 109.341 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.13 141.53 44.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.459 . . . . 55.240000000000002 111.331 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.9 115.63 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.633 -0.877 . . . . 64.409999999999997 108.633 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' HD1' HD12 ' A' ' 100' ' ' ILE . 21.4 t80 -121.26 122.73 40.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 65.010000000000005 110.107 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.57 HG22 HG21 ' A' ' 122' ' ' VAL . 4.2 m -79.59 107.85 12.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.45 . . . . 72.409999999999997 109.784 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.47 HD12 ' HD1' ' A' ' 98' ' ' PHE . 37.2 mm -82.72 110.43 22.46 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 116.222 -0.444 . . . . 60.109999999999999 110.575 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.557 ' HA ' HG21 ' A' ' 120' ' ' THR . 61.3 Cg_endo -72.68 150.29 50.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.41 2.073 . . . . 73.230000000000004 111.88 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -54.32 -27.99 39.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.679 -0.691 . . . . 75.519999999999996 111.975 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.11 -22.14 49.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.328 -0.396 . . . . 73.140000000000001 111.893 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.9 mt -106.35 22.48 15.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.01 0.434 . . . . 73.129999999999995 110.197 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -160.53 -174.99 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.626 . . . . 75.530000000000001 111.053 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -79.85 -3.37 47.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 110.243 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.66 -24.6 48.5 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.898 -0.592 . . . . 75.140000000000001 113.465 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 5.9 tm-20 -65.71 -48.36 72.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.555 -0.535 . . . . 70.209999999999994 109.555 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.474 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 1.6 tpm_? -78.38 -56.58 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.62 -0.718 . . . . 75.25 110.974 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.99 162.54 25.86 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.485 -0.646 . . . . 74.310000000000002 111.485 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.591 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 89.2 m-85 -143.15 -58.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.05 0.425 . . . . 75.400000000000006 110.824 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 71.7 Cg_endo -82.98 140.67 10.19 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.585 1.523 . . . . 74.049999999999997 111.499 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.43 -5.89 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.819 2.346 . . . . 75.519999999999996 112.983 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 t -81.24 -29.56 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.472 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -111.35 109.31 56.46 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.969 -0.56 . . . . 64.329999999999998 110.043 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.27 149.96 87.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.715 2.277 . . . . 73.409999999999997 112.014 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.41 153.9 76.29 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.74 2.294 . . . . 75.400000000000006 112.039 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 47.4 mtmt 59.33 32.91 22.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.05 0.452 . . . . 73.319999999999993 110.759 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.77 32.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.953 -0.567 . . . . 74.120000000000005 111.12 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -73.79 124.66 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.3 -0.63 . . . . 71.230000000000004 109.3 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.2 tm? -119.11 144.47 46.6 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.097 -0.705 . . . . 74.120000000000005 109.097 -172.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.57 HG21 HG22 ' A' ' 99' ' ' THR . 63.9 t -98.38 111.19 27.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 110.166 -0.309 . . . . 74.230000000000004 110.166 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.444 ' CE2' HD11 ' A' ' 121' ' ' LEU . 40.1 m-85 -108.75 118.4 36.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.281 0.562 . . . . 55.210000000000001 110.855 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.671 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 43.8 mt-10 -75.45 109.04 8.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.337 -0.986 . . . . 75.120000000000005 108.337 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 m -95.99 149.13 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 123.508 0.505 . . . . 55.229999999999997 109.646 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.51 119.64 8.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 110.193 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.769 HD22 HG13 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -90.67 104.35 16.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.472 -0.566 . . . . 72.310000000000002 109.472 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.0 -43.9 12.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.801 0.334 . . . . 73.209999999999994 110.752 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.487 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -159.39 164.34 34.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.019999999999996 110.465 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.499 HG22 HG13 ' A' ' 46' ' ' VAL . 2.7 p . . . . . 0 C--O 1.245 0.843 0 N-CA-C 109.771 -0.455 . . . . 71.349999999999994 109.771 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.627 0.251 . . . . 73.310000000000002 110.82 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.53 122.22 27.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.701 0.286 . . . . 70.140000000000001 111.065 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -164.27 142.27 7.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.093 -0.503 . . . . 75.329999999999998 109.728 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -84.11 163.38 19.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 110.476 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -142.59 102.94 4.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 75.319999999999993 111.107 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -145.75 150.86 37.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.475 -0.784 . . . . 73.329999999999998 109.712 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -104.79 -55.04 2.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.08 -0.711 . . . . 71.439999999999998 109.08 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -127.66 135.23 49.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.399 -0.818 . . . . 73.239999999999995 110.165 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt -114.52 -41.42 3.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.845 -0.798 . . . . 75.209999999999994 108.845 172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.09 81.66 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.348 -0.842 . . . . 72.519999999999996 111.278 174.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -79.38 21.13 0.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.034 0.383 . . . . 74.140000000000001 112.034 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.5 pt? -81.89 1.82 33.34 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.764 0.316 . . . . 72.230000000000004 111.089 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.6 86.25 2.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.002 0.429 . . . . 63.329999999999998 109.855 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.48 165.34 28.86 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.811 -0.631 . . . . 72.420000000000002 110.601 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -96.9 162.86 13.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 75.299999999999997 110.659 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 m -109.65 -34.95 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.176 -0.676 . . . . 75.230000000000004 109.176 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.2 158.04 43.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.408 -0.814 . . . . 72.329999999999998 109.092 173.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.03 26.97 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.163 -0.541 . . . . 74.25 112.69 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.12 -19.58 44.86 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.958 2.439 . . . . 73.400000000000006 111.796 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.98 54.35 4.2 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.968 -0.56 . . . . 72.409999999999997 112.433 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -127.77 103.65 7.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.554 -0.536 . . . . 73.519999999999996 109.554 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.1 mpt? -63.49 82.16 0.02 OUTLIER 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.491 0.662 . . . . 74.010000000000005 111.13 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -153.6 179.54 8.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.134 -0.939 . . . . 72.25 108.77 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.43 85.81 3.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 75.019999999999996 110.358 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -92.24 135.04 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.984 -0.747 . . . . 73.129999999999995 108.984 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 60.9 tp -146.18 119.62 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.178 0.436 . . . . 72.129999999999995 112.178 -175.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -101.45 129.52 47.51 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.121 -0.696 . . . . 65.329999999999998 109.121 162.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HZ1' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -125.79 100.71 6.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.745 -1.206 . . . . 71.0 107.745 169.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -119.71 113.29 20.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.945 -0.57 . . . . 74.450000000000003 110.308 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.03 108.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.224 0.535 . . . . 74.030000000000001 110.474 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -82.97 -44.85 14.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.857 -0.61 . . . . 73.129999999999995 109.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.8 m -139.68 110.76 7.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 74.030000000000001 109.45 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.14 133.9 40.2 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.621 2.214 . . . . 71.120000000000005 111.614 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.46 -150.69 23.03 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.166 -0.54 . . . . 71.150000000000006 112.795 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.71 -54.73 40.72 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.707 0.403 . . . . 72.409999999999997 111.254 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' HA2' HG22 ' A' ' 91' ' ' THR . . . 75.7 -9.11 17.47 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.212 -0.518 . . . . 51.130000000000003 113.037 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.49 -6.7 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.115 0.483 . . . . 74.230000000000004 110.7 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 92' ' ' LEU . 40.8 p -83.96 120.11 25.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.795 -0.639 . . . . 54.219999999999999 110.681 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -126.66 89.67 51.59 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.728 -0.215 . . . . 71.519999999999996 110.637 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.8 -175.68 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.87 2.38 . . . . 72.230000000000004 111.993 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -146.55 174.94 10.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.368 -0.378 . . . . 75.109999999999999 110.268 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 140.36 57.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.196 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.12 -1.37 54.67 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.215 -0.516 . . . . 73.239999999999995 112.515 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -92.02 133.08 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 75.150000000000006 110.925 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -83.77 107.83 16.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.851 -0.796 . . . . 63.310000000000002 108.851 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 35.9 m -107.18 147.67 12.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 116.49 -0.323 . . . . 72.019999999999996 111.534 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 m -100.73 108.17 19.95 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.036 -0.983 . . . . 54.210000000000001 110.728 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.808 HG13 HD21 ' A' ' 127' ' ' LEU . 19.7 m -120.36 178.66 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 114.893 -1.048 . . . . 54.299999999999997 111.365 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.644 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 22.4 t-160 -152.8 146.4 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.697 -1.223 . . . . 71.409999999999997 107.697 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.5 m-85 -126.97 159.45 34.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.901 0.382 . . . . 74.140000000000001 111.965 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.878 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 5.6 m-20 -135.78 157.35 47.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.951 -1.022 . . . . 72.430000000000007 108.509 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -118.6 128.93 7.92 Favored Glycine 0 N--CA 1.461 0.312 0 C-N-CA 121.039 -0.6 . . . . 64.230000000000004 112.597 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.523 HH21 HG22 ' A' ' 122' ' ' VAL . 16.2 ttp180 -138.32 145.53 41.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.934 0.397 . . . . 75.299999999999997 110.752 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.0 155.56 64.19 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 75.120000000000005 109.767 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.33 -17.91 49.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.621 2.214 . . . . 75.109999999999999 112.487 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.8 -23.82 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 72.329999999999998 110.598 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.07 -22.53 18.25 Favored Glycine 0 N--CA 1.454 -0.165 0 N-CA-C 111.177 -0.769 . . . . 62.229999999999997 111.177 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -71.77 141.16 49.73 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.726 0.41 . . . . 73.120000000000005 109.949 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 14.6 pt20 -121.2 135.58 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.122 -0.695 . . . . 72.329999999999998 109.122 172.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -69.87 -29.95 67.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.615 -0.266 . . . . 73.530000000000001 111.394 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.09 134.15 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 72.129999999999995 110.779 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.466 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 13.7 p -79.14 86.69 4.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.452 -0.573 . . . . 74.510000000000005 109.452 171.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 m -65.42 -12.01 48.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.176 0.512 . . . . 73.299999999999997 110.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.644 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 8.8 ptp85 -63.56 -31.73 72.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.566 -0.743 . . . . 75.5 109.934 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 t -73.4 -19.14 61.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.831 -0.622 . . . . 52.329999999999998 110.952 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -75.57 -20.56 58.54 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.422 -0.353 . . . . 75.439999999999998 110.06 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.68 48.72 69.64 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.955 -0.566 . . . . 63.329999999999998 113.72 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 64.6 tttp -130.94 124.27 20.53 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.801 -0.444 . . . . 75.340000000000003 109.801 174.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 Cg_endo -83.65 175.13 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.107 2.538 . . . . 73.209999999999994 112.015 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -146.91 128.73 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 71.25 108.515 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 92.6 mt-30 -106.6 131.54 53.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.464 0.173 . . . . 75.030000000000001 110.654 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.86 158.77 43.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.564 -0.289 . . . . 73.400000000000006 110.471 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.1 m -84.32 124.36 31.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 75.200000000000003 110.386 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 tp -59.38 130.3 46.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.365 -0.379 . . . . 75.129999999999995 110.383 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.18 39.02 72.63 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.989 -0.55 . . . . 70.140000000000001 112.521 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.81 161.97 31.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.995 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.78 18.51 8.94 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 116.021 -0.536 . . . . 71.230000000000004 113.462 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.83 -19.75 54.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.599 . . . . 75.439999999999998 109.814 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.96 159.71 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.446 -0.797 . . . . 62.130000000000003 109.48 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.518 HG13 ' H ' ' A' ' 83' ' ' TRP . 21.3 pt -70.28 151.09 9.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 116.406 -0.361 . . . . 75.420000000000002 110.102 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -56.68 -26.68 57.16 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.827 -0.434 . . . . 74.329999999999998 109.827 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.27 -52.06 53.84 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.052 -0.594 . . . . 74.310000000000002 111.853 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.518 ' H ' HG13 ' A' ' 80' ' ' ILE . 40.8 m0 -69.32 -31.29 69.66 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.325 -0.25 . . . . 71.340000000000003 110.325 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.4 -45.75 80.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.132 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.12 -35.35 76.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 74.129999999999995 109.789 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 89' ' ' THR . . . -56.46 -47.07 86.22 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.876 -0.602 . . . . 70.400000000000006 112.353 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG23 HD23 ' A' ' 127' ' ' LEU . 7.1 p -75.05 -34.08 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.809 0.338 . . . . 63.539999999999999 110.622 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.75 70.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.483 -0.326 . . . . 72.340000000000003 111.456 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 86' ' ' GLY . 8.9 t -87.01 3.34 46.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.673 0.273 . . . . 73.040000000000006 111.187 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.3 ptm -130.14 175.74 8.66 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 110.81 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.49 HG22 ' HA2' ' A' ' 36' ' ' GLY . 59.5 p -127.34 178.68 5.9 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.296 -0.411 . . . . 75.530000000000001 110.789 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.646 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -69.22 139.38 54.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.634 -0.257 . . . . 74.120000000000005 110.395 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.488 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 77.93 12.57 84.29 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.956 -0.565 . . . . 72.25 112.219 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -112.72 153.75 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.321 0.248 . . . . 71.340000000000003 110.643 -172.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -134.09 127.82 32.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.353 -0.61 . . . . 74.540000000000006 109.353 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.07 146.85 41.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 55.240000000000002 110.914 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 tt -90.8 111.67 23.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.531 -0.915 . . . . 64.409999999999997 108.531 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -117.9 129.0 55.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.802 0.334 . . . . 65.010000000000005 110.147 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.504 HG23 HG21 ' A' ' 122' ' ' VAL . 27.9 m -84.51 131.12 34.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.655 0.264 . . . . 72.409999999999997 111.138 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.68 103.0 44.83 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-O 120.896 0.379 . . . . 60.109999999999999 110.063 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.602 ' HA ' HG21 ' A' ' 120' ' ' THR . 26.9 Cg_exo -62.67 155.09 61.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.598 2.199 . . . . 73.230000000000004 111.927 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -55.07 -23.38 19.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.992 -0.549 . . . . 75.519999999999996 111.415 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -75.63 -6.5 50.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.241 -0.436 . . . . 73.140000000000001 111.972 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.511 HD12 ' HD2' ' A' ' 101' ' ' PRO . 96.7 mt -127.53 14.46 7.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.707 0.262 . . . . 73.129999999999995 111.707 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.34 -175.77 5.01 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.953 0.406 . . . . 75.530000000000001 111.485 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -66.55 -12.33 57.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.515 -0.766 . . . . 75.329999999999998 111.314 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.91 -32.83 19.51 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.35 -0.386 . . . . 75.140000000000001 113.688 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 tp10 -58.08 -49.23 77.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.367 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.26 -47.74 9.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 75.25 110.971 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.77 153.44 13.05 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 112.076 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.695 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 76.1 m-85 -144.41 -57.19 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 122.314 0.246 . . . . 75.400000000000006 110.944 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.695 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 6.8 Cg_exo -73.49 143.1 34.01 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.896 1.731 . . . . 74.049999999999997 111.235 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.48 -27.66 41.38 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.821 2.347 . . . . 75.519999999999996 112.786 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.465 HG21 HG12 ' A' ' 115' ' ' ILE . 33.3 m -78.19 -18.18 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 111.514 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.507 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 49.0 mm -108.19 103.37 50.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.318 -0.401 . . . . 64.329999999999998 110.188 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.52 164.68 31.97 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.568 2.179 . . . . 73.409999999999997 111.668 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.35 142.6 94.98 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.317 2.012 . . . . 75.400000000000006 112.135 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 67.6 mttm 65.97 27.74 10.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.937 -0.574 . . . . 73.319999999999993 111.283 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.73 116.84 26.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.835 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.602 HG21 ' HA ' ' A' ' 101' ' ' PRO . 70.6 m -74.04 138.37 44.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.015 -0.539 . . . . 71.230000000000004 109.75 174.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -129.64 138.95 51.5 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.263 -0.643 . . . . 74.120000000000005 109.263 -175.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.523 HG22 HH21 ' A' ' 53' ' ' ARG . 48.1 t -98.6 133.72 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.588 0.232 . . . . 74.230000000000004 110.397 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.54 126.51 44.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.069 0.461 . . . . 55.210000000000001 110.533 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.878 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.0 mt-10 -78.23 118.36 20.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.953 -0.758 . . . . 75.120000000000005 108.953 173.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -95.97 135.57 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.443 -0.577 . . . . 55.229999999999997 109.443 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.9 tt0 -135.16 106.51 6.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.283 -0.417 . . . . 75.209999999999994 110.113 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.808 HD21 HG13 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -87.03 108.27 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.829 -0.804 . . . . 72.310000000000002 108.829 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.24 -50.9 7.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.856 -0.424 . . . . 73.209999999999994 109.856 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -169.9 -173.68 1.63 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.969 -0.56 . . . . 73.019999999999996 110.602 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.243 0.736 0 N-CA-C 109.161 -0.681 . . . . 71.349999999999994 109.161 173.216 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.884 0.373 . . . . 73.310000000000002 110.58 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.67 -81.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.388 -0.824 . . . . 70.140000000000001 112.486 172.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 62.34 10.52 3.94 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 110.846 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -92.24 134.22 35.09 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.672 -0.492 . . . . 73.230000000000004 109.672 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -112.41 146.91 37.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.756 -0.461 . . . . 75.319999999999993 109.756 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -74.73 73.04 2.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.205 0.526 . . . . 73.329999999999998 110.311 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -99.54 120.34 39.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.994 -0.548 . . . . 71.439999999999998 109.86 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -125.63 144.86 50.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.906 -0.588 . . . . 73.239999999999995 109.443 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.411 ' HE3' ' OG1' ' A' ' 11' ' ' THR . 86.5 mtp -134.88 120.0 18.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.457 -0.338 . . . . 75.209999999999994 110.67 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.86 49.08 3.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.348 -0.701 . . . . 72.519999999999996 111.348 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.411 ' OG1' ' HE3' ' A' ' 9' ' ' MET . 25.0 m -68.89 138.66 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.658 0.383 . . . . 74.140000000000001 110.851 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.0 pt? -116.97 -2.97 11.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 72.230000000000004 109.805 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.82 115.2 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.462 -0.79 . . . . 63.329999999999998 109.997 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.78 79.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 72.420000000000002 111.943 -174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -168.31 115.46 0.69 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.064 -0.517 . . . . 75.299999999999997 110.009 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -150.98 154.11 36.46 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 110.047 -0.353 . . . . 75.230000000000004 110.047 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -74.34 82.32 1.89 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.711 -0.477 . . . . 72.329999999999998 109.711 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.36 143.25 9.25 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.071 -0.513 . . . . 74.25 112.002 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 49.1 Cg_endo -68.2 88.22 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.603 2.202 . . . . 73.400000000000006 111.958 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.96 -154.14 22.33 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.832 -0.622 . . . . 72.409999999999997 112.791 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -55.51 -18.24 6.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.95 0.5 . . . . 73.519999999999996 112.138 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.494 ' HB2' HE21 ' A' ' 25' ' ' GLN . 84.9 mmm -67.87 -4.58 13.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.116 0.413 . . . . 74.010000000000005 112.116 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 p 55.87 -75.42 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.733 0.813 . . . . 72.25 112.827 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' MET . . . -70.88 108.96 4.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.937 0.399 . . . . 75.019999999999996 110.415 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.607 ' HG3' ' HA ' ' A' ' 19' ' ' PRO . 80.0 mm-40 -135.48 163.37 30.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 73.129999999999995 110.638 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -142.51 102.03 3.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 72.129999999999995 110.134 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -124.63 102.26 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.262 0.553 . . . . 65.329999999999998 110.047 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -112.74 109.7 19.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.272 -0.876 . . . . 71.0 109.16 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -108.66 110.35 21.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.469 -0.567 . . . . 74.450000000000003 109.469 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.75 106.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.109 -0.33 . . . . 74.030000000000001 110.109 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 97' ' ' LEU . 85.4 mt -87.7 -28.84 21.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 110.154 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 28.5 m -140.83 110.92 6.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.48 -0.782 . . . . 74.030000000000001 109.518 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.81 127.0 22.0 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.486 2.124 . . . . 71.120000000000005 111.249 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.11 -174.35 50.32 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 71.150000000000006 112.922 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD2' HG22 ' A' ' 37' ' ' VAL . 23.0 t70 -60.82 -43.06 98.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 110.543 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.3 9.74 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.934 -0.575 . . . . 51.130000000000003 114.43 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.432 HG22 ' OD2' ' A' ' 35' ' ' ASP . 14.0 m -103.57 -28.0 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.087 0.943 . . . . 74.230000000000004 110.807 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 5.5 p -75.95 88.62 2.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.41 0.624 . . . . 54.219999999999999 109.854 173.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' HZ2' ' HB3' ' A' ' 39' ' ' LYS . 8.5 mtpm? -93.29 114.45 62.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.348 -0.842 . . . . 71.519999999999996 111.068 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HG3' ' HG ' ' A' ' 127' ' ' LEU . 56.1 Cg_endo -70.58 107.77 2.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.412 2.074 . . . . 72.230000000000004 110.974 174.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.08 157.72 15.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 75.109999999999999 110.609 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 157.27 32.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 74.420000000000002 111.057 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.08 76.93 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.004 -0.544 . . . . 73.239999999999995 112.128 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -132.08 141.78 49.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.456 0.303 . . . . 75.150000000000006 110.311 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -71.95 107.61 4.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.736 -0.468 . . . . 63.310000000000002 109.736 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 HG11 HG23 ' A' ' 130' ' ' VAL . 33.6 m -106.42 147.42 11.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 120.887 0.375 . . . . 72.019999999999996 110.903 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.2 m -104.81 108.44 19.93 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.472 -0.786 . . . . 54.210000000000001 109.761 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.648 HG13 HD22 ' A' ' 127' ' ' LEU . 21.3 m -118.78 178.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.482 -0.781 . . . . 54.299999999999997 111.97 -171.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -150.61 137.02 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.866 . . . . 71.409999999999997 109.231 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.623 ' HD1' HG12 ' A' ' 125' ' ' VAL . 56.2 m-85 -126.64 159.4 33.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.71 -0.107 . . . . 74.140000000000001 110.71 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.62 136.35 29.05 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.466 0.479 . . . . 72.430000000000007 109.728 167.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 124.82 7.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.475 -0.393 . . . . 64.230000000000004 112.277 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.404 ' O ' HD11 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -141.01 137.46 32.99 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.327 0.584 . . . . 75.299999999999997 110.974 -170.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.19 148.37 39.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 109.744 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 -18.56 37.0 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.799 2.333 . . . . 75.109999999999999 112.457 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -66.56 -31.3 71.93 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.054 -0.521 . . . . 72.329999999999998 110.783 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.43 -21.07 15.21 Favored Glycine 0 C--N 1.327 0.038 0 N-CA-C 109.992 -1.243 . . . . 62.229999999999997 109.992 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -68.87 154.46 41.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.672 -0.764 . . . . 73.120000000000005 110.101 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -142.23 151.77 42.44 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.778 -0.453 . . . . 72.329999999999998 109.778 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.75 -4.54 36.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.714 0.292 . . . . 73.530000000000001 111.422 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -168.26 144.79 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.141 -0.688 . . . . 72.129999999999995 109.141 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.8 p -109.07 85.34 2.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.62 0.724 . . . . 74.510000000000005 110.292 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.1 m -77.83 -18.26 56.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.539 -0.755 . . . . 73.299999999999997 109.401 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -65.05 -32.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.21 -0.904 . . . . 75.5 109.645 173.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -73.57 -24.26 60.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.342 -0.844 . . . . 52.329999999999998 110.869 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -84.27 -28.64 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 75.439999999999998 110.598 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.25 25.1 59.73 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.086 -0.506 . . . . 63.329999999999998 112.194 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.92 129.15 47.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 122.52 0.328 . . . . 75.340000000000003 110.825 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -87.84 157.05 7.41 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.967 2.444 . . . . 73.209999999999994 112.434 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -134.92 130.13 35.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.888 -0.782 . . . . 71.25 108.888 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -107.85 138.24 44.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.504 0.192 . . . . 75.030000000000001 110.756 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -157.21 163.55 38.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.267 -0.424 . . . . 73.400000000000006 110.051 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.9 m -82.46 110.79 17.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.192 -0.299 . . . . 75.200000000000003 110.192 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 88' ' ' ALA . 48.1 tp -61.82 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.238 -0.437 . . . . 75.129999999999995 110.223 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.14 12.48 Favored Glycine 0 C--O 1.237 0.286 0 N-CA-C 111.488 -0.645 . . . . 70.140000000000001 111.488 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.57 154.19 38.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 74.430000000000007 110.504 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.61 33.89 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.147 -0.479 . . . . 71.230000000000004 112.67 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.89 -23.6 67.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.022 0.439 . . . . 75.439999999999998 110.641 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.93 174.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.139 -0.689 . . . . 62.130000000000003 109.139 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.468 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.6 pt -73.61 140.28 18.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.741 -0.466 . . . . 75.420000000000002 109.741 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 30.3 mmtp -58.45 -16.68 16.1 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.689 0.255 . . . . 74.329999999999998 111.689 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.93 -53.02 46.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.416 -0.897 . . . . 74.310000000000002 111.183 172.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.468 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.1 m0 -67.06 -42.1 85.33 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.114 -0.328 . . . . 71.340000000000003 110.114 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 17.8 t70 -52.59 -55.15 24.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.511 -0.768 . . . . 72.430000000000007 110.671 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -65.6 -40.42 92.65 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.094 -0.503 . . . . 74.129999999999995 110.666 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.69 -53.96 30.24 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.919 -0.582 . . . . 70.400000000000006 112.622 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.94 -30.35 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.544 0.212 . . . . 63.539999999999999 111.369 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -67.2 -30.15 70.01 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.725 0.269 . . . . 72.340000000000003 111.725 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 t -88.46 7.32 33.43 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.001 0.371 . . . . 73.040000000000006 112.001 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 11.9 ptp -121.97 -173.87 2.75 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.168 -0.332 . . . . 71.329999999999998 111.113 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -124.31 175.3 7.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.132 -0.486 . . . . 75.530000000000001 110.732 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 127' ' ' LEU . 7.7 tt -63.33 131.84 49.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 74.120000000000005 110.364 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 8.78 83.7 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.416 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.631 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 14.1 tt0 -102.02 140.92 35.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 71.340000000000003 110.585 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.433 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.9 ttpm? -131.79 136.23 47.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.808 -0.442 . . . . 74.540000000000006 109.808 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.13 150.62 35.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.961 0.41 . . . . 55.240000000000002 111.186 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.444 ' HB2' HD13 ' A' ' 31' ' ' LEU . 9.1 tt -90.67 109.42 20.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.984 -1.117 . . . . 64.409999999999997 107.984 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.402 ' HD1' HD11 ' A' ' 100' ' ' ILE . 7.0 t80 -112.0 117.77 33.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 65.010000000000005 110.109 -174.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 31.9 m -77.22 110.54 12.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.401 -0.363 . . . . 72.409999999999997 110.224 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.402 HD11 ' HD1' ' A' ' 98' ' ' PHE . 42.0 mm -90.48 111.6 48.33 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.127 -0.488 . . . . 60.109999999999999 110.488 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.429 ' HA ' HG23 ' A' ' 120' ' ' THR . 34.3 Cg_exo -59.9 144.46 99.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.396 2.064 . . . . 73.230000000000004 110.908 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 46.5 p90 -54.56 -36.32 64.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 75.519999999999996 110.882 -176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -62.99 -24.15 67.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 73.140000000000001 111.398 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.34 16.91 24.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.285 -0.416 . . . . 73.129999999999995 110.723 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.69 7.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 75.530000000000001 111.169 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -74.43 -11.03 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.893 -0.594 . . . . 75.329999999999998 111.016 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.89 63.45 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.928 -0.578 . . . . 75.140000000000001 112.485 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.529 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 4.7 tm-20 -57.62 -54.81 42.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.072 0.463 . . . . 70.209999999999994 109.996 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -103.67 -24.69 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 75.25 110.086 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.06 -175.22 52.57 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 112.317 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.785 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m-85 -151.04 -59.47 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.877 0.471 . . . . 75.400000000000006 110.119 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 72.8 Cg_endo -95.26 157.6 1.66 Allowed 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.653 2.235 . . . . 74.049999999999997 112.193 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.82 -17.28 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.852 2.368 . . . . 75.519999999999996 112.472 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.74 -32.53 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 74.310000000000002 110.251 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.631 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 mm -109.14 99.56 36.45 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.05 -0.523 . . . . 64.329999999999998 109.619 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.648 ' HG2' ' HB1' ' A' ' 119' ' ' ALA . 36.2 Cg_endo -66.08 152.22 81.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.515 2.144 . . . . 73.409999999999997 112.182 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.87 137.13 61.02 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.36 2.04 . . . . 75.400000000000006 111.277 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 64.75 37.5 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.63 0.581 . . . . 73.319999999999993 110.501 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.648 ' HB1' ' HG2' ' A' ' 116' ' ' PRO . . . -92.98 116.33 28.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.607 -0.724 . . . . 74.120000000000005 110.544 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -74.1 133.96 42.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 71.230000000000004 109.389 173.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.457 HD11 ' H ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -124.87 144.3 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 74.120000000000005 109.307 -172.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.457 ' H ' HD11 ' A' ' 121' ' ' LEU . 88.6 t -100.85 128.01 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 109.914 -0.402 . . . . 74.230000000000004 109.914 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -123.02 120.71 34.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.151 0.501 . . . . 55.210000000000001 110.329 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -82.84 111.05 18.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.614 -0.884 . . . . 75.120000000000005 108.614 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.623 HG12 ' HD1' ' A' ' 50' ' ' TYR . 34.2 m -104.81 150.24 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.029 -0.987 . . . . 55.229999999999997 110.614 -173.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.01 128.88 12.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.49 -0.323 . . . . 75.209999999999994 110.439 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.678 HD11 ' HA ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -93.43 118.17 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.929 -0.767 . . . . 72.310000000000002 108.929 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.79 -50.33 5.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.428 0.156 . . . . 73.209999999999994 111.141 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.24 0.543 . . . . 73.019999999999996 111.677 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.599 HG13 HD13 ' A' ' 92' ' ' LEU . 13.3 p . . . . . 0 C--O 1.251 1.167 0 CA-C-N 115.206 -0.906 . . . . 71.349999999999994 108.947 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.951 -0.389 . . . . 73.310000000000002 109.951 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.99 167.02 30.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.807 0.337 . . . . 70.140000000000001 111.325 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -168.53 115.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 75.329999999999998 109.35 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -140.96 114.38 8.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 73.230000000000004 111.232 -173.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -140.08 137.43 34.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.306 -0.628 . . . . 75.319999999999993 109.306 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -128.54 112.24 14.1 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.871 -0.418 . . . . 73.329999999999998 109.871 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -86.34 89.68 7.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 71.439999999999998 111.053 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -157.38 121.75 4.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 73.239999999999995 110.507 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.6 tpt -149.76 121.08 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 75.209999999999994 110.212 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 171.51 48.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.958 -0.565 . . . . 72.519999999999996 112.902 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.1 p -128.37 165.12 21.21 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.695 -0.483 . . . . 74.140000000000001 109.695 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.2 mt -132.23 154.16 49.89 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 110.308 -0.256 . . . . 72.230000000000004 110.308 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -80.04 82.77 6.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.218 0.532 . . . . 63.329999999999998 109.739 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.91 123.62 32.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 72.420000000000002 110.534 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -161.98 103.58 1.15 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.501 -0.555 . . . . 75.299999999999997 109.501 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.3 m -150.27 124.73 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.474 -0.33 . . . . 75.230000000000004 110.33 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -79.72 83.47 5.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.739 -0.467 . . . . 72.329999999999998 109.739 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.08 -163.17 32.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.145 -0.55 . . . . 74.25 112.552 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HG2' ' HG3' ' A' ' 55' ' ' PRO . 79.6 Cg_exo -50.09 94.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.122 2.548 . . . . 73.400000000000006 112.682 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.71 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 109.876 -1.29 . . . . 72.409999999999997 109.876 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -90.45 101.19 13.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.916 -0.772 . . . . 73.519999999999996 108.916 170.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 ptp -65.69 110.56 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.229 0.537 . . . . 74.010000000000005 111.596 -173.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -165.56 175.69 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.802 -0.635 . . . . 72.25 109.804 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.2 75.3 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 75.019999999999996 110.833 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -92.63 135.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 73.129999999999995 109.711 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.8 tp -128.0 118.21 23.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.83 0.348 . . . . 72.129999999999995 110.298 -176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.422 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 43.2 mt-10 -123.72 146.06 48.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 65.329999999999998 111.001 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -141.02 110.67 6.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 71.0 109.459 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.593 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.9 mptt -108.69 110.4 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 74.450000000000003 109.697 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.5 112.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.015 0.436 . . . . 74.030000000000001 110.139 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 97' ' ' LEU . 79.6 mt -92.08 -30.11 16.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.119 -177.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 33.6 m -141.37 110.66 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.982 -0.748 . . . . 74.030000000000001 108.982 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.63 135.65 28.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.271 1.981 . . . . 71.120000000000005 112.043 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.94 -165.0 30.65 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.143 -0.551 . . . . 71.150000000000006 111.747 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.24 -20.71 62.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.63 0.215 . . . . 72.409999999999997 111.165 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.22 -30.32 1.15 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.489 -0.386 . . . . 51.130000000000003 113.481 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.4 -32.85 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 74.230000000000004 110.87 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 1.9 p -80.02 108.17 13.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.498 0.666 . . . . 54.219999999999999 110.61 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HE3' ' OE1' ' A' ' 41' ' ' GLN . 56.5 pttt -94.43 125.91 50.09 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.105 -0.952 . . . . 71.519999999999996 111.426 -173.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.99 106.17 2.12 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.853 2.368 . . . . 72.230000000000004 110.564 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' ' HE3' ' A' ' 39' ' ' LYS . 26.1 mt-30 -88.12 146.06 25.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.379 -0.373 . . . . 75.109999999999999 111.242 -176.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.45 156.77 36.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.857 -0.611 . . . . 74.420000000000002 109.892 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.19 16.6 79.65 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.905 -0.664 . . . . 73.239999999999995 111.68 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -132.94 154.86 50.03 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.737 0.415 . . . . 75.150000000000006 109.982 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.688 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -73.17 127.2 31.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 63.310000000000002 109.944 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.77 150.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 120.818 0.342 . . . . 72.019999999999996 110.642 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 m -111.27 110.53 21.06 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.213 -0.903 . . . . 54.210000000000001 110.698 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.709 HG11 HD22 ' A' ' 127' ' ' LEU . 24.8 m -128.66 177.88 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.719 0.771 . . . . 54.299999999999997 112.914 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.742 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 8.7 m170 -139.68 152.48 46.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.463 -1.244 . . . . 71.409999999999997 108.933 172.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 83' ' ' TRP . 63.6 m-85 -134.91 142.53 46.57 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.542 -0.54 . . . . 74.140000000000001 109.542 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 123' ' ' PHE . 36.5 t0 -137.02 143.76 42.9 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.203 -0.295 . . . . 72.430000000000007 110.203 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.55 140.01 15.22 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.338 -0.458 . . . . 64.230000000000004 112.328 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -157.26 149.31 22.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.375 0.607 . . . . 75.299999999999997 111.781 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.87 153.37 63.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.385 -0.825 . . . . 75.120000000000005 109.595 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.525 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 19.9 Cg_endo -58.11 -20.28 45.32 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.029 2.486 . . . . 75.109999999999999 113.812 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.87 4.16 45.69 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.77 0.319 . . . . 72.329999999999998 111.004 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.37 26.01 37.69 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.184 -0.531 . . . . 62.229999999999997 112.342 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.04 146.77 39.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.807 -0.442 . . . . 73.120000000000005 109.807 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -160.15 157.49 28.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.977 -0.379 . . . . 72.329999999999998 109.977 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -69.21 -42.38 75.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.323 -0.399 . . . . 73.530000000000001 110.706 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.435 ' CG ' HH21 ' A' ' 66' ' ' ARG . 28.0 t70 -170.0 145.71 2.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.725 -0.671 . . . . 72.129999999999995 109.955 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.3 t -82.79 114.8 21.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.624 -0.509 . . . . 74.510000000000005 109.624 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.6 m -86.67 -28.0 23.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 73.299999999999997 111.783 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -69.61 -31.47 69.62 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.142 -0.349 . . . . 75.5 110.828 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 29.8 p -73.6 -2.92 24.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.285 -0.416 . . . . 52.329999999999998 111.09 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.435 HH21 ' CG ' ' A' ' 61' ' ' ASP . 28.5 mmt180 -75.95 -3.93 38.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.52 -0.309 . . . . 75.439999999999998 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 69' ' ' PRO . . . 72.61 8.36 71.66 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.47 -0.395 . . . . 63.329999999999998 113.045 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 55.8 tptt -91.97 106.82 18.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.549 -0.537 . . . . 75.340000000000003 109.549 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.1 Cg_exo -80.86 139.95 12.53 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.176 2.584 . . . . 73.209999999999994 112.1 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -107.62 142.89 36.86 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.793 -0.817 . . . . 71.25 108.793 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 50.7 mt-30 -134.63 138.26 44.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.32 -0.252 . . . . 75.030000000000001 110.32 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.32 164.26 34.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.774 -0.193 . . . . 73.400000000000006 110.657 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.5 m -78.53 111.42 14.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.839 -0.43 . . . . 75.200000000000003 109.839 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.421 HD13 ' HB1' ' A' ' 88' ' ' ALA . 50.7 tp -61.03 142.61 56.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.41 -0.359 . . . . 75.129999999999995 110.765 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.57 30.51 44.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.192 -0.528 . . . . 70.140000000000001 111.967 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.16 160.7 39.19 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.387 -0.227 . . . . 74.430000000000007 110.387 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.98 42.75 2.12 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 116.39 -0.368 . . . . 71.230000000000004 113.131 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -76.81 -47.43 21.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.973 -0.751 . . . . 75.439999999999998 108.973 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.66 175.53 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.222 -0.899 . . . . 62.130000000000003 109.143 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.499 HG13 ' H ' ' A' ' 83' ' ' TRP . 37.2 pt -64.6 144.6 14.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.902 -0.407 . . . . 75.420000000000002 109.902 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 3.9 tmtm? -58.92 -22.52 59.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.308 -0.405 . . . . 74.329999999999998 109.936 -176.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.32 -52.59 51.75 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.921 -0.657 . . . . 74.310000000000002 111.793 175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.499 ' H ' HG13 ' A' ' 80' ' ' ILE . 51.3 m0 -67.39 -41.87 84.26 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.127 -0.324 . . . . 71.340000000000003 110.127 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.2 t70 -54.47 -45.68 73.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.622 -0.717 . . . . 72.430000000000007 110.236 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -64.37 -44.72 90.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 74.129999999999995 110.319 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 89' ' ' THR . . . -54.75 -49.61 61.05 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.733 -0.667 . . . . 70.400000000000006 112.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.6 -30.34 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.49 0.186 . . . . 63.539999999999999 111.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HB1' HD13 ' A' ' 74' ' ' LEU . . . -72.92 -30.23 63.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.617 0.228 . . . . 72.340000000000003 111.617 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 86' ' ' GLY . 14.7 t -81.32 -4.15 54.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.723 0.296 . . . . 73.040000000000006 111.696 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.737 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 15.2 ptp -112.2 -176.66 2.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.886 0.374 . . . . 71.329999999999998 110.792 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.9 p -121.34 176.2 5.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.458 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 127' ' ' LEU . 6.4 tt -62.64 126.94 29.04 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.981 0.419 . . . . 74.120000000000005 110.71 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.84 65.12 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.648 -0.705 . . . . 72.25 112.772 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 32' ' ' THR . 15.0 tt0 -99.4 143.57 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 71.340000000000003 111.071 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -131.11 120.01 22.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.097 -0.705 . . . . 74.540000000000006 109.097 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.8 147.09 50.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.294 0.569 . . . . 55.240000000000002 111.306 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.593 HD22 ' HD3' ' A' ' 29' ' ' LYS . 10.0 tt -90.44 104.96 17.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.676 -1.231 . . . . 64.409999999999997 107.676 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -103.45 118.4 36.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.992 -0.549 . . . . 65.010000000000005 109.731 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 27' ' ' GLU . 27.4 m -89.06 106.53 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.318 -0.401 . . . . 72.409999999999997 110.0 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.6 mm -86.44 113.69 53.83 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.949 -0.569 . . . . 60.109999999999999 111.076 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.553 ' HA ' HG23 ' A' ' 120' ' ' THR . 36.3 Cg_endo -66.12 149.93 85.42 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.372 2.048 . . . . 73.230000000000004 110.33 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.512 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 45.9 p90 -54.45 -31.71 56.06 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.356 0.502 . . . . 75.519999999999996 112.356 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.87 -23.78 64.26 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.004 0.372 . . . . 73.140000000000001 112.004 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.03 6.32 46.85 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.556 0.206 . . . . 73.129999999999995 111.556 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.06 -177.71 6.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 75.530000000000001 111.039 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -67.67 -14.3 62.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 75.329999999999998 110.875 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.62 -23.19 35.21 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.405 0.44 . . . . 75.140000000000001 112.63 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 44.9 tt0 -56.76 -44.24 81.57 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.044 0.449 . . . . 70.209999999999994 110.254 174.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 109' ' ' ARG . 20.1 mtp180 -97.92 -18.82 18.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.528 -0.76 . . . . 75.25 110.42 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 67.23 -110.22 3.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.761 -0.654 . . . . 74.310000000000002 112.681 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 31.8 m-85 102.92 -71.33 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.639 1.575 . . . . 75.400000000000006 112.418 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HG2' ' HB ' ' A' ' 115' ' ' ILE . 41.9 Cg_endo -65.84 149.45 86.63 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 121.439 1.426 . . . . 74.049999999999997 111.748 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.92 -31.85 44.97 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.103 2.536 . . . . 75.519999999999996 113.23 -175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 115' ' ' ILE . 27.4 m -83.2 -20.39 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 74.310000000000002 111.586 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 114' ' ' VAL . 49.2 mm -125.15 94.6 43.27 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.486 -0.325 . . . . 64.329999999999998 110.254 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' HB1' ' A' ' 119' ' ' ALA . 94.6 Cg_endo -81.43 169.9 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.811 2.341 . . . . 73.409999999999997 111.402 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.58 148.46 63.87 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.127 1.884 . . . . 75.400000000000006 111.694 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.92 16.38 8.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.144 0.578 . . . . 73.319999999999993 111.818 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 116' ' ' PRO . . . -72.39 112.21 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.120000000000005 111.752 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.7 m -88.15 119.59 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.502 -0.925 . . . . 71.230000000000004 108.502 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -124.59 147.97 48.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.649 0.262 . . . . 74.120000000000005 110.512 -167.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.573 ' N ' HD12 ' A' ' 121' ' ' LEU . 76.0 t -98.52 131.85 44.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.428 -0.351 . . . . 74.230000000000004 110.705 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 97.4 m-85 -130.01 121.94 27.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.388 -0.369 . . . . 55.210000000000001 110.561 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 16.8 mt-10 -77.4 113.95 15.72 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.264 -0.643 . . . . 75.120000000000005 109.264 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 132.93 42.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.617 -0.719 . . . . 55.229999999999997 109.345 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.742 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.6 tt0 -133.32 112.33 11.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 75.209999999999994 110.629 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.737 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -87.62 106.2 17.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.333 -0.618 . . . . 72.310000000000002 109.333 178.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.546 HD23 ' ND1' ' A' ' 49' ' ' HIS . 3.9 mm? -79.24 -50.63 10.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.215 0.531 . . . . 73.209999999999994 109.949 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . . . -168.35 -176.68 2.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 73.019999999999996 109.683 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.708 -0.849 . . . . 71.349999999999994 108.708 175.365 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.783 -0.451 . . . . 73.310000000000002 109.783 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.15 3.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.18 -0.464 . . . . 70.140000000000001 110.894 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -80.37 92.82 5.86 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.814 -0.439 . . . . 75.329999999999998 109.814 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -78.84 117.47 19.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.866 -0.606 . . . . 73.230000000000004 110.254 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -80.19 116.65 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 75.319999999999993 110.699 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -175.5 138.37 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.614 -0.513 . . . . 73.329999999999998 109.614 174.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -92.19 178.03 5.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.901 -0.407 . . . . 71.439999999999998 109.901 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -140.88 131.18 25.03 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.262 -0.273 . . . . 73.239999999999995 110.262 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.402 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.8 mpt? -85.61 -19.51 30.91 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.387 -0.37 . . . . 75.209999999999994 110.443 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 125.82 14.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.899 -0.592 . . . . 72.519999999999996 112.78 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -105.22 -172.73 2.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.889 -0.411 . . . . 74.140000000000001 109.889 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 53.9 tp -125.69 -69.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.486 -0.561 . . . . 72.230000000000004 109.486 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 42.7 mt-10 -127.43 165.14 20.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.149 -0.478 . . . . 63.329999999999998 109.771 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.59 -64.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.365 0.416 . . . . 72.420000000000002 111.464 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -156.14 173.1 17.33 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.224 -0.444 . . . . 75.299999999999997 110.364 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -70.41 134.62 48.01 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.87 -0.418 . . . . 75.230000000000004 109.87 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.27 77.7 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.526 . . . . 72.329999999999998 110.137 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.99 103.9 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.506 -0.77 . . . . 74.25 111.75 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.16 -8.86 19.75 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.647 2.231 . . . . 73.400000000000006 112.426 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 36.1 2.81 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.555 -0.618 . . . . 72.409999999999997 111.555 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 p -78.59 97.67 5.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.13 0.491 . . . . 73.519999999999996 110.479 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.3 ptm -67.03 87.74 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.473 0.654 . . . . 74.010000000000005 110.656 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 t -157.48 -175.72 5.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.637 -0.71 . . . . 72.25 109.643 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.31 63.17 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 75.019999999999996 110.458 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -92.42 139.69 30.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.822 -0.627 . . . . 73.129999999999995 110.247 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 47.8 tp -145.95 101.72 3.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.26 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -116.84 122.99 45.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.706 -0.479 . . . . 65.329999999999998 109.706 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' NZ ' ' OG1' ' A' ' 89' ' ' THR . 61.5 pttt -126.39 119.29 26.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.114 0.483 . . . . 71.0 110.13 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.648 -0.705 . . . . 74.450000000000003 110.214 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -61.45 110.6 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.134 0.493 . . . . 74.030000000000001 109.739 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.55 HD22 ' HE3' ' A' ' 95' ' ' LYS . 34.8 tp -96.04 -25.13 16.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.018 -0.537 . . . . 73.129999999999995 110.072 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 57.1 m -149.0 110.77 3.52 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.893 -0.594 . . . . 74.030000000000001 109.725 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.38 133.84 21.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.039 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -95.24 -151.86 28.73 Favored Glycine 0 C--O 1.236 0.254 0 CA-C-N 116.063 -0.517 . . . . 71.150000000000006 111.823 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.414 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 44.1 m-20 -63.92 -36.14 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.933 0.367 . . . . 72.409999999999997 111.306 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.48 -30.03 2.83 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 112.479 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.81 -25.11 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.799 0.333 . . . . 74.230000000000004 111.484 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.431 ' HG1' ' HB3' ' A' ' 92' ' ' LEU . 7.8 p -80.31 96.47 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 54.219999999999999 110.701 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -97.89 124.32 48.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.555 . . . . 71.519999999999996 111.651 -173.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.12 154.16 41.74 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.902 2.401 . . . . 72.230000000000004 111.401 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.63 174.82 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.565 -0.288 . . . . 75.109999999999999 110.689 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.2 144.19 57.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.353 -0.385 . . . . 74.420000000000002 111.153 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.74 16.22 71.08 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 112.434 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 27.8 mmmt -109.33 121.8 45.97 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.526 0.331 . . . . 75.150000000000006 111.174 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -74.16 106.1 5.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.15 -0.685 . . . . 63.310000000000002 109.15 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.44 142.14 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.21 0.528 . . . . 72.019999999999996 111.689 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 25.5 m -103.65 108.3 19.52 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.132 -0.94 . . . . 54.210000000000001 109.079 175.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.0 178.15 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.944 -0.571 . . . . 54.299999999999997 111.76 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.474 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.8 t-80 -147.59 139.95 24.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.696 -0.684 . . . . 71.409999999999997 109.366 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.4 m-85 -126.46 149.84 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.37 0.419 . . . . 74.140000000000001 110.543 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.721 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 56.9 m-20 -136.11 128.27 29.86 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.607 -0.516 . . . . 72.430000000000007 109.607 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.73 115.52 4.88 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 121.124 -0.56 . . . . 64.230000000000004 112.34 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 26.7 ttp180 -133.32 144.24 49.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.98 0.419 . . . . 75.299999999999997 110.951 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -74.34 144.55 81.48 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.962 -0.755 . . . . 75.120000000000005 108.962 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -39.96 -48.74 3.74 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.658 2.905 . . . . 75.109999999999999 114.045 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.81 -41.4 97.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.325 0.491 . . . . 72.329999999999998 112.325 -173.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.84 -24.43 0.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.515 -0.85 . . . . 62.229999999999997 113.108 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -66.71 112.83 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.813 -0.228 . . . . 73.120000000000005 111.174 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.562 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 12.1 pt20 -102.11 144.03 31.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.016 -0.364 . . . . 72.329999999999998 110.016 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -96.44 -26.81 15.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.437 -0.347 . . . . 73.530000000000001 110.606 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -148.36 138.18 22.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.09 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.2 p -124.28 90.2 3.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.11 0.481 . . . . 74.510000000000005 110.589 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -68.05 -18.27 64.63 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.361 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG2' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -59.42 -35.27 73.69 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.56 . . . . 75.5 110.248 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.484 ' N ' ' HG2' ' A' ' 64' ' ' ARG . 8.1 m -64.87 -28.5 69.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.755 -0.657 . . . . 52.329999999999998 110.309 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -96.01 -16.79 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.838 -0.619 . . . . 75.439999999999998 110.373 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.05 35.39 91.93 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.691 -0.564 . . . . 63.329999999999998 111.691 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 69' ' ' PRO . 12.9 tmtt? -85.95 116.75 66.96 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 110.232 -0.284 . . . . 75.340000000000003 110.232 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' O ' ' HD3' ' A' ' 68' ' ' LYS . 56.7 Cg_endo -94.18 175.06 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.3 2.666 . . . . 73.209999999999994 112.659 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -149.05 128.75 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.381 -0.6 . . . . 71.25 109.381 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.9 137.09 42.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.562 0.22 . . . . 75.030000000000001 110.891 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.548 ' HZ ' HG22 ' A' ' 87' ' ' VAL . 37.7 p90 -154.64 158.19 39.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.749 -0.463 . . . . 73.400000000000006 109.749 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m -87.21 106.65 18.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.76 0.314 . . . . 75.200000000000003 110.816 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.77 111.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 109.774 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.24 -30.67 2.69 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.058 -0.817 . . . . 70.140000000000001 111.058 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.83 158.27 15.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.882 -0.414 . . . . 74.430000000000007 109.882 176.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 43.27 2.35 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.287 -0.483 . . . . 71.230000000000004 113.185 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.24 -23.74 62.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.044 0.45 . . . . 75.439999999999998 110.39 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.63 168.54 22.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.882 -0.599 . . . . 62.130000000000003 110.254 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.514 HD11 ' O ' ' A' ' 104' ' ' LEU . 12.6 pt -75.48 158.36 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 75.420000000000002 110.352 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 7.0 tmtm? -56.01 -37.41 69.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.79 0.329 . . . . 74.329999999999998 110.472 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.21 -46.33 86.11 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.804 -0.713 . . . . 74.310000000000002 112.158 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -73.1 -38.65 66.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.477 -0.194 . . . . 71.340000000000003 110.477 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.71 78.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.002 0.43 . . . . 72.430000000000007 110.024 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.35 -43.92 89.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.212 -0.449 . . . . 74.129999999999995 109.923 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 89' ' ' THR . . . -52.93 -50.03 52.46 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.85 -0.613 . . . . 70.400000000000006 112.827 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.548 HG22 ' HZ ' ' A' ' 72' ' ' PHE . 18.8 m -75.38 -33.3 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 63.539999999999999 111.328 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.15 -20.77 55.06 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.065 0.394 . . . . 72.340000000000003 112.065 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 86' ' ' GLY . 7.9 t -86.98 0.99 54.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.892 0.33 . . . . 73.040000000000006 111.892 -176.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 19.2 ptp -116.22 -171.18 1.94 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.615 0.245 . . . . 71.329999999999998 111.07 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 p -132.05 178.83 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.195 -0.457 . . . . 75.530000000000001 110.941 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 HG12 ' A' ' 130' ' ' VAL . 3.2 tm? -60.86 128.57 37.14 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 120.783 0.325 . . . . 74.120000000000005 110.753 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.74 87.45 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.62 -0.718 . . . . 72.25 112.592 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.1 tt0 -102.66 143.74 31.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.708 0.289 . . . . 71.340000000000003 110.705 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.55 ' HE3' HD22 ' A' ' 31' ' ' LEU . 37.9 ttpt -136.86 142.48 42.8 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.012 0.434 . . . . 74.540000000000006 110.175 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.94 151.75 48.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.845 -0.616 . . . . 55.240000000000002 110.901 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.0 tp -90.59 105.37 17.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.385 -1.339 . . . . 64.409999999999997 107.385 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 11.3 t80 -110.44 109.65 20.11 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.048 -0.524 . . . . 65.010000000000005 111.086 -167.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.1 m -73.05 113.13 9.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.616 . . . . 72.409999999999997 110.682 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' A' ' 105' ' ' ALA . 35.2 mm -96.75 111.82 58.53 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.363 -0.38 . . . . 60.109999999999999 110.383 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.438 ' HA ' HG21 ' A' ' 120' ' ' THR . 23.3 Cg_endo -61.85 155.55 53.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.531 2.154 . . . . 73.230000000000004 111.261 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.453 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 9.6 p90 -54.37 -42.16 70.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.837 -0.62 . . . . 75.519999999999996 112.265 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.25 -7.6 56.21 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.787 0.291 . . . . 73.140000000000001 111.787 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.514 ' O ' HD11 ' A' ' 80' ' ' ILE . 56.9 mt -102.84 15.3 29.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 73.129999999999995 110.56 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 100' ' ' ILE . . . -152.83 175.01 13.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 75.530000000000001 110.616 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -66.28 -15.64 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 75.329999999999998 110.65 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -62.0 -16.68 53.34 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.013 -0.54 . . . . 75.140000000000001 112.636 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 102' ' ' TYR . 3.3 tm-20 -60.56 -55.87 28.22 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.102 0.477 . . . . 70.209999999999994 109.748 176.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.55 -31.44 14.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 75.25 111.391 -171.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.96 140.64 1.9 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.194 -0.527 . . . . 74.310000000000002 112.441 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.632 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.3 m-85 -137.54 -55.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 122.333 0.253 . . . . 75.400000000000006 110.681 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 80.5 Cg_endo -88.44 139.75 4.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.87 1.713 . . . . 74.049999999999997 111.299 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.14 -24.88 21.37 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.862 2.374 . . . . 75.519999999999996 113.331 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.615 HG21 HG12 ' A' ' 115' ' ' ILE . 27.2 m -72.88 -26.7 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.643 -0.253 . . . . 74.310000000000002 111.498 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 114' ' ' VAL . 49.1 mm -113.18 101.92 54.1 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.782 -0.451 . . . . 64.329999999999998 109.782 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.12 163.83 34.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.63 2.22 . . . . 73.409999999999997 111.97 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.3 148.7 84.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.295 1.997 . . . . 75.400000000000006 111.709 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt 67.89 19.58 9.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 73.319999999999993 111.087 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.21 27.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 111.082 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.438 HG21 ' HA ' ' A' ' 101' ' ' PRO . 47.1 m -86.96 131.97 33.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.032 -0.729 . . . . 71.230000000000004 109.032 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -132.13 136.88 47.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.811 -0.44 . . . . 74.120000000000005 109.811 -171.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.513 ' N ' HD12 ' A' ' 121' ' ' LEU . 52.1 t -104.38 120.58 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 74.230000000000004 110.208 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 96.2 m-85 -109.31 127.22 54.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.251 -0.431 . . . . 55.210000000000001 110.419 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 29.7 mt-10 -75.15 114.1 13.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.408 -0.96 . . . . 75.120000000000005 108.408 168.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.462 HG21 ' HE2' ' A' ' 90' ' ' MET . 11.4 m -107.55 134.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 55.229999999999997 109.964 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 95' ' ' LYS . 41.7 tt0 -138.86 133.87 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.635 -0.257 . . . . 75.209999999999994 110.796 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.625 HD11 ' HB ' ' A' ' 130' ' ' VAL . 1.7 tm? -98.52 105.92 18.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.296 -0.631 . . . . 72.310000000000002 109.296 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.7 mm? -85.41 -41.98 14.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.418 -0.355 . . . . 73.209999999999994 111.189 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -146.7 140.52 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.652 0.263 . . . . 73.019999999999996 111.201 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.625 ' HB ' HD11 ' A' ' 127' ' ' LEU . 5.0 p . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.428 -0.796 . . . . 71.349999999999994 109.929 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.899 0.38 . . . . 73.310000000000002 110.353 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.69 27.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 70.140000000000001 111.553 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -131.92 128.44 38.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.82 -0.437 . . . . 75.329999999999998 109.82 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -91.43 -25.2 19.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.421 0.629 . . . . 73.230000000000004 109.728 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -124.11 154.27 40.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 75.319999999999993 109.01 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -75.98 156.04 34.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.081 0.467 . . . . 73.329999999999998 111.727 -173.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -87.87 100.48 12.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.725 -0.671 . . . . 71.439999999999998 110.103 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -64.76 -19.38 65.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.846 -0.615 . . . . 73.239999999999995 110.539 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -111.92 139.81 47.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 75.209999999999994 109.21 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.91 161.54 30.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.941 -0.647 . . . . 72.519999999999996 112.864 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -89.08 13.17 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.283 0.563 . . . . 74.140000000000001 110.259 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.3 mm? -71.55 135.11 46.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.806 -0.634 . . . . 72.230000000000004 110.629 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.67 -157.92 0.36 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.04 -0.527 . . . . 63.329999999999998 110.081 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.18 -172.63 3.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.955 -0.566 . . . . 72.420000000000002 109.834 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.34 136.68 37.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 75.299999999999997 109.298 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -96.51 168.81 10.32 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.145 0.498 . . . . 75.230000000000004 111.113 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -166.9 99.49 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.384 -0.826 . . . . 72.329999999999998 108.924 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.26 -179.86 34.38 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.007 -0.616 . . . . 74.25 112.223 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 71.82 3.44 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.891 2.394 . . . . 73.400000000000006 112.028 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.6 113.74 5.49 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.292 -0.723 . . . . 72.409999999999997 111.292 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -72.49 73.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.504 0.668 . . . . 73.519999999999996 111.414 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.2 mtp -118.37 12.13 13.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.546 -0.909 . . . . 74.010000000000005 108.546 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.8 p -165.79 159.41 16.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.677 -1.147 . . . . 72.25 108.983 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.82 93.41 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.339 . . . . 75.019999999999996 110.29 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -92.3 144.59 25.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 73.129999999999995 109.532 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.64 110.61 5.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.36 . . . . 72.129999999999995 111.65 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.492 ' H ' ' HB ' ' A' ' 99' ' ' THR . 42.9 mm-40 -109.83 113.51 26.3 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.026 -0.731 . . . . 65.329999999999998 109.026 170.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -111.1 101.34 9.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.529 0.681 . . . . 71.0 109.461 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 43.0 tptt -108.96 117.66 34.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.508 -0.769 . . . . 74.450000000000003 110.17 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.99 106.0 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.483 -0.562 . . . . 74.030000000000001 109.483 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.466 HD11 ' HE2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -86.62 -29.66 22.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 73.129999999999995 109.734 -173.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -152.88 110.66 2.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.63 . . . . 74.030000000000001 109.563 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.58 126.7 20.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.876 2.384 . . . . 71.120000000000005 111.978 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.62 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -102.59 -157.63 25.7 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.358 -0.449 . . . . 71.150000000000006 112.6 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.83 -56.64 19.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.601 0.361 . . . . 72.409999999999997 111.26 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.88 -30.05 10.85 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 119.793 -0.449 . . . . 51.130000000000003 114.205 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.21 -9.72 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.102 0.951 . . . . 74.230000000000004 111.494 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.3 m -109.19 111.68 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.874 -0.417 . . . . 54.219999999999999 109.874 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.707 ' HB3' ' HZ3' ' A' ' 39' ' ' LYS . 8.2 mtpm? -106.47 140.08 20.96 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.417 -0.356 . . . . 71.519999999999996 110.786 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.11 160.56 39.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.266 1.977 . . . . 72.230000000000004 110.672 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -141.29 171.46 14.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.633 0.254 . . . . 75.109999999999999 110.738 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.26 156.56 37.08 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.079 -0.51 . . . . 74.420000000000002 111.403 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.9 27.06 67.51 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.009 -0.541 . . . . 73.239999999999995 112.151 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -130.71 128.04 40.06 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.525 -0.176 . . . . 75.150000000000006 110.525 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 17.1 tppt? -73.45 104.91 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.006 -0.739 . . . . 63.310000000000002 109.006 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.3 m -107.26 152.26 8.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.144 0.497 . . . . 72.019999999999996 112.185 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.0 m -100.42 110.17 22.36 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.053 -0.976 . . . . 54.210000000000001 110.393 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG12 ' HE1' ' A' ' 72' ' ' PHE . 30.4 m -121.57 178.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.35 -0.841 . . . . 54.299999999999997 111.889 -172.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 4.6 t-160 -144.32 138.25 27.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.003 -0.74 . . . . 71.409999999999997 109.003 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.421 ' CD1' HG11 ' A' ' 125' ' ' VAL . 94.5 m-85 -126.64 144.21 50.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.572 -0.285 . . . . 74.140000000000001 110.96 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 58.7 m-20 -136.18 144.66 45.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.931 -0.766 . . . . 72.430000000000007 108.931 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.57 128.34 9.15 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.104 -0.569 . . . . 64.230000000000004 112.65 -173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 13.3 ttm180 -139.61 140.72 37.07 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.56 0.695 . . . . 75.299999999999997 111.343 -175.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 60' ' ' PHE . 83.5 m-85 -81.19 157.82 70.39 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.538 -0.755 . . . . 75.120000000000005 109.468 172.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.97 -15.09 36.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.615 2.21 . . . . 75.109999999999999 112.247 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.29 -5.97 58.38 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.079 -0.509 . . . . 72.329999999999998 110.902 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.69 49.34 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.196 -0.526 . . . . 62.229999999999997 112.625 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.72 122.17 19.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 122.296 0.238 . . . . 73.120000000000005 110.885 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 12.8 pt20 -85.23 132.58 34.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.742 -0.466 . . . . 72.329999999999998 109.742 175.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.568 ' HE2' HD13 ' A' ' 121' ' ' LEU . 44.8 p90 -89.34 -19.6 25.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.627 0.251 . . . . 73.530000000000001 110.847 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -156.97 144.31 18.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.614 -0.513 . . . . 72.129999999999995 109.614 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.8 p -124.46 98.7 5.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 74.510000000000005 110.861 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.04 64.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.344 -0.613 . . . . 73.299999999999997 109.344 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.457 HH12 ' CD ' ' A' ' 124' ' ' GLU . 6.9 ptt-85 -60.85 -41.19 95.36 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.603 -0.726 . . . . 75.5 110.807 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 t -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.978 -0.379 . . . . 52.329999999999998 109.978 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.6 mtt180 -85.15 -28.85 25.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.172 0.511 . . . . 75.439999999999998 110.059 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.08 26.27 64.65 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.578 -0.737 . . . . 63.329999999999998 111.712 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.35 116.84 55.91 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 122.234 0.214 . . . . 75.340000000000003 111.309 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.41 -178.63 3.8 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 73.209999999999994 112.074 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -140.86 163.62 32.43 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.951 -0.759 . . . . 71.25 108.951 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -142.07 138.07 31.47 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.55 0.214 . . . . 75.030000000000001 110.621 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.508 ' HZ ' HG23 ' A' ' 87' ' ' VAL . 20.6 p90 -157.29 165.76 34.97 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.964 -0.384 . . . . 73.400000000000006 109.964 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 m -89.15 108.83 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.348 -0.241 . . . . 75.200000000000003 110.348 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.1 135.14 57.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.171 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.55 58.77 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.26 -0.495 . . . . 70.140000000000001 112.405 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.54 171.46 14.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.996 0.427 . . . . 74.430000000000007 110.999 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.12 55.93 4.95 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.745 -0.661 . . . . 71.230000000000004 112.333 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -119.12 -19.01 8.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.614 0.245 . . . . 75.439999999999998 110.495 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -142.77 162.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.497 -0.319 . . . . 62.130000000000003 110.324 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.8 pt -72.31 151.34 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.958 -0.564 . . . . 75.420000000000002 110.366 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 51.3 mmtt -60.47 -15.81 30.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.331 0.493 . . . . 74.329999999999998 112.331 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.69 -60.27 8.78 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.26 -0.972 . . . . 74.310000000000002 111.254 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -67.07 -39.58 86.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.101 -0.333 . . . . 71.340000000000003 110.101 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 20.8 t70 -52.14 -54.95 24.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.513 -0.767 . . . . 72.430000000000007 110.625 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -68.21 -36.75 80.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.044 -0.525 . . . . 74.129999999999995 110.507 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 89' ' ' THR . . . -52.3 -53.43 31.47 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.536 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.508 HG23 ' HZ ' ' A' ' 72' ' ' PHE . 33.4 m -75.59 -30.89 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.734 0.302 . . . . 63.539999999999999 111.091 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.39 -26.23 67.15 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 86' ' ' GLY . 10.9 t -87.99 0.79 55.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.882 0.327 . . . . 73.040000000000006 111.882 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 16.1 ptp -112.4 -174.98 2.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.06 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -121.98 178.98 4.67 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.218 -0.446 . . . . 75.530000000000001 111.072 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -60.56 128.36 36.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.986 -0.552 . . . . 74.120000000000005 110.653 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.26 35.78 63.71 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.577 -0.344 . . . . 72.25 112.427 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.62 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 28.6 tt0 -128.02 150.45 49.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.666 0.27 . . . . 71.340000000000003 110.324 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HB3' ' HZ3' ' A' ' 95' ' ' LYS . 6.8 ttpm? -133.26 138.84 46.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 74.540000000000006 110.678 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.9 145.07 41.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.768 -0.651 . . . . 55.240000000000002 110.645 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 8.6 tt -90.25 105.56 17.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.321 -1.362 . . . . 64.409999999999997 107.321 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.549 ' HD2' HD13 ' A' ' 100' ' ' ILE . 17.7 t80 -111.65 114.05 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 65.010000000000005 110.031 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 16.2 m -75.71 106.75 7.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 72.409999999999997 110.068 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 98' ' ' PHE . 34.5 mm -80.77 114.31 47.17 Favored Pre-proline 0 C--O 1.243 0.744 0 CA-C-N 116.069 -0.514 . . . . 60.109999999999999 110.568 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.652 ' HA ' HG23 ' A' ' 120' ' ' THR . 21.4 Cg_exo -66.31 149.93 84.84 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.825 2.35 . . . . 73.230000000000004 112.007 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.38 -30.46 52.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.755 -0.657 . . . . 75.519999999999996 111.307 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -65.64 -35.95 82.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.066 -0.516 . . . . 73.140000000000001 111.388 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.48 19.96 15.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 73.129999999999995 111.022 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.09 -178.22 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 75.530000000000001 110.995 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.22 -9.93 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.646 -0.707 . . . . 75.329999999999998 110.424 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.92 40.08 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.856 -0.611 . . . . 75.140000000000001 113.742 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 35.9 tt0 -65.97 -41.36 91.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.652 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.51 -14.07 20.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.052 -0.522 . . . . 75.25 111.053 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 66.89 -82.07 0.12 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-N 116.033 -0.53 . . . . 74.310000000000002 113.777 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.708 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 62.9 m-85 97.92 -74.25 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.859 1.663 . . . . 75.400000000000006 111.478 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 11.3 Cg_endo -89.05 143.16 4.77 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.058 1.839 . . . . 74.049999999999997 111.856 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.62 -18.41 40.11 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.862 2.375 . . . . 75.519999999999996 112.422 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.68 -37.39 79.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.031 -0.532 . . . . 74.310000000000002 109.948 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.8 mm -106.8 106.48 58.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.573 -0.74 . . . . 64.329999999999998 109.498 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.44 148.6 92.56 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.457 2.105 . . . . 73.409999999999997 112.365 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.36 144.35 67.51 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.551 2.168 . . . . 75.400000000000006 112.235 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.804 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 44.7 mtpt 63.59 25.72 14.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.402 -0.817 . . . . 73.319999999999993 111.21 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.49 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 74.120000000000005 111.535 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.652 HG23 ' HA ' ' A' ' 101' ' ' PRO . 28.3 m -86.18 131.24 34.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 71.230000000000004 109.072 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.6 HD11 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -123.82 145.73 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.711 -0.478 . . . . 74.120000000000005 109.711 -170.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.6 ' N ' HD11 ' A' ' 121' ' ' LEU . 97.5 t -98.38 119.8 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.78 0.324 . . . . 74.230000000000004 110.33 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 121' ' ' LEU . 57.7 m-85 -116.08 118.61 33.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 55.210000000000001 110.166 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 38.2 mt-10 -83.22 106.99 15.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.831 . . . . 75.120000000000005 109.037 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.421 HG11 ' CD1' ' A' ' 50' ' ' TYR . 28.9 m -102.92 145.32 12.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 55.229999999999997 110.261 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 43.5 tt0 -143.27 130.12 20.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.542 -0.299 . . . . 75.209999999999994 110.484 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -98.82 105.7 17.88 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.922 -0.77 . . . . 72.310000000000002 108.922 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.89 -48.14 10.33 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.894 0.378 . . . . 73.209999999999994 110.289 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -164.94 -173.68 3.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.656 -0.702 . . . . 73.019999999999996 109.823 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.081 -0.961 . . . . 71.349999999999994 109.762 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.062 -0.348 . . . . 73.310000000000002 110.062 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.04 136.09 57.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.204 -0.453 . . . . 70.140000000000001 111.764 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -145.65 135.65 23.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.249 -0.649 . . . . 75.329999999999998 109.249 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -125.62 144.74 50.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 73.230000000000004 111.149 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -117.72 118.37 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 75.319999999999993 109.767 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -127.78 175.09 8.59 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.61 0.243 . . . . 73.329999999999998 111.121 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.6 p80 46.77 31.85 1.57 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.245 1.018 . . . . 71.439999999999998 112.056 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -90.63 82.27 5.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.409 -0.589 . . . . 73.239999999999995 109.409 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtt -127.49 134.63 49.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.712 -0.677 . . . . 75.209999999999994 110.388 -174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.08 118.87 9.94 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.214 -0.755 . . . . 72.519999999999996 111.214 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 p -62.59 95.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.838 0.351 . . . . 74.140000000000001 111.401 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.21 102.14 9.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.687 -0.857 . . . . 72.230000000000004 108.687 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.76 93.5 4.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.932 -0.576 . . . . 63.329999999999998 110.022 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.99 118.9 32.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 72.420000000000002 110.917 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -87.61 101.79 13.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.18 0.514 . . . . 75.299999999999997 110.146 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 18' ' ' GLY . 39.2 m -148.25 141.44 25.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 75.230000000000004 110.008 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -63.82 -28.91 70.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.878 0.371 . . . . 72.329999999999998 110.602 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.637 ' H ' HG23 ' A' ' 16' ' ' THR . . . 100.75 94.95 2.18 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.615 -0.72 . . . . 74.25 111.337 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.94 90.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.786 2.324 . . . . 73.400000000000006 112.179 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.04 -83.69 0.12 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.513 -0.767 . . . . 72.409999999999997 111.313 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -72.34 83.14 1.05 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.059 0.457 . . . . 73.519999999999996 109.835 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.454 ' HB2' HE21 ' A' ' 25' ' ' GLN . 87.9 mtp -148.01 -160.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 74.010000000000005 109.771 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 p -76.1 -170.8 1.5 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.739 -0.664 . . . . 72.25 110.188 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.1 109.22 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.6 0.238 . . . . 75.019999999999996 110.892 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.695 ' HB2' HG23 ' A' ' 120' ' ' THR . 71.7 mt-30 -92.34 149.92 21.14 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.899 -0.408 . . . . 73.129999999999995 109.899 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -145.76 112.94 6.15 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.816 0.341 . . . . 72.129999999999995 110.96 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 43.6 mt-10 -136.86 135.36 37.8 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.263 -0.643 . . . . 65.329999999999998 109.263 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -132.91 101.12 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.482 0.658 . . . . 71.0 109.668 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -113.34 110.89 21.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.245 -0.889 . . . . 74.450000000000003 110.378 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.13 111.1 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 74.030000000000001 110.445 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.5 mt -85.4 -24.04 27.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 73.129999999999995 110.327 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.1 m -153.35 110.69 2.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.634 -0.712 . . . . 74.030000000000001 109.462 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.83 126.6 13.45 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 71.120000000000005 111.835 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.19 -145.66 15.24 Favored Glycine 0 C--O 1.237 0.296 0 CA-C-N 115.906 -0.588 . . . . 71.150000000000006 112.114 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.464 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.6 m-20 -66.0 -43.92 86.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.787 0.327 . . . . 72.409999999999997 111.501 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.48 -30.14 2.82 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.228 -0.51 . . . . 51.130000000000003 112.333 -175.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 35' ' ' ASP . 33.4 m -89.29 -24.9 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.944 0.402 . . . . 74.230000000000004 110.943 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.4 p -78.03 95.41 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 54.219999999999999 110.524 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -106.41 103.91 48.03 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.577 -0.738 . . . . 71.519999999999996 111.066 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.11 156.62 42.52 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.467 2.111 . . . . 72.230000000000004 111.454 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.76 170.69 14.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.329 . . . . 75.109999999999999 110.74 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.88 156.74 26.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.806 -0.634 . . . . 74.420000000000002 111.047 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.92 25.28 67.29 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 115.889 -0.596 . . . . 73.239999999999995 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -130.01 119.15 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 75.150000000000006 110.748 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -66.34 104.27 1.18 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.159 -0.682 . . . . 63.310000000000002 109.159 172.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 130' ' ' VAL . 29.5 m -106.98 155.56 7.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.301 -0.409 . . . . 72.019999999999996 111.342 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -98.91 108.27 20.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.483 -0.781 . . . . 54.210000000000001 110.646 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.464 HG12 HD21 ' A' ' 127' ' ' LEU . 10.5 m -123.43 178.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 54.299999999999997 111.394 -173.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 65.0 t60 -152.29 133.31 14.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 109.566 170.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -126.79 146.19 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.578 -0.897 . . . . 74.140000000000001 108.578 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 123' ' ' PHE . 0.8 OUTLIER -135.86 152.02 50.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.823 -0.436 . . . . 72.430000000000007 109.823 -177.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.05 129.32 9.78 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.381 -0.438 . . . . 64.230000000000004 113.003 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -147.52 145.94 29.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.2 0.524 . . . . 75.299999999999997 110.302 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -90.22 148.47 39.29 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.306 -0.406 . . . . 75.120000000000005 110.422 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.77 -13.77 28.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.796 2.331 . . . . 75.109999999999999 111.719 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.16 -25.97 64.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.497 -0.774 . . . . 72.329999999999998 110.348 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.89 -14.78 28.99 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.343 -0.844 . . . . 62.229999999999997 111.489 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -103.11 148.67 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.09 0.556 . . . . 73.120000000000005 110.938 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.71 135.07 54.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.589 -0.522 . . . . 72.329999999999998 109.589 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -68.76 -62.34 1.43 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.148 -0.478 . . . . 73.530000000000001 110.783 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -137.51 131.31 31.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.92 -0.77 . . . . 72.129999999999995 108.92 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.534 ' OG ' ' HG3' ' A' ' 64' ' ' ARG . 9.7 t -111.02 134.44 52.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 74.510000000000005 111.108 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.8 m -75.75 -22.98 55.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.103 -0.499 . . . . 73.299999999999997 111.427 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.534 ' HG3' ' OG ' ' A' ' 62' ' ' SER . 6.7 ppt_? -56.82 -30.67 63.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.654 0.264 . . . . 75.5 110.861 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 8.9 m -59.14 -26.53 64.81 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.282 -0.417 . . . . 52.329999999999998 110.99 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -96.2 -16.12 21.64 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.113 -0.494 . . . . 75.439999999999998 110.409 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.95 15.78 69.72 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.804 -0.635 . . . . 63.329999999999998 113.51 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.3 ttpp -88.64 118.99 69.95 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-O 120.742 0.306 . . . . 75.340000000000003 111.009 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -89.27 -173.05 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.459 2.773 . . . . 73.209999999999994 111.753 175.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 81.0 m-85 -137.2 160.31 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 71.25 109.735 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -139.26 131.31 27.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.848 -0.427 . . . . 75.030000000000001 109.848 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -155.89 156.59 34.89 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.786 -0.45 . . . . 73.400000000000006 109.786 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 86.3 m -79.4 114.54 18.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.14 -0.319 . . . . 75.200000000000003 110.14 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.653 HD12 ' HB2' ' A' ' 88' ' ' ALA . 32.6 tp -56.83 123.13 13.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.744 -0.465 . . . . 75.129999999999995 109.744 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.74 -26.46 24.01 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.886 -0.486 . . . . 70.140000000000001 111.886 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.47 5.07 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.004 0.431 . . . . 74.430000000000007 111.231 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.37 16.52 48.78 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.158 -0.544 . . . . 71.230000000000004 113.186 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -56.25 -39.97 73.42 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 110.181 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.451 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 28.3 m -126.43 164.91 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 62.130000000000003 109.177 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.9 pt -67.75 150.05 11.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.123 0.487 . . . . 75.420000000000002 111.482 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 24.8 mmtm -62.8 -17.42 61.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.787 -0.642 . . . . 74.329999999999998 111.845 -175.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.23 20.73 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.349 -0.929 . . . . 74.310000000000002 111.088 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.451 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 18.7 m0 -71.69 -36.54 70.61 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.503 -0.349 . . . . 71.340000000000003 110.216 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.648 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 10.0 t70 -52.82 -55.23 24.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.841 -0.618 . . . . 72.430000000000007 110.39 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.752 ' HA ' HE21 ' A' ' 85' ' ' GLN . 0.0 OUTLIER -72.75 -37.68 67.62 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.156 -0.475 . . . . 74.129999999999995 110.33 -179.098 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.28 -49.79 49.37 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.932 -0.577 . . . . 70.400000000000006 112.038 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.567 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.8 p -75.99 -32.29 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.816 0.341 . . . . 63.539999999999999 111.05 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -60.52 -29.18 68.95 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.8 t -78.69 4.01 14.88 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.932 0.716 . . . . 73.040000000000006 112.932 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.567 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.4 ptp -120.04 -179.47 3.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.203 0.456 . . . . 71.329999999999998 111.442 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.403 HG21 ' HA2' ' A' ' 36' ' ' GLY . 68.7 p -118.88 178.86 4.33 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.963 -0.562 . . . . 75.530000000000001 111.124 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.725 ' HA ' HD13 ' A' ' 127' ' ' LEU . 6.0 tt -67.24 135.87 54.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.072 0.463 . . . . 74.120000000000005 110.704 -176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.537 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.8 17.25 80.04 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.415 -0.812 . . . . 72.25 111.821 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.84 137.51 51.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 71.340000000000003 110.351 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HZ3' ' HB2' ' A' ' 95' ' ' LYS . 4.0 ttmp? -123.83 135.31 53.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.625 -0.716 . . . . 74.540000000000006 109.46 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.91 148.75 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.21 0.529 . . . . 55.240000000000002 111.544 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.0 tt -90.76 114.0 26.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.225 -1.028 . . . . 64.409999999999997 108.225 174.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -119.79 116.6 26.23 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.934 0.397 . . . . 65.010000000000005 110.417 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 18.4 m -75.67 106.44 7.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.085 -0.507 . . . . 72.409999999999997 110.304 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.1 mm -83.69 116.72 66.06 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.29 -0.414 . . . . 60.109999999999999 110.624 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HA ' HG21 ' A' ' 120' ' ' THR . 52.1 Cg_exo -54.63 146.48 53.84 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.015 2.477 . . . . 73.230000000000004 112.066 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -54.22 -39.62 66.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 75.519999999999996 112.081 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -69.93 -25.82 63.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.807 0.337 . . . . 73.140000000000001 111.092 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.26 15.42 15.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.035 0.445 . . . . 73.129999999999995 110.261 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.19 -170.08 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 75.530000000000001 109.827 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.621 ' HE2' HG13 ' A' ' 115' ' ' ILE . 45.0 p90 -81.35 -7.56 59.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.37 . . . . 75.329999999999998 110.59 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.8 -21.32 65.18 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.836 -0.62 . . . . 75.140000000000001 112.934 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.21 -46.13 79.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.369 0.604 . . . . 70.209999999999994 110.402 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -102.86 -36.31 8.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.949 -1.023 . . . . 75.25 111.416 -166.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.19 90.58 0.05 OUTLIER Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.178 -0.534 . . . . 74.310000000000002 112.025 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 95.7 m-85 -82.98 -52.41 0.64 Allowed Pre-proline 0 CA--C 1.537 0.476 0 O-C-N 122.809 -0.23 . . . . 75.400000000000006 110.997 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 96.3 Cg_endo -84.87 143.92 9.57 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.757 1.638 . . . . 74.049999999999997 111.311 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.38 -16.81 30.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.371 . . . . 75.519999999999996 112.631 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.57 -34.74 58.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.074 -0.512 . . . . 74.310000000000002 110.526 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.621 HG13 ' HE2' ' A' ' 106' ' ' TYR . 49.2 mm -103.45 110.39 63.69 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 64.329999999999998 110.327 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.95 155.79 61.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.704 2.269 . . . . 73.409999999999997 111.992 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.34 148.91 88.69 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.239 1.96 . . . . 75.400000000000006 111.283 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.803 ' HZ2' ' HB3' ' A' ' 118' ' ' LYS . 9.2 mtpm? 60.93 23.15 13.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.04 0.536 . . . . 73.319999999999993 111.557 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.89 114.97 27.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.759 0.314 . . . . 74.120000000000005 110.474 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.695 HG23 ' HB2' ' A' ' 25' ' ' GLN . 98.1 m -73.64 133.11 43.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 71.230000000000004 109.118 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.499 HD11 ' N ' ' A' ' 122' ' ' VAL . 1.1 tm? -123.48 142.62 50.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.246 -0.65 . . . . 74.120000000000005 109.246 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.499 ' N ' HD11 ' A' ' 121' ' ' LEU . 67.4 t -98.27 136.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.001 0.429 . . . . 74.230000000000004 110.24 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 49.7 m-85 -123.28 122.18 37.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 55.210000000000001 110.42 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -80.36 107.23 12.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.28 -1.008 . . . . 75.120000000000005 108.28 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.84 150.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.507 -0.77 . . . . 55.229999999999997 111.195 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -150.19 136.33 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.976 -0.557 . . . . 75.209999999999994 110.295 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 92' ' ' LEU . 1.5 tm? -96.81 109.53 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.572 -0.899 . . . . 72.310000000000002 108.572 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.71 -43.5 15.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.913 0.387 . . . . 73.209999999999994 110.426 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -171.23 -178.11 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 73.019999999999996 109.82 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 46' ' ' VAL . 5.2 p . . . . . 0 C--O 1.249 1.069 0 N-CA-C 109.24 -0.652 . . . . 71.349999999999994 109.24 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.68 0.276 . . . . 73.310000000000002 110.572 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.23 157.0 38.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 70.140000000000001 110.72 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -90.05 96.17 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.526 -0.306 . . . . 75.329999999999998 110.817 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -57.81 122.74 13.6 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.395 -0.594 . . . . 73.230000000000004 109.395 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -76.11 104.26 6.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.934 -0.575 . . . . 75.319999999999993 111.521 -171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -68.6 111.22 4.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.235 -0.654 . . . . 73.329999999999998 109.235 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -69.58 150.75 46.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.056 -0.52 . . . . 71.439999999999998 110.783 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -82.84 -60.57 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.747 -0.464 . . . . 73.239999999999995 109.747 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.6 mtp 49.69 28.91 2.84 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.469 -0.787 . . . . 75.209999999999994 112.083 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.58 -83.48 0.36 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.53 -0.628 . . . . 72.519999999999996 111.53 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 m 62.04 -77.2 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.696 0.398 . . . . 74.140000000000001 110.82 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.4 tp -161.21 10.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.375 0.607 . . . . 72.230000000000004 109.607 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 15' ' ' GLN . 42.2 mt-10 -86.83 152.84 22.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.704 -0.68 . . . . 63.329999999999998 110.363 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 74.69 -35.54 0.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.317 0.647 . . . . 72.420000000000002 111.691 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 13' ' ' GLU . 24.4 mt-30 -59.59 138.75 57.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 75.299999999999997 110.159 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -79.94 61.47 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 75.230000000000004 111.328 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 176.37 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.485 -0.78 . . . . 72.329999999999998 109.463 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.27 147.18 11.15 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 74.25 112.026 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.26 74.64 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.98 2.454 . . . . 73.400000000000006 111.679 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.62 -112.73 1.34 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.793 -0.64 . . . . 72.409999999999997 111.898 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 16.3 m -84.42 11.19 8.98 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.839 0.311 . . . . 73.519999999999996 111.839 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.532 ' HB2' ' NE2' ' A' ' 25' ' ' GLN . 89.9 mtp -67.92 121.73 16.66 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.398 -0.593 . . . . 74.010000000000005 109.398 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 m -58.58 -61.18 2.79 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.886 0.698 . . . . 72.25 112.886 -169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.74 111.7 22.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 75.019999999999996 111.119 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' A' ' 22' ' ' MET . 54.9 mt-30 -126.48 142.35 51.57 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.898 -0.778 . . . . 73.129999999999995 108.898 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.31 105.29 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.641 0.257 . . . . 72.129999999999995 110.368 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.82 122.66 18.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.342 -0.614 . . . . 65.329999999999998 109.342 170.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -120.44 122.63 41.11 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.26 -0.644 . . . . 71.0 109.26 175.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 35.1 ttmt -116.1 110.12 18.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 110.073 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.66 104.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 74.030000000000001 110.533 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.2 tp -88.37 -22.18 23.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 73.129999999999995 110.026 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 m -149.92 110.93 3.32 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.636 -0.711 . . . . 74.030000000000001 109.745 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.69 119.05 6.06 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.754 2.302 . . . . 71.120000000000005 111.588 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -86.65 -176.82 49.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.933 -0.651 . . . . 71.150000000000006 112.735 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.83 -33.02 69.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.65 0.262 . . . . 72.409999999999997 111.305 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.26 -30.29 1.63 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 113.511 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -79.37 -38.09 19.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 74.230000000000004 111.048 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.426 ' HG1' ' HB ' ' A' ' 91' ' ' THR . 25.4 p -66.15 94.0 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.514 . . . . 54.219999999999999 110.715 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -102.09 115.78 64.13 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.479 . . . . 71.519999999999996 110.605 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.95 -173.09 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.684 2.256 . . . . 72.230000000000004 112.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -156.66 164.74 37.81 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.148 -0.478 . . . . 75.109999999999999 110.112 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.98 127.69 33.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.239 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.28 31.63 7.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.772 -0.531 . . . . 73.239999999999995 111.772 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 130.29 49.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.984 -0.376 . . . . 75.150000000000006 109.984 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.11 108.26 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.552 . . . . 63.310000000000002 109.511 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.52 158.68 19.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 116.365 -0.379 . . . . 72.019999999999996 111.128 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.8 m -111.92 115.78 29.54 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.956 -0.565 . . . . 54.210000000000001 110.209 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 127' ' ' LEU . 10.3 m -120.99 177.96 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.184 0.516 . . . . 54.299999999999997 111.684 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -149.83 139.64 21.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.306 -0.861 . . . . 71.409999999999997 108.712 175.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -137.72 156.02 48.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.578 -0.283 . . . . 74.140000000000001 110.81 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -152.98 160.53 43.03 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.014 -0.736 . . . . 72.430000000000007 109.014 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 59' ' ' GLN . . . -132.16 151.17 19.78 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.784 -0.722 . . . . 64.230000000000004 113.271 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -148.77 155.05 40.43 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.849 0.459 . . . . 75.299999999999997 109.886 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -87.1 150.17 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 110.407 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.87 -31.77 90.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.908 2.405 . . . . 75.109999999999999 112.954 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.94 -39.95 83.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.472 -0.331 . . . . 72.329999999999998 110.752 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.4 -26.55 1.99 Allowed Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.711 -0.757 . . . . 62.229999999999997 113.429 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -74.79 164.64 26.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.188 0.494 . . . . 73.120000000000005 110.821 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 63.4 tt0 -134.0 141.15 47.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 72.329999999999998 109.911 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -72.23 -54.17 10.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.158 0.504 . . . . 73.530000000000001 110.261 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -151.77 143.97 23.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.648 -0.705 . . . . 72.129999999999995 109.312 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -91.61 90.96 7.81 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.187 0.518 . . . . 74.510000000000005 111.875 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.4 t -73.83 -23.97 59.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.056 -0.52 . . . . 73.299999999999997 110.225 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -68.7 -34.68 76.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.83 -0.433 . . . . 75.5 109.83 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -73.51 -36.21 65.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.751 -0.659 . . . . 52.329999999999998 110.937 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -76.6 -28.61 56.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.437 -0.347 . . . . 75.439999999999998 110.615 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.54 37.08 94.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.24 -0.505 . . . . 63.329999999999998 112.714 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -79.48 115.67 55.01 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 110.183 -0.302 . . . . 75.340000000000003 110.183 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 169.17 15.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.732 2.288 . . . . 73.209999999999994 111.754 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' O ' HG22 ' A' ' 48' ' ' VAL . 77.8 t80 -147.62 115.6 6.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.581 -0.526 . . . . 71.25 109.581 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -100.11 127.31 46.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.74 -0.467 . . . . 75.030000000000001 109.74 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -153.65 170.03 21.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 73.400000000000006 110.77 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 104.56 14.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 75.200000000000003 109.856 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.555 HD13 ' HB1' ' A' ' 88' ' ' ALA . 48.4 tp -59.06 138.91 57.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 75.129999999999995 110.772 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.41 25.91 37.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.061 -0.59 . . . . 70.140000000000001 112.103 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . . . -132.27 178.71 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.22 -0.289 . . . . 74.430000000000007 110.22 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.91 39.47 3.12 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 121.235 -0.507 . . . . 71.230000000000004 112.168 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 6.8 mm-40 -74.88 -34.35 62.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.247 0.546 . . . . 75.439999999999998 109.726 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.58 171.65 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.152 -0.931 . . . . 62.130000000000003 109.163 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.7 pt -59.64 141.28 16.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.936 -0.394 . . . . 75.420000000000002 109.936 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 67.2 mmtt -61.59 -16.21 46.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.287 0.477 . . . . 74.329999999999998 112.287 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.05 -52.0 54.98 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.139 -1.029 . . . . 74.310000000000002 110.87 171.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -73.77 -43.65 58.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.53 -0.335 . . . . 71.340000000000003 110.381 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 29.4 t70 -53.5 -54.9 30.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.1 -0.5 . . . . 72.430000000000007 110.442 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.82 -44.6 69.63 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 110.677 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.21 -47.84 54.61 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.993 -0.548 . . . . 70.400000000000006 112.313 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG23 HD21 ' A' ' 127' ' ' LEU . 8.7 p -75.96 -33.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.8 0.334 . . . . 63.539999999999999 110.775 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.555 ' HB1' HD13 ' A' ' 74' ' ' LEU . . . -60.76 -30.46 70.03 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.946 0.35 . . . . 72.340000000000003 111.946 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 86' ' ' GLY . 9.1 t -82.35 -10.19 59.17 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.419 0.526 . . . . 73.040000000000006 112.419 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.9 ptp -102.97 -170.02 1.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.998 -0.438 . . . . 71.329999999999998 111.001 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.426 ' HB ' ' HG1' ' A' ' 38' ' ' THR . 56.1 p -133.69 179.03 6.48 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.58 -0.282 . . . . 75.530000000000001 111.726 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.693 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.1 tt -64.19 137.83 58.14 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.235 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.507 ' N ' HD21 ' A' ' 92' ' ' LEU . . . 75.12 13.64 82.55 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.651 -0.704 . . . . 72.25 111.908 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.629 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.6 tt0 -111.37 134.13 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 71.340000000000003 110.443 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.558 ' HB3' ' HZ2' ' A' ' 95' ' ' LYS . 6.1 ttpm? -133.96 130.43 37.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.612 -0.722 . . . . 74.540000000000006 109.765 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.14 143.88 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.031 0.443 . . . . 55.240000000000002 110.966 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.89 111.03 22.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.061 -1.088 . . . . 64.409999999999997 108.061 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -112.73 137.99 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 65.010000000000005 110.328 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -89.26 106.68 18.6 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.791 -0.448 . . . . 72.409999999999997 109.791 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.96 113.74 60.66 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 116.38 -0.373 . . . . 60.109999999999999 111.034 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.414 ' HA ' HG22 ' A' ' 120' ' ' THR . 72.7 Cg_endo -75.42 159.35 39.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.795 2.33 . . . . 73.230000000000004 111.908 176.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -60.02 -26.46 66.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.04 0.385 . . . . 75.519999999999996 112.04 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.633 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 11.2 pt20 -66.1 -18.68 65.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.694 0.283 . . . . 73.140000000000001 111.236 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 93.9 mt -115.2 14.91 17.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.387 -0.37 . . . . 73.129999999999995 110.948 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.57 175.46 13.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.273 0.559 . . . . 75.530000000000001 111.551 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -72.6 -11.24 60.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.481 -0.781 . . . . 75.329999999999998 110.654 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.18 -15.28 7.09 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.879 -0.601 . . . . 75.140000000000001 113.578 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.6 tt0 -63.59 -55.22 25.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.223 0.535 . . . . 70.209999999999994 110.144 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -97.34 -5.49 36.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.432 -0.804 . . . . 75.25 110.647 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 64.02 -91.22 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.68 -0.691 . . . . 74.310000000000002 113.618 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.719 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 44.0 m-85 98.94 -65.78 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.793 1.637 . . . . 75.400000000000006 111.562 -172.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.719 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 5.1 Cg_exo -75.81 135.55 17.75 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.703 1.602 . . . . 74.049999999999997 111.262 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.5 -14.93 38.04 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.801 2.334 . . . . 75.519999999999996 112.675 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.0 t -75.49 -20.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 110.211 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.26 116.36 64.54 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.845 -0.616 . . . . 64.329999999999998 110.072 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.38 154.07 70.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.619 2.213 . . . . 73.409999999999997 111.946 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.48 126.88 16.97 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.31 2.007 . . . . 75.400000000000006 111.867 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 56.0 mtmt 57.22 49.75 12.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 73.319999999999993 110.713 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.02 148.88 22.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 74.120000000000005 111.348 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 101' ' ' PRO . 94.7 m -100.66 131.48 46.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.591 -0.732 . . . . 71.230000000000004 109.698 175.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.27 161.63 20.09 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.92 0.39 . . . . 74.120000000000005 111.002 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.0 t -98.61 131.51 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.322 -0.621 . . . . 74.230000000000004 109.322 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.95 123.76 23.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 55.210000000000001 111.252 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -85.76 111.08 19.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.047 -0.723 . . . . 75.120000000000005 109.047 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.41 143.72 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 55.229999999999997 109.952 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -147.48 133.15 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 75.209999999999994 110.812 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.0 tm? -102.64 113.16 26.3 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.968 -0.752 . . . . 72.310000000000002 108.968 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 128' ' ' LEU . 3.8 mm? -89.03 -44.43 10.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.566 -0.288 . . . . 73.209999999999994 111.103 -177.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.55 141.66 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.638 -0.255 . . . . 73.019999999999996 111.121 -177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.252 1.199 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.224 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.607 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 2.2 tpt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.066 -0.346 . . . . 73.310000000000002 110.066 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.39 111.85 19.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 70.140000000000001 110.825 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -79.73 97.41 6.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.4 -0.593 . . . . 75.329999999999998 109.4 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -156.42 127.83 7.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.555 0.217 . . . . 73.230000000000004 111.044 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -97.23 156.53 16.37 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.271 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -109.66 107.83 18.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.244 -1.021 . . . . 73.329999999999998 108.244 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -92.62 126.77 37.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.033 0.444 . . . . 71.439999999999998 111.51 -170.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -128.39 130.56 47.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.764 -0.653 . . . . 73.239999999999995 109.358 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 80.0 mtp -102.54 165.51 11.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.219 0.533 . . . . 75.209999999999994 111.562 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.18 141.75 6.1 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.715 -0.954 . . . . 72.519999999999996 110.715 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -153.77 133.08 12.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.238 0.519 . . . . 74.140000000000001 110.178 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.57 146.63 50.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 72.230000000000004 110.299 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.82 146.27 28.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 63.329999999999998 109.081 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.1 156.01 20.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.135 0.493 . . . . 72.420000000000002 111.512 -174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.89 93.89 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.04 -1.096 . . . . 75.299999999999997 108.04 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.6 p -102.83 26.96 7.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.688 -0.687 . . . . 75.230000000000004 112.456 -170.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -78.06 77.34 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 72.329999999999998 109.915 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.03 58.89 0.39 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.821 -0.627 . . . . 74.25 112.472 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.95 84.7 0.52 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.153 1.902 . . . . 73.400000000000006 110.506 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 46.9 3.3 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.978 -0.849 . . . . 72.409999999999997 110.978 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 p -58.85 -63.95 1.11 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.847 0.356 . . . . 73.519999999999996 110.098 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 86.9 mmm -80.0 144.89 32.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 74.010000000000005 109.961 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.9 t -53.61 -34.45 58.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.26 -0.427 . . . . 72.25 110.631 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.13 106.1 16.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.99 -0.55 . . . . 75.019999999999996 110.841 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -124.93 135.12 52.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.786 -0.82 . . . . 73.129999999999995 108.786 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.32 111.56 5.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.861 0.362 . . . . 72.129999999999995 111.036 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -129.35 139.98 51.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.181 -0.463 . . . . 65.329999999999998 109.873 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' HB3' ' HD1' ' A' ' 98' ' ' PHE . 24.9 pttm -139.0 111.8 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 71.0 109.549 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.23 117.26 20.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 74.450000000000003 109.175 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.11 136.28 26.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.088 0.47 . . . . 74.030000000000001 110.763 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.4 tp -101.42 -28.18 12.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 73.129999999999995 110.198 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -153.87 112.26 2.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.12 -0.696 . . . . 74.030000000000001 109.12 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.11 134.77 47.49 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.581 2.187 . . . . 71.120000000000005 111.824 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.627 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.04 177.81 50.88 Favored Glycine 0 C--O 1.236 0.232 0 C-N-CA 121.271 -0.49 . . . . 71.150000000000006 113.218 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' OD2' HG23 ' A' ' 37' ' ' VAL . 30.6 t70 -64.7 -30.22 71.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.918 0.389 . . . . 72.409999999999997 110.6 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.62 6.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 114.884 0.714 . . . . 51.130000000000003 114.884 168.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG23 ' OD2' ' A' ' 35' ' ' ASP . 6.4 m -89.75 -23.36 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 117.924 0.862 . . . . 74.230000000000004 112.271 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 92' ' ' LEU . 34.0 p -62.66 125.57 24.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.698 -0.228 . . . . 54.219999999999999 111.063 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -100.07 126.98 34.67 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 120.933 0.397 . . . . 71.519999999999996 111.29 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -90.24 160.18 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.158 2.572 . . . . 72.230000000000004 111.847 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.611 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 19.8 pt20 -157.41 158.84 36.63 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 110.116 -0.327 . . . . 75.109999999999999 110.116 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -74.16 109.67 7.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.257 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.15 -21.22 3.51 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.738 -0.744 . . . . 73.239999999999995 113.143 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.611 ' HE2' ' HG2' ' A' ' 41' ' ' GLN . 50.9 mtmt -84.35 129.95 34.83 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.042 0.448 . . . . 75.150000000000006 110.607 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.49 111.28 7.53 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.286 -1.005 . . . . 63.310000000000002 108.286 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 130' ' ' VAL . 33.4 m -106.0 143.75 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.982 0.42 . . . . 72.019999999999996 110.91 -174.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -100.35 111.39 23.65 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.27 -0.877 . . . . 54.210000000000001 109.509 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG11 HG12 ' A' ' 87' ' ' VAL . 31.0 m -121.5 178.13 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 54.299999999999997 110.614 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 17.1 t-160 -147.27 136.37 22.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.2 -0.667 . . . . 71.409999999999997 109.2 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.473 ' HD1' HG11 ' A' ' 125' ' ' VAL . 78.3 m-85 -126.6 152.37 46.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.769 0.319 . . . . 74.140000000000001 111.086 -176.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -144.95 155.11 43.23 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.73 -0.841 . . . . 72.430000000000007 108.73 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.48 132.34 10.24 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.334 -0.46 . . . . 64.230000000000004 112.899 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ttm-85 -141.58 144.99 34.53 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.366 0.603 . . . . 75.299999999999997 110.902 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.92 147.3 61.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 75.120000000000005 109.555 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.63 -24.81 38.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.135 2.557 . . . . 75.109999999999999 113.491 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -74.33 -34.85 63.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.719 0.295 . . . . 72.329999999999998 110.552 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.78 -12.54 4.51 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 116.117 -0.492 . . . . 62.229999999999997 112.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -75.43 147.06 40.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.228 0.211 . . . . 73.120000000000005 110.568 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.88 127.36 26.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.772 -0.455 . . . . 72.329999999999998 109.772 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -67.54 -36.6 81.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.786 -0.643 . . . . 73.530000000000001 111.574 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -165.6 131.32 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 109.792 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 t -86.18 111.46 20.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.5 . . . . 74.510000000000005 110.728 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 m -79.4 -15.47 57.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 73.299999999999997 111.252 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.426 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 14.2 ptp180 -68.0 -32.18 72.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.535 -0.302 . . . . 75.5 110.764 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 t -67.33 -22.2 65.62 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.096 -0.502 . . . . 52.329999999999998 111.215 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -76.09 -8.97 58.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.706 0.289 . . . . 75.439999999999998 111.151 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.81 8.28 5.52 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 115.263 0.865 . . . . 63.329999999999998 115.263 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -99.3 128.85 30.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 117.669 0.735 . . . . 75.340000000000003 110.065 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -86.74 178.45 3.75 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.801 2.334 . . . . 73.209999999999994 111.912 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -134.45 133.31 40.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.485 -0.561 . . . . 71.25 109.485 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 96.4 mt-30 -106.19 133.59 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.632 -0.258 . . . . 75.030000000000001 110.368 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 25.3 p90 -152.47 154.96 36.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.584 0.231 . . . . 73.400000000000006 110.415 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.452 ' N ' ' HG3' ' A' ' 78' ' ' GLU . 55.6 m -74.62 110.26 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.551 -0.295 . . . . 75.200000000000003 110.34 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 88' ' ' ALA . 53.0 tp -67.2 136.7 55.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.488 -0.324 . . . . 75.129999999999995 110.478 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.89 80.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.266 -0.493 . . . . 70.140000000000001 112.33 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.61 167.41 11.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.177 -0.305 . . . . 74.430000000000007 110.177 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.92 50.43 3.9 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.337 -0.459 . . . . 71.230000000000004 112.484 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 73' ' ' THR . 6.7 mm-40 -79.68 -46.33 17.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 75.439999999999998 109.968 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.66 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.331 -0.85 . . . . 62.130000000000003 109.839 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.7 pt -58.54 142.93 13.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.097 0.475 . . . . 75.420000000000002 111.013 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 37.6 mmtm -55.86 -23.22 29.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.814 -0.63 . . . . 74.329999999999998 111.846 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.37 -51.9 56.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.641 -0.79 . . . . 74.310000000000002 111.635 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -70.38 -38.61 74.75 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.267 -0.271 . . . . 71.340000000000003 110.267 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.9 t70 -52.12 -54.66 27.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.117 -0.492 . . . . 72.430000000000007 110.266 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.34 -43.06 95.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.211 -0.45 . . . . 74.129999999999995 110.636 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 89' ' ' THR . . . -52.66 -48.67 55.65 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.953 -0.567 . . . . 70.400000000000006 112.66 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.489 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.1 m -75.65 -33.83 27.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.927 0.394 . . . . 63.539999999999999 111.176 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -73.81 -13.56 60.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.943 0.349 . . . . 72.340000000000003 111.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -95.58 12.14 30.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 121.267 -0.173 . . . . 73.040000000000006 111.325 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.0 ptp -133.32 -177.19 4.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 111.631 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.5 p -135.93 179.11 6.54 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.7 -0.682 . . . . 75.530000000000001 111.33 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 127' ' ' LEU . 1.5 tm? -51.45 124.62 12.41 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.968 0.507 . . . . 74.120000000000005 111.104 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.81 -1.09 89.09 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.009 -0.541 . . . . 72.25 112.877 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.627 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 11.0 tt0 -88.13 143.14 27.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.011 0.434 . . . . 71.340000000000003 110.787 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -142.45 133.51 25.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.531 -0.759 . . . . 74.540000000000006 109.025 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.13 30.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.421 . . . . 55.240000000000002 111.743 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.5 tt -90.86 110.14 21.36 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.475 -0.935 . . . . 64.409999999999997 108.475 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.455 ' HD1' ' HB3' ' A' ' 28' ' ' LYS . 70.3 t80 -122.25 134.31 54.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.144 0.497 . . . . 65.010000000000005 110.888 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.2 m -79.31 120.81 24.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.837 -0.62 . . . . 72.409999999999997 110.264 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.3 mm -99.03 107.24 42.91 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 110.025 -0.361 . . . . 60.109999999999999 110.025 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.461 ' HA ' HG21 ' A' ' 120' ' ' THR . 28.2 Cg_exo -61.94 145.91 96.62 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.72 2.28 . . . . 73.230000000000004 111.245 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -54.33 -35.49 62.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 75.519999999999996 111.47 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -64.24 -26.42 68.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.318 -0.401 . . . . 73.140000000000001 111.263 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.02 11.83 37.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.508 -0.315 . . . . 73.129999999999995 111.02 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.16 -176.77 5.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 75.530000000000001 111.018 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.44 -11.81 60.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.693 -0.685 . . . . 75.329999999999998 110.782 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.89 -14.9 59.4 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.843 -0.617 . . . . 75.140000000000001 112.315 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.34 -55.64 30.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.897 -0.408 . . . . 70.209999999999994 109.897 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -86.2 -41.88 14.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.59 . . . . 75.25 110.758 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.05 143.2 3.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 74.310000000000002 111.608 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.556 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 95.5 m-85 -142.87 -51.69 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 122.84 -0.212 . . . . 75.400000000000006 110.72 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 111' ' ' TYR . 89.3 Cg_endo -82.07 138.41 10.18 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.582 1.522 . . . . 74.049999999999997 110.789 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.26 -21.36 35.84 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 122.868 2.379 . . . . 75.519999999999996 113.349 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.627 HG21 HG12 ' A' ' 115' ' ' ILE . 35.5 m -75.12 -24.83 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.037 0.446 . . . . 74.310000000000002 110.834 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.627 HG12 HG21 ' A' ' 114' ' ' VAL . 49.0 mm -123.0 88.13 50.9 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 109.173 -0.677 . . . . 64.329999999999998 109.173 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.43 173.59 14.23 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.922 2.415 . . . . 73.409999999999997 112.505 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.42 132.54 24.61 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.576 2.184 . . . . 75.400000000000006 112.84 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 62.43 37.64 13.39 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.437 -0.801 . . . . 73.319999999999993 111.671 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.4 114.74 26.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.120000000000005 110.762 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 101' ' ' PRO . 52.9 m -82.3 136.98 34.94 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 71.230000000000004 109.921 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.573 HD11 ' N ' ' A' ' 122' ' ' VAL . 1.7 tm? -134.25 145.17 48.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.669 -0.493 . . . . 74.120000000000005 109.669 -172.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.573 ' N ' HD11 ' A' ' 121' ' ' LEU . 61.8 t -99.82 120.91 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.229 . . . . 74.230000000000004 110.398 -176.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -110.83 131.99 54.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.123 0.487 . . . . 55.210000000000001 111.109 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.13 117.08 28.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.855 -0.794 . . . . 75.120000000000005 108.855 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.473 HG11 ' HD1' ' A' ' 50' ' ' TYR . 19.2 m -109.4 149.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.695 . . . . 55.229999999999997 110.728 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.0 tt0 -145.03 133.48 21.88 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.837 -0.619 . . . . 75.209999999999994 110.202 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -102.36 116.03 31.78 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 122.702 0.401 . . . . 72.310000000000002 110.192 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 49' ' ' HIS . 3.3 mm? -96.75 -37.66 10.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 111.296 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.9 142.26 20.6 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.837 -0.165 . . . . 73.019999999999996 111.016 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' HA ' HG11 ' A' ' 46' ' ' VAL . 3.1 p . . . . . 0 C--O 1.251 1.162 0 CA-C-N 116.49 -0.323 . . . . 71.349999999999994 110.745 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.812 0.339 . . . . 73.310000000000002 110.69 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.67 76.45 7.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 70.140000000000001 110.516 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -81.03 40.61 0.55 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.326 0.584 . . . . 75.329999999999998 110.69 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -162.06 90.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -73.98 103.3 4.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.258 0.552 . . . . 75.319999999999993 111.749 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.06 145.71 48.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.198 -0.91 . . . . 73.329999999999998 110.426 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -77.23 153.46 34.0 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.825 0.345 . . . . 71.439999999999998 111.24 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -134.17 -10.07 2.59 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.893 -0.594 . . . . 73.239999999999995 110.634 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -98.52 101.39 12.81 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.362 -0.381 . . . . 75.209999999999994 110.274 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.25 126.46 0.93 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.657 -0.577 . . . . 72.519999999999996 111.657 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.9 p 50.33 25.61 1.93 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.154 0.582 . . . . 74.140000000000001 112.096 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.4 tp -83.23 -30.43 27.71 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.558 0.694 . . . . 72.230000000000004 109.413 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.26 -164.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.003 -0.998 . . . . 63.329999999999998 109.896 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.4 -79.75 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.675 0.274 . . . . 72.420000000000002 111.247 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -105.6 174.39 5.9 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.929 0.395 . . . . 75.299999999999997 110.991 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 m -138.39 97.19 3.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.531 -0.914 . . . . 75.230000000000004 108.531 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.84 105.26 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 72.329999999999998 110.842 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.91 -55.14 32.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.886 -0.597 . . . . 74.25 112.651 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 25' ' ' GLN . 78.0 Cg_exo -52.51 110.18 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 73.400000000000006 112.913 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.9 163.56 30.77 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.868 -0.605 . . . . 72.409999999999997 111.672 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 t -74.4 -70.88 0.37 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.812 0.306 . . . . 73.519999999999996 110.984 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -85.75 -19.49 30.71 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.764 0.316 . . . . 74.010000000000005 111.08 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 p -79.22 131.53 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 72.25 110.29 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.29 104.37 0.25 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.992 0.425 . . . . 75.019999999999996 111.079 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -92.43 135.42 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 73.129999999999995 110.717 -178.009 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 tp -145.9 137.0 24.66 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.851 0.358 . . . . 72.129999999999995 111.37 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -141.35 140.63 33.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.944 -0.762 . . . . 65.329999999999998 108.944 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.34 119.85 13.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.848 0.356 . . . . 71.0 110.601 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -112.82 125.59 54.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 74.450000000000003 109.776 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 114.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.562 -0.533 . . . . 74.030000000000001 109.562 176.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.7 mt -99.24 -27.01 13.99 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.58 0.229 . . . . 73.129999999999995 111.5 -174.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 7.4 m -153.66 110.64 2.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 110.247 -0.279 . . . . 74.030000000000001 110.247 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.12 124.15 13.01 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.188 . . . . 71.120000000000005 111.619 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -92.36 -174.13 41.84 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.241 -0.504 . . . . 71.150000000000006 113.098 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -44.66 -57.17 3.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.823 0.849 . . . . 72.409999999999997 112.13 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.1 -30.65 9.44 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.013 -0.613 . . . . 51.130000000000003 114.594 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.5 m -90.34 -22.81 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.175 0.988 . . . . 74.230000000000004 111.007 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.409 HG22 HD11 ' A' ' 92' ' ' LEU . 5.2 p -65.14 142.82 58.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 54.219999999999999 110.541 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.19 101.57 16.24 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 71.519999999999996 110.947 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 141.38 26.72 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 72.230000000000004 111.507 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -131.74 160.42 35.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.073 -0.343 . . . . 75.109999999999999 110.073 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 140.83 50.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.358 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.22 64.98 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 73.239999999999995 112.152 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 143.62 33.28 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.779 0.323 . . . . 75.150000000000006 110.162 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 14.1 tppt? -69.89 126.69 30.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.916 -0.584 . . . . 63.310000000000002 110.027 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 130' ' ' VAL . 27.2 m -117.59 141.96 34.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 120.875 0.369 . . . . 72.019999999999996 110.758 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.4 m -99.87 108.53 20.81 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.369 -0.832 . . . . 54.210000000000001 109.749 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.448 HG13 ' HE1' ' A' ' 72' ' ' PHE . 20.9 m -118.26 178.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.27 -0.877 . . . . 54.299999999999997 111.747 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.6 t-160 -155.87 135.97 12.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.393 -0.822 . . . . 71.409999999999997 109.126 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.58 ' HD1' HG12 ' A' ' 125' ' ' VAL . 61.7 m-85 -126.81 155.51 42.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.479 0.18 . . . . 74.140000000000001 110.857 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.72 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 35.4 t70 -136.42 128.19 29.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.994 -0.548 . . . . 72.430000000000007 109.874 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -86.92 100.88 2.61 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.324 -0.465 . . . . 64.230000000000004 112.852 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.495 HH11 ' HG3' ' A' ' 53' ' ' ARG . 24.2 ttm-85 -115.95 144.66 43.76 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.927 0.394 . . . . 75.299999999999997 111.126 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -90.67 151.12 43.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 110.085 -0.339 . . . . 75.120000000000005 110.085 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.52 -8.68 21.61 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.892 2.395 . . . . 75.109999999999999 113.473 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.46 -22.11 25.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.69 0.281 . . . . 72.329999999999998 111.162 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.79 10.14 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.313 -0.47 . . . . 62.229999999999997 112.033 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.666 ' HB3' ' HZ3' ' A' ' 58' ' ' LYS . 6.8 ttpm? -97.53 162.89 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.345 -0.613 . . . . 73.120000000000005 109.345 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 19.4 pt20 -147.76 146.94 29.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.378 -0.23 . . . . 72.329999999999998 110.378 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -76.82 -34.01 57.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.276 -0.42 . . . . 73.530000000000001 111.714 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.24 131.71 17.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.989 -0.374 . . . . 72.129999999999995 109.989 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.544 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 11.3 p -81.73 85.6 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.223 0.535 . . . . 74.510000000000005 110.197 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.66 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 20.1 m -81.47 -21.66 38.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.786 -0.643 . . . . 73.299999999999997 109.985 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -66.94 -36.97 83.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.729 -0.669 . . . . 75.5 109.513 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.6 m -71.54 -21.58 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.468 -0.787 . . . . 52.329999999999998 110.877 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -76.0 -26.32 56.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.233 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.21 31.97 50.26 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.579 -0.737 . . . . 63.329999999999998 113.027 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -79.13 119.8 78.43 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.536 0.168 . . . . 75.340000000000003 110.659 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.63 93.92 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.069 2.513 . . . . 73.209999999999994 111.116 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.34 161.4 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.722 -0.672 . . . . 71.25 109.408 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.32 133.7 33.35 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.292 -0.255 . . . . 75.030000000000001 110.797 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.448 ' HE1' HG13 ' A' ' 48' ' ' VAL . 26.9 p90 -150.81 158.08 43.71 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.422 -0.353 . . . . 73.400000000000006 110.199 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.5 m -77.42 113.04 14.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.07 -0.344 . . . . 75.200000000000003 110.07 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 88' ' ' ALA . 38.5 tp -60.39 140.41 57.2 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.441 -0.345 . . . . 75.129999999999995 110.878 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.13 -21.61 33.53 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 116.337 -0.392 . . . . 70.140000000000001 112.351 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . . . -81.66 178.48 8.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 111.022 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.57 24.51 29.05 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.966 -0.561 . . . . 71.230000000000004 112.056 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 9.8 mm-40 -58.35 -41.49 84.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 109.892 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.451 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 34.5 m -123.68 178.23 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 62.130000000000003 109.058 174.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.9 pt -73.4 144.43 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.341 -0.615 . . . . 75.420000000000002 109.341 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.769 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 5.0 mptp? -61.84 -15.79 44.92 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.064 0.394 . . . . 74.329999999999998 112.064 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.96 33.56 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.553 -0.832 . . . . 74.310000000000002 111.044 171.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.451 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 27.4 m0 -72.33 -36.17 68.77 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 120.851 0.357 . . . . 71.340000000000003 110.238 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.769 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 25.7 t70 -57.62 -55.36 35.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.517 -0.765 . . . . 72.430000000000007 110.747 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -72.51 -38.09 68.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.303 -0.408 . . . . 74.129999999999995 110.15 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' O ' HG21 ' A' ' 89' ' ' THR . . . -54.37 -47.93 66.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.88 -0.6 . . . . 70.400000000000006 112.465 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.2 p -76.05 -35.16 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.773 0.32 . . . . 63.539999999999999 110.862 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.97 -29.27 69.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.679 0.252 . . . . 72.340000000000003 111.679 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 86' ' ' GLY . 6.5 t -79.49 9.11 5.2 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.675 0.62 . . . . 73.040000000000006 112.675 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 17.1 ptp -124.86 -168.4 1.81 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.043 -0.411 . . . . 71.329999999999998 110.896 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -128.92 178.69 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.479 -0.328 . . . . 75.530000000000001 111.404 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.805 ' HA ' HD13 ' A' ' 127' ' ' LEU . 9.6 tt -63.28 135.53 57.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 74.120000000000005 111.196 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.65 10.94 85.69 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.907 -0.588 . . . . 72.25 112.633 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.503 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.7 tt0 -106.18 148.81 27.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 71.340000000000003 110.869 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' HB3' ' HZ3' ' A' ' 95' ' ' LYS . 6.7 ttpm? -142.38 137.65 30.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 110.786 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.9 149.78 34.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.02 -0.536 . . . . 55.240000000000002 110.637 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.661 ' HB2' HD11 ' A' ' 31' ' ' LEU . 8.9 tt -90.72 107.51 19.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.494 -0.928 . . . . 64.409999999999997 108.494 175.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -112.0 125.71 54.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 65.010000000000005 110.168 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.6 m -76.2 130.35 38.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 72.409999999999997 110.268 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.3 mm -108.14 98.81 28.28 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.364 -0.38 . . . . 60.109999999999999 110.021 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.04 153.97 73.76 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.572 2.181 . . . . 73.230000000000004 111.694 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.31 -23.57 66.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.719 0.637 . . . . 75.519999999999996 112.719 -171.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.55 -16.77 57.08 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.674 0.249 . . . . 73.140000000000001 111.674 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.51 15.58 25.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 73.129999999999995 110.905 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.11 -175.8 5.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 111.322 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -73.79 -6.22 45.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.373 -0.83 . . . . 75.329999999999998 111.005 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -52.8 -25.11 21.74 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.367 0.417 . . . . 75.140000000000001 113.262 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.04 -46.22 91.58 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.909 0.385 . . . . 70.209999999999994 110.74 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -99.63 -46.64 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 75.25 111.466 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.7 161.65 3.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.58 -0.343 . . . . 74.310000000000002 112.815 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.699 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 87.9 m-85 -135.82 -57.56 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 119.576 -0.25 . . . . 75.400000000000006 110.767 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.699 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 9.5 Cg_exo -71.69 142.95 40.82 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.857 1.705 . . . . 74.049999999999997 111.022 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.36 -19.08 33.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.591 2.194 . . . . 75.519999999999996 112.147 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.451 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 33.9 t -76.09 -24.4 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 110.627 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.06 98.21 18.07 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.148 -0.478 . . . . 64.329999999999998 109.874 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 114' ' ' VAL . 17.9 Cg_exo -67.34 159.9 50.16 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.002 2.468 . . . . 73.409999999999997 112.573 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.81 136.12 44.15 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.588 2.192 . . . . 75.400000000000006 111.43 174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 61.07 34.84 18.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.073 -0.512 . . . . 73.319999999999993 110.871 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.42 122.79 31.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.789 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -73.83 119.11 17.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.625 -0.509 . . . . 71.230000000000004 109.625 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.92 168.78 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.046 0.451 . . . . 74.120000000000005 110.401 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.6 t -133.0 138.21 52.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.426 -0.953 . . . . 74.230000000000004 108.426 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -130.19 122.81 28.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.345 0.593 . . . . 55.210000000000001 110.734 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 31.2 tt0 -76.44 107.03 8.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.559 -1.275 . . . . 75.120000000000005 107.559 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.58 HG12 ' HD1' ' A' ' 50' ' ' TYR . 31.6 m -104.1 144.14 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 55.229999999999997 110.4 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 39.2 tt0 -147.54 128.31 14.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 75.209999999999994 110.633 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 92' ' ' LEU . 2.5 tm? -98.55 106.17 18.41 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.626 -0.879 . . . . 72.310000000000002 108.626 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.8 mm? -78.57 -48.3 15.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 73.209999999999994 111.002 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.62 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.019999999999996 111.195 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 46' ' ' VAL . 2.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-N 115.926 -0.579 . . . . 71.349999999999994 110.203 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.192 -0.299 . . . . 73.310000000000002 110.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.41 5.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 70.140000000000001 110.491 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -72.72 -42.5 64.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.419 . . . . 75.329999999999998 110.032 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -75.83 116.72 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.566 -0.902 . . . . 73.230000000000004 108.566 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -59.98 94.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.636 . . . . 75.319999999999993 111.62 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -73.3 70.55 1.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.56 -0.533 . . . . 73.329999999999998 109.56 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -95.22 128.72 42.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.941 -0.763 . . . . 71.439999999999998 108.941 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -131.84 134.78 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.757 0.313 . . . . 73.239999999999995 110.558 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.21 174.28 13.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.328 -0.619 . . . . 75.209999999999994 109.328 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.65 -129.07 2.4 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.058 -0.591 . . . . 72.519999999999996 111.656 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -73.89 81.11 1.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.938 0.369 . . . . 74.140000000000001 110.177 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.6 mt 60.84 20.17 10.39 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.808 -0.633 . . . . 72.230000000000004 110.539 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.88 18.81 2.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.822 -0.626 . . . . 63.329999999999998 110.813 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.63 106.88 16.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 72.420000000000002 110.854 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 69.97 -5.29 1.29 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.755 -0.657 . . . . 75.299999999999997 112.105 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 p -77.39 87.42 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 75.230000000000004 110.67 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -140.87 13.17 2.27 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.684 -0.689 . . . . 72.329999999999998 110.584 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 22' ' ' MET . . . 112.12 88.17 1.75 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.097 -0.501 . . . . 74.25 112.224 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.15 122.49 5.74 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.73 2.287 . . . . 73.400000000000006 112.471 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.19 -127.27 8.13 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 121.138 -0.553 . . . . 72.409999999999997 112.711 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 m -74.35 79.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.923 0.392 . . . . 73.519999999999996 110.83 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.464 ' HG3' ' HA3' ' A' ' 18' ' ' GLY . 24.8 mmt -142.29 -48.29 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.152 -0.476 . . . . 74.010000000000005 110.027 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -156.62 -179.51 8.26 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.647 -0.706 . . . . 72.25 109.573 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.4 95.36 6.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 75.019999999999996 110.453 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -92.42 135.32 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.508 . . . . 73.129999999999995 110.252 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -131.55 102.03 5.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.326 -0.99 . . . . 72.129999999999995 108.326 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.34 125.57 15.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 65.329999999999998 109.224 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -125.48 126.22 44.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 71.0 110.469 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -109.19 121.01 44.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.696 -0.683 . . . . 74.450000000000003 110.232 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.33 103.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.902 -0.407 . . . . 74.030000000000001 109.902 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.41 -19.66 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.42 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 37.9 m -149.57 110.83 3.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.992 -0.549 . . . . 74.030000000000001 109.712 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.75 130.63 23.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 71.120000000000005 111.824 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.17 -153.28 19.88 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.06 -0.518 . . . . 71.150000000000006 112.545 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.73 -36.9 42.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.161 0.505 . . . . 72.409999999999997 110.28 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.553 ' HA2' HG23 ' A' ' 91' ' ' THR . . . 81.01 -17.72 11.07 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.623 -0.717 . . . . 51.130000000000003 113.329 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 m -89.4 -20.31 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.971 0.36 . . . . 74.230000000000004 111.971 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.4 p -79.95 144.17 33.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.998 0.428 . . . . 54.219999999999999 111.062 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.737 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.58 96.24 49.06 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.958 -0.564 . . . . 71.519999999999996 109.784 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.562 ' HA ' HG22 ' A' ' 130' ' ' VAL . 51.6 Cg_exo -55.94 145.14 75.39 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.009 2.473 . . . . 72.230000000000004 113.188 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.17 146.0 44.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.971 -0.559 . . . . 75.109999999999999 109.939 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.6 166.14 24.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.728 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.07 7.3 70.46 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.221 -0.514 . . . . 73.239999999999995 112.711 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.95 149.88 40.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.943 0.401 . . . . 75.150000000000006 111.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.712 ' HB2' ' HZ2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -78.06 104.09 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.89 -0.782 . . . . 63.310000000000002 108.89 171.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.33 151.63 8.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.276 0.56 . . . . 72.019999999999996 111.661 -173.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.2 m -99.13 108.38 20.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.005 -0.998 . . . . 54.210000000000001 110.015 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.468 HG23 ' CE2' ' A' ' 72' ' ' PHE . 14.7 m -122.57 178.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.924 -0.58 . . . . 54.299999999999997 110.466 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -154.22 149.46 27.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.134 -0.691 . . . . 71.409999999999997 109.134 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -151.33 152.27 32.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.499 0.19 . . . . 74.140000000000001 110.615 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -135.74 134.59 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.157 -0.682 . . . . 72.430000000000007 109.157 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.23 139.71 15.35 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.281 -0.485 . . . . 64.230000000000004 112.818 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.544 HH21 HG23 ' A' ' 122' ' ' VAL . 11.1 ttp180 -142.03 137.15 30.9 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.092 0.472 . . . . 75.299999999999997 110.432 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -79.95 152.83 74.77 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.731 -0.668 . . . . 75.120000000000005 109.939 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.45 -18.68 32.72 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.666 2.244 . . . . 75.109999999999999 111.774 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.28 -38.87 88.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.392 -0.822 . . . . 72.329999999999998 110.367 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.09 -19.25 5.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.015 -0.538 . . . . 62.229999999999997 112.357 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -86.32 142.93 28.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.6 0.2 . . . . 73.120000000000005 110.571 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.2 mt-30 -86.45 155.25 20.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.604 -0.517 . . . . 72.329999999999998 109.604 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -76.16 -62.02 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.483 -0.562 . . . . 73.530000000000001 109.483 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -145.26 132.99 21.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.634 -0.712 . . . . 72.129999999999995 109.265 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 33.1 t -89.54 85.66 6.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 74.510000000000005 109.85 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 99.9 p -65.25 -26.78 68.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.486 . . . . 73.299999999999997 109.928 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 64' ' ' ARG . 5.3 ptp180 -60.35 -44.29 95.69 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.746 -0.661 . . . . 75.5 110.477 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -69.81 -23.44 63.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.061 0.458 . . . . 52.329999999999998 110.199 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 62' ' ' SER . 17.4 mtp180 -75.91 -21.85 56.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.294 -0.632 . . . . 75.439999999999998 109.294 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.07 46.53 7.6 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.404 -0.816 . . . . 63.329999999999998 114.128 170.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -145.8 128.98 8.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.101 0.451 . . . . 75.340000000000003 110.477 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.91 -177.42 2.81 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.24 2.627 . . . . 73.209999999999994 111.914 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.4 152.36 48.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.242 -0.651 . . . . 71.25 109.242 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -134.14 129.58 36.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.356 -0.239 . . . . 75.030000000000001 110.356 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' A' ' 48' ' ' VAL . 12.6 p90 -154.61 169.86 22.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.715 -0.221 . . . . 73.400000000000006 110.543 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.471 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 21.7 m -80.88 119.09 22.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.421 -0.354 . . . . 75.200000000000003 111.204 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 88' ' ' ALA . 56.8 tp -70.21 137.69 51.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.09 -0.505 . . . . 75.129999999999995 110.347 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.17 24.99 64.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.014 -0.612 . . . . 70.140000000000001 112.422 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.67 172.3 11.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.727 0.299 . . . . 74.430000000000007 110.407 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 15.93 8.4 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 113.315 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 73' ' ' THR . 26.6 mm-40 -55.68 -42.99 75.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.269 0.557 . . . . 75.439999999999998 110.314 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.526 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 30.4 m -134.91 176.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 62.130000000000003 109.987 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.9 pt -69.21 150.01 10.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 116.499 -0.318 . . . . 75.420000000000002 110.392 177.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.473 ' HD2' HE21 ' A' ' 85' ' ' GLN . 4.7 tmtm? -58.59 -25.22 62.37 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 110.274 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.62 -52.16 54.21 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.055 -0.593 . . . . 74.310000000000002 111.963 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 49.8 m0 -68.14 -35.12 77.58 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.084 -0.339 . . . . 71.340000000000003 110.084 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.08 -49.37 71.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.105 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.473 HE21 ' HD2' ' A' ' 81' ' ' LYS . 80.3 mt-30 -59.14 -49.18 78.86 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.294 -0.412 . . . . 74.129999999999995 110.237 175.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.24 -50.05 48.05 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.455 -0.793 . . . . 70.400000000000006 113.003 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -75.36 -33.25 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.71 0.291 . . . . 63.539999999999999 111.763 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.595 ' HB3' HD13 ' A' ' 74' ' ' LEU . . . -77.69 -20.8 53.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.366 0.506 . . . . 72.340000000000003 112.366 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.3 t -85.76 -10.27 55.81 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.171 0.434 . . . . 73.040000000000006 112.171 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.9 ptp -107.19 -176.46 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 111.637 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.553 HG23 ' HA2' ' A' ' 36' ' ' GLY . 17.3 p -118.56 178.83 4.32 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.899 -0.591 . . . . 75.530000000000001 110.89 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.791 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.3 tt -67.28 126.42 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.096 0.474 . . . . 74.120000000000005 110.542 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.62 11.97 82.3 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.707 -0.679 . . . . 72.25 112.531 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 19.1 tt0 -100.5 146.48 27.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.841 0.353 . . . . 71.340000000000003 110.618 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.4 ttpm? -137.45 136.92 38.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.848 -0.614 . . . . 74.540000000000006 109.957 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.82 148.11 46.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.313 -0.403 . . . . 55.240000000000002 110.691 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.5 tt -90.75 105.47 17.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.628 -1.249 . . . . 64.409999999999997 107.628 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.86 126.43 50.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 65.010000000000005 110.268 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.3 m -84.89 106.44 16.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.949 -0.759 . . . . 72.409999999999997 108.949 174.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.98 110.77 40.44 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.435 -0.348 . . . . 60.109999999999999 110.77 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.93 140.87 47.01 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.486 2.124 . . . . 73.230000000000004 111.233 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 46.3 p90 -54.5 -35.06 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 75.519999999999996 111.781 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.528 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 13.8 pt20 -61.83 -20.87 64.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 111.543 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.528 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 95.6 mt -113.45 19.0 17.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.535 -0.302 . . . . 73.129999999999995 110.657 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.8 171.54 14.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.665 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -72.12 -17.34 61.98 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.282 -0.872 . . . . 75.329999999999998 110.587 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.89 -15.97 44.76 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.907 -0.588 . . . . 75.140000000000001 112.366 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.734 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 3.6 tm-20 -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.119 -0.326 . . . . 70.209999999999994 110.119 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -78.46 -52.83 7.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.426 -0.583 . . . . 75.25 109.426 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.97 153.36 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.936 -0.575 . . . . 74.310000000000002 113.008 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.541 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 54.2 m-85 -142.49 -59.84 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 122.574 0.35 . . . . 75.400000000000006 110.651 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 75.6 Cg_endo -84.51 151.18 11.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 121.899 1.733 . . . . 74.049999999999997 111.882 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.9 -21.49 64.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.683 2.255 . . . . 75.519999999999996 112.634 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.616 HG21 HG12 ' A' ' 115' ' ' ILE . 33.8 m -71.91 -22.45 21.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.301 -0.408 . . . . 74.310000000000002 110.724 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.616 HG12 HG21 ' A' ' 114' ' ' VAL . 47.1 mm -121.81 87.68 46.69 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 109.165 -0.68 . . . . 64.329999999999998 109.165 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.98 156.34 63.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 73.409999999999997 111.785 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.11 135.85 60.2 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.358 2.038 . . . . 75.400000000000006 112.217 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 98.1 mttt 61.83 35.12 16.73 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.778 -0.647 . . . . 73.319999999999993 111.493 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.29 125.04 34.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.053 -0.521 . . . . 74.120000000000005 111.562 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.6 m -74.09 132.81 42.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.921 -0.581 . . . . 71.230000000000004 109.442 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -129.58 150.41 50.92 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.883 -0.414 . . . . 74.120000000000005 109.883 -171.239 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.567 ' N ' HD12 ' A' ' 121' ' ' LEU . 90.0 t -98.73 131.06 46.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 110.378 -0.23 . . . . 74.230000000000004 110.378 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.448 ' CE2' HD13 ' A' ' 121' ' ' LEU . 56.5 m-85 -130.32 118.76 21.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 55.210000000000001 110.644 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 46.8 mt-10 -77.73 107.8 10.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.759 -0.83 . . . . 75.120000000000005 108.759 171.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.15 147.33 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 123.325 0.391 . . . . 55.229999999999997 110.312 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.96 128.92 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 75.209999999999994 110.703 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.9 tm? -96.14 115.91 28.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.85 -43.41 10.05 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.643 0.258 . . . . 73.209999999999994 110.998 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.39 135.29 17.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.348 -0.387 . . . . 73.019999999999996 110.388 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.562 HG22 ' HA ' ' A' ' 40' ' ' PRO . 2.9 p . . . . . 0 C--O 1.251 1.149 0 CA-C-N 116.23 -0.441 . . . . 71.349999999999994 111.235 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.872 -0.418 . . . . 62.340000000000003 109.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.3 tp -145.92 102.02 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.784 0.326 . . . . 71.530000000000001 111.019 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' H ' ' HB ' ' A' ' 99' ' ' THR . 50.1 mm-40 -113.62 140.68 48.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.99 -0.744 . . . . 65.329999999999998 108.99 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 9.1 ptpp? -128.32 111.92 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 71.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -123.41 110.0 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 109.878 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 9.9 p -71.37 128.06 34.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.842 0.353 . . . . 70.430000000000007 111.314 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 97' ' ' LEU . 3.0 mm? -86.96 -38.08 16.97 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.592 -0.522 . . . . 73.129999999999995 109.592 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.1 m -141.6 112.7 6.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.966 -0.561 . . . . 74.030000000000001 110.187 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.15 146.09 62.81 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.51 2.14 . . . . 71.120000000000005 111.638 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.62 -164.64 28.23 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.271 -0.49 . . . . 71.120000000000005 112.717 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.79 -40.89 63.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.092 0.472 . . . . 72.409999999999997 110.996 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 -30.78 2.48 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.734 -0.667 . . . . 51.130000000000003 112.657 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.6 -24.5 8.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.032 0.444 . . . . 73.239999999999995 110.43 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.2 p -75.05 139.58 42.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.552 -0.749 . . . . 54.219999999999999 110.436 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -126.41 113.72 23.29 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.504 -0.316 . . . . 63.140000000000001 110.896 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.64 130.95 14.17 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.429 2.086 . . . . 71.040000000000006 111.451 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.47 149.28 44.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.43 -0.35 . . . . 75.109999999999999 110.815 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.32 164.5 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.111 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.24 34.48 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.156 -0.474 . . . . 65.140000000000001 112.73 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -101.44 146.7 27.27 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.430000000000007 111.597 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -77.42 110.85 12.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.299 -0.864 . . . . 61.229999999999997 109.282 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.9 m -106.4 148.76 10.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.945 0.403 . . . . 64.049999999999997 111.662 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.9 m -102.53 108.19 19.4 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 115.02 -0.991 . . . . 54.210000000000001 110.515 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.48 HG21 ' HE1' ' A' ' 72' ' ' PHE . 33.1 m -119.21 178.36 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 114.64 -1.164 . . . . 41.030000000000001 111.931 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 13.8 t-160 -157.51 147.32 20.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.199 -1.037 . . . . 71.409999999999997 108.199 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.6 m-85 -132.99 157.39 45.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.822 0.283 . . . . 71.340000000000003 111.383 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.841 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 45.0 m-20 -136.0 122.32 20.52 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.693 -0.685 . . . . 72.430000000000007 109.863 170.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.29 129.79 10.32 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.664 -0.574 . . . . 64.230000000000004 111.664 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -149.0 143.77 26.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 71.310000000000002 110.825 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 147.5 40.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.943 -0.391 . . . . 75.120000000000005 109.943 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.32 -22.49 49.66 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.894 2.396 . . . . 74.209999999999994 112.067 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.32 -34.27 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.5 -0.773 . . . . 72.299999999999997 110.797 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.59 -38.45 2.19 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.059 -0.816 . . . . 52.539999999999999 111.059 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.95 123.12 16.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.508 -0.346 . . . . 64.140000000000001 110.328 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -75.65 144.19 41.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.506 . . . . 72.329999999999998 110.917 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -72.93 -45.22 59.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.521 -0.548 . . . . 73.530000000000001 109.521 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -166.7 131.3 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 72.129999999999995 109.459 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -78.74 85.6 4.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.239 0.542 . . . . 73.409999999999997 109.865 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -72.66 -14.0 61.49 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.438 0.637 . . . . 61.149999999999999 110.086 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.701 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 13.1 ptt-85 -64.46 -35.96 82.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.42 -0.809 . . . . 74.420000000000002 110.678 171.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -69.17 -18.2 63.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.098 0.475 . . . . 52.329999999999998 110.057 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -82.32 -14.2 55.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.989 -0.551 . . . . 75.439999999999998 110.574 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.81 32.82 59.27 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.816 -0.629 . . . . 63.329999999999998 113.578 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -106.47 109.57 63.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.755 0.278 . . . . 75.340000000000003 110.98 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -90.5 125.68 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.948 2.432 . . . . 73.209999999999994 112.054 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.77 162.63 14.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.33 -0.618 . . . . 71.230000000000004 109.33 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.95 137.35 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.414 -0.178 . . . . 75.030000000000001 110.767 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.48 ' HE1' HG21 ' A' ' 48' ' ' VAL . 35.1 p90 -159.27 155.28 26.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.213 -0.195 . . . . 73.400000000000006 110.616 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.6 m -72.09 113.8 9.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.431 -0.35 . . . . 75.200000000000003 110.687 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.489 HD13 HG13 ' A' ' 87' ' ' VAL . 55.8 tp -61.97 133.56 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.7 -0.482 . . . . 75.129999999999995 109.7 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.75 68.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 51.530000000000001 112.803 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.39 11.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 74.430000000000007 110.525 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.91 31.68 3.33 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.475 -0.393 . . . . 54.409999999999997 112.631 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -63.74 -43.54 96.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 110.593 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.685 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 26.8 m -128.75 177.73 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 32.009999999999998 110.147 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.458 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.3 pt -68.92 152.77 9.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.687 0.279 . . . . 75.420000000000002 110.389 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 5.6 tmtm? -56.25 -29.02 60.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.073 -0.512 . . . . 73.310000000000002 109.94 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.44 -54.43 36.09 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.133 -0.556 . . . . 34.43 112.057 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.685 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 26.0 m0 -68.75 -38.17 79.93 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.52 -0.178 . . . . 71.340000000000003 110.52 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -54.51 -49.3 70.51 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.215 0.531 . . . . 72.430000000000007 110.389 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -65.03 -41.32 95.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 73.310000000000002 110.267 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.04 43.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.924 -0.58 . . . . 70.400000000000006 112.492 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.489 HG13 HD13 ' A' ' 74' ' ' LEU . 6.6 p -71.03 -31.81 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.685 0.279 . . . . 62.310000000000002 111.068 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -70.59 -30.66 67.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 72.340000000000003 111.659 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 -15.65 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.93 0.344 . . . . 72.319999999999993 111.93 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 87' ' ' VAL . 16.5 ptm -91.01 -175.39 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.581 0.229 . . . . 71.329999999999998 110.828 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -126.51 175.23 8.06 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 75.530000000000001 111.14 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.787 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.2 tt -73.84 137.58 43.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.698 0.285 . . . . 74.120000000000005 110.26 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.498 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.25 10.58 85.9 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.652 -0.579 . . . . 72.25 111.652 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.86 149.65 30.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.607 -0.296 . . . . 71.340000000000003 110.63 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . 13.9 ptmt -140.43 133.45 29.35 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.498 -0.556 . . . . 74.540000000000006 109.498 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -131.43 156.71 45.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.693 -0.685 . . . . 55.240000000000002 111.037 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 31' ' ' LEU . 8.7 tt -90.73 107.2 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.061 -1.089 . . . . 62.350000000000001 108.061 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -111.46 114.43 27.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.85 -0.426 . . . . 65.010000000000005 109.85 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 22.3 m -76.88 118.44 19.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.5 -0.318 . . . . 71.140000000000001 110.805 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 105' ' ' ALA . 40.0 mm -101.75 110.84 63.05 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 120.675 0.274 . . . . 60.109999999999999 110.414 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.3 Cg_endo -62.46 143.44 93.24 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.634 2.222 . . . . 51.240000000000002 111.889 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -54.26 -32.58 56.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.691 -0.686 . . . . 74.230000000000004 111.982 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.32 -23.34 65.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.074 0.398 . . . . 73.140000000000001 112.074 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.3 mt -96.12 -28.25 14.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.671 0.272 . . . . 72.140000000000001 111.549 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.444 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -110.06 -174.34 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 75.530000000000001 111.127 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -70.12 -7.44 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.621 . . . . 72.409999999999997 111.08 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.33 -28.84 51.52 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 113.089 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 7.6 tm-20 -64.28 -49.85 70.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.365 -0.605 . . . . 70.209999999999994 109.365 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -27.32 58.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.491 -0.777 . . . . 72.200000000000003 110.48 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 112' ' ' PRO . . . 80.14 -82.83 1.43 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.616 -0.72 . . . . 74.310000000000002 111.77 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.612 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 58.8 m-85 89.33 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.209 1.404 . . . . 75.400000000000006 111.986 -175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 59.4 Cg_endo -89.0 152.67 5.8 Favored 'Trans proline' 0 C--N 1.366 1.482 0 CA-C-N 121.693 1.64 . . . . 74.049999999999997 111.665 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.33 -7.78 13.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.557 2.171 . . . . 75.519999999999996 112.369 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.95 -31.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 109.938 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.89 101.92 48.68 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.812 -0.631 . . . . 64.329999999999998 109.899 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 Cg_endo -67.08 119.64 6.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.241 1.961 . . . . 73.409999999999997 111.388 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.34 133.96 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.683 2.922 . . . . 61.409999999999997 113.42 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 54.0 mtmt 73.0 31.68 1.45 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.645 0.778 . . . . 73.319999999999993 111.124 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -93.77 123.86 37.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.878 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 101' ' ' PRO . 74.0 m -73.69 127.64 33.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.257 -0.646 . . . . 71.230000000000004 109.257 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -120.88 137.09 54.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.547 -0.538 . . . . 73.030000000000001 109.547 -170.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.522 ' N ' HD13 ' A' ' 121' ' ' LEU . 88.7 t -98.51 131.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.691 0.281 . . . . 74.230000000000004 110.424 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.29 123.04 41.22 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.947 -0.39 . . . . 52.100000000000001 109.947 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 51.0 mt-10 -75.34 115.34 14.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.553 -0.906 . . . . 64.310000000000002 108.553 171.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 m -95.74 137.17 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.653 0.595 . . . . 41.0 109.413 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 36.3 tt0 -136.61 117.71 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.589 -0.522 . . . . 75.209999999999994 109.589 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.787 HD12 ' HA ' ' A' ' 92' ' ' LEU . 3.1 tm? -99.87 106.3 18.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.72 -0.845 . . . . 72.310000000000002 108.72 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 49' ' ' HIS . 3.6 mm? -78.2 -45.83 22.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.41 -0.589 . . . . 73.209999999999994 109.41 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -170.81 -173.61 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.528 -0.76 . . . . 55.219999999999999 109.92 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.114 -0.946 . . . . 71.349999999999994 108.669 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.393 -0.595 . . . . 62.340000000000003 109.393 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -144.4 102.41 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.945 0.402 . . . . 71.530000000000001 110.397 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 48.8 mt-10 -142.72 130.59 21.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 65.329999999999998 110.122 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -133.2 101.42 5.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.767 -0.827 . . . . 71.0 108.767 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -108.71 110.33 21.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 73.319999999999993 109.763 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.59 114.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.189 0.518 . . . . 70.430000000000007 110.336 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.7 mt -88.88 -33.02 17.47 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.843 -0.617 . . . . 73.129999999999995 110.117 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 44.7 m -145.49 120.58 5.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.523 -0.762 . . . . 74.030000000000001 109.397 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 146.44 51.99 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.608 2.205 . . . . 71.120000000000005 112.427 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -99.91 -172.06 30.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 112.431 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 78.2 m-20 -63.85 -36.88 85.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.034 0.445 . . . . 72.409999999999997 110.397 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.35 -30.29 2.18 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.774 -0.648 . . . . 51.130000000000003 113.039 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 m -82.25 -35.65 13.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.148 0.499 . . . . 73.239999999999995 110.07 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 12.3 p -84.83 115.57 22.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.585 -0.734 . . . . 54.219999999999999 109.476 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 39' ' ' LYS . 8.3 mtmp? -124.39 132.23 24.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 63.140000000000001 111.063 -171.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.18 166.73 20.39 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.549 2.166 . . . . 71.040000000000006 110.997 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -165.21 166.38 18.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.404 -0.221 . . . . 75.109999999999999 110.404 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.39 141.66 52.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.337 -0.392 . . . . 74.420000000000002 110.936 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.59 20.3 41.3 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.068 -0.515 . . . . 65.140000000000001 111.877 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -130.61 138.16 49.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.695 0.398 . . . . 74.430000000000007 110.869 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -79.6 106.07 11.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.491 -0.929 . . . . 61.229999999999997 108.491 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 130' ' ' VAL . 28.2 m -106.49 146.19 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.365 . . . . 64.049999999999997 111.254 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.1 m -96.35 108.07 20.53 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.613 -0.721 . . . . 54.210000000000001 109.926 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.744 HG12 HD22 ' A' ' 127' ' ' LEU . 18.4 m -124.45 178.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.519 0.676 . . . . 41.030000000000001 111.234 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 64' ' ' ARG . 15.4 t-80 -151.6 140.63 21.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.947 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 86.0 m-85 -126.5 144.01 51.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.595 -0.891 . . . . 71.340000000000003 108.595 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 8.9 t70 -136.15 110.71 8.59 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.469 -0.567 . . . . 72.430000000000007 109.469 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.46 137.4 30.88 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.938 -0.574 . . . . 64.230000000000004 112.154 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -148.01 137.16 22.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.002 0.43 . . . . 71.310000000000002 110.519 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 88.9 m-85 -78.53 146.8 70.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 75.120000000000005 110.168 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 30.5 Cg_exo -62.92 -10.39 20.12 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.97 2.446 . . . . 74.209999999999994 113.289 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -87.16 -4.94 59.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.675 0.274 . . . . 72.299999999999997 110.916 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.17 -24.58 15.79 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.742 -0.543 . . . . 52.539999999999999 111.742 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 4.8 ttmp? -59.09 148.63 30.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.204 0.602 . . . . 64.140000000000001 110.896 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -94.88 143.62 26.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.025 -0.361 . . . . 72.329999999999998 110.025 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -86.47 -55.66 3.78 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.957 0.408 . . . . 73.530000000000001 110.558 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -138.67 131.41 29.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.348 -0.387 . . . . 72.129999999999995 110.323 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -76.19 85.12 3.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 73.409999999999997 109.95 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.0 p -90.33 -46.91 8.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.441 . . . . 61.149999999999999 109.95 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.479 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.3 ptt180 -60.64 -31.61 70.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.987 -0.551 . . . . 74.420000000000002 110.137 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -70.68 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 52.329999999999998 111.378 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -93.17 -2.27 55.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.907 0.384 . . . . 75.439999999999998 110.234 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.18 39.2 69.83 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.71 -0.677 . . . . 63.329999999999998 113.768 174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -141.81 122.63 8.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.796 0.298 . . . . 75.340000000000003 110.582 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.81 177.66 6.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.795 2.33 . . . . 73.209999999999994 111.861 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -135.02 129.92 34.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 71.230000000000004 109.848 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -100.45 141.91 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.293 -0.262 . . . . 75.030000000000001 110.293 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.53 ' HZ ' HG11 ' A' ' 87' ' ' VAL . 11.6 p90 -154.34 158.17 39.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.726 0.298 . . . . 73.400000000000006 110.265 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -83.69 109.43 17.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 110.033 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.72 142.06 56.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.447 -0.342 . . . . 75.129999999999995 110.435 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.21 26.9 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.891 -0.484 . . . . 51.530000000000001 111.891 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.81 168.95 18.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.696 0.398 . . . . 74.430000000000007 109.966 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.42 28.48 1.48 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.397 -0.43 . . . . 54.409999999999997 113.304 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.04 -34.84 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.292 0.568 . . . . 75.439999999999998 109.767 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 83' ' ' TRP . 27.1 m -131.13 165.27 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.233 -0.894 . . . . 32.009999999999998 110.421 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 pt -80.66 164.63 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 75.420000000000002 110.526 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -55.9 -28.54 57.2 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.201 0.445 . . . . 73.310000000000002 112.201 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.52 -59.5 9.74 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 120.432 -0.889 . . . . 34.43 111.681 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.469 ' O ' HG12 ' A' ' 87' ' ' VAL . 27.0 m0 -66.0 -37.02 84.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.665 -0.268 . . . . 71.340000000000003 110.287 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.57 -55.01 39.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.936 -0.575 . . . . 72.430000000000007 110.842 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.83 -42.56 90.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.453 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.52 -48.68 69.01 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.014 -0.612 . . . . 70.400000000000006 112.682 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG11 ' HZ ' ' A' ' 72' ' ' PHE . 14.2 p -75.21 -32.94 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.826 0.346 . . . . 62.310000000000002 111.077 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.36 68.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.514 -0.312 . . . . 72.340000000000003 111.649 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 t -86.23 -4.46 59.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.215 0.45 . . . . 72.319999999999993 112.215 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 19.4 ptm -106.81 176.0 5.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.669 0.271 . . . . 71.329999999999998 110.889 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.1 p -118.65 174.55 6.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.764 0.316 . . . . 75.530000000000001 111.306 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.629 HD12 HG23 ' A' ' 130' ' ' VAL . 7.6 tt -73.16 138.34 45.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 111.134 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.495 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.34 34.8 44.52 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.737 -0.665 . . . . 72.25 111.926 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 33.7 tt0 -134.52 153.71 51.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.945 0.402 . . . . 71.340000000000003 111.694 -169.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -131.41 122.36 26.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 74.540000000000006 109.845 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.76 141.57 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 55.240000000000002 110.62 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.7 tt -90.89 113.75 26.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.951 -0.759 . . . . 62.350000000000001 108.951 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -114.37 121.2 42.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.841 0.353 . . . . 65.010000000000005 110.389 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 31.2 m -78.67 116.06 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 71.140000000000001 110.294 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.7 mm -89.87 113.29 56.43 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 116.385 -0.371 . . . . 60.109999999999999 110.853 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.75 155.0 39.45 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.547 2.165 . . . . 51.240000000000002 111.556 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -54.17 -30.83 50.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.959 -0.564 . . . . 74.230000000000004 112.075 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.02 -26.8 64.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.729 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.4 mt -96.19 11.74 33.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.359 0.124 . . . . 72.140000000000001 111.286 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 -178.2 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 75.530000000000001 110.466 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -69.72 -8.27 46.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 72.409999999999997 110.783 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.83 -20.39 32.82 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.065 -0.516 . . . . 75.140000000000001 112.817 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -58.17 -51.95 67.58 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.562 -0.533 . . . . 70.209999999999994 109.562 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -84.33 -53.82 5.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.45 -0.795 . . . . 72.200000000000003 110.77 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.96 146.17 12.69 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.097 -0.501 . . . . 74.310000000000002 112.158 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -139.06 -55.41 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 122.369 0.268 . . . . 75.400000000000006 110.854 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 13.4 Cg_exo -70.01 128.34 15.66 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.942 1.761 . . . . 74.049999999999997 110.631 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 76.5 Cg_exo -51.58 -27.67 26.29 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.82 2.347 . . . . 75.519999999999996 113.342 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.2 t -73.87 -35.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 74.310000000000002 110.56 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.54 106.17 17.35 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 64.329999999999998 109.549 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 95.3 Cg_endo -79.66 163.38 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.406 2.071 . . . . 73.409999999999997 112.364 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.11 143.9 91.71 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.212 1.941 . . . . 61.409999999999997 111.17 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 65.92 28.19 10.7 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.24 0.338 . . . . 73.319999999999993 111.276 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -76.34 148.96 37.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.18 0.514 . . . . 74.120000000000005 112.067 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.3 m -108.9 131.33 55.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.439 -0.8 . . . . 71.230000000000004 109.379 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -138.48 147.27 43.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.208 -0.664 . . . . 73.030000000000001 109.208 -175.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.578 ' N ' HD13 ' A' ' 121' ' ' LEU . 94.7 t -105.03 144.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.388 . . . . 74.230000000000004 110.98 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 121' ' ' LEU . 27.8 m-85 -133.01 125.6 30.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.021 0.439 . . . . 52.100000000000001 110.715 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 58.5 mt-10 -76.4 114.85 15.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.23 -0.656 . . . . 64.310000000000002 109.23 170.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.3 m -95.87 133.55 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 41.0 108.765 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 45.5 tt0 -139.02 116.64 11.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.39 -0.368 . . . . 75.209999999999994 110.265 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.744 HD22 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -96.04 111.71 23.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.557 -0.905 . . . . 72.310000000000002 108.557 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.05 -50.82 7.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.921 0.391 . . . . 73.209999999999994 110.065 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -167.1 178.82 5.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 55.219999999999999 109.905 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 92' ' ' LEU . 46.6 t . . . . . 0 C--O 1.251 1.142 0 N-CA-C 108.843 -0.799 . . . . 71.349999999999994 108.843 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 . . . . . 0 C--O 1.232 0.174 0 N-CA-C 108.635 -0.876 . . . . 62.340000000000003 108.635 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 102.04 8.42 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.039 0.447 . . . . 71.530000000000001 111.02 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.27 130.1 56.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 65.329999999999998 109.993 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.676 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -140.88 117.18 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.549 -0.751 . . . . 71.0 109.209 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.55 118.09 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.481 -0.327 . . . . 73.319999999999993 110.542 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.02 134.0 27.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 70.430000000000007 110.374 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.87 -18.45 13.69 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.409 -0.36 . . . . 73.129999999999995 110.688 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 88.2 m -142.71 110.63 5.7 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.148 -0.316 . . . . 74.030000000000001 110.148 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.23 126.13 10.83 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.766 2.311 . . . . 71.120000000000005 111.053 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.2 -171.29 47.3 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.236 -0.507 . . . . 71.120000000000005 113.177 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -57.61 -34.76 69.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.603 0.361 . . . . 72.409999999999997 111.346 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.523 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 76.08 -25.59 1.54 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.281 -0.485 . . . . 51.130000000000003 113.474 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 35' ' ' ASP . 34.1 m -75.12 -21.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.872 0.368 . . . . 73.239999999999995 111.471 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -81.07 128.92 34.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 54.219999999999999 111.222 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -100.09 110.24 58.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.47 . . . . 63.140000000000001 109.988 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.24 134.15 13.99 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 71.040000000000006 111.161 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -127.96 141.72 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 75.109999999999999 110.371 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 162.13 29.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.01 -0.541 . . . . 74.420000000000002 111.776 -176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.95 77.17 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.562 -0.744 . . . . 65.140000000000001 112.981 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.4 170.73 15.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 111.719 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -78.64 142.75 36.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 61.229999999999997 111.495 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.15 141.94 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.845 -0.616 . . . . 64.049999999999997 110.112 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.3 m -93.68 108.12 19.9 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.764 -0.653 . . . . 54.210000000000001 110.277 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.525 HG12 HD22 ' A' ' 127' ' ' LEU . 20.4 m -123.78 178.33 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.995 -1.002 . . . . 41.030000000000001 111.325 -172.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.589 ' HB3' HD21 ' A' ' 128' ' ' LEU . 8.9 t-80 -157.83 143.35 17.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.391 -0.822 . . . . 71.409999999999997 109.136 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 49.2 p90 -141.49 150.21 41.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.49 0.186 . . . . 71.340000000000003 110.953 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.19 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.063 -0.517 . . . . 72.430000000000007 110.292 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.28 148.44 17.05 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 116.323 -0.399 . . . . 64.230000000000004 112.484 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.54 143.25 17.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.881 -0.414 . . . . 71.310000000000002 109.881 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.91 140.21 27.66 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 75.120000000000005 110.401 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.82 -13.3 21.72 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.721 2.281 . . . . 74.209999999999994 111.432 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.57 -25.71 39.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.044 -0.98 . . . . 72.299999999999997 110.883 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.31 23.73 12.31 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.278 -0.729 . . . . 52.539999999999999 111.278 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -149.16 147.12 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.933 -0.395 . . . . 64.140000000000001 109.933 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.05 136.62 53.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.128 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -65.25 -54.28 31.66 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.326 -0.397 . . . . 73.530000000000001 110.002 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.23 160.65 43.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.621 -0.718 . . . . 72.129999999999995 109.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 64' ' ' ARG . 39.5 m -117.41 121.57 41.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.379 -0.373 . . . . 73.409999999999997 110.457 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.6 m -70.35 -29.25 65.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 61.149999999999999 109.88 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.527 HH12 ' HD2' ' A' ' 95' ' ' LYS . 8.8 ptm180 -59.85 -31.03 69.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 74.420000000000002 111.336 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.2 m -57.05 -30.25 64.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.451 -0.34 . . . . 52.329999999999998 110.655 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.652 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 5.4 mmp_? -81.09 -10.55 59.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.158 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.31 48.66 84.16 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 112.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 20.5 tptm -112.61 115.23 49.31 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 122.826 -0.22 . . . . 75.340000000000003 110.481 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 4.1 Cg_exo -81.26 167.62 17.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.15 2.566 . . . . 73.209999999999994 111.928 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 97.1 m-85 -136.2 158.97 43.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 71.230000000000004 110.087 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 97.6 mt-30 -143.57 135.87 26.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.874 -0.417 . . . . 75.030000000000001 109.874 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HE1' HG11 ' A' ' 48' ' ' VAL . 11.6 p90 -150.54 160.42 43.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 121.057 -0.257 . . . . 73.400000000000006 110.623 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.508 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 15.2 m -85.42 104.66 15.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 75.200000000000003 110.271 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 88' ' ' ALA . 51.0 tp -55.89 137.09 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 75.129999999999995 111.046 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.02 -30.45 5.48 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.091 -0.576 . . . . 51.530000000000001 112.626 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.05 178.27 7.65 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.279 . . . . 74.430000000000007 111.095 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.48 53.9 4.78 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.883 -0.487 . . . . 54.409999999999997 111.883 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 73' ' ' THR . 5.7 mm-40 -90.71 -44.93 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.043 0.449 . . . . 75.439999999999998 110.552 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.5 m -136.82 177.89 5.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.678 -0.692 . . . . 32.009999999999998 110.089 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 104' ' ' LEU . 18.0 pt -68.19 140.97 18.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 109.95 -0.389 . . . . 75.420000000000002 109.95 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 61.6 mmtt -63.71 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.617 0.599 . . . . 73.310000000000002 112.617 -173.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -56.98 22.26 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.43 -0.89 . . . . 34.43 111.017 171.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -69.15 -40.17 78.36 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.271 -0.27 . . . . 71.340000000000003 110.271 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.631 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 12.4 t70 -51.75 -55.19 21.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.746 -0.661 . . . . 72.430000000000007 110.528 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.99 -42.17 70.0 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.077 -0.51 . . . . 73.310000000000002 110.685 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.31 -49.97 48.79 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.045 -0.598 . . . . 70.400000000000006 112.073 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.7 p -75.93 -31.93 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.692 0.282 . . . . 62.310000000000002 110.942 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -59.74 -35.29 74.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.692 0.282 . . . . 72.340000000000003 111.735 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 t -87.73 6.56 34.37 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.269 0.47 . . . . 72.319999999999993 112.269 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 13.8 ptp -112.01 177.89 4.5 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.046 -0.408 . . . . 71.329999999999998 110.552 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.523 HG21 ' HA2' ' A' ' 36' ' ' GLY . 42.5 p -121.1 178.82 4.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.852 0.358 . . . . 75.530000000000001 111.708 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -61.99 129.97 43.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.703 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.69 17.25 77.8 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.781 -0.645 . . . . 72.25 112.457 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 32' ' ' THR . 14.6 tt0 -106.98 136.35 46.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 71.340000000000003 110.313 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HD2' HH12 ' A' ' 64' ' ' ARG . 28.3 ttpp -131.7 126.76 35.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.988 -0.551 . . . . 74.540000000000006 110.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.87 142.12 50.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 55.240000000000002 110.892 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 tt -90.79 117.23 29.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.395 -0.965 . . . . 62.350000000000001 108.395 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.37 122.44 38.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.5 . . . . 65.010000000000005 109.649 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 54.1 m -81.89 106.51 13.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.66 -0.496 . . . . 71.140000000000001 109.66 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 105' ' ' ALA . 27.0 mm -85.64 112.3 43.64 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 115.978 -0.555 . . . . 60.109999999999999 110.236 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.628 ' HA ' HG23 ' A' ' 120' ' ' THR . 38.2 Cg_endo -66.4 159.33 50.81 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.205 1.937 . . . . 51.240000000000002 111.075 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 38.4 p90 -54.41 -31.5 55.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 111.348 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.47 -30.04 70.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.515 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 80' ' ' ILE . 88.0 mt -105.38 13.13 30.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.327 -0.397 . . . . 72.140000000000001 111.544 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -147.15 176.17 10.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.075 0.464 . . . . 75.530000000000001 111.435 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -68.47 -14.98 63.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.559 -0.746 . . . . 72.409999999999997 110.617 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.91 -16.42 47.02 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.926 -0.579 . . . . 75.140000000000001 113.045 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 35.0 tt0 -56.2 -55.23 35.66 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.074 0.464 . . . . 70.209999999999994 110.327 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -98.81 -35.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.831 . . . . 72.200000000000003 110.52 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.67 161.98 10.99 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.805 -0.634 . . . . 74.310000000000002 112.399 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.716 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.7 m-85 -135.39 -57.18 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 122.23 0.212 . . . . 75.400000000000006 110.486 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 68.7 Cg_endo -91.25 142.41 2.99 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.003 1.802 . . . . 74.049999999999997 111.854 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 50.1 Cg_exo -55.05 -18.69 17.88 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.771 2.314 . . . . 75.519999999999996 112.737 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.61 -36.88 77.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.017 -0.538 . . . . 74.310000000000002 110.201 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.4 mm -110.16 99.11 38.3 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 109.304 -0.628 . . . . 64.329999999999998 109.304 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 159.79 51.96 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.626 2.217 . . . . 73.409999999999997 112.513 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.71 147.25 89.75 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.233 1.955 . . . . 61.409999999999997 111.665 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 7.0 mtmp? 69.69 22.85 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.069 0.548 . . . . 73.319999999999993 110.629 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.56 131.62 35.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.114 0.483 . . . . 74.120000000000005 111.31 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.628 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -97.98 127.99 44.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.182 -0.673 . . . . 71.230000000000004 109.182 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -129.44 143.6 50.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.789 -0.448 . . . . 73.030000000000001 109.789 -171.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.57 ' N ' HD13 ' A' ' 121' ' ' LEU . 46.9 t -98.3 131.82 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.117 -0.327 . . . . 74.230000000000004 110.117 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.55 132.17 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.656 0.265 . . . . 52.100000000000001 111.153 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 30.9 mt-10 -82.44 112.29 19.24 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.12 -0.696 . . . . 64.310000000000002 109.12 170.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.491 HG23 ' HE1' ' A' ' 90' ' ' MET . 11.1 m -97.06 135.45 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.097 -0.705 . . . . 41.0 109.097 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 95' ' ' LYS . 45.2 tt0 -141.3 121.46 13.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.319 -0.401 . . . . 75.209999999999994 110.427 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -93.54 113.95 26.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.613 -0.884 . . . . 72.310000000000002 108.613 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.9 mm? -87.78 -50.72 6.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.804 0.335 . . . . 73.209999999999994 110.125 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.22 -173.41 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 55.219999999999999 110.094 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.768 -0.634 . . . . 71.349999999999994 109.532 173.562 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.232 0.141 0 N-CA-C 108.649 -0.871 . . . . 62.340000000000003 108.649 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 55.0 tp -145.83 102.8 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.418 0.525 . . . . 71.530000000000001 112.418 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -111.93 132.43 54.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.067 -0.716 . . . . 65.329999999999998 109.067 165.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -129.95 101.27 5.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.508 -0.923 . . . . 71.0 108.508 176.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -123.03 113.74 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 73.319999999999993 110.736 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 6.5 p -64.38 114.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 70.430000000000007 110.863 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.18 -49.75 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.445 -0.576 . . . . 73.129999999999995 109.445 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -112.4 113.54 51.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.369 -0.832 . . . . 74.030000000000001 109.423 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.79 140.86 52.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.634 2.223 . . . . 71.120000000000005 112.438 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -98.53 -169.38 31.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.39 -0.433 . . . . 71.120000000000005 112.66 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.42 -46.07 67.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.781 0.324 . . . . 72.409999999999997 110.434 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 95.2 -20.74 47.85 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.093 -0.503 . . . . 51.130000000000003 113.931 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -103.24 -0.86 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 117.687 0.743 . . . . 73.239999999999995 112.634 -172.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.3 p -85.07 142.18 29.73 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.713 0.292 . . . . 54.219999999999999 110.568 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -113.43 119.57 41.6 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.387 -0.369 . . . . 63.140000000000001 110.025 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 14.4 Cg_exo -69.56 143.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.18 . . . . 71.040000000000006 111.582 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.54 141.82 23.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.826 0.346 . . . . 75.109999999999999 110.52 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.752 -0.658 . . . . 74.420000000000002 111.71 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.98 19.56 57.37 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.628 -0.715 . . . . 65.140000000000001 113.058 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.47 161.73 36.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.077 0.439 . . . . 74.430000000000007 110.813 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.6 tppp? -81.63 117.12 21.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.836 -0.62 . . . . 61.229999999999997 109.636 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG11 HD22 ' A' ' 74' ' ' LEU . 27.5 m -110.35 151.38 12.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 120.901 0.382 . . . . 64.049999999999997 110.539 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -117.01 108.18 15.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.562 -0.745 . . . . 54.210000000000001 110.169 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.01 178.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.589 -0.732 . . . . 41.030000000000001 110.494 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 63.7 t60 -149.24 146.48 27.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.09 -0.707 . . . . 71.409999999999997 109.09 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -126.59 152.53 46.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.701 -0.481 . . . . 71.340000000000003 109.701 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.744 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 35.7 m-20 -135.6 112.74 10.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.498 -0.927 . . . . 72.430000000000007 108.498 172.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.95 111.13 3.33 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.936 -0.575 . . . . 64.230000000000004 112.609 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 53' ' ' ARG . 22.3 ttt180 -122.38 137.49 54.84 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.32 0.581 . . . . 71.310000000000002 111.019 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -89.23 151.91 47.17 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 109.886 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.64 -17.63 36.27 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.177 2.585 . . . . 74.209999999999994 114.006 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.94 -14.74 53.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.853 0.359 . . . . 72.299999999999997 110.606 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.36 -1.02 37.35 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.219 -0.515 . . . . 52.539999999999999 112.425 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -94.43 157.23 16.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.544 -0.539 . . . . 64.140000000000001 109.544 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.73 -0.471 . . . . 72.329999999999998 109.73 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.23 -46.97 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.530000000000001 111.324 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.01 131.28 45.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.355 -0.384 . . . . 72.129999999999995 110.959 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 m -104.92 85.63 2.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 73.409999999999997 109.375 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -56.95 -28.86 62.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.059 -0.518 . . . . 61.149999999999999 110.835 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -53.91 -31.76 51.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.749 -0.66 . . . . 74.420000000000002 111.311 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -59.1 -37.32 76.88 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.886 0.374 . . . . 52.329999999999998 110.728 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -80.29 -11.54 59.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.992 -0.549 . . . . 75.439999999999998 110.564 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.41 18.99 59.42 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.132 -0.485 . . . . 63.329999999999998 112.106 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -82.14 119.13 74.34 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 122.363 0.265 . . . . 75.340000000000003 110.375 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.55 162.5 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.046 2.497 . . . . 73.209999999999994 112.352 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -122.69 117.0 24.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.37 -0.604 . . . . 71.230000000000004 109.37 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.59 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 92.2 mt-30 -107.06 140.96 39.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.573 -0.285 . . . . 75.030000000000001 110.468 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -156.89 167.6 29.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.479 -0.328 . . . . 73.400000000000006 110.23 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 m -82.07 108.93 15.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 110.294 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.436 HD22 HG11 ' A' ' 46' ' ' VAL . 45.1 tp -62.1 111.03 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.702 -0.481 . . . . 75.129999999999995 109.702 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.14 -24.56 5.64 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.214 -0.755 . . . . 51.530000000000001 111.214 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.63 145.2 47.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.4 -0.222 . . . . 74.430000000000007 110.4 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.41 43.61 2.33 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.429 -0.35 . . . . 54.409999999999997 113.064 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -82.54 -47.61 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 75.439999999999998 110.198 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.06 162.56 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.75 . . . . 32.009999999999998 110.949 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.447 HG12 ' CE3' ' A' ' 83' ' ' TRP . 35.4 pt -80.07 159.02 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.573 -0.528 . . . . 75.420000000000002 109.573 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 55.4 mmtt -60.41 -21.14 61.88 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.418 0.155 . . . . 73.310000000000002 111.418 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -47.97 88.19 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.599 -0.81 . . . . 34.43 111.574 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CE3' HG12 ' A' ' 80' ' ' ILE . 18.1 m0 -79.76 -29.28 40.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.589 0.233 . . . . 71.340000000000003 110.401 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 6.6 t70 -58.0 -55.05 39.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.616 0.722 . . . . 72.430000000000007 109.792 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -67.68 -35.86 79.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.496 -0.774 . . . . 73.310000000000002 109.861 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.9 -49.35 58.99 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.766 -0.652 . . . . 70.400000000000006 112.434 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 12.2 p -75.24 -32.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 62.310000000000002 110.274 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -30.08 71.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.33 -0.396 . . . . 72.340000000000003 112.015 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -90.4 -14.86 32.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.116 0.413 . . . . 72.319999999999993 112.116 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.888 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.8 ptp -93.92 -179.77 5.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.691 0.281 . . . . 71.329999999999998 110.879 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.424 HG21 ' HA2' ' A' ' 36' ' ' GLY . 16.7 p -138.83 178.95 6.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.197 -0.456 . . . . 75.530000000000001 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -58.81 124.5 20.01 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.886 0.474 . . . . 74.120000000000005 110.694 -176.24 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.68 37.63 57.57 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.398 176.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.629 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.9 tt0 -124.2 126.62 46.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 71.340000000000003 110.975 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 24.5 ttmm -114.9 115.06 26.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.803 -0.635 . . . . 74.540000000000006 109.549 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -113.52 145.42 41.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 110.638 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 28' ' ' LYS . 9.4 tt -90.63 105.4 17.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.04 -1.096 . . . . 62.350000000000001 108.04 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -112.13 126.39 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.337 -0.392 . . . . 65.010000000000005 110.423 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 26' ' ' LEU . 7.9 m -85.12 118.16 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.446 -0.343 . . . . 71.140000000000001 110.639 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.8 mm -99.05 108.57 50.19 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 110.387 -0.227 . . . . 60.109999999999999 110.387 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.99 140.94 39.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.097 2.531 . . . . 51.240000000000002 111.275 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.97 -29.56 57.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.454 -0.339 . . . . 74.230000000000004 111.836 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.2 -30.07 70.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.514 . . . . 73.140000000000001 111.644 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.88 9.06 43.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 72.140000000000001 111.777 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.26 178.95 8.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.145 0.498 . . . . 75.530000000000001 111.658 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -73.61 -2.47 23.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.495 -0.775 . . . . 72.409999999999997 111.332 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.31 -14.25 56.35 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.189 -0.459 . . . . 75.140000000000001 112.085 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 8.4 tm-20 -66.77 -49.42 65.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.413 -0.588 . . . . 70.209999999999994 109.413 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 117' ' ' PRO . 40.4 ttm180 -67.86 -52.08 40.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 72.200000000000003 110.695 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.61 172.29 3.84 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.101 -0.571 . . . . 74.310000000000002 111.952 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 88.5 m-85 -147.17 -63.64 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.782 0.291 . . . . 75.400000000000006 111.298 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 2.3 Cg_endo -84.23 141.36 9.14 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.213 1.942 . . . . 74.049999999999997 111.988 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.63 -21.93 57.89 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.692 2.261 . . . . 75.519999999999996 111.747 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.77 -35.34 63.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.772 -0.649 . . . . 74.310000000000002 110.115 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.02 92.95 46.66 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 64.329999999999998 109.218 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -52.02 147.24 27.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.038 2.492 . . . . 73.409999999999997 112.673 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 21.1 Cg_endo -59.83 153.43 56.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.727 2.285 . . . . 61.409999999999997 111.435 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 19.4 mtmm 59.1 53.11 5.69 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.393 0.616 . . . . 73.319999999999993 110.431 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.53 132.38 54.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.325 -0.852 . . . . 74.120000000000005 111.123 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.6 m -83.05 130.48 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.38 -0.6 . . . . 71.230000000000004 109.38 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -123.06 143.39 49.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.672 -0.492 . . . . 73.030000000000001 109.672 -173.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.576 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.2 t -100.53 116.13 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 74.230000000000004 109.832 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -109.06 116.58 32.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.096 -0.335 . . . . 52.100000000000001 110.096 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.8 mt-10 -78.58 106.86 10.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.181 -1.044 . . . . 64.310000000000002 108.181 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 13.4 m -97.59 149.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.047 -0.979 . . . . 41.0 110.112 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 63.8 tt0 -147.22 131.6 17.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.76 -0.2 . . . . 75.209999999999994 110.795 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.888 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 3.2 tm? -103.08 112.97 26.07 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.865 -0.42 . . . . 72.310000000000002 109.865 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -90.86 -41.48 11.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 110.324 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.43 139.1 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 55.219999999999999 109.932 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 119.37 -0.348 . . . . 71.349999999999994 110.401 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 62.340000000000003 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 5.9 tt -145.7 102.39 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.509 -0.552 . . . . 71.530000000000001 109.509 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.73 149.82 42.71 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.981 -0.554 . . . . 65.329999999999998 110.185 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 18.4 ptpt -127.98 103.7 7.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.637 -0.71 . . . . 71.0 109.448 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.64 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 66.8 mttm -109.1 110.39 21.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.825 -0.435 . . . . 73.319999999999993 109.825 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 30' ' ' VAL . 5.8 p -71.87 97.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.486 0.66 . . . . 70.430000000000007 110.134 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.721 HD23 ' HD3' ' A' ' 95' ' ' LYS . 33.9 tp -76.94 -29.2 55.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 109.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 32.1 m -145.51 115.82 4.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 74.030000000000001 109.74 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.3 128.74 13.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.065 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.69 -159.81 22.05 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.177 -0.535 . . . . 71.120000000000005 112.44 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.46 -37.44 87.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.088 0.471 . . . . 72.409999999999997 110.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.21 -29.84 3.81 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.952 -0.567 . . . . 51.130000000000003 112.134 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.26 -34.12 7.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.737 0.303 . . . . 73.239999999999995 110.711 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 p -71.77 94.07 1.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.295 0.569 . . . . 54.219999999999999 110.983 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -88.06 125.91 62.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.494 -0.775 . . . . 63.140000000000001 110.452 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG3' ' O ' ' A' ' 90' ' ' MET . 86.3 Cg_endo -78.07 176.4 10.02 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.62 2.213 . . . . 71.040000000000006 111.547 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.97 167.25 14.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 109.905 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 156.24 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.345 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.71 73.64 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.15 -0.548 . . . . 65.140000000000001 112.562 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 4.3 mmmp? -116.19 130.02 56.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.683 0.278 . . . . 74.430000000000007 110.738 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.83 104.01 3.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.68 -0.859 . . . . 61.229999999999997 108.68 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 34.1 m -105.86 142.54 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.157 0.503 . . . . 64.049999999999997 110.951 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.8 m -99.27 120.32 39.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.112 -0.949 . . . . 54.210000000000001 109.27 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 87' ' ' VAL . 32.6 m -136.68 177.97 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.569 0.699 . . . . 41.030000000000001 112.454 -172.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 7.3 m170 -137.59 152.62 49.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.504 -1.226 . . . . 71.409999999999997 109.098 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -128.0 142.85 51.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 71.340000000000003 109.534 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.782 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 24.0 m-20 -135.4 119.73 17.87 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.017 -0.734 . . . . 72.430000000000007 109.017 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -82.68 114.32 3.82 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.214 -0.448 . . . . 64.230000000000004 112.295 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.522 HH11 HD12 ' A' ' 97' ' ' LEU . 42.1 ttm180 -130.8 148.5 52.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.428 0.633 . . . . 71.310000000000002 111.364 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -90.12 156.37 46.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.224 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.38 2.3 1.26 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.946 2.43 . . . . 74.209999999999994 112.861 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.76 -29.9 25.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.236 0.541 . . . . 72.299999999999997 110.517 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.85 -25.47 8.43 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.706 -0.679 . . . . 52.539999999999999 111.882 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -84.61 157.32 21.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.825 -0.435 . . . . 64.140000000000001 109.825 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 13.9 pt20 -141.84 -175.28 4.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.715 0.293 . . . . 72.329999999999998 110.905 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -86.06 -64.86 1.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 73.530000000000001 110.108 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -144.91 156.66 44.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.009 -0.367 . . . . 72.129999999999995 110.009 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.3 p -87.26 91.53 8.75 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.359 -0.608 . . . . 73.409999999999997 109.359 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.425 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 31.4 m -64.33 -27.39 68.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.829 -0.623 . . . . 61.149999999999999 111.155 -174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.24 69.4 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.434 -0.348 . . . . 74.420000000000002 110.424 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -73.8 -6.23 45.75 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.001 -0.545 . . . . 52.329999999999998 111.593 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 25.3 mmm180 -75.69 -2.82 31.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.084 0.468 . . . . 75.439999999999998 110.759 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.25 8.57 65.88 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 63.329999999999998 113.953 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HD2' ' HD2' ' A' ' 69' ' ' PRO . 52.5 tptt -122.89 121.58 27.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 117.051 0.426 . . . . 75.340000000000003 109.971 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.598 ' HD2' ' HD2' ' A' ' 68' ' ' LYS . 68.1 Cg_endo -85.27 160.06 11.27 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.658 2.239 . . . . 73.209999999999994 112.276 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -114.33 158.14 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.127 -0.694 . . . . 71.230000000000004 109.127 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 85.7 mt-30 -134.77 139.48 45.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.574 0.226 . . . . 75.030000000000001 110.825 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.536 ' HE1' HG21 ' A' ' 48' ' ' VAL . 33.5 p90 -156.16 151.88 27.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.508 -0.553 . . . . 73.400000000000006 109.508 173.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.5 m -73.66 109.03 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 75.200000000000003 110.905 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 88' ' ' ALA . 57.2 tp -60.8 135.31 57.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.057 -0.519 . . . . 75.129999999999995 110.209 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.83 -11.52 71.91 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.119 -0.562 . . . . 51.530000000000001 112.135 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.13 160.95 14.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.202 -0.296 . . . . 74.430000000000007 110.202 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.65 2.62 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 121.2 -0.524 . . . . 54.409999999999997 112.756 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -85.75 -25.46 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 75.439999999999998 110.304 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.48 168.21 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.76 -0.655 . . . . 32.009999999999998 109.722 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.4 pt -72.91 154.7 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.997 -0.372 . . . . 75.420000000000002 109.997 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 4.5 tmtm? -60.09 -28.42 67.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.475 -0.33 . . . . 73.310000000000002 110.756 -172.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.88 -54.55 36.55 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.923 -0.656 . . . . 34.43 112.003 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.452 ' O ' HG12 ' A' ' 87' ' ' VAL . 48.2 m0 -66.48 -41.25 89.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.025 -0.361 . . . . 71.340000000000003 110.025 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.11 -50.95 60.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.474 -0.785 . . . . 72.430000000000007 110.886 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -66.54 -46.34 76.46 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.347 -0.388 . . . . 73.310000000000002 110.307 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.38 -48.39 54.48 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.606 -0.724 . . . . 70.400000000000006 112.834 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 48' ' ' VAL . 12.3 p -75.55 -33.2 26.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 62.310000000000002 111.139 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -68.23 -25.95 65.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.706 0.261 . . . . 72.340000000000003 111.706 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 86' ' ' GLY . 11.7 t -89.54 17.58 6.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 72.319999999999993 112.89 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 12.3 ptp -125.37 178.15 5.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.901 -0.499 . . . . 71.329999999999998 111.412 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -116.65 177.31 4.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.294 -0.412 . . . . 75.530000000000001 110.477 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.833 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -69.45 129.71 40.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.091 -0.337 . . . . 74.120000000000005 110.091 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.419 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 88.82 6.11 73.04 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.326 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' THR . 19.6 tt0 -100.18 133.76 44.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.340000000000003 111.022 -175.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.721 ' HD3' HD23 ' A' ' 31' ' ' LEU . 50.0 tttm -117.67 117.52 29.58 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -122.65 137.72 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.216 0.531 . . . . 55.240000000000002 111.275 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 7.8 tt -90.78 106.29 18.41 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.972 -1.121 . . . . 62.350000000000001 107.972 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -115.25 124.82 52.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.113 -0.329 . . . . 65.010000000000005 110.113 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.516 HG23 HG22 ' A' ' 122' ' ' VAL . 4.3 m -80.36 111.75 17.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 71.140000000000001 110.546 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 105' ' ' ALA . 32.6 mm -93.58 113.22 59.71 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.618 -0.264 . . . . 60.109999999999999 110.449 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HA ' HG23 ' A' ' 120' ' ' THR . 43.8 Cg_endo -67.31 151.63 80.41 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.758 2.305 . . . . 51.240000000000002 111.783 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -55.99 -31.79 63.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 111.972 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.559 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 13.6 pt20 -65.52 -27.62 68.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.409 . . . . 73.140000000000001 110.954 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.559 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 91.9 mt -109.07 22.86 15.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 72.140000000000001 110.096 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 100' ' ' ILE . . . -149.18 176.61 10.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.887 -0.597 . . . . 75.530000000000001 111.406 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -76.65 -11.77 59.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.409999999999997 110.282 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.69 31.32 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.835 -0.62 . . . . 75.140000000000001 113.377 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.57 -49.32 76.77 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.408 -0.59 . . . . 70.209999999999994 109.408 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -91.92 -26.22 18.54 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.548 -0.751 . . . . 72.200000000000003 110.55 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 82.0 -66.25 3.9 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.745 -0.662 . . . . 74.310000000000002 111.584 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 50.5 m-85 94.56 -74.36 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.324 1.45 . . . . 75.400000000000006 111.567 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 110' ' ' GLY . 95.4 Cg_endo -81.15 139.2 11.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 CA-C-N 121.332 1.512 . . . . 74.049999999999997 110.84 174.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.11 -11.36 15.43 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.79 2.327 . . . . 75.519999999999996 112.457 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.72 -31.79 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.138 0.494 . . . . 74.310000000000002 110.026 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.9 mm -100.76 120.71 54.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.687 -0.688 . . . . 64.329999999999998 109.711 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 58.3 Cg_endo -70.97 151.09 61.89 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.354 2.036 . . . . 73.409999999999997 112.173 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 39.0 Cg_endo -66.43 141.0 59.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.294 1.996 . . . . 61.409999999999997 111.739 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 8.6 mtmp? 71.49 26.51 3.21 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.006 -0.543 . . . . 73.319999999999993 111.126 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -84.77 142.53 29.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 74.120000000000005 111.365 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 101' ' ' PRO . 91.7 m -95.21 137.34 34.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.695 -0.684 . . . . 71.230000000000004 109.419 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -128.57 139.98 52.02 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.78 -0.452 . . . . 73.030000000000001 109.78 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 121' ' ' LEU . 99.3 t -98.54 122.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.715 0.293 . . . . 74.230000000000004 110.32 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -113.6 120.09 39.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.836 0.35 . . . . 52.100000000000001 110.194 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 22.2 mt-10 -81.49 110.99 17.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.641 -0.874 . . . . 64.310000000000002 108.641 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.547 HG23 ' HE1' ' A' ' 90' ' ' MET . 4.0 m -99.84 139.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.739 -0.664 . . . . 41.0 109.483 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.4 tt0 -131.79 119.02 20.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.506 -0.316 . . . . 75.209999999999994 110.31 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.833 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -87.76 113.78 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 72.310000000000002 109.688 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.402 HD21 ' ND1' ' A' ' 49' ' ' HIS . 3.7 mm? -91.73 -43.09 9.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.364 -0.38 . . . . 73.209999999999994 110.693 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.47 142.13 24.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.542 -0.299 . . . . 55.219999999999999 110.886 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.602 -0.713 . . . . 71.349999999999994 110.411 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.597 0.237 . . . . 62.340000000000003 110.506 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.0 tp -106.23 101.84 11.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.974 -0.75 . . . . 71.530000000000001 108.974 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -147.67 106.11 3.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.802 -0.636 . . . . 65.329999999999998 110.388 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -136.97 144.91 43.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.932 0.396 . . . . 71.0 110.065 175.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -140.3 113.17 8.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 73.319999999999993 109.543 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.67 128.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.783 0.325 . . . . 70.430000000000007 110.661 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 97' ' ' LEU . 2.7 mm? -91.99 -42.78 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.268 0.556 . . . . 73.129999999999995 109.751 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 110.9 6.92 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.683 -0.689 . . . . 74.030000000000001 110.565 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.62 137.96 44.02 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.583 2.189 . . . . 71.120000000000005 111.698 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.26 -143.68 10.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.082 -0.58 . . . . 71.120000000000005 112.43 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.8 -37.42 81.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 72.409999999999997 110.535 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.84 -30.51 1.29 Allowed Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.704 -0.68 . . . . 51.130000000000003 113.751 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.85 -9.86 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 73.239999999999995 111.015 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -87.25 115.84 24.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.824 -0.626 . . . . 54.219999999999999 110.791 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 9.1 mtpm? -92.43 114.44 62.37 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 110.317 -0.253 . . . . 63.140000000000001 110.317 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.21 108.18 1.92 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.754 2.303 . . . . 71.040000000000006 112.183 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.26 120.96 34.13 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.036 -0.529 . . . . 75.109999999999999 109.692 173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.36 154.18 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 74.420000000000002 111.021 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.37 -28.08 8.93 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.043 -0.526 . . . . 65.140000000000001 112.023 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -86.04 159.21 19.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.159 0.504 . . . . 74.430000000000007 111.264 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -77.89 112.24 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.479 -0.782 . . . . 61.229999999999997 109.101 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.46 152.52 8.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.059 0.456 . . . . 64.049999999999997 111.384 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.2 m -106.5 110.83 23.16 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.072 -0.967 . . . . 54.210000000000001 110.014 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.437 HG21 ' HE1' ' A' ' 72' ' ' PHE . 25.7 m -119.3 178.28 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.336 -0.847 . . . . 41.030000000000001 111.181 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 22.8 t-80 -157.09 142.47 17.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.732 -0.84 . . . . 71.409999999999997 108.732 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.2 m-85 -126.95 153.18 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 71.340000000000003 110.165 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 16.8 t70 -136.67 109.49 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.539 -0.541 . . . . 72.430000000000007 109.539 174.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.8 147.27 32.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.356 -0.45 . . . . 64.230000000000004 113.587 -172.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 121' ' ' LEU . 25.8 ttm180 -162.14 144.56 11.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.315 0.578 . . . . 71.310000000000002 111.131 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.29 147.74 54.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 109.834 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.77 -17.92 61.73 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.373 2.049 . . . . 74.209999999999994 111.533 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.9 -25.74 62.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.566 -0.743 . . . . 72.299999999999997 110.461 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.58 -39.94 1.89 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.959 -0.564 . . . . 52.539999999999999 111.861 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -56.71 148.44 20.24 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.975 0.51 . . . . 64.140000000000001 111.493 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.41 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 19.8 pt20 -130.66 141.53 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.245 -0.65 . . . . 72.329999999999998 109.245 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -80.12 -38.42 31.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.812 0.301 . . . . 73.530000000000001 111.812 -173.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -152.92 133.64 13.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.318 -0.253 . . . . 72.129999999999995 110.318 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 t -81.07 91.14 6.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 73.409999999999997 109.436 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.9 m -67.6 -17.1 64.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.676 -0.693 . . . . 61.149999999999999 110.861 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -31.31 62.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.004 -0.544 . . . . 74.420000000000002 110.984 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 t -63.84 -46.22 86.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.769 0.318 . . . . 52.329999999999998 110.616 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 66' ' ' ARG . 5.8 ptt180 -75.87 -12.41 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.533 -0.303 . . . . 75.439999999999998 111.411 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.6 36.53 48.27 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.125 -0.488 . . . . 63.329999999999998 113.823 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.1 tppt? -92.21 113.43 59.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.163 -0.31 . . . . 75.340000000000003 110.163 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.4 Cg_endo -81.91 150.66 16.24 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.245 2.63 . . . . 73.209999999999994 111.894 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -114.28 160.61 18.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.92 -0.77 . . . . 71.230000000000004 108.92 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -140.62 146.85 38.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.093 -0.336 . . . . 75.030000000000001 110.093 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HE1' HG21 ' A' ' 48' ' ' VAL . 39.8 p90 -166.98 161.59 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 73.400000000000006 110.289 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 m -74.92 112.78 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.514 -0.312 . . . . 75.200000000000003 110.206 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 88' ' ' ALA . 47.2 tp -67.81 136.5 54.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.574 -0.285 . . . . 75.129999999999995 110.78 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 40.1 32.66 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.303 -0.475 . . . . 51.530000000000001 111.931 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.68 178.34 8.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.39 0.276 . . . . 74.430000000000007 110.31 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.34 46.19 3.59 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.036 -0.602 . . . . 54.409999999999997 112.173 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 9.3 mm-40 -85.04 -47.8 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 75.439999999999998 111.051 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.85 178.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.674 . . . . 32.009999999999998 109.67 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.97 142.92 15.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.172 0.511 . . . . 75.420000000000002 111.035 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -58.14 -30.61 66.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 73.310000000000002 111.862 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.02 -51.04 59.74 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.884 -0.674 . . . . 34.43 111.616 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -69.14 -47.67 64.45 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.792 -0.204 . . . . 71.340000000000003 110.636 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.27 -54.92 33.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.033 0.444 . . . . 72.430000000000007 111.149 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -72.07 -38.3 69.47 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.1 -0.5 . . . . 73.310000000000002 110.501 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.536 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.42 -50.11 57.94 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.935 -0.575 . . . . 70.400000000000006 112.215 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.641 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.1 p -75.72 -31.12 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 62.310000000000002 110.977 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -62.43 -33.49 74.91 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.741 0.305 . . . . 72.340000000000003 111.746 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 86' ' ' GLY . 11.0 t -79.5 7.41 8.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.461 0.541 . . . . 72.319999999999993 112.461 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 7.7 ptm -116.32 -176.51 2.97 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.196 -0.315 . . . . 71.329999999999998 110.456 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.9 p -118.21 178.81 4.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.775 0.321 . . . . 75.530000000000001 111.637 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.847 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.3 tt -68.69 135.16 50.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.863 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.433 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 71.96 23.68 77.64 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.633 -0.712 . . . . 72.25 112.299 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -112.46 148.54 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.859 0.361 . . . . 71.340000000000003 111.271 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -130.09 124.68 33.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.638 -0.71 . . . . 74.540000000000006 110.323 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.21 141.29 39.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 55.240000000000002 110.414 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.579 ' HB2' HD21 ' A' ' 31' ' ' LEU . 9.1 tt -92.19 123.95 35.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.119 -0.697 . . . . 62.350000000000001 109.119 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -130.21 134.51 47.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.918 0.389 . . . . 65.010000000000005 110.656 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 51.8 m -83.51 112.68 20.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.004 -0.544 . . . . 71.140000000000001 109.923 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.2 mm -84.84 110.93 31.6 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 116.382 -0.372 . . . . 60.109999999999999 110.607 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 120' ' ' THR . 24.4 Cg_exo -64.22 142.91 81.98 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.117 2.545 . . . . 51.240000000000002 111.565 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.596 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 51.3 p90 -54.39 -39.36 67.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.799 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -70.2 -13.78 62.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.376 -0.375 . . . . 73.140000000000001 111.829 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.93 16.55 24.16 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.997 0.427 . . . . 72.140000000000001 110.153 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.05 178.65 9.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.654 -0.703 . . . . 75.530000000000001 111.141 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -60.06 -25.09 65.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 72.409999999999997 110.705 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.73 -19.9 30.15 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.634 -0.712 . . . . 75.140000000000001 113.301 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.596 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 43.2 tt0 -56.16 -47.55 78.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 70.209999999999994 110.169 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -107.6 -15.33 14.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.4 -0.818 . . . . 72.200000000000003 110.907 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.75 -171.78 6.92 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 116.072 -0.513 . . . . 74.310000000000002 112.63 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.765 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 63.7 m-85 -147.53 -61.39 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.614 0.207 . . . . 75.400000000000006 110.677 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 50.9 Cg_endo -93.17 152.02 2.56 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.247 1.964 . . . . 74.049999999999997 112.037 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.63 -19.73 38.79 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.535 2.157 . . . . 75.519999999999996 111.765 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.98 -35.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.929 -0.578 . . . . 74.310000000000002 110.355 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.3 mm -121.25 80.75 36.72 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 108.538 -0.912 . . . . 64.329999999999998 108.538 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.22 169.32 22.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.88 2.387 . . . . 73.409999999999997 112.319 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 71.5 Cg_exo -50.14 148.98 12.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 61.409999999999997 112.228 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.3 mtmt 72.19 17.46 4.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.738 0.649 . . . . 73.319999999999993 111.312 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.06 104.42 8.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 111.43 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 101' ' ' PRO . 99.8 m -83.71 134.47 34.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.205 -0.665 . . . . 71.230000000000004 109.205 171.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -136.96 147.02 46.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.962 -0.385 . . . . 73.030000000000001 109.962 -170.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.542 ' N ' HD13 ' A' ' 121' ' ' LEU . 60.7 t -98.39 137.33 26.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 110.28 -175.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.44 129.38 31.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.54 -0.3 . . . . 52.100000000000001 110.411 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 59.3 mt-10 -75.15 118.57 18.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.756 -0.831 . . . . 64.310000000000002 108.756 167.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.59 136.8 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.834 -0.802 . . . . 41.0 108.834 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 47.8 tt0 -138.59 114.97 10.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.124 -0.489 . . . . 75.209999999999994 109.73 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.6 tm? -97.42 111.84 23.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.252 -0.648 . . . . 72.310000000000002 109.252 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.5 mm? -89.0 -41.26 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.47 -0.332 . . . . 73.209999999999994 110.647 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.77 145.87 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.572 -0.285 . . . . 55.219999999999999 111.038 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.25 1.105 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.059 178.563 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 110.043 -0.355 . . . . 62.340000000000003 110.043 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.88 121.65 35.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.172 -0.677 . . . . 71.530000000000001 109.172 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.724 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 40.3 mt-10 -129.71 108.17 9.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 65.329999999999998 110.344 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 21.1 pttp -109.41 101.53 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.353 -0.61 . . . . 71.0 109.353 173.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.724 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 87.0 mttt -118.91 110.4 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.318 . . . . 73.319999999999993 110.415 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.73 119.21 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.051 -0.351 . . . . 70.430000000000007 110.051 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD23 ' HD3' ' A' ' 95' ' ' LYS . 32.7 tp -94.86 -30.99 13.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.267 0.556 . . . . 73.129999999999995 109.977 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 57.3 m -147.14 110.85 4.03 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.494 -0.775 . . . . 74.030000000000001 109.44 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 22.5 Cg_exo -65.48 146.35 84.86 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.037 2.492 . . . . 71.120000000000005 112.64 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.36 -158.67 31.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 71.120000000000005 111.987 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 37' ' ' VAL . 25.0 m-20 -71.27 -56.78 5.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.283 0.563 . . . . 72.409999999999997 110.582 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 -30.23 3.78 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.403 -0.817 . . . . 51.130000000000003 111.889 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 35' ' ' ASP . 30.3 m -78.54 -32.33 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.166 0.508 . . . . 73.239999999999995 110.245 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.547 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 6.0 p -71.15 105.93 3.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.341 -0.614 . . . . 54.219999999999999 109.341 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -91.63 109.31 35.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.812 -0.631 . . . . 63.140000000000001 110.928 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 38' ' ' THR . 60.9 Cg_endo -95.85 174.06 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.508 2.805 . . . . 71.040000000000006 111.411 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.74 163.0 40.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 110.812 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.27 166.12 23.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.726 -0.67 . . . . 74.420000000000002 111.609 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.04 86.33 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.969 -0.56 . . . . 65.140000000000001 112.443 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -119.2 155.76 31.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.607 0.241 . . . . 74.430000000000007 110.476 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -81.01 113.41 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.322 -0.622 . . . . 61.229999999999997 109.322 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HB ' HD21 ' A' ' 127' ' ' LEU . 33.9 m -106.61 145.89 13.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.908 0.385 . . . . 64.049999999999997 111.423 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.5 m -98.86 108.47 21.16 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.175 -0.921 . . . . 54.210000000000001 110.117 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -115.44 178.5 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 124.355 1.034 . . . . 41.030000000000001 111.575 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 11.0 t-160 -152.98 136.55 15.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.989 -1.115 . . . . 71.409999999999997 107.989 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -126.85 151.7 48.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.807 0.299 . . . . 71.340000000000003 111.807 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.706 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 33.5 t70 -138.85 118.54 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.998 -0.547 . . . . 72.430000000000007 110.095 169.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.16 138.93 17.12 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.371 -0.442 . . . . 64.230000000000004 112.624 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.634 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 28.1 ttm180 -157.51 149.26 22.13 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.341 0.591 . . . . 71.310000000000002 111.751 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -87.58 153.83 53.21 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.713 -0.676 . . . . 75.120000000000005 109.332 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.64 -20.13 56.43 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.708 2.272 . . . . 74.209999999999994 113.412 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.58 3.54 52.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.558 0.218 . . . . 72.299999999999997 111.26 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.07 -31.73 8.31 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.336 -0.459 . . . . 52.539999999999999 112.143 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.45 145.5 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.908 -0.405 . . . . 64.140000000000001 109.908 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.634 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 20.2 pt20 -151.64 147.59 26.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.516 176.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -62.23 -38.4 89.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 73.530000000000001 111.307 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.4 156.56 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.265 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 22.9 t -87.41 86.79 7.27 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.706 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 14.7 m -60.07 -30.11 68.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 61.149999999999999 110.453 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.564 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 34.8 ptt180 -71.32 -44.46 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 74.420000000000002 110.972 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -4.47 34.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.622 0.248 . . . . 52.329999999999998 111.142 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 62' ' ' SER . 27.2 mmt180 -76.63 -12.71 60.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.575 -0.284 . . . . 75.439999999999998 110.869 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.08 77.4 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.959 -0.639 . . . . 63.329999999999998 112.282 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.74 104.39 55.31 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-O 120.562 0.22 . . . . 75.340000000000003 110.783 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.86 166.35 19.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.004 2.469 . . . . 73.209999999999994 110.985 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.74 131.92 21.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.792 -0.447 . . . . 71.230000000000004 109.792 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 97.4 mt-30 -113.15 131.95 55.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.558 0.218 . . . . 75.030000000000001 110.501 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.574 ' HZ ' HG11 ' A' ' 87' ' ' VAL . 24.5 p90 -154.37 161.13 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.462 -0.335 . . . . 73.400000000000006 110.484 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 m -77.32 115.95 17.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.447 . . . . 75.200000000000003 110.752 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 127.91 33.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.036 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.93 43.68 7.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.161 -0.542 . . . . 51.530000000000001 112.075 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.69 173.78 14.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.821 0.343 . . . . 74.430000000000007 111.018 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.61 27.64 3.28 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.157 -0.474 . . . . 54.409999999999997 112.678 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 5.6 mm-40 -65.01 -43.78 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.227 0.537 . . . . 75.439999999999998 110.279 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.71 178.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.505 -0.77 . . . . 32.009999999999998 110.195 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.482 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.1 pt -62.49 143.59 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 110.01 -0.367 . . . . 75.420000000000002 110.01 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -58.23 -23.97 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.463 -0.335 . . . . 73.310000000000002 110.823 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.73 -50.45 67.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.948 -0.644 . . . . 34.43 111.835 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.482 ' H ' HG13 ' A' ' 80' ' ' ILE . 53.2 m0 -69.05 -42.09 76.75 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.153 -0.314 . . . . 71.340000000000003 110.153 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -54.05 -49.94 67.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.721 -0.672 . . . . 72.430000000000007 110.64 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.42 -41.24 80.67 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 110.501 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.34 -48.65 53.7 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.425 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.574 HG11 ' HZ ' ' A' ' 72' ' ' PHE . 7.1 p -75.68 -36.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 62.310000000000002 110.993 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.36 70.47 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.945 0.35 . . . . 72.340000000000003 111.945 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.3 t -84.56 -20.39 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.116 0.413 . . . . 72.319999999999993 112.116 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 18.0 ptp -88.82 -174.47 4.52 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 71.329999999999998 111.35 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 p -119.42 178.78 4.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.679 -0.692 . . . . 75.530000000000001 110.285 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.859 ' HA ' HD12 ' A' ' 127' ' ' LEU . 9.2 tt -72.0 132.94 44.97 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.986 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.93 34.87 46.53 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.383 -0.826 . . . . 72.25 112.252 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -125.95 138.18 53.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.965 0.412 . . . . 71.340000000000003 111.627 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.589 ' HD3' HD23 ' A' ' 31' ' ' LEU . 19.2 ttmm -107.6 113.8 27.35 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.446 -0.797 . . . . 74.540000000000006 109.745 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.46 132.59 56.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.42 . . . . 55.240000000000002 110.656 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.53 108.4 19.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.873 -1.158 . . . . 62.350000000000001 107.873 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CD1' HD13 ' A' ' 100' ' ' ILE . 12.3 t80 -116.77 123.53 47.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.151 -0.477 . . . . 65.010000000000005 109.956 -174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.9 m -81.17 106.33 13.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.526 -0.546 . . . . 71.140000000000001 109.526 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.439 HD13 ' CD1' ' A' ' 98' ' ' PHE . 47.5 mm -78.25 115.08 48.11 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 115.815 -0.63 . . . . 60.109999999999999 110.777 -175.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' A' ' 104' ' ' LEU . 22.0 Cg_exo -64.94 141.3 70.21 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.876 2.384 . . . . 51.240000000000002 110.916 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -58.12 -25.65 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.708 0.633 . . . . 74.230000000000004 112.708 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -75.26 -13.68 60.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.794 0.33 . . . . 73.140000000000001 111.405 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.471 HD12 ' HD2' ' A' ' 101' ' ' PRO . 88.1 mt -102.05 16.94 24.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.776 0.322 . . . . 72.140000000000001 110.382 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -159.79 -174.47 4.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.85 -0.614 . . . . 75.530000000000001 110.516 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -76.0 -5.42 46.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 72.409999999999997 110.358 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.49 -21.98 58.32 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.783 -0.644 . . . . 75.140000000000001 113.407 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 7.4 pt-20 -62.23 -42.61 99.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.902 0.382 . . . . 70.209999999999994 110.782 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 12.5 ttm180 -92.29 -42.51 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 72.200000000000003 110.399 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.94 141.4 4.14 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.817 -0.629 . . . . 74.310000000000002 111.629 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 49.2 m-85 -137.21 -58.16 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.691 0.246 . . . . 75.400000000000006 110.901 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 8.4 Cg_exo -72.98 147.75 43.99 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.974 1.783 . . . . 74.049999999999997 111.185 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.75 -19.2 60.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 75.519999999999996 112.183 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.601 HG23 HG12 ' A' ' 115' ' ' ILE . 35.1 m -86.31 -17.87 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 74.310000000000002 111.106 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.612 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.2 mm -114.27 102.06 54.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.851 0.357 . . . . 64.329999999999998 110.365 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.57 170.62 19.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.665 2.243 . . . . 73.409999999999997 112.056 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.2 144.92 96.25 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.559 2.173 . . . . 61.409999999999997 111.725 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 61.41 26.9 16.6 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.717 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.45 103.12 7.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 74.120000000000005 111.494 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -73.52 122.62 22.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -124.58 144.52 50.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.012 -0.366 . . . . 73.030000000000001 110.012 -167.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 121' ' ' LEU . 85.5 t -98.42 133.1 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.732 0.301 . . . . 74.230000000000004 110.439 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 121' ' ' LEU . 75.8 m-85 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 52.100000000000001 110.531 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 64.4 mt-10 -74.94 106.51 6.48 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.898 -1.149 . . . . 64.310000000000002 107.898 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.23 129.18 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.056 -0.72 . . . . 41.0 109.056 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.4 tt0 -134.77 120.75 19.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.528 -0.305 . . . . 75.209999999999994 110.412 -170.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 92' ' ' LEU . 3.3 tm? -97.21 110.21 22.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.368 -0.604 . . . . 72.310000000000002 109.368 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.7 mm? -86.97 -50.54 6.6 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.46 -0.337 . . . . 73.209999999999994 110.641 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.5 -177.03 6.3 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.635 -0.426 . . . . 55.219999999999999 112.133 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.38 -0.827 . . . . 71.349999999999994 109.425 176.684 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.081 -0.711 . . . . 62.340000000000003 109.081 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.24 111.8 5.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.207 -0.294 . . . . 71.530000000000001 110.207 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.03 108.29 9.98 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.059 -0.349 . . . . 65.329999999999998 110.059 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -114.36 103.87 11.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.083 -0.71 . . . . 71.0 109.083 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.71 110.5 21.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 73.319999999999993 110.028 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 111.69 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 70.430000000000007 110.769 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.86 -42.43 24.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.329 -0.989 . . . . 73.129999999999995 108.329 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -149.83 119.93 3.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.222 -0.899 . . . . 74.030000000000001 109.258 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.45 138.31 24.3 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.631 2.221 . . . . 71.120000000000005 112.259 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -89.7 -167.74 42.67 Favored Glycine 0 C--O 1.236 0.244 0 CA-C-N 116.088 -0.505 . . . . 71.120000000000005 112.625 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.64 ' HB3' HG22 ' A' ' 37' ' ' VAL . 72.4 m-20 -56.34 -44.55 80.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.99 0.424 . . . . 72.409999999999997 111.387 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 80.41 -30.65 2.45 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.919 -0.582 . . . . 51.130000000000003 112.093 -175.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' A' ' 35' ' ' ASP . 35.6 m -76.81 -25.52 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.958 0.408 . . . . 73.239999999999995 109.996 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 19.5 p -97.86 89.68 4.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 54.219999999999999 109.748 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HA ' HG22 ' A' ' 91' ' ' THR . 58.8 mttp -95.91 149.56 36.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 115.748 -0.66 . . . . 63.140000000000001 111.106 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.88 154.49 23.01 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.715 2.277 . . . . 71.040000000000006 111.594 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -133.59 130.06 37.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.109999999999999 110.065 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.56 122.74 17.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.493 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.62 -4.66 32.71 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.356 -0.449 . . . . 65.140000000000001 112.044 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -109.56 165.92 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 74.430000000000007 110.796 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.7 tppp? -67.45 149.09 50.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 61.229999999999997 111.179 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 130' ' ' VAL . 16.9 m -140.14 141.89 32.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.903 -0.59 . . . . 64.049999999999997 109.7 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.9 m -115.09 108.42 16.63 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.514 -0.766 . . . . 54.210000000000001 109.497 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.25 178.21 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.818 -0.628 . . . . 41.030000000000001 112.27 -170.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 8.5 t-160 -150.07 147.73 28.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.926 -1.034 . . . . 71.409999999999997 108.329 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.2 153.31 44.85 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 111.365 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 36.6 t70 -136.27 109.26 7.66 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.663 -0.866 . . . . 72.430000000000007 108.663 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.54 146.97 33.47 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.461 -0.399 . . . . 64.230000000000004 113.121 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.456 ' NH2' HH21 ' A' ' 64' ' ' ARG . 22.3 ttm180 -160.16 149.05 17.26 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.006 0.431 . . . . 71.310000000000002 111.176 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -90.54 151.03 43.68 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.319 -0.4 . . . . 75.120000000000005 110.313 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.21 -13.08 33.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.792 2.328 . . . . 74.209999999999994 111.819 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.63 -17.44 64.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.589 -0.732 . . . . 72.299999999999997 110.346 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.21 28.84 10.2 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.95 -0.568 . . . . 52.539999999999999 112.374 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -155.21 161.42 41.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.649 -0.501 . . . . 64.140000000000001 109.649 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 9.8 pt20 -142.52 155.83 45.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.684 0.278 . . . . 72.329999999999998 110.535 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.37 -18.63 25.14 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.013 -0.539 . . . . 73.530000000000001 111.467 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -137.38 145.57 43.44 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.015 -0.365 . . . . 72.129999999999995 110.015 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.4 p -102.17 85.61 2.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.422 0.63 . . . . 73.409999999999997 110.173 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.744 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 16.1 m -67.78 -20.68 65.24 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.683 -0.69 . . . . 61.149999999999999 110.317 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.456 HH21 ' NH2' ' A' ' 53' ' ' ARG . 12.8 ptp180 -62.95 -44.38 96.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.403 -0.817 . . . . 74.420000000000002 110.732 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -70.85 -16.62 62.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.242 -0.436 . . . . 52.329999999999998 111.213 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.593 ' HD3' ' HA ' ' A' ' 63' ' ' SER . 56.9 mtp180 -82.9 -28.84 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 75.439999999999998 109.882 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.52 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.407 -0.815 . . . . 63.329999999999998 114.238 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -91.1 110.21 40.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.938 0.369 . . . . 75.340000000000003 110.299 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.83 168.55 23.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.818 2.345 . . . . 73.209999999999994 112.22 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -147.4 131.24 17.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.748 -0.464 . . . . 71.230000000000004 109.748 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.583 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 90.6 mt-30 -107.69 143.92 35.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.699 -0.228 . . . . 75.030000000000001 110.539 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 39.2 p90 -163.04 170.67 17.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 73.400000000000006 110.254 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.0 m -87.42 117.86 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.43 -0.35 . . . . 75.200000000000003 110.5 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 88' ' ' ALA . 64.4 tp -63.12 138.48 58.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.025 -0.534 . . . . 75.129999999999995 110.812 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 -22.58 37.76 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 116.141 -0.481 . . . . 51.530000000000001 112.133 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.31 178.47 6.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 74.430000000000007 111.597 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.07 24.39 21.94 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.866 -0.606 . . . . 54.409999999999997 112.278 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 72' ' ' PHE . 10.5 mm-40 -61.45 -45.76 92.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.285 0.564 . . . . 75.439999999999998 110.316 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.445 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 31.2 m -127.26 163.79 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.63 -0.713 . . . . 32.009999999999998 109.756 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.7 pt -60.48 141.01 17.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.807 -0.442 . . . . 75.420000000000002 109.807 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.838 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 4.3 mptp? -58.47 -15.54 11.43 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.02 0.378 . . . . 73.310000000000002 112.02 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.1 -56.02 27.57 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.374 -0.917 . . . . 34.43 111.199 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.445 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 43.7 m0 -69.66 -38.72 77.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.002 -0.369 . . . . 71.340000000000003 110.002 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.838 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 24.4 t70 -54.87 -48.97 72.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.441 -0.8 . . . . 72.430000000000007 110.822 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 31.2 mm-40 -71.54 -34.59 70.16 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.352 -0.385 . . . . 73.310000000000002 110.111 176.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.51 -48.21 55.63 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.0 -0.545 . . . . 70.400000000000006 112.287 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.579 HG23 HD23 ' A' ' 127' ' ' LEU . 3.5 p -75.63 -36.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.775 0.321 . . . . 62.310000000000002 110.801 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -64.73 -20.61 66.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.687 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 86' ' ' GLY . 12.6 t -95.53 10.99 34.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.171 0.434 . . . . 72.319999999999993 112.171 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.767 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.2 ptp -127.72 177.3 6.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.939 0.399 . . . . 71.329999999999998 111.664 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 39' ' ' LYS . 22.9 p -130.97 178.74 6.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.712 -0.676 . . . . 75.530000000000001 110.725 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.938 ' HA ' HD12 ' A' ' 127' ' ' LEU . 3.8 tt -65.32 130.31 42.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.807 0.336 . . . . 74.120000000000005 110.314 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.524 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.7 26.8 55.68 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.687 -0.688 . . . . 72.25 112.107 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.454 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 22.2 tt0 -123.71 141.19 52.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 71.340000000000003 110.534 -176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 125' ' ' VAL . 29.2 ttpp -138.95 135.75 34.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 74.540000000000006 109.531 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.58 152.03 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.442 . . . . 55.240000000000002 111.693 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.404 ' C ' HD23 ' A' ' 97' ' ' LEU . 7.3 tt -91.18 114.07 26.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.06 -1.089 . . . . 62.350000000000001 108.06 174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.47 ' HD1' HD13 ' A' ' 100' ' ' ILE . 7.2 t80 -117.32 121.08 40.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.356 . . . . 65.010000000000005 110.579 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 m -80.92 112.88 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 71.140000000000001 109.76 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.592 HG22 ' HB2' ' A' ' 105' ' ' ALA . 23.7 mm -88.46 110.56 37.61 Favored Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.695 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.19 139.96 62.77 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.769 2.313 . . . . 51.240000000000002 111.358 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -55.95 -28.43 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.241 0.46 . . . . 74.230000000000004 112.241 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.36 -37.28 86.67 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.975 0.417 . . . . 73.140000000000001 110.66 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.2 mt -99.4 18.79 16.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.878 -0.601 . . . . 72.140000000000001 109.987 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 80' ' ' ILE . . . -136.61 171.47 14.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.671 . . . . 75.530000000000001 111.24 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.447 ' HB2' ' HE1' ' A' ' 111' ' ' TYR . 44.9 p90 -76.86 -10.08 59.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 72.409999999999997 110.191 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -25.21 64.06 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.453 -0.794 . . . . 75.140000000000001 112.911 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 2.5 tm-20 -61.35 -54.53 42.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.982 -0.747 . . . . 70.209999999999994 108.982 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -64.87 -49.27 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.036 -0.984 . . . . 72.200000000000003 111.219 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.89 75.7 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.057 -0.592 . . . . 74.310000000000002 111.732 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.728 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m-85 -59.35 -54.0 60.5 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 111.594 0.22 . . . . 75.400000000000006 111.594 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 76.9 Cg_endo -96.72 148.99 1.06 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.53 2.154 . . . . 74.049999999999997 112.101 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 47.3 Cg_exo -57.39 -20.4 39.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.602 2.201 . . . . 75.519999999999996 112.069 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.58 -28.95 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 110.423 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.93 99.0 36.94 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.146 -0.686 . . . . 64.329999999999998 109.146 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 51.3 Cg_exo -54.56 140.64 75.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.72 2.28 . . . . 73.409999999999997 112.717 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 39.5 Cg_exo -61.83 142.52 93.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.362 2.041 . . . . 61.409999999999997 111.318 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 99.7 mttt 63.48 25.8 14.6 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 73.319999999999993 111.612 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.86 135.75 33.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.948 0.404 . . . . 74.120000000000005 111.028 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.4 m -87.41 140.18 29.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 71.230000000000004 109.663 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.97 165.88 12.61 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.487 0.185 . . . . 73.030000000000001 110.619 -174.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.38 132.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.812 -0.44 . . . . 74.230000000000004 109.812 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -135.42 125.56 26.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.647 0.261 . . . . 52.100000000000001 110.43 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 30.9 tt0 -84.4 110.04 18.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.808 -1.182 . . . . 64.310000000000002 107.808 172.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.471 HG23 ' CE ' ' A' ' 90' ' ' MET . 15.3 m -99.64 141.4 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.546 -0.752 . . . . 41.0 110.907 -175.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 46.1 tt0 -131.29 125.65 33.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 75.209999999999994 110.26 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.938 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -99.94 107.96 20.07 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.798 -0.445 . . . . 72.310000000000002 109.798 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.2 mm? -85.75 -43.01 13.71 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.292 -0.413 . . . . 73.209999999999994 110.448 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.37 169.45 24.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.286 -0.415 . . . . 55.219999999999999 110.363 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 46' ' ' VAL . 30.0 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.461 0.116 0 N-CA-C 108.487 -0.931 . . . . 62.340000000000003 108.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.9 tp -138.69 102.28 4.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 71.530000000000001 110.16 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.27 164.1 35.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 65.329999999999998 110.229 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -145.65 118.98 8.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 71.0 109.425 173.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -108.91 110.43 21.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.227 -0.657 . . . . 73.319999999999993 109.227 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.64 122.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.894 0.378 . . . . 70.430000000000007 111.316 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 31' ' ' LEU . 2.5 mm? -87.68 -38.89 15.46 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.311 -0.626 . . . . 73.129999999999995 109.311 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -135.4 111.02 10.64 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.324 -0.853 . . . . 74.030000000000001 109.969 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.65 138.65 46.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.495 2.13 . . . . 71.120000000000005 112.228 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.87 -164.78 40.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.244 -0.503 . . . . 71.120000000000005 112.103 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' HB2' ' HG1' ' A' ' 38' ' ' THR . 47.1 m-20 -63.71 -25.79 68.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.728 0.299 . . . . 72.409999999999997 110.966 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.95 -30.26 1.81 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.478 -0.392 . . . . 51.130000000000003 113.092 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -93.43 -23.47 5.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.729 0.299 . . . . 73.239999999999995 110.892 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.456 ' HG1' ' HB2' ' A' ' 35' ' ' ASP . 7.6 p -76.42 88.47 3.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.165 0.507 . . . . 54.219999999999999 110.705 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -85.88 112.82 47.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 63.140000000000001 111.072 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 114.81 2.5 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.203 2.602 . . . . 71.040000000000006 111.576 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.45 175.13 5.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 110.741 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 157.21 36.01 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.355 -0.384 . . . . 74.420000000000002 110.5 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.69 22.74 68.84 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.068 -0.514 . . . . 65.140000000000001 111.964 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -116.66 136.25 53.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.66 0.267 . . . . 74.430000000000007 110.828 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.77 101.63 10.25 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.738 -0.838 . . . . 61.229999999999997 108.738 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.24 142.02 20.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 121.029 0.443 . . . . 64.049999999999997 111.276 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -105.67 108.47 20.01 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.137 -0.938 . . . . 54.210000000000001 109.301 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.17 172.14 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.164 0.507 . . . . 41.030000000000001 111.021 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 14.5 t-160 -134.03 132.08 39.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.186 -1.042 . . . . 71.409999999999997 108.186 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 29.2 p90 -128.37 145.46 51.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.707 0.289 . . . . 71.340000000000003 111.361 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.849 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 26.0 t70 -137.81 119.76 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 72.430000000000007 109.809 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -79.55 127.63 8.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.37 -0.443 . . . . 64.230000000000004 112.259 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.648 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 20.4 ttm180 -147.11 151.83 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 111.053 -173.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.31 150.02 42.25 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.839 -0.43 . . . . 75.120000000000005 109.839 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.02 -13.6 28.47 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.518 2.146 . . . . 74.209999999999994 111.656 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.98 -32.46 73.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.264 -0.88 . . . . 72.299999999999997 110.532 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.07 -42.04 1.68 Allowed Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.276 -0.73 . . . . 52.539999999999999 111.276 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -79.87 157.87 26.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.774 0.321 . . . . 64.140000000000001 110.522 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.648 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 13.5 pt20 -125.23 165.19 18.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 110.803 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -86.7 -16.74 35.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.733 0.271 . . . . 73.530000000000001 111.733 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.58 153.75 6.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.215 -0.661 . . . . 72.129999999999995 109.215 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 46.4 m -89.48 97.0 10.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.07 0.462 . . . . 73.409999999999997 110.837 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 50.9 m -93.49 -18.43 22.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.288 0.566 . . . . 61.149999999999999 110.267 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HD2' ' NH2' ' A' ' 53' ' ' ARG . 7.9 ptm180 -68.37 -47.48 67.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.78 -0.645 . . . . 74.420000000000002 111.013 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 p -68.92 -27.86 66.14 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.76 0.314 . . . . 52.329999999999998 111.785 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 62' ' ' SER . 19.8 mtp180 -75.6 -21.52 57.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.416 -0.356 . . . . 75.439999999999998 110.719 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.19 48.09 65.01 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.881 -0.599 . . . . 63.329999999999998 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 68' ' ' LYS . 1.6 tmtp? -95.95 111.76 57.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.814 -0.809 . . . . 75.340000000000003 108.814 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.64 152.35 7.55 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.802 2.335 . . . . 73.209999999999994 112.635 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -122.18 137.68 54.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.359 -0.608 . . . . 71.230000000000004 109.359 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.39 129.24 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.355 . . . . 75.030000000000001 110.168 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -149.46 160.11 43.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 73.400000000000006 110.554 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.3 m -83.45 104.86 13.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 75.200000000000003 109.937 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.83 131.4 49.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 110.001 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.67 -25.78 26.94 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.145 -0.55 . . . . 51.530000000000001 111.98 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.47 171.19 15.47 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.658 0.266 . . . . 74.430000000000007 110.501 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.54 35.77 2.25 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.233 -0.508 . . . . 54.409999999999997 113.233 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -84.88 -38.74 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.214 0.53 . . . . 75.439999999999998 109.844 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.64 157.95 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.409 -0.814 . . . . 32.009999999999998 109.366 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.8 pt -92.26 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.186 -0.301 . . . . 75.420000000000002 110.186 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 9.5 mmtm -51.62 -19.1 1.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.096 0.776 . . . . 73.310000000000002 113.096 -173.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.07 -63.0 4.91 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.446 -0.883 . . . . 34.43 111.72 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -70.85 -28.42 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 110.234 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.705 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 16.8 t70 -58.44 -51.66 68.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 72.430000000000007 110.087 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.28 -37.56 87.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.968 -0.382 . . . . 73.310000000000002 109.968 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -51.69 40.78 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.736 -0.666 . . . . 70.400000000000006 112.648 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.2 p -75.65 -31.38 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.038 0.447 . . . . 62.310000000000002 111.086 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.76 66.3 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -83.01 -5.48 59.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.003 0.371 . . . . 72.319999999999993 112.003 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.1 ptp -110.45 177.7 4.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.692 0.282 . . . . 71.329999999999998 111.136 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 p -127.66 177.98 6.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.089 -0.505 . . . . 75.530000000000001 110.173 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.7 ' HA ' HD12 ' A' ' 127' ' ' LEU . 5.1 tt -63.88 130.6 44.78 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.541 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.514 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 83.71 13.0 76.54 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.405 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -102.63 129.2 49.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.042 0.449 . . . . 71.340000000000003 111.382 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -110.64 116.92 32.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.273 -0.876 . . . . 74.540000000000006 108.893 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.33 142.8 50.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.228 0.537 . . . . 55.240000000000002 111.151 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.86 109.6 20.82 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.679 -0.859 . . . . 62.350000000000001 108.679 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 28' ' ' LYS . 12.6 t80 -105.17 134.65 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 65.010000000000005 110.511 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.6 m -93.56 112.82 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 71.140000000000001 110.138 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.579 HG21 ' HB2' ' A' ' 105' ' ' ALA . 26.8 mm -103.12 114.0 65.44 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 116.552 -0.295 . . . . 60.109999999999999 110.569 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' A' ' 104' ' ' LEU . 34.3 Cg_exo -59.57 155.1 43.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.52 2.147 . . . . 51.240000000000002 111.659 175.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -54.81 -32.18 59.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.936 0.398 . . . . 74.230000000000004 111.111 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -76.22 -10.01 59.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 73.140000000000001 111.795 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.574 HD12 ' HD2' ' A' ' 101' ' ' PRO . 82.3 mt -115.27 19.58 15.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.641 0.258 . . . . 72.140000000000001 110.768 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -163.46 -172.24 2.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.029 0.443 . . . . 75.530000000000001 110.776 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -76.39 -3.99 39.94 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.91 -0.586 . . . . 72.409999999999997 110.897 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.59 60.22 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 113.093 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.39 -55.84 9.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.835 0.35 . . . . 70.209999999999994 110.431 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.21 -49.81 16.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.813 -0.631 . . . . 72.200000000000003 110.987 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.92 80.41 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.348 -0.453 . . . . 74.310000000000002 112.84 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.539 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.5 m-85 -77.22 -50.67 2.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 111.819 0.303 . . . . 75.400000000000006 111.819 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 3.5 Cg_exo -77.48 128.47 9.58 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.233 1.955 . . . . 74.049999999999997 111.51 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.4 -11.9 21.65 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.849 2.366 . . . . 75.519999999999996 113.152 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.406 HG23 HG12 ' A' ' 115' ' ' ILE . 27.6 m -81.4 -17.93 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.992 0.425 . . . . 74.310000000000002 110.684 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 114' ' ' VAL . 49.9 mm -105.32 122.24 43.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 64.329999999999998 109.947 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 55.0 Cg_endo -70.95 130.6 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.374 2.049 . . . . 73.409999999999997 112.173 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 20.7 Cg_exo -67.26 149.36 81.34 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.822 2.348 . . . . 61.409999999999997 112.044 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm 64.28 27.63 13.83 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.298 0.639 . . . . 73.319999999999993 111.1 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.83 148.9 32.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 74.120000000000005 111.246 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.6 m -82.85 132.31 35.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.718 -0.674 . . . . 71.230000000000004 109.843 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -117.69 139.39 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.785 -0.45 . . . . 73.030000000000001 109.785 -173.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.4 t -106.25 138.81 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.536 -0.302 . . . . 74.230000000000004 110.241 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.21 125.24 38.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.074 -0.343 . . . . 52.100000000000001 110.074 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 35.6 tt0 -75.1 106.84 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.124 -1.435 . . . . 64.310000000000002 107.124 168.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 m -111.71 137.93 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.949 -0.568 . . . . 41.0 109.868 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.9 tt0 -144.02 126.68 16.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.854 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.3 tm? -79.34 101.69 8.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.310000000000002 108.302 176.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.94 -49.89 18.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 73.209999999999994 109.549 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.74 156.64 20.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 55.219999999999999 111.027 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.901 -0.591 . . . . 71.349999999999994 109.497 175.565 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.423 -0.955 . . . . 62.340000000000003 108.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.3 102.29 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 71.530000000000001 111.923 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -110.42 113.67 26.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 65.329999999999998 109.654 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -113.82 101.35 9.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.629 -0.878 . . . . 71.0 108.629 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.82 118.96 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.644 -0.707 . . . . 73.319999999999993 110.435 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.3 113.08 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.081 -0.509 . . . . 70.430000000000007 109.807 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -76.66 -40.78 48.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.332 -0.618 . . . . 73.129999999999995 109.332 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.3 m -147.08 114.67 4.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.606 -0.724 . . . . 74.030000000000001 109.305 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.44 150.3 87.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.713 2.275 . . . . 71.120000000000005 112.611 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -106.46 -135.29 7.97 Favored Glycine 0 C--O 1.237 0.31 0 CA-C-N 115.968 -0.56 . . . . 71.120000000000005 112.005 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.491 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 31.6 m-20 -73.4 -50.62 20.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 72.409999999999997 111.251 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.83 -25.18 8.91 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.926 -0.654 . . . . 51.130000000000003 112.172 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 35' ' ' ASP . 33.7 m -98.64 -24.59 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.019 0.438 . . . . 73.239999999999995 111.157 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.491 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.8 p -79.1 92.97 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.16 0.505 . . . . 54.219999999999999 110.242 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -88.6 128.59 52.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.738 -0.664 . . . . 63.140000000000001 110.938 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.98 122.93 6.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.487 2.124 . . . . 71.040000000000006 112.048 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.44 148.5 22.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.811 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.91 138.16 46.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.420000000000002 109.763 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.29 68.51 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.182 -0.532 . . . . 65.140000000000001 112.085 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -91.66 134.2 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 74.430000000000007 110.982 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.24 108.34 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.846 -0.798 . . . . 61.229999999999997 108.846 171.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.551 HG12 HG23 ' A' ' 130' ' ' VAL . 27.5 m -106.39 147.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.797 0.332 . . . . 64.049999999999997 110.805 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.1 m -104.62 108.17 19.49 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.787 -0.642 . . . . 54.210000000000001 110.064 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.789 HG12 HD22 ' A' ' 127' ' ' LEU . 15.8 m -125.96 178.23 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.631 -0.713 . . . . 41.030000000000001 110.636 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.81 154.19 36.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.84 -0.8 . . . . 71.409999999999997 108.84 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 36.9 p90 -134.06 158.14 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.429 -0.212 . . . . 71.340000000000003 110.429 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.698 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 1.4 m-20 -134.65 123.37 23.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.131 -0.692 . . . . 72.430000000000007 109.131 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.0 94.46 1.76 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.879 -0.601 . . . . 64.230000000000004 112.908 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.524 ' HA ' ' HB3' ' A' ' 59' ' ' GLN . 19.3 ttm180 -106.25 137.36 44.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.363 0.602 . . . . 71.310000000000002 110.774 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -78.06 154.73 80.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 75.120000000000005 109.789 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.97 -23.71 29.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.767 2.311 . . . . 74.209999999999994 112.05 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.21 -24.24 40.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.379 -0.828 . . . . 72.299999999999997 111.177 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.13 -2.86 56.71 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.63 -0.714 . . . . 52.539999999999999 111.439 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -110.37 156.31 20.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.976 0.51 . . . . 64.140000000000001 110.042 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 26.0 pt20 -141.23 163.56 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.908 -0.405 . . . . 72.329999999999998 109.908 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.63 -46.63 78.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 111.479 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -170.33 133.21 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.851 -0.425 . . . . 72.129999999999995 109.851 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -69.35 106.67 3.0 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.886 0.374 . . . . 73.409999999999997 110.219 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.3 p -76.46 -26.23 55.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 61.149999999999999 110.776 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -31.39 71.94 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.939 0.4 . . . . 74.420000000000002 110.048 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -60.84 -13.59 16.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.695 . . . . 52.329999999999998 111.225 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -78.36 -16.37 57.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.775 0.321 . . . . 75.439999999999998 111.075 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.5 34.33 73.56 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.159 -0.543 . . . . 63.329999999999998 112.344 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 113.65 14.89 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 110.252 -0.277 . . . . 75.340000000000003 110.252 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -95.61 177.2 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.187 2.592 . . . . 73.209999999999994 113.271 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -125.9 142.23 51.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.581 -0.896 . . . . 71.230000000000004 108.581 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -112.68 135.29 53.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.522 -0.177 . . . . 75.030000000000001 110.522 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -150.75 161.12 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.774 -0.454 . . . . 73.400000000000006 109.774 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.484 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 56.9 m -86.09 115.95 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.482 0.182 . . . . 75.200000000000003 110.642 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 88' ' ' ALA . 63.6 tp -64.15 138.64 58.55 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.253 -0.431 . . . . 75.129999999999995 110.452 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.38 32.39 31.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.128 -0.558 . . . . 51.530000000000001 111.949 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.15 160.27 43.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.04 -0.355 . . . . 74.430000000000007 110.04 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 29.04 1.51 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.566 -0.349 . . . . 54.409999999999997 113.47 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 73' ' ' THR . 10.9 mm-40 -62.32 -46.65 87.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.502 0.668 . . . . 75.439999999999998 109.568 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.82 178.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.729 -1.123 . . . . 32.009999999999998 109.689 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 83' ' ' TRP . 28.1 pt -68.59 145.53 13.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 123.333 0.396 . . . . 75.420000000000002 110.77 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.49 -20.46 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.261 -0.427 . . . . 73.310000000000002 111.579 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.05 21.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 34.43 111.535 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.456 ' H ' HG13 ' A' ' 80' ' ' ILE . 47.8 m0 -68.98 -37.91 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.675 0.274 . . . . 71.340000000000003 110.298 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.93 -55.03 35.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.885 -0.598 . . . . 72.430000000000007 110.499 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.37 -34.74 70.7 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.025 -0.534 . . . . 73.310000000000002 110.513 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.444 ' O ' HG22 ' A' ' 89' ' ' THR . . . -55.02 -49.83 61.23 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.917 -0.583 . . . . 70.400000000000006 112.138 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 90' ' ' MET . 21.6 m -75.8 -31.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.777 0.323 . . . . 62.310000000000002 111.12 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -63.82 -32.0 73.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.609 -0.269 . . . . 72.340000000000003 111.54 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.0 t -82.27 -10.72 59.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.823 0.305 . . . . 72.319999999999993 111.823 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 16.7 ptp -103.59 -172.05 2.04 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.712 0.292 . . . . 71.329999999999998 110.964 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -133.18 179.01 6.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.216 -0.447 . . . . 75.530000000000001 110.805 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 129' ' ' ALA . 3.4 tm? -62.9 138.49 58.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.802 0.334 . . . . 74.120000000000005 110.537 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.418 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.78 24.65 75.7 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.483 -0.78 . . . . 72.25 112.395 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 21.9 tt0 -121.2 135.32 55.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 71.340000000000003 110.792 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -117.87 128.42 54.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.507 -0.77 . . . . 74.540000000000006 109.341 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.13 141.53 44.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.459 . . . . 55.240000000000002 111.331 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 9.0 tt -90.9 115.63 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.633 -0.877 . . . . 62.350000000000001 108.633 174.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' HD1' HD13 ' A' ' 100' ' ' ILE . 21.4 t80 -121.26 122.73 40.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 65.010000000000005 110.107 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.593 HG23 HG22 ' A' ' 122' ' ' VAL . 4.2 m -79.59 107.85 12.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.45 . . . . 71.140000000000001 109.784 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.519 HD13 ' HD1' ' A' ' 98' ' ' PHE . 37.2 mm -82.72 110.43 22.46 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 116.222 -0.444 . . . . 60.109999999999999 110.575 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.558 ' HA ' HG23 ' A' ' 120' ' ' THR . 61.3 Cg_endo -72.68 150.29 50.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.41 2.073 . . . . 51.240000000000002 111.88 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -54.32 -27.99 39.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.679 -0.691 . . . . 74.230000000000004 111.975 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.11 -22.14 49.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.328 -0.396 . . . . 73.140000000000001 111.893 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.9 mt -106.35 22.48 15.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.01 0.434 . . . . 72.140000000000001 110.197 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -160.53 -174.99 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.626 . . . . 75.530000000000001 111.053 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -79.85 -3.37 47.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.548 -0.751 . . . . 72.409999999999997 110.243 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.66 -24.6 48.5 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.898 -0.592 . . . . 75.140000000000001 113.465 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 5.9 tm-20 -65.71 -48.36 72.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.555 -0.535 . . . . 70.209999999999994 109.555 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.522 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 1.6 tpm_? -78.38 -56.58 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.62 -0.718 . . . . 72.200000000000003 110.974 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.99 162.54 25.86 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.485 -0.646 . . . . 74.310000000000002 111.485 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.633 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 89.2 m-85 -143.15 -58.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.05 0.425 . . . . 75.400000000000006 110.824 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 71.7 Cg_endo -82.98 140.67 10.19 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.585 1.523 . . . . 74.049999999999997 111.499 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 35.9 Cg_exo -59.43 -5.89 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.819 2.346 . . . . 75.519999999999996 112.983 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 t -81.24 -29.56 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.472 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -111.35 109.31 56.46 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.969 -0.56 . . . . 64.329999999999998 110.043 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 22.8 Cg_exo -65.27 149.96 87.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.715 2.277 . . . . 73.409999999999997 112.014 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 23.8 Cg_exo -66.41 153.9 76.29 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.74 2.294 . . . . 61.409999999999997 112.039 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 47.4 mtmt 59.33 32.91 22.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.05 0.452 . . . . 73.319999999999993 110.759 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.77 32.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.953 -0.567 . . . . 74.120000000000005 111.12 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -73.79 124.66 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.3 -0.63 . . . . 71.230000000000004 109.3 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.2 tm? -119.11 144.47 46.6 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.097 -0.705 . . . . 73.030000000000001 109.097 -172.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.593 HG22 HG23 ' A' ' 99' ' ' THR . 63.9 t -98.38 111.19 27.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 110.166 -0.309 . . . . 74.230000000000004 110.166 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.457 ' CE2' HD12 ' A' ' 121' ' ' LEU . 40.1 m-85 -108.75 118.4 36.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.281 0.562 . . . . 52.100000000000001 110.855 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.698 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 43.8 mt-10 -75.45 109.04 8.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.337 -0.986 . . . . 64.310000000000002 108.337 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' HE1' ' A' ' 90' ' ' MET . 11.6 m -95.99 149.13 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 123.508 0.505 . . . . 41.0 109.646 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.51 119.64 8.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 110.193 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.789 HD22 HG12 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -90.67 104.35 16.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.472 -0.566 . . . . 72.310000000000002 109.472 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.0 -43.9 12.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.801 0.334 . . . . 73.209999999999994 110.752 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.488 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -159.39 164.34 34.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 55.219999999999999 110.465 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.551 HG23 HG12 ' A' ' 46' ' ' VAL . 2.7 p . . . . . 0 C--O 1.245 0.843 0 N-CA-C 109.771 -0.455 . . . . 71.349999999999994 109.771 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 . . . . . 0 C--O 1.232 0.149 0 N-CA-C 108.984 -0.747 . . . . 62.340000000000003 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.456 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 60.9 tp -146.18 119.62 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.178 0.436 . . . . 71.530000000000001 112.178 -175.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -101.45 129.52 47.51 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.121 -0.696 . . . . 65.329999999999998 109.121 162.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -125.79 100.71 6.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.745 -1.206 . . . . 71.0 107.745 169.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -119.71 113.29 20.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.945 -0.57 . . . . 73.319999999999993 110.308 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.03 108.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.224 0.535 . . . . 70.430000000000007 110.474 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -82.97 -44.85 14.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.857 -0.61 . . . . 73.129999999999995 109.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.8 m -139.68 110.76 7.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 74.030000000000001 109.45 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.14 133.9 40.2 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.621 2.214 . . . . 71.120000000000005 111.614 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.46 -150.69 23.03 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.166 -0.54 . . . . 71.120000000000005 112.795 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.71 -54.73 40.72 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.707 0.403 . . . . 72.409999999999997 111.254 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.5 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 75.7 -9.11 17.47 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.212 -0.518 . . . . 51.130000000000003 113.037 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.49 -6.7 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.115 0.483 . . . . 73.239999999999995 110.7 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 92' ' ' LEU . 40.8 p -83.96 120.11 25.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.795 -0.639 . . . . 54.219999999999999 110.681 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -126.66 89.67 51.59 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.728 -0.215 . . . . 63.140000000000001 110.637 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.8 -175.68 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.87 2.38 . . . . 71.040000000000006 111.993 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -146.55 174.94 10.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.368 -0.378 . . . . 75.109999999999999 110.268 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 140.36 57.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.196 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.12 -1.37 54.67 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.215 -0.516 . . . . 65.140000000000001 112.515 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -92.02 133.08 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 74.430000000000007 110.925 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -83.77 107.83 16.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.851 -0.796 . . . . 61.229999999999997 108.851 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 35.9 m -107.18 147.67 12.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 116.49 -0.323 . . . . 64.049999999999997 111.534 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 m -100.73 108.17 19.95 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.036 -0.983 . . . . 54.210000000000001 110.728 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.822 HG12 HD22 ' A' ' 127' ' ' LEU . 19.7 m -120.36 178.66 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 114.893 -1.048 . . . . 41.030000000000001 111.365 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.658 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 22.4 t-160 -152.8 146.4 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.697 -1.223 . . . . 71.409999999999997 107.697 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.5 m-85 -126.97 159.45 34.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.901 0.382 . . . . 71.340000000000003 111.965 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.888 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 5.6 m-20 -135.78 157.35 47.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.951 -1.022 . . . . 72.430000000000007 108.509 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -118.6 128.93 7.92 Favored Glycine 0 N--CA 1.461 0.312 0 C-N-CA 121.039 -0.6 . . . . 64.230000000000004 112.597 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.552 HH21 HG21 ' A' ' 122' ' ' VAL . 16.2 ttp180 -138.32 145.53 41.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.934 0.397 . . . . 71.310000000000002 110.752 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.0 155.56 64.19 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 75.120000000000005 109.767 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.33 -17.91 49.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.621 2.214 . . . . 74.209999999999994 112.487 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.8 -23.82 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 72.299999999999997 110.598 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.07 -22.53 18.25 Favored Glycine 0 N--CA 1.454 -0.165 0 N-CA-C 111.177 -0.769 . . . . 52.539999999999999 111.177 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -71.77 141.16 49.73 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.726 0.41 . . . . 64.140000000000001 109.949 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 14.6 pt20 -121.2 135.58 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.122 -0.695 . . . . 72.329999999999998 109.122 172.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -69.87 -29.95 67.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.615 -0.266 . . . . 73.530000000000001 111.394 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.09 134.15 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 72.129999999999995 110.779 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.459 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 13.7 p -79.14 86.69 4.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.452 -0.573 . . . . 73.409999999999997 109.452 171.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 m -65.42 -12.01 48.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.176 0.512 . . . . 61.149999999999999 110.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.658 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 8.8 ptp85 -63.56 -31.73 72.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.934 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 t -73.4 -19.14 61.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.831 -0.622 . . . . 52.329999999999998 110.952 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -75.57 -20.56 58.54 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.422 -0.353 . . . . 75.439999999999998 110.06 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.68 48.72 69.64 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.955 -0.566 . . . . 63.329999999999998 113.72 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 64.6 tttp -130.94 124.27 20.53 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.801 -0.444 . . . . 75.340000000000003 109.801 174.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 Cg_endo -83.65 175.13 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.107 2.538 . . . . 73.209999999999994 112.015 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -146.91 128.73 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 71.230000000000004 108.515 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 92.6 mt-30 -106.6 131.54 53.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.464 0.173 . . . . 75.030000000000001 110.654 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.86 158.77 43.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.564 -0.289 . . . . 73.400000000000006 110.471 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.1 m -84.32 124.36 31.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 75.200000000000003 110.386 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 tp -59.38 130.3 46.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.365 -0.379 . . . . 75.129999999999995 110.383 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.18 39.02 72.63 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.989 -0.55 . . . . 51.530000000000001 112.521 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.81 161.97 31.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.995 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.78 18.51 8.94 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 116.021 -0.536 . . . . 54.409999999999997 113.462 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.83 -19.75 54.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.599 . . . . 75.439999999999998 109.814 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.96 159.71 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.446 -0.797 . . . . 32.009999999999998 109.48 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 83' ' ' TRP . 21.3 pt -70.28 151.09 9.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 116.406 -0.361 . . . . 75.420000000000002 110.102 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -56.68 -26.68 57.16 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.827 -0.434 . . . . 73.310000000000002 109.827 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.27 -52.06 53.84 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.052 -0.594 . . . . 34.43 111.853 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.555 ' H ' HG13 ' A' ' 80' ' ' ILE . 40.8 m0 -69.32 -31.29 69.66 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.325 -0.25 . . . . 71.340000000000003 110.325 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.4 -45.75 80.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.132 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.12 -35.35 76.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 109.789 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 89' ' ' THR . . . -56.46 -47.07 86.22 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.876 -0.602 . . . . 70.400000000000006 112.353 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.627 HG23 HD23 ' A' ' 127' ' ' LEU . 7.1 p -75.05 -34.08 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.809 0.338 . . . . 62.310000000000002 110.622 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.75 70.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.483 -0.326 . . . . 72.340000000000003 111.456 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 86' ' ' GLY . 8.9 t -87.01 3.34 46.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.673 0.273 . . . . 72.319999999999993 111.187 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 15.3 ptm -130.14 175.74 8.66 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 110.81 -177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.5 HG21 ' HA2' ' A' ' 36' ' ' GLY . 59.5 p -127.34 178.68 5.9 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.296 -0.411 . . . . 75.530000000000001 110.789 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -69.22 139.38 54.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.634 -0.257 . . . . 74.120000000000005 110.395 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.499 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 77.93 12.57 84.29 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.956 -0.565 . . . . 72.25 112.219 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -112.72 153.75 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.321 0.248 . . . . 71.340000000000003 110.643 -172.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -134.09 127.82 32.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.353 -0.61 . . . . 74.540000000000006 109.353 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.07 146.85 41.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 55.240000000000002 110.914 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 8.6 tt -90.8 111.67 23.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.531 -0.915 . . . . 62.350000000000001 108.531 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -117.9 129.0 55.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.802 0.334 . . . . 65.010000000000005 110.147 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 122' ' ' VAL . 27.9 m -84.51 131.12 34.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.655 0.264 . . . . 71.140000000000001 111.138 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.68 103.0 44.83 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-O 120.896 0.379 . . . . 60.109999999999999 110.063 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.616 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.9 Cg_exo -62.67 155.09 61.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.598 2.199 . . . . 51.240000000000002 111.927 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -55.07 -23.38 19.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 111.415 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -75.63 -6.5 50.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.241 -0.436 . . . . 73.140000000000001 111.972 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.53 HD12 ' HD2' ' A' ' 101' ' ' PRO . 96.7 mt -127.53 14.46 7.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.707 0.262 . . . . 72.140000000000001 111.707 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.34 -175.77 5.01 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.953 0.406 . . . . 75.530000000000001 111.485 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -66.55 -12.33 57.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.515 -0.766 . . . . 72.409999999999997 111.314 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.91 -32.83 19.51 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.35 -0.386 . . . . 75.140000000000001 113.688 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 tp10 -58.08 -49.23 77.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.367 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.26 -47.74 9.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 72.200000000000003 110.971 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.77 153.44 13.05 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 112.076 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.705 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 76.1 m-85 -144.41 -57.19 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 122.314 0.246 . . . . 75.400000000000006 110.944 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 6.8 Cg_exo -73.49 143.1 34.01 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.896 1.731 . . . . 74.049999999999997 111.235 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.48 -27.66 41.38 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.821 2.347 . . . . 75.519999999999996 112.786 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 115' ' ' ILE . 33.3 m -78.19 -18.18 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 111.514 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.513 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 49.0 mm -108.19 103.37 50.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.318 -0.401 . . . . 64.329999999999998 110.188 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.52 164.68 31.97 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.568 2.179 . . . . 73.409999999999997 111.668 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.35 142.6 94.98 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.317 2.012 . . . . 61.409999999999997 112.135 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 67.6 mttm 65.97 27.74 10.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.937 -0.574 . . . . 73.319999999999993 111.283 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.73 116.84 26.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.835 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.616 HG23 ' HA ' ' A' ' 101' ' ' PRO . 70.6 m -74.04 138.37 44.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.015 -0.539 . . . . 71.230000000000004 109.75 174.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -129.64 138.95 51.5 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.263 -0.643 . . . . 73.030000000000001 109.263 -175.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.552 HG21 HH21 ' A' ' 53' ' ' ARG . 48.1 t -98.6 133.72 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.588 0.232 . . . . 74.230000000000004 110.397 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.54 126.51 44.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.069 0.461 . . . . 52.100000000000001 110.533 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.0 mt-10 -78.23 118.36 20.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.953 -0.758 . . . . 64.310000000000002 108.953 173.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -95.97 135.57 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.443 -0.577 . . . . 41.0 109.443 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.9 tt0 -135.16 106.51 6.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.283 -0.417 . . . . 75.209999999999994 110.113 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.822 HD22 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -87.03 108.27 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.829 -0.804 . . . . 72.310000000000002 108.829 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.24 -50.9 7.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.856 -0.424 . . . . 73.209999999999994 109.856 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -169.9 -173.68 1.63 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.969 -0.56 . . . . 55.219999999999999 110.602 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.243 0.736 0 N-CA-C 109.161 -0.681 . . . . 71.349999999999994 109.161 173.216 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.847 0.356 . . . . 62.340000000000003 110.638 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -142.51 102.03 3.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 71.530000000000001 110.134 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -124.63 102.26 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.262 0.553 . . . . 65.329999999999998 110.047 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -112.74 109.7 19.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.272 -0.876 . . . . 71.0 109.16 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -108.66 110.35 21.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.469 -0.567 . . . . 73.319999999999993 109.469 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.75 106.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.109 -0.33 . . . . 70.430000000000007 110.109 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 97' ' ' LEU . 85.4 mt -87.7 -28.84 21.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 110.154 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 28.5 m -140.83 110.92 6.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.48 -0.782 . . . . 74.030000000000001 109.518 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.81 127.0 22.0 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.486 2.124 . . . . 71.120000000000005 111.249 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.11 -174.35 50.32 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 71.120000000000005 112.922 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' OD2' HG22 ' A' ' 37' ' ' VAL . 23.0 t70 -60.82 -43.06 98.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 110.543 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.3 9.74 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.934 -0.575 . . . . 51.130000000000003 114.43 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG22 ' OD2' ' A' ' 35' ' ' ASP . 14.0 m -103.57 -28.0 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.087 0.943 . . . . 73.239999999999995 110.807 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 5.5 p -75.95 88.62 2.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.41 0.624 . . . . 54.219999999999999 109.854 173.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -93.29 114.45 62.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.348 -0.842 . . . . 63.140000000000001 111.068 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HG3' ' HG ' ' A' ' 127' ' ' LEU . 56.1 Cg_endo -70.58 107.77 2.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.412 2.074 . . . . 71.040000000000006 110.974 174.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.08 157.72 15.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 75.109999999999999 110.609 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 157.27 32.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 74.420000000000002 111.057 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.08 76.93 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.004 -0.544 . . . . 65.140000000000001 112.128 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -132.08 141.78 49.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.456 0.303 . . . . 74.430000000000007 110.311 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -71.95 107.61 4.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.736 -0.468 . . . . 61.229999999999997 109.736 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 130' ' ' VAL . 33.6 m -106.42 147.42 11.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 120.887 0.375 . . . . 64.049999999999997 110.903 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.2 m -104.81 108.44 19.93 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.472 -0.786 . . . . 54.210000000000001 109.761 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.651 HG12 HD22 ' A' ' 127' ' ' LEU . 21.3 m -118.78 178.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.482 -0.781 . . . . 41.030000000000001 111.97 -171.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -150.61 137.02 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.866 . . . . 71.409999999999997 109.231 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.638 ' HD1' HG12 ' A' ' 125' ' ' VAL . 56.2 m-85 -126.64 159.4 33.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.71 -0.107 . . . . 71.340000000000003 110.71 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.62 136.35 29.05 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.466 0.479 . . . . 72.430000000000007 109.728 167.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 124.82 7.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.475 -0.393 . . . . 64.230000000000004 112.277 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -141.01 137.46 32.99 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.327 0.584 . . . . 71.310000000000002 110.974 -170.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.19 148.37 39.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 109.744 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 -18.56 37.0 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.799 2.333 . . . . 74.209999999999994 112.457 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -66.56 -31.3 71.93 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.054 -0.521 . . . . 72.299999999999997 110.783 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.43 -21.07 15.21 Favored Glycine 0 C--N 1.327 0.038 0 N-CA-C 109.992 -1.243 . . . . 52.539999999999999 109.992 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -68.87 154.46 41.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.672 -0.764 . . . . 64.140000000000001 110.101 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -142.23 151.77 42.44 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.778 -0.453 . . . . 72.329999999999998 109.778 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.75 -4.54 36.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.714 0.292 . . . . 73.530000000000001 111.422 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -168.26 144.79 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.141 -0.688 . . . . 72.129999999999995 109.141 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.8 p -109.07 85.34 2.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.62 0.724 . . . . 73.409999999999997 110.292 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.1 m -77.83 -18.26 56.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.539 -0.755 . . . . 61.149999999999999 109.401 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -65.05 -32.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.21 -0.904 . . . . 74.420000000000002 109.645 173.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -73.57 -24.26 60.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.342 -0.844 . . . . 52.329999999999998 110.869 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -84.27 -28.64 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 75.439999999999998 110.598 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.25 25.1 59.73 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.086 -0.506 . . . . 63.329999999999998 112.194 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.92 129.15 47.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 122.52 0.328 . . . . 75.340000000000003 110.825 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -87.84 157.05 7.41 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.967 2.444 . . . . 73.209999999999994 112.434 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -134.92 130.13 35.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.888 -0.782 . . . . 71.230000000000004 108.888 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -107.85 138.24 44.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.504 0.192 . . . . 75.030000000000001 110.756 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -157.21 163.55 38.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.267 -0.424 . . . . 73.400000000000006 110.051 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.9 m -82.46 110.79 17.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.192 -0.299 . . . . 75.200000000000003 110.192 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 88' ' ' ALA . 48.1 tp -61.82 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.238 -0.437 . . . . 75.129999999999995 110.223 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.14 12.48 Favored Glycine 0 C--O 1.237 0.286 0 N-CA-C 111.488 -0.645 . . . . 51.530000000000001 111.488 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.57 154.19 38.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 74.430000000000007 110.504 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.61 33.89 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.147 -0.479 . . . . 54.409999999999997 112.67 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.89 -23.6 67.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.022 0.439 . . . . 75.439999999999998 110.641 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.93 174.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.139 -0.689 . . . . 32.009999999999998 109.139 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.6 pt -73.61 140.28 18.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.741 -0.466 . . . . 75.420000000000002 109.741 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 30.3 mmtp -58.45 -16.68 16.1 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.689 0.255 . . . . 73.310000000000002 111.689 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.93 -53.02 46.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.416 -0.897 . . . . 34.43 111.183 172.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.522 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.1 m0 -67.06 -42.1 85.33 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.114 -0.328 . . . . 71.340000000000003 110.114 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.501 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 17.8 t70 -52.59 -55.15 24.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.511 -0.768 . . . . 72.430000000000007 110.671 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -65.6 -40.42 92.65 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.094 -0.503 . . . . 73.310000000000002 110.666 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.69 -53.96 30.24 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.919 -0.582 . . . . 70.400000000000006 112.622 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.94 -30.35 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.544 0.212 . . . . 62.310000000000002 111.369 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -67.2 -30.15 70.01 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.725 0.269 . . . . 72.340000000000003 111.725 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 t -88.46 7.32 33.43 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.001 0.371 . . . . 72.319999999999993 112.001 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 11.9 ptp -121.97 -173.87 2.75 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.168 -0.332 . . . . 71.329999999999998 111.113 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -124.31 175.3 7.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.132 -0.486 . . . . 75.530000000000001 110.732 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.684 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.7 tt -63.33 131.84 49.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 74.120000000000005 110.364 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 8.78 83.7 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.416 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.639 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 14.1 tt0 -102.02 140.92 35.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 71.340000000000003 110.585 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.9 ttpm? -131.79 136.23 47.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.808 -0.442 . . . . 74.540000000000006 109.808 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.13 150.62 35.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.961 0.41 . . . . 55.240000000000002 111.186 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.455 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.1 tt -90.67 109.42 20.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.984 -1.117 . . . . 62.350000000000001 107.984 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HD1' HD13 ' A' ' 100' ' ' ILE . 7.0 t80 -112.0 117.77 33.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 65.010000000000005 110.109 -174.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 31.9 m -77.22 110.54 12.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.401 -0.363 . . . . 71.140000000000001 110.224 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.427 HD13 ' HD1' ' A' ' 98' ' ' PHE . 42.0 mm -90.48 111.6 48.33 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.127 -0.488 . . . . 60.109999999999999 110.488 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HA ' HG23 ' A' ' 120' ' ' THR . 34.3 Cg_exo -59.9 144.46 99.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.396 2.064 . . . . 51.240000000000002 110.908 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.546 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 46.5 p90 -54.56 -36.32 64.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 74.230000000000004 110.882 -176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -62.99 -24.15 67.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 73.140000000000001 111.398 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.34 16.91 24.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.285 -0.416 . . . . 72.140000000000001 110.723 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.69 7.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 75.530000000000001 111.169 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -74.43 -11.03 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.893 -0.594 . . . . 72.409999999999997 111.016 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.89 63.45 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.928 -0.578 . . . . 75.140000000000001 112.485 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 4.7 tm-20 -57.62 -54.81 42.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.072 0.463 . . . . 70.209999999999994 109.996 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -103.67 -24.69 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 72.200000000000003 110.086 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.06 -175.22 52.57 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 112.317 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.799 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m-85 -151.04 -59.47 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.877 0.471 . . . . 75.400000000000006 110.119 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 72.8 Cg_endo -95.26 157.6 1.66 Allowed 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.653 2.235 . . . . 74.049999999999997 112.193 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.82 -17.28 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.852 2.368 . . . . 75.519999999999996 112.472 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.74 -32.53 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 74.310000000000002 110.251 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.651 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 mm -109.14 99.56 36.45 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.05 -0.523 . . . . 64.329999999999998 109.619 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.635 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 36.2 Cg_endo -66.08 152.22 81.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.515 2.144 . . . . 73.409999999999997 112.182 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 34.3 Cg_exo -62.87 137.13 61.02 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.36 2.04 . . . . 61.409999999999997 111.277 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 64.75 37.5 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.63 0.581 . . . . 73.319999999999993 110.501 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -92.98 116.33 28.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.607 -0.724 . . . . 74.120000000000005 110.544 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -74.1 133.96 42.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 71.230000000000004 109.389 173.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -124.87 144.3 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 73.030000000000001 109.307 -172.08 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.419 ' H ' HD13 ' A' ' 121' ' ' LEU . 88.6 t -100.85 128.01 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 109.914 -0.402 . . . . 74.230000000000004 109.914 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -123.02 120.71 34.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.151 0.501 . . . . 52.100000000000001 110.329 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -82.84 111.05 18.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.614 -0.884 . . . . 64.310000000000002 108.614 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.638 HG12 ' HD1' ' A' ' 50' ' ' TYR . 34.2 m -104.81 150.24 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.029 -0.987 . . . . 41.0 110.614 -173.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.01 128.88 12.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.49 -0.323 . . . . 75.209999999999994 110.439 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -93.43 118.17 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.929 -0.767 . . . . 72.310000000000002 108.929 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.79 -50.33 5.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.428 0.156 . . . . 73.209999999999994 111.141 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.24 0.543 . . . . 55.219999999999999 111.677 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 92' ' ' LEU . 13.3 p . . . . . 0 C--O 1.251 1.167 0 CA-C-N 115.206 -0.906 . . . . 71.349999999999994 108.947 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 . . . . . 0 C--O 1.232 0.139 0 N-CA-C 109.711 -0.477 . . . . 62.340000000000003 109.711 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.8 tp -128.0 118.21 23.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.83 0.348 . . . . 71.530000000000001 110.298 -176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 29' ' ' LYS . 43.2 mt-10 -123.72 146.06 48.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 65.329999999999998 111.001 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -141.02 110.67 6.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 71.0 109.459 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.604 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.9 mptt -108.69 110.4 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 73.319999999999993 109.697 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.5 112.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.015 0.436 . . . . 70.430000000000007 110.139 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.6 mt -92.08 -30.11 16.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.119 -177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 33.6 m -141.37 110.66 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.982 -0.748 . . . . 74.030000000000001 108.982 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.63 135.65 28.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.271 1.981 . . . . 71.120000000000005 112.043 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.94 -165.0 30.65 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.143 -0.551 . . . . 71.120000000000005 111.747 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.24 -20.71 62.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.63 0.215 . . . . 72.409999999999997 111.165 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.22 -30.32 1.15 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.489 -0.386 . . . . 51.130000000000003 113.481 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.4 -32.85 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 73.239999999999995 110.87 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 1.9 p -80.02 108.17 13.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.498 0.666 . . . . 54.219999999999999 110.61 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 41' ' ' GLN . 56.5 pttt -94.43 125.91 50.09 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.105 -0.952 . . . . 63.140000000000001 111.426 -173.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.99 106.17 2.12 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.853 2.368 . . . . 71.040000000000006 110.564 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' OE1' ' HE3' ' A' ' 39' ' ' LYS . 26.1 mt-30 -88.12 146.06 25.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.379 -0.373 . . . . 75.109999999999999 111.242 -176.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.45 156.77 36.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.857 -0.611 . . . . 74.420000000000002 109.892 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.19 16.6 79.65 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.905 -0.664 . . . . 65.140000000000001 111.68 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -132.94 154.86 50.03 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.737 0.415 . . . . 74.430000000000007 109.982 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.718 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -73.17 127.2 31.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 61.229999999999997 109.944 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 130' ' ' VAL . 35.9 m -124.77 150.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 120.818 0.342 . . . . 64.049999999999997 110.642 177.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 m -111.27 110.53 21.06 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.213 -0.903 . . . . 54.210000000000001 110.698 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.737 HG12 HD22 ' A' ' 127' ' ' LEU . 24.8 m -128.66 177.88 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.719 0.771 . . . . 41.030000000000001 112.914 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 8.7 m170 -139.68 152.48 46.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.463 -1.244 . . . . 71.409999999999997 108.933 172.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 83' ' ' TRP . 63.6 m-85 -134.91 142.53 46.57 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.542 -0.54 . . . . 71.340000000000003 109.542 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 36.5 t0 -137.02 143.76 42.9 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.203 -0.295 . . . . 72.430000000000007 110.203 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.55 140.01 15.22 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.338 -0.458 . . . . 64.230000000000004 112.328 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -157.26 149.31 22.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.375 0.607 . . . . 71.310000000000002 111.781 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.87 153.37 63.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.385 -0.825 . . . . 75.120000000000005 109.595 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.11 -20.28 45.32 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.029 2.486 . . . . 74.209999999999994 113.812 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.87 4.16 45.69 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.77 0.319 . . . . 72.299999999999997 111.004 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.37 26.01 37.69 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.184 -0.531 . . . . 52.539999999999999 112.342 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.04 146.77 39.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.807 -0.442 . . . . 64.140000000000001 109.807 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -160.15 157.49 28.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.977 -0.379 . . . . 72.329999999999998 109.977 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -69.21 -42.38 75.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.323 -0.399 . . . . 73.530000000000001 110.706 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.451 ' CG ' HH21 ' A' ' 66' ' ' ARG . 28.0 t70 -170.0 145.71 2.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.725 -0.671 . . . . 72.129999999999995 109.955 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.3 t -82.79 114.8 21.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.624 -0.509 . . . . 73.409999999999997 109.624 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.6 m -86.67 -28.0 23.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 61.149999999999999 111.783 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -69.61 -31.47 69.62 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.142 -0.349 . . . . 74.420000000000002 110.828 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 29.8 p -73.6 -2.92 24.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.285 -0.416 . . . . 52.329999999999998 111.09 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.451 HH21 ' CG ' ' A' ' 61' ' ' ASP . 28.5 mmt180 -75.95 -3.93 38.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.52 -0.309 . . . . 75.439999999999998 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.36 71.66 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.47 -0.395 . . . . 63.329999999999998 113.045 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 55.8 tptt -91.97 106.82 18.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.549 -0.537 . . . . 75.340000000000003 109.549 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.1 Cg_exo -80.86 139.95 12.53 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.176 2.584 . . . . 73.209999999999994 112.1 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -107.62 142.89 36.86 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.793 -0.817 . . . . 71.230000000000004 108.793 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.718 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 50.7 mt-30 -134.63 138.26 44.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.32 -0.252 . . . . 75.030000000000001 110.32 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.32 164.26 34.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.774 -0.193 . . . . 73.400000000000006 110.657 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.5 m -78.53 111.42 14.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.839 -0.43 . . . . 75.200000000000003 109.839 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 88' ' ' ALA . 50.7 tp -61.03 142.61 56.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.41 -0.359 . . . . 75.129999999999995 110.765 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.57 30.51 44.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.192 -0.528 . . . . 51.530000000000001 111.967 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.16 160.7 39.19 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.387 -0.227 . . . . 74.430000000000007 110.387 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.98 42.75 2.12 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 116.39 -0.368 . . . . 54.409999999999997 113.131 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -76.81 -47.43 21.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.973 -0.751 . . . . 75.439999999999998 108.973 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 35.2 m -121.66 175.53 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.222 -0.899 . . . . 32.009999999999998 109.143 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.547 HG13 ' H ' ' A' ' 83' ' ' TRP . 37.2 pt -64.6 144.6 14.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.902 -0.407 . . . . 75.420000000000002 109.902 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 3.9 tmtm? -58.92 -22.52 59.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.308 -0.405 . . . . 73.310000000000002 109.936 -176.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.32 -52.59 51.75 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.921 -0.657 . . . . 34.43 111.793 175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.547 ' H ' HG13 ' A' ' 80' ' ' ILE . 51.3 m0 -67.39 -41.87 84.26 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.127 -0.324 . . . . 71.340000000000003 110.127 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.2 t70 -54.47 -45.68 73.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.622 -0.717 . . . . 72.430000000000007 110.236 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -64.37 -44.72 90.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 73.310000000000002 110.319 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.75 -49.61 61.05 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.733 -0.667 . . . . 70.400000000000006 112.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.6 -30.34 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.49 0.186 . . . . 62.310000000000002 111.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -72.92 -30.23 63.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.617 0.228 . . . . 72.340000000000003 111.617 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.7 t -81.32 -4.15 54.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.723 0.296 . . . . 72.319999999999993 111.696 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 15.2 ptp -112.2 -176.66 2.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.886 0.374 . . . . 71.329999999999998 110.792 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.9 p -121.34 176.2 5.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.458 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -62.64 126.94 29.04 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.981 0.419 . . . . 74.120000000000005 110.71 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.84 65.12 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.648 -0.705 . . . . 72.25 112.772 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 32' ' ' THR . 15.0 tt0 -99.4 143.57 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 71.340000000000003 111.071 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -131.11 120.01 22.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.097 -0.705 . . . . 74.540000000000006 109.097 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.8 147.09 50.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.294 0.569 . . . . 55.240000000000002 111.306 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD22 ' HD3' ' A' ' 29' ' ' LYS . 10.0 tt -90.44 104.96 17.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.676 -1.231 . . . . 62.350000000000001 107.676 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -103.45 118.4 36.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.992 -0.549 . . . . 65.010000000000005 109.731 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -89.06 106.53 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.318 -0.401 . . . . 71.140000000000001 110.0 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 25.6 mm -86.44 113.69 53.83 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.949 -0.569 . . . . 60.109999999999999 111.076 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 120' ' ' THR . 36.3 Cg_endo -66.12 149.93 85.42 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.372 2.048 . . . . 51.240000000000002 110.33 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.495 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 45.9 p90 -54.45 -31.71 56.06 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.356 0.502 . . . . 74.230000000000004 112.356 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.87 -23.78 64.26 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.004 0.372 . . . . 73.140000000000001 112.004 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.03 6.32 46.85 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.556 0.206 . . . . 72.140000000000001 111.556 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.06 -177.71 6.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 75.530000000000001 111.039 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -67.67 -14.3 62.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 72.409999999999997 110.875 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.62 -23.19 35.21 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.405 0.44 . . . . 75.140000000000001 112.63 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 44.9 tt0 -56.76 -44.24 81.57 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.044 0.449 . . . . 70.209999999999994 110.254 174.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 109' ' ' ARG . 20.1 mtp180 -97.92 -18.82 18.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.528 -0.76 . . . . 72.200000000000003 110.42 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 115' ' ' ILE . . . 67.23 -110.22 3.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.761 -0.654 . . . . 74.310000000000002 112.681 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 31.8 m-85 102.92 -71.33 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.639 1.575 . . . . 75.400000000000006 112.418 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.729 ' HG2' ' HB ' ' A' ' 115' ' ' ILE . 41.9 Cg_endo -65.84 149.45 86.63 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 121.439 1.426 . . . . 74.049999999999997 111.748 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 71.5 Cg_exo -51.92 -31.85 44.97 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.103 2.536 . . . . 75.519999999999996 113.23 -175.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 115' ' ' ILE . 27.4 m -83.2 -20.39 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 74.310000000000002 111.586 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 114' ' ' VAL . 49.2 mm -125.15 94.6 43.27 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.486 -0.325 . . . . 64.329999999999998 110.254 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 169.9 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.811 2.341 . . . . 73.409999999999997 111.402 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.58 148.46 63.87 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.127 1.884 . . . . 61.409999999999997 111.694 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.92 16.38 8.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.144 0.578 . . . . 73.319999999999993 111.818 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.39 112.21 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.120000000000005 111.752 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.7 m -88.15 119.59 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.502 -0.925 . . . . 71.230000000000004 108.502 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -124.59 147.97 48.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.649 0.262 . . . . 73.030000000000001 110.512 -167.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.595 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.0 t -98.52 131.85 44.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.428 -0.351 . . . . 74.230000000000004 110.705 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 97.4 m-85 -130.01 121.94 27.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.388 -0.369 . . . . 52.100000000000001 110.561 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 16.8 mt-10 -77.4 113.95 15.72 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.264 -0.643 . . . . 64.310000000000002 109.264 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 132.93 42.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.617 -0.719 . . . . 41.0 109.345 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.6 tt0 -133.32 112.33 11.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 75.209999999999994 110.629 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.749 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -87.62 106.2 17.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.333 -0.618 . . . . 72.310000000000002 109.333 178.615 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.564 HD21 ' ND1' ' A' ' 49' ' ' HIS . 3.9 mm? -79.24 -50.63 10.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.215 0.531 . . . . 73.209999999999994 109.949 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.572 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . . . -168.35 -176.68 2.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 55.219999999999999 109.683 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 46' ' ' VAL . 31.3 t . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.708 -0.849 . . . . 71.349999999999994 108.708 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 110.247 -0.279 . . . . 62.340000000000003 110.247 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 47.8 tp -145.95 101.72 3.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.193 -0.458 . . . . 71.530000000000001 110.26 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -116.84 122.99 45.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.706 -0.479 . . . . 65.329999999999998 109.706 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' NZ ' ' OG1' ' A' ' 89' ' ' THR . 61.5 pttt -126.39 119.29 26.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.114 0.483 . . . . 71.0 110.13 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.648 -0.705 . . . . 73.319999999999993 110.214 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -61.45 110.6 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.134 0.493 . . . . 70.430000000000007 109.739 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.562 HD23 ' HE3' ' A' ' 95' ' ' LYS . 34.8 tp -96.04 -25.13 16.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.018 -0.537 . . . . 73.129999999999995 110.072 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 57.1 m -149.0 110.77 3.52 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.893 -0.594 . . . . 74.030000000000001 109.725 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.38 133.84 21.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.039 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -95.24 -151.86 28.73 Favored Glycine 0 C--O 1.236 0.254 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 111.823 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' HG1' ' A' ' 38' ' ' THR . 44.1 m-20 -63.92 -36.14 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.933 0.367 . . . . 72.409999999999997 111.306 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.48 -30.03 2.83 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 112.479 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.81 -25.11 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.799 0.333 . . . . 73.239999999999995 111.484 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.444 ' HG1' ' HB2' ' A' ' 35' ' ' ASP . 7.8 p -80.31 96.47 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 54.219999999999999 110.701 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 22.4 pttp -97.89 124.32 48.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.555 . . . . 63.140000000000001 111.651 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -75.12 154.16 41.74 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.902 2.401 . . . . 71.040000000000006 111.401 173.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.63 174.82 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.565 -0.288 . . . . 75.109999999999999 110.689 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.2 144.19 57.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.353 -0.385 . . . . 74.420000000000002 111.153 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.74 16.22 71.08 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.166 -0.47 . . . . 65.140000000000001 112.434 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 27.8 mmmt -109.33 121.8 45.97 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.526 0.331 . . . . 74.430000000000007 111.174 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -74.16 106.1 5.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.15 -0.685 . . . . 61.229999999999997 109.15 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.44 142.14 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.21 0.528 . . . . 64.049999999999997 111.689 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 25.5 m -103.65 108.3 19.52 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.132 -0.94 . . . . 54.210000000000001 109.079 175.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.0 178.15 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.944 -0.571 . . . . 41.030000000000001 111.76 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.494 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.8 t-80 -147.59 139.95 24.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.696 -0.684 . . . . 71.409999999999997 109.366 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.4 m-85 -126.46 149.84 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.37 0.419 . . . . 71.340000000000003 110.543 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 56.9 m-20 -136.11 128.27 29.86 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.607 -0.516 . . . . 72.430000000000007 109.607 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.73 115.52 4.88 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 121.124 -0.56 . . . . 64.230000000000004 112.34 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 26.7 ttp180 -133.32 144.24 49.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 110.951 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -74.34 144.55 81.48 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.962 -0.755 . . . . 75.120000000000005 108.962 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -39.96 -48.74 3.74 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.658 2.905 . . . . 74.209999999999994 114.045 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.81 -41.4 97.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.325 0.491 . . . . 72.299999999999997 112.325 -173.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.84 -24.43 0.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.515 -0.85 . . . . 52.539999999999999 113.108 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -66.71 112.83 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.813 -0.228 . . . . 64.140000000000001 111.174 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.566 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 12.1 pt20 -102.11 144.03 31.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.016 -0.364 . . . . 72.329999999999998 110.016 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -96.44 -26.81 15.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.437 -0.347 . . . . 73.530000000000001 110.606 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -148.36 138.18 22.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.09 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.2 p -124.28 90.2 3.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.11 0.481 . . . . 73.409999999999997 110.589 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -68.05 -18.27 64.63 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 61.149999999999999 110.361 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HG2' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -59.42 -35.27 73.69 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.56 . . . . 74.420000000000002 110.248 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.496 ' N ' ' HG2' ' A' ' 64' ' ' ARG . 8.1 m -64.87 -28.5 69.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.755 -0.657 . . . . 52.329999999999998 110.309 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -96.01 -16.79 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.838 -0.619 . . . . 75.439999999999998 110.373 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.05 35.39 91.93 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.691 -0.564 . . . . 63.329999999999998 111.691 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 69' ' ' PRO . 12.9 tmtt? -85.95 116.75 66.96 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 110.232 -0.284 . . . . 75.340000000000003 110.232 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.451 ' O ' ' HD3' ' A' ' 68' ' ' LYS . 56.7 Cg_endo -94.18 175.06 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.3 2.666 . . . . 73.209999999999994 112.659 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -149.05 128.75 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.381 -0.6 . . . . 71.230000000000004 109.381 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.9 137.09 42.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.562 0.22 . . . . 75.030000000000001 110.891 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 37.7 p90 -154.64 158.19 39.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.749 -0.463 . . . . 73.400000000000006 109.749 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m -87.21 106.65 18.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.76 0.314 . . . . 75.200000000000003 110.816 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.77 111.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 109.774 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.24 -30.67 2.69 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.058 -0.817 . . . . 51.530000000000001 111.058 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.83 158.27 15.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.882 -0.414 . . . . 74.430000000000007 109.882 176.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 43.27 2.35 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.287 -0.483 . . . . 54.409999999999997 113.185 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.24 -23.74 62.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.044 0.45 . . . . 75.439999999999998 110.39 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.63 168.54 22.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.882 -0.599 . . . . 32.009999999999998 110.254 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 104' ' ' LEU . 12.6 pt -75.48 158.36 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 75.420000000000002 110.352 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 7.0 tmtm? -56.01 -37.41 69.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.79 0.329 . . . . 73.310000000000002 110.472 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.21 -46.33 86.11 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.804 -0.713 . . . . 34.43 112.158 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -73.1 -38.65 66.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.477 -0.194 . . . . 71.340000000000003 110.477 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.71 78.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.002 0.43 . . . . 72.430000000000007 110.024 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.35 -43.92 89.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 109.923 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.93 -50.03 52.46 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.85 -0.613 . . . . 70.400000000000006 112.827 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.566 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.8 m -75.38 -33.3 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 62.310000000000002 111.328 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.15 -20.77 55.06 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.065 0.394 . . . . 72.340000000000003 112.065 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 86' ' ' GLY . 7.9 t -86.98 0.99 54.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.892 0.33 . . . . 72.319999999999993 111.892 -176.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.625 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 19.2 ptp -116.22 -171.18 1.94 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.615 0.245 . . . . 71.329999999999998 111.07 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 p -132.05 178.83 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.195 -0.457 . . . . 75.530000000000001 110.941 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.636 HD23 HG12 ' A' ' 130' ' ' VAL . 3.2 tm? -60.86 128.57 37.14 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 120.783 0.325 . . . . 74.120000000000005 110.753 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.74 87.45 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.62 -0.718 . . . . 72.25 112.592 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.1 tt0 -102.66 143.74 31.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.708 0.289 . . . . 71.340000000000003 110.705 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HE3' HD23 ' A' ' 31' ' ' LEU . 37.9 ttpt -136.86 142.48 42.8 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.012 0.434 . . . . 74.540000000000006 110.175 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.94 151.75 48.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.845 -0.616 . . . . 55.240000000000002 110.901 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.0 tp -90.59 105.37 17.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.385 -1.339 . . . . 62.350000000000001 107.385 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 11.3 t80 -110.44 109.65 20.11 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.048 -0.524 . . . . 65.010000000000005 111.086 -167.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.1 m -73.05 113.13 9.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.616 . . . . 71.140000000000001 110.682 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' A' ' 105' ' ' ALA . 35.2 mm -96.75 111.82 58.53 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.363 -0.38 . . . . 60.109999999999999 110.383 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HA ' HG23 ' A' ' 120' ' ' THR . 23.3 Cg_endo -61.85 155.55 53.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.531 2.154 . . . . 51.240000000000002 111.261 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 9.6 p90 -54.37 -42.16 70.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.837 -0.62 . . . . 74.230000000000004 112.265 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.25 -7.6 56.21 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.787 0.291 . . . . 73.140000000000001 111.787 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 80' ' ' ILE . 56.9 mt -102.84 15.3 29.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 72.140000000000001 110.56 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -152.83 175.01 13.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 75.530000000000001 110.616 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -66.28 -15.64 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 72.409999999999997 110.65 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -62.0 -16.68 53.34 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.013 -0.54 . . . . 75.140000000000001 112.636 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 102' ' ' TYR . 3.3 tm-20 -60.56 -55.87 28.22 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.102 0.477 . . . . 70.209999999999994 109.748 176.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.55 -31.44 14.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 72.200000000000003 111.391 -171.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.96 140.64 1.9 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.194 -0.527 . . . . 74.310000000000002 112.441 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.671 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.3 m-85 -137.54 -55.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 122.333 0.253 . . . . 75.400000000000006 110.681 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 80.5 Cg_endo -88.44 139.75 4.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.87 1.713 . . . . 74.049999999999997 111.299 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 72.8 Cg_exo -52.14 -24.88 21.37 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.862 2.374 . . . . 75.519999999999996 113.331 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 115' ' ' ILE . 27.2 m -72.88 -26.7 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.643 -0.253 . . . . 74.310000000000002 111.498 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 114' ' ' VAL . 49.1 mm -113.18 101.92 54.1 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.782 -0.451 . . . . 64.329999999999998 109.782 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.12 163.83 34.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.63 2.22 . . . . 73.409999999999997 111.97 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.3 148.7 84.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.295 1.997 . . . . 61.409999999999997 111.709 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt 67.89 19.58 9.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 73.319999999999993 111.087 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.21 27.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 111.082 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 101' ' ' PRO . 47.1 m -86.96 131.97 33.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.032 -0.729 . . . . 71.230000000000004 109.032 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -132.13 136.88 47.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.811 -0.44 . . . . 73.030000000000001 109.811 -171.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.535 ' N ' HD13 ' A' ' 121' ' ' LEU . 52.1 t -104.38 120.58 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 74.230000000000004 110.208 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 96.2 m-85 -109.31 127.22 54.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.251 -0.431 . . . . 52.100000000000001 110.419 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 29.7 mt-10 -75.15 114.1 13.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.408 -0.96 . . . . 64.310000000000002 108.408 168.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.488 HG23 ' HE3' ' A' ' 90' ' ' MET . 11.4 m -107.55 134.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 41.0 109.964 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.86 133.87 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.635 -0.257 . . . . 75.209999999999994 110.796 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.641 HD11 ' HB ' ' A' ' 130' ' ' VAL . 1.7 tm? -98.52 105.92 18.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.296 -0.631 . . . . 72.310000000000002 109.296 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.7 mm? -85.41 -41.98 14.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.418 -0.355 . . . . 73.209999999999994 111.189 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -146.7 140.52 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.652 0.263 . . . . 55.219999999999999 111.201 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 127' ' ' LEU . 5.0 p . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.428 -0.796 . . . . 71.349999999999994 109.929 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 109.532 -0.544 . . . . 62.340000000000003 109.532 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.64 110.61 5.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.36 . . . . 71.530000000000001 111.65 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.499 ' H ' ' HB ' ' A' ' 99' ' ' THR . 42.9 mm-40 -109.83 113.51 26.3 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.026 -0.731 . . . . 65.329999999999998 109.026 170.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -111.1 101.34 9.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.529 0.681 . . . . 71.0 109.461 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 43.0 tptt -108.96 117.66 34.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.508 -0.769 . . . . 73.319999999999993 110.17 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.99 106.0 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.483 -0.562 . . . . 70.430000000000007 109.483 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.49 HD12 ' HE2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -86.62 -29.66 22.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 73.129999999999995 109.734 -173.173 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -152.88 110.66 2.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.63 . . . . 74.030000000000001 109.563 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.58 126.7 20.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.876 2.384 . . . . 71.120000000000005 111.978 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.619 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -102.59 -157.63 25.7 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.358 -0.449 . . . . 71.120000000000005 112.6 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.83 -56.64 19.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.601 0.361 . . . . 72.409999999999997 111.26 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.88 -30.05 10.85 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 119.793 -0.449 . . . . 51.130000000000003 114.205 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.21 -9.72 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.102 0.951 . . . . 73.239999999999995 111.494 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.3 m -109.19 111.68 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.874 -0.417 . . . . 54.219999999999999 109.874 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 8.2 mtpm? -106.47 140.08 20.96 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.417 -0.356 . . . . 63.140000000000001 110.786 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.11 160.56 39.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.266 1.977 . . . . 71.040000000000006 110.672 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -141.29 171.46 14.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.633 0.254 . . . . 75.109999999999999 110.738 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.26 156.56 37.08 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.079 -0.51 . . . . 74.420000000000002 111.403 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.9 27.06 67.51 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.009 -0.541 . . . . 65.140000000000001 112.151 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -130.71 128.04 40.06 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.525 -0.176 . . . . 74.430000000000007 110.525 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 17.1 tppt? -73.45 104.91 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.006 -0.739 . . . . 61.229999999999997 109.006 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.3 m -107.26 152.26 8.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.144 0.497 . . . . 64.049999999999997 112.185 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.0 m -100.42 110.17 22.36 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.053 -0.976 . . . . 54.210000000000001 110.393 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' A' ' 72' ' ' PHE . 30.4 m -121.57 178.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.35 -0.841 . . . . 41.030000000000001 111.889 -172.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 4.6 t-160 -144.32 138.25 27.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.003 -0.74 . . . . 71.409999999999997 109.003 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' CD1' HG12 ' A' ' 125' ' ' VAL . 94.5 m-85 -126.64 144.21 50.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.572 -0.285 . . . . 71.340000000000003 110.96 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 58.7 m-20 -136.18 144.66 45.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.931 -0.766 . . . . 72.430000000000007 108.931 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.57 128.34 9.15 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.104 -0.569 . . . . 64.230000000000004 112.65 -173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 13.3 ttm180 -139.61 140.72 37.07 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.56 0.695 . . . . 71.310000000000002 111.343 -175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 60' ' ' PHE . 83.5 m-85 -81.19 157.82 70.39 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.538 -0.755 . . . . 75.120000000000005 109.468 172.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.97 -15.09 36.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.615 2.21 . . . . 74.209999999999994 112.247 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.29 -5.97 58.38 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.079 -0.509 . . . . 72.299999999999997 110.902 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.69 49.34 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.196 -0.526 . . . . 52.539999999999999 112.625 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.72 122.17 19.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 122.296 0.238 . . . . 64.140000000000001 110.885 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 12.8 pt20 -85.23 132.58 34.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.742 -0.466 . . . . 72.329999999999998 109.742 175.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 121' ' ' LEU . 44.8 p90 -89.34 -19.6 25.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.627 0.251 . . . . 73.530000000000001 110.847 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -156.97 144.31 18.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.614 -0.513 . . . . 72.129999999999995 109.614 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.8 p -124.46 98.7 5.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 110.861 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.04 64.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.344 -0.613 . . . . 61.149999999999999 109.344 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.472 HH12 ' CD ' ' A' ' 124' ' ' GLU . 6.9 ptt-85 -60.85 -41.19 95.36 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.603 -0.726 . . . . 74.420000000000002 110.807 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 t -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.978 -0.379 . . . . 52.329999999999998 109.978 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 66' ' ' ARG . 44.6 mtt180 -85.15 -28.85 25.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.172 0.511 . . . . 75.439999999999998 110.059 176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.08 26.27 64.65 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.578 -0.737 . . . . 63.329999999999998 111.712 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.35 116.84 55.91 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 122.234 0.214 . . . . 75.340000000000003 111.309 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.41 -178.63 3.8 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 73.209999999999994 112.074 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -140.86 163.62 32.43 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.951 -0.759 . . . . 71.230000000000004 108.951 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -142.07 138.07 31.47 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.55 0.214 . . . . 75.030000000000001 110.621 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 20.6 p90 -157.29 165.76 34.97 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.964 -0.384 . . . . 73.400000000000006 109.964 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 m -89.15 108.83 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.348 -0.241 . . . . 75.200000000000003 110.348 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.1 135.14 57.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.171 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.55 58.77 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.26 -0.495 . . . . 51.530000000000001 112.405 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.54 171.46 14.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.996 0.427 . . . . 74.430000000000007 110.999 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.12 55.93 4.95 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.745 -0.661 . . . . 54.409999999999997 112.333 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -119.12 -19.01 8.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.614 0.245 . . . . 75.439999999999998 110.495 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -142.77 162.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.497 -0.319 . . . . 32.009999999999998 110.324 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 104' ' ' LEU . 15.8 pt -72.31 151.34 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.958 -0.564 . . . . 75.420000000000002 110.366 174.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 51.3 mmtt -60.47 -15.81 30.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.331 0.493 . . . . 73.310000000000002 112.331 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.69 -60.27 8.78 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.26 -0.972 . . . . 34.43 111.254 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -67.07 -39.58 86.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.101 -0.333 . . . . 71.340000000000003 110.101 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 20.8 t70 -52.14 -54.95 24.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.513 -0.767 . . . . 72.430000000000007 110.625 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -68.21 -36.75 80.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.044 -0.525 . . . . 73.310000000000002 110.507 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -53.43 31.47 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.536 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' MET . 33.4 m -75.59 -30.89 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.734 0.302 . . . . 62.310000000000002 111.091 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.39 -26.23 67.15 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 86' ' ' GLY . 10.9 t -87.99 0.79 55.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.882 0.327 . . . . 72.319999999999993 111.882 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 16.1 ptp -112.4 -174.98 2.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.06 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -121.98 178.98 4.67 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.218 -0.446 . . . . 75.530000000000001 111.072 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -60.56 128.36 36.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.986 -0.552 . . . . 74.120000000000005 110.653 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.409 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 71.26 35.78 63.71 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.577 -0.344 . . . . 72.25 112.427 176.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.619 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 28.6 tt0 -128.02 150.45 49.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.666 0.27 . . . . 71.340000000000003 110.324 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HE2' HD12 ' A' ' 31' ' ' LEU . 6.8 ttpm? -133.26 138.84 46.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 74.540000000000006 110.678 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.9 145.07 41.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.768 -0.651 . . . . 55.240000000000002 110.645 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 8.6 tt -90.25 105.56 17.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.321 -1.362 . . . . 62.350000000000001 107.321 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.56 ' HD2' HD13 ' A' ' 100' ' ' ILE . 17.7 t80 -111.65 114.05 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 65.010000000000005 110.031 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 16.2 m -75.71 106.75 7.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 110.068 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.56 HD13 ' HD2' ' A' ' 98' ' ' PHE . 34.5 mm -80.77 114.31 47.17 Favored Pre-proline 0 C--O 1.243 0.744 0 CA-C-N 116.069 -0.514 . . . . 60.109999999999999 110.568 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.663 ' HA ' HG23 ' A' ' 120' ' ' THR . 21.4 Cg_exo -66.31 149.93 84.84 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.825 2.35 . . . . 51.240000000000002 112.007 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.38 -30.46 52.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.755 -0.657 . . . . 74.230000000000004 111.307 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -65.64 -35.95 82.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.066 -0.516 . . . . 73.140000000000001 111.388 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 80' ' ' ILE . 93.3 mt -100.48 19.96 15.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.140000000000001 111.022 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.09 -178.22 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 75.530000000000001 110.995 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.22 -9.93 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.646 -0.707 . . . . 72.409999999999997 110.424 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.92 40.08 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.856 -0.611 . . . . 75.140000000000001 113.742 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 35.9 tt0 -65.97 -41.36 91.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.652 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.51 -14.07 20.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.052 -0.522 . . . . 72.200000000000003 111.053 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 66.89 -82.07 0.12 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-N 116.033 -0.53 . . . . 74.310000000000002 113.777 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.747 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 62.9 m-85 97.92 -74.25 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.859 1.663 . . . . 75.400000000000006 111.478 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 11.3 Cg_endo -89.05 143.16 4.77 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.058 1.839 . . . . 74.049999999999997 111.856 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.62 -18.41 40.11 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.862 2.375 . . . . 75.519999999999996 112.422 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.68 -37.39 79.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.031 -0.532 . . . . 74.310000000000002 109.948 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.8 mm -106.8 106.48 58.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.573 -0.74 . . . . 64.329999999999998 109.498 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.44 148.6 92.56 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.457 2.105 . . . . 73.409999999999997 112.365 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.36 144.35 67.51 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.551 2.168 . . . . 61.409999999999997 112.235 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 44.7 mtpt 63.59 25.72 14.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.402 -0.817 . . . . 73.319999999999993 111.21 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.49 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 74.120000000000005 111.535 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 101' ' ' PRO . 28.3 m -86.18 131.24 34.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 71.230000000000004 109.072 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -123.82 145.73 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.711 -0.478 . . . . 73.030000000000001 109.711 -170.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.615 ' N ' HD13 ' A' ' 121' ' ' LEU . 97.5 t -98.38 119.8 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.78 0.324 . . . . 74.230000000000004 110.33 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.409 ' CE1' HD12 ' A' ' 121' ' ' LEU . 57.7 m-85 -116.08 118.61 33.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 52.100000000000001 110.166 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 38.2 mt-10 -83.22 106.99 15.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.831 . . . . 64.310000000000002 109.037 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.442 ' O ' ' HE1' ' A' ' 90' ' ' MET . 28.9 m -102.92 145.32 12.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 41.0 110.261 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 43.5 tt0 -143.27 130.12 20.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.542 -0.299 . . . . 75.209999999999994 110.484 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -98.82 105.7 17.88 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.922 -0.77 . . . . 72.310000000000002 108.922 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.89 -48.14 10.33 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.894 0.378 . . . . 73.209999999999994 110.289 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -164.94 -173.68 3.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.656 -0.702 . . . . 55.219999999999999 109.823 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.081 -0.961 . . . . 71.349999999999994 109.762 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.715 ' HB2' HG21 ' A' ' 120' ' ' THR . 71.7 mt-30 . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.899 -0.408 . . . . 62.340000000000003 109.899 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -145.76 112.94 6.15 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.816 0.341 . . . . 71.530000000000001 110.96 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 43.6 mt-10 -136.86 135.36 37.8 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.263 -0.643 . . . . 65.329999999999998 109.263 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -132.91 101.12 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.482 0.658 . . . . 71.0 109.668 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -113.34 110.89 21.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.245 -0.889 . . . . 73.319999999999993 110.378 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.13 111.1 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 70.430000000000007 110.445 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.5 mt -85.4 -24.04 27.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 73.129999999999995 110.327 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.1 m -153.35 110.69 2.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.634 -0.712 . . . . 74.030000000000001 109.462 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.83 126.6 13.45 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 71.120000000000005 111.835 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.19 -145.66 15.24 Favored Glycine 0 C--O 1.237 0.296 0 CA-C-N 115.906 -0.588 . . . . 71.120000000000005 112.114 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.477 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.6 m-20 -66.0 -43.92 86.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.787 0.327 . . . . 72.409999999999997 111.501 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.48 -30.14 2.82 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.228 -0.51 . . . . 51.130000000000003 112.333 -175.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' HB3' ' A' ' 35' ' ' ASP . 33.4 m -89.29 -24.9 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.943 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.4 p -78.03 95.41 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 54.219999999999999 110.524 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -106.41 103.91 48.03 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.577 -0.738 . . . . 63.140000000000001 111.066 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.11 156.62 42.52 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.467 2.111 . . . . 71.040000000000006 111.454 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.76 170.69 14.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.329 . . . . 75.109999999999999 110.74 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.88 156.74 26.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.806 -0.634 . . . . 74.420000000000002 111.047 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.92 25.28 67.29 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 115.889 -0.596 . . . . 65.140000000000001 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -130.01 119.15 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 74.430000000000007 110.748 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -66.34 104.27 1.18 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.159 -0.682 . . . . 61.229999999999997 109.159 172.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.549 HG12 HG23 ' A' ' 130' ' ' VAL . 29.5 m -106.98 155.56 7.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.301 -0.409 . . . . 64.049999999999997 111.342 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -98.91 108.27 20.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.483 -0.781 . . . . 54.210000000000001 110.646 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.508 HG12 HD22 ' A' ' 127' ' ' LEU . 10.5 m -123.43 178.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 41.030000000000001 111.394 -173.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 65.0 t60 -152.29 133.31 14.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 109.566 170.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -126.79 146.19 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.578 -0.897 . . . . 71.340000000000003 108.578 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' PHE . 0.8 OUTLIER -135.86 152.02 50.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.823 -0.436 . . . . 72.430000000000007 109.823 -177.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.05 129.32 9.78 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.381 -0.438 . . . . 64.230000000000004 113.003 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -147.52 145.94 29.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.2 0.524 . . . . 71.310000000000002 110.302 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.413 ' HE1' ' HB2' ' A' ' 60' ' ' PHE . 77.6 m-85 -90.22 148.47 39.29 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.306 -0.406 . . . . 75.120000000000005 110.422 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.77 -13.77 28.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.796 2.331 . . . . 74.209999999999994 111.719 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.16 -25.97 64.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.497 -0.774 . . . . 72.299999999999997 110.348 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.89 -14.78 28.99 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.343 -0.844 . . . . 52.539999999999999 111.489 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -103.11 148.67 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.09 0.556 . . . . 64.140000000000001 110.938 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.71 135.07 54.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.589 -0.522 . . . . 72.329999999999998 109.589 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.413 ' HB2' ' HE1' ' A' ' 54' ' ' PHE . 79.6 t80 -68.76 -62.34 1.43 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.148 -0.478 . . . . 73.530000000000001 110.783 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -137.51 131.31 31.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.92 -0.77 . . . . 72.129999999999995 108.92 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.547 ' OG ' ' HG3' ' A' ' 64' ' ' ARG . 9.7 t -111.02 134.44 52.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.108 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.8 m -75.75 -22.98 55.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.103 -0.499 . . . . 61.149999999999999 111.427 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.547 ' HG3' ' OG ' ' A' ' 62' ' ' SER . 6.7 ppt_? -56.82 -30.67 63.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.654 0.264 . . . . 74.420000000000002 110.861 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 8.9 m -59.14 -26.53 64.81 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.282 -0.417 . . . . 52.329999999999998 110.99 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -96.2 -16.12 21.64 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.113 -0.494 . . . . 75.439999999999998 110.409 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.95 15.78 69.72 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.804 -0.635 . . . . 63.329999999999998 113.51 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.3 ttpp -88.64 118.99 69.95 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-O 120.742 0.306 . . . . 75.340000000000003 111.009 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -89.27 -173.05 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.459 2.773 . . . . 73.209999999999994 111.753 175.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.435 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 81.0 m-85 -137.2 160.31 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 71.230000000000004 109.735 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -139.26 131.31 27.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.848 -0.427 . . . . 75.030000000000001 109.848 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -155.89 156.59 34.89 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.786 -0.45 . . . . 73.400000000000006 109.786 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 86.3 m -79.4 114.54 18.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.14 -0.319 . . . . 75.200000000000003 110.14 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.726 HD11 ' HB2' ' A' ' 88' ' ' ALA . 32.6 tp -56.83 123.13 13.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.744 -0.465 . . . . 75.129999999999995 109.744 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.74 -26.46 24.01 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.886 -0.486 . . . . 51.530000000000001 111.886 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.47 5.07 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.004 0.431 . . . . 74.430000000000007 111.231 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.37 16.52 48.78 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.158 -0.544 . . . . 54.409999999999997 113.186 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -56.25 -39.97 73.42 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 110.181 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 28.3 m -126.43 164.91 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 32.009999999999998 109.177 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 104' ' ' LEU . 14.9 pt -67.75 150.05 11.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.123 0.487 . . . . 75.420000000000002 111.482 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 24.8 mmtm -62.8 -17.42 61.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.787 -0.642 . . . . 73.310000000000002 111.845 -175.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.23 20.73 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.349 -0.929 . . . . 34.43 111.088 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.455 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 18.7 m0 -71.69 -36.54 70.61 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.503 -0.349 . . . . 71.340000000000003 110.216 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.678 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 10.0 t70 -52.82 -55.23 24.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.841 -0.618 . . . . 72.430000000000007 110.39 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 15.2 mm-40 -72.75 -37.68 67.62 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.156 -0.475 . . . . 73.310000000000002 110.33 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.28 -49.79 49.37 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.932 -0.577 . . . . 70.400000000000006 112.038 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.8 p -75.99 -32.29 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.816 0.341 . . . . 62.310000000000002 111.05 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.726 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.52 -29.18 68.95 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.8 t -78.69 4.01 14.88 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.932 0.716 . . . . 72.319999999999993 112.932 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.4 ptp -120.04 -179.47 3.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.203 0.456 . . . . 71.329999999999998 111.442 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.414 HG21 ' HA2' ' A' ' 36' ' ' GLY . 68.7 p -118.88 178.86 4.33 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.963 -0.562 . . . . 75.530000000000001 111.124 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.0 tt -67.24 135.87 54.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.072 0.463 . . . . 74.120000000000005 110.704 -176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.551 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.8 17.25 80.04 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.415 -0.812 . . . . 72.25 111.821 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.84 137.51 51.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 71.340000000000003 110.351 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -123.83 135.31 53.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.625 -0.716 . . . . 74.540000000000006 109.46 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.91 148.75 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.21 0.529 . . . . 55.240000000000002 111.544 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.0 tt -90.76 114.0 26.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.225 -1.028 . . . . 62.350000000000001 108.225 174.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -119.79 116.6 26.23 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.934 0.397 . . . . 65.010000000000005 110.417 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 18.4 m -75.67 106.44 7.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.085 -0.507 . . . . 71.140000000000001 110.304 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.1 mm -83.69 116.72 66.06 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.29 -0.414 . . . . 60.109999999999999 110.624 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.543 ' HA ' HG23 ' A' ' 120' ' ' THR . 52.1 Cg_exo -54.63 146.48 53.84 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.015 2.477 . . . . 51.240000000000002 112.066 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -54.22 -39.62 66.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 112.081 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -69.93 -25.82 63.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.807 0.337 . . . . 73.140000000000001 111.092 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 80' ' ' ILE . 85.7 mt -93.26 15.42 15.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.035 0.445 . . . . 72.140000000000001 110.261 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.19 -170.08 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 75.530000000000001 109.827 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.621 ' HE2' HG13 ' A' ' 115' ' ' ILE . 45.0 p90 -81.35 -7.56 59.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.37 . . . . 72.409999999999997 110.59 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.8 -21.32 65.18 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.836 -0.62 . . . . 75.140000000000001 112.934 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.21 -46.13 79.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.369 0.604 . . . . 70.209999999999994 110.402 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -102.86 -36.31 8.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.949 -1.023 . . . . 72.200000000000003 111.416 -166.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.19 90.58 0.05 OUTLIER Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.178 -0.534 . . . . 74.310000000000002 112.025 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.577 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 95.7 m-85 -82.98 -52.41 0.64 Allowed Pre-proline 0 CA--C 1.537 0.476 0 O-C-N 122.809 -0.23 . . . . 75.400000000000006 110.997 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 96.3 Cg_endo -84.87 143.92 9.57 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.757 1.638 . . . . 74.049999999999997 111.311 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.38 -16.81 30.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.371 . . . . 75.519999999999996 112.631 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.57 -34.74 58.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.074 -0.512 . . . . 74.310000000000002 110.526 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.621 HG13 ' HE2' ' A' ' 106' ' ' TYR . 49.2 mm -103.45 110.39 63.69 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 64.329999999999998 110.327 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.95 155.79 61.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.704 2.269 . . . . 73.409999999999997 111.992 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.34 148.91 88.69 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.239 1.96 . . . . 61.409999999999997 111.283 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 118' ' ' LYS . 9.2 mtpm? 60.93 23.15 13.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.04 0.536 . . . . 73.319999999999993 111.557 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.89 114.97 27.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.759 0.314 . . . . 74.120000000000005 110.474 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 25' ' ' GLN . 98.1 m -73.64 133.11 43.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 71.230000000000004 109.118 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.52 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.1 tm? -123.48 142.62 50.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.246 -0.65 . . . . 73.030000000000001 109.246 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.52 ' N ' HD13 ' A' ' 121' ' ' LEU . 67.4 t -98.27 136.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.001 0.429 . . . . 74.230000000000004 110.24 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 49.7 m-85 -123.28 122.18 37.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 52.100000000000001 110.42 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -80.36 107.23 12.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.28 -1.008 . . . . 64.310000000000002 108.28 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.84 150.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.507 -0.77 . . . . 41.0 111.195 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -150.19 136.33 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.976 -0.557 . . . . 75.209999999999994 110.295 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.5 tm? -96.81 109.53 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.572 -0.899 . . . . 72.310000000000002 108.572 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.71 -43.5 15.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.913 0.387 . . . . 73.209999999999994 110.426 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -171.23 -178.11 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 55.219999999999999 109.82 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.549 HG23 HG12 ' A' ' 46' ' ' VAL . 5.2 p . . . . . 0 C--O 1.249 1.069 0 N-CA-C 109.24 -0.652 . . . . 71.349999999999994 109.24 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 108.898 -0.778 . . . . 62.340000000000003 108.898 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.31 105.29 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.641 0.257 . . . . 71.530000000000001 110.368 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' PHE . 37.7 mt-10 -137.82 122.66 18.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.342 -0.614 . . . . 65.329999999999998 109.342 170.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.595 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -120.44 122.63 41.11 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.26 -0.644 . . . . 71.0 109.26 175.204 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 35.1 ttmt -116.1 110.12 18.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.073 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.66 104.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 70.430000000000007 110.533 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 ' HE2' ' A' ' 95' ' ' LYS . 35.2 tp -88.37 -22.18 23.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 73.129999999999995 110.026 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 m -149.92 110.93 3.32 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.636 -0.711 . . . . 74.030000000000001 109.745 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.69 119.05 6.06 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.754 2.302 . . . . 71.120000000000005 111.588 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.634 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -86.65 -176.82 49.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.933 -0.651 . . . . 71.120000000000005 112.735 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.83 -33.02 69.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.65 0.262 . . . . 72.409999999999997 111.305 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.26 -30.29 1.63 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 113.511 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -79.37 -38.09 19.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 73.239999999999995 111.048 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 p -66.15 94.0 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.514 . . . . 54.219999999999999 110.715 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -102.09 115.78 64.13 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.479 . . . . 63.140000000000001 110.605 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.95 -173.09 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.684 2.256 . . . . 71.040000000000006 112.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -156.66 164.74 37.81 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.148 -0.478 . . . . 75.109999999999999 110.112 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.98 127.69 33.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.239 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.28 31.63 7.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.772 -0.531 . . . . 65.140000000000001 111.772 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 130.29 49.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.984 -0.376 . . . . 74.430000000000007 109.984 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.11 108.26 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.552 . . . . 61.229999999999997 109.511 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.52 158.68 19.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 116.365 -0.379 . . . . 64.049999999999997 111.128 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 28.8 m -111.92 115.78 29.54 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.956 -0.565 . . . . 54.210000000000001 110.209 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 127' ' ' LEU . 10.3 m -120.99 177.96 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.184 0.516 . . . . 41.030000000000001 111.684 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.407 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.1 t-80 -149.83 139.64 21.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.306 -0.861 . . . . 71.409999999999997 108.712 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -137.72 156.02 48.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.578 -0.283 . . . . 71.340000000000003 110.81 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -152.98 160.53 43.03 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.014 -0.736 . . . . 72.430000000000007 109.014 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 59' ' ' GLN . . . -132.16 151.17 19.78 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.784 -0.722 . . . . 64.230000000000004 113.271 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -148.77 155.05 40.43 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.849 0.459 . . . . 71.310000000000002 109.886 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -87.1 150.17 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 110.407 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.87 -31.77 90.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.908 2.405 . . . . 74.209999999999994 112.954 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.94 -39.95 83.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.472 -0.331 . . . . 72.299999999999997 110.752 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.4 -26.55 1.99 Allowed Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.711 -0.757 . . . . 52.539999999999999 113.429 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -74.79 164.64 26.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.188 0.494 . . . . 64.140000000000001 110.821 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 63.4 tt0 -134.0 141.15 47.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 72.329999999999998 109.911 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -72.23 -54.17 10.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.158 0.504 . . . . 73.530000000000001 110.261 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -151.77 143.97 23.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.648 -0.705 . . . . 72.129999999999995 109.312 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -91.61 90.96 7.81 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.187 0.518 . . . . 73.409999999999997 111.875 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.4 t -73.83 -23.97 59.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.056 -0.52 . . . . 61.149999999999999 110.225 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 4.6 ptm180 -68.7 -34.68 76.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.83 -0.433 . . . . 74.420000000000002 109.83 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -73.51 -36.21 65.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.751 -0.659 . . . . 52.329999999999998 110.937 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -76.6 -28.61 56.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.437 -0.347 . . . . 75.439999999999998 110.615 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.54 37.08 94.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.24 -0.505 . . . . 63.329999999999998 112.714 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -79.48 115.67 55.01 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 110.183 -0.302 . . . . 75.340000000000003 110.183 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 169.17 15.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.732 2.288 . . . . 73.209999999999994 111.754 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.409 ' O ' HG22 ' A' ' 48' ' ' VAL . 77.8 t80 -147.62 115.6 6.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.581 -0.526 . . . . 71.230000000000004 109.581 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -100.11 127.31 46.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.74 -0.467 . . . . 75.030000000000001 109.74 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -153.65 170.03 21.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 73.400000000000006 110.77 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 104.56 14.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 75.200000000000003 109.856 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 88' ' ' ALA . 48.4 tp -59.06 138.91 57.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 75.129999999999995 110.772 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.41 25.91 37.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.061 -0.59 . . . . 51.530000000000001 112.103 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . . . -132.27 178.71 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.22 -0.289 . . . . 74.430000000000007 110.22 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.91 39.47 3.12 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 121.235 -0.507 . . . . 54.409999999999997 112.168 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 76' ' ' ALA . 6.8 mm-40 -74.88 -34.35 62.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.247 0.546 . . . . 75.439999999999998 109.726 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.58 171.65 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.152 -0.931 . . . . 32.009999999999998 109.163 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.7 pt -59.64 141.28 16.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.936 -0.394 . . . . 75.420000000000002 109.936 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 67.2 mmtt -61.59 -16.21 46.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.287 0.477 . . . . 73.310000000000002 112.287 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.05 -52.0 54.98 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.139 -1.029 . . . . 34.43 110.87 171.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -73.77 -43.65 58.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.53 -0.335 . . . . 71.340000000000003 110.381 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.583 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 29.4 t70 -53.5 -54.9 30.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.1 -0.5 . . . . 72.430000000000007 110.442 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.82 -44.6 69.63 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.677 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.21 -47.84 54.61 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.993 -0.548 . . . . 70.400000000000006 112.313 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG22 HD23 ' A' ' 127' ' ' LEU . 8.7 p -75.96 -33.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.8 0.334 . . . . 62.310000000000002 110.775 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.594 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.76 -30.46 70.03 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.946 0.35 . . . . 72.340000000000003 111.946 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 86' ' ' GLY . 9.1 t -82.35 -10.19 59.17 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.419 0.526 . . . . 72.319999999999993 112.419 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.9 ptp -102.97 -170.02 1.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.998 -0.438 . . . . 71.329999999999998 111.001 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 127' ' ' LEU . 56.1 p -133.69 179.03 6.48 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.58 -0.282 . . . . 75.530000000000001 111.726 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.693 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.1 tt -64.19 137.83 58.14 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.235 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 75.12 13.64 82.55 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.651 -0.704 . . . . 72.25 111.908 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.634 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.6 tt0 -111.37 134.13 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 71.340000000000003 110.443 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' HD23 ' A' ' 31' ' ' LEU . 6.1 ttpm? -133.96 130.43 37.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.612 -0.722 . . . . 74.540000000000006 109.765 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.14 143.88 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.031 0.443 . . . . 55.240000000000002 110.966 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.89 111.03 22.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.061 -1.088 . . . . 62.350000000000001 108.061 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 16.9 t80 -112.73 137.99 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 65.010000000000005 110.328 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -89.26 106.68 18.6 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.791 -0.448 . . . . 71.140000000000001 109.791 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.96 113.74 60.66 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 116.38 -0.373 . . . . 60.109999999999999 111.034 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.42 159.35 39.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.795 2.33 . . . . 51.240000000000002 111.908 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -60.02 -26.46 66.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.04 0.385 . . . . 74.230000000000004 112.04 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.656 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 11.2 pt20 -66.1 -18.68 65.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.694 0.283 . . . . 73.140000000000001 111.236 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.656 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 93.9 mt -115.2 14.91 17.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.387 -0.37 . . . . 72.140000000000001 110.948 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.57 175.46 13.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.273 0.559 . . . . 75.530000000000001 111.551 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -72.6 -11.24 60.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.481 -0.781 . . . . 72.409999999999997 110.654 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.18 -15.28 7.09 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.879 -0.601 . . . . 75.140000000000001 113.578 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.6 tt0 -63.59 -55.22 25.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.223 0.535 . . . . 70.209999999999994 110.144 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -97.34 -5.49 36.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.432 -0.804 . . . . 72.200000000000003 110.647 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 64.02 -91.22 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.68 -0.691 . . . . 74.310000000000002 113.618 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.737 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 44.0 m-85 98.94 -65.78 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.793 1.637 . . . . 75.400000000000006 111.562 -172.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 5.1 Cg_exo -75.81 135.55 17.75 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.703 1.602 . . . . 74.049999999999997 111.262 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.5 -14.93 38.04 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.801 2.334 . . . . 75.519999999999996 112.675 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.0 t -75.49 -20.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 110.211 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.26 116.36 64.54 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.845 -0.616 . . . . 64.329999999999998 110.072 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.38 154.07 70.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.619 2.213 . . . . 73.409999999999997 111.946 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.48 126.88 16.97 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.31 2.007 . . . . 61.409999999999997 111.867 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 56.0 mtmt 57.22 49.75 12.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 73.319999999999993 110.713 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.02 148.88 22.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 74.120000000000005 111.348 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.7 m -100.66 131.48 46.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.591 -0.732 . . . . 71.230000000000004 109.698 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.27 161.63 20.09 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.92 0.39 . . . . 73.030000000000001 111.002 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.0 t -98.61 131.51 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.322 -0.621 . . . . 74.230000000000004 109.322 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.95 123.76 23.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 52.100000000000001 111.252 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 48.5 mt-10 -85.76 111.08 19.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.047 -0.723 . . . . 64.310000000000002 109.047 173.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.41 143.72 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 41.0 109.952 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -147.48 133.15 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 75.209999999999994 110.812 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.0 tm? -102.64 113.16 26.3 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.968 -0.752 . . . . 72.310000000000002 108.968 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.03 -44.43 10.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.566 -0.288 . . . . 73.209999999999994 111.103 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -145.55 141.66 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.638 -0.255 . . . . 55.219999999999999 111.121 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.252 1.199 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.224 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 108.786 -0.82 . . . . 62.340000000000003 108.786 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.32 111.56 5.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.861 0.362 . . . . 71.530000000000001 111.036 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -129.35 139.98 51.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.181 -0.463 . . . . 65.329999999999998 109.873 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HB3' ' HD1' ' A' ' 98' ' ' PHE . 24.9 pttm -139.0 111.8 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 71.0 109.549 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.23 117.26 20.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 73.319999999999993 109.175 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.11 136.28 26.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.088 0.47 . . . . 70.430000000000007 110.763 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.4 tp -101.42 -28.18 12.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 73.129999999999995 110.198 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -153.87 112.26 2.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.12 -0.696 . . . . 74.030000000000001 109.12 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.11 134.77 47.49 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.581 2.187 . . . . 71.120000000000005 111.824 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.04 177.81 50.88 Favored Glycine 0 C--O 1.236 0.232 0 C-N-CA 121.271 -0.49 . . . . 71.120000000000005 113.218 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' OD2' HG22 ' A' ' 37' ' ' VAL . 30.6 t70 -64.7 -30.22 71.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.918 0.389 . . . . 72.409999999999997 110.6 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.62 6.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 114.884 0.714 . . . . 51.130000000000003 114.884 168.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.466 HG22 ' OD2' ' A' ' 35' ' ' ASP . 6.4 m -89.75 -23.36 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 117.924 0.862 . . . . 73.239999999999995 112.271 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.601 HG21 ' HB2' ' A' ' 92' ' ' LEU . 34.0 p -62.66 125.57 24.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.698 -0.228 . . . . 54.219999999999999 111.063 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -100.07 126.98 34.67 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 120.933 0.397 . . . . 63.140000000000001 111.29 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -90.24 160.18 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.158 2.572 . . . . 71.040000000000006 111.847 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.623 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 19.8 pt20 -157.41 158.84 36.63 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 110.116 -0.327 . . . . 75.109999999999999 110.116 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -74.16 109.67 7.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.257 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.15 -21.22 3.51 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.738 -0.744 . . . . 65.140000000000001 113.143 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.623 ' HE2' ' HG2' ' A' ' 41' ' ' GLN . 50.9 mtmt -84.35 129.95 34.83 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.042 0.448 . . . . 74.430000000000007 110.607 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.49 111.28 7.53 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.286 -1.005 . . . . 61.229999999999997 108.286 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 130' ' ' VAL . 33.4 m -106.0 143.75 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.982 0.42 . . . . 64.049999999999997 110.91 -174.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -100.35 111.39 23.65 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.27 -0.877 . . . . 54.210000000000001 109.509 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 87' ' ' VAL . 31.0 m -121.5 178.13 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 41.030000000000001 110.614 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 17.1 t-160 -147.27 136.37 22.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.2 -0.667 . . . . 71.409999999999997 109.2 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.485 ' HD1' HG12 ' A' ' 125' ' ' VAL . 78.3 m-85 -126.6 152.37 46.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.769 0.319 . . . . 71.340000000000003 111.086 -176.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -144.95 155.11 43.23 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.73 -0.841 . . . . 72.430000000000007 108.73 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.48 132.34 10.24 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.334 -0.46 . . . . 64.230000000000004 112.899 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ttm-85 -141.58 144.99 34.53 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.366 0.603 . . . . 71.310000000000002 110.902 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.92 147.3 61.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 75.120000000000005 109.555 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.63 -24.81 38.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.135 2.557 . . . . 74.209999999999994 113.491 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -74.33 -34.85 63.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.719 0.295 . . . . 72.299999999999997 110.552 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.78 -12.54 4.51 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 116.117 -0.492 . . . . 52.539999999999999 112.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -75.43 147.06 40.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.228 0.211 . . . . 64.140000000000001 110.568 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.88 127.36 26.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.772 -0.455 . . . . 72.329999999999998 109.772 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -67.54 -36.6 81.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.786 -0.643 . . . . 73.530000000000001 111.574 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -165.6 131.32 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 109.792 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 t -86.18 111.46 20.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.5 . . . . 73.409999999999997 110.728 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 m -79.4 -15.47 57.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 61.149999999999999 111.252 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 14.2 ptp180 -68.0 -32.18 72.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.535 -0.302 . . . . 74.420000000000002 110.764 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 t -67.33 -22.2 65.62 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.096 -0.502 . . . . 52.329999999999998 111.215 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -76.09 -8.97 58.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.706 0.289 . . . . 75.439999999999998 111.151 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.81 8.28 5.52 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 115.263 0.865 . . . . 63.329999999999998 115.263 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -99.3 128.85 30.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 117.669 0.735 . . . . 75.340000000000003 110.065 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -86.74 178.45 3.75 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.801 2.334 . . . . 73.209999999999994 111.912 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -134.45 133.31 40.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.485 -0.561 . . . . 71.230000000000004 109.485 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 96.4 mt-30 -106.19 133.59 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.632 -0.258 . . . . 75.030000000000001 110.368 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 25.3 p90 -152.47 154.96 36.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.584 0.231 . . . . 73.400000000000006 110.415 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.455 ' N ' ' HG3' ' A' ' 78' ' ' GLU . 55.6 m -74.62 110.26 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.551 -0.295 . . . . 75.200000000000003 110.34 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 88' ' ' ALA . 53.0 tp -67.2 136.7 55.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.488 -0.324 . . . . 75.129999999999995 110.478 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.89 80.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.266 -0.493 . . . . 51.530000000000001 112.33 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.61 167.41 11.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.177 -0.305 . . . . 74.430000000000007 110.177 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.92 50.43 3.9 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.337 -0.459 . . . . 54.409999999999997 112.484 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 73' ' ' THR . 6.7 mm-40 -79.68 -46.33 17.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 75.439999999999998 109.968 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.66 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.331 -0.85 . . . . 32.009999999999998 109.839 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.429 HG13 ' H ' ' A' ' 83' ' ' TRP . 30.7 pt -58.54 142.93 13.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.097 0.475 . . . . 75.420000000000002 111.013 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 37.6 mmtm -55.86 -23.22 29.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.814 -0.63 . . . . 73.310000000000002 111.846 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.37 -51.9 56.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.641 -0.79 . . . . 34.43 111.635 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.429 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.2 m0 -70.38 -38.61 74.75 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.267 -0.271 . . . . 71.340000000000003 110.267 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.9 t70 -52.12 -54.66 27.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.117 -0.492 . . . . 72.430000000000007 110.266 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.34 -43.06 95.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.211 -0.45 . . . . 73.310000000000002 110.636 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.66 -48.67 55.65 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.953 -0.567 . . . . 70.400000000000006 112.66 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.538 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.1 m -75.65 -33.83 27.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.927 0.394 . . . . 62.310000000000002 111.176 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -73.81 -13.56 60.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.943 0.349 . . . . 72.340000000000003 111.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -95.58 12.14 30.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 121.267 -0.173 . . . . 72.319999999999993 111.325 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.0 ptp -133.32 -177.19 4.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 111.631 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.5 p -135.93 179.11 6.54 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.7 -0.682 . . . . 75.530000000000001 111.33 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.653 ' HA ' HD12 ' A' ' 127' ' ' LEU . 1.5 tm? -51.45 124.62 12.41 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.968 0.507 . . . . 74.120000000000005 111.104 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 84.81 -1.09 89.09 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.009 -0.541 . . . . 72.25 112.877 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 11.0 tt0 -88.13 143.14 27.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.011 0.434 . . . . 71.340000000000003 110.787 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -142.45 133.51 25.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.531 -0.759 . . . . 74.540000000000006 109.025 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.13 30.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.421 . . . . 55.240000000000002 111.743 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.5 tt -90.86 110.14 21.36 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.475 -0.935 . . . . 62.350000000000001 108.475 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.474 ' HD1' ' HB3' ' A' ' 28' ' ' LYS . 70.3 t80 -122.25 134.31 54.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.144 0.497 . . . . 65.010000000000005 110.888 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.2 m -79.31 120.81 24.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.837 -0.62 . . . . 71.140000000000001 110.264 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.3 mm -99.03 107.24 42.91 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 110.025 -0.361 . . . . 60.109999999999999 110.025 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HA ' HG23 ' A' ' 120' ' ' THR . 28.2 Cg_exo -61.94 145.91 96.62 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.72 2.28 . . . . 51.240000000000002 111.245 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -54.33 -35.49 62.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 111.47 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -64.24 -26.42 68.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.318 -0.401 . . . . 73.140000000000001 111.263 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.02 11.83 37.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.508 -0.315 . . . . 72.140000000000001 111.02 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.16 -176.77 5.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 75.530000000000001 111.018 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.44 -11.81 60.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.693 -0.685 . . . . 72.409999999999997 110.782 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.89 -14.9 59.4 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.843 -0.617 . . . . 75.140000000000001 112.315 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.34 -55.64 30.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.897 -0.408 . . . . 70.209999999999994 109.897 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -86.2 -41.88 14.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.59 . . . . 72.200000000000003 110.758 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.05 143.2 3.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 74.310000000000002 111.608 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.654 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 95.5 m-85 -142.87 -51.69 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 122.84 -0.212 . . . . 75.400000000000006 110.72 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.654 ' HD2' ' H ' ' A' ' 111' ' ' TYR . 89.3 Cg_endo -82.07 138.41 10.18 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.582 1.522 . . . . 74.049999999999997 110.789 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 50.9 Cg_exo -56.26 -21.36 35.84 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 122.868 2.379 . . . . 75.519999999999996 113.349 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 115' ' ' ILE . 35.5 m -75.12 -24.83 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.037 0.446 . . . . 74.310000000000002 110.834 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.647 HG12 HG23 ' A' ' 114' ' ' VAL . 49.0 mm -123.0 88.13 50.9 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 109.173 -0.677 . . . . 64.329999999999998 109.173 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.43 173.59 14.23 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.922 2.415 . . . . 73.409999999999997 112.505 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.42 132.54 24.61 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.576 2.184 . . . . 61.409999999999997 112.84 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 62.43 37.64 13.39 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.437 -0.801 . . . . 73.319999999999993 111.671 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.4 114.74 26.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.120000000000005 110.762 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.9 m -82.3 136.98 34.94 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 71.230000000000004 109.921 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.7 tm? -134.25 145.17 48.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.669 -0.493 . . . . 73.030000000000001 109.669 -172.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 121' ' ' LEU . 61.8 t -99.82 120.91 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.229 . . . . 74.230000000000004 110.398 -176.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -110.83 131.99 54.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.123 0.487 . . . . 52.100000000000001 111.109 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.13 117.08 28.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.855 -0.794 . . . . 64.310000000000002 108.855 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.485 HG12 ' HD1' ' A' ' 50' ' ' TYR . 19.2 m -109.4 149.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.695 . . . . 41.0 110.728 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.0 tt0 -145.03 133.48 21.88 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.837 -0.619 . . . . 75.209999999999994 110.202 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -102.36 116.03 31.78 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 122.702 0.401 . . . . 72.310000000000002 110.192 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.3 mm? -96.75 -37.66 10.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 111.296 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.9 142.26 20.6 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.837 -0.165 . . . . 55.219999999999999 111.016 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 46' ' ' VAL . 3.1 p . . . . . 0 C--O 1.251 1.162 0 CA-C-N 116.49 -0.323 . . . . 71.349999999999994 110.745 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.641 0.258 . . . . 62.340000000000003 110.717 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 tp -145.9 137.0 24.66 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.851 0.358 . . . . 71.530000000000001 111.37 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -141.35 140.63 33.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.944 -0.762 . . . . 65.329999999999998 108.944 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.34 119.85 13.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.848 0.356 . . . . 71.0 110.601 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -112.82 125.59 54.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 73.319999999999993 109.776 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 114.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.562 -0.533 . . . . 70.430000000000007 109.562 176.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.7 mt -99.24 -27.01 13.99 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.58 0.229 . . . . 73.129999999999995 111.5 -174.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 7.4 m -153.66 110.64 2.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 110.247 -0.279 . . . . 74.030000000000001 110.247 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.12 124.15 13.01 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.188 . . . . 71.120000000000005 111.619 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -92.36 -174.13 41.84 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.241 -0.504 . . . . 71.120000000000005 113.098 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -44.66 -57.17 3.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.823 0.849 . . . . 72.409999999999997 112.13 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.1 -30.65 9.44 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.013 -0.613 . . . . 51.130000000000003 114.594 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.5 m -90.34 -22.81 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.175 0.988 . . . . 73.239999999999995 111.007 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.419 HG21 HD13 ' A' ' 92' ' ' LEU . 5.2 p -65.14 142.82 58.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 54.219999999999999 110.541 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.19 101.57 16.24 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 63.140000000000001 110.947 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 141.38 26.72 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 71.040000000000006 111.507 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -131.74 160.42 35.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.073 -0.343 . . . . 75.109999999999999 110.073 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 140.83 50.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.358 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.22 64.98 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 65.140000000000001 112.152 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 143.62 33.28 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.779 0.323 . . . . 74.430000000000007 110.162 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 14.1 tppt? -69.89 126.69 30.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.916 -0.584 . . . . 61.229999999999997 110.027 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 130' ' ' VAL . 27.2 m -117.59 141.96 34.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 120.875 0.369 . . . . 64.049999999999997 110.758 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.4 m -99.87 108.53 20.81 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.369 -0.832 . . . . 54.210000000000001 109.749 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 87' ' ' VAL . 20.9 m -118.26 178.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.27 -0.877 . . . . 41.030000000000001 111.747 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.6 t-160 -155.87 135.97 12.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.393 -0.822 . . . . 71.409999999999997 109.126 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HD1' HG12 ' A' ' 125' ' ' VAL . 61.7 m-85 -126.81 155.51 42.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.479 0.18 . . . . 71.340000000000003 110.857 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 35.4 t70 -136.42 128.19 29.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.994 -0.548 . . . . 72.430000000000007 109.874 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -86.92 100.88 2.61 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.324 -0.465 . . . . 64.230000000000004 112.852 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 53' ' ' ARG . 24.2 ttm-85 -115.95 144.66 43.76 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.927 0.394 . . . . 71.310000000000002 111.126 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -90.67 151.12 43.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 110.085 -0.339 . . . . 75.120000000000005 110.085 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.52 -8.68 21.61 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.892 2.395 . . . . 74.209999999999994 113.473 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.46 -22.11 25.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.69 0.281 . . . . 72.299999999999997 111.162 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.79 10.14 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.313 -0.47 . . . . 52.539999999999999 112.033 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -97.53 162.89 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.345 -0.613 . . . . 64.140000000000001 109.345 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 19.4 pt20 -147.76 146.94 29.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.378 -0.23 . . . . 72.329999999999998 110.378 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -76.82 -34.01 57.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.276 -0.42 . . . . 73.530000000000001 111.714 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.24 131.71 17.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.989 -0.374 . . . . 72.129999999999995 109.989 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.541 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 11.3 p -81.73 85.6 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.223 0.535 . . . . 73.409999999999997 110.197 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.683 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 20.1 m -81.47 -21.66 38.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.786 -0.643 . . . . 61.149999999999999 109.985 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.42 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -66.94 -36.97 83.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.729 -0.669 . . . . 74.420000000000002 109.513 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.6 m -71.54 -21.58 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.468 -0.787 . . . . 52.329999999999998 110.877 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -76.0 -26.32 56.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.233 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.21 31.97 50.26 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.579 -0.737 . . . . 63.329999999999998 113.027 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 39.7 ttmt -79.13 119.8 78.43 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.536 0.168 . . . . 75.340000000000003 110.659 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.3 Cg_endo -82.63 93.92 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.069 2.513 . . . . 73.209999999999994 111.116 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.34 161.4 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.722 -0.672 . . . . 71.230000000000004 109.408 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.32 133.7 33.35 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.292 -0.255 . . . . 75.030000000000001 110.797 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HE1' HG11 ' A' ' 48' ' ' VAL . 26.9 p90 -150.81 158.08 43.71 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.422 -0.353 . . . . 73.400000000000006 110.199 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.5 m -77.42 113.04 14.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.07 -0.344 . . . . 75.200000000000003 110.07 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 88' ' ' ALA . 38.5 tp -60.39 140.41 57.2 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.441 -0.345 . . . . 75.129999999999995 110.878 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.13 -21.61 33.53 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 116.337 -0.392 . . . . 51.530000000000001 112.351 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.66 178.48 8.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 111.022 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.57 24.51 29.05 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.966 -0.561 . . . . 54.409999999999997 112.056 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.35 -41.49 84.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 109.892 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.453 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 34.5 m -123.68 178.23 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 32.009999999999998 109.058 174.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.9 pt -73.4 144.43 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.341 -0.615 . . . . 75.420000000000002 109.341 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.799 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 5.0 mptp? -61.84 -15.79 44.92 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.064 0.394 . . . . 73.310000000000002 112.064 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.96 33.56 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.553 -0.832 . . . . 34.43 111.044 171.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 27.4 m0 -72.33 -36.17 68.77 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 120.851 0.357 . . . . 71.340000000000003 110.238 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.799 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 25.7 t70 -57.62 -55.36 35.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.517 -0.765 . . . . 72.430000000000007 110.747 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -72.51 -38.09 68.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.303 -0.408 . . . . 73.310000000000002 110.15 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.619 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.37 -47.93 66.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.88 -0.6 . . . . 70.400000000000006 112.465 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.2 p -76.05 -35.16 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.773 0.32 . . . . 62.310000000000002 110.862 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.97 -29.27 69.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.679 0.252 . . . . 72.340000000000003 111.679 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 86' ' ' GLY . 6.5 t -79.49 9.11 5.2 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.675 0.62 . . . . 72.319999999999993 112.675 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 17.1 ptp -124.86 -168.4 1.81 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.043 -0.411 . . . . 71.329999999999998 110.896 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -128.92 178.69 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.479 -0.328 . . . . 75.530000000000001 111.404 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 127' ' ' LEU . 9.6 tt -63.28 135.53 57.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 74.120000000000005 111.196 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.65 10.94 85.69 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.907 -0.588 . . . . 72.25 112.633 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.503 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.7 tt0 -106.18 148.81 27.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 71.340000000000003 110.869 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -142.38 137.65 30.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 110.786 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.9 149.78 34.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.02 -0.536 . . . . 55.240000000000002 110.637 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.685 ' HB2' HD11 ' A' ' 31' ' ' LEU . 8.9 tt -90.72 107.51 19.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.494 -0.928 . . . . 62.350000000000001 108.494 175.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -112.0 125.71 54.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 65.010000000000005 110.168 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.6 m -76.2 130.35 38.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 71.140000000000001 110.268 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 43.3 mm -108.14 98.81 28.28 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.364 -0.38 . . . . 60.109999999999999 110.021 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' ILE . 44.7 Cg_endo -68.04 153.97 73.76 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.572 2.181 . . . . 51.240000000000002 111.694 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.31 -23.57 66.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.719 0.637 . . . . 74.230000000000004 112.719 -171.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.55 -16.77 57.08 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.674 0.249 . . . . 73.140000000000001 111.674 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.51 15.58 25.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 72.140000000000001 110.905 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.11 -175.8 5.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 111.322 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -73.79 -6.22 45.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.373 -0.83 . . . . 72.409999999999997 111.005 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -52.8 -25.11 21.74 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.367 0.417 . . . . 75.140000000000001 113.262 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.3 tt0 -61.04 -46.22 91.58 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.909 0.385 . . . . 70.209999999999994 110.74 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -99.63 -46.64 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 72.200000000000003 111.466 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.7 161.65 3.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.58 -0.343 . . . . 74.310000000000002 112.815 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.708 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 87.9 m-85 -135.82 -57.56 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 119.576 -0.25 . . . . 75.400000000000006 110.767 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 9.5 Cg_exo -71.69 142.95 40.82 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.857 1.705 . . . . 74.049999999999997 111.022 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 44.1 Cg_exo -57.36 -19.08 33.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.591 2.194 . . . . 75.519999999999996 112.147 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.461 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 33.9 t -76.09 -24.4 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 110.627 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.06 98.21 18.07 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.148 -0.478 . . . . 64.329999999999998 109.874 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 114' ' ' VAL . 17.9 Cg_exo -67.34 159.9 50.16 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.002 2.468 . . . . 73.409999999999997 112.573 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.81 136.12 44.15 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.588 2.192 . . . . 61.409999999999997 111.43 174.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 62.6 mttp 61.07 34.84 18.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.073 -0.512 . . . . 73.319999999999993 110.871 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.42 122.79 31.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.789 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -73.83 119.11 17.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.625 -0.509 . . . . 71.230000000000004 109.625 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.92 168.78 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.046 0.451 . . . . 73.030000000000001 110.401 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.6 t -133.0 138.21 52.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.426 -0.953 . . . . 74.230000000000004 108.426 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 46.8 m-85 -130.19 122.81 28.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.345 0.593 . . . . 52.100000000000001 110.734 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 31.2 tt0 -76.44 107.03 8.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.559 -1.275 . . . . 64.310000000000002 107.559 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.598 HG12 ' HD1' ' A' ' 50' ' ' TYR . 31.6 m -104.1 144.14 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 41.0 110.4 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 39.2 tt0 -147.54 128.31 14.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 75.209999999999994 110.633 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.5 tm? -98.55 106.17 18.41 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.626 -0.879 . . . . 72.310000000000002 108.626 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.8 mm? -78.57 -48.3 15.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 73.209999999999994 111.002 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.62 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 55.219999999999999 111.195 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.467 HG23 HG12 ' A' ' 46' ' ' VAL . 2.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-N 115.926 -0.579 . . . . 71.349999999999994 110.203 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.252 -0.277 . . . . 62.340000000000003 110.252 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -131.55 102.03 5.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.326 -0.99 . . . . 71.530000000000001 108.326 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.34 125.57 15.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 65.329999999999998 109.224 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -125.48 126.22 44.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 71.0 110.469 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -109.19 121.01 44.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.696 -0.683 . . . . 73.319999999999993 110.232 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.33 103.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.902 -0.407 . . . . 70.430000000000007 109.902 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.41 -19.66 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.42 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 37.9 m -149.57 110.83 3.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.992 -0.549 . . . . 74.030000000000001 109.712 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.75 130.63 23.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 71.120000000000005 111.824 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.17 -153.28 19.88 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.06 -0.518 . . . . 71.120000000000005 112.545 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.73 -36.9 42.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.161 0.505 . . . . 72.409999999999997 110.28 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.569 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.01 -17.72 11.07 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.623 -0.717 . . . . 51.130000000000003 113.329 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 m -89.4 -20.31 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.971 0.36 . . . . 73.239999999999995 111.971 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.4 p -79.95 144.17 33.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.998 0.428 . . . . 54.219999999999999 111.062 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.58 96.24 49.06 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.958 -0.564 . . . . 63.140000000000001 109.784 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 130' ' ' VAL . 51.6 Cg_exo -55.94 145.14 75.39 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.009 2.473 . . . . 71.040000000000006 113.188 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.17 146.0 44.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.971 -0.559 . . . . 75.109999999999999 109.939 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.6 166.14 24.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.728 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.07 7.3 70.46 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.221 -0.514 . . . . 65.140000000000001 112.711 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.95 149.88 40.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.943 0.401 . . . . 74.430000000000007 111.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.662 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -78.06 104.09 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.89 -0.782 . . . . 61.229999999999997 108.89 171.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.33 151.63 8.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.276 0.56 . . . . 64.049999999999997 111.661 -173.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 30.2 m -99.13 108.38 20.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.005 -0.998 . . . . 54.210000000000001 110.015 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.482 HG21 ' CE2' ' A' ' 72' ' ' PHE . 14.7 m -122.57 178.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.924 -0.58 . . . . 41.030000000000001 110.466 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 69' ' ' PRO . 50.0 t-80 -154.22 149.46 27.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.134 -0.691 . . . . 71.409999999999997 109.134 173.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -151.33 152.27 32.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.499 0.19 . . . . 71.340000000000003 110.615 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -135.74 134.59 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.157 -0.682 . . . . 72.430000000000007 109.157 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.23 139.71 15.35 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.281 -0.485 . . . . 64.230000000000004 112.818 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.58 HH21 HG21 ' A' ' 122' ' ' VAL . 11.1 ttp180 -142.03 137.15 30.9 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.092 0.472 . . . . 71.310000000000002 110.432 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -79.95 152.83 74.77 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.731 -0.668 . . . . 75.120000000000005 109.939 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.45 -18.68 32.72 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.666 2.244 . . . . 74.209999999999994 111.774 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.28 -38.87 88.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.392 -0.822 . . . . 72.299999999999997 110.367 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.09 -19.25 5.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.015 -0.538 . . . . 52.539999999999999 112.357 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -86.32 142.93 28.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.6 0.2 . . . . 64.140000000000001 110.571 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.2 mt-30 -86.45 155.25 20.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.604 -0.517 . . . . 72.329999999999998 109.604 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -76.16 -62.02 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.483 -0.562 . . . . 73.530000000000001 109.483 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -145.26 132.99 21.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.634 -0.712 . . . . 72.129999999999995 109.265 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 33.1 t -89.54 85.66 6.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 73.409999999999997 109.85 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 99.9 p -65.25 -26.78 68.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.486 . . . . 61.149999999999999 109.928 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 64' ' ' ARG . 5.3 ptp180 -60.35 -44.29 95.69 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.746 -0.661 . . . . 74.420000000000002 110.477 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -69.81 -23.44 63.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.061 0.458 . . . . 52.329999999999998 110.199 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' SER . 17.4 mtp180 -75.91 -21.85 56.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.294 -0.632 . . . . 75.439999999999998 109.294 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.07 46.53 7.6 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.404 -0.816 . . . . 63.329999999999998 114.128 170.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -145.8 128.98 8.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.101 0.451 . . . . 75.340000000000003 110.477 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 1.4 Cg_endo -84.91 -177.42 2.81 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.24 2.627 . . . . 73.209999999999994 111.914 174.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.4 152.36 48.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.242 -0.651 . . . . 71.230000000000004 109.242 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -134.14 129.58 36.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.356 -0.239 . . . . 75.030000000000001 110.356 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' CE2' HG21 ' A' ' 48' ' ' VAL . 12.6 p90 -154.61 169.86 22.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.715 -0.221 . . . . 73.400000000000006 110.543 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.522 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 21.7 m -80.88 119.09 22.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.421 -0.354 . . . . 75.200000000000003 111.204 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 88' ' ' ALA . 56.8 tp -70.21 137.69 51.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.09 -0.505 . . . . 75.129999999999995 110.347 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.17 24.99 64.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.014 -0.612 . . . . 51.530000000000001 112.422 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.67 172.3 11.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.727 0.299 . . . . 74.430000000000007 110.407 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 15.93 8.4 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.111 -0.495 . . . . 54.409999999999997 113.315 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 73' ' ' THR . 26.6 mm-40 -55.68 -42.99 75.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.269 0.557 . . . . 75.439999999999998 110.314 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.533 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 30.4 m -134.91 176.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 32.009999999999998 109.987 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.9 pt -69.21 150.01 10.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 116.499 -0.318 . . . . 75.420000000000002 110.392 177.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -58.59 -25.22 62.37 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 110.274 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.62 -52.16 54.21 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.055 -0.593 . . . . 34.43 111.963 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.533 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 49.8 m0 -68.14 -35.12 77.58 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.084 -0.339 . . . . 71.340000000000003 110.084 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.08 -49.37 71.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.105 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.14 -49.18 78.86 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.294 -0.412 . . . . 73.310000000000002 110.237 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.24 -50.05 48.05 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.455 -0.793 . . . . 70.400000000000006 113.003 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -75.36 -33.25 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.71 0.291 . . . . 62.310000000000002 111.763 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -77.69 -20.8 53.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.366 0.506 . . . . 72.340000000000003 112.366 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.3 t -85.76 -10.27 55.81 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.171 0.434 . . . . 72.319999999999993 112.171 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.9 ptp -107.19 -176.46 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 111.637 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.569 HG21 ' HA2' ' A' ' 36' ' ' GLY . 17.3 p -118.56 178.83 4.32 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.899 -0.591 . . . . 75.530000000000001 110.89 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.794 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.3 tt -67.28 126.42 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.096 0.474 . . . . 74.120000000000005 110.542 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.404 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 81.62 11.97 82.3 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.707 -0.679 . . . . 72.25 112.531 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 19.1 tt0 -100.5 146.48 27.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.841 0.353 . . . . 71.340000000000003 110.618 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.4 ttpm? -137.45 136.92 38.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.848 -0.614 . . . . 74.540000000000006 109.957 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.82 148.11 46.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.313 -0.403 . . . . 55.240000000000002 110.691 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.5 tt -90.75 105.47 17.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.628 -1.249 . . . . 62.350000000000001 107.628 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.86 126.43 50.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 65.010000000000005 110.268 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.3 m -84.89 106.44 16.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.949 -0.759 . . . . 71.140000000000001 108.949 174.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.98 110.77 40.44 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.435 -0.348 . . . . 60.109999999999999 110.77 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.93 140.87 47.01 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.486 2.124 . . . . 51.240000000000002 111.233 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 46.3 p90 -54.5 -35.06 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 111.781 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 13.8 pt20 -61.83 -20.87 64.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 111.543 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.554 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 95.6 mt -113.45 19.0 17.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.535 -0.302 . . . . 72.140000000000001 110.657 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.8 171.54 14.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.665 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -72.12 -17.34 61.98 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.282 -0.872 . . . . 72.409999999999997 110.587 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.89 -15.97 44.76 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.907 -0.588 . . . . 75.140000000000001 112.366 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 3.6 tm-20 -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.119 -0.326 . . . . 70.209999999999994 110.119 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -78.46 -52.83 7.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.426 -0.583 . . . . 72.200000000000003 109.426 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.97 153.36 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.936 -0.575 . . . . 74.310000000000002 113.008 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.592 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 54.2 m-85 -142.49 -59.84 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 122.574 0.35 . . . . 75.400000000000006 110.651 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 75.6 Cg_endo -84.51 151.18 11.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 121.899 1.733 . . . . 74.049999999999997 111.882 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.9 -21.49 64.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.683 2.255 . . . . 75.519999999999996 112.634 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.641 HG23 HG12 ' A' ' 115' ' ' ILE . 33.8 m -71.91 -22.45 21.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.301 -0.408 . . . . 74.310000000000002 110.724 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.641 HG12 HG23 ' A' ' 114' ' ' VAL . 47.1 mm -121.81 87.68 46.69 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 109.165 -0.68 . . . . 64.329999999999998 109.165 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 35.8 Cg_endo -64.98 156.34 63.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 73.409999999999997 111.785 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.11 135.85 60.2 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.358 2.038 . . . . 61.409999999999997 112.217 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 98.1 mttt 61.83 35.12 16.73 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.778 -0.647 . . . . 73.319999999999993 111.493 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -89.29 125.04 34.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.053 -0.521 . . . . 74.120000000000005 111.562 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.6 m -74.09 132.81 42.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.921 -0.581 . . . . 71.230000000000004 109.442 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.582 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -129.58 150.41 50.92 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.883 -0.414 . . . . 73.030000000000001 109.883 -171.239 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.582 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.0 t -98.73 131.06 46.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 110.378 -0.23 . . . . 74.230000000000004 110.378 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.456 ' CE2' HD12 ' A' ' 121' ' ' LEU . 56.5 m-85 -130.32 118.76 21.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 52.100000000000001 110.644 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 46.8 mt-10 -77.73 107.8 10.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.759 -0.83 . . . . 64.310000000000002 108.759 171.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.15 147.33 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 123.325 0.391 . . . . 41.0 110.312 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.96 128.92 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 75.209999999999994 110.703 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.9 tm? -96.14 115.91 28.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.85 -43.41 10.05 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.643 0.258 . . . . 73.209999999999994 110.998 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -150.39 135.29 17.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.348 -0.387 . . . . 55.219999999999999 110.388 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.508 HG21 ' HA ' ' A' ' 40' ' ' PRO . 2.9 p . . . . . 0 C--O 1.251 1.149 0 CA-C-N 116.23 -0.441 . . . . 71.349999999999994 111.235 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 109.697 -0.483 . . . . 73.310000000000002 109.697 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.62 97.39 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 60.100000000000001 111.691 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -108.14 106.67 16.98 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.814 -1.18 . . . . 74.230000000000004 107.814 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -57.5 102.66 0.1 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.589 -0.732 . . . . 73.230000000000004 111.246 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -67.42 81.92 0.16 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 75.319999999999993 109.74 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -93.05 124.68 37.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.45 -0.574 . . . . 73.329999999999998 109.45 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -158.26 121.16 3.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.484 -0.325 . . . . 65.319999999999993 110.203 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.75 79.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 73.239999999999995 109.663 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.0 tpt -83.87 -59.65 2.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 52.340000000000003 110.305 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.2 -167.33 29.63 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.79 -0.641 . . . . 72.519999999999996 112.092 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 p -135.73 110.97 8.99 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 110.05 -0.352 . . . . 61.109999999999999 110.05 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.24 -48.58 70.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.539 . . . . 72.230000000000004 109.546 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -112.54 114.74 27.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.383 -0.826 . . . . 63.329999999999998 109.128 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.16 -35.19 31.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.232 -0.44 . . . . 33.229999999999997 111.477 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 54.04 56.13 7.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.169 -0.678 . . . . 71.120000000000005 109.169 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.7 p 47.37 80.71 0.05 OUTLIER 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.366 -0.834 . . . . 75.230000000000004 110.735 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 0.1 OUTLIER -60.58 141.79 56.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.126 -0.943 . . . . 72.329999999999998 111.133 -177.177 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.01 -152.79 18.09 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.241 -0.743 . . . . 74.25 111.241 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.2 -11.08 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.535 2.156 . . . . 73.400000000000006 112.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.65 -158.37 27.72 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.565 -0.614 . . . . 53.439999999999998 111.565 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.4 m -62.4 131.91 50.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.449 0.299 . . . . 73.519999999999996 110.763 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.1 mmt -68.85 79.03 0.31 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.26 0.553 . . . . 72.150000000000006 110.974 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.4 m -157.87 -161.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.244 -0.889 . . . . 71.329999999999998 109.34 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.42 90.14 0.23 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.904 0.383 . . . . 62.109999999999999 110.783 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -92.12 137.77 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 62.340000000000003 109.872 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.3 tp -145.92 102.02 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.784 0.326 . . . . 71.530000000000001 111.019 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' H ' ' HB ' ' A' ' 99' ' ' THR . 50.1 mm-40 -113.62 140.68 48.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.99 -0.744 . . . . 65.329999999999998 108.99 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 9.1 ptpp? -128.32 111.92 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 71.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -123.41 110.0 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 109.878 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 9.9 p -71.37 128.06 34.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.842 0.353 . . . . 70.430000000000007 111.314 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 97' ' ' LEU . 3.0 mm? -86.96 -38.08 16.97 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.592 -0.522 . . . . 73.129999999999995 109.592 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.1 m -141.6 112.7 6.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.966 -0.561 . . . . 74.030000000000001 110.187 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.15 146.09 62.81 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.51 2.14 . . . . 71.120000000000005 111.638 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.62 -164.64 28.23 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.271 -0.49 . . . . 71.120000000000005 112.717 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.79 -40.89 63.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.092 0.472 . . . . 72.409999999999997 110.996 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 -30.78 2.48 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.734 -0.667 . . . . 51.130000000000003 112.657 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.6 -24.5 8.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.032 0.444 . . . . 73.239999999999995 110.43 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.2 p -75.05 139.58 42.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.552 -0.749 . . . . 54.219999999999999 110.436 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -126.41 113.72 23.29 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.504 -0.316 . . . . 63.140000000000001 110.896 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.64 130.95 14.17 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.429 2.086 . . . . 71.040000000000006 111.451 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.47 149.28 44.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.43 -0.35 . . . . 75.109999999999999 110.815 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.32 164.5 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.111 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.24 34.48 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.156 -0.474 . . . . 65.140000000000001 112.73 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -101.44 146.7 27.27 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.430000000000007 111.597 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -77.42 110.85 12.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.299 -0.864 . . . . 61.229999999999997 109.282 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.9 m -106.4 148.76 10.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.945 0.403 . . . . 64.049999999999997 111.662 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.9 m -102.53 108.19 19.4 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 115.02 -0.991 . . . . 54.210000000000001 110.515 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.48 HG21 ' HE1' ' A' ' 72' ' ' PHE . 33.1 m -119.21 178.36 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 114.64 -1.164 . . . . 41.030000000000001 111.931 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 13.8 t-160 -157.51 147.32 20.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.199 -1.037 . . . . 71.409999999999997 108.199 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.6 m-85 -132.99 157.39 45.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.822 0.283 . . . . 71.340000000000003 111.383 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.841 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 45.0 m-20 -136.0 122.32 20.52 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.693 -0.685 . . . . 72.430000000000007 109.863 170.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.29 129.79 10.32 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.664 -0.574 . . . . 64.230000000000004 111.664 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -149.0 143.77 26.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 71.310000000000002 110.825 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 147.5 40.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.943 -0.391 . . . . 75.120000000000005 109.943 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.32 -22.49 49.66 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.894 2.396 . . . . 74.209999999999994 112.067 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.32 -34.27 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.5 -0.773 . . . . 72.299999999999997 110.797 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.59 -38.45 2.19 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.059 -0.816 . . . . 52.539999999999999 111.059 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.95 123.12 16.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.508 -0.346 . . . . 64.140000000000001 110.328 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -75.65 144.19 41.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.506 . . . . 72.329999999999998 110.917 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -72.93 -45.22 59.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.521 -0.548 . . . . 73.530000000000001 109.521 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -166.7 131.3 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 72.129999999999995 109.459 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -78.74 85.6 4.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.239 0.542 . . . . 73.409999999999997 109.865 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -72.66 -14.0 61.49 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.438 0.637 . . . . 61.149999999999999 110.086 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.701 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 13.1 ptt-85 -64.46 -35.96 82.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.42 -0.809 . . . . 74.420000000000002 110.678 171.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -69.17 -18.2 63.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.098 0.475 . . . . 52.329999999999998 110.057 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -82.32 -14.2 55.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.989 -0.551 . . . . 75.439999999999998 110.574 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.81 32.82 59.27 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.816 -0.629 . . . . 63.329999999999998 113.578 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -106.47 109.57 63.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.755 0.278 . . . . 75.340000000000003 110.98 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -90.5 125.68 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.948 2.432 . . . . 73.209999999999994 112.054 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.77 162.63 14.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.33 -0.618 . . . . 71.230000000000004 109.33 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.95 137.35 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.414 -0.178 . . . . 75.030000000000001 110.767 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.48 ' HE1' HG21 ' A' ' 48' ' ' VAL . 35.1 p90 -159.27 155.28 26.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.213 -0.195 . . . . 73.400000000000006 110.616 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.6 m -72.09 113.8 9.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.431 -0.35 . . . . 75.200000000000003 110.687 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.489 HD13 HG13 ' A' ' 87' ' ' VAL . 55.8 tp -61.97 133.56 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.7 -0.482 . . . . 75.129999999999995 109.7 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.75 68.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 51.530000000000001 112.803 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.39 11.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 74.430000000000007 110.525 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.91 31.68 3.33 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.475 -0.393 . . . . 54.409999999999997 112.631 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -63.74 -43.54 96.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 110.593 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.685 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 26.8 m -128.75 177.73 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 32.009999999999998 110.147 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.458 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.3 pt -68.92 152.77 9.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.687 0.279 . . . . 75.420000000000002 110.389 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 5.6 tmtm? -56.25 -29.02 60.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.073 -0.512 . . . . 73.310000000000002 109.94 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.44 -54.43 36.09 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.133 -0.556 . . . . 34.43 112.057 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.685 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 26.0 m0 -68.75 -38.17 79.93 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.52 -0.178 . . . . 71.340000000000003 110.52 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -54.51 -49.3 70.51 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.215 0.531 . . . . 72.430000000000007 110.389 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -65.03 -41.32 95.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 73.310000000000002 110.267 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.04 43.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.924 -0.58 . . . . 70.400000000000006 112.492 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.489 HG13 HD13 ' A' ' 74' ' ' LEU . 6.6 p -71.03 -31.81 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.685 0.279 . . . . 62.310000000000002 111.068 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -70.59 -30.66 67.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 72.340000000000003 111.659 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 -15.65 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.93 0.344 . . . . 72.319999999999993 111.93 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 87' ' ' VAL . 16.5 ptm -91.01 -175.39 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.581 0.229 . . . . 71.329999999999998 110.828 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -126.51 175.23 8.06 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 75.530000000000001 111.14 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.787 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.2 tt -73.84 137.58 43.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.698 0.285 . . . . 74.120000000000005 110.26 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.498 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.25 10.58 85.9 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.652 -0.579 . . . . 72.25 111.652 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.86 149.65 30.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.607 -0.296 . . . . 71.340000000000003 110.63 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . 13.9 ptmt -140.43 133.45 29.35 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.498 -0.556 . . . . 74.540000000000006 109.498 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -131.43 156.71 45.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.693 -0.685 . . . . 55.240000000000002 111.037 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 31' ' ' LEU . 8.7 tt -90.73 107.2 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.061 -1.089 . . . . 62.350000000000001 108.061 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -111.46 114.43 27.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.85 -0.426 . . . . 65.010000000000005 109.85 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 22.3 m -76.88 118.44 19.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.5 -0.318 . . . . 71.140000000000001 110.805 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 105' ' ' ALA . 40.0 mm -101.75 110.84 63.05 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 120.675 0.274 . . . . 60.109999999999999 110.414 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.3 Cg_endo -62.46 143.44 93.24 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.634 2.222 . . . . 51.240000000000002 111.889 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -54.26 -32.58 56.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.691 -0.686 . . . . 74.230000000000004 111.982 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.32 -23.34 65.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.074 0.398 . . . . 73.140000000000001 112.074 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.3 mt -96.12 -28.25 14.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.671 0.272 . . . . 72.140000000000001 111.549 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.444 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -110.06 -174.34 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 75.530000000000001 111.127 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -70.12 -7.44 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.621 . . . . 72.409999999999997 111.08 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.33 -28.84 51.52 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 113.089 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 7.6 tm-20 -64.28 -49.85 70.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.365 -0.605 . . . . 70.209999999999994 109.365 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -27.32 58.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.491 -0.777 . . . . 72.200000000000003 110.48 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 112' ' ' PRO . . . 80.14 -82.83 1.43 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.616 -0.72 . . . . 74.310000000000002 111.77 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.612 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 58.8 m-85 89.33 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.209 1.404 . . . . 75.400000000000006 111.986 -175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 59.4 Cg_endo -89.0 152.67 5.8 Favored 'Trans proline' 0 C--N 1.366 1.482 0 CA-C-N 121.693 1.64 . . . . 74.049999999999997 111.665 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.33 -7.78 13.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.557 2.171 . . . . 75.519999999999996 112.369 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.95 -31.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 109.938 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.89 101.92 48.68 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.812 -0.631 . . . . 64.329999999999998 109.899 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 Cg_endo -67.08 119.64 6.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.241 1.961 . . . . 73.409999999999997 111.388 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.34 133.96 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.683 2.922 . . . . 61.409999999999997 113.42 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 54.0 mtmt 73.0 31.68 1.45 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.645 0.778 . . . . 73.319999999999993 111.124 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -93.77 123.86 37.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.878 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 101' ' ' PRO . 74.0 m -73.69 127.64 33.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.257 -0.646 . . . . 71.230000000000004 109.257 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -120.88 137.09 54.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.547 -0.538 . . . . 73.030000000000001 109.547 -170.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.522 ' N ' HD13 ' A' ' 121' ' ' LEU . 88.7 t -98.51 131.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.691 0.281 . . . . 74.230000000000004 110.424 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.29 123.04 41.22 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.947 -0.39 . . . . 52.100000000000001 109.947 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 51.0 mt-10 -75.34 115.34 14.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.553 -0.906 . . . . 64.310000000000002 108.553 171.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 m -95.74 137.17 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.653 0.595 . . . . 41.0 109.413 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 36.3 tt0 -136.61 117.71 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.589 -0.522 . . . . 75.209999999999994 109.589 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.787 HD12 ' HA ' ' A' ' 92' ' ' LEU . 3.1 tm? -99.87 106.3 18.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.72 -0.845 . . . . 72.310000000000002 108.72 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 49' ' ' HIS . 3.6 mm? -78.2 -45.83 22.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.41 -0.589 . . . . 73.209999999999994 109.41 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -170.81 -173.61 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.528 -0.76 . . . . 55.219999999999999 109.92 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.114 -0.946 . . . . 71.349999999999994 108.669 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.688 0.28 . . . . 73.310000000000002 110.543 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.36 114.63 26.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 60.100000000000001 110.078 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -71.56 95.7 1.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.325 0.583 . . . . 74.230000000000004 111.263 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -77.3 93.31 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 73.230000000000004 109.714 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -137.59 0.95 2.31 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.63 -0.259 . . . . 75.319999999999993 111.667 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -125.27 155.34 40.32 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.884 -0.413 . . . . 73.329999999999998 109.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -153.33 141.6 20.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.744 -0.207 . . . . 65.319999999999993 110.716 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -99.13 -24.89 14.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.351 -0.386 . . . . 73.239999999999995 110.888 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.9 tpp -82.47 131.38 35.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.857 0.361 . . . . 52.340000000000003 111.063 -177.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -179.37 18.6 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.073 -0.811 . . . . 72.519999999999996 111.073 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.3 m -75.33 87.47 2.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.037 0.419 . . . . 61.109999999999999 109.942 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt 56.31 52.39 10.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.012 -0.736 . . . . 72.230000000000004 109.012 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 73.29 -18.7 0.36 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.977 -1.01 . . . . 63.329999999999998 112.097 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.54 160.2 22.63 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.022 0.439 . . . . 33.229999999999997 110.803 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.31 174.07 7.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.803 -0.635 . . . . 71.120000000000005 110.171 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -86.37 166.72 15.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.308 -0.406 . . . . 75.230000000000004 110.569 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -79.58 172.93 13.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.081 -0.509 . . . . 72.329999999999998 109.968 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.44 151.01 39.27 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.029 -0.605 . . . . 74.25 111.735 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.29 152.09 66.38 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.399 2.066 . . . . 73.400000000000006 112.011 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.96 17.09 9.89 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.176 -0.535 . . . . 53.439999999999998 112.166 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -73.11 138.65 45.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.572 0.225 . . . . 73.519999999999996 110.652 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 22' ' ' MET . 23.2 ptm -74.05 95.67 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 72.150000000000006 110.433 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 t -176.57 176.27 1.6 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.782 -0.644 . . . . 71.329999999999998 110.005 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.25 111.28 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.464 -0.569 . . . . 62.109999999999999 109.464 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.674 ' H ' ' HB3' ' A' ' 101' ' ' PRO . 8.8 mm-40 -91.89 135.48 33.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.393 -0.595 . . . . 62.340000000000003 109.393 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -144.4 102.41 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.945 0.402 . . . . 71.530000000000001 110.397 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 48.8 mt-10 -142.72 130.59 21.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 65.329999999999998 110.122 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -133.2 101.42 5.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.767 -0.827 . . . . 71.0 108.767 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -108.71 110.33 21.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 73.319999999999993 109.763 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.59 114.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.189 0.518 . . . . 70.430000000000007 110.336 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.7 mt -88.88 -33.02 17.47 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.843 -0.617 . . . . 73.129999999999995 110.117 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 44.7 m -145.49 120.58 5.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.523 -0.762 . . . . 74.030000000000001 109.397 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 146.44 51.99 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.608 2.205 . . . . 71.120000000000005 112.427 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -99.91 -172.06 30.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 112.431 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 78.2 m-20 -63.85 -36.88 85.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.034 0.445 . . . . 72.409999999999997 110.397 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.35 -30.29 2.18 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.774 -0.648 . . . . 51.130000000000003 113.039 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 m -82.25 -35.65 13.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.148 0.499 . . . . 73.239999999999995 110.07 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 12.3 p -84.83 115.57 22.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.585 -0.734 . . . . 54.219999999999999 109.476 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 39' ' ' LYS . 8.3 mtmp? -124.39 132.23 24.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 63.140000000000001 111.063 -171.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.18 166.73 20.39 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.549 2.166 . . . . 71.040000000000006 110.997 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -165.21 166.38 18.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.404 -0.221 . . . . 75.109999999999999 110.404 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.39 141.66 52.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.337 -0.392 . . . . 74.420000000000002 110.936 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.59 20.3 41.3 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.068 -0.515 . . . . 65.140000000000001 111.877 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -130.61 138.16 49.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.695 0.398 . . . . 74.430000000000007 110.869 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -79.6 106.07 11.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.491 -0.929 . . . . 61.229999999999997 108.491 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 130' ' ' VAL . 28.2 m -106.49 146.19 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.365 . . . . 64.049999999999997 111.254 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.1 m -96.35 108.07 20.53 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.613 -0.721 . . . . 54.210000000000001 109.926 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.744 HG12 HD22 ' A' ' 127' ' ' LEU . 18.4 m -124.45 178.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.519 0.676 . . . . 41.030000000000001 111.234 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 64' ' ' ARG . 15.4 t-80 -151.6 140.63 21.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.947 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 86.0 m-85 -126.5 144.01 51.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.595 -0.891 . . . . 71.340000000000003 108.595 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 8.9 t70 -136.15 110.71 8.59 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.469 -0.567 . . . . 72.430000000000007 109.469 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.46 137.4 30.88 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.938 -0.574 . . . . 64.230000000000004 112.154 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -148.01 137.16 22.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.002 0.43 . . . . 71.310000000000002 110.519 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 88.9 m-85 -78.53 146.8 70.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 75.120000000000005 110.168 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 30.5 Cg_exo -62.92 -10.39 20.12 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.97 2.446 . . . . 74.209999999999994 113.289 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -87.16 -4.94 59.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.675 0.274 . . . . 72.299999999999997 110.916 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.17 -24.58 15.79 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.742 -0.543 . . . . 52.539999999999999 111.742 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 4.8 ttmp? -59.09 148.63 30.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.204 0.602 . . . . 64.140000000000001 110.896 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -94.88 143.62 26.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.025 -0.361 . . . . 72.329999999999998 110.025 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -86.47 -55.66 3.78 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.957 0.408 . . . . 73.530000000000001 110.558 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -138.67 131.41 29.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.348 -0.387 . . . . 72.129999999999995 110.323 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -76.19 85.12 3.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 73.409999999999997 109.95 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.0 p -90.33 -46.91 8.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.441 . . . . 61.149999999999999 109.95 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.479 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.3 ptt180 -60.64 -31.61 70.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.987 -0.551 . . . . 74.420000000000002 110.137 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -70.68 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 52.329999999999998 111.378 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -93.17 -2.27 55.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.907 0.384 . . . . 75.439999999999998 110.234 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.18 39.2 69.83 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.71 -0.677 . . . . 63.329999999999998 113.768 174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -141.81 122.63 8.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.796 0.298 . . . . 75.340000000000003 110.582 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.81 177.66 6.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.795 2.33 . . . . 73.209999999999994 111.861 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -135.02 129.92 34.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 71.230000000000004 109.848 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -100.45 141.91 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.293 -0.262 . . . . 75.030000000000001 110.293 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.53 ' HZ ' HG11 ' A' ' 87' ' ' VAL . 11.6 p90 -154.34 158.17 39.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.726 0.298 . . . . 73.400000000000006 110.265 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -83.69 109.43 17.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 110.033 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.72 142.06 56.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.447 -0.342 . . . . 75.129999999999995 110.435 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.21 26.9 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.891 -0.484 . . . . 51.530000000000001 111.891 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.81 168.95 18.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.696 0.398 . . . . 74.430000000000007 109.966 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.42 28.48 1.48 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.397 -0.43 . . . . 54.409999999999997 113.304 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.04 -34.84 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.292 0.568 . . . . 75.439999999999998 109.767 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 83' ' ' TRP . 27.1 m -131.13 165.27 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.233 -0.894 . . . . 32.009999999999998 110.421 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 pt -80.66 164.63 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 75.420000000000002 110.526 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -55.9 -28.54 57.2 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.201 0.445 . . . . 73.310000000000002 112.201 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.52 -59.5 9.74 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 120.432 -0.889 . . . . 34.43 111.681 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.469 ' O ' HG12 ' A' ' 87' ' ' VAL . 27.0 m0 -66.0 -37.02 84.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.665 -0.268 . . . . 71.340000000000003 110.287 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.57 -55.01 39.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.936 -0.575 . . . . 72.430000000000007 110.842 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.83 -42.56 90.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.453 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.52 -48.68 69.01 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.014 -0.612 . . . . 70.400000000000006 112.682 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG11 ' HZ ' ' A' ' 72' ' ' PHE . 14.2 p -75.21 -32.94 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.826 0.346 . . . . 62.310000000000002 111.077 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.36 68.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.514 -0.312 . . . . 72.340000000000003 111.649 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 t -86.23 -4.46 59.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.215 0.45 . . . . 72.319999999999993 112.215 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 19.4 ptm -106.81 176.0 5.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.669 0.271 . . . . 71.329999999999998 110.889 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.1 p -118.65 174.55 6.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.764 0.316 . . . . 75.530000000000001 111.306 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.629 HD12 HG23 ' A' ' 130' ' ' VAL . 7.6 tt -73.16 138.34 45.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 111.134 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.495 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.34 34.8 44.52 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.737 -0.665 . . . . 72.25 111.926 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 33.7 tt0 -134.52 153.71 51.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.945 0.402 . . . . 71.340000000000003 111.694 -169.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -131.41 122.36 26.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 74.540000000000006 109.845 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.76 141.57 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 55.240000000000002 110.62 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.7 tt -90.89 113.75 26.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.951 -0.759 . . . . 62.350000000000001 108.951 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -114.37 121.2 42.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.841 0.353 . . . . 65.010000000000005 110.389 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 31.2 m -78.67 116.06 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 71.140000000000001 110.294 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.7 mm -89.87 113.29 56.43 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 116.385 -0.371 . . . . 60.109999999999999 110.853 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.674 ' HB3' ' H ' ' A' ' 25' ' ' GLN . 73.5 Cg_endo -75.75 155.0 39.45 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.547 2.165 . . . . 51.240000000000002 111.556 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -54.17 -30.83 50.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.959 -0.564 . . . . 74.230000000000004 112.075 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.02 -26.8 64.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.729 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.4 mt -96.19 11.74 33.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.359 0.124 . . . . 72.140000000000001 111.286 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 -178.2 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 75.530000000000001 110.466 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -69.72 -8.27 46.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 72.409999999999997 110.783 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.83 -20.39 32.82 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.065 -0.516 . . . . 75.140000000000001 112.817 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -58.17 -51.95 67.58 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.562 -0.533 . . . . 70.209999999999994 109.562 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -84.33 -53.82 5.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.45 -0.795 . . . . 72.200000000000003 110.77 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.96 146.17 12.69 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.097 -0.501 . . . . 74.310000000000002 112.158 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -139.06 -55.41 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 122.369 0.268 . . . . 75.400000000000006 110.854 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 13.4 Cg_exo -70.01 128.34 15.66 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.942 1.761 . . . . 74.049999999999997 110.631 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 76.5 Cg_exo -51.58 -27.67 26.29 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.82 2.347 . . . . 75.519999999999996 113.342 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.2 t -73.87 -35.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 74.310000000000002 110.56 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.54 106.17 17.35 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 64.329999999999998 109.549 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 95.3 Cg_endo -79.66 163.38 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.406 2.071 . . . . 73.409999999999997 112.364 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.11 143.9 91.71 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.212 1.941 . . . . 61.409999999999997 111.17 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 65.92 28.19 10.7 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.24 0.338 . . . . 73.319999999999993 111.276 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -76.34 148.96 37.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.18 0.514 . . . . 74.120000000000005 112.067 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.3 m -108.9 131.33 55.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.439 -0.8 . . . . 71.230000000000004 109.379 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -138.48 147.27 43.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.208 -0.664 . . . . 73.030000000000001 109.208 -175.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.578 ' N ' HD13 ' A' ' 121' ' ' LEU . 94.7 t -105.03 144.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.388 . . . . 74.230000000000004 110.98 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 121' ' ' LEU . 27.8 m-85 -133.01 125.6 30.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.021 0.439 . . . . 52.100000000000001 110.715 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 58.5 mt-10 -76.4 114.85 15.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.23 -0.656 . . . . 64.310000000000002 109.23 170.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.3 m -95.87 133.55 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 41.0 108.765 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 45.5 tt0 -139.02 116.64 11.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.39 -0.368 . . . . 75.209999999999994 110.265 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.744 HD22 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -96.04 111.71 23.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.557 -0.905 . . . . 72.310000000000002 108.557 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.05 -50.82 7.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.921 0.391 . . . . 73.209999999999994 110.065 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -167.1 178.82 5.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 55.219999999999999 109.905 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 92' ' ' LEU . 46.6 t . . . . . 0 C--O 1.251 1.142 0 N-CA-C 108.843 -0.799 . . . . 71.349999999999994 108.843 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.727 0.298 . . . . 73.310000000000002 110.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.86 88.58 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 60.100000000000001 110.181 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -55.26 106.01 0.21 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.033 -0.53 . . . . 74.230000000000004 110.071 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -69.79 127.08 31.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.447 -0.797 . . . . 73.230000000000004 111.742 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -146.78 130.43 16.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.924 -0.58 . . . . 75.319999999999993 110.108 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -73.45 158.99 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.529 -0.915 . . . . 73.329999999999998 108.529 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -54.73 99.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 65.319999999999993 110.943 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -62.15 111.71 2.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.861 -0.609 . . . . 73.239999999999995 110.676 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.8 mmm -85.21 145.49 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 52.340000000000003 109.815 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.9 95.43 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.125 -0.559 . . . . 72.519999999999996 112.218 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -57.32 100.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.766 0.317 . . . . 61.109999999999999 110.429 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.3 178.4 3.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 111.568 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.23 105.26 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 63.329999999999998 110.804 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 98.74 5.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.48 -0.563 . . . . 33.229999999999997 109.48 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.01 -19.73 43.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.094 -0.503 . . . . 71.120000000000005 110.264 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.6 m -110.48 138.1 47.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.025 -0.534 . . . . 75.230000000000004 109.824 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -83.04 157.93 22.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.931 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.84 165.68 26.81 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.991 -0.549 . . . . 74.25 111.795 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.85 99.19 0.21 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.49 2.126 . . . . 73.400000000000006 112.032 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.11 21.16 9.12 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.005 -0.543 . . . . 53.439999999999998 112.96 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.1 m -67.1 81.4 0.12 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.797 0.332 . . . . 73.519999999999996 110.866 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 58.13 15.44 3.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.807 -0.633 . . . . 72.150000000000006 111.803 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -150.16 128.86 12.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 71.329999999999998 109.273 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.46 127.21 31.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 62.109999999999999 111.688 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -95.88 135.46 37.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.635 -0.876 . . . . 62.340000000000003 108.635 172.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 102.04 8.42 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.039 0.447 . . . . 71.530000000000001 111.02 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.27 130.1 56.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 65.329999999999998 109.993 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.676 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -140.88 117.18 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.549 -0.751 . . . . 71.0 109.209 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.55 118.09 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.481 -0.327 . . . . 73.319999999999993 110.542 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.02 134.0 27.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 70.430000000000007 110.374 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.87 -18.45 13.69 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.409 -0.36 . . . . 73.129999999999995 110.688 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 88.2 m -142.71 110.63 5.7 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.148 -0.316 . . . . 74.030000000000001 110.148 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.23 126.13 10.83 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.766 2.311 . . . . 71.120000000000005 111.053 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.2 -171.29 47.3 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.236 -0.507 . . . . 71.120000000000005 113.177 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -57.61 -34.76 69.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.603 0.361 . . . . 72.409999999999997 111.346 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 76.08 -25.59 1.54 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.281 -0.485 . . . . 51.130000000000003 113.474 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 35' ' ' ASP . 34.1 m -75.12 -21.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.872 0.368 . . . . 73.239999999999995 111.471 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -81.07 128.92 34.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 54.219999999999999 111.222 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -100.09 110.24 58.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.47 . . . . 63.140000000000001 109.988 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.24 134.15 13.99 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 71.040000000000006 111.161 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -127.96 141.72 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 75.109999999999999 110.371 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 162.13 29.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.01 -0.541 . . . . 74.420000000000002 111.776 -176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.95 77.17 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.562 -0.744 . . . . 65.140000000000001 112.981 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.4 170.73 15.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 111.719 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -78.64 142.75 36.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 61.229999999999997 111.495 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.15 141.94 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.845 -0.616 . . . . 64.049999999999997 110.112 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.3 m -93.68 108.12 19.9 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.764 -0.653 . . . . 54.210000000000001 110.277 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.525 HG12 HD22 ' A' ' 127' ' ' LEU . 20.4 m -123.78 178.33 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.995 -1.002 . . . . 41.030000000000001 111.325 -172.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.589 ' HB3' HD21 ' A' ' 128' ' ' LEU . 8.9 t-80 -157.83 143.35 17.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.391 -0.822 . . . . 71.409999999999997 109.136 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 49.2 p90 -141.49 150.21 41.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.49 0.186 . . . . 71.340000000000003 110.953 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.19 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.063 -0.517 . . . . 72.430000000000007 110.292 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.28 148.44 17.05 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 116.323 -0.399 . . . . 64.230000000000004 112.484 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.54 143.25 17.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.881 -0.414 . . . . 71.310000000000002 109.881 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.91 140.21 27.66 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 75.120000000000005 110.401 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.82 -13.3 21.72 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.721 2.281 . . . . 74.209999999999994 111.432 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.57 -25.71 39.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.044 -0.98 . . . . 72.299999999999997 110.883 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.31 23.73 12.31 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.278 -0.729 . . . . 52.539999999999999 111.278 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -149.16 147.12 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.933 -0.395 . . . . 64.140000000000001 109.933 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.05 136.62 53.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.128 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -65.25 -54.28 31.66 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.326 -0.397 . . . . 73.530000000000001 110.002 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.23 160.65 43.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.621 -0.718 . . . . 72.129999999999995 109.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 64' ' ' ARG . 39.5 m -117.41 121.57 41.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.379 -0.373 . . . . 73.409999999999997 110.457 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.6 m -70.35 -29.25 65.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 61.149999999999999 109.88 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.527 HH12 ' HD2' ' A' ' 95' ' ' LYS . 8.8 ptm180 -59.85 -31.03 69.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 74.420000000000002 111.336 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.2 m -57.05 -30.25 64.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.451 -0.34 . . . . 52.329999999999998 110.655 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.652 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 5.4 mmp_? -81.09 -10.55 59.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.158 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.31 48.66 84.16 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 112.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 20.5 tptm -112.61 115.23 49.31 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 122.826 -0.22 . . . . 75.340000000000003 110.481 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 4.1 Cg_exo -81.26 167.62 17.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.15 2.566 . . . . 73.209999999999994 111.928 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 97.1 m-85 -136.2 158.97 43.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 71.230000000000004 110.087 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 97.6 mt-30 -143.57 135.87 26.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.874 -0.417 . . . . 75.030000000000001 109.874 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HE1' HG11 ' A' ' 48' ' ' VAL . 11.6 p90 -150.54 160.42 43.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 121.057 -0.257 . . . . 73.400000000000006 110.623 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.508 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 15.2 m -85.42 104.66 15.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 75.200000000000003 110.271 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 88' ' ' ALA . 51.0 tp -55.89 137.09 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 75.129999999999995 111.046 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.02 -30.45 5.48 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.091 -0.576 . . . . 51.530000000000001 112.626 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.05 178.27 7.65 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.279 . . . . 74.430000000000007 111.095 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.48 53.9 4.78 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.883 -0.487 . . . . 54.409999999999997 111.883 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 73' ' ' THR . 5.7 mm-40 -90.71 -44.93 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.043 0.449 . . . . 75.439999999999998 110.552 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.5 m -136.82 177.89 5.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.678 -0.692 . . . . 32.009999999999998 110.089 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 104' ' ' LEU . 18.0 pt -68.19 140.97 18.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 109.95 -0.389 . . . . 75.420000000000002 109.95 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 61.6 mmtt -63.71 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.617 0.599 . . . . 73.310000000000002 112.617 -173.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -56.98 22.26 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.43 -0.89 . . . . 34.43 111.017 171.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -69.15 -40.17 78.36 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.271 -0.27 . . . . 71.340000000000003 110.271 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.631 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 12.4 t70 -51.75 -55.19 21.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.746 -0.661 . . . . 72.430000000000007 110.528 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.99 -42.17 70.0 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.077 -0.51 . . . . 73.310000000000002 110.685 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.31 -49.97 48.79 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.045 -0.598 . . . . 70.400000000000006 112.073 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.7 p -75.93 -31.93 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.692 0.282 . . . . 62.310000000000002 110.942 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -59.74 -35.29 74.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.692 0.282 . . . . 72.340000000000003 111.735 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 t -87.73 6.56 34.37 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.269 0.47 . . . . 72.319999999999993 112.269 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 13.8 ptp -112.01 177.89 4.5 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.046 -0.408 . . . . 71.329999999999998 110.552 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.523 HG21 ' HA2' ' A' ' 36' ' ' GLY . 42.5 p -121.1 178.82 4.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.852 0.358 . . . . 75.530000000000001 111.708 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -61.99 129.97 43.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.703 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.69 17.25 77.8 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.781 -0.645 . . . . 72.25 112.457 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 32' ' ' THR . 14.6 tt0 -106.98 136.35 46.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 71.340000000000003 110.313 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HD2' HH12 ' A' ' 64' ' ' ARG . 28.3 ttpp -131.7 126.76 35.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.988 -0.551 . . . . 74.540000000000006 110.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.87 142.12 50.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 55.240000000000002 110.892 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 tt -90.79 117.23 29.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.395 -0.965 . . . . 62.350000000000001 108.395 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.37 122.44 38.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.5 . . . . 65.010000000000005 109.649 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 54.1 m -81.89 106.51 13.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.66 -0.496 . . . . 71.140000000000001 109.66 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 105' ' ' ALA . 27.0 mm -85.64 112.3 43.64 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 115.978 -0.555 . . . . 60.109999999999999 110.236 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.628 ' HA ' HG23 ' A' ' 120' ' ' THR . 38.2 Cg_endo -66.4 159.33 50.81 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.205 1.937 . . . . 51.240000000000002 111.075 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 38.4 p90 -54.41 -31.5 55.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 111.348 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.47 -30.04 70.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.515 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 80' ' ' ILE . 88.0 mt -105.38 13.13 30.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.327 -0.397 . . . . 72.140000000000001 111.544 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -147.15 176.17 10.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.075 0.464 . . . . 75.530000000000001 111.435 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -68.47 -14.98 63.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.559 -0.746 . . . . 72.409999999999997 110.617 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.91 -16.42 47.02 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.926 -0.579 . . . . 75.140000000000001 113.045 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 35.0 tt0 -56.2 -55.23 35.66 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.074 0.464 . . . . 70.209999999999994 110.327 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -98.81 -35.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.831 . . . . 72.200000000000003 110.52 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.67 161.98 10.99 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.805 -0.634 . . . . 74.310000000000002 112.399 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.716 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.7 m-85 -135.39 -57.18 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 122.23 0.212 . . . . 75.400000000000006 110.486 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 68.7 Cg_endo -91.25 142.41 2.99 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.003 1.802 . . . . 74.049999999999997 111.854 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 50.1 Cg_exo -55.05 -18.69 17.88 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.771 2.314 . . . . 75.519999999999996 112.737 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.61 -36.88 77.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.017 -0.538 . . . . 74.310000000000002 110.201 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.4 mm -110.16 99.11 38.3 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 109.304 -0.628 . . . . 64.329999999999998 109.304 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 159.79 51.96 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.626 2.217 . . . . 73.409999999999997 112.513 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.71 147.25 89.75 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.233 1.955 . . . . 61.409999999999997 111.665 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 7.0 mtmp? 69.69 22.85 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.069 0.548 . . . . 73.319999999999993 110.629 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.56 131.62 35.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.114 0.483 . . . . 74.120000000000005 111.31 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.628 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -97.98 127.99 44.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.182 -0.673 . . . . 71.230000000000004 109.182 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -129.44 143.6 50.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.789 -0.448 . . . . 73.030000000000001 109.789 -171.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.57 ' N ' HD13 ' A' ' 121' ' ' LEU . 46.9 t -98.3 131.82 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.117 -0.327 . . . . 74.230000000000004 110.117 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.55 132.17 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.656 0.265 . . . . 52.100000000000001 111.153 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 30.9 mt-10 -82.44 112.29 19.24 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.12 -0.696 . . . . 64.310000000000002 109.12 170.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.491 HG23 ' HE1' ' A' ' 90' ' ' MET . 11.1 m -97.06 135.45 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.097 -0.705 . . . . 41.0 109.097 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 95' ' ' LYS . 45.2 tt0 -141.3 121.46 13.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.319 -0.401 . . . . 75.209999999999994 110.427 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -93.54 113.95 26.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.613 -0.884 . . . . 72.310000000000002 108.613 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.9 mm? -87.78 -50.72 6.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.804 0.335 . . . . 73.209999999999994 110.125 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.22 -173.41 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 55.219999999999999 110.094 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.768 -0.634 . . . . 71.349999999999994 109.532 173.562 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.048 -0.353 . . . . 73.310000000000002 110.048 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.94 131.68 1.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.278 -0.419 . . . . 60.100000000000001 110.153 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -119.19 95.35 4.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.483 -0.326 . . . . 74.230000000000004 110.309 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -68.89 84.51 0.32 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.743 -0.836 . . . . 73.230000000000004 108.743 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -98.24 160.6 14.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.35 -0.841 . . . . 75.319999999999993 111.454 -171.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -83.81 162.48 20.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 73.329999999999998 110.061 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -96.91 101.57 13.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.281 -0.418 . . . . 65.319999999999993 109.891 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -74.07 141.59 45.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.853 -0.425 . . . . 73.239999999999995 109.853 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp -137.38 -179.91 6.01 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.213 -0.449 . . . . 52.340000000000003 110.4 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.34 124.47 5.31 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.278 -0.729 . . . . 72.519999999999996 111.278 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -77.86 117.42 19.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.825 0.312 . . . . 61.109999999999999 110.367 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.9 mp -54.99 -62.23 1.8 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.385 0.428 . . . . 72.230000000000004 109.858 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -103.15 119.2 38.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 63.329999999999998 109.198 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.11 -177.33 1.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 33.229999999999997 111.399 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -64.29 148.21 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 71.120000000000005 110.809 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 p -84.81 13.29 6.0 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.177 0.513 . . . . 75.230000000000004 111.489 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -145.66 140.07 27.05 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.946 -0.57 . . . . 72.329999999999998 109.97 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.86 -143.04 3.56 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.601 -0.6 . . . . 74.25 111.601 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.5 34.94 0.54 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.182 2.588 . . . . 73.400000000000006 112.284 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.71 70.9 2.95 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.31 -0.471 . . . . 53.439999999999998 112.637 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.2 t -152.48 135.35 15.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.252 -0.647 . . . . 73.519999999999996 109.252 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -81.3 -19.94 41.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.691 0.282 . . . . 72.150000000000006 111.158 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -78.93 166.58 22.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 71.329999999999998 110.651 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.24 109.88 1.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.676 -0.693 . . . . 62.109999999999999 111.266 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -92.27 135.0 34.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.649 -0.871 . . . . 62.340000000000003 108.649 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 55.0 tp -145.83 102.8 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.418 0.525 . . . . 71.530000000000001 112.418 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -111.93 132.43 54.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.067 -0.716 . . . . 65.329999999999998 109.067 165.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -129.95 101.27 5.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.508 -0.923 . . . . 71.0 108.508 176.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -123.03 113.74 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 73.319999999999993 110.736 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 6.5 p -64.38 114.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 70.430000000000007 110.863 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.18 -49.75 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.445 -0.576 . . . . 73.129999999999995 109.445 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -112.4 113.54 51.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.369 -0.832 . . . . 74.030000000000001 109.423 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.79 140.86 52.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.634 2.223 . . . . 71.120000000000005 112.438 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -98.53 -169.38 31.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.39 -0.433 . . . . 71.120000000000005 112.66 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.42 -46.07 67.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.781 0.324 . . . . 72.409999999999997 110.434 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 95.2 -20.74 47.85 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.093 -0.503 . . . . 51.130000000000003 113.931 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -103.24 -0.86 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 117.687 0.743 . . . . 73.239999999999995 112.634 -172.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.3 p -85.07 142.18 29.73 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.713 0.292 . . . . 54.219999999999999 110.568 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -113.43 119.57 41.6 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.387 -0.369 . . . . 63.140000000000001 110.025 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 14.4 Cg_exo -69.56 143.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.18 . . . . 71.040000000000006 111.582 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.54 141.82 23.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.826 0.346 . . . . 75.109999999999999 110.52 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.752 -0.658 . . . . 74.420000000000002 111.71 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.98 19.56 57.37 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.628 -0.715 . . . . 65.140000000000001 113.058 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.47 161.73 36.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.077 0.439 . . . . 74.430000000000007 110.813 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.6 tppp? -81.63 117.12 21.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.836 -0.62 . . . . 61.229999999999997 109.636 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG11 HD22 ' A' ' 74' ' ' LEU . 27.5 m -110.35 151.38 12.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 120.901 0.382 . . . . 64.049999999999997 110.539 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -117.01 108.18 15.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.562 -0.745 . . . . 54.210000000000001 110.169 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.01 178.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.589 -0.732 . . . . 41.030000000000001 110.494 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 63.7 t60 -149.24 146.48 27.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.09 -0.707 . . . . 71.409999999999997 109.09 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -126.59 152.53 46.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.701 -0.481 . . . . 71.340000000000003 109.701 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.744 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 35.7 m-20 -135.6 112.74 10.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.498 -0.927 . . . . 72.430000000000007 108.498 172.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.95 111.13 3.33 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.936 -0.575 . . . . 64.230000000000004 112.609 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 53' ' ' ARG . 22.3 ttt180 -122.38 137.49 54.84 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.32 0.581 . . . . 71.310000000000002 111.019 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -89.23 151.91 47.17 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 109.886 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.64 -17.63 36.27 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.177 2.585 . . . . 74.209999999999994 114.006 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.94 -14.74 53.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.853 0.359 . . . . 72.299999999999997 110.606 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.36 -1.02 37.35 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.219 -0.515 . . . . 52.539999999999999 112.425 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -94.43 157.23 16.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.544 -0.539 . . . . 64.140000000000001 109.544 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.73 -0.471 . . . . 72.329999999999998 109.73 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.23 -46.97 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.530000000000001 111.324 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.01 131.28 45.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.355 -0.384 . . . . 72.129999999999995 110.959 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 m -104.92 85.63 2.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 73.409999999999997 109.375 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -56.95 -28.86 62.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.059 -0.518 . . . . 61.149999999999999 110.835 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -53.91 -31.76 51.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.749 -0.66 . . . . 74.420000000000002 111.311 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -59.1 -37.32 76.88 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.886 0.374 . . . . 52.329999999999998 110.728 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -80.29 -11.54 59.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.992 -0.549 . . . . 75.439999999999998 110.564 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.41 18.99 59.42 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.132 -0.485 . . . . 63.329999999999998 112.106 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -82.14 119.13 74.34 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 122.363 0.265 . . . . 75.340000000000003 110.375 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.55 162.5 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.046 2.497 . . . . 73.209999999999994 112.352 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -122.69 117.0 24.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.37 -0.604 . . . . 71.230000000000004 109.37 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.59 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 92.2 mt-30 -107.06 140.96 39.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.573 -0.285 . . . . 75.030000000000001 110.468 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -156.89 167.6 29.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.479 -0.328 . . . . 73.400000000000006 110.23 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 m -82.07 108.93 15.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 110.294 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.436 HD22 HG11 ' A' ' 46' ' ' VAL . 45.1 tp -62.1 111.03 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.702 -0.481 . . . . 75.129999999999995 109.702 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.14 -24.56 5.64 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.214 -0.755 . . . . 51.530000000000001 111.214 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.63 145.2 47.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.4 -0.222 . . . . 74.430000000000007 110.4 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.41 43.61 2.33 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.429 -0.35 . . . . 54.409999999999997 113.064 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -82.54 -47.61 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 75.439999999999998 110.198 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.06 162.56 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.75 . . . . 32.009999999999998 110.949 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.447 HG12 ' CE3' ' A' ' 83' ' ' TRP . 35.4 pt -80.07 159.02 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.573 -0.528 . . . . 75.420000000000002 109.573 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 55.4 mmtt -60.41 -21.14 61.88 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.418 0.155 . . . . 73.310000000000002 111.418 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -47.97 88.19 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.599 -0.81 . . . . 34.43 111.574 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CE3' HG12 ' A' ' 80' ' ' ILE . 18.1 m0 -79.76 -29.28 40.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.589 0.233 . . . . 71.340000000000003 110.401 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 6.6 t70 -58.0 -55.05 39.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.616 0.722 . . . . 72.430000000000007 109.792 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -67.68 -35.86 79.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.496 -0.774 . . . . 73.310000000000002 109.861 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.9 -49.35 58.99 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.766 -0.652 . . . . 70.400000000000006 112.434 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 12.2 p -75.24 -32.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 62.310000000000002 110.274 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -30.08 71.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.33 -0.396 . . . . 72.340000000000003 112.015 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -90.4 -14.86 32.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.116 0.413 . . . . 72.319999999999993 112.116 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.888 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.8 ptp -93.92 -179.77 5.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.691 0.281 . . . . 71.329999999999998 110.879 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.424 HG21 ' HA2' ' A' ' 36' ' ' GLY . 16.7 p -138.83 178.95 6.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.197 -0.456 . . . . 75.530000000000001 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -58.81 124.5 20.01 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.886 0.474 . . . . 74.120000000000005 110.694 -176.24 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.68 37.63 57.57 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.398 176.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.629 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.9 tt0 -124.2 126.62 46.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 71.340000000000003 110.975 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 24.5 ttmm -114.9 115.06 26.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.803 -0.635 . . . . 74.540000000000006 109.549 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -113.52 145.42 41.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 110.638 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 28' ' ' LYS . 9.4 tt -90.63 105.4 17.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.04 -1.096 . . . . 62.350000000000001 108.04 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -112.13 126.39 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.337 -0.392 . . . . 65.010000000000005 110.423 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 26' ' ' LEU . 7.9 m -85.12 118.16 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.446 -0.343 . . . . 71.140000000000001 110.639 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.8 mm -99.05 108.57 50.19 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 110.387 -0.227 . . . . 60.109999999999999 110.387 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.99 140.94 39.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.097 2.531 . . . . 51.240000000000002 111.275 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.97 -29.56 57.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.454 -0.339 . . . . 74.230000000000004 111.836 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.2 -30.07 70.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.514 . . . . 73.140000000000001 111.644 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.88 9.06 43.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 72.140000000000001 111.777 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.26 178.95 8.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.145 0.498 . . . . 75.530000000000001 111.658 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -73.61 -2.47 23.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.495 -0.775 . . . . 72.409999999999997 111.332 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.31 -14.25 56.35 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.189 -0.459 . . . . 75.140000000000001 112.085 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 8.4 tm-20 -66.77 -49.42 65.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.413 -0.588 . . . . 70.209999999999994 109.413 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 117' ' ' PRO . 40.4 ttm180 -67.86 -52.08 40.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 72.200000000000003 110.695 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.61 172.29 3.84 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.101 -0.571 . . . . 74.310000000000002 111.952 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 88.5 m-85 -147.17 -63.64 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.782 0.291 . . . . 75.400000000000006 111.298 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 2.3 Cg_endo -84.23 141.36 9.14 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.213 1.942 . . . . 74.049999999999997 111.988 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.63 -21.93 57.89 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.692 2.261 . . . . 75.519999999999996 111.747 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.77 -35.34 63.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.772 -0.649 . . . . 74.310000000000002 110.115 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.02 92.95 46.66 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 64.329999999999998 109.218 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -52.02 147.24 27.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.038 2.492 . . . . 73.409999999999997 112.673 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 21.1 Cg_endo -59.83 153.43 56.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.727 2.285 . . . . 61.409999999999997 111.435 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 19.4 mtmm 59.1 53.11 5.69 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.393 0.616 . . . . 73.319999999999993 110.431 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.53 132.38 54.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.325 -0.852 . . . . 74.120000000000005 111.123 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.6 m -83.05 130.48 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.38 -0.6 . . . . 71.230000000000004 109.38 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -123.06 143.39 49.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.672 -0.492 . . . . 73.030000000000001 109.672 -173.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.576 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.2 t -100.53 116.13 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 74.230000000000004 109.832 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -109.06 116.58 32.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.096 -0.335 . . . . 52.100000000000001 110.096 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.8 mt-10 -78.58 106.86 10.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.181 -1.044 . . . . 64.310000000000002 108.181 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 13.4 m -97.59 149.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.047 -0.979 . . . . 41.0 110.112 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 63.8 tt0 -147.22 131.6 17.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.76 -0.2 . . . . 75.209999999999994 110.795 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.888 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 3.2 tm? -103.08 112.97 26.07 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.865 -0.42 . . . . 72.310000000000002 109.865 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -90.86 -41.48 11.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 110.324 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.43 139.1 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 55.219999999999999 109.932 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 119.37 -0.348 . . . . 71.349999999999994 110.401 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.709 0.29 . . . . 73.310000000000002 110.383 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.89 -70.68 0.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.522 . . . . 60.100000000000001 109.592 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -94.1 54.37 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.969 0.89 . . . . 74.230000000000004 109.037 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -140.0 81.08 1.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.764 -1.107 . . . . 73.230000000000004 108.856 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -92.26 -76.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 75.319999999999993 110.824 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -66.26 142.36 57.71 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.048 -0.524 . . . . 73.329999999999998 110.353 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.548 ' NE2' ' SD ' ' A' ' 9' ' ' MET . 84.0 t60 -145.93 39.54 1.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.193 0.52 . . . . 65.319999999999993 110.406 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -65.4 86.1 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.013 0.435 . . . . 73.239999999999995 109.959 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.548 ' SD ' ' NE2' ' A' ' 7' ' ' HIS . 16.4 ptm -103.06 4.27 37.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.695 -0.684 . . . . 52.340000000000003 110.108 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.1 -157.54 6.12 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.533 -0.758 . . . . 72.519999999999996 112.401 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -76.97 167.52 21.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.676 0.751 . . . . 61.109999999999999 111.972 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 12' ' ' LEU . 2.1 pt? -158.11 14.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.357 -1.292 . . . . 72.230000000000004 108.339 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -100.48 171.58 7.65 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.862 -1.063 . . . . 63.329999999999998 110.348 -172.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.04 37.67 29.28 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.55 0.531 . . . . 33.229999999999997 110.44 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -66.68 -14.33 62.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.711 -0.677 . . . . 71.120000000000005 111.308 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -59.82 87.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.368 0.604 . . . . 75.230000000000004 110.214 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.36 -5.89 49.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.391 -0.822 . . . . 72.329999999999998 111.668 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.2 171.04 26.67 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.719 -0.552 . . . . 74.25 111.719 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.1 125.26 9.68 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.662 2.241 . . . . 73.400000000000006 112.039 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.39 25.01 9.45 Favored Glycine 0 N--CA 1.453 -0.168 0 N-CA-C 111.615 -0.594 . . . . 53.439999999999998 111.615 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -156.84 176.3 12.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.613 -0.514 . . . . 73.519999999999996 109.613 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.28 58.84 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.221 0.534 . . . . 72.150000000000006 110.11 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -76.7 37.81 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.603 -0.726 . . . . 71.329999999999998 111.482 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.66 89.04 1.73 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 62.109999999999999 110.015 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -132.28 135.31 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.716 -0.675 . . . . 62.340000000000003 109.497 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 5.9 tt -145.7 102.39 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.509 -0.552 . . . . 71.530000000000001 109.509 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.73 149.82 42.71 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.981 -0.554 . . . . 65.329999999999998 110.185 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 18.4 ptpt -127.98 103.7 7.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.637 -0.71 . . . . 71.0 109.448 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.64 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 66.8 mttm -109.1 110.39 21.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.825 -0.435 . . . . 73.319999999999993 109.825 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 30' ' ' VAL . 5.8 p -71.87 97.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.486 0.66 . . . . 70.430000000000007 110.134 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.721 HD23 ' HD3' ' A' ' 95' ' ' LYS . 33.9 tp -76.94 -29.2 55.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 109.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 32.1 m -145.51 115.82 4.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 74.030000000000001 109.74 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.3 128.74 13.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.065 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.69 -159.81 22.05 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.177 -0.535 . . . . 71.120000000000005 112.44 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.46 -37.44 87.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.088 0.471 . . . . 72.409999999999997 110.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.21 -29.84 3.81 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.952 -0.567 . . . . 51.130000000000003 112.134 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.26 -34.12 7.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.737 0.303 . . . . 73.239999999999995 110.711 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 p -71.77 94.07 1.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.295 0.569 . . . . 54.219999999999999 110.983 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -88.06 125.91 62.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.494 -0.775 . . . . 63.140000000000001 110.452 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG3' ' O ' ' A' ' 90' ' ' MET . 86.3 Cg_endo -78.07 176.4 10.02 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.62 2.213 . . . . 71.040000000000006 111.547 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.97 167.25 14.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 109.905 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 156.24 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.345 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.71 73.64 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.15 -0.548 . . . . 65.140000000000001 112.562 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 4.3 mmmp? -116.19 130.02 56.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.683 0.278 . . . . 74.430000000000007 110.738 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.83 104.01 3.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.68 -0.859 . . . . 61.229999999999997 108.68 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 34.1 m -105.86 142.54 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.157 0.503 . . . . 64.049999999999997 110.951 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.8 m -99.27 120.32 39.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.112 -0.949 . . . . 54.210000000000001 109.27 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 87' ' ' VAL . 32.6 m -136.68 177.97 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.569 0.699 . . . . 41.030000000000001 112.454 -172.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 7.3 m170 -137.59 152.62 49.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.504 -1.226 . . . . 71.409999999999997 109.098 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -128.0 142.85 51.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 71.340000000000003 109.534 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.782 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 24.0 m-20 -135.4 119.73 17.87 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.017 -0.734 . . . . 72.430000000000007 109.017 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -82.68 114.32 3.82 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.214 -0.448 . . . . 64.230000000000004 112.295 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.522 HH11 HD12 ' A' ' 97' ' ' LEU . 42.1 ttm180 -130.8 148.5 52.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.428 0.633 . . . . 71.310000000000002 111.364 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -90.12 156.37 46.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.224 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.38 2.3 1.26 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.946 2.43 . . . . 74.209999999999994 112.861 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.76 -29.9 25.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.236 0.541 . . . . 72.299999999999997 110.517 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.85 -25.47 8.43 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.706 -0.679 . . . . 52.539999999999999 111.882 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -84.61 157.32 21.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.825 -0.435 . . . . 64.140000000000001 109.825 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 13.9 pt20 -141.84 -175.28 4.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.715 0.293 . . . . 72.329999999999998 110.905 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -86.06 -64.86 1.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 73.530000000000001 110.108 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -144.91 156.66 44.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.009 -0.367 . . . . 72.129999999999995 110.009 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.3 p -87.26 91.53 8.75 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.359 -0.608 . . . . 73.409999999999997 109.359 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.425 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 31.4 m -64.33 -27.39 68.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.829 -0.623 . . . . 61.149999999999999 111.155 -174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.24 69.4 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.434 -0.348 . . . . 74.420000000000002 110.424 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -73.8 -6.23 45.75 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.001 -0.545 . . . . 52.329999999999998 111.593 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 25.3 mmm180 -75.69 -2.82 31.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.084 0.468 . . . . 75.439999999999998 110.759 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.25 8.57 65.88 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 63.329999999999998 113.953 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HD2' ' HD2' ' A' ' 69' ' ' PRO . 52.5 tptt -122.89 121.58 27.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 117.051 0.426 . . . . 75.340000000000003 109.971 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.598 ' HD2' ' HD2' ' A' ' 68' ' ' LYS . 68.1 Cg_endo -85.27 160.06 11.27 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.658 2.239 . . . . 73.209999999999994 112.276 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -114.33 158.14 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.127 -0.694 . . . . 71.230000000000004 109.127 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 85.7 mt-30 -134.77 139.48 45.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.574 0.226 . . . . 75.030000000000001 110.825 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.536 ' HE1' HG21 ' A' ' 48' ' ' VAL . 33.5 p90 -156.16 151.88 27.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.508 -0.553 . . . . 73.400000000000006 109.508 173.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.5 m -73.66 109.03 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 75.200000000000003 110.905 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 88' ' ' ALA . 57.2 tp -60.8 135.31 57.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.057 -0.519 . . . . 75.129999999999995 110.209 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.83 -11.52 71.91 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.119 -0.562 . . . . 51.530000000000001 112.135 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.13 160.95 14.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.202 -0.296 . . . . 74.430000000000007 110.202 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.65 2.62 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 121.2 -0.524 . . . . 54.409999999999997 112.756 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -85.75 -25.46 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 75.439999999999998 110.304 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.48 168.21 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.76 -0.655 . . . . 32.009999999999998 109.722 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.4 pt -72.91 154.7 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.997 -0.372 . . . . 75.420000000000002 109.997 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 4.5 tmtm? -60.09 -28.42 67.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.475 -0.33 . . . . 73.310000000000002 110.756 -172.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.88 -54.55 36.55 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.923 -0.656 . . . . 34.43 112.003 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.452 ' O ' HG12 ' A' ' 87' ' ' VAL . 48.2 m0 -66.48 -41.25 89.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.025 -0.361 . . . . 71.340000000000003 110.025 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.11 -50.95 60.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.474 -0.785 . . . . 72.430000000000007 110.886 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -66.54 -46.34 76.46 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.347 -0.388 . . . . 73.310000000000002 110.307 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.38 -48.39 54.48 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.606 -0.724 . . . . 70.400000000000006 112.834 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 48' ' ' VAL . 12.3 p -75.55 -33.2 26.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 62.310000000000002 111.139 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -68.23 -25.95 65.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.706 0.261 . . . . 72.340000000000003 111.706 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 86' ' ' GLY . 11.7 t -89.54 17.58 6.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 72.319999999999993 112.89 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 12.3 ptp -125.37 178.15 5.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.901 -0.499 . . . . 71.329999999999998 111.412 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -116.65 177.31 4.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.294 -0.412 . . . . 75.530000000000001 110.477 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.833 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -69.45 129.71 40.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.091 -0.337 . . . . 74.120000000000005 110.091 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 88.82 6.11 73.04 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.326 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' THR . 19.6 tt0 -100.18 133.76 44.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.340000000000003 111.022 -175.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.721 ' HD3' HD23 ' A' ' 31' ' ' LEU . 50.0 tttm -117.67 117.52 29.58 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -122.65 137.72 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.216 0.531 . . . . 55.240000000000002 111.275 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 7.8 tt -90.78 106.29 18.41 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.972 -1.121 . . . . 62.350000000000001 107.972 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -115.25 124.82 52.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.113 -0.329 . . . . 65.010000000000005 110.113 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.516 HG23 HG22 ' A' ' 122' ' ' VAL . 4.3 m -80.36 111.75 17.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 71.140000000000001 110.546 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 105' ' ' ALA . 32.6 mm -93.58 113.22 59.71 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.618 -0.264 . . . . 60.109999999999999 110.449 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HA ' HG23 ' A' ' 120' ' ' THR . 43.8 Cg_endo -67.31 151.63 80.41 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.758 2.305 . . . . 51.240000000000002 111.783 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -55.99 -31.79 63.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 111.972 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.559 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 13.6 pt20 -65.52 -27.62 68.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.409 . . . . 73.140000000000001 110.954 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.559 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 91.9 mt -109.07 22.86 15.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 72.140000000000001 110.096 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 100' ' ' ILE . . . -149.18 176.61 10.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.887 -0.597 . . . . 75.530000000000001 111.406 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -76.65 -11.77 59.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.409999999999997 110.282 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.69 31.32 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.835 -0.62 . . . . 75.140000000000001 113.377 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.57 -49.32 76.77 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.408 -0.59 . . . . 70.209999999999994 109.408 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -91.92 -26.22 18.54 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.548 -0.751 . . . . 72.200000000000003 110.55 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 82.0 -66.25 3.9 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.745 -0.662 . . . . 74.310000000000002 111.584 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 50.5 m-85 94.56 -74.36 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.324 1.45 . . . . 75.400000000000006 111.567 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 110' ' ' GLY . 95.4 Cg_endo -81.15 139.2 11.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 CA-C-N 121.332 1.512 . . . . 74.049999999999997 110.84 174.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.11 -11.36 15.43 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.79 2.327 . . . . 75.519999999999996 112.457 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.72 -31.79 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.138 0.494 . . . . 74.310000000000002 110.026 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.9 mm -100.76 120.71 54.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.687 -0.688 . . . . 64.329999999999998 109.711 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 58.3 Cg_endo -70.97 151.09 61.89 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.354 2.036 . . . . 73.409999999999997 112.173 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 39.0 Cg_endo -66.43 141.0 59.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.294 1.996 . . . . 61.409999999999997 111.739 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 8.6 mtmp? 71.49 26.51 3.21 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.006 -0.543 . . . . 73.319999999999993 111.126 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -84.77 142.53 29.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 74.120000000000005 111.365 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 101' ' ' PRO . 91.7 m -95.21 137.34 34.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.695 -0.684 . . . . 71.230000000000004 109.419 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -128.57 139.98 52.02 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.78 -0.452 . . . . 73.030000000000001 109.78 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 121' ' ' LEU . 99.3 t -98.54 122.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.715 0.293 . . . . 74.230000000000004 110.32 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -113.6 120.09 39.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.836 0.35 . . . . 52.100000000000001 110.194 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 22.2 mt-10 -81.49 110.99 17.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.641 -0.874 . . . . 64.310000000000002 108.641 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.547 HG23 ' HE1' ' A' ' 90' ' ' MET . 4.0 m -99.84 139.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.739 -0.664 . . . . 41.0 109.483 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.4 tt0 -131.79 119.02 20.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.506 -0.316 . . . . 75.209999999999994 110.31 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.833 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -87.76 113.78 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 72.310000000000002 109.688 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.402 HD21 ' ND1' ' A' ' 49' ' ' HIS . 3.7 mm? -91.73 -43.09 9.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.364 -0.38 . . . . 73.209999999999994 110.693 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.47 142.13 24.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.542 -0.299 . . . . 55.219999999999999 110.886 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.602 -0.713 . . . . 71.349999999999994 110.411 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.85 0.357 . . . . 73.310000000000002 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.56 134.81 40.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 60.100000000000001 109.823 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 m170 -76.24 75.06 3.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 74.230000000000004 111.028 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.65 -11.86 4.39 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.821 -0.627 . . . . 73.230000000000004 110.446 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -158.24 127.26 5.63 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.979 -0.555 . . . . 75.319999999999993 109.991 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -164.19 137.33 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 110.128 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -144.0 113.12 6.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 65.319999999999993 109.601 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -84.16 128.52 34.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.076 -0.511 . . . . 73.239999999999995 110.44 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ttt -119.41 134.73 55.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.516 -0.55 . . . . 52.340000000000003 109.516 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.47 124.29 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.606 -0.598 . . . . 72.519999999999996 111.606 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.64 HG23 ' H ' ' A' ' 13' ' ' GLU . 12.9 t -71.63 -17.0 62.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.534 0.207 . . . . 61.109999999999999 110.849 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.8 mt 66.71 1.69 2.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.112 0.565 . . . . 72.230000000000004 112.332 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.64 ' H ' HG23 ' A' ' 11' ' ' THR . 40.9 mt-10 -97.75 124.27 42.03 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 110.008 -0.367 . . . . 63.329999999999998 110.008 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.0 101.18 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 33.229999999999997 110.728 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -70.96 -30.48 66.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 71.120000000000005 109.576 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -129.26 117.36 20.58 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.075 -0.966 . . . . 75.230000000000004 109.398 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -75.5 -43.64 48.07 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.612 -0.267 . . . . 72.329999999999998 110.841 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.16 -130.29 1.24 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.594 -0.812 . . . . 74.25 113.072 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.22 134.26 22.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.891 2.394 . . . . 73.400000000000006 113.103 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.16 39.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.765 -0.934 . . . . 53.439999999999998 110.765 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.5 t -101.15 166.36 10.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.814 0.34 . . . . 73.519999999999996 111.024 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.7 ttp -113.94 3.14 15.27 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.439 0.638 . . . . 72.150000000000006 109.601 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -99.45 179.41 4.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.635 -0.711 . . . . 71.329999999999998 110.526 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.423 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . . . -90.85 122.77 33.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.062 -0.347 . . . . 62.109999999999999 110.062 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -92.18 135.41 34.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.21 -0.45 . . . . 62.340000000000003 110.506 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.0 tp -106.23 101.84 11.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.974 -0.75 . . . . 71.530000000000001 108.974 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -147.67 106.11 3.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.802 -0.636 . . . . 65.329999999999998 110.388 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -136.97 144.91 43.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.932 0.396 . . . . 71.0 110.065 175.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -140.3 113.17 8.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 73.319999999999993 109.543 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.67 128.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.783 0.325 . . . . 70.430000000000007 110.661 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 97' ' ' LEU . 2.7 mm? -91.99 -42.78 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.268 0.556 . . . . 73.129999999999995 109.751 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 110.9 6.92 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.683 -0.689 . . . . 74.030000000000001 110.565 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.62 137.96 44.02 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.583 2.189 . . . . 71.120000000000005 111.698 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.26 -143.68 10.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.082 -0.58 . . . . 71.120000000000005 112.43 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.8 -37.42 81.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 72.409999999999997 110.535 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.84 -30.51 1.29 Allowed Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.704 -0.68 . . . . 51.130000000000003 113.751 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.85 -9.86 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 73.239999999999995 111.015 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -87.25 115.84 24.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.824 -0.626 . . . . 54.219999999999999 110.791 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 9.1 mtpm? -92.43 114.44 62.37 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 110.317 -0.253 . . . . 63.140000000000001 110.317 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.21 108.18 1.92 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.754 2.303 . . . . 71.040000000000006 112.183 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.26 120.96 34.13 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.036 -0.529 . . . . 75.109999999999999 109.692 173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.36 154.18 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 74.420000000000002 111.021 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.37 -28.08 8.93 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.043 -0.526 . . . . 65.140000000000001 112.023 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -86.04 159.21 19.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.159 0.504 . . . . 74.430000000000007 111.264 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -77.89 112.24 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.479 -0.782 . . . . 61.229999999999997 109.101 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.46 152.52 8.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.059 0.456 . . . . 64.049999999999997 111.384 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.2 m -106.5 110.83 23.16 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.072 -0.967 . . . . 54.210000000000001 110.014 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.437 HG21 ' HE1' ' A' ' 72' ' ' PHE . 25.7 m -119.3 178.28 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.336 -0.847 . . . . 41.030000000000001 111.181 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 22.8 t-80 -157.09 142.47 17.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.732 -0.84 . . . . 71.409999999999997 108.732 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.2 m-85 -126.95 153.18 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 71.340000000000003 110.165 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 16.8 t70 -136.67 109.49 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.539 -0.541 . . . . 72.430000000000007 109.539 174.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.8 147.27 32.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.356 -0.45 . . . . 64.230000000000004 113.587 -172.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 121' ' ' LEU . 25.8 ttm180 -162.14 144.56 11.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.315 0.578 . . . . 71.310000000000002 111.131 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.29 147.74 54.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 109.834 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.77 -17.92 61.73 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.373 2.049 . . . . 74.209999999999994 111.533 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.9 -25.74 62.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.566 -0.743 . . . . 72.299999999999997 110.461 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.58 -39.94 1.89 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.959 -0.564 . . . . 52.539999999999999 111.861 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -56.71 148.44 20.24 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.975 0.51 . . . . 64.140000000000001 111.493 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 19.8 pt20 -130.66 141.53 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.245 -0.65 . . . . 72.329999999999998 109.245 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -80.12 -38.42 31.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.812 0.301 . . . . 73.530000000000001 111.812 -173.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -152.92 133.64 13.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.318 -0.253 . . . . 72.129999999999995 110.318 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 t -81.07 91.14 6.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 73.409999999999997 109.436 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.9 m -67.6 -17.1 64.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.676 -0.693 . . . . 61.149999999999999 110.861 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -31.31 62.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.004 -0.544 . . . . 74.420000000000002 110.984 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 t -63.84 -46.22 86.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.769 0.318 . . . . 52.329999999999998 110.616 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 66' ' ' ARG . 5.8 ptt180 -75.87 -12.41 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.533 -0.303 . . . . 75.439999999999998 111.411 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.6 36.53 48.27 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.125 -0.488 . . . . 63.329999999999998 113.823 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.1 tppt? -92.21 113.43 59.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.163 -0.31 . . . . 75.340000000000003 110.163 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.4 Cg_endo -81.91 150.66 16.24 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.245 2.63 . . . . 73.209999999999994 111.894 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -114.28 160.61 18.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.92 -0.77 . . . . 71.230000000000004 108.92 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -140.62 146.85 38.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.093 -0.336 . . . . 75.030000000000001 110.093 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HE1' HG21 ' A' ' 48' ' ' VAL . 39.8 p90 -166.98 161.59 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 73.400000000000006 110.289 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 m -74.92 112.78 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.514 -0.312 . . . . 75.200000000000003 110.206 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 88' ' ' ALA . 47.2 tp -67.81 136.5 54.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.574 -0.285 . . . . 75.129999999999995 110.78 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 40.1 32.66 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.303 -0.475 . . . . 51.530000000000001 111.931 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.68 178.34 8.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.39 0.276 . . . . 74.430000000000007 110.31 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.34 46.19 3.59 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.036 -0.602 . . . . 54.409999999999997 112.173 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 9.3 mm-40 -85.04 -47.8 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 75.439999999999998 111.051 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.85 178.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.674 . . . . 32.009999999999998 109.67 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.97 142.92 15.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.172 0.511 . . . . 75.420000000000002 111.035 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -58.14 -30.61 66.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 73.310000000000002 111.862 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.02 -51.04 59.74 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.884 -0.674 . . . . 34.43 111.616 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -69.14 -47.67 64.45 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.792 -0.204 . . . . 71.340000000000003 110.636 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.27 -54.92 33.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.033 0.444 . . . . 72.430000000000007 111.149 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -72.07 -38.3 69.47 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.1 -0.5 . . . . 73.310000000000002 110.501 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.536 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.42 -50.11 57.94 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.935 -0.575 . . . . 70.400000000000006 112.215 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.641 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.1 p -75.72 -31.12 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 62.310000000000002 110.977 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -62.43 -33.49 74.91 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.741 0.305 . . . . 72.340000000000003 111.746 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 86' ' ' GLY . 11.0 t -79.5 7.41 8.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.461 0.541 . . . . 72.319999999999993 112.461 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 7.7 ptm -116.32 -176.51 2.97 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.196 -0.315 . . . . 71.329999999999998 110.456 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.9 p -118.21 178.81 4.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.775 0.321 . . . . 75.530000000000001 111.637 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.847 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.3 tt -68.69 135.16 50.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.863 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.433 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 71.96 23.68 77.64 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.633 -0.712 . . . . 72.25 112.299 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -112.46 148.54 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.859 0.361 . . . . 71.340000000000003 111.271 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -130.09 124.68 33.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.638 -0.71 . . . . 74.540000000000006 110.323 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.21 141.29 39.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 55.240000000000002 110.414 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.579 ' HB2' HD21 ' A' ' 31' ' ' LEU . 9.1 tt -92.19 123.95 35.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.119 -0.697 . . . . 62.350000000000001 109.119 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -130.21 134.51 47.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.918 0.389 . . . . 65.010000000000005 110.656 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 51.8 m -83.51 112.68 20.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.004 -0.544 . . . . 71.140000000000001 109.923 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.2 mm -84.84 110.93 31.6 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 116.382 -0.372 . . . . 60.109999999999999 110.607 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 120' ' ' THR . 24.4 Cg_exo -64.22 142.91 81.98 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.117 2.545 . . . . 51.240000000000002 111.565 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.596 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 51.3 p90 -54.39 -39.36 67.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.799 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 13.9 pt20 -70.2 -13.78 62.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.376 -0.375 . . . . 73.140000000000001 111.829 -174.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.93 16.55 24.16 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.997 0.427 . . . . 72.140000000000001 110.153 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.05 178.65 9.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.654 -0.703 . . . . 75.530000000000001 111.141 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -60.06 -25.09 65.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 72.409999999999997 110.705 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.73 -19.9 30.15 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.634 -0.712 . . . . 75.140000000000001 113.301 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.596 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 43.2 tt0 -56.16 -47.55 78.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 70.209999999999994 110.169 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -107.6 -15.33 14.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.4 -0.818 . . . . 72.200000000000003 110.907 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.75 -171.78 6.92 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 116.072 -0.513 . . . . 74.310000000000002 112.63 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.765 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 63.7 m-85 -147.53 -61.39 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.614 0.207 . . . . 75.400000000000006 110.677 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 50.9 Cg_endo -93.17 152.02 2.56 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.247 1.964 . . . . 74.049999999999997 112.037 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.63 -19.73 38.79 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.535 2.157 . . . . 75.519999999999996 111.765 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.98 -35.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.929 -0.578 . . . . 74.310000000000002 110.355 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.3 mm -121.25 80.75 36.72 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 108.538 -0.912 . . . . 64.329999999999998 108.538 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.22 169.32 22.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.88 2.387 . . . . 73.409999999999997 112.319 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 71.5 Cg_exo -50.14 148.98 12.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 61.409999999999997 112.228 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.3 mtmt 72.19 17.46 4.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.738 0.649 . . . . 73.319999999999993 111.312 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.06 104.42 8.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 111.43 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 101' ' ' PRO . 99.8 m -83.71 134.47 34.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.205 -0.665 . . . . 71.230000000000004 109.205 171.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -136.96 147.02 46.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.962 -0.385 . . . . 73.030000000000001 109.962 -170.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.542 ' N ' HD13 ' A' ' 121' ' ' LEU . 60.7 t -98.39 137.33 26.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 110.28 -175.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.44 129.38 31.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.54 -0.3 . . . . 52.100000000000001 110.411 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 59.3 mt-10 -75.15 118.57 18.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.756 -0.831 . . . . 64.310000000000002 108.756 167.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.59 136.8 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.834 -0.802 . . . . 41.0 108.834 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 47.8 tt0 -138.59 114.97 10.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.124 -0.489 . . . . 75.209999999999994 109.73 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.6 tm? -97.42 111.84 23.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.252 -0.648 . . . . 72.310000000000002 109.252 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.5 mm? -89.0 -41.26 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.47 -0.332 . . . . 73.209999999999994 110.647 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.77 145.87 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.572 -0.285 . . . . 55.219999999999999 111.038 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.25 1.105 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.059 178.563 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.758 0.313 . . . . 73.310000000000002 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.08 86.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.175 0.512 . . . . 60.100000000000001 111.771 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -99.38 115.27 28.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.187 -0.672 . . . . 74.230000000000004 109.187 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -61.78 95.95 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.241 0.543 . . . . 73.230000000000004 109.672 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -76.26 147.94 37.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 75.319999999999993 111.69 -172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -60.7 118.21 6.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.424 -0.807 . . . . 73.329999999999998 109.253 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -59.3 110.24 1.04 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.933 0.397 . . . . 65.319999999999993 110.027 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -162.28 147.26 12.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.804 -0.634 . . . . 73.239999999999995 109.516 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm -63.47 91.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 52.340000000000003 110.391 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.43 -169.93 46.03 Favored Glycine 0 C--O 1.235 0.213 0 CA-C-N 115.782 -0.645 . . . . 72.519999999999996 112.049 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 t -166.98 174.46 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.033 0.444 . . . . 61.109999999999999 110.649 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.4 mp -90.53 148.4 22.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 109.604 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.11 156.28 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 63.329999999999998 111.527 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.27 146.72 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.943 -0.571 . . . . 33.229999999999997 110.101 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.7 101.93 0.16 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.415 0.626 . . . . 71.120000000000005 110.437 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -90.06 17.31 7.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.695 -0.684 . . . . 75.230000000000004 110.87 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -119.39 148.5 43.14 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 72.329999999999998 110.298 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' H ' ' HD2' ' A' ' 19' ' ' PRO . . . -109.32 -61.59 0.53 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.18 -0.464 . . . . 74.25 113.508 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 18' ' ' GLY . 71.1 Cg_endo -71.49 24.91 0.23 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.088 2.526 . . . . 73.400000000000006 114.167 -172.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.57 30.58 78.3 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.246 -0.502 . . . . 53.439999999999998 113.234 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -66.4 78.01 0.1 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.698 0.761 . . . . 73.519999999999996 110.462 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.2 ptt? 179.7 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.675 -1.148 . . . . 72.150000000000006 108.856 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.5 m -99.86 175.45 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.563 -0.744 . . . . 71.329999999999998 109.858 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.23 98.07 8.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.664 0.269 . . . . 62.109999999999999 110.598 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -108.0 142.89 37.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 62.340000000000003 110.043 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.88 121.65 35.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.172 -0.677 . . . . 71.530000000000001 109.172 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.724 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 40.3 mt-10 -129.71 108.17 9.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 65.329999999999998 110.344 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 21.1 pttp -109.41 101.53 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.353 -0.61 . . . . 71.0 109.353 173.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.724 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 87.0 mttt -118.91 110.4 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.318 . . . . 73.319999999999993 110.415 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.73 119.21 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.051 -0.351 . . . . 70.430000000000007 110.051 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD23 ' HD3' ' A' ' 95' ' ' LYS . 32.7 tp -94.86 -30.99 13.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.267 0.556 . . . . 73.129999999999995 109.977 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 57.3 m -147.14 110.85 4.03 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.494 -0.775 . . . . 74.030000000000001 109.44 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 22.5 Cg_exo -65.48 146.35 84.86 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.037 2.492 . . . . 71.120000000000005 112.64 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.36 -158.67 31.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 71.120000000000005 111.987 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 37' ' ' VAL . 25.0 m-20 -71.27 -56.78 5.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.283 0.563 . . . . 72.409999999999997 110.582 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 -30.23 3.78 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.403 -0.817 . . . . 51.130000000000003 111.889 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 35' ' ' ASP . 30.3 m -78.54 -32.33 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.166 0.508 . . . . 73.239999999999995 110.245 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.547 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 6.0 p -71.15 105.93 3.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.341 -0.614 . . . . 54.219999999999999 109.341 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -91.63 109.31 35.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.812 -0.631 . . . . 63.140000000000001 110.928 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 38' ' ' THR . 60.9 Cg_endo -95.85 174.06 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.508 2.805 . . . . 71.040000000000006 111.411 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.74 163.0 40.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 110.812 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.27 166.12 23.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.726 -0.67 . . . . 74.420000000000002 111.609 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.04 86.33 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.969 -0.56 . . . . 65.140000000000001 112.443 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -119.2 155.76 31.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.607 0.241 . . . . 74.430000000000007 110.476 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -81.01 113.41 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.322 -0.622 . . . . 61.229999999999997 109.322 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HB ' HD21 ' A' ' 127' ' ' LEU . 33.9 m -106.61 145.89 13.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.908 0.385 . . . . 64.049999999999997 111.423 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.5 m -98.86 108.47 21.16 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.175 -0.921 . . . . 54.210000000000001 110.117 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -115.44 178.5 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 124.355 1.034 . . . . 41.030000000000001 111.575 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 11.0 t-160 -152.98 136.55 15.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.989 -1.115 . . . . 71.409999999999997 107.989 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -126.85 151.7 48.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.807 0.299 . . . . 71.340000000000003 111.807 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.706 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 33.5 t70 -138.85 118.54 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.998 -0.547 . . . . 72.430000000000007 110.095 169.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.16 138.93 17.12 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.371 -0.442 . . . . 64.230000000000004 112.624 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.634 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 28.1 ttm180 -157.51 149.26 22.13 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.341 0.591 . . . . 71.310000000000002 111.751 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -87.58 153.83 53.21 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.713 -0.676 . . . . 75.120000000000005 109.332 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.64 -20.13 56.43 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.708 2.272 . . . . 74.209999999999994 113.412 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.58 3.54 52.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.558 0.218 . . . . 72.299999999999997 111.26 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.07 -31.73 8.31 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.336 -0.459 . . . . 52.539999999999999 112.143 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.45 145.5 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.908 -0.405 . . . . 64.140000000000001 109.908 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.634 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 20.2 pt20 -151.64 147.59 26.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.516 176.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -62.23 -38.4 89.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 73.530000000000001 111.307 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.4 156.56 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.265 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 22.9 t -87.41 86.79 7.27 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.706 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 14.7 m -60.07 -30.11 68.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 61.149999999999999 110.453 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.564 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 34.8 ptt180 -71.32 -44.46 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 74.420000000000002 110.972 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -4.47 34.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.622 0.248 . . . . 52.329999999999998 111.142 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 62' ' ' SER . 27.2 mmt180 -76.63 -12.71 60.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.575 -0.284 . . . . 75.439999999999998 110.869 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.08 77.4 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.959 -0.639 . . . . 63.329999999999998 112.282 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.74 104.39 55.31 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-O 120.562 0.22 . . . . 75.340000000000003 110.783 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.86 166.35 19.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.004 2.469 . . . . 73.209999999999994 110.985 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.74 131.92 21.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.792 -0.447 . . . . 71.230000000000004 109.792 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 97.4 mt-30 -113.15 131.95 55.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.558 0.218 . . . . 75.030000000000001 110.501 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.574 ' HZ ' HG11 ' A' ' 87' ' ' VAL . 24.5 p90 -154.37 161.13 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.462 -0.335 . . . . 73.400000000000006 110.484 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 m -77.32 115.95 17.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.447 . . . . 75.200000000000003 110.752 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 127.91 33.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.036 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.93 43.68 7.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.161 -0.542 . . . . 51.530000000000001 112.075 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.69 173.78 14.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.821 0.343 . . . . 74.430000000000007 111.018 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.61 27.64 3.28 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.157 -0.474 . . . . 54.409999999999997 112.678 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 5.6 mm-40 -65.01 -43.78 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.227 0.537 . . . . 75.439999999999998 110.279 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.71 178.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.505 -0.77 . . . . 32.009999999999998 110.195 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.482 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.1 pt -62.49 143.59 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 110.01 -0.367 . . . . 75.420000000000002 110.01 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -58.23 -23.97 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.463 -0.335 . . . . 73.310000000000002 110.823 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.73 -50.45 67.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.948 -0.644 . . . . 34.43 111.835 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.482 ' H ' HG13 ' A' ' 80' ' ' ILE . 53.2 m0 -69.05 -42.09 76.75 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.153 -0.314 . . . . 71.340000000000003 110.153 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -54.05 -49.94 67.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.721 -0.672 . . . . 72.430000000000007 110.64 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.42 -41.24 80.67 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 110.501 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.34 -48.65 53.7 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.425 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.574 HG11 ' HZ ' ' A' ' 72' ' ' PHE . 7.1 p -75.68 -36.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 62.310000000000002 110.993 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.36 70.47 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.945 0.35 . . . . 72.340000000000003 111.945 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.3 t -84.56 -20.39 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.116 0.413 . . . . 72.319999999999993 112.116 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 18.0 ptp -88.82 -174.47 4.52 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 71.329999999999998 111.35 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 p -119.42 178.78 4.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.679 -0.692 . . . . 75.530000000000001 110.285 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.859 ' HA ' HD12 ' A' ' 127' ' ' LEU . 9.2 tt -72.0 132.94 44.97 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.986 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.93 34.87 46.53 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.383 -0.826 . . . . 72.25 112.252 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -125.95 138.18 53.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.965 0.412 . . . . 71.340000000000003 111.627 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.589 ' HD3' HD23 ' A' ' 31' ' ' LEU . 19.2 ttmm -107.6 113.8 27.35 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.446 -0.797 . . . . 74.540000000000006 109.745 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.46 132.59 56.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.42 . . . . 55.240000000000002 110.656 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.53 108.4 19.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.873 -1.158 . . . . 62.350000000000001 107.873 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CD1' HD13 ' A' ' 100' ' ' ILE . 12.3 t80 -116.77 123.53 47.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.151 -0.477 . . . . 65.010000000000005 109.956 -174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.9 m -81.17 106.33 13.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.526 -0.546 . . . . 71.140000000000001 109.526 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.439 HD13 ' CD1' ' A' ' 98' ' ' PHE . 47.5 mm -78.25 115.08 48.11 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 115.815 -0.63 . . . . 60.109999999999999 110.777 -175.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' A' ' 104' ' ' LEU . 22.0 Cg_exo -64.94 141.3 70.21 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.876 2.384 . . . . 51.240000000000002 110.916 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -58.12 -25.65 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.708 0.633 . . . . 74.230000000000004 112.708 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -75.26 -13.68 60.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.794 0.33 . . . . 73.140000000000001 111.405 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.471 HD12 ' HD2' ' A' ' 101' ' ' PRO . 88.1 mt -102.05 16.94 24.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.776 0.322 . . . . 72.140000000000001 110.382 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -159.79 -174.47 4.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.85 -0.614 . . . . 75.530000000000001 110.516 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -76.0 -5.42 46.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 72.409999999999997 110.358 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.49 -21.98 58.32 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.783 -0.644 . . . . 75.140000000000001 113.407 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 7.4 pt-20 -62.23 -42.61 99.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.902 0.382 . . . . 70.209999999999994 110.782 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 12.5 ttm180 -92.29 -42.51 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 72.200000000000003 110.399 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.94 141.4 4.14 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.817 -0.629 . . . . 74.310000000000002 111.629 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 49.2 m-85 -137.21 -58.16 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.691 0.246 . . . . 75.400000000000006 110.901 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 8.4 Cg_exo -72.98 147.75 43.99 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.974 1.783 . . . . 74.049999999999997 111.185 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.75 -19.2 60.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 75.519999999999996 112.183 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.601 HG23 HG12 ' A' ' 115' ' ' ILE . 35.1 m -86.31 -17.87 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 74.310000000000002 111.106 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.612 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.2 mm -114.27 102.06 54.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.851 0.357 . . . . 64.329999999999998 110.365 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.57 170.62 19.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.665 2.243 . . . . 73.409999999999997 112.056 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.2 144.92 96.25 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.559 2.173 . . . . 61.409999999999997 111.725 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 61.41 26.9 16.6 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.717 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.45 103.12 7.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 74.120000000000005 111.494 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -73.52 122.62 22.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -124.58 144.52 50.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.012 -0.366 . . . . 73.030000000000001 110.012 -167.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 121' ' ' LEU . 85.5 t -98.42 133.1 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.732 0.301 . . . . 74.230000000000004 110.439 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 121' ' ' LEU . 75.8 m-85 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 52.100000000000001 110.531 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 64.4 mt-10 -74.94 106.51 6.48 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.898 -1.149 . . . . 64.310000000000002 107.898 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.23 129.18 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.056 -0.72 . . . . 41.0 109.056 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.4 tt0 -134.77 120.75 19.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.528 -0.305 . . . . 75.209999999999994 110.412 -170.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 92' ' ' LEU . 3.3 tm? -97.21 110.21 22.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.368 -0.604 . . . . 72.310000000000002 109.368 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.7 mm? -86.97 -50.54 6.6 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.46 -0.337 . . . . 73.209999999999994 110.641 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.5 -177.03 6.3 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.635 -0.426 . . . . 55.219999999999999 112.133 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.38 -0.827 . . . . 71.349999999999994 109.425 176.684 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.511 0.196 . . . . 73.310000000000002 110.488 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.85 110.27 0.88 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 60.100000000000001 111.516 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -70.93 120.89 17.17 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.934 -0.575 . . . . 74.230000000000004 109.493 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -66.18 100.95 0.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.379 0.609 . . . . 73.230000000000004 110.985 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -91.36 113.24 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.043 -0.981 . . . . 75.319999999999993 109.77 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -74.72 136.96 41.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 73.329999999999998 111.079 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -79.04 128.31 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.346 -0.613 . . . . 65.319999999999993 109.346 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -80.76 39.4 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 -0.288 . . . . 73.239999999999995 110.749 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.3 mtt -117.65 9.0 12.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.053 0.454 . . . . 52.340000000000003 110.208 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.85 153.04 21.34 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.695 -0.684 . . . . 72.519999999999996 112.509 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 109.69 21.04 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.312 -0.255 . . . . 61.109999999999999 110.312 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.38 97.77 5.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 72.230000000000004 109.962 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.61 103.14 11.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.808 -0.633 . . . . 63.329999999999998 109.557 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.18 90.63 3.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 33.229999999999997 111.121 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -86.46 31.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.558 0.694 . . . . 71.120000000000005 109.61 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.1 p -86.1 82.83 7.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.34 -0.845 . . . . 75.230000000000004 111.919 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.17 -71.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 72.329999999999998 110.309 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.93 -170.61 26.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.165 -0.541 . . . . 74.25 111.887 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.21 122.33 10.74 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.603 2.202 . . . . 73.400000000000006 112.028 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.72 -179.37 38.73 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 111.788 -0.525 . . . . 53.439999999999998 111.788 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 m -72.21 77.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.098 0.475 . . . . 73.519999999999996 111.076 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.6 mmm -107.8 108.95 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.881 -0.6 . . . . 72.150000000000006 109.782 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.0 m -62.64 -41.26 98.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 71.329999999999998 111.577 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.29 96.75 6.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.929 0.395 . . . . 62.109999999999999 111.462 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -139.26 135.14 33.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.593 -0.731 . . . . 62.340000000000003 109.081 172.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.24 111.8 5.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.207 -0.294 . . . . 71.530000000000001 110.207 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.03 108.29 9.98 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.059 -0.349 . . . . 65.329999999999998 110.059 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -114.36 103.87 11.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.083 -0.71 . . . . 71.0 109.083 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.71 110.5 21.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 73.319999999999993 110.028 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 111.69 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 70.430000000000007 110.769 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.86 -42.43 24.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.329 -0.989 . . . . 73.129999999999995 108.329 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -149.83 119.93 3.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.222 -0.899 . . . . 74.030000000000001 109.258 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.45 138.31 24.3 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.631 2.221 . . . . 71.120000000000005 112.259 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -89.7 -167.74 42.67 Favored Glycine 0 C--O 1.236 0.244 0 CA-C-N 116.088 -0.505 . . . . 71.120000000000005 112.625 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.64 ' HB3' HG22 ' A' ' 37' ' ' VAL . 72.4 m-20 -56.34 -44.55 80.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.99 0.424 . . . . 72.409999999999997 111.387 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 80.41 -30.65 2.45 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.919 -0.582 . . . . 51.130000000000003 112.093 -175.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' A' ' 35' ' ' ASP . 35.6 m -76.81 -25.52 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.958 0.408 . . . . 73.239999999999995 109.996 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 19.5 p -97.86 89.68 4.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 54.219999999999999 109.748 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HA ' HG22 ' A' ' 91' ' ' THR . 58.8 mttp -95.91 149.56 36.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 115.748 -0.66 . . . . 63.140000000000001 111.106 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.88 154.49 23.01 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.715 2.277 . . . . 71.040000000000006 111.594 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -133.59 130.06 37.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.109999999999999 110.065 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.56 122.74 17.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.493 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.62 -4.66 32.71 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.356 -0.449 . . . . 65.140000000000001 112.044 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -109.56 165.92 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 74.430000000000007 110.796 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.7 tppp? -67.45 149.09 50.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 61.229999999999997 111.179 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 130' ' ' VAL . 16.9 m -140.14 141.89 32.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.903 -0.59 . . . . 64.049999999999997 109.7 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.9 m -115.09 108.42 16.63 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.514 -0.766 . . . . 54.210000000000001 109.497 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.25 178.21 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.818 -0.628 . . . . 41.030000000000001 112.27 -170.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 8.5 t-160 -150.07 147.73 28.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.926 -1.034 . . . . 71.409999999999997 108.329 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.2 153.31 44.85 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 111.365 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 36.6 t70 -136.27 109.26 7.66 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.663 -0.866 . . . . 72.430000000000007 108.663 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.54 146.97 33.47 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.461 -0.399 . . . . 64.230000000000004 113.121 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' NH2' HH21 ' A' ' 64' ' ' ARG . 22.3 ttm180 -160.16 149.05 17.26 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.006 0.431 . . . . 71.310000000000002 111.176 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -90.54 151.03 43.68 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.319 -0.4 . . . . 75.120000000000005 110.313 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.21 -13.08 33.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.792 2.328 . . . . 74.209999999999994 111.819 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.63 -17.44 64.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.589 -0.732 . . . . 72.299999999999997 110.346 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.21 28.84 10.2 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.95 -0.568 . . . . 52.539999999999999 112.374 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -155.21 161.42 41.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.649 -0.501 . . . . 64.140000000000001 109.649 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 9.8 pt20 -142.52 155.83 45.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.684 0.278 . . . . 72.329999999999998 110.535 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.37 -18.63 25.14 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.013 -0.539 . . . . 73.530000000000001 111.467 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -137.38 145.57 43.44 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.015 -0.365 . . . . 72.129999999999995 110.015 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.4 p -102.17 85.61 2.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.422 0.63 . . . . 73.409999999999997 110.173 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.744 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 16.1 m -67.78 -20.68 65.24 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.683 -0.69 . . . . 61.149999999999999 110.317 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.456 HH21 ' NH2' ' A' ' 53' ' ' ARG . 12.8 ptp180 -62.95 -44.38 96.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.403 -0.817 . . . . 74.420000000000002 110.732 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -70.85 -16.62 62.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.242 -0.436 . . . . 52.329999999999998 111.213 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.593 ' HD3' ' HA ' ' A' ' 63' ' ' SER . 56.9 mtp180 -82.9 -28.84 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 75.439999999999998 109.882 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.52 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.407 -0.815 . . . . 63.329999999999998 114.238 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -91.1 110.21 40.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.938 0.369 . . . . 75.340000000000003 110.299 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.83 168.55 23.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.818 2.345 . . . . 73.209999999999994 112.22 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -147.4 131.24 17.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.748 -0.464 . . . . 71.230000000000004 109.748 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.583 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 90.6 mt-30 -107.69 143.92 35.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.699 -0.228 . . . . 75.030000000000001 110.539 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 39.2 p90 -163.04 170.67 17.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 73.400000000000006 110.254 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.0 m -87.42 117.86 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.43 -0.35 . . . . 75.200000000000003 110.5 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 88' ' ' ALA . 64.4 tp -63.12 138.48 58.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.025 -0.534 . . . . 75.129999999999995 110.812 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 -22.58 37.76 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 116.141 -0.481 . . . . 51.530000000000001 112.133 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.31 178.47 6.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 74.430000000000007 111.597 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.07 24.39 21.94 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.866 -0.606 . . . . 54.409999999999997 112.278 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 72' ' ' PHE . 10.5 mm-40 -61.45 -45.76 92.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.285 0.564 . . . . 75.439999999999998 110.316 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.445 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 31.2 m -127.26 163.79 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.63 -0.713 . . . . 32.009999999999998 109.756 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.7 pt -60.48 141.01 17.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.807 -0.442 . . . . 75.420000000000002 109.807 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.838 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 4.3 mptp? -58.47 -15.54 11.43 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.02 0.378 . . . . 73.310000000000002 112.02 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.1 -56.02 27.57 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.374 -0.917 . . . . 34.43 111.199 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.445 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 43.7 m0 -69.66 -38.72 77.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.002 -0.369 . . . . 71.340000000000003 110.002 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.838 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 24.4 t70 -54.87 -48.97 72.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.441 -0.8 . . . . 72.430000000000007 110.822 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 31.2 mm-40 -71.54 -34.59 70.16 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.352 -0.385 . . . . 73.310000000000002 110.111 176.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.51 -48.21 55.63 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.0 -0.545 . . . . 70.400000000000006 112.287 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.579 HG23 HD23 ' A' ' 127' ' ' LEU . 3.5 p -75.63 -36.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.775 0.321 . . . . 62.310000000000002 110.801 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -64.73 -20.61 66.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.687 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 86' ' ' GLY . 12.6 t -95.53 10.99 34.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.171 0.434 . . . . 72.319999999999993 112.171 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.767 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.2 ptp -127.72 177.3 6.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.939 0.399 . . . . 71.329999999999998 111.664 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 39' ' ' LYS . 22.9 p -130.97 178.74 6.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.712 -0.676 . . . . 75.530000000000001 110.725 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.938 ' HA ' HD12 ' A' ' 127' ' ' LEU . 3.8 tt -65.32 130.31 42.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.807 0.336 . . . . 74.120000000000005 110.314 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.524 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.7 26.8 55.68 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.687 -0.688 . . . . 72.25 112.107 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.454 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 22.2 tt0 -123.71 141.19 52.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 71.340000000000003 110.534 -176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 125' ' ' VAL . 29.2 ttpp -138.95 135.75 34.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 74.540000000000006 109.531 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.58 152.03 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.442 . . . . 55.240000000000002 111.693 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.404 ' C ' HD23 ' A' ' 97' ' ' LEU . 7.3 tt -91.18 114.07 26.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.06 -1.089 . . . . 62.350000000000001 108.06 174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' HD1' HD13 ' A' ' 100' ' ' ILE . 7.2 t80 -117.32 121.08 40.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.356 . . . . 65.010000000000005 110.579 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 m -80.92 112.88 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 71.140000000000001 109.76 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.592 HG22 ' HB2' ' A' ' 105' ' ' ALA . 23.7 mm -88.46 110.56 37.61 Favored Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.695 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.19 139.96 62.77 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.769 2.313 . . . . 51.240000000000002 111.358 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -55.95 -28.43 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.241 0.46 . . . . 74.230000000000004 112.241 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.36 -37.28 86.67 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.975 0.417 . . . . 73.140000000000001 110.66 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.2 mt -99.4 18.79 16.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.878 -0.601 . . . . 72.140000000000001 109.987 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 80' ' ' ILE . . . -136.61 171.47 14.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.671 . . . . 75.530000000000001 111.24 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.447 ' HB2' ' HE1' ' A' ' 111' ' ' TYR . 44.9 p90 -76.86 -10.08 59.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 72.409999999999997 110.191 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -25.21 64.06 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.453 -0.794 . . . . 75.140000000000001 112.911 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 2.5 tm-20 -61.35 -54.53 42.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.982 -0.747 . . . . 70.209999999999994 108.982 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -64.87 -49.27 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.036 -0.984 . . . . 72.200000000000003 111.219 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.89 75.7 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.057 -0.592 . . . . 74.310000000000002 111.732 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.728 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m-85 -59.35 -54.0 60.5 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 111.594 0.22 . . . . 75.400000000000006 111.594 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 76.9 Cg_endo -96.72 148.99 1.06 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.53 2.154 . . . . 74.049999999999997 112.101 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 47.3 Cg_exo -57.39 -20.4 39.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.602 2.201 . . . . 75.519999999999996 112.069 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.58 -28.95 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 110.423 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.93 99.0 36.94 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.146 -0.686 . . . . 64.329999999999998 109.146 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 51.3 Cg_exo -54.56 140.64 75.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.72 2.28 . . . . 73.409999999999997 112.717 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 39.5 Cg_exo -61.83 142.52 93.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.362 2.041 . . . . 61.409999999999997 111.318 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 99.7 mttt 63.48 25.8 14.6 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 73.319999999999993 111.612 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.86 135.75 33.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.948 0.404 . . . . 74.120000000000005 111.028 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.4 m -87.41 140.18 29.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 71.230000000000004 109.663 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.97 165.88 12.61 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.487 0.185 . . . . 73.030000000000001 110.619 -174.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.38 132.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.812 -0.44 . . . . 74.230000000000004 109.812 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -135.42 125.56 26.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.647 0.261 . . . . 52.100000000000001 110.43 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 30.9 tt0 -84.4 110.04 18.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.808 -1.182 . . . . 64.310000000000002 107.808 172.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.471 HG23 ' CE ' ' A' ' 90' ' ' MET . 15.3 m -99.64 141.4 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.546 -0.752 . . . . 41.0 110.907 -175.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 46.1 tt0 -131.29 125.65 33.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 75.209999999999994 110.26 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.938 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -99.94 107.96 20.07 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.798 -0.445 . . . . 72.310000000000002 109.798 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.2 mm? -85.75 -43.01 13.71 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.292 -0.413 . . . . 73.209999999999994 110.448 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.37 169.45 24.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.286 -0.415 . . . . 55.219999999999999 110.363 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 46' ' ' VAL . 30.0 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 tmm? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.937 0.398 . . . . 73.310000000000002 109.952 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.69 171.23 15.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.888 -0.596 . . . . 60.100000000000001 109.96 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -114.32 135.61 53.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 74.230000000000004 110.662 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.04 76.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.015 -0.735 . . . . 73.230000000000004 109.015 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -109.7 23.4 14.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 75.319999999999993 111.343 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -85.94 -25.65 25.97 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.473 -0.936 . . . . 73.329999999999998 108.473 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 74.24 7.33 4.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.437 -1.256 . . . . 65.319999999999993 113.512 163.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -79.11 88.57 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.354 -0.61 . . . . 73.239999999999995 109.354 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.4 ttm -55.83 -62.04 1.96 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.08 -0.964 . . . . 52.340000000000003 111.59 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.4 -45.59 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.887 -0.673 . . . . 72.519999999999996 111.693 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -140.62 136.46 32.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.907 0.384 . . . . 61.109999999999999 110.092 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.2 tp -165.21 -49.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.801 -0.814 . . . . 72.230000000000004 108.801 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -86.62 48.51 1.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 63.329999999999998 109.485 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.63 63.62 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.57 -0.741 . . . . 33.229999999999997 111.858 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -94.34 110.03 21.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.423 -0.584 . . . . 71.120000000000005 109.423 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.9 m -52.82 117.74 3.16 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.097 -0.502 . . . . 75.230000000000004 111.234 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.47 -26.94 66.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.056 -0.52 . . . . 72.329999999999998 110.756 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 79.89 1.33 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.116 -0.564 . . . . 74.25 112.856 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.44 -31.62 86.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.842 2.361 . . . . 73.400000000000006 112.234 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.86 55.07 4.81 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.795 -0.639 . . . . 53.439999999999998 111.803 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 m -61.29 106.44 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.616 0.246 . . . . 73.519999999999996 110.681 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.8 mtt -76.59 46.56 0.45 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.058 0.456 . . . . 72.150000000000006 111.625 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -152.66 -89.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.326 -0.62 . . . . 71.329999999999998 109.326 175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 174.53 143.69 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.051 -0.522 . . . . 62.109999999999999 110.187 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -129.95 134.96 47.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.487 -0.931 . . . . 62.340000000000003 108.487 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.9 tp -138.69 102.28 4.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 71.530000000000001 110.16 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.27 164.1 35.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 65.329999999999998 110.229 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -145.65 118.98 8.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 71.0 109.425 173.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -108.91 110.43 21.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.227 -0.657 . . . . 73.319999999999993 109.227 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.64 122.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.894 0.378 . . . . 70.430000000000007 111.316 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 31' ' ' LEU . 2.5 mm? -87.68 -38.89 15.46 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.311 -0.626 . . . . 73.129999999999995 109.311 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -135.4 111.02 10.64 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.324 -0.853 . . . . 74.030000000000001 109.969 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.65 138.65 46.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.495 2.13 . . . . 71.120000000000005 112.228 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.87 -164.78 40.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.244 -0.503 . . . . 71.120000000000005 112.103 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' HB2' ' HG1' ' A' ' 38' ' ' THR . 47.1 m-20 -63.71 -25.79 68.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.728 0.299 . . . . 72.409999999999997 110.966 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.95 -30.26 1.81 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.478 -0.392 . . . . 51.130000000000003 113.092 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -93.43 -23.47 5.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.729 0.299 . . . . 73.239999999999995 110.892 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.456 ' HG1' ' HB2' ' A' ' 35' ' ' ASP . 7.6 p -76.42 88.47 3.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.165 0.507 . . . . 54.219999999999999 110.705 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -85.88 112.82 47.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 63.140000000000001 111.072 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 114.81 2.5 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.203 2.602 . . . . 71.040000000000006 111.576 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.45 175.13 5.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 110.741 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 157.21 36.01 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.355 -0.384 . . . . 74.420000000000002 110.5 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.69 22.74 68.84 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.068 -0.514 . . . . 65.140000000000001 111.964 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -116.66 136.25 53.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.66 0.267 . . . . 74.430000000000007 110.828 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.77 101.63 10.25 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.738 -0.838 . . . . 61.229999999999997 108.738 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.24 142.02 20.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 121.029 0.443 . . . . 64.049999999999997 111.276 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -105.67 108.47 20.01 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.137 -0.938 . . . . 54.210000000000001 109.301 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.17 172.14 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.164 0.507 . . . . 41.030000000000001 111.021 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 14.5 t-160 -134.03 132.08 39.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.186 -1.042 . . . . 71.409999999999997 108.186 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 29.2 p90 -128.37 145.46 51.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.707 0.289 . . . . 71.340000000000003 111.361 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.849 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 26.0 t70 -137.81 119.76 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 72.430000000000007 109.809 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -79.55 127.63 8.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.37 -0.443 . . . . 64.230000000000004 112.259 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.648 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 20.4 ttm180 -147.11 151.83 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 111.053 -173.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.31 150.02 42.25 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.839 -0.43 . . . . 75.120000000000005 109.839 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.02 -13.6 28.47 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.518 2.146 . . . . 74.209999999999994 111.656 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.98 -32.46 73.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.264 -0.88 . . . . 72.299999999999997 110.532 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.07 -42.04 1.68 Allowed Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.276 -0.73 . . . . 52.539999999999999 111.276 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -79.87 157.87 26.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.774 0.321 . . . . 64.140000000000001 110.522 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.648 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 13.5 pt20 -125.23 165.19 18.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 110.803 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -86.7 -16.74 35.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.733 0.271 . . . . 73.530000000000001 111.733 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.58 153.75 6.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.215 -0.661 . . . . 72.129999999999995 109.215 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 46.4 m -89.48 97.0 10.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.07 0.462 . . . . 73.409999999999997 110.837 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 50.9 m -93.49 -18.43 22.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.288 0.566 . . . . 61.149999999999999 110.267 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HD2' ' NH2' ' A' ' 53' ' ' ARG . 7.9 ptm180 -68.37 -47.48 67.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.78 -0.645 . . . . 74.420000000000002 111.013 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 p -68.92 -27.86 66.14 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.76 0.314 . . . . 52.329999999999998 111.785 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 62' ' ' SER . 19.8 mtp180 -75.6 -21.52 57.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.416 -0.356 . . . . 75.439999999999998 110.719 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.19 48.09 65.01 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.881 -0.599 . . . . 63.329999999999998 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 68' ' ' LYS . 1.6 tmtp? -95.95 111.76 57.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.814 -0.809 . . . . 75.340000000000003 108.814 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.64 152.35 7.55 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.802 2.335 . . . . 73.209999999999994 112.635 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -122.18 137.68 54.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.359 -0.608 . . . . 71.230000000000004 109.359 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.39 129.24 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.355 . . . . 75.030000000000001 110.168 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -149.46 160.11 43.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 73.400000000000006 110.554 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.3 m -83.45 104.86 13.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 75.200000000000003 109.937 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.83 131.4 49.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 110.001 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.67 -25.78 26.94 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.145 -0.55 . . . . 51.530000000000001 111.98 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.47 171.19 15.47 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.658 0.266 . . . . 74.430000000000007 110.501 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.54 35.77 2.25 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.233 -0.508 . . . . 54.409999999999997 113.233 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -84.88 -38.74 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.214 0.53 . . . . 75.439999999999998 109.844 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.64 157.95 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.409 -0.814 . . . . 32.009999999999998 109.366 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.8 pt -92.26 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.186 -0.301 . . . . 75.420000000000002 110.186 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 9.5 mmtm -51.62 -19.1 1.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.096 0.776 . . . . 73.310000000000002 113.096 -173.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.07 -63.0 4.91 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.446 -0.883 . . . . 34.43 111.72 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -70.85 -28.42 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 110.234 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.705 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 16.8 t70 -58.44 -51.66 68.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 72.430000000000007 110.087 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.28 -37.56 87.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.968 -0.382 . . . . 73.310000000000002 109.968 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -51.69 40.78 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.736 -0.666 . . . . 70.400000000000006 112.648 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.2 p -75.65 -31.38 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.038 0.447 . . . . 62.310000000000002 111.086 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.76 66.3 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -83.01 -5.48 59.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.003 0.371 . . . . 72.319999999999993 112.003 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.1 ptp -110.45 177.7 4.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.692 0.282 . . . . 71.329999999999998 111.136 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 p -127.66 177.98 6.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.089 -0.505 . . . . 75.530000000000001 110.173 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.7 ' HA ' HD12 ' A' ' 127' ' ' LEU . 5.1 tt -63.88 130.6 44.78 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.541 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.514 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 83.71 13.0 76.54 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.405 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -102.63 129.2 49.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.042 0.449 . . . . 71.340000000000003 111.382 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -110.64 116.92 32.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.273 -0.876 . . . . 74.540000000000006 108.893 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.33 142.8 50.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.228 0.537 . . . . 55.240000000000002 111.151 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.86 109.6 20.82 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.679 -0.859 . . . . 62.350000000000001 108.679 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 28' ' ' LYS . 12.6 t80 -105.17 134.65 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 65.010000000000005 110.511 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.6 m -93.56 112.82 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 71.140000000000001 110.138 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.579 HG21 ' HB2' ' A' ' 105' ' ' ALA . 26.8 mm -103.12 114.0 65.44 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 116.552 -0.295 . . . . 60.109999999999999 110.569 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' A' ' 104' ' ' LEU . 34.3 Cg_exo -59.57 155.1 43.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.52 2.147 . . . . 51.240000000000002 111.659 175.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -54.81 -32.18 59.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.936 0.398 . . . . 74.230000000000004 111.111 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -76.22 -10.01 59.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 73.140000000000001 111.795 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.574 HD12 ' HD2' ' A' ' 101' ' ' PRO . 82.3 mt -115.27 19.58 15.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.641 0.258 . . . . 72.140000000000001 110.768 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -163.46 -172.24 2.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.029 0.443 . . . . 75.530000000000001 110.776 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -76.39 -3.99 39.94 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.91 -0.586 . . . . 72.409999999999997 110.897 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.59 60.22 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 113.093 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.39 -55.84 9.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.835 0.35 . . . . 70.209999999999994 110.431 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.21 -49.81 16.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.813 -0.631 . . . . 72.200000000000003 110.987 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.92 80.41 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.348 -0.453 . . . . 74.310000000000002 112.84 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.539 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.5 m-85 -77.22 -50.67 2.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 111.819 0.303 . . . . 75.400000000000006 111.819 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 3.5 Cg_exo -77.48 128.47 9.58 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.233 1.955 . . . . 74.049999999999997 111.51 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.4 -11.9 21.65 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.849 2.366 . . . . 75.519999999999996 113.152 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.406 HG23 HG12 ' A' ' 115' ' ' ILE . 27.6 m -81.4 -17.93 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.992 0.425 . . . . 74.310000000000002 110.684 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 114' ' ' VAL . 49.9 mm -105.32 122.24 43.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 64.329999999999998 109.947 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 55.0 Cg_endo -70.95 130.6 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.374 2.049 . . . . 73.409999999999997 112.173 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 20.7 Cg_exo -67.26 149.36 81.34 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.822 2.348 . . . . 61.409999999999997 112.044 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm 64.28 27.63 13.83 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.298 0.639 . . . . 73.319999999999993 111.1 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.83 148.9 32.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 74.120000000000005 111.246 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.6 m -82.85 132.31 35.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.718 -0.674 . . . . 71.230000000000004 109.843 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -117.69 139.39 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.785 -0.45 . . . . 73.030000000000001 109.785 -173.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.4 t -106.25 138.81 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.536 -0.302 . . . . 74.230000000000004 110.241 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.21 125.24 38.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.074 -0.343 . . . . 52.100000000000001 110.074 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 35.6 tt0 -75.1 106.84 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.124 -1.435 . . . . 64.310000000000002 107.124 168.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 m -111.71 137.93 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.949 -0.568 . . . . 41.0 109.868 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.9 tt0 -144.02 126.68 16.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.854 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.3 tm? -79.34 101.69 8.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.310000000000002 108.302 176.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.94 -49.89 18.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 73.209999999999994 109.549 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.74 156.64 20.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 55.219999999999999 111.027 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.901 -0.591 . . . . 71.349999999999994 109.497 175.565 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.076 -0.342 . . . . 73.310000000000002 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.48 164.6 33.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 60.100000000000001 109.984 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -86.94 140.93 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.921 0.391 . . . . 74.230000000000004 110.628 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -120.11 50.46 1.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.748 -0.834 . . . . 73.230000000000004 108.748 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -71.76 -14.89 62.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.478 -0.783 . . . . 75.319999999999993 110.37 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -107.02 157.54 17.73 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.678 -0.86 . . . . 73.329999999999998 108.678 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -136.65 151.53 49.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.715 0.293 . . . . 65.319999999999993 110.567 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -94.95 142.42 27.5 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.07 -0.514 . . . . 73.239999999999995 111.317 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.96 121.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.185 -0.672 . . . . 52.340000000000003 109.185 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.61 82.6 0.31 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.161 -0.542 . . . . 72.519999999999996 112.62 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -89.77 104.05 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.01 -0.367 . . . . 61.109999999999999 110.01 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.48 113.93 21.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.023 -0.535 . . . . 72.230000000000004 109.651 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.9 134.7 35.07 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.418 -0.355 . . . . 63.329999999999998 110.119 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -110.93 107.95 17.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 33.229999999999997 110.803 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -81.75 168.83 17.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.985 0.421 . . . . 71.120000000000005 110.561 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 p -86.71 151.2 23.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 75.230000000000004 110.671 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 171.77 8.11 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.621 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.62 -157.54 9.1 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.127 -0.488 . . . . 74.25 112.175 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.73 -43.63 12.35 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 73.400000000000006 112.276 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.39 -91.55 0.21 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 53.439999999999998 112.034 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -96.24 151.95 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 73.519999999999996 110.41 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -87.25 -3.69 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.198 -0.455 . . . . 72.150000000000006 110.501 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 p -61.8 169.58 2.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.966 -0.561 . . . . 71.329999999999998 111.204 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 92.48 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 62.109999999999999 111.426 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -93.02 135.92 33.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.423 -0.955 . . . . 62.340000000000003 108.423 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.3 102.29 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 71.530000000000001 111.923 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -110.42 113.67 26.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 65.329999999999998 109.654 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -113.82 101.35 9.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.629 -0.878 . . . . 71.0 108.629 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.82 118.96 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.644 -0.707 . . . . 73.319999999999993 110.435 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.3 113.08 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.081 -0.509 . . . . 70.430000000000007 109.807 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -76.66 -40.78 48.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.332 -0.618 . . . . 73.129999999999995 109.332 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.3 m -147.08 114.67 4.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.606 -0.724 . . . . 74.030000000000001 109.305 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.44 150.3 87.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.713 2.275 . . . . 71.120000000000005 112.611 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -106.46 -135.29 7.97 Favored Glycine 0 C--O 1.237 0.31 0 CA-C-N 115.968 -0.56 . . . . 71.120000000000005 112.005 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 31.6 m-20 -73.4 -50.62 20.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 72.409999999999997 111.251 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.83 -25.18 8.91 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.926 -0.654 . . . . 51.130000000000003 112.172 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 35' ' ' ASP . 33.7 m -98.64 -24.59 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.019 0.438 . . . . 73.239999999999995 111.157 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.491 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.8 p -79.1 92.97 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.16 0.505 . . . . 54.219999999999999 110.242 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -88.6 128.59 52.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.738 -0.664 . . . . 63.140000000000001 110.938 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.98 122.93 6.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.487 2.124 . . . . 71.040000000000006 112.048 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.44 148.5 22.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.811 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.91 138.16 46.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.420000000000002 109.763 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.29 68.51 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.182 -0.532 . . . . 65.140000000000001 112.085 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -91.66 134.2 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 74.430000000000007 110.982 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.24 108.34 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.846 -0.798 . . . . 61.229999999999997 108.846 171.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.551 HG12 HG23 ' A' ' 130' ' ' VAL . 27.5 m -106.39 147.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.797 0.332 . . . . 64.049999999999997 110.805 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.1 m -104.62 108.17 19.49 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.787 -0.642 . . . . 54.210000000000001 110.064 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.789 HG12 HD22 ' A' ' 127' ' ' LEU . 15.8 m -125.96 178.23 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.631 -0.713 . . . . 41.030000000000001 110.636 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.81 154.19 36.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.84 -0.8 . . . . 71.409999999999997 108.84 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 36.9 p90 -134.06 158.14 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.429 -0.212 . . . . 71.340000000000003 110.429 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.698 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 1.4 m-20 -134.65 123.37 23.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.131 -0.692 . . . . 72.430000000000007 109.131 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.0 94.46 1.76 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.879 -0.601 . . . . 64.230000000000004 112.908 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.524 ' HA ' ' HB3' ' A' ' 59' ' ' GLN . 19.3 ttm180 -106.25 137.36 44.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.363 0.602 . . . . 71.310000000000002 110.774 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -78.06 154.73 80.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 75.120000000000005 109.789 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.97 -23.71 29.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.767 2.311 . . . . 74.209999999999994 112.05 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.21 -24.24 40.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.379 -0.828 . . . . 72.299999999999997 111.177 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.13 -2.86 56.71 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.63 -0.714 . . . . 52.539999999999999 111.439 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -110.37 156.31 20.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.976 0.51 . . . . 64.140000000000001 110.042 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 26.0 pt20 -141.23 163.56 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.908 -0.405 . . . . 72.329999999999998 109.908 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.63 -46.63 78.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 111.479 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -170.33 133.21 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.851 -0.425 . . . . 72.129999999999995 109.851 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -69.35 106.67 3.0 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.886 0.374 . . . . 73.409999999999997 110.219 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.3 p -76.46 -26.23 55.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 61.149999999999999 110.776 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -31.39 71.94 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.939 0.4 . . . . 74.420000000000002 110.048 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -60.84 -13.59 16.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.695 . . . . 52.329999999999998 111.225 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -78.36 -16.37 57.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.775 0.321 . . . . 75.439999999999998 111.075 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.5 34.33 73.56 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.159 -0.543 . . . . 63.329999999999998 112.344 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 113.65 14.89 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 110.252 -0.277 . . . . 75.340000000000003 110.252 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -95.61 177.2 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.187 2.592 . . . . 73.209999999999994 113.271 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -125.9 142.23 51.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.581 -0.896 . . . . 71.230000000000004 108.581 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -112.68 135.29 53.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.522 -0.177 . . . . 75.030000000000001 110.522 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -150.75 161.12 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.774 -0.454 . . . . 73.400000000000006 109.774 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.484 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 56.9 m -86.09 115.95 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.482 0.182 . . . . 75.200000000000003 110.642 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 88' ' ' ALA . 63.6 tp -64.15 138.64 58.55 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.253 -0.431 . . . . 75.129999999999995 110.452 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.38 32.39 31.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.128 -0.558 . . . . 51.530000000000001 111.949 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.15 160.27 43.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.04 -0.355 . . . . 74.430000000000007 110.04 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 29.04 1.51 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.566 -0.349 . . . . 54.409999999999997 113.47 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 73' ' ' THR . 10.9 mm-40 -62.32 -46.65 87.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.502 0.668 . . . . 75.439999999999998 109.568 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.82 178.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.729 -1.123 . . . . 32.009999999999998 109.689 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 83' ' ' TRP . 28.1 pt -68.59 145.53 13.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 123.333 0.396 . . . . 75.420000000000002 110.77 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.49 -20.46 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.261 -0.427 . . . . 73.310000000000002 111.579 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.05 21.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 34.43 111.535 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.456 ' H ' HG13 ' A' ' 80' ' ' ILE . 47.8 m0 -68.98 -37.91 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.675 0.274 . . . . 71.340000000000003 110.298 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.93 -55.03 35.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.885 -0.598 . . . . 72.430000000000007 110.499 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.37 -34.74 70.7 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.025 -0.534 . . . . 73.310000000000002 110.513 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.444 ' O ' HG22 ' A' ' 89' ' ' THR . . . -55.02 -49.83 61.23 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.917 -0.583 . . . . 70.400000000000006 112.138 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 90' ' ' MET . 21.6 m -75.8 -31.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.777 0.323 . . . . 62.310000000000002 111.12 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -63.82 -32.0 73.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.609 -0.269 . . . . 72.340000000000003 111.54 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.0 t -82.27 -10.72 59.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.823 0.305 . . . . 72.319999999999993 111.823 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 16.7 ptp -103.59 -172.05 2.04 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.712 0.292 . . . . 71.329999999999998 110.964 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -133.18 179.01 6.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.216 -0.447 . . . . 75.530000000000001 110.805 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 129' ' ' ALA . 3.4 tm? -62.9 138.49 58.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.802 0.334 . . . . 74.120000000000005 110.537 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.418 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.78 24.65 75.7 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.483 -0.78 . . . . 72.25 112.395 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 21.9 tt0 -121.2 135.32 55.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 71.340000000000003 110.792 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -117.87 128.42 54.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.507 -0.77 . . . . 74.540000000000006 109.341 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.13 141.53 44.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.459 . . . . 55.240000000000002 111.331 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 9.0 tt -90.9 115.63 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.633 -0.877 . . . . 62.350000000000001 108.633 174.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' HD1' HD13 ' A' ' 100' ' ' ILE . 21.4 t80 -121.26 122.73 40.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 65.010000000000005 110.107 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.593 HG23 HG22 ' A' ' 122' ' ' VAL . 4.2 m -79.59 107.85 12.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.45 . . . . 71.140000000000001 109.784 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.519 HD13 ' HD1' ' A' ' 98' ' ' PHE . 37.2 mm -82.72 110.43 22.46 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 116.222 -0.444 . . . . 60.109999999999999 110.575 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.558 ' HA ' HG23 ' A' ' 120' ' ' THR . 61.3 Cg_endo -72.68 150.29 50.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.41 2.073 . . . . 51.240000000000002 111.88 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -54.32 -27.99 39.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.679 -0.691 . . . . 74.230000000000004 111.975 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.11 -22.14 49.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.328 -0.396 . . . . 73.140000000000001 111.893 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.9 mt -106.35 22.48 15.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.01 0.434 . . . . 72.140000000000001 110.197 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -160.53 -174.99 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.626 . . . . 75.530000000000001 111.053 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -79.85 -3.37 47.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.548 -0.751 . . . . 72.409999999999997 110.243 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.66 -24.6 48.5 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.898 -0.592 . . . . 75.140000000000001 113.465 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 5.9 tm-20 -65.71 -48.36 72.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.555 -0.535 . . . . 70.209999999999994 109.555 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.522 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 1.6 tpm_? -78.38 -56.58 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.62 -0.718 . . . . 72.200000000000003 110.974 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.99 162.54 25.86 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.485 -0.646 . . . . 74.310000000000002 111.485 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.633 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 89.2 m-85 -143.15 -58.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.05 0.425 . . . . 75.400000000000006 110.824 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 71.7 Cg_endo -82.98 140.67 10.19 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.585 1.523 . . . . 74.049999999999997 111.499 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 35.9 Cg_exo -59.43 -5.89 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.819 2.346 . . . . 75.519999999999996 112.983 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 t -81.24 -29.56 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.472 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -111.35 109.31 56.46 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.969 -0.56 . . . . 64.329999999999998 110.043 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 22.8 Cg_exo -65.27 149.96 87.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.715 2.277 . . . . 73.409999999999997 112.014 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 23.8 Cg_exo -66.41 153.9 76.29 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.74 2.294 . . . . 61.409999999999997 112.039 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 47.4 mtmt 59.33 32.91 22.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.05 0.452 . . . . 73.319999999999993 110.759 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.77 32.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.953 -0.567 . . . . 74.120000000000005 111.12 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -73.79 124.66 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.3 -0.63 . . . . 71.230000000000004 109.3 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.2 tm? -119.11 144.47 46.6 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.097 -0.705 . . . . 73.030000000000001 109.097 -172.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.593 HG22 HG23 ' A' ' 99' ' ' THR . 63.9 t -98.38 111.19 27.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 110.166 -0.309 . . . . 74.230000000000004 110.166 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.457 ' CE2' HD12 ' A' ' 121' ' ' LEU . 40.1 m-85 -108.75 118.4 36.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.281 0.562 . . . . 52.100000000000001 110.855 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.698 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 43.8 mt-10 -75.45 109.04 8.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.337 -0.986 . . . . 64.310000000000002 108.337 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' HE1' ' A' ' 90' ' ' MET . 11.6 m -95.99 149.13 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 123.508 0.505 . . . . 41.0 109.646 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.51 119.64 8.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 110.193 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.789 HD22 HG12 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -90.67 104.35 16.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.472 -0.566 . . . . 72.310000000000002 109.472 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.0 -43.9 12.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.801 0.334 . . . . 73.209999999999994 110.752 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.488 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -159.39 164.34 34.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 55.219999999999999 110.465 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.551 HG23 HG12 ' A' ' 46' ' ' VAL . 2.7 p . . . . . 0 C--O 1.245 0.843 0 N-CA-C 109.771 -0.455 . . . . 71.349999999999994 109.771 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.627 0.251 . . . . 73.310000000000002 110.82 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.53 122.22 27.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.701 0.286 . . . . 60.100000000000001 111.065 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -164.27 142.27 7.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.093 -0.503 . . . . 74.230000000000004 109.728 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -84.11 163.38 19.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 110.476 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -142.59 102.94 4.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 75.319999999999993 111.107 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -145.75 150.86 37.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.475 -0.784 . . . . 73.329999999999998 109.712 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -104.79 -55.04 2.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.08 -0.711 . . . . 65.319999999999993 109.08 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -127.66 135.23 49.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.399 -0.818 . . . . 73.239999999999995 110.165 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt -114.52 -41.42 3.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.845 -0.798 . . . . 52.340000000000003 108.845 172.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.09 81.66 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.348 -0.842 . . . . 72.519999999999996 111.278 174.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -79.38 21.13 0.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.034 0.383 . . . . 61.109999999999999 112.034 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 12' ' ' LEU . 2.5 pt? -81.89 1.82 33.34 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.764 0.316 . . . . 72.230000000000004 111.089 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.6 86.25 2.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.002 0.429 . . . . 63.329999999999998 109.855 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.48 165.34 28.86 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.811 -0.631 . . . . 33.229999999999997 110.601 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -96.9 162.86 13.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 71.120000000000005 110.659 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 m -109.65 -34.95 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.176 -0.676 . . . . 75.230000000000004 109.176 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.2 158.04 43.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.408 -0.814 . . . . 72.329999999999998 109.092 173.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.03 26.97 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.163 -0.541 . . . . 74.25 112.69 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.12 -19.58 44.86 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.958 2.439 . . . . 73.400000000000006 111.796 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.98 54.35 4.2 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.968 -0.56 . . . . 53.439999999999998 112.433 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -127.77 103.65 7.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.554 -0.536 . . . . 73.519999999999996 109.554 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.1 mpt? -63.49 82.16 0.02 OUTLIER 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.491 0.662 . . . . 72.150000000000006 111.13 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -153.6 179.54 8.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.134 -0.939 . . . . 71.329999999999998 108.77 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.43 85.81 3.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 62.109999999999999 110.358 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -92.24 135.04 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.984 -0.747 . . . . 62.340000000000003 108.984 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.456 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 60.9 tp -146.18 119.62 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.178 0.436 . . . . 71.530000000000001 112.178 -175.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -101.45 129.52 47.51 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.121 -0.696 . . . . 65.329999999999998 109.121 162.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -125.79 100.71 6.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.745 -1.206 . . . . 71.0 107.745 169.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -119.71 113.29 20.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.945 -0.57 . . . . 73.319999999999993 110.308 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.03 108.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.224 0.535 . . . . 70.430000000000007 110.474 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -82.97 -44.85 14.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.857 -0.61 . . . . 73.129999999999995 109.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.8 m -139.68 110.76 7.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 74.030000000000001 109.45 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.14 133.9 40.2 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.621 2.214 . . . . 71.120000000000005 111.614 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.46 -150.69 23.03 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.166 -0.54 . . . . 71.120000000000005 112.795 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.71 -54.73 40.72 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.707 0.403 . . . . 72.409999999999997 111.254 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.5 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 75.7 -9.11 17.47 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.212 -0.518 . . . . 51.130000000000003 113.037 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.49 -6.7 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.115 0.483 . . . . 73.239999999999995 110.7 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 92' ' ' LEU . 40.8 p -83.96 120.11 25.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.795 -0.639 . . . . 54.219999999999999 110.681 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -126.66 89.67 51.59 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.728 -0.215 . . . . 63.140000000000001 110.637 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.8 -175.68 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.87 2.38 . . . . 71.040000000000006 111.993 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -146.55 174.94 10.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.368 -0.378 . . . . 75.109999999999999 110.268 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 140.36 57.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.196 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.12 -1.37 54.67 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.215 -0.516 . . . . 65.140000000000001 112.515 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -92.02 133.08 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 74.430000000000007 110.925 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -83.77 107.83 16.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.851 -0.796 . . . . 61.229999999999997 108.851 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 35.9 m -107.18 147.67 12.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 116.49 -0.323 . . . . 64.049999999999997 111.534 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 m -100.73 108.17 19.95 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.036 -0.983 . . . . 54.210000000000001 110.728 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.822 HG12 HD22 ' A' ' 127' ' ' LEU . 19.7 m -120.36 178.66 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 114.893 -1.048 . . . . 41.030000000000001 111.365 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.658 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 22.4 t-160 -152.8 146.4 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.697 -1.223 . . . . 71.409999999999997 107.697 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.5 m-85 -126.97 159.45 34.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.901 0.382 . . . . 71.340000000000003 111.965 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.888 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 5.6 m-20 -135.78 157.35 47.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.951 -1.022 . . . . 72.430000000000007 108.509 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -118.6 128.93 7.92 Favored Glycine 0 N--CA 1.461 0.312 0 C-N-CA 121.039 -0.6 . . . . 64.230000000000004 112.597 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.552 HH21 HG21 ' A' ' 122' ' ' VAL . 16.2 ttp180 -138.32 145.53 41.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.934 0.397 . . . . 71.310000000000002 110.752 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.0 155.56 64.19 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 75.120000000000005 109.767 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.33 -17.91 49.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.621 2.214 . . . . 74.209999999999994 112.487 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.8 -23.82 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 72.299999999999997 110.598 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.07 -22.53 18.25 Favored Glycine 0 N--CA 1.454 -0.165 0 N-CA-C 111.177 -0.769 . . . . 52.539999999999999 111.177 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -71.77 141.16 49.73 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.726 0.41 . . . . 64.140000000000001 109.949 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 14.6 pt20 -121.2 135.58 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.122 -0.695 . . . . 72.329999999999998 109.122 172.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -69.87 -29.95 67.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.615 -0.266 . . . . 73.530000000000001 111.394 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.09 134.15 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 72.129999999999995 110.779 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.459 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 13.7 p -79.14 86.69 4.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.452 -0.573 . . . . 73.409999999999997 109.452 171.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 m -65.42 -12.01 48.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.176 0.512 . . . . 61.149999999999999 110.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.658 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 8.8 ptp85 -63.56 -31.73 72.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.934 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 t -73.4 -19.14 61.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.831 -0.622 . . . . 52.329999999999998 110.952 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -75.57 -20.56 58.54 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.422 -0.353 . . . . 75.439999999999998 110.06 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.68 48.72 69.64 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.955 -0.566 . . . . 63.329999999999998 113.72 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 64.6 tttp -130.94 124.27 20.53 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.801 -0.444 . . . . 75.340000000000003 109.801 174.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 Cg_endo -83.65 175.13 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.107 2.538 . . . . 73.209999999999994 112.015 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -146.91 128.73 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 71.230000000000004 108.515 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 92.6 mt-30 -106.6 131.54 53.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.464 0.173 . . . . 75.030000000000001 110.654 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.86 158.77 43.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.564 -0.289 . . . . 73.400000000000006 110.471 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.1 m -84.32 124.36 31.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 75.200000000000003 110.386 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 tp -59.38 130.3 46.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.365 -0.379 . . . . 75.129999999999995 110.383 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.18 39.02 72.63 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.989 -0.55 . . . . 51.530000000000001 112.521 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.81 161.97 31.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.995 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.78 18.51 8.94 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 116.021 -0.536 . . . . 54.409999999999997 113.462 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.83 -19.75 54.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.599 . . . . 75.439999999999998 109.814 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.96 159.71 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.446 -0.797 . . . . 32.009999999999998 109.48 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 83' ' ' TRP . 21.3 pt -70.28 151.09 9.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 116.406 -0.361 . . . . 75.420000000000002 110.102 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -56.68 -26.68 57.16 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.827 -0.434 . . . . 73.310000000000002 109.827 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.27 -52.06 53.84 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.052 -0.594 . . . . 34.43 111.853 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.555 ' H ' HG13 ' A' ' 80' ' ' ILE . 40.8 m0 -69.32 -31.29 69.66 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.325 -0.25 . . . . 71.340000000000003 110.325 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.4 -45.75 80.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.132 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.12 -35.35 76.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 109.789 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 89' ' ' THR . . . -56.46 -47.07 86.22 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.876 -0.602 . . . . 70.400000000000006 112.353 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.627 HG23 HD23 ' A' ' 127' ' ' LEU . 7.1 p -75.05 -34.08 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.809 0.338 . . . . 62.310000000000002 110.622 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.75 70.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.483 -0.326 . . . . 72.340000000000003 111.456 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 86' ' ' GLY . 8.9 t -87.01 3.34 46.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.673 0.273 . . . . 72.319999999999993 111.187 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 15.3 ptm -130.14 175.74 8.66 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 110.81 -177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.5 HG21 ' HA2' ' A' ' 36' ' ' GLY . 59.5 p -127.34 178.68 5.9 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.296 -0.411 . . . . 75.530000000000001 110.789 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -69.22 139.38 54.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.634 -0.257 . . . . 74.120000000000005 110.395 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.499 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 77.93 12.57 84.29 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.956 -0.565 . . . . 72.25 112.219 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -112.72 153.75 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.321 0.248 . . . . 71.340000000000003 110.643 -172.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -134.09 127.82 32.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.353 -0.61 . . . . 74.540000000000006 109.353 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.07 146.85 41.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 55.240000000000002 110.914 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 8.6 tt -90.8 111.67 23.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.531 -0.915 . . . . 62.350000000000001 108.531 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -117.9 129.0 55.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.802 0.334 . . . . 65.010000000000005 110.147 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 122' ' ' VAL . 27.9 m -84.51 131.12 34.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.655 0.264 . . . . 71.140000000000001 111.138 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.68 103.0 44.83 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-O 120.896 0.379 . . . . 60.109999999999999 110.063 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.616 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.9 Cg_exo -62.67 155.09 61.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.598 2.199 . . . . 51.240000000000002 111.927 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -55.07 -23.38 19.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 111.415 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -75.63 -6.5 50.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.241 -0.436 . . . . 73.140000000000001 111.972 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.53 HD12 ' HD2' ' A' ' 101' ' ' PRO . 96.7 mt -127.53 14.46 7.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.707 0.262 . . . . 72.140000000000001 111.707 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.34 -175.77 5.01 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.953 0.406 . . . . 75.530000000000001 111.485 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -66.55 -12.33 57.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.515 -0.766 . . . . 72.409999999999997 111.314 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.91 -32.83 19.51 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.35 -0.386 . . . . 75.140000000000001 113.688 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 tp10 -58.08 -49.23 77.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.367 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.26 -47.74 9.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 72.200000000000003 110.971 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.77 153.44 13.05 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 112.076 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.705 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 76.1 m-85 -144.41 -57.19 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 122.314 0.246 . . . . 75.400000000000006 110.944 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 6.8 Cg_exo -73.49 143.1 34.01 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.896 1.731 . . . . 74.049999999999997 111.235 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.48 -27.66 41.38 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.821 2.347 . . . . 75.519999999999996 112.786 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 115' ' ' ILE . 33.3 m -78.19 -18.18 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 111.514 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.513 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 49.0 mm -108.19 103.37 50.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.318 -0.401 . . . . 64.329999999999998 110.188 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.52 164.68 31.97 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.568 2.179 . . . . 73.409999999999997 111.668 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.35 142.6 94.98 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.317 2.012 . . . . 61.409999999999997 112.135 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 67.6 mttm 65.97 27.74 10.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.937 -0.574 . . . . 73.319999999999993 111.283 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.73 116.84 26.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.835 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.616 HG23 ' HA ' ' A' ' 101' ' ' PRO . 70.6 m -74.04 138.37 44.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.015 -0.539 . . . . 71.230000000000004 109.75 174.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -129.64 138.95 51.5 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.263 -0.643 . . . . 73.030000000000001 109.263 -175.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.552 HG21 HH21 ' A' ' 53' ' ' ARG . 48.1 t -98.6 133.72 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.588 0.232 . . . . 74.230000000000004 110.397 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.54 126.51 44.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.069 0.461 . . . . 52.100000000000001 110.533 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.0 mt-10 -78.23 118.36 20.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.953 -0.758 . . . . 64.310000000000002 108.953 173.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -95.97 135.57 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.443 -0.577 . . . . 41.0 109.443 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.9 tt0 -135.16 106.51 6.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.283 -0.417 . . . . 75.209999999999994 110.113 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.822 HD22 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -87.03 108.27 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.829 -0.804 . . . . 72.310000000000002 108.829 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.24 -50.9 7.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.856 -0.424 . . . . 73.209999999999994 109.856 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -169.9 -173.68 1.63 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.969 -0.56 . . . . 55.219999999999999 110.602 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.243 0.736 0 N-CA-C 109.161 -0.681 . . . . 71.349999999999994 109.161 173.216 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.884 0.373 . . . . 73.310000000000002 110.58 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.67 -81.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.388 -0.824 . . . . 60.100000000000001 112.486 172.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 62.34 10.52 3.94 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.256 -0.429 . . . . 74.230000000000004 110.846 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -92.24 134.22 35.09 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.672 -0.492 . . . . 73.230000000000004 109.672 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -112.41 146.91 37.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.756 -0.461 . . . . 75.319999999999993 109.756 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -74.73 73.04 2.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.205 0.526 . . . . 73.329999999999998 110.311 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -99.54 120.34 39.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.994 -0.548 . . . . 65.319999999999993 109.86 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -125.63 144.86 50.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.906 -0.588 . . . . 73.239999999999995 109.443 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.5 mtp -134.88 120.0 18.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.457 -0.338 . . . . 52.340000000000003 110.67 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.86 49.08 3.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.348 -0.701 . . . . 72.519999999999996 111.348 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.429 ' HB ' ' SD ' ' A' ' 22' ' ' MET . 25.0 m -68.89 138.66 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.658 0.383 . . . . 61.109999999999999 110.851 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 12' ' ' LEU . 2.0 pt? -116.97 -2.97 11.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 72.230000000000004 109.805 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.82 115.2 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.462 -0.79 . . . . 63.329999999999998 109.997 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.78 79.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 33.229999999999997 111.943 -174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -168.31 115.46 0.69 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.064 -0.517 . . . . 71.120000000000005 110.009 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -150.98 154.11 36.46 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 110.047 -0.353 . . . . 75.230000000000004 110.047 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -74.34 82.32 1.89 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.711 -0.477 . . . . 72.329999999999998 109.711 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.36 143.25 9.25 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.071 -0.513 . . . . 74.25 112.002 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 49.1 Cg_endo -68.2 88.22 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.603 2.202 . . . . 73.400000000000006 111.958 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.96 -154.14 22.33 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.832 -0.622 . . . . 53.439999999999998 112.791 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -55.51 -18.24 6.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.95 0.5 . . . . 73.519999999999996 112.138 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.568 ' HB2' HE21 ' A' ' 25' ' ' GLN . 84.9 mmm -67.87 -4.58 13.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.116 0.413 . . . . 72.150000000000006 112.116 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 p 55.87 -75.42 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.733 0.813 . . . . 71.329999999999998 112.827 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' MET . . . -70.88 108.96 4.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.937 0.399 . . . . 62.109999999999999 110.415 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.619 ' HG3' ' HA ' ' A' ' 19' ' ' PRO . 80.0 mm-40 -135.48 163.37 30.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 62.340000000000003 110.638 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -142.51 102.03 3.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 71.530000000000001 110.134 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -124.63 102.26 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.262 0.553 . . . . 65.329999999999998 110.047 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -112.74 109.7 19.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.272 -0.876 . . . . 71.0 109.16 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -108.66 110.35 21.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.469 -0.567 . . . . 73.319999999999993 109.469 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.75 106.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.109 -0.33 . . . . 70.430000000000007 110.109 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 97' ' ' LEU . 85.4 mt -87.7 -28.84 21.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 110.154 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 28.5 m -140.83 110.92 6.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.48 -0.782 . . . . 74.030000000000001 109.518 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.81 127.0 22.0 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.486 2.124 . . . . 71.120000000000005 111.249 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.11 -174.35 50.32 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 71.120000000000005 112.922 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' OD2' HG22 ' A' ' 37' ' ' VAL . 23.0 t70 -60.82 -43.06 98.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 110.543 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.3 9.74 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.934 -0.575 . . . . 51.130000000000003 114.43 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG22 ' OD2' ' A' ' 35' ' ' ASP . 14.0 m -103.57 -28.0 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.087 0.943 . . . . 73.239999999999995 110.807 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 5.5 p -75.95 88.62 2.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.41 0.624 . . . . 54.219999999999999 109.854 173.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -93.29 114.45 62.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.348 -0.842 . . . . 63.140000000000001 111.068 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HG3' ' HG ' ' A' ' 127' ' ' LEU . 56.1 Cg_endo -70.58 107.77 2.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.412 2.074 . . . . 71.040000000000006 110.974 174.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.08 157.72 15.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 75.109999999999999 110.609 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 157.27 32.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 74.420000000000002 111.057 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.08 76.93 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.004 -0.544 . . . . 65.140000000000001 112.128 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -132.08 141.78 49.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.456 0.303 . . . . 74.430000000000007 110.311 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -71.95 107.61 4.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.736 -0.468 . . . . 61.229999999999997 109.736 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 130' ' ' VAL . 33.6 m -106.42 147.42 11.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 120.887 0.375 . . . . 64.049999999999997 110.903 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.2 m -104.81 108.44 19.93 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.472 -0.786 . . . . 54.210000000000001 109.761 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.651 HG12 HD22 ' A' ' 127' ' ' LEU . 21.3 m -118.78 178.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.482 -0.781 . . . . 41.030000000000001 111.97 -171.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -150.61 137.02 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.866 . . . . 71.409999999999997 109.231 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.638 ' HD1' HG12 ' A' ' 125' ' ' VAL . 56.2 m-85 -126.64 159.4 33.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.71 -0.107 . . . . 71.340000000000003 110.71 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.62 136.35 29.05 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.466 0.479 . . . . 72.430000000000007 109.728 167.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 124.82 7.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.475 -0.393 . . . . 64.230000000000004 112.277 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -141.01 137.46 32.99 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.327 0.584 . . . . 71.310000000000002 110.974 -170.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.19 148.37 39.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 109.744 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 -18.56 37.0 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.799 2.333 . . . . 74.209999999999994 112.457 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -66.56 -31.3 71.93 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.054 -0.521 . . . . 72.299999999999997 110.783 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.43 -21.07 15.21 Favored Glycine 0 C--N 1.327 0.038 0 N-CA-C 109.992 -1.243 . . . . 52.539999999999999 109.992 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -68.87 154.46 41.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.672 -0.764 . . . . 64.140000000000001 110.101 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -142.23 151.77 42.44 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.778 -0.453 . . . . 72.329999999999998 109.778 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.75 -4.54 36.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.714 0.292 . . . . 73.530000000000001 111.422 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -168.26 144.79 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.141 -0.688 . . . . 72.129999999999995 109.141 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.8 p -109.07 85.34 2.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.62 0.724 . . . . 73.409999999999997 110.292 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.1 m -77.83 -18.26 56.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.539 -0.755 . . . . 61.149999999999999 109.401 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -65.05 -32.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.21 -0.904 . . . . 74.420000000000002 109.645 173.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -73.57 -24.26 60.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.342 -0.844 . . . . 52.329999999999998 110.869 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -84.27 -28.64 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 75.439999999999998 110.598 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.25 25.1 59.73 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.086 -0.506 . . . . 63.329999999999998 112.194 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.92 129.15 47.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 122.52 0.328 . . . . 75.340000000000003 110.825 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -87.84 157.05 7.41 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.967 2.444 . . . . 73.209999999999994 112.434 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -134.92 130.13 35.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.888 -0.782 . . . . 71.230000000000004 108.888 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -107.85 138.24 44.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.504 0.192 . . . . 75.030000000000001 110.756 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -157.21 163.55 38.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.267 -0.424 . . . . 73.400000000000006 110.051 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.9 m -82.46 110.79 17.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.192 -0.299 . . . . 75.200000000000003 110.192 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 88' ' ' ALA . 48.1 tp -61.82 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.238 -0.437 . . . . 75.129999999999995 110.223 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.14 12.48 Favored Glycine 0 C--O 1.237 0.286 0 N-CA-C 111.488 -0.645 . . . . 51.530000000000001 111.488 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.57 154.19 38.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 74.430000000000007 110.504 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.61 33.89 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.147 -0.479 . . . . 54.409999999999997 112.67 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.89 -23.6 67.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.022 0.439 . . . . 75.439999999999998 110.641 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.93 174.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.139 -0.689 . . . . 32.009999999999998 109.139 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.6 pt -73.61 140.28 18.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.741 -0.466 . . . . 75.420000000000002 109.741 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 30.3 mmtp -58.45 -16.68 16.1 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.689 0.255 . . . . 73.310000000000002 111.689 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.93 -53.02 46.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.416 -0.897 . . . . 34.43 111.183 172.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.522 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.1 m0 -67.06 -42.1 85.33 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.114 -0.328 . . . . 71.340000000000003 110.114 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.501 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 17.8 t70 -52.59 -55.15 24.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.511 -0.768 . . . . 72.430000000000007 110.671 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -65.6 -40.42 92.65 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.094 -0.503 . . . . 73.310000000000002 110.666 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.69 -53.96 30.24 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.919 -0.582 . . . . 70.400000000000006 112.622 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.94 -30.35 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.544 0.212 . . . . 62.310000000000002 111.369 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -67.2 -30.15 70.01 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.725 0.269 . . . . 72.340000000000003 111.725 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 t -88.46 7.32 33.43 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.001 0.371 . . . . 72.319999999999993 112.001 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 11.9 ptp -121.97 -173.87 2.75 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.168 -0.332 . . . . 71.329999999999998 111.113 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -124.31 175.3 7.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.132 -0.486 . . . . 75.530000000000001 110.732 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.684 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.7 tt -63.33 131.84 49.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 74.120000000000005 110.364 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 8.78 83.7 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.416 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.639 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 14.1 tt0 -102.02 140.92 35.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 71.340000000000003 110.585 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.9 ttpm? -131.79 136.23 47.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.808 -0.442 . . . . 74.540000000000006 109.808 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.13 150.62 35.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.961 0.41 . . . . 55.240000000000002 111.186 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.1 tt -90.67 109.42 20.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.984 -1.117 . . . . 62.350000000000001 107.984 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HD1' HD13 ' A' ' 100' ' ' ILE . 7.0 t80 -112.0 117.77 33.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 65.010000000000005 110.109 -174.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 31.9 m -77.22 110.54 12.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.401 -0.363 . . . . 71.140000000000001 110.224 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.427 HD13 ' HD1' ' A' ' 98' ' ' PHE . 42.0 mm -90.48 111.6 48.33 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.127 -0.488 . . . . 60.109999999999999 110.488 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HA ' HG23 ' A' ' 120' ' ' THR . 34.3 Cg_exo -59.9 144.46 99.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.396 2.064 . . . . 51.240000000000002 110.908 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.546 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 46.5 p90 -54.56 -36.32 64.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 74.230000000000004 110.882 -176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -62.99 -24.15 67.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 73.140000000000001 111.398 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.34 16.91 24.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.285 -0.416 . . . . 72.140000000000001 110.723 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.69 7.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 75.530000000000001 111.169 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -74.43 -11.03 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.893 -0.594 . . . . 72.409999999999997 111.016 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.89 63.45 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.928 -0.578 . . . . 75.140000000000001 112.485 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 4.7 tm-20 -57.62 -54.81 42.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.072 0.463 . . . . 70.209999999999994 109.996 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -103.67 -24.69 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 72.200000000000003 110.086 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.06 -175.22 52.57 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 112.317 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.799 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m-85 -151.04 -59.47 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.877 0.471 . . . . 75.400000000000006 110.119 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 72.8 Cg_endo -95.26 157.6 1.66 Allowed 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.653 2.235 . . . . 74.049999999999997 112.193 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.82 -17.28 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.852 2.368 . . . . 75.519999999999996 112.472 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.74 -32.53 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 74.310000000000002 110.251 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.651 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 mm -109.14 99.56 36.45 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.05 -0.523 . . . . 64.329999999999998 109.619 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.635 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 36.2 Cg_endo -66.08 152.22 81.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.515 2.144 . . . . 73.409999999999997 112.182 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 34.3 Cg_exo -62.87 137.13 61.02 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.36 2.04 . . . . 61.409999999999997 111.277 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 64.75 37.5 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.63 0.581 . . . . 73.319999999999993 110.501 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -92.98 116.33 28.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.607 -0.724 . . . . 74.120000000000005 110.544 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -74.1 133.96 42.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 71.230000000000004 109.389 173.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -124.87 144.3 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 73.030000000000001 109.307 -172.08 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.419 ' H ' HD13 ' A' ' 121' ' ' LEU . 88.6 t -100.85 128.01 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 109.914 -0.402 . . . . 74.230000000000004 109.914 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -123.02 120.71 34.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.151 0.501 . . . . 52.100000000000001 110.329 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -82.84 111.05 18.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.614 -0.884 . . . . 64.310000000000002 108.614 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.638 HG12 ' HD1' ' A' ' 50' ' ' TYR . 34.2 m -104.81 150.24 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.029 -0.987 . . . . 41.0 110.614 -173.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.01 128.88 12.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.49 -0.323 . . . . 75.209999999999994 110.439 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -93.43 118.17 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.929 -0.767 . . . . 72.310000000000002 108.929 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.79 -50.33 5.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.428 0.156 . . . . 73.209999999999994 111.141 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.24 0.543 . . . . 55.219999999999999 111.677 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 92' ' ' LEU . 13.3 p . . . . . 0 C--O 1.251 1.167 0 CA-C-N 115.206 -0.906 . . . . 71.349999999999994 108.947 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.951 -0.389 . . . . 73.310000000000002 109.951 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.99 167.02 30.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.807 0.337 . . . . 60.100000000000001 111.325 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -168.53 115.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 74.230000000000004 109.35 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -140.96 114.38 8.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 73.230000000000004 111.232 -173.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -140.08 137.43 34.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.306 -0.628 . . . . 75.319999999999993 109.306 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -128.54 112.24 14.1 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.871 -0.418 . . . . 73.329999999999998 109.871 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -86.34 89.68 7.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 65.319999999999993 111.053 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -157.38 121.75 4.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 73.239999999999995 110.507 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.6 tpt -149.76 121.08 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 52.340000000000003 110.212 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 171.51 48.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.958 -0.565 . . . . 72.519999999999996 112.902 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.1 p -128.37 165.12 21.21 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.695 -0.483 . . . . 61.109999999999999 109.695 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.2 mt -132.23 154.16 49.89 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 110.308 -0.256 . . . . 72.230000000000004 110.308 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -80.04 82.77 6.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.218 0.532 . . . . 63.329999999999998 109.739 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.91 123.62 32.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 33.229999999999997 110.534 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -161.98 103.58 1.15 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.501 -0.555 . . . . 71.120000000000005 109.501 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.3 m -150.27 124.73 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.474 -0.33 . . . . 75.230000000000004 110.33 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -79.72 83.47 5.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.739 -0.467 . . . . 72.329999999999998 109.739 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.08 -163.17 32.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.145 -0.55 . . . . 74.25 112.552 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HG2' ' HG3' ' A' ' 55' ' ' PRO . 79.6 Cg_exo -50.09 94.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.122 2.548 . . . . 73.400000000000006 112.682 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.71 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 109.876 -1.29 . . . . 53.439999999999998 109.876 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -90.45 101.19 13.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.916 -0.772 . . . . 73.519999999999996 108.916 170.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 ptp -65.69 110.56 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.229 0.537 . . . . 72.150000000000006 111.596 -173.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -165.56 175.69 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.802 -0.635 . . . . 71.329999999999998 109.804 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.2 75.3 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 62.109999999999999 110.833 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -92.63 135.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 62.340000000000003 109.711 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.8 tp -128.0 118.21 23.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.83 0.348 . . . . 71.530000000000001 110.298 -176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 29' ' ' LYS . 43.2 mt-10 -123.72 146.06 48.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 65.329999999999998 111.001 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -141.02 110.67 6.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 71.0 109.459 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.604 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.9 mptt -108.69 110.4 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 73.319999999999993 109.697 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.5 112.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.015 0.436 . . . . 70.430000000000007 110.139 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.6 mt -92.08 -30.11 16.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.119 -177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 33.6 m -141.37 110.66 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.982 -0.748 . . . . 74.030000000000001 108.982 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.63 135.65 28.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.271 1.981 . . . . 71.120000000000005 112.043 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.94 -165.0 30.65 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.143 -0.551 . . . . 71.120000000000005 111.747 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.24 -20.71 62.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.63 0.215 . . . . 72.409999999999997 111.165 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.22 -30.32 1.15 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.489 -0.386 . . . . 51.130000000000003 113.481 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.4 -32.85 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 73.239999999999995 110.87 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 1.9 p -80.02 108.17 13.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.498 0.666 . . . . 54.219999999999999 110.61 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 41' ' ' GLN . 56.5 pttt -94.43 125.91 50.09 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.105 -0.952 . . . . 63.140000000000001 111.426 -173.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.99 106.17 2.12 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.853 2.368 . . . . 71.040000000000006 110.564 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' OE1' ' HE3' ' A' ' 39' ' ' LYS . 26.1 mt-30 -88.12 146.06 25.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.379 -0.373 . . . . 75.109999999999999 111.242 -176.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.45 156.77 36.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.857 -0.611 . . . . 74.420000000000002 109.892 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.19 16.6 79.65 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.905 -0.664 . . . . 65.140000000000001 111.68 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -132.94 154.86 50.03 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.737 0.415 . . . . 74.430000000000007 109.982 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.718 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -73.17 127.2 31.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 61.229999999999997 109.944 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 130' ' ' VAL . 35.9 m -124.77 150.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 120.818 0.342 . . . . 64.049999999999997 110.642 177.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 m -111.27 110.53 21.06 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.213 -0.903 . . . . 54.210000000000001 110.698 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.737 HG12 HD22 ' A' ' 127' ' ' LEU . 24.8 m -128.66 177.88 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.719 0.771 . . . . 41.030000000000001 112.914 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 8.7 m170 -139.68 152.48 46.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.463 -1.244 . . . . 71.409999999999997 108.933 172.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 83' ' ' TRP . 63.6 m-85 -134.91 142.53 46.57 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.542 -0.54 . . . . 71.340000000000003 109.542 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 36.5 t0 -137.02 143.76 42.9 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.203 -0.295 . . . . 72.430000000000007 110.203 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.55 140.01 15.22 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.338 -0.458 . . . . 64.230000000000004 112.328 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -157.26 149.31 22.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.375 0.607 . . . . 71.310000000000002 111.781 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.87 153.37 63.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.385 -0.825 . . . . 75.120000000000005 109.595 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 19.9 Cg_endo -58.11 -20.28 45.32 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.029 2.486 . . . . 74.209999999999994 113.812 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.87 4.16 45.69 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.77 0.319 . . . . 72.299999999999997 111.004 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.37 26.01 37.69 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.184 -0.531 . . . . 52.539999999999999 112.342 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.04 146.77 39.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.807 -0.442 . . . . 64.140000000000001 109.807 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -160.15 157.49 28.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.977 -0.379 . . . . 72.329999999999998 109.977 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -69.21 -42.38 75.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.323 -0.399 . . . . 73.530000000000001 110.706 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.451 ' CG ' HH21 ' A' ' 66' ' ' ARG . 28.0 t70 -170.0 145.71 2.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.725 -0.671 . . . . 72.129999999999995 109.955 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.3 t -82.79 114.8 21.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.624 -0.509 . . . . 73.409999999999997 109.624 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.6 m -86.67 -28.0 23.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 61.149999999999999 111.783 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -69.61 -31.47 69.62 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.142 -0.349 . . . . 74.420000000000002 110.828 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 29.8 p -73.6 -2.92 24.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.285 -0.416 . . . . 52.329999999999998 111.09 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.451 HH21 ' CG ' ' A' ' 61' ' ' ASP . 28.5 mmt180 -75.95 -3.93 38.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.52 -0.309 . . . . 75.439999999999998 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.36 71.66 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.47 -0.395 . . . . 63.329999999999998 113.045 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 55.8 tptt -91.97 106.82 18.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.549 -0.537 . . . . 75.340000000000003 109.549 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.1 Cg_exo -80.86 139.95 12.53 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.176 2.584 . . . . 73.209999999999994 112.1 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -107.62 142.89 36.86 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.793 -0.817 . . . . 71.230000000000004 108.793 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.718 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 50.7 mt-30 -134.63 138.26 44.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.32 -0.252 . . . . 75.030000000000001 110.32 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.32 164.26 34.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.774 -0.193 . . . . 73.400000000000006 110.657 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.5 m -78.53 111.42 14.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.839 -0.43 . . . . 75.200000000000003 109.839 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 88' ' ' ALA . 50.7 tp -61.03 142.61 56.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.41 -0.359 . . . . 75.129999999999995 110.765 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.57 30.51 44.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.192 -0.528 . . . . 51.530000000000001 111.967 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.16 160.7 39.19 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.387 -0.227 . . . . 74.430000000000007 110.387 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.98 42.75 2.12 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 116.39 -0.368 . . . . 54.409999999999997 113.131 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -76.81 -47.43 21.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.973 -0.751 . . . . 75.439999999999998 108.973 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 35.2 m -121.66 175.53 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.222 -0.899 . . . . 32.009999999999998 109.143 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.547 HG13 ' H ' ' A' ' 83' ' ' TRP . 37.2 pt -64.6 144.6 14.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.902 -0.407 . . . . 75.420000000000002 109.902 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 3.9 tmtm? -58.92 -22.52 59.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.308 -0.405 . . . . 73.310000000000002 109.936 -176.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.32 -52.59 51.75 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.921 -0.657 . . . . 34.43 111.793 175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.547 ' H ' HG13 ' A' ' 80' ' ' ILE . 51.3 m0 -67.39 -41.87 84.26 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.127 -0.324 . . . . 71.340000000000003 110.127 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.2 t70 -54.47 -45.68 73.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.622 -0.717 . . . . 72.430000000000007 110.236 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -64.37 -44.72 90.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 73.310000000000002 110.319 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.75 -49.61 61.05 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.733 -0.667 . . . . 70.400000000000006 112.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.6 -30.34 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.49 0.186 . . . . 62.310000000000002 111.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -72.92 -30.23 63.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.617 0.228 . . . . 72.340000000000003 111.617 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.7 t -81.32 -4.15 54.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.723 0.296 . . . . 72.319999999999993 111.696 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 15.2 ptp -112.2 -176.66 2.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.886 0.374 . . . . 71.329999999999998 110.792 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.9 p -121.34 176.2 5.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.458 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -62.64 126.94 29.04 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.981 0.419 . . . . 74.120000000000005 110.71 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.84 65.12 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.648 -0.705 . . . . 72.25 112.772 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 32' ' ' THR . 15.0 tt0 -99.4 143.57 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 71.340000000000003 111.071 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -131.11 120.01 22.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.097 -0.705 . . . . 74.540000000000006 109.097 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.8 147.09 50.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.294 0.569 . . . . 55.240000000000002 111.306 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD22 ' HD3' ' A' ' 29' ' ' LYS . 10.0 tt -90.44 104.96 17.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.676 -1.231 . . . . 62.350000000000001 107.676 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -103.45 118.4 36.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.992 -0.549 . . . . 65.010000000000005 109.731 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -89.06 106.53 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.318 -0.401 . . . . 71.140000000000001 110.0 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 25.6 mm -86.44 113.69 53.83 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.949 -0.569 . . . . 60.109999999999999 111.076 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 120' ' ' THR . 36.3 Cg_endo -66.12 149.93 85.42 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.372 2.048 . . . . 51.240000000000002 110.33 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.495 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 45.9 p90 -54.45 -31.71 56.06 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.356 0.502 . . . . 74.230000000000004 112.356 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.87 -23.78 64.26 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.004 0.372 . . . . 73.140000000000001 112.004 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.03 6.32 46.85 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.556 0.206 . . . . 72.140000000000001 111.556 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.06 -177.71 6.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 75.530000000000001 111.039 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -67.67 -14.3 62.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 72.409999999999997 110.875 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.62 -23.19 35.21 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.405 0.44 . . . . 75.140000000000001 112.63 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 44.9 tt0 -56.76 -44.24 81.57 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.044 0.449 . . . . 70.209999999999994 110.254 174.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 109' ' ' ARG . 20.1 mtp180 -97.92 -18.82 18.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.528 -0.76 . . . . 72.200000000000003 110.42 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 115' ' ' ILE . . . 67.23 -110.22 3.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.761 -0.654 . . . . 74.310000000000002 112.681 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 31.8 m-85 102.92 -71.33 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.639 1.575 . . . . 75.400000000000006 112.418 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.729 ' HG2' ' HB ' ' A' ' 115' ' ' ILE . 41.9 Cg_endo -65.84 149.45 86.63 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 121.439 1.426 . . . . 74.049999999999997 111.748 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 71.5 Cg_exo -51.92 -31.85 44.97 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.103 2.536 . . . . 75.519999999999996 113.23 -175.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 115' ' ' ILE . 27.4 m -83.2 -20.39 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 74.310000000000002 111.586 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 114' ' ' VAL . 49.2 mm -125.15 94.6 43.27 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.486 -0.325 . . . . 64.329999999999998 110.254 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 169.9 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.811 2.341 . . . . 73.409999999999997 111.402 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.58 148.46 63.87 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.127 1.884 . . . . 61.409999999999997 111.694 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.92 16.38 8.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.144 0.578 . . . . 73.319999999999993 111.818 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.39 112.21 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.120000000000005 111.752 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.7 m -88.15 119.59 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.502 -0.925 . . . . 71.230000000000004 108.502 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -124.59 147.97 48.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.649 0.262 . . . . 73.030000000000001 110.512 -167.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.595 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.0 t -98.52 131.85 44.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.428 -0.351 . . . . 74.230000000000004 110.705 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 97.4 m-85 -130.01 121.94 27.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.388 -0.369 . . . . 52.100000000000001 110.561 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 16.8 mt-10 -77.4 113.95 15.72 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.264 -0.643 . . . . 64.310000000000002 109.264 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 132.93 42.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.617 -0.719 . . . . 41.0 109.345 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.6 tt0 -133.32 112.33 11.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 75.209999999999994 110.629 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.749 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -87.62 106.2 17.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.333 -0.618 . . . . 72.310000000000002 109.333 178.615 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.564 HD21 ' ND1' ' A' ' 49' ' ' HIS . 3.9 mm? -79.24 -50.63 10.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.215 0.531 . . . . 73.209999999999994 109.949 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.572 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . . . -168.35 -176.68 2.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 55.219999999999999 109.683 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 46' ' ' VAL . 31.3 t . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.708 -0.849 . . . . 71.349999999999994 108.708 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.59 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.783 -0.451 . . . . 73.310000000000002 109.783 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.15 3.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.18 -0.464 . . . . 60.100000000000001 110.894 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -80.37 92.82 5.86 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.814 -0.439 . . . . 74.230000000000004 109.814 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -78.84 117.47 19.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.866 -0.606 . . . . 73.230000000000004 110.254 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -80.19 116.65 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 75.319999999999993 110.699 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -175.5 138.37 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.614 -0.513 . . . . 73.329999999999998 109.614 174.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -92.19 178.03 5.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.901 -0.407 . . . . 65.319999999999993 109.901 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -140.88 131.18 25.03 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.262 -0.273 . . . . 73.239999999999995 110.262 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.402 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.8 mpt? -85.61 -19.51 30.91 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.387 -0.37 . . . . 52.340000000000003 110.443 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 125.82 14.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.899 -0.592 . . . . 72.519999999999996 112.78 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -105.22 -172.73 2.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.889 -0.411 . . . . 61.109999999999999 109.889 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 53.9 tp -125.69 -69.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.486 -0.561 . . . . 72.230000000000004 109.486 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.482 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 42.7 mt-10 -127.43 165.14 20.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.149 -0.478 . . . . 63.329999999999998 109.771 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.59 -64.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.365 0.416 . . . . 33.229999999999997 111.464 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -156.14 173.1 17.33 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.224 -0.444 . . . . 71.120000000000005 110.364 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -70.41 134.62 48.01 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.87 -0.418 . . . . 75.230000000000004 109.87 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.27 77.7 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.526 . . . . 72.329999999999998 110.137 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.99 103.9 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.506 -0.77 . . . . 74.25 111.75 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.16 -8.86 19.75 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.647 2.231 . . . . 73.400000000000006 112.426 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 36.1 2.81 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.555 -0.618 . . . . 53.439999999999998 111.555 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 p -78.59 97.67 5.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.13 0.491 . . . . 73.519999999999996 110.479 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.3 ptm -67.03 87.74 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.473 0.654 . . . . 72.150000000000006 110.656 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 t -157.48 -175.72 5.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.637 -0.71 . . . . 71.329999999999998 109.643 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.31 63.17 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 62.109999999999999 110.458 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -92.42 139.69 30.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.822 -0.627 . . . . 62.340000000000003 110.247 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 47.8 tp -145.95 101.72 3.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.193 -0.458 . . . . 71.530000000000001 110.26 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -116.84 122.99 45.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.706 -0.479 . . . . 65.329999999999998 109.706 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' NZ ' ' OG1' ' A' ' 89' ' ' THR . 61.5 pttt -126.39 119.29 26.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.114 0.483 . . . . 71.0 110.13 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.648 -0.705 . . . . 73.319999999999993 110.214 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -61.45 110.6 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.134 0.493 . . . . 70.430000000000007 109.739 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.562 HD23 ' HE3' ' A' ' 95' ' ' LYS . 34.8 tp -96.04 -25.13 16.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.018 -0.537 . . . . 73.129999999999995 110.072 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 57.1 m -149.0 110.77 3.52 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.893 -0.594 . . . . 74.030000000000001 109.725 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.38 133.84 21.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.039 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -95.24 -151.86 28.73 Favored Glycine 0 C--O 1.236 0.254 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 111.823 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' HG1' ' A' ' 38' ' ' THR . 44.1 m-20 -63.92 -36.14 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.933 0.367 . . . . 72.409999999999997 111.306 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.48 -30.03 2.83 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 112.479 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.81 -25.11 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.799 0.333 . . . . 73.239999999999995 111.484 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.444 ' HG1' ' HB2' ' A' ' 35' ' ' ASP . 7.8 p -80.31 96.47 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 54.219999999999999 110.701 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 22.4 pttp -97.89 124.32 48.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.555 . . . . 63.140000000000001 111.651 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -75.12 154.16 41.74 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.902 2.401 . . . . 71.040000000000006 111.401 173.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.63 174.82 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.565 -0.288 . . . . 75.109999999999999 110.689 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.2 144.19 57.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.353 -0.385 . . . . 74.420000000000002 111.153 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.74 16.22 71.08 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.166 -0.47 . . . . 65.140000000000001 112.434 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 27.8 mmmt -109.33 121.8 45.97 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.526 0.331 . . . . 74.430000000000007 111.174 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -74.16 106.1 5.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.15 -0.685 . . . . 61.229999999999997 109.15 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.44 142.14 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.21 0.528 . . . . 64.049999999999997 111.689 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 25.5 m -103.65 108.3 19.52 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.132 -0.94 . . . . 54.210000000000001 109.079 175.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.0 178.15 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.944 -0.571 . . . . 41.030000000000001 111.76 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.494 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.8 t-80 -147.59 139.95 24.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.696 -0.684 . . . . 71.409999999999997 109.366 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.4 m-85 -126.46 149.84 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.37 0.419 . . . . 71.340000000000003 110.543 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 56.9 m-20 -136.11 128.27 29.86 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.607 -0.516 . . . . 72.430000000000007 109.607 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.73 115.52 4.88 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 121.124 -0.56 . . . . 64.230000000000004 112.34 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 26.7 ttp180 -133.32 144.24 49.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 110.951 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -74.34 144.55 81.48 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.962 -0.755 . . . . 75.120000000000005 108.962 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -39.96 -48.74 3.74 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.658 2.905 . . . . 74.209999999999994 114.045 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.81 -41.4 97.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.325 0.491 . . . . 72.299999999999997 112.325 -173.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.84 -24.43 0.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.515 -0.85 . . . . 52.539999999999999 113.108 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -66.71 112.83 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.813 -0.228 . . . . 64.140000000000001 111.174 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.566 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 12.1 pt20 -102.11 144.03 31.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.016 -0.364 . . . . 72.329999999999998 110.016 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -96.44 -26.81 15.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.437 -0.347 . . . . 73.530000000000001 110.606 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -148.36 138.18 22.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.09 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.2 p -124.28 90.2 3.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.11 0.481 . . . . 73.409999999999997 110.589 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -68.05 -18.27 64.63 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 61.149999999999999 110.361 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HG2' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -59.42 -35.27 73.69 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.56 . . . . 74.420000000000002 110.248 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.496 ' N ' ' HG2' ' A' ' 64' ' ' ARG . 8.1 m -64.87 -28.5 69.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.755 -0.657 . . . . 52.329999999999998 110.309 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -96.01 -16.79 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.838 -0.619 . . . . 75.439999999999998 110.373 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.05 35.39 91.93 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.691 -0.564 . . . . 63.329999999999998 111.691 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 69' ' ' PRO . 12.9 tmtt? -85.95 116.75 66.96 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 110.232 -0.284 . . . . 75.340000000000003 110.232 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.451 ' O ' ' HD3' ' A' ' 68' ' ' LYS . 56.7 Cg_endo -94.18 175.06 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.3 2.666 . . . . 73.209999999999994 112.659 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -149.05 128.75 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.381 -0.6 . . . . 71.230000000000004 109.381 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.9 137.09 42.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.562 0.22 . . . . 75.030000000000001 110.891 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 37.7 p90 -154.64 158.19 39.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.749 -0.463 . . . . 73.400000000000006 109.749 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m -87.21 106.65 18.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.76 0.314 . . . . 75.200000000000003 110.816 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.77 111.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 109.774 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.24 -30.67 2.69 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.058 -0.817 . . . . 51.530000000000001 111.058 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.83 158.27 15.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.882 -0.414 . . . . 74.430000000000007 109.882 176.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 43.27 2.35 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.287 -0.483 . . . . 54.409999999999997 113.185 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.24 -23.74 62.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.044 0.45 . . . . 75.439999999999998 110.39 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.63 168.54 22.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.882 -0.599 . . . . 32.009999999999998 110.254 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 104' ' ' LEU . 12.6 pt -75.48 158.36 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 75.420000000000002 110.352 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 7.0 tmtm? -56.01 -37.41 69.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.79 0.329 . . . . 73.310000000000002 110.472 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.21 -46.33 86.11 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.804 -0.713 . . . . 34.43 112.158 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -73.1 -38.65 66.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.477 -0.194 . . . . 71.340000000000003 110.477 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.71 78.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.002 0.43 . . . . 72.430000000000007 110.024 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.35 -43.92 89.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 109.923 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.93 -50.03 52.46 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.85 -0.613 . . . . 70.400000000000006 112.827 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.566 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.8 m -75.38 -33.3 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 62.310000000000002 111.328 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.15 -20.77 55.06 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.065 0.394 . . . . 72.340000000000003 112.065 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 86' ' ' GLY . 7.9 t -86.98 0.99 54.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.892 0.33 . . . . 72.319999999999993 111.892 -176.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.625 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 19.2 ptp -116.22 -171.18 1.94 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.615 0.245 . . . . 71.329999999999998 111.07 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 p -132.05 178.83 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.195 -0.457 . . . . 75.530000000000001 110.941 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.636 HD23 HG12 ' A' ' 130' ' ' VAL . 3.2 tm? -60.86 128.57 37.14 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 120.783 0.325 . . . . 74.120000000000005 110.753 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.74 87.45 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.62 -0.718 . . . . 72.25 112.592 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.1 tt0 -102.66 143.74 31.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.708 0.289 . . . . 71.340000000000003 110.705 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HE3' HD23 ' A' ' 31' ' ' LEU . 37.9 ttpt -136.86 142.48 42.8 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.012 0.434 . . . . 74.540000000000006 110.175 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.94 151.75 48.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.845 -0.616 . . . . 55.240000000000002 110.901 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.0 tp -90.59 105.37 17.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.385 -1.339 . . . . 62.350000000000001 107.385 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 11.3 t80 -110.44 109.65 20.11 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.048 -0.524 . . . . 65.010000000000005 111.086 -167.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.1 m -73.05 113.13 9.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.616 . . . . 71.140000000000001 110.682 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' A' ' 105' ' ' ALA . 35.2 mm -96.75 111.82 58.53 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.363 -0.38 . . . . 60.109999999999999 110.383 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HA ' HG23 ' A' ' 120' ' ' THR . 23.3 Cg_endo -61.85 155.55 53.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.531 2.154 . . . . 51.240000000000002 111.261 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 9.6 p90 -54.37 -42.16 70.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.837 -0.62 . . . . 74.230000000000004 112.265 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.25 -7.6 56.21 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.787 0.291 . . . . 73.140000000000001 111.787 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 80' ' ' ILE . 56.9 mt -102.84 15.3 29.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 72.140000000000001 110.56 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -152.83 175.01 13.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 75.530000000000001 110.616 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -66.28 -15.64 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 72.409999999999997 110.65 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -62.0 -16.68 53.34 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.013 -0.54 . . . . 75.140000000000001 112.636 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 102' ' ' TYR . 3.3 tm-20 -60.56 -55.87 28.22 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.102 0.477 . . . . 70.209999999999994 109.748 176.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.55 -31.44 14.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 72.200000000000003 111.391 -171.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.96 140.64 1.9 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.194 -0.527 . . . . 74.310000000000002 112.441 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.671 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.3 m-85 -137.54 -55.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 122.333 0.253 . . . . 75.400000000000006 110.681 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 80.5 Cg_endo -88.44 139.75 4.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.87 1.713 . . . . 74.049999999999997 111.299 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 72.8 Cg_exo -52.14 -24.88 21.37 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.862 2.374 . . . . 75.519999999999996 113.331 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 115' ' ' ILE . 27.2 m -72.88 -26.7 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.643 -0.253 . . . . 74.310000000000002 111.498 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 114' ' ' VAL . 49.1 mm -113.18 101.92 54.1 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.782 -0.451 . . . . 64.329999999999998 109.782 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.12 163.83 34.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.63 2.22 . . . . 73.409999999999997 111.97 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.3 148.7 84.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.295 1.997 . . . . 61.409999999999997 111.709 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt 67.89 19.58 9.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 73.319999999999993 111.087 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.21 27.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 111.082 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 101' ' ' PRO . 47.1 m -86.96 131.97 33.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.032 -0.729 . . . . 71.230000000000004 109.032 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -132.13 136.88 47.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.811 -0.44 . . . . 73.030000000000001 109.811 -171.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.535 ' N ' HD13 ' A' ' 121' ' ' LEU . 52.1 t -104.38 120.58 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 74.230000000000004 110.208 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 96.2 m-85 -109.31 127.22 54.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.251 -0.431 . . . . 52.100000000000001 110.419 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 29.7 mt-10 -75.15 114.1 13.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.408 -0.96 . . . . 64.310000000000002 108.408 168.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.488 HG23 ' HE3' ' A' ' 90' ' ' MET . 11.4 m -107.55 134.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 41.0 109.964 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.86 133.87 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.635 -0.257 . . . . 75.209999999999994 110.796 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.641 HD11 ' HB ' ' A' ' 130' ' ' VAL . 1.7 tm? -98.52 105.92 18.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.296 -0.631 . . . . 72.310000000000002 109.296 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.7 mm? -85.41 -41.98 14.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.418 -0.355 . . . . 73.209999999999994 111.189 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -146.7 140.52 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.652 0.263 . . . . 55.219999999999999 111.201 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 127' ' ' LEU . 5.0 p . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.428 -0.796 . . . . 71.349999999999994 109.929 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.899 0.38 . . . . 73.310000000000002 110.353 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.69 27.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 60.100000000000001 111.553 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -131.92 128.44 38.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.82 -0.437 . . . . 74.230000000000004 109.82 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -91.43 -25.2 19.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.421 0.629 . . . . 73.230000000000004 109.728 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -124.11 154.27 40.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 75.319999999999993 109.01 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -75.98 156.04 34.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.081 0.467 . . . . 73.329999999999998 111.727 -173.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -87.87 100.48 12.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.725 -0.671 . . . . 65.319999999999993 110.103 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -64.76 -19.38 65.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.846 -0.615 . . . . 73.239999999999995 110.539 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -111.92 139.81 47.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 52.340000000000003 109.21 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.91 161.54 30.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.941 -0.647 . . . . 72.519999999999996 112.864 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -89.08 13.17 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.283 0.563 . . . . 61.109999999999999 110.259 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.534 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.3 mm? -71.55 135.11 46.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.806 -0.634 . . . . 72.230000000000004 110.629 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.67 -157.92 0.36 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.04 -0.527 . . . . 63.329999999999998 110.081 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.18 -172.63 3.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.955 -0.566 . . . . 33.229999999999997 109.834 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.34 136.68 37.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 71.120000000000005 109.298 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -96.51 168.81 10.32 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.145 0.498 . . . . 75.230000000000004 111.113 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -166.9 99.49 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.384 -0.826 . . . . 72.329999999999998 108.924 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.26 -179.86 34.38 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.007 -0.616 . . . . 74.25 112.223 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 71.82 3.44 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.891 2.394 . . . . 73.400000000000006 112.028 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.6 113.74 5.49 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.292 -0.723 . . . . 53.439999999999998 111.292 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -72.49 73.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.504 0.668 . . . . 73.519999999999996 111.414 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.2 mtp -118.37 12.13 13.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.546 -0.909 . . . . 72.150000000000006 108.546 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.8 p -165.79 159.41 16.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.677 -1.147 . . . . 71.329999999999998 108.983 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.82 93.41 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.339 . . . . 62.109999999999999 110.29 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -92.3 144.59 25.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 62.340000000000003 109.532 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.64 110.61 5.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.36 . . . . 71.530000000000001 111.65 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.499 ' H ' ' HB ' ' A' ' 99' ' ' THR . 42.9 mm-40 -109.83 113.51 26.3 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.026 -0.731 . . . . 65.329999999999998 109.026 170.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -111.1 101.34 9.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.529 0.681 . . . . 71.0 109.461 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 43.0 tptt -108.96 117.66 34.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.508 -0.769 . . . . 73.319999999999993 110.17 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.99 106.0 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.483 -0.562 . . . . 70.430000000000007 109.483 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.49 HD12 ' HE2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -86.62 -29.66 22.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 73.129999999999995 109.734 -173.173 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -152.88 110.66 2.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.63 . . . . 74.030000000000001 109.563 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.58 126.7 20.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.876 2.384 . . . . 71.120000000000005 111.978 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.619 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -102.59 -157.63 25.7 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.358 -0.449 . . . . 71.120000000000005 112.6 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.83 -56.64 19.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.601 0.361 . . . . 72.409999999999997 111.26 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.88 -30.05 10.85 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 119.793 -0.449 . . . . 51.130000000000003 114.205 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.21 -9.72 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.102 0.951 . . . . 73.239999999999995 111.494 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.3 m -109.19 111.68 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.874 -0.417 . . . . 54.219999999999999 109.874 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 8.2 mtpm? -106.47 140.08 20.96 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.417 -0.356 . . . . 63.140000000000001 110.786 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.11 160.56 39.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.266 1.977 . . . . 71.040000000000006 110.672 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -141.29 171.46 14.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.633 0.254 . . . . 75.109999999999999 110.738 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.26 156.56 37.08 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.079 -0.51 . . . . 74.420000000000002 111.403 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.9 27.06 67.51 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.009 -0.541 . . . . 65.140000000000001 112.151 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -130.71 128.04 40.06 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.525 -0.176 . . . . 74.430000000000007 110.525 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 17.1 tppt? -73.45 104.91 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.006 -0.739 . . . . 61.229999999999997 109.006 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.3 m -107.26 152.26 8.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.144 0.497 . . . . 64.049999999999997 112.185 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.0 m -100.42 110.17 22.36 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.053 -0.976 . . . . 54.210000000000001 110.393 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' A' ' 72' ' ' PHE . 30.4 m -121.57 178.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.35 -0.841 . . . . 41.030000000000001 111.889 -172.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 4.6 t-160 -144.32 138.25 27.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.003 -0.74 . . . . 71.409999999999997 109.003 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' CD1' HG12 ' A' ' 125' ' ' VAL . 94.5 m-85 -126.64 144.21 50.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.572 -0.285 . . . . 71.340000000000003 110.96 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 58.7 m-20 -136.18 144.66 45.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.931 -0.766 . . . . 72.430000000000007 108.931 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.57 128.34 9.15 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.104 -0.569 . . . . 64.230000000000004 112.65 -173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 13.3 ttm180 -139.61 140.72 37.07 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.56 0.695 . . . . 71.310000000000002 111.343 -175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 60' ' ' PHE . 83.5 m-85 -81.19 157.82 70.39 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.538 -0.755 . . . . 75.120000000000005 109.468 172.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.97 -15.09 36.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.615 2.21 . . . . 74.209999999999994 112.247 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.29 -5.97 58.38 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.079 -0.509 . . . . 72.299999999999997 110.902 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.69 49.34 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.196 -0.526 . . . . 52.539999999999999 112.625 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.72 122.17 19.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 122.296 0.238 . . . . 64.140000000000001 110.885 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 12.8 pt20 -85.23 132.58 34.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.742 -0.466 . . . . 72.329999999999998 109.742 175.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 121' ' ' LEU . 44.8 p90 -89.34 -19.6 25.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.627 0.251 . . . . 73.530000000000001 110.847 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -156.97 144.31 18.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.614 -0.513 . . . . 72.129999999999995 109.614 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.8 p -124.46 98.7 5.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 110.861 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.04 64.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.344 -0.613 . . . . 61.149999999999999 109.344 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.472 HH12 ' CD ' ' A' ' 124' ' ' GLU . 6.9 ptt-85 -60.85 -41.19 95.36 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.603 -0.726 . . . . 74.420000000000002 110.807 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 t -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.978 -0.379 . . . . 52.329999999999998 109.978 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 66' ' ' ARG . 44.6 mtt180 -85.15 -28.85 25.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.172 0.511 . . . . 75.439999999999998 110.059 176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.08 26.27 64.65 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.578 -0.737 . . . . 63.329999999999998 111.712 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.35 116.84 55.91 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 122.234 0.214 . . . . 75.340000000000003 111.309 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.41 -178.63 3.8 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 73.209999999999994 112.074 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -140.86 163.62 32.43 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.951 -0.759 . . . . 71.230000000000004 108.951 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -142.07 138.07 31.47 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.55 0.214 . . . . 75.030000000000001 110.621 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 20.6 p90 -157.29 165.76 34.97 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.964 -0.384 . . . . 73.400000000000006 109.964 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 m -89.15 108.83 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.348 -0.241 . . . . 75.200000000000003 110.348 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.1 135.14 57.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.171 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.55 58.77 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.26 -0.495 . . . . 51.530000000000001 112.405 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.54 171.46 14.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.996 0.427 . . . . 74.430000000000007 110.999 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.12 55.93 4.95 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.745 -0.661 . . . . 54.409999999999997 112.333 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -119.12 -19.01 8.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.614 0.245 . . . . 75.439999999999998 110.495 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -142.77 162.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.497 -0.319 . . . . 32.009999999999998 110.324 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 104' ' ' LEU . 15.8 pt -72.31 151.34 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.958 -0.564 . . . . 75.420000000000002 110.366 174.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 51.3 mmtt -60.47 -15.81 30.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.331 0.493 . . . . 73.310000000000002 112.331 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.69 -60.27 8.78 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.26 -0.972 . . . . 34.43 111.254 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -67.07 -39.58 86.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.101 -0.333 . . . . 71.340000000000003 110.101 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 20.8 t70 -52.14 -54.95 24.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.513 -0.767 . . . . 72.430000000000007 110.625 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -68.21 -36.75 80.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.044 -0.525 . . . . 73.310000000000002 110.507 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -53.43 31.47 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.536 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' MET . 33.4 m -75.59 -30.89 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.734 0.302 . . . . 62.310000000000002 111.091 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.39 -26.23 67.15 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 86' ' ' GLY . 10.9 t -87.99 0.79 55.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.882 0.327 . . . . 72.319999999999993 111.882 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 16.1 ptp -112.4 -174.98 2.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.06 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -121.98 178.98 4.67 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.218 -0.446 . . . . 75.530000000000001 111.072 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -60.56 128.36 36.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.986 -0.552 . . . . 74.120000000000005 110.653 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 71.26 35.78 63.71 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.577 -0.344 . . . . 72.25 112.427 176.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.619 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 28.6 tt0 -128.02 150.45 49.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.666 0.27 . . . . 71.340000000000003 110.324 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HE2' HD12 ' A' ' 31' ' ' LEU . 6.8 ttpm? -133.26 138.84 46.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 74.540000000000006 110.678 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.9 145.07 41.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.768 -0.651 . . . . 55.240000000000002 110.645 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 8.6 tt -90.25 105.56 17.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.321 -1.362 . . . . 62.350000000000001 107.321 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.56 ' HD2' HD13 ' A' ' 100' ' ' ILE . 17.7 t80 -111.65 114.05 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 65.010000000000005 110.031 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 16.2 m -75.71 106.75 7.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 110.068 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.56 HD13 ' HD2' ' A' ' 98' ' ' PHE . 34.5 mm -80.77 114.31 47.17 Favored Pre-proline 0 C--O 1.243 0.744 0 CA-C-N 116.069 -0.514 . . . . 60.109999999999999 110.568 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.663 ' HA ' HG23 ' A' ' 120' ' ' THR . 21.4 Cg_exo -66.31 149.93 84.84 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.825 2.35 . . . . 51.240000000000002 112.007 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.38 -30.46 52.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.755 -0.657 . . . . 74.230000000000004 111.307 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -65.64 -35.95 82.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.066 -0.516 . . . . 73.140000000000001 111.388 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 80' ' ' ILE . 93.3 mt -100.48 19.96 15.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.140000000000001 111.022 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.09 -178.22 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 75.530000000000001 110.995 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.22 -9.93 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.646 -0.707 . . . . 72.409999999999997 110.424 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.92 40.08 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.856 -0.611 . . . . 75.140000000000001 113.742 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 35.9 tt0 -65.97 -41.36 91.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.652 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.51 -14.07 20.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.052 -0.522 . . . . 72.200000000000003 111.053 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 66.89 -82.07 0.12 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-N 116.033 -0.53 . . . . 74.310000000000002 113.777 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.747 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 62.9 m-85 97.92 -74.25 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.859 1.663 . . . . 75.400000000000006 111.478 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 11.3 Cg_endo -89.05 143.16 4.77 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.058 1.839 . . . . 74.049999999999997 111.856 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.62 -18.41 40.11 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.862 2.375 . . . . 75.519999999999996 112.422 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.68 -37.39 79.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.031 -0.532 . . . . 74.310000000000002 109.948 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.8 mm -106.8 106.48 58.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.573 -0.74 . . . . 64.329999999999998 109.498 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.44 148.6 92.56 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.457 2.105 . . . . 73.409999999999997 112.365 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.36 144.35 67.51 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.551 2.168 . . . . 61.409999999999997 112.235 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 44.7 mtpt 63.59 25.72 14.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.402 -0.817 . . . . 73.319999999999993 111.21 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.49 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 74.120000000000005 111.535 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 101' ' ' PRO . 28.3 m -86.18 131.24 34.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 71.230000000000004 109.072 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -123.82 145.73 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.711 -0.478 . . . . 73.030000000000001 109.711 -170.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.615 ' N ' HD13 ' A' ' 121' ' ' LEU . 97.5 t -98.38 119.8 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.78 0.324 . . . . 74.230000000000004 110.33 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.409 ' CE1' HD12 ' A' ' 121' ' ' LEU . 57.7 m-85 -116.08 118.61 33.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 52.100000000000001 110.166 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 38.2 mt-10 -83.22 106.99 15.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.831 . . . . 64.310000000000002 109.037 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.442 ' O ' ' HE1' ' A' ' 90' ' ' MET . 28.9 m -102.92 145.32 12.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 41.0 110.261 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 43.5 tt0 -143.27 130.12 20.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.542 -0.299 . . . . 75.209999999999994 110.484 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -98.82 105.7 17.88 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.922 -0.77 . . . . 72.310000000000002 108.922 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.89 -48.14 10.33 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.894 0.378 . . . . 73.209999999999994 110.289 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -164.94 -173.68 3.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.656 -0.702 . . . . 55.219999999999999 109.823 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.081 -0.961 . . . . 71.349999999999994 109.762 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.062 -0.348 . . . . 73.310000000000002 110.062 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.04 136.09 57.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.204 -0.453 . . . . 60.100000000000001 111.764 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -145.65 135.65 23.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.249 -0.649 . . . . 74.230000000000004 109.249 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -125.62 144.74 50.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 73.230000000000004 111.149 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -117.72 118.37 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 75.319999999999993 109.767 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -127.78 175.09 8.59 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.61 0.243 . . . . 73.329999999999998 111.121 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.6 p80 46.77 31.85 1.57 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.245 1.018 . . . . 65.319999999999993 112.056 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -90.63 82.27 5.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.409 -0.589 . . . . 73.239999999999995 109.409 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtt -127.49 134.63 49.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.712 -0.677 . . . . 52.340000000000003 110.388 -174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.08 118.87 9.94 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.214 -0.755 . . . . 72.519999999999996 111.214 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 p -62.59 95.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.838 0.351 . . . . 61.109999999999999 111.401 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.21 102.14 9.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.687 -0.857 . . . . 72.230000000000004 108.687 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.76 93.5 4.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.932 -0.576 . . . . 63.329999999999998 110.022 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.99 118.9 32.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 33.229999999999997 110.917 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -87.61 101.79 13.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.18 0.514 . . . . 71.120000000000005 110.146 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 18' ' ' GLY . 39.2 m -148.25 141.44 25.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 75.230000000000004 110.008 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -63.82 -28.91 70.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.878 0.371 . . . . 72.329999999999998 110.602 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.705 ' H ' HG22 ' A' ' 16' ' ' THR . . . 100.75 94.95 2.18 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.615 -0.72 . . . . 74.25 111.337 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD2' ' HA2' ' A' ' 18' ' ' GLY . 16.3 Cg_endo -55.94 90.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.786 2.324 . . . . 73.400000000000006 112.179 -177.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.04 -83.69 0.12 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.513 -0.767 . . . . 53.439999999999998 111.313 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -72.34 83.14 1.05 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.059 0.457 . . . . 73.519999999999996 109.835 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 87.9 mtp -148.01 -160.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 72.150000000000006 109.771 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 p -76.1 -170.8 1.5 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.739 -0.664 . . . . 71.329999999999998 110.188 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.1 109.22 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.6 0.238 . . . . 62.109999999999999 110.892 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.715 ' HB2' HG21 ' A' ' 120' ' ' THR . 23.5 mt-30 -92.34 149.92 21.14 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.899 -0.408 . . . . 62.340000000000003 109.899 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -145.76 112.94 6.15 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.816 0.341 . . . . 71.530000000000001 110.96 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 43.6 mt-10 -136.86 135.36 37.8 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.263 -0.643 . . . . 65.329999999999998 109.263 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -132.91 101.12 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.482 0.658 . . . . 71.0 109.668 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -113.34 110.89 21.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.245 -0.889 . . . . 73.319999999999993 110.378 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.13 111.1 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 70.430000000000007 110.445 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.5 mt -85.4 -24.04 27.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 73.129999999999995 110.327 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.1 m -153.35 110.69 2.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.634 -0.712 . . . . 74.030000000000001 109.462 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.83 126.6 13.45 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 71.120000000000005 111.835 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.19 -145.66 15.24 Favored Glycine 0 C--O 1.237 0.296 0 CA-C-N 115.906 -0.588 . . . . 71.120000000000005 112.114 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.477 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.6 m-20 -66.0 -43.92 86.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.787 0.327 . . . . 72.409999999999997 111.501 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.48 -30.14 2.82 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.228 -0.51 . . . . 51.130000000000003 112.333 -175.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' HB3' ' A' ' 35' ' ' ASP . 33.4 m -89.29 -24.9 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.943 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.4 p -78.03 95.41 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 54.219999999999999 110.524 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -106.41 103.91 48.03 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.577 -0.738 . . . . 63.140000000000001 111.066 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.11 156.62 42.52 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.467 2.111 . . . . 71.040000000000006 111.454 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.76 170.69 14.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.329 . . . . 75.109999999999999 110.74 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.88 156.74 26.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.806 -0.634 . . . . 74.420000000000002 111.047 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.92 25.28 67.29 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 115.889 -0.596 . . . . 65.140000000000001 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -130.01 119.15 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 74.430000000000007 110.748 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -66.34 104.27 1.18 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.159 -0.682 . . . . 61.229999999999997 109.159 172.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.549 HG12 HG23 ' A' ' 130' ' ' VAL . 29.5 m -106.98 155.56 7.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.301 -0.409 . . . . 64.049999999999997 111.342 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -98.91 108.27 20.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.483 -0.781 . . . . 54.210000000000001 110.646 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.508 HG12 HD22 ' A' ' 127' ' ' LEU . 10.5 m -123.43 178.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 41.030000000000001 111.394 -173.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 65.0 t60 -152.29 133.31 14.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 109.566 170.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -126.79 146.19 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.578 -0.897 . . . . 71.340000000000003 108.578 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' PHE . 0.8 OUTLIER -135.86 152.02 50.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.823 -0.436 . . . . 72.430000000000007 109.823 -177.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.05 129.32 9.78 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.381 -0.438 . . . . 64.230000000000004 113.003 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -147.52 145.94 29.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.2 0.524 . . . . 71.310000000000002 110.302 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.413 ' HE1' ' HB2' ' A' ' 60' ' ' PHE . 77.6 m-85 -90.22 148.47 39.29 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.306 -0.406 . . . . 75.120000000000005 110.422 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.77 -13.77 28.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.796 2.331 . . . . 74.209999999999994 111.719 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.16 -25.97 64.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.497 -0.774 . . . . 72.299999999999997 110.348 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.89 -14.78 28.99 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.343 -0.844 . . . . 52.539999999999999 111.489 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -103.11 148.67 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.09 0.556 . . . . 64.140000000000001 110.938 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.71 135.07 54.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.589 -0.522 . . . . 72.329999999999998 109.589 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.413 ' HB2' ' HE1' ' A' ' 54' ' ' PHE . 79.6 t80 -68.76 -62.34 1.43 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.148 -0.478 . . . . 73.530000000000001 110.783 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -137.51 131.31 31.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.92 -0.77 . . . . 72.129999999999995 108.92 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.547 ' OG ' ' HG3' ' A' ' 64' ' ' ARG . 9.7 t -111.02 134.44 52.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.108 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.8 m -75.75 -22.98 55.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.103 -0.499 . . . . 61.149999999999999 111.427 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.547 ' HG3' ' OG ' ' A' ' 62' ' ' SER . 6.7 ppt_? -56.82 -30.67 63.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.654 0.264 . . . . 74.420000000000002 110.861 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 8.9 m -59.14 -26.53 64.81 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.282 -0.417 . . . . 52.329999999999998 110.99 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -96.2 -16.12 21.64 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.113 -0.494 . . . . 75.439999999999998 110.409 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.95 15.78 69.72 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.804 -0.635 . . . . 63.329999999999998 113.51 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.3 ttpp -88.64 118.99 69.95 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-O 120.742 0.306 . . . . 75.340000000000003 111.009 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -89.27 -173.05 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.459 2.773 . . . . 73.209999999999994 111.753 175.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.435 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 81.0 m-85 -137.2 160.31 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 71.230000000000004 109.735 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -139.26 131.31 27.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.848 -0.427 . . . . 75.030000000000001 109.848 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -155.89 156.59 34.89 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.786 -0.45 . . . . 73.400000000000006 109.786 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 86.3 m -79.4 114.54 18.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.14 -0.319 . . . . 75.200000000000003 110.14 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.726 HD11 ' HB2' ' A' ' 88' ' ' ALA . 32.6 tp -56.83 123.13 13.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.744 -0.465 . . . . 75.129999999999995 109.744 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.74 -26.46 24.01 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.886 -0.486 . . . . 51.530000000000001 111.886 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.47 5.07 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.004 0.431 . . . . 74.430000000000007 111.231 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.37 16.52 48.78 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.158 -0.544 . . . . 54.409999999999997 113.186 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -56.25 -39.97 73.42 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 110.181 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 28.3 m -126.43 164.91 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 32.009999999999998 109.177 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 104' ' ' LEU . 14.9 pt -67.75 150.05 11.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.123 0.487 . . . . 75.420000000000002 111.482 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 24.8 mmtm -62.8 -17.42 61.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.787 -0.642 . . . . 73.310000000000002 111.845 -175.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.23 20.73 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.349 -0.929 . . . . 34.43 111.088 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.455 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 18.7 m0 -71.69 -36.54 70.61 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.503 -0.349 . . . . 71.340000000000003 110.216 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.678 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 10.0 t70 -52.82 -55.23 24.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.841 -0.618 . . . . 72.430000000000007 110.39 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 15.2 mm-40 -72.75 -37.68 67.62 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.156 -0.475 . . . . 73.310000000000002 110.33 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.28 -49.79 49.37 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.932 -0.577 . . . . 70.400000000000006 112.038 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.8 p -75.99 -32.29 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.816 0.341 . . . . 62.310000000000002 111.05 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.726 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.52 -29.18 68.95 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.8 t -78.69 4.01 14.88 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.932 0.716 . . . . 72.319999999999993 112.932 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.4 ptp -120.04 -179.47 3.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.203 0.456 . . . . 71.329999999999998 111.442 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.414 HG21 ' HA2' ' A' ' 36' ' ' GLY . 68.7 p -118.88 178.86 4.33 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.963 -0.562 . . . . 75.530000000000001 111.124 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.0 tt -67.24 135.87 54.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.072 0.463 . . . . 74.120000000000005 110.704 -176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.551 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.8 17.25 80.04 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.415 -0.812 . . . . 72.25 111.821 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.84 137.51 51.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 71.340000000000003 110.351 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -123.83 135.31 53.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.625 -0.716 . . . . 74.540000000000006 109.46 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.91 148.75 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.21 0.529 . . . . 55.240000000000002 111.544 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.0 tt -90.76 114.0 26.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.225 -1.028 . . . . 62.350000000000001 108.225 174.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -119.79 116.6 26.23 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.934 0.397 . . . . 65.010000000000005 110.417 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 18.4 m -75.67 106.44 7.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.085 -0.507 . . . . 71.140000000000001 110.304 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.1 mm -83.69 116.72 66.06 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.29 -0.414 . . . . 60.109999999999999 110.624 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.543 ' HA ' HG23 ' A' ' 120' ' ' THR . 52.1 Cg_exo -54.63 146.48 53.84 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.015 2.477 . . . . 51.240000000000002 112.066 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -54.22 -39.62 66.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 112.081 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -69.93 -25.82 63.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.807 0.337 . . . . 73.140000000000001 111.092 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 80' ' ' ILE . 85.7 mt -93.26 15.42 15.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.035 0.445 . . . . 72.140000000000001 110.261 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.19 -170.08 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 75.530000000000001 109.827 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.621 ' HE2' HG13 ' A' ' 115' ' ' ILE . 45.0 p90 -81.35 -7.56 59.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.37 . . . . 72.409999999999997 110.59 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.8 -21.32 65.18 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.836 -0.62 . . . . 75.140000000000001 112.934 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.21 -46.13 79.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.369 0.604 . . . . 70.209999999999994 110.402 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -102.86 -36.31 8.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.949 -1.023 . . . . 72.200000000000003 111.416 -166.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.19 90.58 0.05 OUTLIER Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.178 -0.534 . . . . 74.310000000000002 112.025 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.577 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 95.7 m-85 -82.98 -52.41 0.64 Allowed Pre-proline 0 CA--C 1.537 0.476 0 O-C-N 122.809 -0.23 . . . . 75.400000000000006 110.997 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 96.3 Cg_endo -84.87 143.92 9.57 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.757 1.638 . . . . 74.049999999999997 111.311 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.38 -16.81 30.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.371 . . . . 75.519999999999996 112.631 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.57 -34.74 58.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.074 -0.512 . . . . 74.310000000000002 110.526 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.621 HG13 ' HE2' ' A' ' 106' ' ' TYR . 49.2 mm -103.45 110.39 63.69 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 64.329999999999998 110.327 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.95 155.79 61.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.704 2.269 . . . . 73.409999999999997 111.992 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.34 148.91 88.69 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.239 1.96 . . . . 61.409999999999997 111.283 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 118' ' ' LYS . 9.2 mtpm? 60.93 23.15 13.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.04 0.536 . . . . 73.319999999999993 111.557 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.89 114.97 27.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.759 0.314 . . . . 74.120000000000005 110.474 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 25' ' ' GLN . 98.1 m -73.64 133.11 43.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 71.230000000000004 109.118 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.52 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.1 tm? -123.48 142.62 50.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.246 -0.65 . . . . 73.030000000000001 109.246 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.52 ' N ' HD13 ' A' ' 121' ' ' LEU . 67.4 t -98.27 136.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.001 0.429 . . . . 74.230000000000004 110.24 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 49.7 m-85 -123.28 122.18 37.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 52.100000000000001 110.42 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -80.36 107.23 12.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.28 -1.008 . . . . 64.310000000000002 108.28 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.84 150.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.507 -0.77 . . . . 41.0 111.195 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -150.19 136.33 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.976 -0.557 . . . . 75.209999999999994 110.295 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.5 tm? -96.81 109.53 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.572 -0.899 . . . . 72.310000000000002 108.572 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.71 -43.5 15.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.913 0.387 . . . . 73.209999999999994 110.426 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -171.23 -178.11 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 55.219999999999999 109.82 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.549 HG23 HG12 ' A' ' 46' ' ' VAL . 5.2 p . . . . . 0 C--O 1.249 1.069 0 N-CA-C 109.24 -0.652 . . . . 71.349999999999994 109.24 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.68 0.276 . . . . 73.310000000000002 110.572 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.23 157.0 38.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 60.100000000000001 110.72 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -90.05 96.17 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.526 -0.306 . . . . 74.230000000000004 110.817 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -57.81 122.74 13.6 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.395 -0.594 . . . . 73.230000000000004 109.395 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -76.11 104.26 6.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.934 -0.575 . . . . 75.319999999999993 111.521 -171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -68.6 111.22 4.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.235 -0.654 . . . . 73.329999999999998 109.235 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -69.58 150.75 46.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.056 -0.52 . . . . 65.319999999999993 110.783 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -82.84 -60.57 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.747 -0.464 . . . . 73.239999999999995 109.747 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.6 mtp 49.69 28.91 2.84 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.469 -0.787 . . . . 52.340000000000003 112.083 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.58 -83.48 0.36 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.53 -0.628 . . . . 72.519999999999996 111.53 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 m 62.04 -77.2 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.696 0.398 . . . . 61.109999999999999 110.82 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.4 tp -161.21 10.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.375 0.607 . . . . 72.230000000000004 109.607 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 42.2 mt-10 -86.83 152.84 22.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.704 -0.68 . . . . 63.329999999999998 110.363 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . 74.69 -35.54 0.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.317 0.647 . . . . 33.229999999999997 111.691 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -59.59 138.75 57.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 71.120000000000005 110.159 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -79.94 61.47 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 75.230000000000004 111.328 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 176.37 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.485 -0.78 . . . . 72.329999999999998 109.463 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.27 147.18 11.15 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 74.25 112.026 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HA ' HE22 ' A' ' 25' ' ' GLN . 14.9 Cg_exo -68.26 74.64 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.98 2.454 . . . . 73.400000000000006 111.679 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.62 -112.73 1.34 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.793 -0.64 . . . . 53.439999999999998 111.898 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -84.42 11.19 8.98 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.839 0.311 . . . . 73.519999999999996 111.839 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.92 121.73 16.66 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.398 -0.593 . . . . 72.150000000000006 109.398 175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.404 ' HA ' ' CE2' ' A' ' 102' ' ' TYR . 20.4 m -58.58 -61.18 2.79 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.886 0.698 . . . . 71.329999999999998 112.886 -169.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.74 111.7 22.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 62.109999999999999 111.119 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.616 HE22 ' HA ' ' A' ' 19' ' ' PRO . 14.5 mt-30 -126.48 142.35 51.57 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.898 -0.778 . . . . 62.340000000000003 108.898 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.31 105.29 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.641 0.257 . . . . 71.530000000000001 110.368 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' PHE . 37.7 mt-10 -137.82 122.66 18.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.342 -0.614 . . . . 65.329999999999998 109.342 170.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.595 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -120.44 122.63 41.11 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.26 -0.644 . . . . 71.0 109.26 175.204 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 35.1 ttmt -116.1 110.12 18.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.073 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.66 104.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 70.430000000000007 110.533 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 ' HE2' ' A' ' 95' ' ' LYS . 35.2 tp -88.37 -22.18 23.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 73.129999999999995 110.026 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 m -149.92 110.93 3.32 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.636 -0.711 . . . . 74.030000000000001 109.745 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.69 119.05 6.06 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.754 2.302 . . . . 71.120000000000005 111.588 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.634 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -86.65 -176.82 49.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.933 -0.651 . . . . 71.120000000000005 112.735 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.83 -33.02 69.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.65 0.262 . . . . 72.409999999999997 111.305 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.26 -30.29 1.63 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 113.511 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -79.37 -38.09 19.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 73.239999999999995 111.048 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 p -66.15 94.0 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.514 . . . . 54.219999999999999 110.715 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -102.09 115.78 64.13 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.479 . . . . 63.140000000000001 110.605 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.95 -173.09 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.684 2.256 . . . . 71.040000000000006 112.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -156.66 164.74 37.81 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.148 -0.478 . . . . 75.109999999999999 110.112 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.98 127.69 33.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.239 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.28 31.63 7.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.772 -0.531 . . . . 65.140000000000001 111.772 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 130.29 49.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.984 -0.376 . . . . 74.430000000000007 109.984 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.11 108.26 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.552 . . . . 61.229999999999997 109.511 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.52 158.68 19.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 116.365 -0.379 . . . . 64.049999999999997 111.128 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 28.8 m -111.92 115.78 29.54 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.956 -0.565 . . . . 54.210000000000001 110.209 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 127' ' ' LEU . 10.3 m -120.99 177.96 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.184 0.516 . . . . 41.030000000000001 111.684 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.407 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.1 t-80 -149.83 139.64 21.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.306 -0.861 . . . . 71.409999999999997 108.712 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -137.72 156.02 48.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.578 -0.283 . . . . 71.340000000000003 110.81 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -152.98 160.53 43.03 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.014 -0.736 . . . . 72.430000000000007 109.014 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 59' ' ' GLN . . . -132.16 151.17 19.78 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.784 -0.722 . . . . 64.230000000000004 113.271 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -148.77 155.05 40.43 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.849 0.459 . . . . 71.310000000000002 109.886 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -87.1 150.17 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 110.407 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.87 -31.77 90.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.908 2.405 . . . . 74.209999999999994 112.954 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.94 -39.95 83.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.472 -0.331 . . . . 72.299999999999997 110.752 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.4 -26.55 1.99 Allowed Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.711 -0.757 . . . . 52.539999999999999 113.429 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -74.79 164.64 26.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.188 0.494 . . . . 64.140000000000001 110.821 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 63.4 tt0 -134.0 141.15 47.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 72.329999999999998 109.911 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -72.23 -54.17 10.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.158 0.504 . . . . 73.530000000000001 110.261 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -151.77 143.97 23.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.648 -0.705 . . . . 72.129999999999995 109.312 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -91.61 90.96 7.81 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.187 0.518 . . . . 73.409999999999997 111.875 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.4 t -73.83 -23.97 59.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.056 -0.52 . . . . 61.149999999999999 110.225 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 4.6 ptm180 -68.7 -34.68 76.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.83 -0.433 . . . . 74.420000000000002 109.83 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -73.51 -36.21 65.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.751 -0.659 . . . . 52.329999999999998 110.937 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -76.6 -28.61 56.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.437 -0.347 . . . . 75.439999999999998 110.615 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.54 37.08 94.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.24 -0.505 . . . . 63.329999999999998 112.714 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -79.48 115.67 55.01 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 110.183 -0.302 . . . . 75.340000000000003 110.183 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 169.17 15.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.732 2.288 . . . . 73.209999999999994 111.754 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.409 ' O ' HG22 ' A' ' 48' ' ' VAL . 77.8 t80 -147.62 115.6 6.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.581 -0.526 . . . . 71.230000000000004 109.581 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -100.11 127.31 46.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.74 -0.467 . . . . 75.030000000000001 109.74 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -153.65 170.03 21.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 73.400000000000006 110.77 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 104.56 14.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 75.200000000000003 109.856 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 88' ' ' ALA . 48.4 tp -59.06 138.91 57.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 75.129999999999995 110.772 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.41 25.91 37.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.061 -0.59 . . . . 51.530000000000001 112.103 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . . . -132.27 178.71 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.22 -0.289 . . . . 74.430000000000007 110.22 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.91 39.47 3.12 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 121.235 -0.507 . . . . 54.409999999999997 112.168 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 76' ' ' ALA . 6.8 mm-40 -74.88 -34.35 62.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.247 0.546 . . . . 75.439999999999998 109.726 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.58 171.65 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.152 -0.931 . . . . 32.009999999999998 109.163 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.7 pt -59.64 141.28 16.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.936 -0.394 . . . . 75.420000000000002 109.936 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 67.2 mmtt -61.59 -16.21 46.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.287 0.477 . . . . 73.310000000000002 112.287 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.05 -52.0 54.98 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.139 -1.029 . . . . 34.43 110.87 171.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -73.77 -43.65 58.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.53 -0.335 . . . . 71.340000000000003 110.381 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.583 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 29.4 t70 -53.5 -54.9 30.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.1 -0.5 . . . . 72.430000000000007 110.442 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.82 -44.6 69.63 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.677 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.21 -47.84 54.61 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.993 -0.548 . . . . 70.400000000000006 112.313 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG22 HD23 ' A' ' 127' ' ' LEU . 8.7 p -75.96 -33.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.8 0.334 . . . . 62.310000000000002 110.775 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.594 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.76 -30.46 70.03 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.946 0.35 . . . . 72.340000000000003 111.946 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 86' ' ' GLY . 9.1 t -82.35 -10.19 59.17 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.419 0.526 . . . . 72.319999999999993 112.419 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.9 ptp -102.97 -170.02 1.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.998 -0.438 . . . . 71.329999999999998 111.001 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 127' ' ' LEU . 56.1 p -133.69 179.03 6.48 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.58 -0.282 . . . . 75.530000000000001 111.726 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.693 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.1 tt -64.19 137.83 58.14 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.235 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 75.12 13.64 82.55 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.651 -0.704 . . . . 72.25 111.908 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.634 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.6 tt0 -111.37 134.13 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 71.340000000000003 110.443 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' HD23 ' A' ' 31' ' ' LEU . 6.1 ttpm? -133.96 130.43 37.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.612 -0.722 . . . . 74.540000000000006 109.765 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.14 143.88 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.031 0.443 . . . . 55.240000000000002 110.966 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.89 111.03 22.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.061 -1.088 . . . . 62.350000000000001 108.061 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 16.9 t80 -112.73 137.99 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 65.010000000000005 110.328 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -89.26 106.68 18.6 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.791 -0.448 . . . . 71.140000000000001 109.791 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.96 113.74 60.66 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 116.38 -0.373 . . . . 60.109999999999999 111.034 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.42 159.35 39.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.795 2.33 . . . . 51.240000000000002 111.908 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 23' ' ' SER . 49.1 p90 -60.02 -26.46 66.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.04 0.385 . . . . 74.230000000000004 112.04 -174.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.656 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 11.2 pt20 -66.1 -18.68 65.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.694 0.283 . . . . 73.140000000000001 111.236 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.656 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 93.9 mt -115.2 14.91 17.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.387 -0.37 . . . . 72.140000000000001 110.948 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.57 175.46 13.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.273 0.559 . . . . 75.530000000000001 111.551 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -72.6 -11.24 60.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.481 -0.781 . . . . 72.409999999999997 110.654 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.18 -15.28 7.09 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.879 -0.601 . . . . 75.140000000000001 113.578 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.6 tt0 -63.59 -55.22 25.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.223 0.535 . . . . 70.209999999999994 110.144 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -97.34 -5.49 36.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.432 -0.804 . . . . 72.200000000000003 110.647 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 64.02 -91.22 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.68 -0.691 . . . . 74.310000000000002 113.618 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.737 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 44.0 m-85 98.94 -65.78 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.793 1.637 . . . . 75.400000000000006 111.562 -172.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 5.1 Cg_exo -75.81 135.55 17.75 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.703 1.602 . . . . 74.049999999999997 111.262 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.5 -14.93 38.04 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.801 2.334 . . . . 75.519999999999996 112.675 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.0 t -75.49 -20.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 110.211 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.26 116.36 64.54 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.845 -0.616 . . . . 64.329999999999998 110.072 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.38 154.07 70.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.619 2.213 . . . . 73.409999999999997 111.946 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.48 126.88 16.97 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.31 2.007 . . . . 61.409999999999997 111.867 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 56.0 mtmt 57.22 49.75 12.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 73.319999999999993 110.713 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.02 148.88 22.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 74.120000000000005 111.348 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.7 m -100.66 131.48 46.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.591 -0.732 . . . . 71.230000000000004 109.698 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.27 161.63 20.09 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.92 0.39 . . . . 73.030000000000001 111.002 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.0 t -98.61 131.51 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.322 -0.621 . . . . 74.230000000000004 109.322 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.95 123.76 23.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 52.100000000000001 111.252 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 48.5 mt-10 -85.76 111.08 19.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.047 -0.723 . . . . 64.310000000000002 109.047 173.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.41 143.72 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 41.0 109.952 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -147.48 133.15 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 75.209999999999994 110.812 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.0 tm? -102.64 113.16 26.3 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.968 -0.752 . . . . 72.310000000000002 108.968 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.03 -44.43 10.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.566 -0.288 . . . . 73.209999999999994 111.103 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -145.55 141.66 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.638 -0.255 . . . . 55.219999999999999 111.121 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.252 1.199 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.224 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.066 -0.346 . . . . 73.310000000000002 110.066 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.39 111.85 19.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 60.100000000000001 110.825 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -79.73 97.41 6.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.4 -0.593 . . . . 74.230000000000004 109.4 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -156.42 127.83 7.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.555 0.217 . . . . 73.230000000000004 111.044 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -97.23 156.53 16.37 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.271 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -109.66 107.83 18.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.244 -1.021 . . . . 73.329999999999998 108.244 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -92.62 126.77 37.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.033 0.444 . . . . 65.319999999999993 111.51 -170.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -128.39 130.56 47.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.764 -0.653 . . . . 73.239999999999995 109.358 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 80.0 mtp -102.54 165.51 11.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.219 0.533 . . . . 52.340000000000003 111.562 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.18 141.75 6.1 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.715 -0.954 . . . . 72.519999999999996 110.715 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -153.77 133.08 12.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.238 0.519 . . . . 61.109999999999999 110.178 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.57 146.63 50.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 72.230000000000004 110.299 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.82 146.27 28.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 63.329999999999998 109.081 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.1 156.01 20.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.135 0.493 . . . . 33.229999999999997 111.512 -174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.89 93.89 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.04 -1.096 . . . . 71.120000000000005 108.04 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.6 p -102.83 26.96 7.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.688 -0.687 . . . . 75.230000000000004 112.456 -170.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.06 77.34 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 72.329999999999998 109.915 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.03 58.89 0.39 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.821 -0.627 . . . . 74.25 112.472 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.95 84.7 0.52 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.153 1.902 . . . . 73.400000000000006 110.506 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 46.9 3.3 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.978 -0.849 . . . . 53.439999999999998 110.978 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 p -58.85 -63.95 1.11 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.847 0.356 . . . . 73.519999999999996 110.098 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 86.9 mmm -80.0 144.89 32.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 72.150000000000006 109.961 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.9 t -53.61 -34.45 58.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.26 -0.427 . . . . 71.329999999999998 110.631 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.13 106.1 16.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.99 -0.55 . . . . 62.109999999999999 110.841 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -124.93 135.12 52.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.786 -0.82 . . . . 62.340000000000003 108.786 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.32 111.56 5.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.861 0.362 . . . . 71.530000000000001 111.036 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -129.35 139.98 51.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.181 -0.463 . . . . 65.329999999999998 109.873 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HB3' ' HD1' ' A' ' 98' ' ' PHE . 24.9 pttm -139.0 111.8 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 71.0 109.549 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.23 117.26 20.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 73.319999999999993 109.175 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.11 136.28 26.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.088 0.47 . . . . 70.430000000000007 110.763 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.4 tp -101.42 -28.18 12.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 73.129999999999995 110.198 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -153.87 112.26 2.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.12 -0.696 . . . . 74.030000000000001 109.12 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.11 134.77 47.49 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.581 2.187 . . . . 71.120000000000005 111.824 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.04 177.81 50.88 Favored Glycine 0 C--O 1.236 0.232 0 C-N-CA 121.271 -0.49 . . . . 71.120000000000005 113.218 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' OD2' HG22 ' A' ' 37' ' ' VAL . 30.6 t70 -64.7 -30.22 71.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.918 0.389 . . . . 72.409999999999997 110.6 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.62 6.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 114.884 0.714 . . . . 51.130000000000003 114.884 168.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.466 HG22 ' OD2' ' A' ' 35' ' ' ASP . 6.4 m -89.75 -23.36 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 117.924 0.862 . . . . 73.239999999999995 112.271 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.601 HG21 ' HB2' ' A' ' 92' ' ' LEU . 34.0 p -62.66 125.57 24.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.698 -0.228 . . . . 54.219999999999999 111.063 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -100.07 126.98 34.67 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 120.933 0.397 . . . . 63.140000000000001 111.29 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -90.24 160.18 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.158 2.572 . . . . 71.040000000000006 111.847 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.623 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 19.8 pt20 -157.41 158.84 36.63 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 110.116 -0.327 . . . . 75.109999999999999 110.116 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -74.16 109.67 7.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.257 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.15 -21.22 3.51 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.738 -0.744 . . . . 65.140000000000001 113.143 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.623 ' HE2' ' HG2' ' A' ' 41' ' ' GLN . 50.9 mtmt -84.35 129.95 34.83 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.042 0.448 . . . . 74.430000000000007 110.607 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.49 111.28 7.53 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.286 -1.005 . . . . 61.229999999999997 108.286 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 130' ' ' VAL . 33.4 m -106.0 143.75 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.982 0.42 . . . . 64.049999999999997 110.91 -174.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -100.35 111.39 23.65 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.27 -0.877 . . . . 54.210000000000001 109.509 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 87' ' ' VAL . 31.0 m -121.5 178.13 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 41.030000000000001 110.614 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 17.1 t-160 -147.27 136.37 22.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.2 -0.667 . . . . 71.409999999999997 109.2 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.485 ' HD1' HG12 ' A' ' 125' ' ' VAL . 78.3 m-85 -126.6 152.37 46.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.769 0.319 . . . . 71.340000000000003 111.086 -176.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -144.95 155.11 43.23 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.73 -0.841 . . . . 72.430000000000007 108.73 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.48 132.34 10.24 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.334 -0.46 . . . . 64.230000000000004 112.899 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ttm-85 -141.58 144.99 34.53 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.366 0.603 . . . . 71.310000000000002 110.902 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.92 147.3 61.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 75.120000000000005 109.555 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.63 -24.81 38.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.135 2.557 . . . . 74.209999999999994 113.491 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -74.33 -34.85 63.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.719 0.295 . . . . 72.299999999999997 110.552 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.78 -12.54 4.51 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 116.117 -0.492 . . . . 52.539999999999999 112.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -75.43 147.06 40.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.228 0.211 . . . . 64.140000000000001 110.568 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.88 127.36 26.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.772 -0.455 . . . . 72.329999999999998 109.772 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -67.54 -36.6 81.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.786 -0.643 . . . . 73.530000000000001 111.574 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -165.6 131.32 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 109.792 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 t -86.18 111.46 20.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.5 . . . . 73.409999999999997 110.728 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 m -79.4 -15.47 57.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 61.149999999999999 111.252 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 14.2 ptp180 -68.0 -32.18 72.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.535 -0.302 . . . . 74.420000000000002 110.764 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 t -67.33 -22.2 65.62 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.096 -0.502 . . . . 52.329999999999998 111.215 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -76.09 -8.97 58.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.706 0.289 . . . . 75.439999999999998 111.151 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.81 8.28 5.52 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 115.263 0.865 . . . . 63.329999999999998 115.263 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -99.3 128.85 30.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 117.669 0.735 . . . . 75.340000000000003 110.065 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -86.74 178.45 3.75 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.801 2.334 . . . . 73.209999999999994 111.912 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -134.45 133.31 40.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.485 -0.561 . . . . 71.230000000000004 109.485 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 96.4 mt-30 -106.19 133.59 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.632 -0.258 . . . . 75.030000000000001 110.368 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 25.3 p90 -152.47 154.96 36.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.584 0.231 . . . . 73.400000000000006 110.415 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.455 ' N ' ' HG3' ' A' ' 78' ' ' GLU . 55.6 m -74.62 110.26 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.551 -0.295 . . . . 75.200000000000003 110.34 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 88' ' ' ALA . 53.0 tp -67.2 136.7 55.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.488 -0.324 . . . . 75.129999999999995 110.478 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.89 80.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.266 -0.493 . . . . 51.530000000000001 112.33 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.61 167.41 11.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.177 -0.305 . . . . 74.430000000000007 110.177 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.92 50.43 3.9 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.337 -0.459 . . . . 54.409999999999997 112.484 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 73' ' ' THR . 6.7 mm-40 -79.68 -46.33 17.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 75.439999999999998 109.968 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.66 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.331 -0.85 . . . . 32.009999999999998 109.839 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.429 HG13 ' H ' ' A' ' 83' ' ' TRP . 30.7 pt -58.54 142.93 13.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.097 0.475 . . . . 75.420000000000002 111.013 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 37.6 mmtm -55.86 -23.22 29.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.814 -0.63 . . . . 73.310000000000002 111.846 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.37 -51.9 56.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.641 -0.79 . . . . 34.43 111.635 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.429 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.2 m0 -70.38 -38.61 74.75 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.267 -0.271 . . . . 71.340000000000003 110.267 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.9 t70 -52.12 -54.66 27.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.117 -0.492 . . . . 72.430000000000007 110.266 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.34 -43.06 95.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.211 -0.45 . . . . 73.310000000000002 110.636 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.66 -48.67 55.65 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.953 -0.567 . . . . 70.400000000000006 112.66 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.538 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.1 m -75.65 -33.83 27.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.927 0.394 . . . . 62.310000000000002 111.176 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -73.81 -13.56 60.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.943 0.349 . . . . 72.340000000000003 111.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -95.58 12.14 30.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 121.267 -0.173 . . . . 72.319999999999993 111.325 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.0 ptp -133.32 -177.19 4.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 111.631 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.5 p -135.93 179.11 6.54 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.7 -0.682 . . . . 75.530000000000001 111.33 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.653 ' HA ' HD12 ' A' ' 127' ' ' LEU . 1.5 tm? -51.45 124.62 12.41 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.968 0.507 . . . . 74.120000000000005 111.104 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 84.81 -1.09 89.09 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.009 -0.541 . . . . 72.25 112.877 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 11.0 tt0 -88.13 143.14 27.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.011 0.434 . . . . 71.340000000000003 110.787 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -142.45 133.51 25.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.531 -0.759 . . . . 74.540000000000006 109.025 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.13 30.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.421 . . . . 55.240000000000002 111.743 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.5 tt -90.86 110.14 21.36 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.475 -0.935 . . . . 62.350000000000001 108.475 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.474 ' HD1' ' HB3' ' A' ' 28' ' ' LYS . 70.3 t80 -122.25 134.31 54.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.144 0.497 . . . . 65.010000000000005 110.888 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.2 m -79.31 120.81 24.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.837 -0.62 . . . . 71.140000000000001 110.264 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.3 mm -99.03 107.24 42.91 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 110.025 -0.361 . . . . 60.109999999999999 110.025 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HA ' HG23 ' A' ' 120' ' ' THR . 28.2 Cg_exo -61.94 145.91 96.62 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.72 2.28 . . . . 51.240000000000002 111.245 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -54.33 -35.49 62.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 111.47 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -64.24 -26.42 68.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.318 -0.401 . . . . 73.140000000000001 111.263 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.02 11.83 37.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.508 -0.315 . . . . 72.140000000000001 111.02 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.16 -176.77 5.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 75.530000000000001 111.018 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.44 -11.81 60.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.693 -0.685 . . . . 72.409999999999997 110.782 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.89 -14.9 59.4 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.843 -0.617 . . . . 75.140000000000001 112.315 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.34 -55.64 30.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.897 -0.408 . . . . 70.209999999999994 109.897 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -86.2 -41.88 14.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.59 . . . . 72.200000000000003 110.758 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.05 143.2 3.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 74.310000000000002 111.608 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.654 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 95.5 m-85 -142.87 -51.69 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 122.84 -0.212 . . . . 75.400000000000006 110.72 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.654 ' HD2' ' H ' ' A' ' 111' ' ' TYR . 89.3 Cg_endo -82.07 138.41 10.18 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.582 1.522 . . . . 74.049999999999997 110.789 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 50.9 Cg_exo -56.26 -21.36 35.84 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 122.868 2.379 . . . . 75.519999999999996 113.349 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 115' ' ' ILE . 35.5 m -75.12 -24.83 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.037 0.446 . . . . 74.310000000000002 110.834 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.647 HG12 HG23 ' A' ' 114' ' ' VAL . 49.0 mm -123.0 88.13 50.9 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 109.173 -0.677 . . . . 64.329999999999998 109.173 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.43 173.59 14.23 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.922 2.415 . . . . 73.409999999999997 112.505 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.42 132.54 24.61 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.576 2.184 . . . . 61.409999999999997 112.84 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 62.43 37.64 13.39 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.437 -0.801 . . . . 73.319999999999993 111.671 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.4 114.74 26.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.120000000000005 110.762 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.9 m -82.3 136.98 34.94 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 71.230000000000004 109.921 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.7 tm? -134.25 145.17 48.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.669 -0.493 . . . . 73.030000000000001 109.669 -172.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 121' ' ' LEU . 61.8 t -99.82 120.91 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.229 . . . . 74.230000000000004 110.398 -176.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -110.83 131.99 54.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.123 0.487 . . . . 52.100000000000001 111.109 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.13 117.08 28.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.855 -0.794 . . . . 64.310000000000002 108.855 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.485 HG12 ' HD1' ' A' ' 50' ' ' TYR . 19.2 m -109.4 149.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.695 . . . . 41.0 110.728 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.0 tt0 -145.03 133.48 21.88 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.837 -0.619 . . . . 75.209999999999994 110.202 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -102.36 116.03 31.78 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 122.702 0.401 . . . . 72.310000000000002 110.192 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.3 mm? -96.75 -37.66 10.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 111.296 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.9 142.26 20.6 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.837 -0.165 . . . . 55.219999999999999 111.016 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 46' ' ' VAL . 3.1 p . . . . . 0 C--O 1.251 1.162 0 CA-C-N 116.49 -0.323 . . . . 71.349999999999994 110.745 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.812 0.339 . . . . 73.310000000000002 110.69 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.67 76.45 7.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 60.100000000000001 110.516 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -81.03 40.61 0.55 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.326 0.584 . . . . 74.230000000000004 110.69 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -162.06 90.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -73.98 103.3 4.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.258 0.552 . . . . 75.319999999999993 111.749 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.06 145.71 48.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.198 -0.91 . . . . 73.329999999999998 110.426 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -77.23 153.46 34.0 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.825 0.345 . . . . 65.319999999999993 111.24 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -134.17 -10.07 2.59 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.893 -0.594 . . . . 73.239999999999995 110.634 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -98.52 101.39 12.81 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.362 -0.381 . . . . 52.340000000000003 110.274 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.25 126.46 0.93 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.657 -0.577 . . . . 72.519999999999996 111.657 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.9 p 50.33 25.61 1.93 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.154 0.582 . . . . 61.109999999999999 112.096 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.4 tp -83.23 -30.43 27.71 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.558 0.694 . . . . 72.230000000000004 109.413 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.26 -164.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.003 -0.998 . . . . 63.329999999999998 109.896 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.4 -79.75 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.675 0.274 . . . . 33.229999999999997 111.247 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -105.6 174.39 5.9 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.929 0.395 . . . . 71.120000000000005 110.991 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 m -138.39 97.19 3.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.531 -0.914 . . . . 75.230000000000004 108.531 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.84 105.26 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 72.329999999999998 110.842 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.91 -55.14 32.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.886 -0.597 . . . . 74.25 112.651 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 25' ' ' GLN . 78.0 Cg_exo -52.51 110.18 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 73.400000000000006 112.913 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.9 163.56 30.77 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.868 -0.605 . . . . 53.439999999999998 111.672 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 t -74.4 -70.88 0.37 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.812 0.306 . . . . 73.519999999999996 110.984 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -85.75 -19.49 30.71 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.764 0.316 . . . . 72.150000000000006 111.08 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 p -79.22 131.53 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 71.329999999999998 110.29 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.29 104.37 0.25 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.992 0.425 . . . . 62.109999999999999 111.079 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -92.43 135.42 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 62.340000000000003 110.717 -178.009 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 tp -145.9 137.0 24.66 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.851 0.358 . . . . 71.530000000000001 111.37 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -141.35 140.63 33.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.944 -0.762 . . . . 65.329999999999998 108.944 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.34 119.85 13.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.848 0.356 . . . . 71.0 110.601 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -112.82 125.59 54.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 73.319999999999993 109.776 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 114.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.562 -0.533 . . . . 70.430000000000007 109.562 176.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.7 mt -99.24 -27.01 13.99 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.58 0.229 . . . . 73.129999999999995 111.5 -174.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 7.4 m -153.66 110.64 2.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 110.247 -0.279 . . . . 74.030000000000001 110.247 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.12 124.15 13.01 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.188 . . . . 71.120000000000005 111.619 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -92.36 -174.13 41.84 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.241 -0.504 . . . . 71.120000000000005 113.098 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -44.66 -57.17 3.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.823 0.849 . . . . 72.409999999999997 112.13 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.1 -30.65 9.44 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.013 -0.613 . . . . 51.130000000000003 114.594 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.5 m -90.34 -22.81 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.175 0.988 . . . . 73.239999999999995 111.007 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.419 HG21 HD13 ' A' ' 92' ' ' LEU . 5.2 p -65.14 142.82 58.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 54.219999999999999 110.541 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.19 101.57 16.24 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 63.140000000000001 110.947 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 141.38 26.72 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 71.040000000000006 111.507 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -131.74 160.42 35.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.073 -0.343 . . . . 75.109999999999999 110.073 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 140.83 50.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.358 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.22 64.98 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 65.140000000000001 112.152 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 143.62 33.28 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.779 0.323 . . . . 74.430000000000007 110.162 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 14.1 tppt? -69.89 126.69 30.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.916 -0.584 . . . . 61.229999999999997 110.027 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 130' ' ' VAL . 27.2 m -117.59 141.96 34.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 120.875 0.369 . . . . 64.049999999999997 110.758 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.4 m -99.87 108.53 20.81 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.369 -0.832 . . . . 54.210000000000001 109.749 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 87' ' ' VAL . 20.9 m -118.26 178.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.27 -0.877 . . . . 41.030000000000001 111.747 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.6 t-160 -155.87 135.97 12.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.393 -0.822 . . . . 71.409999999999997 109.126 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HD1' HG12 ' A' ' 125' ' ' VAL . 61.7 m-85 -126.81 155.51 42.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.479 0.18 . . . . 71.340000000000003 110.857 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 35.4 t70 -136.42 128.19 29.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.994 -0.548 . . . . 72.430000000000007 109.874 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -86.92 100.88 2.61 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.324 -0.465 . . . . 64.230000000000004 112.852 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 53' ' ' ARG . 24.2 ttm-85 -115.95 144.66 43.76 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.927 0.394 . . . . 71.310000000000002 111.126 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -90.67 151.12 43.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 110.085 -0.339 . . . . 75.120000000000005 110.085 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.52 -8.68 21.61 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.892 2.395 . . . . 74.209999999999994 113.473 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.46 -22.11 25.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.69 0.281 . . . . 72.299999999999997 111.162 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.79 10.14 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.313 -0.47 . . . . 52.539999999999999 112.033 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -97.53 162.89 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.345 -0.613 . . . . 64.140000000000001 109.345 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 19.4 pt20 -147.76 146.94 29.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.378 -0.23 . . . . 72.329999999999998 110.378 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -76.82 -34.01 57.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.276 -0.42 . . . . 73.530000000000001 111.714 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.24 131.71 17.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.989 -0.374 . . . . 72.129999999999995 109.989 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.541 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 11.3 p -81.73 85.6 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.223 0.535 . . . . 73.409999999999997 110.197 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.683 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 20.1 m -81.47 -21.66 38.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.786 -0.643 . . . . 61.149999999999999 109.985 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.42 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -66.94 -36.97 83.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.729 -0.669 . . . . 74.420000000000002 109.513 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.6 m -71.54 -21.58 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.468 -0.787 . . . . 52.329999999999998 110.877 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -76.0 -26.32 56.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.233 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.21 31.97 50.26 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.579 -0.737 . . . . 63.329999999999998 113.027 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 39.7 ttmt -79.13 119.8 78.43 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.536 0.168 . . . . 75.340000000000003 110.659 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.3 Cg_endo -82.63 93.92 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.069 2.513 . . . . 73.209999999999994 111.116 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.34 161.4 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.722 -0.672 . . . . 71.230000000000004 109.408 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.32 133.7 33.35 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.292 -0.255 . . . . 75.030000000000001 110.797 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HE1' HG11 ' A' ' 48' ' ' VAL . 26.9 p90 -150.81 158.08 43.71 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.422 -0.353 . . . . 73.400000000000006 110.199 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.5 m -77.42 113.04 14.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.07 -0.344 . . . . 75.200000000000003 110.07 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 88' ' ' ALA . 38.5 tp -60.39 140.41 57.2 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.441 -0.345 . . . . 75.129999999999995 110.878 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.13 -21.61 33.53 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 116.337 -0.392 . . . . 51.530000000000001 112.351 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.66 178.48 8.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 111.022 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.57 24.51 29.05 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.966 -0.561 . . . . 54.409999999999997 112.056 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.35 -41.49 84.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 109.892 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.453 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 34.5 m -123.68 178.23 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 32.009999999999998 109.058 174.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.9 pt -73.4 144.43 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.341 -0.615 . . . . 75.420000000000002 109.341 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.799 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 5.0 mptp? -61.84 -15.79 44.92 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.064 0.394 . . . . 73.310000000000002 112.064 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.96 33.56 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.553 -0.832 . . . . 34.43 111.044 171.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 27.4 m0 -72.33 -36.17 68.77 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 120.851 0.357 . . . . 71.340000000000003 110.238 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.799 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 25.7 t70 -57.62 -55.36 35.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.517 -0.765 . . . . 72.430000000000007 110.747 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -72.51 -38.09 68.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.303 -0.408 . . . . 73.310000000000002 110.15 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.619 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.37 -47.93 66.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.88 -0.6 . . . . 70.400000000000006 112.465 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.2 p -76.05 -35.16 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.773 0.32 . . . . 62.310000000000002 110.862 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.97 -29.27 69.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.679 0.252 . . . . 72.340000000000003 111.679 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 86' ' ' GLY . 6.5 t -79.49 9.11 5.2 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.675 0.62 . . . . 72.319999999999993 112.675 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 17.1 ptp -124.86 -168.4 1.81 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.043 -0.411 . . . . 71.329999999999998 110.896 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -128.92 178.69 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.479 -0.328 . . . . 75.530000000000001 111.404 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 127' ' ' LEU . 9.6 tt -63.28 135.53 57.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 74.120000000000005 111.196 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.65 10.94 85.69 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.907 -0.588 . . . . 72.25 112.633 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.503 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.7 tt0 -106.18 148.81 27.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 71.340000000000003 110.869 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -142.38 137.65 30.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 110.786 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.9 149.78 34.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.02 -0.536 . . . . 55.240000000000002 110.637 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.685 ' HB2' HD11 ' A' ' 31' ' ' LEU . 8.9 tt -90.72 107.51 19.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.494 -0.928 . . . . 62.350000000000001 108.494 175.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -112.0 125.71 54.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 65.010000000000005 110.168 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.6 m -76.2 130.35 38.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 71.140000000000001 110.268 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 43.3 mm -108.14 98.81 28.28 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.364 -0.38 . . . . 60.109999999999999 110.021 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' ILE . 44.7 Cg_endo -68.04 153.97 73.76 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.572 2.181 . . . . 51.240000000000002 111.694 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.31 -23.57 66.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.719 0.637 . . . . 74.230000000000004 112.719 -171.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.55 -16.77 57.08 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.674 0.249 . . . . 73.140000000000001 111.674 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.51 15.58 25.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 72.140000000000001 110.905 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.11 -175.8 5.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 111.322 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -73.79 -6.22 45.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.373 -0.83 . . . . 72.409999999999997 111.005 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -52.8 -25.11 21.74 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.367 0.417 . . . . 75.140000000000001 113.262 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.3 tt0 -61.04 -46.22 91.58 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.909 0.385 . . . . 70.209999999999994 110.74 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -99.63 -46.64 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 72.200000000000003 111.466 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.7 161.65 3.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.58 -0.343 . . . . 74.310000000000002 112.815 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.708 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 87.9 m-85 -135.82 -57.56 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 119.576 -0.25 . . . . 75.400000000000006 110.767 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 9.5 Cg_exo -71.69 142.95 40.82 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.857 1.705 . . . . 74.049999999999997 111.022 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 44.1 Cg_exo -57.36 -19.08 33.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.591 2.194 . . . . 75.519999999999996 112.147 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.461 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 33.9 t -76.09 -24.4 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 110.627 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.06 98.21 18.07 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.148 -0.478 . . . . 64.329999999999998 109.874 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 114' ' ' VAL . 17.9 Cg_exo -67.34 159.9 50.16 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.002 2.468 . . . . 73.409999999999997 112.573 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.81 136.12 44.15 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.588 2.192 . . . . 61.409999999999997 111.43 174.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 62.6 mttp 61.07 34.84 18.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.073 -0.512 . . . . 73.319999999999993 110.871 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.42 122.79 31.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.789 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -73.83 119.11 17.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.625 -0.509 . . . . 71.230000000000004 109.625 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.92 168.78 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.046 0.451 . . . . 73.030000000000001 110.401 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.6 t -133.0 138.21 52.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.426 -0.953 . . . . 74.230000000000004 108.426 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 46.8 m-85 -130.19 122.81 28.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.345 0.593 . . . . 52.100000000000001 110.734 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 31.2 tt0 -76.44 107.03 8.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.559 -1.275 . . . . 64.310000000000002 107.559 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.598 HG12 ' HD1' ' A' ' 50' ' ' TYR . 31.6 m -104.1 144.14 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 41.0 110.4 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 39.2 tt0 -147.54 128.31 14.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 75.209999999999994 110.633 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.5 tm? -98.55 106.17 18.41 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.626 -0.879 . . . . 72.310000000000002 108.626 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.8 mm? -78.57 -48.3 15.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 73.209999999999994 111.002 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.62 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 55.219999999999999 111.195 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.467 HG23 HG12 ' A' ' 46' ' ' VAL . 2.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-N 115.926 -0.579 . . . . 71.349999999999994 110.203 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.192 -0.299 . . . . 73.310000000000002 110.192 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.41 5.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 60.100000000000001 110.491 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -72.72 -42.5 64.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.419 . . . . 74.230000000000004 110.032 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -75.83 116.72 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.566 -0.902 . . . . 73.230000000000004 108.566 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -59.98 94.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.636 . . . . 75.319999999999993 111.62 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -73.3 70.55 1.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.56 -0.533 . . . . 73.329999999999998 109.56 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -95.22 128.72 42.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.941 -0.763 . . . . 65.319999999999993 108.941 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -131.84 134.78 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.757 0.313 . . . . 73.239999999999995 110.558 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.21 174.28 13.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.328 -0.619 . . . . 52.340000000000003 109.328 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.65 -129.07 2.4 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.058 -0.591 . . . . 72.519999999999996 111.656 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -73.89 81.11 1.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.938 0.369 . . . . 61.109999999999999 110.177 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.6 mt 60.84 20.17 10.39 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.808 -0.633 . . . . 72.230000000000004 110.539 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.88 18.81 2.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.822 -0.626 . . . . 63.329999999999998 110.813 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.63 106.88 16.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 33.229999999999997 110.854 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 69.97 -5.29 1.29 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.755 -0.657 . . . . 71.120000000000005 112.105 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 p -77.39 87.42 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 75.230000000000004 110.67 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -140.87 13.17 2.27 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.684 -0.689 . . . . 72.329999999999998 110.584 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 22' ' ' MET . . . 112.12 88.17 1.75 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.097 -0.501 . . . . 74.25 112.224 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.15 122.49 5.74 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.73 2.287 . . . . 73.400000000000006 112.471 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.19 -127.27 8.13 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 121.138 -0.553 . . . . 53.439999999999998 112.711 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 m -74.35 79.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.923 0.392 . . . . 73.519999999999996 110.83 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.467 ' HG3' ' HA3' ' A' ' 18' ' ' GLY . 24.8 mmt -142.29 -48.29 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.152 -0.476 . . . . 72.150000000000006 110.027 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -156.62 -179.51 8.26 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.647 -0.706 . . . . 71.329999999999998 109.573 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.4 95.36 6.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 62.109999999999999 110.453 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -92.42 135.32 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.508 . . . . 62.340000000000003 110.252 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -131.55 102.03 5.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.326 -0.99 . . . . 71.530000000000001 108.326 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.34 125.57 15.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 65.329999999999998 109.224 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -125.48 126.22 44.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 71.0 110.469 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -109.19 121.01 44.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.696 -0.683 . . . . 73.319999999999993 110.232 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.33 103.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.902 -0.407 . . . . 70.430000000000007 109.902 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.41 -19.66 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.42 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 37.9 m -149.57 110.83 3.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.992 -0.549 . . . . 74.030000000000001 109.712 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.75 130.63 23.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 71.120000000000005 111.824 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.17 -153.28 19.88 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.06 -0.518 . . . . 71.120000000000005 112.545 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.73 -36.9 42.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.161 0.505 . . . . 72.409999999999997 110.28 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.01 -17.72 11.07 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.623 -0.717 . . . . 51.130000000000003 113.329 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 m -89.4 -20.31 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.971 0.36 . . . . 73.239999999999995 111.971 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.4 p -79.95 144.17 33.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.998 0.428 . . . . 54.219999999999999 111.062 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.58 96.24 49.06 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.958 -0.564 . . . . 63.140000000000001 109.784 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 130' ' ' VAL . 51.6 Cg_exo -55.94 145.14 75.39 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.009 2.473 . . . . 71.040000000000006 113.188 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.17 146.0 44.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.971 -0.559 . . . . 75.109999999999999 109.939 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.6 166.14 24.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.728 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.07 7.3 70.46 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.221 -0.514 . . . . 65.140000000000001 112.711 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.95 149.88 40.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.943 0.401 . . . . 74.430000000000007 111.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.662 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -78.06 104.09 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.89 -0.782 . . . . 61.229999999999997 108.89 171.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.33 151.63 8.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.276 0.56 . . . . 64.049999999999997 111.661 -173.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 30.2 m -99.13 108.38 20.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.005 -0.998 . . . . 54.210000000000001 110.015 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.482 HG21 ' CE2' ' A' ' 72' ' ' PHE . 14.7 m -122.57 178.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.924 -0.58 . . . . 41.030000000000001 110.466 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 69' ' ' PRO . 50.0 t-80 -154.22 149.46 27.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.134 -0.691 . . . . 71.409999999999997 109.134 173.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -151.33 152.27 32.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.499 0.19 . . . . 71.340000000000003 110.615 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -135.74 134.59 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.157 -0.682 . . . . 72.430000000000007 109.157 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.23 139.71 15.35 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.281 -0.485 . . . . 64.230000000000004 112.818 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.58 HH21 HG21 ' A' ' 122' ' ' VAL . 11.1 ttp180 -142.03 137.15 30.9 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.092 0.472 . . . . 71.310000000000002 110.432 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -79.95 152.83 74.77 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.731 -0.668 . . . . 75.120000000000005 109.939 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.45 -18.68 32.72 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.666 2.244 . . . . 74.209999999999994 111.774 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.28 -38.87 88.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.392 -0.822 . . . . 72.299999999999997 110.367 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.09 -19.25 5.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.015 -0.538 . . . . 52.539999999999999 112.357 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -86.32 142.93 28.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.6 0.2 . . . . 64.140000000000001 110.571 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.2 mt-30 -86.45 155.25 20.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.604 -0.517 . . . . 72.329999999999998 109.604 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -76.16 -62.02 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.483 -0.562 . . . . 73.530000000000001 109.483 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -145.26 132.99 21.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.634 -0.712 . . . . 72.129999999999995 109.265 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 33.1 t -89.54 85.66 6.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 73.409999999999997 109.85 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 99.9 p -65.25 -26.78 68.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.486 . . . . 61.149999999999999 109.928 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 64' ' ' ARG . 5.3 ptp180 -60.35 -44.29 95.69 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.746 -0.661 . . . . 74.420000000000002 110.477 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -69.81 -23.44 63.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.061 0.458 . . . . 52.329999999999998 110.199 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' SER . 17.4 mtp180 -75.91 -21.85 56.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.294 -0.632 . . . . 75.439999999999998 109.294 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.07 46.53 7.6 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.404 -0.816 . . . . 63.329999999999998 114.128 170.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -145.8 128.98 8.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.101 0.451 . . . . 75.340000000000003 110.477 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 1.4 Cg_endo -84.91 -177.42 2.81 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.24 2.627 . . . . 73.209999999999994 111.914 174.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.4 152.36 48.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.242 -0.651 . . . . 71.230000000000004 109.242 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -134.14 129.58 36.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.356 -0.239 . . . . 75.030000000000001 110.356 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' CE2' HG21 ' A' ' 48' ' ' VAL . 12.6 p90 -154.61 169.86 22.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.715 -0.221 . . . . 73.400000000000006 110.543 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.522 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 21.7 m -80.88 119.09 22.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.421 -0.354 . . . . 75.200000000000003 111.204 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 88' ' ' ALA . 56.8 tp -70.21 137.69 51.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.09 -0.505 . . . . 75.129999999999995 110.347 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.17 24.99 64.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.014 -0.612 . . . . 51.530000000000001 112.422 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.67 172.3 11.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.727 0.299 . . . . 74.430000000000007 110.407 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 15.93 8.4 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.111 -0.495 . . . . 54.409999999999997 113.315 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 73' ' ' THR . 26.6 mm-40 -55.68 -42.99 75.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.269 0.557 . . . . 75.439999999999998 110.314 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.533 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 30.4 m -134.91 176.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 32.009999999999998 109.987 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.9 pt -69.21 150.01 10.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 116.499 -0.318 . . . . 75.420000000000002 110.392 177.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -58.59 -25.22 62.37 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 110.274 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.62 -52.16 54.21 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.055 -0.593 . . . . 34.43 111.963 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.533 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 49.8 m0 -68.14 -35.12 77.58 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.084 -0.339 . . . . 71.340000000000003 110.084 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.08 -49.37 71.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.105 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.14 -49.18 78.86 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.294 -0.412 . . . . 73.310000000000002 110.237 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.24 -50.05 48.05 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.455 -0.793 . . . . 70.400000000000006 113.003 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -75.36 -33.25 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.71 0.291 . . . . 62.310000000000002 111.763 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -77.69 -20.8 53.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.366 0.506 . . . . 72.340000000000003 112.366 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.3 t -85.76 -10.27 55.81 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.171 0.434 . . . . 72.319999999999993 112.171 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.9 ptp -107.19 -176.46 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 111.637 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.569 HG21 ' HA2' ' A' ' 36' ' ' GLY . 17.3 p -118.56 178.83 4.32 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.899 -0.591 . . . . 75.530000000000001 110.89 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.794 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.3 tt -67.28 126.42 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.096 0.474 . . . . 74.120000000000005 110.542 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.404 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 81.62 11.97 82.3 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.707 -0.679 . . . . 72.25 112.531 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 19.1 tt0 -100.5 146.48 27.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.841 0.353 . . . . 71.340000000000003 110.618 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.4 ttpm? -137.45 136.92 38.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.848 -0.614 . . . . 74.540000000000006 109.957 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.82 148.11 46.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.313 -0.403 . . . . 55.240000000000002 110.691 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.5 tt -90.75 105.47 17.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.628 -1.249 . . . . 62.350000000000001 107.628 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.86 126.43 50.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 65.010000000000005 110.268 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.3 m -84.89 106.44 16.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.949 -0.759 . . . . 71.140000000000001 108.949 174.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.98 110.77 40.44 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.435 -0.348 . . . . 60.109999999999999 110.77 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.93 140.87 47.01 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.486 2.124 . . . . 51.240000000000002 111.233 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 46.3 p90 -54.5 -35.06 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 111.781 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 13.8 pt20 -61.83 -20.87 64.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 111.543 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.554 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 95.6 mt -113.45 19.0 17.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.535 -0.302 . . . . 72.140000000000001 110.657 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.8 171.54 14.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.665 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -72.12 -17.34 61.98 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.282 -0.872 . . . . 72.409999999999997 110.587 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.89 -15.97 44.76 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.907 -0.588 . . . . 75.140000000000001 112.366 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 3.6 tm-20 -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.119 -0.326 . . . . 70.209999999999994 110.119 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -78.46 -52.83 7.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.426 -0.583 . . . . 72.200000000000003 109.426 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.97 153.36 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.936 -0.575 . . . . 74.310000000000002 113.008 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.592 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 54.2 m-85 -142.49 -59.84 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 122.574 0.35 . . . . 75.400000000000006 110.651 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 75.6 Cg_endo -84.51 151.18 11.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 121.899 1.733 . . . . 74.049999999999997 111.882 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.9 -21.49 64.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.683 2.255 . . . . 75.519999999999996 112.634 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.641 HG23 HG12 ' A' ' 115' ' ' ILE . 33.8 m -71.91 -22.45 21.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.301 -0.408 . . . . 74.310000000000002 110.724 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.641 HG12 HG23 ' A' ' 114' ' ' VAL . 47.1 mm -121.81 87.68 46.69 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 109.165 -0.68 . . . . 64.329999999999998 109.165 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 35.8 Cg_endo -64.98 156.34 63.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 73.409999999999997 111.785 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.11 135.85 60.2 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.358 2.038 . . . . 61.409999999999997 112.217 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 98.1 mttt 61.83 35.12 16.73 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.778 -0.647 . . . . 73.319999999999993 111.493 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -89.29 125.04 34.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.053 -0.521 . . . . 74.120000000000005 111.562 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.6 m -74.09 132.81 42.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.921 -0.581 . . . . 71.230000000000004 109.442 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.582 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -129.58 150.41 50.92 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.883 -0.414 . . . . 73.030000000000001 109.883 -171.239 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.582 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.0 t -98.73 131.06 46.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 110.378 -0.23 . . . . 74.230000000000004 110.378 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.456 ' CE2' HD12 ' A' ' 121' ' ' LEU . 56.5 m-85 -130.32 118.76 21.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 52.100000000000001 110.644 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 46.8 mt-10 -77.73 107.8 10.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.759 -0.83 . . . . 64.310000000000002 108.759 171.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.15 147.33 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 123.325 0.391 . . . . 41.0 110.312 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.96 128.92 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 75.209999999999994 110.703 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.9 tm? -96.14 115.91 28.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.85 -43.41 10.05 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.643 0.258 . . . . 73.209999999999994 110.998 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -150.39 135.29 17.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.348 -0.387 . . . . 55.219999999999999 110.388 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.508 HG21 ' HA ' ' A' ' 40' ' ' PRO . 2.9 p . . . . . 0 C--O 1.251 1.149 0 CA-C-N 116.23 -0.441 . . . . 71.349999999999994 111.235 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.872 -0.418 . . . . 62.340000000000003 109.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.3 tp -145.92 102.02 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.784 0.326 . . . . 71.530000000000001 111.019 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' H ' ' HB ' ' A' ' 99' ' ' THR . 50.1 mm-40 -113.62 140.68 48.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.99 -0.744 . . . . 65.329999999999998 108.99 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 9.1 ptpp? -128.32 111.92 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 71.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -123.41 110.0 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 109.878 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 9.9 p -71.37 128.06 34.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.842 0.353 . . . . 70.430000000000007 111.314 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 97' ' ' LEU . 3.0 mm? -86.96 -38.08 16.97 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.592 -0.522 . . . . 73.129999999999995 109.592 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.1 m -141.6 112.7 6.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.966 -0.561 . . . . 74.030000000000001 110.187 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.15 146.09 62.81 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.51 2.14 . . . . 71.120000000000005 111.638 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.62 -164.64 28.23 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.271 -0.49 . . . . 71.120000000000005 112.717 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.79 -40.89 63.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.092 0.472 . . . . 72.409999999999997 110.996 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 -30.78 2.48 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.734 -0.667 . . . . 51.130000000000003 112.657 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.6 -24.5 8.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.032 0.444 . . . . 73.239999999999995 110.43 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.2 p -75.05 139.58 42.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.552 -0.749 . . . . 54.219999999999999 110.436 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -126.41 113.72 23.29 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.504 -0.316 . . . . 63.140000000000001 110.896 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.64 130.95 14.17 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.429 2.086 . . . . 71.040000000000006 111.451 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.47 149.28 44.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.43 -0.35 . . . . 75.109999999999999 110.815 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.32 164.5 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.111 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.24 34.48 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.156 -0.474 . . . . 65.140000000000001 112.73 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -101.44 146.7 27.27 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.430000000000007 111.597 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -77.42 110.85 12.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.299 -0.864 . . . . 61.229999999999997 109.282 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.9 m -106.4 148.76 10.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.945 0.403 . . . . 64.049999999999997 111.662 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.9 m -102.53 108.19 19.4 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 115.02 -0.991 . . . . 54.210000000000001 110.515 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.48 HG21 ' HE1' ' A' ' 72' ' ' PHE . 33.1 m -119.21 178.36 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 114.64 -1.164 . . . . 41.030000000000001 111.931 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 13.8 t-160 -157.51 147.32 20.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.199 -1.037 . . . . 71.409999999999997 108.199 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.6 m-85 -132.99 157.39 45.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.822 0.283 . . . . 71.340000000000003 111.383 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.841 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 45.0 m-20 -136.0 122.32 20.52 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.693 -0.685 . . . . 72.430000000000007 109.863 170.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.29 129.79 10.32 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.664 -0.574 . . . . 64.230000000000004 111.664 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -149.0 143.77 26.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 71.310000000000002 110.825 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 147.5 40.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.943 -0.391 . . . . 75.120000000000005 109.943 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.32 -22.49 49.66 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.894 2.396 . . . . 74.209999999999994 112.067 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.32 -34.27 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.5 -0.773 . . . . 72.299999999999997 110.797 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.59 -38.45 2.19 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.059 -0.816 . . . . 52.539999999999999 111.059 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.95 123.12 16.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.508 -0.346 . . . . 64.140000000000001 110.328 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -75.65 144.19 41.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.506 . . . . 72.329999999999998 110.917 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -72.93 -45.22 59.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.521 -0.548 . . . . 73.530000000000001 109.521 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -166.7 131.3 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 72.129999999999995 109.459 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -78.74 85.6 4.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.239 0.542 . . . . 73.409999999999997 109.865 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -72.66 -14.0 61.49 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.438 0.637 . . . . 61.149999999999999 110.086 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.701 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 13.1 ptt-85 -64.46 -35.96 82.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.42 -0.809 . . . . 74.420000000000002 110.678 171.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -69.17 -18.2 63.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.098 0.475 . . . . 52.329999999999998 110.057 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -82.32 -14.2 55.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.989 -0.551 . . . . 75.439999999999998 110.574 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.81 32.82 59.27 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.816 -0.629 . . . . 63.329999999999998 113.578 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -106.47 109.57 63.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.755 0.278 . . . . 75.340000000000003 110.98 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -90.5 125.68 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.948 2.432 . . . . 73.209999999999994 112.054 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.77 162.63 14.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.33 -0.618 . . . . 71.230000000000004 109.33 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.95 137.35 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.414 -0.178 . . . . 75.030000000000001 110.767 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.48 ' HE1' HG21 ' A' ' 48' ' ' VAL . 35.1 p90 -159.27 155.28 26.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.213 -0.195 . . . . 73.400000000000006 110.616 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.6 m -72.09 113.8 9.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.431 -0.35 . . . . 75.200000000000003 110.687 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.489 HD13 HG13 ' A' ' 87' ' ' VAL . 55.8 tp -61.97 133.56 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.7 -0.482 . . . . 75.129999999999995 109.7 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.75 68.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 51.530000000000001 112.803 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.39 11.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 74.430000000000007 110.525 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.91 31.68 3.33 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.475 -0.393 . . . . 54.409999999999997 112.631 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -63.74 -43.54 96.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 110.593 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.685 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 26.8 m -128.75 177.73 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 32.009999999999998 110.147 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.458 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.3 pt -68.92 152.77 9.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.687 0.279 . . . . 75.420000000000002 110.389 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 5.6 tmtm? -56.25 -29.02 60.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.073 -0.512 . . . . 73.310000000000002 109.94 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.44 -54.43 36.09 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.133 -0.556 . . . . 34.43 112.057 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.685 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 26.0 m0 -68.75 -38.17 79.93 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.52 -0.178 . . . . 71.340000000000003 110.52 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -54.51 -49.3 70.51 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.215 0.531 . . . . 72.430000000000007 110.389 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -65.03 -41.32 95.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 73.310000000000002 110.267 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.04 43.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.924 -0.58 . . . . 70.400000000000006 112.492 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.489 HG13 HD13 ' A' ' 74' ' ' LEU . 6.6 p -71.03 -31.81 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.685 0.279 . . . . 62.310000000000002 111.068 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -70.59 -30.66 67.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 72.340000000000003 111.659 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 -15.65 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.93 0.344 . . . . 72.319999999999993 111.93 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 87' ' ' VAL . 16.5 ptm -91.01 -175.39 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.581 0.229 . . . . 71.329999999999998 110.828 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -126.51 175.23 8.06 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 75.530000000000001 111.14 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.787 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.2 tt -73.84 137.58 43.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.698 0.285 . . . . 74.120000000000005 110.26 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.498 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.25 10.58 85.9 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.652 -0.579 . . . . 72.25 111.652 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.86 149.65 30.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.607 -0.296 . . . . 71.340000000000003 110.63 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . 13.9 ptmt -140.43 133.45 29.35 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.498 -0.556 . . . . 74.540000000000006 109.498 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -131.43 156.71 45.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.693 -0.685 . . . . 55.240000000000002 111.037 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 31' ' ' LEU . 8.7 tt -90.73 107.2 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.061 -1.089 . . . . 62.350000000000001 108.061 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -111.46 114.43 27.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.85 -0.426 . . . . 65.010000000000005 109.85 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 22.3 m -76.88 118.44 19.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.5 -0.318 . . . . 71.140000000000001 110.805 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 105' ' ' ALA . 40.0 mm -101.75 110.84 63.05 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 120.675 0.274 . . . . 60.109999999999999 110.414 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.3 Cg_endo -62.46 143.44 93.24 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.634 2.222 . . . . 51.240000000000002 111.889 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -54.26 -32.58 56.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.691 -0.686 . . . . 74.230000000000004 111.982 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.32 -23.34 65.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.074 0.398 . . . . 73.140000000000001 112.074 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.3 mt -96.12 -28.25 14.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.671 0.272 . . . . 72.140000000000001 111.549 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.444 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -110.06 -174.34 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 75.530000000000001 111.127 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -70.12 -7.44 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.621 . . . . 72.409999999999997 111.08 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.33 -28.84 51.52 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 113.089 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 7.6 tm-20 -64.28 -49.85 70.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.365 -0.605 . . . . 70.209999999999994 109.365 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -27.32 58.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.491 -0.777 . . . . 72.200000000000003 110.48 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 112' ' ' PRO . . . 80.14 -82.83 1.43 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.616 -0.72 . . . . 74.310000000000002 111.77 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.612 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 58.8 m-85 89.33 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.209 1.404 . . . . 75.400000000000006 111.986 -175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 59.4 Cg_endo -89.0 152.67 5.8 Favored 'Trans proline' 0 C--N 1.366 1.482 0 CA-C-N 121.693 1.64 . . . . 74.049999999999997 111.665 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.33 -7.78 13.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.557 2.171 . . . . 75.519999999999996 112.369 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.95 -31.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 109.938 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.89 101.92 48.68 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.812 -0.631 . . . . 64.329999999999998 109.899 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 Cg_endo -67.08 119.64 6.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.241 1.961 . . . . 73.409999999999997 111.388 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.34 133.96 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.683 2.922 . . . . 61.409999999999997 113.42 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 54.0 mtmt 73.0 31.68 1.45 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.645 0.778 . . . . 73.319999999999993 111.124 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -93.77 123.86 37.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.878 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 101' ' ' PRO . 74.0 m -73.69 127.64 33.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.257 -0.646 . . . . 71.230000000000004 109.257 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -120.88 137.09 54.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.547 -0.538 . . . . 73.030000000000001 109.547 -170.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.522 ' N ' HD13 ' A' ' 121' ' ' LEU . 88.7 t -98.51 131.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.691 0.281 . . . . 74.230000000000004 110.424 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.29 123.04 41.22 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.947 -0.39 . . . . 52.100000000000001 109.947 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 51.0 mt-10 -75.34 115.34 14.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.553 -0.906 . . . . 64.310000000000002 108.553 171.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 m -95.74 137.17 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.653 0.595 . . . . 41.0 109.413 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 36.3 tt0 -136.61 117.71 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.589 -0.522 . . . . 75.209999999999994 109.589 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.787 HD12 ' HA ' ' A' ' 92' ' ' LEU . 3.1 tm? -99.87 106.3 18.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.72 -0.845 . . . . 72.310000000000002 108.72 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 49' ' ' HIS . 3.6 mm? -78.2 -45.83 22.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.41 -0.589 . . . . 73.209999999999994 109.41 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -170.81 -173.61 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.528 -0.76 . . . . 55.219999999999999 109.92 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.114 -0.946 . . . . 71.349999999999994 108.669 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.393 -0.595 . . . . 62.340000000000003 109.393 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -144.4 102.41 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.945 0.402 . . . . 71.530000000000001 110.397 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 48.8 mt-10 -142.72 130.59 21.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 65.329999999999998 110.122 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -133.2 101.42 5.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.767 -0.827 . . . . 71.0 108.767 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -108.71 110.33 21.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 73.319999999999993 109.763 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.59 114.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.189 0.518 . . . . 70.430000000000007 110.336 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.7 mt -88.88 -33.02 17.47 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.843 -0.617 . . . . 73.129999999999995 110.117 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 44.7 m -145.49 120.58 5.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.523 -0.762 . . . . 74.030000000000001 109.397 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 146.44 51.99 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.608 2.205 . . . . 71.120000000000005 112.427 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -99.91 -172.06 30.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 112.431 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 78.2 m-20 -63.85 -36.88 85.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.034 0.445 . . . . 72.409999999999997 110.397 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.35 -30.29 2.18 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.774 -0.648 . . . . 51.130000000000003 113.039 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 m -82.25 -35.65 13.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.148 0.499 . . . . 73.239999999999995 110.07 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 12.3 p -84.83 115.57 22.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.585 -0.734 . . . . 54.219999999999999 109.476 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 39' ' ' LYS . 8.3 mtmp? -124.39 132.23 24.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 63.140000000000001 111.063 -171.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.18 166.73 20.39 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.549 2.166 . . . . 71.040000000000006 110.997 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -165.21 166.38 18.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.404 -0.221 . . . . 75.109999999999999 110.404 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.39 141.66 52.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.337 -0.392 . . . . 74.420000000000002 110.936 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.59 20.3 41.3 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.068 -0.515 . . . . 65.140000000000001 111.877 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -130.61 138.16 49.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.695 0.398 . . . . 74.430000000000007 110.869 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -79.6 106.07 11.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.491 -0.929 . . . . 61.229999999999997 108.491 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 130' ' ' VAL . 28.2 m -106.49 146.19 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.365 . . . . 64.049999999999997 111.254 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.1 m -96.35 108.07 20.53 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.613 -0.721 . . . . 54.210000000000001 109.926 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.744 HG12 HD22 ' A' ' 127' ' ' LEU . 18.4 m -124.45 178.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.519 0.676 . . . . 41.030000000000001 111.234 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 64' ' ' ARG . 15.4 t-80 -151.6 140.63 21.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.947 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 86.0 m-85 -126.5 144.01 51.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.595 -0.891 . . . . 71.340000000000003 108.595 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 8.9 t70 -136.15 110.71 8.59 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.469 -0.567 . . . . 72.430000000000007 109.469 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.46 137.4 30.88 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.938 -0.574 . . . . 64.230000000000004 112.154 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -148.01 137.16 22.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.002 0.43 . . . . 71.310000000000002 110.519 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 88.9 m-85 -78.53 146.8 70.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 75.120000000000005 110.168 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 30.5 Cg_exo -62.92 -10.39 20.12 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.97 2.446 . . . . 74.209999999999994 113.289 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -87.16 -4.94 59.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.675 0.274 . . . . 72.299999999999997 110.916 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.17 -24.58 15.79 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.742 -0.543 . . . . 52.539999999999999 111.742 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 4.8 ttmp? -59.09 148.63 30.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.204 0.602 . . . . 64.140000000000001 110.896 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -94.88 143.62 26.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.025 -0.361 . . . . 72.329999999999998 110.025 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -86.47 -55.66 3.78 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.957 0.408 . . . . 73.530000000000001 110.558 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -138.67 131.41 29.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.348 -0.387 . . . . 72.129999999999995 110.323 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -76.19 85.12 3.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 73.409999999999997 109.95 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.0 p -90.33 -46.91 8.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.441 . . . . 61.149999999999999 109.95 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.479 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.3 ptt180 -60.64 -31.61 70.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.987 -0.551 . . . . 74.420000000000002 110.137 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -70.68 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 52.329999999999998 111.378 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -93.17 -2.27 55.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.907 0.384 . . . . 75.439999999999998 110.234 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.18 39.2 69.83 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.71 -0.677 . . . . 63.329999999999998 113.768 174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -141.81 122.63 8.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.796 0.298 . . . . 75.340000000000003 110.582 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.81 177.66 6.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.795 2.33 . . . . 73.209999999999994 111.861 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -135.02 129.92 34.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 71.230000000000004 109.848 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -100.45 141.91 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.293 -0.262 . . . . 75.030000000000001 110.293 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.53 ' HZ ' HG11 ' A' ' 87' ' ' VAL . 11.6 p90 -154.34 158.17 39.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.726 0.298 . . . . 73.400000000000006 110.265 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -83.69 109.43 17.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 110.033 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.72 142.06 56.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.447 -0.342 . . . . 75.129999999999995 110.435 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.21 26.9 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.891 -0.484 . . . . 51.530000000000001 111.891 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.81 168.95 18.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.696 0.398 . . . . 74.430000000000007 109.966 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.42 28.48 1.48 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.397 -0.43 . . . . 54.409999999999997 113.304 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.04 -34.84 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.292 0.568 . . . . 75.439999999999998 109.767 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 83' ' ' TRP . 27.1 m -131.13 165.27 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.233 -0.894 . . . . 32.009999999999998 110.421 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 pt -80.66 164.63 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 75.420000000000002 110.526 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -55.9 -28.54 57.2 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.201 0.445 . . . . 73.310000000000002 112.201 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.52 -59.5 9.74 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 120.432 -0.889 . . . . 34.43 111.681 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.469 ' O ' HG12 ' A' ' 87' ' ' VAL . 27.0 m0 -66.0 -37.02 84.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.665 -0.268 . . . . 71.340000000000003 110.287 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.57 -55.01 39.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.936 -0.575 . . . . 72.430000000000007 110.842 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.83 -42.56 90.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.453 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.52 -48.68 69.01 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.014 -0.612 . . . . 70.400000000000006 112.682 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG11 ' HZ ' ' A' ' 72' ' ' PHE . 14.2 p -75.21 -32.94 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.826 0.346 . . . . 62.310000000000002 111.077 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.36 68.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.514 -0.312 . . . . 72.340000000000003 111.649 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 t -86.23 -4.46 59.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.215 0.45 . . . . 72.319999999999993 112.215 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 19.4 ptm -106.81 176.0 5.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.669 0.271 . . . . 71.329999999999998 110.889 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.1 p -118.65 174.55 6.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.764 0.316 . . . . 75.530000000000001 111.306 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.629 HD12 HG23 ' A' ' 130' ' ' VAL . 7.6 tt -73.16 138.34 45.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 111.134 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.495 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.34 34.8 44.52 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.737 -0.665 . . . . 72.25 111.926 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 33.7 tt0 -134.52 153.71 51.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.945 0.402 . . . . 71.340000000000003 111.694 -169.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -131.41 122.36 26.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 74.540000000000006 109.845 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.76 141.57 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 55.240000000000002 110.62 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.7 tt -90.89 113.75 26.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.951 -0.759 . . . . 62.350000000000001 108.951 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -114.37 121.2 42.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.841 0.353 . . . . 65.010000000000005 110.389 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 31.2 m -78.67 116.06 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 71.140000000000001 110.294 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.7 mm -89.87 113.29 56.43 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 116.385 -0.371 . . . . 60.109999999999999 110.853 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.75 155.0 39.45 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.547 2.165 . . . . 51.240000000000002 111.556 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -54.17 -30.83 50.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.959 -0.564 . . . . 74.230000000000004 112.075 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.02 -26.8 64.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.729 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.4 mt -96.19 11.74 33.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.359 0.124 . . . . 72.140000000000001 111.286 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 -178.2 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 75.530000000000001 110.466 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -69.72 -8.27 46.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 72.409999999999997 110.783 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.83 -20.39 32.82 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.065 -0.516 . . . . 75.140000000000001 112.817 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -58.17 -51.95 67.58 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.562 -0.533 . . . . 70.209999999999994 109.562 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -84.33 -53.82 5.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.45 -0.795 . . . . 72.200000000000003 110.77 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.96 146.17 12.69 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.097 -0.501 . . . . 74.310000000000002 112.158 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -139.06 -55.41 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 122.369 0.268 . . . . 75.400000000000006 110.854 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 13.4 Cg_exo -70.01 128.34 15.66 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.942 1.761 . . . . 74.049999999999997 110.631 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 76.5 Cg_exo -51.58 -27.67 26.29 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.82 2.347 . . . . 75.519999999999996 113.342 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.2 t -73.87 -35.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 74.310000000000002 110.56 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.54 106.17 17.35 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 64.329999999999998 109.549 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 95.3 Cg_endo -79.66 163.38 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.406 2.071 . . . . 73.409999999999997 112.364 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.11 143.9 91.71 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.212 1.941 . . . . 61.409999999999997 111.17 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 65.92 28.19 10.7 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.24 0.338 . . . . 73.319999999999993 111.276 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -76.34 148.96 37.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.18 0.514 . . . . 74.120000000000005 112.067 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.3 m -108.9 131.33 55.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.439 -0.8 . . . . 71.230000000000004 109.379 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -138.48 147.27 43.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.208 -0.664 . . . . 73.030000000000001 109.208 -175.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.578 ' N ' HD13 ' A' ' 121' ' ' LEU . 94.7 t -105.03 144.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.388 . . . . 74.230000000000004 110.98 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 121' ' ' LEU . 27.8 m-85 -133.01 125.6 30.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.021 0.439 . . . . 52.100000000000001 110.715 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 58.5 mt-10 -76.4 114.85 15.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.23 -0.656 . . . . 64.310000000000002 109.23 170.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.3 m -95.87 133.55 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 41.0 108.765 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 45.5 tt0 -139.02 116.64 11.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.39 -0.368 . . . . 75.209999999999994 110.265 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.744 HD22 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -96.04 111.71 23.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.557 -0.905 . . . . 72.310000000000002 108.557 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.05 -50.82 7.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.921 0.391 . . . . 73.209999999999994 110.065 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -167.1 178.82 5.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 55.219999999999999 109.905 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 92' ' ' LEU . 46.6 t . . . . . 0 C--O 1.251 1.142 0 N-CA-C 108.843 -0.799 . . . . 71.349999999999994 108.843 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 . . . . . 0 C--O 1.232 0.174 0 N-CA-C 108.635 -0.876 . . . . 62.340000000000003 108.635 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 102.04 8.42 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.039 0.447 . . . . 71.530000000000001 111.02 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.27 130.1 56.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 65.329999999999998 109.993 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.676 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -140.88 117.18 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.549 -0.751 . . . . 71.0 109.209 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.55 118.09 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.481 -0.327 . . . . 73.319999999999993 110.542 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.02 134.0 27.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 70.430000000000007 110.374 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.87 -18.45 13.69 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.409 -0.36 . . . . 73.129999999999995 110.688 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 88.2 m -142.71 110.63 5.7 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.148 -0.316 . . . . 74.030000000000001 110.148 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.23 126.13 10.83 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.766 2.311 . . . . 71.120000000000005 111.053 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.2 -171.29 47.3 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.236 -0.507 . . . . 71.120000000000005 113.177 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -57.61 -34.76 69.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.603 0.361 . . . . 72.409999999999997 111.346 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.523 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 76.08 -25.59 1.54 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.281 -0.485 . . . . 51.130000000000003 113.474 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 35' ' ' ASP . 34.1 m -75.12 -21.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.872 0.368 . . . . 73.239999999999995 111.471 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -81.07 128.92 34.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 54.219999999999999 111.222 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -100.09 110.24 58.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.47 . . . . 63.140000000000001 109.988 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.24 134.15 13.99 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 71.040000000000006 111.161 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -127.96 141.72 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 75.109999999999999 110.371 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 162.13 29.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.01 -0.541 . . . . 74.420000000000002 111.776 -176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.95 77.17 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.562 -0.744 . . . . 65.140000000000001 112.981 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.4 170.73 15.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 111.719 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -78.64 142.75 36.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 61.229999999999997 111.495 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.15 141.94 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.845 -0.616 . . . . 64.049999999999997 110.112 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.3 m -93.68 108.12 19.9 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.764 -0.653 . . . . 54.210000000000001 110.277 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.525 HG12 HD22 ' A' ' 127' ' ' LEU . 20.4 m -123.78 178.33 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.995 -1.002 . . . . 41.030000000000001 111.325 -172.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.589 ' HB3' HD21 ' A' ' 128' ' ' LEU . 8.9 t-80 -157.83 143.35 17.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.391 -0.822 . . . . 71.409999999999997 109.136 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 49.2 p90 -141.49 150.21 41.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.49 0.186 . . . . 71.340000000000003 110.953 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.19 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.063 -0.517 . . . . 72.430000000000007 110.292 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.28 148.44 17.05 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 116.323 -0.399 . . . . 64.230000000000004 112.484 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.54 143.25 17.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.881 -0.414 . . . . 71.310000000000002 109.881 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.91 140.21 27.66 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 75.120000000000005 110.401 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.82 -13.3 21.72 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.721 2.281 . . . . 74.209999999999994 111.432 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.57 -25.71 39.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.044 -0.98 . . . . 72.299999999999997 110.883 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.31 23.73 12.31 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.278 -0.729 . . . . 52.539999999999999 111.278 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -149.16 147.12 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.933 -0.395 . . . . 64.140000000000001 109.933 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.05 136.62 53.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.128 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -65.25 -54.28 31.66 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.326 -0.397 . . . . 73.530000000000001 110.002 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.23 160.65 43.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.621 -0.718 . . . . 72.129999999999995 109.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 64' ' ' ARG . 39.5 m -117.41 121.57 41.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.379 -0.373 . . . . 73.409999999999997 110.457 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.6 m -70.35 -29.25 65.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 61.149999999999999 109.88 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.527 HH12 ' HD2' ' A' ' 95' ' ' LYS . 8.8 ptm180 -59.85 -31.03 69.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 74.420000000000002 111.336 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.2 m -57.05 -30.25 64.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.451 -0.34 . . . . 52.329999999999998 110.655 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.652 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 5.4 mmp_? -81.09 -10.55 59.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.158 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.31 48.66 84.16 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 112.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 20.5 tptm -112.61 115.23 49.31 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 122.826 -0.22 . . . . 75.340000000000003 110.481 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 4.1 Cg_exo -81.26 167.62 17.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.15 2.566 . . . . 73.209999999999994 111.928 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 97.1 m-85 -136.2 158.97 43.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 71.230000000000004 110.087 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 97.6 mt-30 -143.57 135.87 26.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.874 -0.417 . . . . 75.030000000000001 109.874 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HE1' HG11 ' A' ' 48' ' ' VAL . 11.6 p90 -150.54 160.42 43.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 121.057 -0.257 . . . . 73.400000000000006 110.623 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.508 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 15.2 m -85.42 104.66 15.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 75.200000000000003 110.271 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 88' ' ' ALA . 51.0 tp -55.89 137.09 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 75.129999999999995 111.046 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.02 -30.45 5.48 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.091 -0.576 . . . . 51.530000000000001 112.626 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.05 178.27 7.65 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.279 . . . . 74.430000000000007 111.095 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.48 53.9 4.78 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.883 -0.487 . . . . 54.409999999999997 111.883 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 73' ' ' THR . 5.7 mm-40 -90.71 -44.93 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.043 0.449 . . . . 75.439999999999998 110.552 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.5 m -136.82 177.89 5.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.678 -0.692 . . . . 32.009999999999998 110.089 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 104' ' ' LEU . 18.0 pt -68.19 140.97 18.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 109.95 -0.389 . . . . 75.420000000000002 109.95 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 61.6 mmtt -63.71 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.617 0.599 . . . . 73.310000000000002 112.617 -173.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -56.98 22.26 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.43 -0.89 . . . . 34.43 111.017 171.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -69.15 -40.17 78.36 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.271 -0.27 . . . . 71.340000000000003 110.271 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.631 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 12.4 t70 -51.75 -55.19 21.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.746 -0.661 . . . . 72.430000000000007 110.528 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.99 -42.17 70.0 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.077 -0.51 . . . . 73.310000000000002 110.685 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.31 -49.97 48.79 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.045 -0.598 . . . . 70.400000000000006 112.073 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.7 p -75.93 -31.93 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.692 0.282 . . . . 62.310000000000002 110.942 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -59.74 -35.29 74.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.692 0.282 . . . . 72.340000000000003 111.735 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 t -87.73 6.56 34.37 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.269 0.47 . . . . 72.319999999999993 112.269 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 13.8 ptp -112.01 177.89 4.5 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.046 -0.408 . . . . 71.329999999999998 110.552 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.523 HG21 ' HA2' ' A' ' 36' ' ' GLY . 42.5 p -121.1 178.82 4.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.852 0.358 . . . . 75.530000000000001 111.708 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -61.99 129.97 43.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.703 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.69 17.25 77.8 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.781 -0.645 . . . . 72.25 112.457 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 32' ' ' THR . 14.6 tt0 -106.98 136.35 46.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 71.340000000000003 110.313 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HD2' HH12 ' A' ' 64' ' ' ARG . 28.3 ttpp -131.7 126.76 35.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.988 -0.551 . . . . 74.540000000000006 110.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.87 142.12 50.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 55.240000000000002 110.892 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 tt -90.79 117.23 29.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.395 -0.965 . . . . 62.350000000000001 108.395 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.37 122.44 38.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.5 . . . . 65.010000000000005 109.649 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 54.1 m -81.89 106.51 13.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.66 -0.496 . . . . 71.140000000000001 109.66 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 105' ' ' ALA . 27.0 mm -85.64 112.3 43.64 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 115.978 -0.555 . . . . 60.109999999999999 110.236 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.628 ' HA ' HG23 ' A' ' 120' ' ' THR . 38.2 Cg_endo -66.4 159.33 50.81 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.205 1.937 . . . . 51.240000000000002 111.075 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 38.4 p90 -54.41 -31.5 55.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 111.348 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.47 -30.04 70.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.515 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 80' ' ' ILE . 88.0 mt -105.38 13.13 30.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.327 -0.397 . . . . 72.140000000000001 111.544 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -147.15 176.17 10.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.075 0.464 . . . . 75.530000000000001 111.435 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -68.47 -14.98 63.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.559 -0.746 . . . . 72.409999999999997 110.617 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.91 -16.42 47.02 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.926 -0.579 . . . . 75.140000000000001 113.045 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 35.0 tt0 -56.2 -55.23 35.66 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.074 0.464 . . . . 70.209999999999994 110.327 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -98.81 -35.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.831 . . . . 72.200000000000003 110.52 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.67 161.98 10.99 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.805 -0.634 . . . . 74.310000000000002 112.399 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.716 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.7 m-85 -135.39 -57.18 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 122.23 0.212 . . . . 75.400000000000006 110.486 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 68.7 Cg_endo -91.25 142.41 2.99 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.003 1.802 . . . . 74.049999999999997 111.854 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 50.1 Cg_exo -55.05 -18.69 17.88 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.771 2.314 . . . . 75.519999999999996 112.737 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.61 -36.88 77.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.017 -0.538 . . . . 74.310000000000002 110.201 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.4 mm -110.16 99.11 38.3 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 109.304 -0.628 . . . . 64.329999999999998 109.304 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 159.79 51.96 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.626 2.217 . . . . 73.409999999999997 112.513 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.71 147.25 89.75 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.233 1.955 . . . . 61.409999999999997 111.665 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 7.0 mtmp? 69.69 22.85 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.069 0.548 . . . . 73.319999999999993 110.629 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.56 131.62 35.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.114 0.483 . . . . 74.120000000000005 111.31 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.628 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -97.98 127.99 44.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.182 -0.673 . . . . 71.230000000000004 109.182 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -129.44 143.6 50.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.789 -0.448 . . . . 73.030000000000001 109.789 -171.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.57 ' N ' HD13 ' A' ' 121' ' ' LEU . 46.9 t -98.3 131.82 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.117 -0.327 . . . . 74.230000000000004 110.117 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.55 132.17 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.656 0.265 . . . . 52.100000000000001 111.153 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 30.9 mt-10 -82.44 112.29 19.24 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.12 -0.696 . . . . 64.310000000000002 109.12 170.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.491 HG23 ' HE1' ' A' ' 90' ' ' MET . 11.1 m -97.06 135.45 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.097 -0.705 . . . . 41.0 109.097 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 95' ' ' LYS . 45.2 tt0 -141.3 121.46 13.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.319 -0.401 . . . . 75.209999999999994 110.427 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -93.54 113.95 26.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.613 -0.884 . . . . 72.310000000000002 108.613 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.9 mm? -87.78 -50.72 6.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.804 0.335 . . . . 73.209999999999994 110.125 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.22 -173.41 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 55.219999999999999 110.094 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.768 -0.634 . . . . 71.349999999999994 109.532 173.562 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 . . . . . 0 C--O 1.232 0.141 0 N-CA-C 108.649 -0.871 . . . . 62.340000000000003 108.649 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 55.0 tp -145.83 102.8 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.418 0.525 . . . . 71.530000000000001 112.418 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -111.93 132.43 54.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.067 -0.716 . . . . 65.329999999999998 109.067 165.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -129.95 101.27 5.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.508 -0.923 . . . . 71.0 108.508 176.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -123.03 113.74 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 73.319999999999993 110.736 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 6.5 p -64.38 114.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 70.430000000000007 110.863 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.18 -49.75 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.445 -0.576 . . . . 73.129999999999995 109.445 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -112.4 113.54 51.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.369 -0.832 . . . . 74.030000000000001 109.423 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.79 140.86 52.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.634 2.223 . . . . 71.120000000000005 112.438 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -98.53 -169.38 31.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.39 -0.433 . . . . 71.120000000000005 112.66 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.42 -46.07 67.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.781 0.324 . . . . 72.409999999999997 110.434 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 95.2 -20.74 47.85 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.093 -0.503 . . . . 51.130000000000003 113.931 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -103.24 -0.86 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 117.687 0.743 . . . . 73.239999999999995 112.634 -172.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.3 p -85.07 142.18 29.73 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.713 0.292 . . . . 54.219999999999999 110.568 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -113.43 119.57 41.6 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.387 -0.369 . . . . 63.140000000000001 110.025 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 14.4 Cg_exo -69.56 143.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.18 . . . . 71.040000000000006 111.582 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.54 141.82 23.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.826 0.346 . . . . 75.109999999999999 110.52 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.752 -0.658 . . . . 74.420000000000002 111.71 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.98 19.56 57.37 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.628 -0.715 . . . . 65.140000000000001 113.058 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.47 161.73 36.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.077 0.439 . . . . 74.430000000000007 110.813 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.6 tppp? -81.63 117.12 21.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.836 -0.62 . . . . 61.229999999999997 109.636 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG11 HD22 ' A' ' 74' ' ' LEU . 27.5 m -110.35 151.38 12.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 120.901 0.382 . . . . 64.049999999999997 110.539 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -117.01 108.18 15.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.562 -0.745 . . . . 54.210000000000001 110.169 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.01 178.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.589 -0.732 . . . . 41.030000000000001 110.494 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 63.7 t60 -149.24 146.48 27.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.09 -0.707 . . . . 71.409999999999997 109.09 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -126.59 152.53 46.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.701 -0.481 . . . . 71.340000000000003 109.701 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.744 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 35.7 m-20 -135.6 112.74 10.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.498 -0.927 . . . . 72.430000000000007 108.498 172.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.95 111.13 3.33 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.936 -0.575 . . . . 64.230000000000004 112.609 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 53' ' ' ARG . 22.3 ttt180 -122.38 137.49 54.84 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.32 0.581 . . . . 71.310000000000002 111.019 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -89.23 151.91 47.17 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 109.886 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.64 -17.63 36.27 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.177 2.585 . . . . 74.209999999999994 114.006 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.94 -14.74 53.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.853 0.359 . . . . 72.299999999999997 110.606 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.36 -1.02 37.35 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.219 -0.515 . . . . 52.539999999999999 112.425 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -94.43 157.23 16.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.544 -0.539 . . . . 64.140000000000001 109.544 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.73 -0.471 . . . . 72.329999999999998 109.73 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.23 -46.97 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.530000000000001 111.324 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.01 131.28 45.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.355 -0.384 . . . . 72.129999999999995 110.959 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 m -104.92 85.63 2.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 73.409999999999997 109.375 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -56.95 -28.86 62.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.059 -0.518 . . . . 61.149999999999999 110.835 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -53.91 -31.76 51.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.749 -0.66 . . . . 74.420000000000002 111.311 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -59.1 -37.32 76.88 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.886 0.374 . . . . 52.329999999999998 110.728 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -80.29 -11.54 59.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.992 -0.549 . . . . 75.439999999999998 110.564 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.41 18.99 59.42 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.132 -0.485 . . . . 63.329999999999998 112.106 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -82.14 119.13 74.34 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 122.363 0.265 . . . . 75.340000000000003 110.375 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.55 162.5 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.046 2.497 . . . . 73.209999999999994 112.352 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -122.69 117.0 24.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.37 -0.604 . . . . 71.230000000000004 109.37 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.59 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 92.2 mt-30 -107.06 140.96 39.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.573 -0.285 . . . . 75.030000000000001 110.468 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -156.89 167.6 29.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.479 -0.328 . . . . 73.400000000000006 110.23 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 m -82.07 108.93 15.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 110.294 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.436 HD22 HG11 ' A' ' 46' ' ' VAL . 45.1 tp -62.1 111.03 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.702 -0.481 . . . . 75.129999999999995 109.702 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.14 -24.56 5.64 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.214 -0.755 . . . . 51.530000000000001 111.214 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.63 145.2 47.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.4 -0.222 . . . . 74.430000000000007 110.4 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.41 43.61 2.33 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.429 -0.35 . . . . 54.409999999999997 113.064 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -82.54 -47.61 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 75.439999999999998 110.198 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.06 162.56 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.75 . . . . 32.009999999999998 110.949 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.447 HG12 ' CE3' ' A' ' 83' ' ' TRP . 35.4 pt -80.07 159.02 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.573 -0.528 . . . . 75.420000000000002 109.573 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 55.4 mmtt -60.41 -21.14 61.88 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.418 0.155 . . . . 73.310000000000002 111.418 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -47.97 88.19 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.599 -0.81 . . . . 34.43 111.574 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CE3' HG12 ' A' ' 80' ' ' ILE . 18.1 m0 -79.76 -29.28 40.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.589 0.233 . . . . 71.340000000000003 110.401 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 6.6 t70 -58.0 -55.05 39.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.616 0.722 . . . . 72.430000000000007 109.792 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -67.68 -35.86 79.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.496 -0.774 . . . . 73.310000000000002 109.861 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.9 -49.35 58.99 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.766 -0.652 . . . . 70.400000000000006 112.434 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 12.2 p -75.24 -32.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 62.310000000000002 110.274 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -30.08 71.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.33 -0.396 . . . . 72.340000000000003 112.015 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -90.4 -14.86 32.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.116 0.413 . . . . 72.319999999999993 112.116 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.888 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.8 ptp -93.92 -179.77 5.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.691 0.281 . . . . 71.329999999999998 110.879 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.424 HG21 ' HA2' ' A' ' 36' ' ' GLY . 16.7 p -138.83 178.95 6.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.197 -0.456 . . . . 75.530000000000001 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -58.81 124.5 20.01 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.886 0.474 . . . . 74.120000000000005 110.694 -176.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.68 37.63 57.57 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.398 176.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.629 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.9 tt0 -124.2 126.62 46.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 71.340000000000003 110.975 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 24.5 ttmm -114.9 115.06 26.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.803 -0.635 . . . . 74.540000000000006 109.549 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -113.52 145.42 41.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 110.638 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 28' ' ' LYS . 9.4 tt -90.63 105.4 17.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.04 -1.096 . . . . 62.350000000000001 108.04 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -112.13 126.39 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.337 -0.392 . . . . 65.010000000000005 110.423 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 26' ' ' LEU . 7.9 m -85.12 118.16 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.446 -0.343 . . . . 71.140000000000001 110.639 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.8 mm -99.05 108.57 50.19 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 110.387 -0.227 . . . . 60.109999999999999 110.387 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.99 140.94 39.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.097 2.531 . . . . 51.240000000000002 111.275 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.97 -29.56 57.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.454 -0.339 . . . . 74.230000000000004 111.836 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.2 -30.07 70.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.514 . . . . 73.140000000000001 111.644 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.88 9.06 43.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 72.140000000000001 111.777 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.26 178.95 8.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.145 0.498 . . . . 75.530000000000001 111.658 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -73.61 -2.47 23.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.495 -0.775 . . . . 72.409999999999997 111.332 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.31 -14.25 56.35 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.189 -0.459 . . . . 75.140000000000001 112.085 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 8.4 tm-20 -66.77 -49.42 65.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.413 -0.588 . . . . 70.209999999999994 109.413 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 117' ' ' PRO . 40.4 ttm180 -67.86 -52.08 40.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 72.200000000000003 110.695 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.61 172.29 3.84 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.101 -0.571 . . . . 74.310000000000002 111.952 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 88.5 m-85 -147.17 -63.64 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.782 0.291 . . . . 75.400000000000006 111.298 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 2.3 Cg_endo -84.23 141.36 9.14 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.213 1.942 . . . . 74.049999999999997 111.988 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.63 -21.93 57.89 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.692 2.261 . . . . 75.519999999999996 111.747 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.77 -35.34 63.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.772 -0.649 . . . . 74.310000000000002 110.115 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.02 92.95 46.66 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 64.329999999999998 109.218 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -52.02 147.24 27.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.038 2.492 . . . . 73.409999999999997 112.673 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 21.1 Cg_endo -59.83 153.43 56.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.727 2.285 . . . . 61.409999999999997 111.435 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 19.4 mtmm 59.1 53.11 5.69 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.393 0.616 . . . . 73.319999999999993 110.431 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.53 132.38 54.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.325 -0.852 . . . . 74.120000000000005 111.123 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.6 m -83.05 130.48 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.38 -0.6 . . . . 71.230000000000004 109.38 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -123.06 143.39 49.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.672 -0.492 . . . . 73.030000000000001 109.672 -173.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.576 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.2 t -100.53 116.13 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 74.230000000000004 109.832 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -109.06 116.58 32.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.096 -0.335 . . . . 52.100000000000001 110.096 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.8 mt-10 -78.58 106.86 10.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.181 -1.044 . . . . 64.310000000000002 108.181 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 13.4 m -97.59 149.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.047 -0.979 . . . . 41.0 110.112 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 63.8 tt0 -147.22 131.6 17.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.76 -0.2 . . . . 75.209999999999994 110.795 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.888 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 3.2 tm? -103.08 112.97 26.07 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.865 -0.42 . . . . 72.310000000000002 109.865 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -90.86 -41.48 11.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 110.324 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.43 139.1 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 55.219999999999999 109.932 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 119.37 -0.348 . . . . 71.349999999999994 110.401 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 62.340000000000003 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 5.9 tt -145.7 102.39 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.509 -0.552 . . . . 71.530000000000001 109.509 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.73 149.82 42.71 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.981 -0.554 . . . . 65.329999999999998 110.185 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 18.4 ptpt -127.98 103.7 7.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.637 -0.71 . . . . 71.0 109.448 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.64 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 66.8 mttm -109.1 110.39 21.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.825 -0.435 . . . . 73.319999999999993 109.825 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 30' ' ' VAL . 5.8 p -71.87 97.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.486 0.66 . . . . 70.430000000000007 110.134 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.721 HD23 ' HD3' ' A' ' 95' ' ' LYS . 33.9 tp -76.94 -29.2 55.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 109.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 32.1 m -145.51 115.82 4.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 74.030000000000001 109.74 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.3 128.74 13.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.065 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.69 -159.81 22.05 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.177 -0.535 . . . . 71.120000000000005 112.44 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.46 -37.44 87.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.088 0.471 . . . . 72.409999999999997 110.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.21 -29.84 3.81 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.952 -0.567 . . . . 51.130000000000003 112.134 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.26 -34.12 7.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.737 0.303 . . . . 73.239999999999995 110.711 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 p -71.77 94.07 1.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.295 0.569 . . . . 54.219999999999999 110.983 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -88.06 125.91 62.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.494 -0.775 . . . . 63.140000000000001 110.452 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG3' ' O ' ' A' ' 90' ' ' MET . 86.3 Cg_endo -78.07 176.4 10.02 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.62 2.213 . . . . 71.040000000000006 111.547 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.97 167.25 14.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 109.905 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 156.24 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.345 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.71 73.64 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.15 -0.548 . . . . 65.140000000000001 112.562 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 4.3 mmmp? -116.19 130.02 56.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.683 0.278 . . . . 74.430000000000007 110.738 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.83 104.01 3.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.68 -0.859 . . . . 61.229999999999997 108.68 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 34.1 m -105.86 142.54 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.157 0.503 . . . . 64.049999999999997 110.951 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.8 m -99.27 120.32 39.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.112 -0.949 . . . . 54.210000000000001 109.27 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 87' ' ' VAL . 32.6 m -136.68 177.97 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.569 0.699 . . . . 41.030000000000001 112.454 -172.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 7.3 m170 -137.59 152.62 49.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.504 -1.226 . . . . 71.409999999999997 109.098 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -128.0 142.85 51.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 71.340000000000003 109.534 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.782 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 24.0 m-20 -135.4 119.73 17.87 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.017 -0.734 . . . . 72.430000000000007 109.017 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -82.68 114.32 3.82 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.214 -0.448 . . . . 64.230000000000004 112.295 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.522 HH11 HD12 ' A' ' 97' ' ' LEU . 42.1 ttm180 -130.8 148.5 52.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.428 0.633 . . . . 71.310000000000002 111.364 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -90.12 156.37 46.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.224 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.38 2.3 1.26 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.946 2.43 . . . . 74.209999999999994 112.861 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.76 -29.9 25.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.236 0.541 . . . . 72.299999999999997 110.517 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.85 -25.47 8.43 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.706 -0.679 . . . . 52.539999999999999 111.882 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -84.61 157.32 21.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.825 -0.435 . . . . 64.140000000000001 109.825 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 13.9 pt20 -141.84 -175.28 4.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.715 0.293 . . . . 72.329999999999998 110.905 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -86.06 -64.86 1.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 73.530000000000001 110.108 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -144.91 156.66 44.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.009 -0.367 . . . . 72.129999999999995 110.009 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.3 p -87.26 91.53 8.75 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.359 -0.608 . . . . 73.409999999999997 109.359 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.425 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 31.4 m -64.33 -27.39 68.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.829 -0.623 . . . . 61.149999999999999 111.155 -174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.24 69.4 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.434 -0.348 . . . . 74.420000000000002 110.424 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -73.8 -6.23 45.75 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.001 -0.545 . . . . 52.329999999999998 111.593 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 25.3 mmm180 -75.69 -2.82 31.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.084 0.468 . . . . 75.439999999999998 110.759 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.25 8.57 65.88 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 63.329999999999998 113.953 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HD2' ' HD2' ' A' ' 69' ' ' PRO . 52.5 tptt -122.89 121.58 27.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 117.051 0.426 . . . . 75.340000000000003 109.971 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.598 ' HD2' ' HD2' ' A' ' 68' ' ' LYS . 68.1 Cg_endo -85.27 160.06 11.27 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.658 2.239 . . . . 73.209999999999994 112.276 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -114.33 158.14 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.127 -0.694 . . . . 71.230000000000004 109.127 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 85.7 mt-30 -134.77 139.48 45.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.574 0.226 . . . . 75.030000000000001 110.825 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.536 ' HE1' HG21 ' A' ' 48' ' ' VAL . 33.5 p90 -156.16 151.88 27.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.508 -0.553 . . . . 73.400000000000006 109.508 173.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.5 m -73.66 109.03 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 75.200000000000003 110.905 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 88' ' ' ALA . 57.2 tp -60.8 135.31 57.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.057 -0.519 . . . . 75.129999999999995 110.209 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.83 -11.52 71.91 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.119 -0.562 . . . . 51.530000000000001 112.135 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.13 160.95 14.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.202 -0.296 . . . . 74.430000000000007 110.202 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.65 2.62 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 121.2 -0.524 . . . . 54.409999999999997 112.756 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -85.75 -25.46 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 75.439999999999998 110.304 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.48 168.21 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.76 -0.655 . . . . 32.009999999999998 109.722 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.4 pt -72.91 154.7 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.997 -0.372 . . . . 75.420000000000002 109.997 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 4.5 tmtm? -60.09 -28.42 67.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.475 -0.33 . . . . 73.310000000000002 110.756 -172.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.88 -54.55 36.55 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.923 -0.656 . . . . 34.43 112.003 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.452 ' O ' HG12 ' A' ' 87' ' ' VAL . 48.2 m0 -66.48 -41.25 89.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.025 -0.361 . . . . 71.340000000000003 110.025 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.11 -50.95 60.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.474 -0.785 . . . . 72.430000000000007 110.886 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -66.54 -46.34 76.46 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.347 -0.388 . . . . 73.310000000000002 110.307 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.38 -48.39 54.48 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.606 -0.724 . . . . 70.400000000000006 112.834 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 48' ' ' VAL . 12.3 p -75.55 -33.2 26.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 62.310000000000002 111.139 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -68.23 -25.95 65.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.706 0.261 . . . . 72.340000000000003 111.706 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 86' ' ' GLY . 11.7 t -89.54 17.58 6.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 72.319999999999993 112.89 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 12.3 ptp -125.37 178.15 5.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.901 -0.499 . . . . 71.329999999999998 111.412 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -116.65 177.31 4.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.294 -0.412 . . . . 75.530000000000001 110.477 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.833 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -69.45 129.71 40.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.091 -0.337 . . . . 74.120000000000005 110.091 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.419 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 88.82 6.11 73.04 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.326 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' THR . 19.6 tt0 -100.18 133.76 44.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.340000000000003 111.022 -175.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.721 ' HD3' HD23 ' A' ' 31' ' ' LEU . 50.0 tttm -117.67 117.52 29.58 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -122.65 137.72 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.216 0.531 . . . . 55.240000000000002 111.275 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 7.8 tt -90.78 106.29 18.41 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.972 -1.121 . . . . 62.350000000000001 107.972 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -115.25 124.82 52.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.113 -0.329 . . . . 65.010000000000005 110.113 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.516 HG23 HG22 ' A' ' 122' ' ' VAL . 4.3 m -80.36 111.75 17.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 71.140000000000001 110.546 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 105' ' ' ALA . 32.6 mm -93.58 113.22 59.71 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.618 -0.264 . . . . 60.109999999999999 110.449 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HA ' HG23 ' A' ' 120' ' ' THR . 43.8 Cg_endo -67.31 151.63 80.41 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.758 2.305 . . . . 51.240000000000002 111.783 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -55.99 -31.79 63.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 111.972 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.559 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 4.1 pt20 -65.52 -27.62 68.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.409 . . . . 73.140000000000001 110.954 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.559 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 91.9 mt -109.07 22.86 15.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 72.140000000000001 110.096 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 100' ' ' ILE . . . -149.18 176.61 10.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.887 -0.597 . . . . 75.530000000000001 111.406 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -76.65 -11.77 59.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.409999999999997 110.282 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.69 31.32 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.835 -0.62 . . . . 75.140000000000001 113.377 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.57 -49.32 76.77 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.408 -0.59 . . . . 70.209999999999994 109.408 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -91.92 -26.22 18.54 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.548 -0.751 . . . . 72.200000000000003 110.55 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 82.0 -66.25 3.9 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.745 -0.662 . . . . 74.310000000000002 111.584 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 50.5 m-85 94.56 -74.36 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.324 1.45 . . . . 75.400000000000006 111.567 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 110' ' ' GLY . 95.4 Cg_endo -81.15 139.2 11.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 CA-C-N 121.332 1.512 . . . . 74.049999999999997 110.84 174.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.11 -11.36 15.43 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.79 2.327 . . . . 75.519999999999996 112.457 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.72 -31.79 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.138 0.494 . . . . 74.310000000000002 110.026 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.9 mm -100.76 120.71 54.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.687 -0.688 . . . . 64.329999999999998 109.711 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 58.3 Cg_endo -70.97 151.09 61.89 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.354 2.036 . . . . 73.409999999999997 112.173 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 39.0 Cg_endo -66.43 141.0 59.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.294 1.996 . . . . 61.409999999999997 111.739 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 8.6 mtmp? 71.49 26.51 3.21 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.006 -0.543 . . . . 73.319999999999993 111.126 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -84.77 142.53 29.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 74.120000000000005 111.365 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 101' ' ' PRO . 91.7 m -95.21 137.34 34.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.695 -0.684 . . . . 71.230000000000004 109.419 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -128.57 139.98 52.02 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.78 -0.452 . . . . 73.030000000000001 109.78 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 121' ' ' LEU . 99.3 t -98.54 122.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.715 0.293 . . . . 74.230000000000004 110.32 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -113.6 120.09 39.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.836 0.35 . . . . 52.100000000000001 110.194 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 22.2 mt-10 -81.49 110.99 17.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.641 -0.874 . . . . 64.310000000000002 108.641 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.547 HG23 ' HE1' ' A' ' 90' ' ' MET . 4.0 m -99.84 139.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.739 -0.664 . . . . 41.0 109.483 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.4 tt0 -131.79 119.02 20.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.506 -0.316 . . . . 75.209999999999994 110.31 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.833 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -87.76 113.78 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 72.310000000000002 109.688 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.402 HD21 ' ND1' ' A' ' 49' ' ' HIS . 3.7 mm? -91.73 -43.09 9.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.364 -0.38 . . . . 73.209999999999994 110.693 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.47 142.13 24.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.542 -0.299 . . . . 55.219999999999999 110.886 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.602 -0.713 . . . . 71.349999999999994 110.411 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.597 0.237 . . . . 62.340000000000003 110.506 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.0 tp -106.23 101.84 11.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.974 -0.75 . . . . 71.530000000000001 108.974 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -147.67 106.11 3.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.802 -0.636 . . . . 65.329999999999998 110.388 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -136.97 144.91 43.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.932 0.396 . . . . 71.0 110.065 175.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -140.3 113.17 8.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 73.319999999999993 109.543 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.67 128.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.783 0.325 . . . . 70.430000000000007 110.661 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 97' ' ' LEU . 2.7 mm? -91.99 -42.78 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.268 0.556 . . . . 73.129999999999995 109.751 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 110.9 6.92 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.683 -0.689 . . . . 74.030000000000001 110.565 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.62 137.96 44.02 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.583 2.189 . . . . 71.120000000000005 111.698 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.26 -143.68 10.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.082 -0.58 . . . . 71.120000000000005 112.43 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.8 -37.42 81.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 72.409999999999997 110.535 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.84 -30.51 1.29 Allowed Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.704 -0.68 . . . . 51.130000000000003 113.751 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.85 -9.86 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 73.239999999999995 111.015 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -87.25 115.84 24.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.824 -0.626 . . . . 54.219999999999999 110.791 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 9.1 mtpm? -92.43 114.44 62.37 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 110.317 -0.253 . . . . 63.140000000000001 110.317 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.21 108.18 1.92 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.754 2.303 . . . . 71.040000000000006 112.183 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.26 120.96 34.13 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.036 -0.529 . . . . 75.109999999999999 109.692 173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.36 154.18 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 74.420000000000002 111.021 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.37 -28.08 8.93 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.043 -0.526 . . . . 65.140000000000001 112.023 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -86.04 159.21 19.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.159 0.504 . . . . 74.430000000000007 111.264 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -77.89 112.24 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.479 -0.782 . . . . 61.229999999999997 109.101 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.46 152.52 8.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.059 0.456 . . . . 64.049999999999997 111.384 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.2 m -106.5 110.83 23.16 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.072 -0.967 . . . . 54.210000000000001 110.014 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.437 HG21 ' HE1' ' A' ' 72' ' ' PHE . 25.7 m -119.3 178.28 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.336 -0.847 . . . . 41.030000000000001 111.181 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 22.8 t-80 -157.09 142.47 17.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.732 -0.84 . . . . 71.409999999999997 108.732 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.2 m-85 -126.95 153.18 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 71.340000000000003 110.165 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 16.8 t70 -136.67 109.49 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.539 -0.541 . . . . 72.430000000000007 109.539 174.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.8 147.27 32.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.356 -0.45 . . . . 64.230000000000004 113.587 -172.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 121' ' ' LEU . 25.8 ttm180 -162.14 144.56 11.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.315 0.578 . . . . 71.310000000000002 111.131 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.29 147.74 54.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 109.834 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.77 -17.92 61.73 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.373 2.049 . . . . 74.209999999999994 111.533 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.9 -25.74 62.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.566 -0.743 . . . . 72.299999999999997 110.461 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.58 -39.94 1.89 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.959 -0.564 . . . . 52.539999999999999 111.861 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -56.71 148.44 20.24 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.975 0.51 . . . . 64.140000000000001 111.493 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.41 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 19.8 pt20 -130.66 141.53 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.245 -0.65 . . . . 72.329999999999998 109.245 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -80.12 -38.42 31.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.812 0.301 . . . . 73.530000000000001 111.812 -173.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -152.92 133.64 13.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.318 -0.253 . . . . 72.129999999999995 110.318 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 t -81.07 91.14 6.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 73.409999999999997 109.436 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.9 m -67.6 -17.1 64.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.676 -0.693 . . . . 61.149999999999999 110.861 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -31.31 62.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.004 -0.544 . . . . 74.420000000000002 110.984 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 t -63.84 -46.22 86.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.769 0.318 . . . . 52.329999999999998 110.616 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 66' ' ' ARG . 5.8 ptt180 -75.87 -12.41 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.533 -0.303 . . . . 75.439999999999998 111.411 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.6 36.53 48.27 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.125 -0.488 . . . . 63.329999999999998 113.823 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.1 tppt? -92.21 113.43 59.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.163 -0.31 . . . . 75.340000000000003 110.163 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.4 Cg_endo -81.91 150.66 16.24 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.245 2.63 . . . . 73.209999999999994 111.894 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -114.28 160.61 18.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.92 -0.77 . . . . 71.230000000000004 108.92 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -140.62 146.85 38.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.093 -0.336 . . . . 75.030000000000001 110.093 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HE1' HG21 ' A' ' 48' ' ' VAL . 39.8 p90 -166.98 161.59 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 73.400000000000006 110.289 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 m -74.92 112.78 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.514 -0.312 . . . . 75.200000000000003 110.206 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 88' ' ' ALA . 47.2 tp -67.81 136.5 54.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.574 -0.285 . . . . 75.129999999999995 110.78 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 40.1 32.66 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.303 -0.475 . . . . 51.530000000000001 111.931 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.68 178.34 8.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.39 0.276 . . . . 74.430000000000007 110.31 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.34 46.19 3.59 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.036 -0.602 . . . . 54.409999999999997 112.173 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 9.3 mm-40 -85.04 -47.8 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 75.439999999999998 111.051 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.85 178.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.674 . . . . 32.009999999999998 109.67 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.97 142.92 15.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.172 0.511 . . . . 75.420000000000002 111.035 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -58.14 -30.61 66.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 73.310000000000002 111.862 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.02 -51.04 59.74 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.884 -0.674 . . . . 34.43 111.616 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -69.14 -47.67 64.45 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.792 -0.204 . . . . 71.340000000000003 110.636 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.27 -54.92 33.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.033 0.444 . . . . 72.430000000000007 111.149 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -72.07 -38.3 69.47 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.1 -0.5 . . . . 73.310000000000002 110.501 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.536 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.42 -50.11 57.94 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.935 -0.575 . . . . 70.400000000000006 112.215 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.641 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.1 p -75.72 -31.12 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 62.310000000000002 110.977 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -62.43 -33.49 74.91 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.741 0.305 . . . . 72.340000000000003 111.746 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 86' ' ' GLY . 11.0 t -79.5 7.41 8.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.461 0.541 . . . . 72.319999999999993 112.461 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 7.7 ptm -116.32 -176.51 2.97 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.196 -0.315 . . . . 71.329999999999998 110.456 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.9 p -118.21 178.81 4.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.775 0.321 . . . . 75.530000000000001 111.637 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.847 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.3 tt -68.69 135.16 50.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.863 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.433 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 71.96 23.68 77.64 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.633 -0.712 . . . . 72.25 112.299 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -112.46 148.54 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.859 0.361 . . . . 71.340000000000003 111.271 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -130.09 124.68 33.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.638 -0.71 . . . . 74.540000000000006 110.323 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.21 141.29 39.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 55.240000000000002 110.414 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.579 ' HB2' HD21 ' A' ' 31' ' ' LEU . 9.1 tt -92.19 123.95 35.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.119 -0.697 . . . . 62.350000000000001 109.119 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -130.21 134.51 47.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.918 0.389 . . . . 65.010000000000005 110.656 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 51.8 m -83.51 112.68 20.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.004 -0.544 . . . . 71.140000000000001 109.923 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.2 mm -84.84 110.93 31.6 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 116.382 -0.372 . . . . 60.109999999999999 110.607 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 120' ' ' THR . 24.4 Cg_exo -64.22 142.91 81.98 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.117 2.545 . . . . 51.240000000000002 111.565 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.596 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 51.3 p90 -54.39 -39.36 67.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.799 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -70.2 -13.78 62.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.376 -0.375 . . . . 73.140000000000001 111.829 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.93 16.55 24.16 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.997 0.427 . . . . 72.140000000000001 110.153 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.05 178.65 9.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.654 -0.703 . . . . 75.530000000000001 111.141 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -60.06 -25.09 65.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 72.409999999999997 110.705 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.73 -19.9 30.15 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.634 -0.712 . . . . 75.140000000000001 113.301 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.596 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 43.2 tt0 -56.16 -47.55 78.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 70.209999999999994 110.169 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -107.6 -15.33 14.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.4 -0.818 . . . . 72.200000000000003 110.907 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.75 -171.78 6.92 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 116.072 -0.513 . . . . 74.310000000000002 112.63 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.765 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 63.7 m-85 -147.53 -61.39 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.614 0.207 . . . . 75.400000000000006 110.677 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 50.9 Cg_endo -93.17 152.02 2.56 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.247 1.964 . . . . 74.049999999999997 112.037 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.63 -19.73 38.79 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.535 2.157 . . . . 75.519999999999996 111.765 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.98 -35.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.929 -0.578 . . . . 74.310000000000002 110.355 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.3 mm -121.25 80.75 36.72 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 108.538 -0.912 . . . . 64.329999999999998 108.538 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.22 169.32 22.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.88 2.387 . . . . 73.409999999999997 112.319 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 71.5 Cg_exo -50.14 148.98 12.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 61.409999999999997 112.228 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.3 mtmt 72.19 17.46 4.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.738 0.649 . . . . 73.319999999999993 111.312 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.06 104.42 8.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 111.43 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 101' ' ' PRO . 99.8 m -83.71 134.47 34.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.205 -0.665 . . . . 71.230000000000004 109.205 171.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -136.96 147.02 46.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.962 -0.385 . . . . 73.030000000000001 109.962 -170.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.542 ' N ' HD13 ' A' ' 121' ' ' LEU . 60.7 t -98.39 137.33 26.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 110.28 -175.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.44 129.38 31.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.54 -0.3 . . . . 52.100000000000001 110.411 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 59.3 mt-10 -75.15 118.57 18.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.756 -0.831 . . . . 64.310000000000002 108.756 167.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.59 136.8 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.834 -0.802 . . . . 41.0 108.834 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 47.8 tt0 -138.59 114.97 10.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.124 -0.489 . . . . 75.209999999999994 109.73 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.6 tm? -97.42 111.84 23.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.252 -0.648 . . . . 72.310000000000002 109.252 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.5 mm? -89.0 -41.26 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.47 -0.332 . . . . 73.209999999999994 110.647 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.77 145.87 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.572 -0.285 . . . . 55.219999999999999 111.038 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.25 1.105 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.059 178.563 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 110.043 -0.355 . . . . 62.340000000000003 110.043 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.88 121.65 35.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.172 -0.677 . . . . 71.530000000000001 109.172 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.724 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 40.3 mt-10 -129.71 108.17 9.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 65.329999999999998 110.344 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 21.1 pttp -109.41 101.53 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.353 -0.61 . . . . 71.0 109.353 173.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.724 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 87.0 mttt -118.91 110.4 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.318 . . . . 73.319999999999993 110.415 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.73 119.21 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.051 -0.351 . . . . 70.430000000000007 110.051 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD23 ' HD3' ' A' ' 95' ' ' LYS . 32.7 tp -94.86 -30.99 13.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.267 0.556 . . . . 73.129999999999995 109.977 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 57.3 m -147.14 110.85 4.03 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.494 -0.775 . . . . 74.030000000000001 109.44 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 22.5 Cg_exo -65.48 146.35 84.86 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.037 2.492 . . . . 71.120000000000005 112.64 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.36 -158.67 31.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 71.120000000000005 111.987 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 37' ' ' VAL . 25.0 m-20 -71.27 -56.78 5.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.283 0.563 . . . . 72.409999999999997 110.582 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 -30.23 3.78 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.403 -0.817 . . . . 51.130000000000003 111.889 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 35' ' ' ASP . 30.3 m -78.54 -32.33 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.166 0.508 . . . . 73.239999999999995 110.245 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.547 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 6.0 p -71.15 105.93 3.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.341 -0.614 . . . . 54.219999999999999 109.341 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -91.63 109.31 35.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.812 -0.631 . . . . 63.140000000000001 110.928 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 38' ' ' THR . 60.9 Cg_endo -95.85 174.06 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.508 2.805 . . . . 71.040000000000006 111.411 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.74 163.0 40.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 110.812 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.27 166.12 23.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.726 -0.67 . . . . 74.420000000000002 111.609 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.04 86.33 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.969 -0.56 . . . . 65.140000000000001 112.443 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -119.2 155.76 31.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.607 0.241 . . . . 74.430000000000007 110.476 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -81.01 113.41 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.322 -0.622 . . . . 61.229999999999997 109.322 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HB ' HD21 ' A' ' 127' ' ' LEU . 33.9 m -106.61 145.89 13.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.908 0.385 . . . . 64.049999999999997 111.423 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.5 m -98.86 108.47 21.16 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.175 -0.921 . . . . 54.210000000000001 110.117 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -115.44 178.5 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 124.355 1.034 . . . . 41.030000000000001 111.575 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 11.0 t-160 -152.98 136.55 15.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.989 -1.115 . . . . 71.409999999999997 107.989 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -126.85 151.7 48.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.807 0.299 . . . . 71.340000000000003 111.807 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.706 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 33.5 t70 -138.85 118.54 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.998 -0.547 . . . . 72.430000000000007 110.095 169.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.16 138.93 17.12 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.371 -0.442 . . . . 64.230000000000004 112.624 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.634 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 28.1 ttm180 -157.51 149.26 22.13 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.341 0.591 . . . . 71.310000000000002 111.751 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -87.58 153.83 53.21 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.713 -0.676 . . . . 75.120000000000005 109.332 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.64 -20.13 56.43 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.708 2.272 . . . . 74.209999999999994 113.412 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.58 3.54 52.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.558 0.218 . . . . 72.299999999999997 111.26 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.07 -31.73 8.31 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.336 -0.459 . . . . 52.539999999999999 112.143 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.45 145.5 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.908 -0.405 . . . . 64.140000000000001 109.908 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.634 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 20.2 pt20 -151.64 147.59 26.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.516 176.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -62.23 -38.4 89.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 73.530000000000001 111.307 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.4 156.56 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.265 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 22.9 t -87.41 86.79 7.27 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.706 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 14.7 m -60.07 -30.11 68.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 61.149999999999999 110.453 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.564 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 34.8 ptt180 -71.32 -44.46 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 74.420000000000002 110.972 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -4.47 34.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.622 0.248 . . . . 52.329999999999998 111.142 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 62' ' ' SER . 27.2 mmt180 -76.63 -12.71 60.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.575 -0.284 . . . . 75.439999999999998 110.869 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.08 77.4 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.959 -0.639 . . . . 63.329999999999998 112.282 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.74 104.39 55.31 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-O 120.562 0.22 . . . . 75.340000000000003 110.783 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.86 166.35 19.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.004 2.469 . . . . 73.209999999999994 110.985 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.74 131.92 21.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.792 -0.447 . . . . 71.230000000000004 109.792 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 97.4 mt-30 -113.15 131.95 55.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.558 0.218 . . . . 75.030000000000001 110.501 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.574 ' HZ ' HG11 ' A' ' 87' ' ' VAL . 24.5 p90 -154.37 161.13 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.462 -0.335 . . . . 73.400000000000006 110.484 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 m -77.32 115.95 17.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.447 . . . . 75.200000000000003 110.752 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 127.91 33.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.036 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.93 43.68 7.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.161 -0.542 . . . . 51.530000000000001 112.075 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.69 173.78 14.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.821 0.343 . . . . 74.430000000000007 111.018 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.61 27.64 3.28 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.157 -0.474 . . . . 54.409999999999997 112.678 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 5.6 mm-40 -65.01 -43.78 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.227 0.537 . . . . 75.439999999999998 110.279 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.71 178.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.505 -0.77 . . . . 32.009999999999998 110.195 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.482 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.1 pt -62.49 143.59 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 110.01 -0.367 . . . . 75.420000000000002 110.01 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -58.23 -23.97 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.463 -0.335 . . . . 73.310000000000002 110.823 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.73 -50.45 67.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.948 -0.644 . . . . 34.43 111.835 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.482 ' H ' HG13 ' A' ' 80' ' ' ILE . 53.2 m0 -69.05 -42.09 76.75 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.153 -0.314 . . . . 71.340000000000003 110.153 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -54.05 -49.94 67.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.721 -0.672 . . . . 72.430000000000007 110.64 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.42 -41.24 80.67 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 110.501 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.34 -48.65 53.7 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.425 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.574 HG11 ' HZ ' ' A' ' 72' ' ' PHE . 7.1 p -75.68 -36.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 62.310000000000002 110.993 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.36 70.47 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.945 0.35 . . . . 72.340000000000003 111.945 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.3 t -84.56 -20.39 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.116 0.413 . . . . 72.319999999999993 112.116 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 18.0 ptp -88.82 -174.47 4.52 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 71.329999999999998 111.35 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 p -119.42 178.78 4.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.679 -0.692 . . . . 75.530000000000001 110.285 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.859 ' HA ' HD12 ' A' ' 127' ' ' LEU . 9.2 tt -72.0 132.94 44.97 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.986 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.93 34.87 46.53 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.383 -0.826 . . . . 72.25 112.252 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -125.95 138.18 53.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.965 0.412 . . . . 71.340000000000003 111.627 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.589 ' HD3' HD23 ' A' ' 31' ' ' LEU . 19.2 ttmm -107.6 113.8 27.35 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.446 -0.797 . . . . 74.540000000000006 109.745 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.46 132.59 56.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.42 . . . . 55.240000000000002 110.656 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.53 108.4 19.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.873 -1.158 . . . . 62.350000000000001 107.873 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CD1' HD13 ' A' ' 100' ' ' ILE . 12.3 t80 -116.77 123.53 47.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.151 -0.477 . . . . 65.010000000000005 109.956 -174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.9 m -81.17 106.33 13.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.526 -0.546 . . . . 71.140000000000001 109.526 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.439 HD13 ' CD1' ' A' ' 98' ' ' PHE . 47.5 mm -78.25 115.08 48.11 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 115.815 -0.63 . . . . 60.109999999999999 110.777 -175.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' A' ' 104' ' ' LEU . 22.0 Cg_exo -64.94 141.3 70.21 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.876 2.384 . . . . 51.240000000000002 110.916 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -58.12 -25.65 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.708 0.633 . . . . 74.230000000000004 112.708 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -75.26 -13.68 60.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.794 0.33 . . . . 73.140000000000001 111.405 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.471 HD12 ' HD2' ' A' ' 101' ' ' PRO . 88.1 mt -102.05 16.94 24.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.776 0.322 . . . . 72.140000000000001 110.382 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -159.79 -174.47 4.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.85 -0.614 . . . . 75.530000000000001 110.516 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -76.0 -5.42 46.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 72.409999999999997 110.358 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.49 -21.98 58.32 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.783 -0.644 . . . . 75.140000000000001 113.407 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 7.4 pt-20 -62.23 -42.61 99.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.902 0.382 . . . . 70.209999999999994 110.782 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 12.5 ttm180 -92.29 -42.51 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 72.200000000000003 110.399 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.94 141.4 4.14 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.817 -0.629 . . . . 74.310000000000002 111.629 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 49.2 m-85 -137.21 -58.16 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.691 0.246 . . . . 75.400000000000006 110.901 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 8.4 Cg_exo -72.98 147.75 43.99 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.974 1.783 . . . . 74.049999999999997 111.185 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.75 -19.2 60.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 75.519999999999996 112.183 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.601 HG23 HG12 ' A' ' 115' ' ' ILE . 35.1 m -86.31 -17.87 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 74.310000000000002 111.106 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.612 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.2 mm -114.27 102.06 54.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.851 0.357 . . . . 64.329999999999998 110.365 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.57 170.62 19.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.665 2.243 . . . . 73.409999999999997 112.056 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.2 144.92 96.25 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.559 2.173 . . . . 61.409999999999997 111.725 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 61.41 26.9 16.6 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.717 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.45 103.12 7.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 74.120000000000005 111.494 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -73.52 122.62 22.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -124.58 144.52 50.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.012 -0.366 . . . . 73.030000000000001 110.012 -167.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 121' ' ' LEU . 85.5 t -98.42 133.1 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.732 0.301 . . . . 74.230000000000004 110.439 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 121' ' ' LEU . 75.8 m-85 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 52.100000000000001 110.531 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 64.4 mt-10 -74.94 106.51 6.48 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.898 -1.149 . . . . 64.310000000000002 107.898 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.23 129.18 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.056 -0.72 . . . . 41.0 109.056 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.4 tt0 -134.77 120.75 19.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.528 -0.305 . . . . 75.209999999999994 110.412 -170.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 92' ' ' LEU . 3.3 tm? -97.21 110.21 22.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.368 -0.604 . . . . 72.310000000000002 109.368 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.7 mm? -86.97 -50.54 6.6 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.46 -0.337 . . . . 73.209999999999994 110.641 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.5 -177.03 6.3 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.635 -0.426 . . . . 55.219999999999999 112.133 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.38 -0.827 . . . . 71.349999999999994 109.425 176.684 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.081 -0.711 . . . . 62.340000000000003 109.081 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.24 111.8 5.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.207 -0.294 . . . . 71.530000000000001 110.207 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.03 108.29 9.98 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.059 -0.349 . . . . 65.329999999999998 110.059 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -114.36 103.87 11.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.083 -0.71 . . . . 71.0 109.083 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.71 110.5 21.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 73.319999999999993 110.028 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 111.69 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 70.430000000000007 110.769 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.86 -42.43 24.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.329 -0.989 . . . . 73.129999999999995 108.329 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -149.83 119.93 3.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.222 -0.899 . . . . 74.030000000000001 109.258 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.45 138.31 24.3 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.631 2.221 . . . . 71.120000000000005 112.259 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -89.7 -167.74 42.67 Favored Glycine 0 C--O 1.236 0.244 0 CA-C-N 116.088 -0.505 . . . . 71.120000000000005 112.625 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.64 ' HB3' HG22 ' A' ' 37' ' ' VAL . 72.4 m-20 -56.34 -44.55 80.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.99 0.424 . . . . 72.409999999999997 111.387 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 80.41 -30.65 2.45 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.919 -0.582 . . . . 51.130000000000003 112.093 -175.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' A' ' 35' ' ' ASP . 35.6 m -76.81 -25.52 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.958 0.408 . . . . 73.239999999999995 109.996 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 19.5 p -97.86 89.68 4.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 54.219999999999999 109.748 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HA ' HG22 ' A' ' 91' ' ' THR . 58.8 mttp -95.91 149.56 36.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 115.748 -0.66 . . . . 63.140000000000001 111.106 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.88 154.49 23.01 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.715 2.277 . . . . 71.040000000000006 111.594 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -133.59 130.06 37.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.109999999999999 110.065 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.56 122.74 17.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.493 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.62 -4.66 32.71 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.356 -0.449 . . . . 65.140000000000001 112.044 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -109.56 165.92 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 74.430000000000007 110.796 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.7 tppp? -67.45 149.09 50.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 61.229999999999997 111.179 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 130' ' ' VAL . 16.9 m -140.14 141.89 32.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.903 -0.59 . . . . 64.049999999999997 109.7 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.9 m -115.09 108.42 16.63 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.514 -0.766 . . . . 54.210000000000001 109.497 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.25 178.21 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.818 -0.628 . . . . 41.030000000000001 112.27 -170.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 8.5 t-160 -150.07 147.73 28.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.926 -1.034 . . . . 71.409999999999997 108.329 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.2 153.31 44.85 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 111.365 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 36.6 t70 -136.27 109.26 7.66 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.663 -0.866 . . . . 72.430000000000007 108.663 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.54 146.97 33.47 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.461 -0.399 . . . . 64.230000000000004 113.121 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.456 ' NH2' HH21 ' A' ' 64' ' ' ARG . 22.3 ttm180 -160.16 149.05 17.26 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.006 0.431 . . . . 71.310000000000002 111.176 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -90.54 151.03 43.68 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.319 -0.4 . . . . 75.120000000000005 110.313 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.21 -13.08 33.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.792 2.328 . . . . 74.209999999999994 111.819 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.63 -17.44 64.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.589 -0.732 . . . . 72.299999999999997 110.346 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.21 28.84 10.2 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.95 -0.568 . . . . 52.539999999999999 112.374 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -155.21 161.42 41.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.649 -0.501 . . . . 64.140000000000001 109.649 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 9.8 pt20 -142.52 155.83 45.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.684 0.278 . . . . 72.329999999999998 110.535 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.37 -18.63 25.14 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.013 -0.539 . . . . 73.530000000000001 111.467 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -137.38 145.57 43.44 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.015 -0.365 . . . . 72.129999999999995 110.015 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.4 p -102.17 85.61 2.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.422 0.63 . . . . 73.409999999999997 110.173 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.744 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 16.1 m -67.78 -20.68 65.24 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.683 -0.69 . . . . 61.149999999999999 110.317 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.456 HH21 ' NH2' ' A' ' 53' ' ' ARG . 12.8 ptp180 -62.95 -44.38 96.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.403 -0.817 . . . . 74.420000000000002 110.732 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -70.85 -16.62 62.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.242 -0.436 . . . . 52.329999999999998 111.213 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.593 ' HD3' ' HA ' ' A' ' 63' ' ' SER . 56.9 mtp180 -82.9 -28.84 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 75.439999999999998 109.882 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.52 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.407 -0.815 . . . . 63.329999999999998 114.238 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -91.1 110.21 40.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.938 0.369 . . . . 75.340000000000003 110.299 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.83 168.55 23.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.818 2.345 . . . . 73.209999999999994 112.22 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -147.4 131.24 17.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.748 -0.464 . . . . 71.230000000000004 109.748 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.583 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 90.6 mt-30 -107.69 143.92 35.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.699 -0.228 . . . . 75.030000000000001 110.539 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 39.2 p90 -163.04 170.67 17.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 73.400000000000006 110.254 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.0 m -87.42 117.86 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.43 -0.35 . . . . 75.200000000000003 110.5 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 88' ' ' ALA . 64.4 tp -63.12 138.48 58.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.025 -0.534 . . . . 75.129999999999995 110.812 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 -22.58 37.76 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 116.141 -0.481 . . . . 51.530000000000001 112.133 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.31 178.47 6.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 74.430000000000007 111.597 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.07 24.39 21.94 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.866 -0.606 . . . . 54.409999999999997 112.278 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 72' ' ' PHE . 10.5 mm-40 -61.45 -45.76 92.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.285 0.564 . . . . 75.439999999999998 110.316 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.445 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 31.2 m -127.26 163.79 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.63 -0.713 . . . . 32.009999999999998 109.756 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.7 pt -60.48 141.01 17.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.807 -0.442 . . . . 75.420000000000002 109.807 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.838 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 4.3 mptp? -58.47 -15.54 11.43 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.02 0.378 . . . . 73.310000000000002 112.02 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.1 -56.02 27.57 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.374 -0.917 . . . . 34.43 111.199 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.445 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 43.7 m0 -69.66 -38.72 77.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.002 -0.369 . . . . 71.340000000000003 110.002 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.838 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 24.4 t70 -54.87 -48.97 72.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.441 -0.8 . . . . 72.430000000000007 110.822 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 31.2 mm-40 -71.54 -34.59 70.16 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.352 -0.385 . . . . 73.310000000000002 110.111 176.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.51 -48.21 55.63 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.0 -0.545 . . . . 70.400000000000006 112.287 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.579 HG23 HD23 ' A' ' 127' ' ' LEU . 3.5 p -75.63 -36.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.775 0.321 . . . . 62.310000000000002 110.801 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -64.73 -20.61 66.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.687 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 86' ' ' GLY . 12.6 t -95.53 10.99 34.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.171 0.434 . . . . 72.319999999999993 112.171 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.767 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.2 ptp -127.72 177.3 6.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.939 0.399 . . . . 71.329999999999998 111.664 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 39' ' ' LYS . 22.9 p -130.97 178.74 6.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.712 -0.676 . . . . 75.530000000000001 110.725 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.938 ' HA ' HD12 ' A' ' 127' ' ' LEU . 3.8 tt -65.32 130.31 42.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.807 0.336 . . . . 74.120000000000005 110.314 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.524 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.7 26.8 55.68 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.687 -0.688 . . . . 72.25 112.107 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.454 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 22.2 tt0 -123.71 141.19 52.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 71.340000000000003 110.534 -176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 125' ' ' VAL . 29.2 ttpp -138.95 135.75 34.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 74.540000000000006 109.531 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.58 152.03 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.442 . . . . 55.240000000000002 111.693 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.404 ' C ' HD23 ' A' ' 97' ' ' LEU . 7.3 tt -91.18 114.07 26.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.06 -1.089 . . . . 62.350000000000001 108.06 174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.47 ' HD1' HD13 ' A' ' 100' ' ' ILE . 7.2 t80 -117.32 121.08 40.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.356 . . . . 65.010000000000005 110.579 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 m -80.92 112.88 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 71.140000000000001 109.76 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.592 HG22 ' HB2' ' A' ' 105' ' ' ALA . 23.7 mm -88.46 110.56 37.61 Favored Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.695 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.19 139.96 62.77 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.769 2.313 . . . . 51.240000000000002 111.358 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -55.95 -28.43 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.241 0.46 . . . . 74.230000000000004 112.241 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.36 -37.28 86.67 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.975 0.417 . . . . 73.140000000000001 110.66 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.2 mt -99.4 18.79 16.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.878 -0.601 . . . . 72.140000000000001 109.987 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 80' ' ' ILE . . . -136.61 171.47 14.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.671 . . . . 75.530000000000001 111.24 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.447 ' HB2' ' HE1' ' A' ' 111' ' ' TYR . 44.9 p90 -76.86 -10.08 59.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 72.409999999999997 110.191 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -25.21 64.06 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.453 -0.794 . . . . 75.140000000000001 112.911 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 2.5 tm-20 -61.35 -54.53 42.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.982 -0.747 . . . . 70.209999999999994 108.982 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -64.87 -49.27 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.036 -0.984 . . . . 72.200000000000003 111.219 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.89 75.7 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.057 -0.592 . . . . 74.310000000000002 111.732 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.728 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m-85 -59.35 -54.0 60.5 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 111.594 0.22 . . . . 75.400000000000006 111.594 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 76.9 Cg_endo -96.72 148.99 1.06 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.53 2.154 . . . . 74.049999999999997 112.101 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 47.3 Cg_exo -57.39 -20.4 39.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.602 2.201 . . . . 75.519999999999996 112.069 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.58 -28.95 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 110.423 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.93 99.0 36.94 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.146 -0.686 . . . . 64.329999999999998 109.146 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 51.3 Cg_exo -54.56 140.64 75.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.72 2.28 . . . . 73.409999999999997 112.717 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 39.5 Cg_exo -61.83 142.52 93.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.362 2.041 . . . . 61.409999999999997 111.318 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 99.7 mttt 63.48 25.8 14.6 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 73.319999999999993 111.612 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.86 135.75 33.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.948 0.404 . . . . 74.120000000000005 111.028 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.4 m -87.41 140.18 29.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 71.230000000000004 109.663 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.97 165.88 12.61 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.487 0.185 . . . . 73.030000000000001 110.619 -174.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.38 132.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.812 -0.44 . . . . 74.230000000000004 109.812 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -135.42 125.56 26.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.647 0.261 . . . . 52.100000000000001 110.43 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 30.9 tt0 -84.4 110.04 18.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.808 -1.182 . . . . 64.310000000000002 107.808 172.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.471 HG23 ' CE ' ' A' ' 90' ' ' MET . 15.3 m -99.64 141.4 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.546 -0.752 . . . . 41.0 110.907 -175.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 46.1 tt0 -131.29 125.65 33.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 75.209999999999994 110.26 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.938 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -99.94 107.96 20.07 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.798 -0.445 . . . . 72.310000000000002 109.798 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.2 mm? -85.75 -43.01 13.71 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.292 -0.413 . . . . 73.209999999999994 110.448 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.37 169.45 24.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.286 -0.415 . . . . 55.219999999999999 110.363 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 46' ' ' VAL . 30.0 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.461 0.116 0 N-CA-C 108.487 -0.931 . . . . 62.340000000000003 108.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.9 tp -138.69 102.28 4.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 71.530000000000001 110.16 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.27 164.1 35.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 65.329999999999998 110.229 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -145.65 118.98 8.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 71.0 109.425 173.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -108.91 110.43 21.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.227 -0.657 . . . . 73.319999999999993 109.227 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.64 122.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.894 0.378 . . . . 70.430000000000007 111.316 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 31' ' ' LEU . 2.5 mm? -87.68 -38.89 15.46 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.311 -0.626 . . . . 73.129999999999995 109.311 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -135.4 111.02 10.64 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.324 -0.853 . . . . 74.030000000000001 109.969 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.65 138.65 46.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.495 2.13 . . . . 71.120000000000005 112.228 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.87 -164.78 40.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.244 -0.503 . . . . 71.120000000000005 112.103 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' HB2' ' HG1' ' A' ' 38' ' ' THR . 47.1 m-20 -63.71 -25.79 68.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.728 0.299 . . . . 72.409999999999997 110.966 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.95 -30.26 1.81 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.478 -0.392 . . . . 51.130000000000003 113.092 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -93.43 -23.47 5.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.729 0.299 . . . . 73.239999999999995 110.892 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.456 ' HG1' ' HB2' ' A' ' 35' ' ' ASP . 7.6 p -76.42 88.47 3.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.165 0.507 . . . . 54.219999999999999 110.705 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -85.88 112.82 47.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 63.140000000000001 111.072 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 114.81 2.5 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.203 2.602 . . . . 71.040000000000006 111.576 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.45 175.13 5.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 110.741 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 157.21 36.01 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.355 -0.384 . . . . 74.420000000000002 110.5 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.69 22.74 68.84 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.068 -0.514 . . . . 65.140000000000001 111.964 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -116.66 136.25 53.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.66 0.267 . . . . 74.430000000000007 110.828 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.77 101.63 10.25 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.738 -0.838 . . . . 61.229999999999997 108.738 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.24 142.02 20.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 121.029 0.443 . . . . 64.049999999999997 111.276 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -105.67 108.47 20.01 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.137 -0.938 . . . . 54.210000000000001 109.301 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.17 172.14 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.164 0.507 . . . . 41.030000000000001 111.021 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 14.5 t-160 -134.03 132.08 39.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.186 -1.042 . . . . 71.409999999999997 108.186 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 29.2 p90 -128.37 145.46 51.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.707 0.289 . . . . 71.340000000000003 111.361 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.849 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 26.0 t70 -137.81 119.76 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 72.430000000000007 109.809 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -79.55 127.63 8.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.37 -0.443 . . . . 64.230000000000004 112.259 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.648 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 20.4 ttm180 -147.11 151.83 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 111.053 -173.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.31 150.02 42.25 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.839 -0.43 . . . . 75.120000000000005 109.839 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.02 -13.6 28.47 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.518 2.146 . . . . 74.209999999999994 111.656 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.98 -32.46 73.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.264 -0.88 . . . . 72.299999999999997 110.532 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.07 -42.04 1.68 Allowed Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.276 -0.73 . . . . 52.539999999999999 111.276 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -79.87 157.87 26.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.774 0.321 . . . . 64.140000000000001 110.522 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.648 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 13.5 pt20 -125.23 165.19 18.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 110.803 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -86.7 -16.74 35.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.733 0.271 . . . . 73.530000000000001 111.733 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.58 153.75 6.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.215 -0.661 . . . . 72.129999999999995 109.215 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 46.4 m -89.48 97.0 10.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.07 0.462 . . . . 73.409999999999997 110.837 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 50.9 m -93.49 -18.43 22.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.288 0.566 . . . . 61.149999999999999 110.267 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HD2' ' NH2' ' A' ' 53' ' ' ARG . 7.9 ptm180 -68.37 -47.48 67.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.78 -0.645 . . . . 74.420000000000002 111.013 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 p -68.92 -27.86 66.14 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.76 0.314 . . . . 52.329999999999998 111.785 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 62' ' ' SER . 19.8 mtp180 -75.6 -21.52 57.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.416 -0.356 . . . . 75.439999999999998 110.719 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.19 48.09 65.01 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.881 -0.599 . . . . 63.329999999999998 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 68' ' ' LYS . 1.6 tmtp? -95.95 111.76 57.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.814 -0.809 . . . . 75.340000000000003 108.814 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.64 152.35 7.55 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.802 2.335 . . . . 73.209999999999994 112.635 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -122.18 137.68 54.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.359 -0.608 . . . . 71.230000000000004 109.359 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.39 129.24 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.355 . . . . 75.030000000000001 110.168 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -149.46 160.11 43.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 73.400000000000006 110.554 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.3 m -83.45 104.86 13.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 75.200000000000003 109.937 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.83 131.4 49.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 110.001 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.67 -25.78 26.94 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.145 -0.55 . . . . 51.530000000000001 111.98 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.47 171.19 15.47 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.658 0.266 . . . . 74.430000000000007 110.501 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.54 35.77 2.25 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.233 -0.508 . . . . 54.409999999999997 113.233 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -84.88 -38.74 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.214 0.53 . . . . 75.439999999999998 109.844 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.64 157.95 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.409 -0.814 . . . . 32.009999999999998 109.366 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.8 pt -92.26 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.186 -0.301 . . . . 75.420000000000002 110.186 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 9.5 mmtm -51.62 -19.1 1.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.096 0.776 . . . . 73.310000000000002 113.096 -173.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.07 -63.0 4.91 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.446 -0.883 . . . . 34.43 111.72 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -70.85 -28.42 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 110.234 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.705 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 16.8 t70 -58.44 -51.66 68.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 72.430000000000007 110.087 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.28 -37.56 87.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.968 -0.382 . . . . 73.310000000000002 109.968 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -51.69 40.78 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.736 -0.666 . . . . 70.400000000000006 112.648 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.2 p -75.65 -31.38 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.038 0.447 . . . . 62.310000000000002 111.086 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.76 66.3 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -83.01 -5.48 59.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.003 0.371 . . . . 72.319999999999993 112.003 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.1 ptp -110.45 177.7 4.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.692 0.282 . . . . 71.329999999999998 111.136 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 p -127.66 177.98 6.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.089 -0.505 . . . . 75.530000000000001 110.173 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.7 ' HA ' HD12 ' A' ' 127' ' ' LEU . 5.1 tt -63.88 130.6 44.78 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.541 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.514 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 83.71 13.0 76.54 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.405 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -102.63 129.2 49.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.042 0.449 . . . . 71.340000000000003 111.382 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -110.64 116.92 32.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.273 -0.876 . . . . 74.540000000000006 108.893 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.33 142.8 50.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.228 0.537 . . . . 55.240000000000002 111.151 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.86 109.6 20.82 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.679 -0.859 . . . . 62.350000000000001 108.679 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 28' ' ' LYS . 12.6 t80 -105.17 134.65 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 65.010000000000005 110.511 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.6 m -93.56 112.82 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 71.140000000000001 110.138 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.579 HG21 ' HB2' ' A' ' 105' ' ' ALA . 26.8 mm -103.12 114.0 65.44 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 116.552 -0.295 . . . . 60.109999999999999 110.569 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' A' ' 104' ' ' LEU . 34.3 Cg_exo -59.57 155.1 43.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.52 2.147 . . . . 51.240000000000002 111.659 175.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -54.81 -32.18 59.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.936 0.398 . . . . 74.230000000000004 111.111 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -76.22 -10.01 59.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 73.140000000000001 111.795 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.574 HD12 ' HD2' ' A' ' 101' ' ' PRO . 82.3 mt -115.27 19.58 15.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.641 0.258 . . . . 72.140000000000001 110.768 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -163.46 -172.24 2.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.029 0.443 . . . . 75.530000000000001 110.776 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -76.39 -3.99 39.94 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.91 -0.586 . . . . 72.409999999999997 110.897 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.59 60.22 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 113.093 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.39 -55.84 9.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.835 0.35 . . . . 70.209999999999994 110.431 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.21 -49.81 16.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.813 -0.631 . . . . 72.200000000000003 110.987 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.92 80.41 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.348 -0.453 . . . . 74.310000000000002 112.84 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.539 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.5 m-85 -77.22 -50.67 2.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 111.819 0.303 . . . . 75.400000000000006 111.819 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 3.5 Cg_exo -77.48 128.47 9.58 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.233 1.955 . . . . 74.049999999999997 111.51 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.4 -11.9 21.65 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.849 2.366 . . . . 75.519999999999996 113.152 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.406 HG23 HG12 ' A' ' 115' ' ' ILE . 27.6 m -81.4 -17.93 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.992 0.425 . . . . 74.310000000000002 110.684 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 114' ' ' VAL . 49.9 mm -105.32 122.24 43.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 64.329999999999998 109.947 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 55.0 Cg_endo -70.95 130.6 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.374 2.049 . . . . 73.409999999999997 112.173 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 20.7 Cg_exo -67.26 149.36 81.34 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.822 2.348 . . . . 61.409999999999997 112.044 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm 64.28 27.63 13.83 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.298 0.639 . . . . 73.319999999999993 111.1 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.83 148.9 32.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 74.120000000000005 111.246 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.6 m -82.85 132.31 35.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.718 -0.674 . . . . 71.230000000000004 109.843 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -117.69 139.39 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.785 -0.45 . . . . 73.030000000000001 109.785 -173.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.4 t -106.25 138.81 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.536 -0.302 . . . . 74.230000000000004 110.241 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.21 125.24 38.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.074 -0.343 . . . . 52.100000000000001 110.074 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 35.6 tt0 -75.1 106.84 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.124 -1.435 . . . . 64.310000000000002 107.124 168.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 m -111.71 137.93 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.949 -0.568 . . . . 41.0 109.868 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.9 tt0 -144.02 126.68 16.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.854 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.3 tm? -79.34 101.69 8.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.310000000000002 108.302 176.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.94 -49.89 18.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 73.209999999999994 109.549 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.74 156.64 20.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 55.219999999999999 111.027 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.901 -0.591 . . . . 71.349999999999994 109.497 175.565 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.423 -0.955 . . . . 62.340000000000003 108.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.3 102.29 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 71.530000000000001 111.923 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -110.42 113.67 26.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 65.329999999999998 109.654 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -113.82 101.35 9.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.629 -0.878 . . . . 71.0 108.629 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.82 118.96 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.644 -0.707 . . . . 73.319999999999993 110.435 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.3 113.08 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.081 -0.509 . . . . 70.430000000000007 109.807 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -76.66 -40.78 48.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.332 -0.618 . . . . 73.129999999999995 109.332 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.3 m -147.08 114.67 4.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.606 -0.724 . . . . 74.030000000000001 109.305 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.44 150.3 87.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.713 2.275 . . . . 71.120000000000005 112.611 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -106.46 -135.29 7.97 Favored Glycine 0 C--O 1.237 0.31 0 CA-C-N 115.968 -0.56 . . . . 71.120000000000005 112.005 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.491 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 31.6 m-20 -73.4 -50.62 20.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 72.409999999999997 111.251 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.83 -25.18 8.91 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.926 -0.654 . . . . 51.130000000000003 112.172 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 35' ' ' ASP . 33.7 m -98.64 -24.59 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.019 0.438 . . . . 73.239999999999995 111.157 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.491 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.8 p -79.1 92.97 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.16 0.505 . . . . 54.219999999999999 110.242 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -88.6 128.59 52.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.738 -0.664 . . . . 63.140000000000001 110.938 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.98 122.93 6.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.487 2.124 . . . . 71.040000000000006 112.048 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.44 148.5 22.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.811 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.91 138.16 46.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.420000000000002 109.763 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.29 68.51 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.182 -0.532 . . . . 65.140000000000001 112.085 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -91.66 134.2 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 74.430000000000007 110.982 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.24 108.34 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.846 -0.798 . . . . 61.229999999999997 108.846 171.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.551 HG12 HG23 ' A' ' 130' ' ' VAL . 27.5 m -106.39 147.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.797 0.332 . . . . 64.049999999999997 110.805 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.1 m -104.62 108.17 19.49 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.787 -0.642 . . . . 54.210000000000001 110.064 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.789 HG12 HD22 ' A' ' 127' ' ' LEU . 15.8 m -125.96 178.23 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.631 -0.713 . . . . 41.030000000000001 110.636 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.81 154.19 36.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.84 -0.8 . . . . 71.409999999999997 108.84 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 36.9 p90 -134.06 158.14 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.429 -0.212 . . . . 71.340000000000003 110.429 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.698 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 1.4 m-20 -134.65 123.37 23.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.131 -0.692 . . . . 72.430000000000007 109.131 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.0 94.46 1.76 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.879 -0.601 . . . . 64.230000000000004 112.908 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.524 ' HA ' ' HB3' ' A' ' 59' ' ' GLN . 19.3 ttm180 -106.25 137.36 44.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.363 0.602 . . . . 71.310000000000002 110.774 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -78.06 154.73 80.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 75.120000000000005 109.789 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.97 -23.71 29.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.767 2.311 . . . . 74.209999999999994 112.05 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.21 -24.24 40.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.379 -0.828 . . . . 72.299999999999997 111.177 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.13 -2.86 56.71 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.63 -0.714 . . . . 52.539999999999999 111.439 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -110.37 156.31 20.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.976 0.51 . . . . 64.140000000000001 110.042 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 26.0 pt20 -141.23 163.56 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.908 -0.405 . . . . 72.329999999999998 109.908 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.63 -46.63 78.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 111.479 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -170.33 133.21 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.851 -0.425 . . . . 72.129999999999995 109.851 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -69.35 106.67 3.0 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.886 0.374 . . . . 73.409999999999997 110.219 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.3 p -76.46 -26.23 55.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 61.149999999999999 110.776 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -31.39 71.94 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.939 0.4 . . . . 74.420000000000002 110.048 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -60.84 -13.59 16.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.695 . . . . 52.329999999999998 111.225 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -78.36 -16.37 57.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.775 0.321 . . . . 75.439999999999998 111.075 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.5 34.33 73.56 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.159 -0.543 . . . . 63.329999999999998 112.344 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 113.65 14.89 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 110.252 -0.277 . . . . 75.340000000000003 110.252 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -95.61 177.2 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.187 2.592 . . . . 73.209999999999994 113.271 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -125.9 142.23 51.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.581 -0.896 . . . . 71.230000000000004 108.581 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -112.68 135.29 53.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.522 -0.177 . . . . 75.030000000000001 110.522 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -150.75 161.12 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.774 -0.454 . . . . 73.400000000000006 109.774 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.484 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 56.9 m -86.09 115.95 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.482 0.182 . . . . 75.200000000000003 110.642 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 88' ' ' ALA . 63.6 tp -64.15 138.64 58.55 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.253 -0.431 . . . . 75.129999999999995 110.452 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.38 32.39 31.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.128 -0.558 . . . . 51.530000000000001 111.949 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.15 160.27 43.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.04 -0.355 . . . . 74.430000000000007 110.04 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 29.04 1.51 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.566 -0.349 . . . . 54.409999999999997 113.47 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 73' ' ' THR . 10.9 mm-40 -62.32 -46.65 87.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.502 0.668 . . . . 75.439999999999998 109.568 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.82 178.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.729 -1.123 . . . . 32.009999999999998 109.689 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 83' ' ' TRP . 28.1 pt -68.59 145.53 13.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 123.333 0.396 . . . . 75.420000000000002 110.77 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.49 -20.46 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.261 -0.427 . . . . 73.310000000000002 111.579 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.05 21.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 34.43 111.535 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.456 ' H ' HG13 ' A' ' 80' ' ' ILE . 47.8 m0 -68.98 -37.91 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.675 0.274 . . . . 71.340000000000003 110.298 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.93 -55.03 35.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.885 -0.598 . . . . 72.430000000000007 110.499 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.37 -34.74 70.7 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.025 -0.534 . . . . 73.310000000000002 110.513 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.444 ' O ' HG22 ' A' ' 89' ' ' THR . . . -55.02 -49.83 61.23 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.917 -0.583 . . . . 70.400000000000006 112.138 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 90' ' ' MET . 21.6 m -75.8 -31.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.777 0.323 . . . . 62.310000000000002 111.12 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -63.82 -32.0 73.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.609 -0.269 . . . . 72.340000000000003 111.54 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.0 t -82.27 -10.72 59.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.823 0.305 . . . . 72.319999999999993 111.823 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 16.7 ptp -103.59 -172.05 2.04 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.712 0.292 . . . . 71.329999999999998 110.964 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -133.18 179.01 6.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.216 -0.447 . . . . 75.530000000000001 110.805 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 129' ' ' ALA . 3.4 tm? -62.9 138.49 58.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.802 0.334 . . . . 74.120000000000005 110.537 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.418 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.78 24.65 75.7 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.483 -0.78 . . . . 72.25 112.395 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 21.9 tt0 -121.2 135.32 55.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 71.340000000000003 110.792 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -117.87 128.42 54.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.507 -0.77 . . . . 74.540000000000006 109.341 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.13 141.53 44.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.459 . . . . 55.240000000000002 111.331 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 9.0 tt -90.9 115.63 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.633 -0.877 . . . . 62.350000000000001 108.633 174.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' HD1' HD13 ' A' ' 100' ' ' ILE . 21.4 t80 -121.26 122.73 40.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 65.010000000000005 110.107 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.593 HG23 HG22 ' A' ' 122' ' ' VAL . 4.2 m -79.59 107.85 12.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.45 . . . . 71.140000000000001 109.784 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.519 HD13 ' HD1' ' A' ' 98' ' ' PHE . 37.2 mm -82.72 110.43 22.46 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 116.222 -0.444 . . . . 60.109999999999999 110.575 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.558 ' HA ' HG23 ' A' ' 120' ' ' THR . 61.3 Cg_endo -72.68 150.29 50.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.41 2.073 . . . . 51.240000000000002 111.88 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -54.32 -27.99 39.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.679 -0.691 . . . . 74.230000000000004 111.975 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.11 -22.14 49.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.328 -0.396 . . . . 73.140000000000001 111.893 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.9 mt -106.35 22.48 15.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.01 0.434 . . . . 72.140000000000001 110.197 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -160.53 -174.99 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.626 . . . . 75.530000000000001 111.053 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -79.85 -3.37 47.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.548 -0.751 . . . . 72.409999999999997 110.243 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.66 -24.6 48.5 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.898 -0.592 . . . . 75.140000000000001 113.465 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 5.9 tm-20 -65.71 -48.36 72.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.555 -0.535 . . . . 70.209999999999994 109.555 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.522 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 1.6 tpm_? -78.38 -56.58 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.62 -0.718 . . . . 72.200000000000003 110.974 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.99 162.54 25.86 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.485 -0.646 . . . . 74.310000000000002 111.485 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.633 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 89.2 m-85 -143.15 -58.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.05 0.425 . . . . 75.400000000000006 110.824 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 71.7 Cg_endo -82.98 140.67 10.19 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.585 1.523 . . . . 74.049999999999997 111.499 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 35.9 Cg_exo -59.43 -5.89 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.819 2.346 . . . . 75.519999999999996 112.983 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 t -81.24 -29.56 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.472 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -111.35 109.31 56.46 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.969 -0.56 . . . . 64.329999999999998 110.043 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 22.8 Cg_exo -65.27 149.96 87.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.715 2.277 . . . . 73.409999999999997 112.014 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 23.8 Cg_exo -66.41 153.9 76.29 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.74 2.294 . . . . 61.409999999999997 112.039 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 47.4 mtmt 59.33 32.91 22.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.05 0.452 . . . . 73.319999999999993 110.759 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.77 32.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.953 -0.567 . . . . 74.120000000000005 111.12 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -73.79 124.66 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.3 -0.63 . . . . 71.230000000000004 109.3 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.2 tm? -119.11 144.47 46.6 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.097 -0.705 . . . . 73.030000000000001 109.097 -172.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.593 HG22 HG23 ' A' ' 99' ' ' THR . 63.9 t -98.38 111.19 27.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 110.166 -0.309 . . . . 74.230000000000004 110.166 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.457 ' CE2' HD12 ' A' ' 121' ' ' LEU . 40.1 m-85 -108.75 118.4 36.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.281 0.562 . . . . 52.100000000000001 110.855 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.698 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 43.8 mt-10 -75.45 109.04 8.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.337 -0.986 . . . . 64.310000000000002 108.337 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' HE1' ' A' ' 90' ' ' MET . 11.6 m -95.99 149.13 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 123.508 0.505 . . . . 41.0 109.646 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.51 119.64 8.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 110.193 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.789 HD22 HG12 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -90.67 104.35 16.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.472 -0.566 . . . . 72.310000000000002 109.472 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.0 -43.9 12.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.801 0.334 . . . . 73.209999999999994 110.752 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.488 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -159.39 164.34 34.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 55.219999999999999 110.465 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.551 HG23 HG12 ' A' ' 46' ' ' VAL . 2.7 p . . . . . 0 C--O 1.245 0.843 0 N-CA-C 109.771 -0.455 . . . . 71.349999999999994 109.771 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 . . . . . 0 C--O 1.232 0.149 0 N-CA-C 108.984 -0.747 . . . . 62.340000000000003 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.456 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 60.9 tp -146.18 119.62 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.178 0.436 . . . . 71.530000000000001 112.178 -175.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -101.45 129.52 47.51 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.121 -0.696 . . . . 65.329999999999998 109.121 162.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -125.79 100.71 6.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.745 -1.206 . . . . 71.0 107.745 169.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -119.71 113.29 20.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.945 -0.57 . . . . 73.319999999999993 110.308 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.03 108.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.224 0.535 . . . . 70.430000000000007 110.474 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -82.97 -44.85 14.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.857 -0.61 . . . . 73.129999999999995 109.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.8 m -139.68 110.76 7.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 74.030000000000001 109.45 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.14 133.9 40.2 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.621 2.214 . . . . 71.120000000000005 111.614 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.46 -150.69 23.03 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.166 -0.54 . . . . 71.120000000000005 112.795 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.71 -54.73 40.72 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.707 0.403 . . . . 72.409999999999997 111.254 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.5 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 75.7 -9.11 17.47 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.212 -0.518 . . . . 51.130000000000003 113.037 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.49 -6.7 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.115 0.483 . . . . 73.239999999999995 110.7 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 92' ' ' LEU . 40.8 p -83.96 120.11 25.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.795 -0.639 . . . . 54.219999999999999 110.681 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -126.66 89.67 51.59 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.728 -0.215 . . . . 63.140000000000001 110.637 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.8 -175.68 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.87 2.38 . . . . 71.040000000000006 111.993 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -146.55 174.94 10.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.368 -0.378 . . . . 75.109999999999999 110.268 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 140.36 57.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.196 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.12 -1.37 54.67 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.215 -0.516 . . . . 65.140000000000001 112.515 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -92.02 133.08 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 74.430000000000007 110.925 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -83.77 107.83 16.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.851 -0.796 . . . . 61.229999999999997 108.851 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 35.9 m -107.18 147.67 12.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 116.49 -0.323 . . . . 64.049999999999997 111.534 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 m -100.73 108.17 19.95 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.036 -0.983 . . . . 54.210000000000001 110.728 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.822 HG12 HD22 ' A' ' 127' ' ' LEU . 19.7 m -120.36 178.66 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 114.893 -1.048 . . . . 41.030000000000001 111.365 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.658 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 22.4 t-160 -152.8 146.4 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.697 -1.223 . . . . 71.409999999999997 107.697 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.5 m-85 -126.97 159.45 34.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.901 0.382 . . . . 71.340000000000003 111.965 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.888 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 5.6 m-20 -135.78 157.35 47.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.951 -1.022 . . . . 72.430000000000007 108.509 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -118.6 128.93 7.92 Favored Glycine 0 N--CA 1.461 0.312 0 C-N-CA 121.039 -0.6 . . . . 64.230000000000004 112.597 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.552 HH21 HG21 ' A' ' 122' ' ' VAL . 16.2 ttp180 -138.32 145.53 41.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.934 0.397 . . . . 71.310000000000002 110.752 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.0 155.56 64.19 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 75.120000000000005 109.767 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.33 -17.91 49.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.621 2.214 . . . . 74.209999999999994 112.487 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.8 -23.82 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 72.299999999999997 110.598 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.07 -22.53 18.25 Favored Glycine 0 N--CA 1.454 -0.165 0 N-CA-C 111.177 -0.769 . . . . 52.539999999999999 111.177 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -71.77 141.16 49.73 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.726 0.41 . . . . 64.140000000000001 109.949 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 14.6 pt20 -121.2 135.58 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.122 -0.695 . . . . 72.329999999999998 109.122 172.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -69.87 -29.95 67.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.615 -0.266 . . . . 73.530000000000001 111.394 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.09 134.15 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 72.129999999999995 110.779 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.459 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 13.7 p -79.14 86.69 4.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.452 -0.573 . . . . 73.409999999999997 109.452 171.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 m -65.42 -12.01 48.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.176 0.512 . . . . 61.149999999999999 110.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.658 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 8.8 ptp85 -63.56 -31.73 72.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.934 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 t -73.4 -19.14 61.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.831 -0.622 . . . . 52.329999999999998 110.952 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -75.57 -20.56 58.54 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.422 -0.353 . . . . 75.439999999999998 110.06 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.68 48.72 69.64 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.955 -0.566 . . . . 63.329999999999998 113.72 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 64.6 tttp -130.94 124.27 20.53 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.801 -0.444 . . . . 75.340000000000003 109.801 174.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 Cg_endo -83.65 175.13 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.107 2.538 . . . . 73.209999999999994 112.015 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -146.91 128.73 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 71.230000000000004 108.515 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 92.6 mt-30 -106.6 131.54 53.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.464 0.173 . . . . 75.030000000000001 110.654 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.86 158.77 43.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.564 -0.289 . . . . 73.400000000000006 110.471 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.1 m -84.32 124.36 31.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 75.200000000000003 110.386 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 tp -59.38 130.3 46.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.365 -0.379 . . . . 75.129999999999995 110.383 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.18 39.02 72.63 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.989 -0.55 . . . . 51.530000000000001 112.521 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.81 161.97 31.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.995 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.78 18.51 8.94 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 116.021 -0.536 . . . . 54.409999999999997 113.462 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.83 -19.75 54.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.599 . . . . 75.439999999999998 109.814 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.96 159.71 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.446 -0.797 . . . . 32.009999999999998 109.48 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 83' ' ' TRP . 21.3 pt -70.28 151.09 9.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 116.406 -0.361 . . . . 75.420000000000002 110.102 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -56.68 -26.68 57.16 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.827 -0.434 . . . . 73.310000000000002 109.827 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.27 -52.06 53.84 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.052 -0.594 . . . . 34.43 111.853 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.555 ' H ' HG13 ' A' ' 80' ' ' ILE . 40.8 m0 -69.32 -31.29 69.66 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.325 -0.25 . . . . 71.340000000000003 110.325 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.4 -45.75 80.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.132 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.12 -35.35 76.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 109.789 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 89' ' ' THR . . . -56.46 -47.07 86.22 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.876 -0.602 . . . . 70.400000000000006 112.353 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.627 HG23 HD23 ' A' ' 127' ' ' LEU . 7.1 p -75.05 -34.08 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.809 0.338 . . . . 62.310000000000002 110.622 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.75 70.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.483 -0.326 . . . . 72.340000000000003 111.456 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 86' ' ' GLY . 8.9 t -87.01 3.34 46.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.673 0.273 . . . . 72.319999999999993 111.187 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 15.3 ptm -130.14 175.74 8.66 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 110.81 -177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.5 HG21 ' HA2' ' A' ' 36' ' ' GLY . 59.5 p -127.34 178.68 5.9 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.296 -0.411 . . . . 75.530000000000001 110.789 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -69.22 139.38 54.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.634 -0.257 . . . . 74.120000000000005 110.395 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.499 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 77.93 12.57 84.29 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.956 -0.565 . . . . 72.25 112.219 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -112.72 153.75 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.321 0.248 . . . . 71.340000000000003 110.643 -172.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -134.09 127.82 32.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.353 -0.61 . . . . 74.540000000000006 109.353 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.07 146.85 41.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 55.240000000000002 110.914 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 8.6 tt -90.8 111.67 23.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.531 -0.915 . . . . 62.350000000000001 108.531 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -117.9 129.0 55.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.802 0.334 . . . . 65.010000000000005 110.147 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 122' ' ' VAL . 27.9 m -84.51 131.12 34.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.655 0.264 . . . . 71.140000000000001 111.138 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.68 103.0 44.83 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-O 120.896 0.379 . . . . 60.109999999999999 110.063 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.616 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.9 Cg_exo -62.67 155.09 61.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.598 2.199 . . . . 51.240000000000002 111.927 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -55.07 -23.38 19.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 111.415 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -75.63 -6.5 50.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.241 -0.436 . . . . 73.140000000000001 111.972 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.53 HD12 ' HD2' ' A' ' 101' ' ' PRO . 96.7 mt -127.53 14.46 7.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.707 0.262 . . . . 72.140000000000001 111.707 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.34 -175.77 5.01 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.953 0.406 . . . . 75.530000000000001 111.485 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -66.55 -12.33 57.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.515 -0.766 . . . . 72.409999999999997 111.314 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.91 -32.83 19.51 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.35 -0.386 . . . . 75.140000000000001 113.688 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 tp10 -58.08 -49.23 77.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.367 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.26 -47.74 9.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 72.200000000000003 110.971 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.77 153.44 13.05 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 112.076 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.705 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 76.1 m-85 -144.41 -57.19 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 122.314 0.246 . . . . 75.400000000000006 110.944 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 6.8 Cg_exo -73.49 143.1 34.01 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.896 1.731 . . . . 74.049999999999997 111.235 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.48 -27.66 41.38 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.821 2.347 . . . . 75.519999999999996 112.786 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 115' ' ' ILE . 33.3 m -78.19 -18.18 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 111.514 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.513 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 49.0 mm -108.19 103.37 50.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.318 -0.401 . . . . 64.329999999999998 110.188 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.52 164.68 31.97 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.568 2.179 . . . . 73.409999999999997 111.668 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.35 142.6 94.98 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.317 2.012 . . . . 61.409999999999997 112.135 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 67.6 mttm 65.97 27.74 10.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.937 -0.574 . . . . 73.319999999999993 111.283 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.73 116.84 26.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.835 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.616 HG23 ' HA ' ' A' ' 101' ' ' PRO . 70.6 m -74.04 138.37 44.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.015 -0.539 . . . . 71.230000000000004 109.75 174.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -129.64 138.95 51.5 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.263 -0.643 . . . . 73.030000000000001 109.263 -175.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.552 HG21 HH21 ' A' ' 53' ' ' ARG . 48.1 t -98.6 133.72 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.588 0.232 . . . . 74.230000000000004 110.397 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.54 126.51 44.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.069 0.461 . . . . 52.100000000000001 110.533 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.0 mt-10 -78.23 118.36 20.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.953 -0.758 . . . . 64.310000000000002 108.953 173.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -95.97 135.57 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.443 -0.577 . . . . 41.0 109.443 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.9 tt0 -135.16 106.51 6.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.283 -0.417 . . . . 75.209999999999994 110.113 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.822 HD22 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -87.03 108.27 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.829 -0.804 . . . . 72.310000000000002 108.829 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.24 -50.9 7.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.856 -0.424 . . . . 73.209999999999994 109.856 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -169.9 -173.68 1.63 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.969 -0.56 . . . . 55.219999999999999 110.602 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.243 0.736 0 N-CA-C 109.161 -0.681 . . . . 71.349999999999994 109.161 173.216 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.847 0.356 . . . . 62.340000000000003 110.638 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -142.51 102.03 3.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 71.530000000000001 110.134 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -124.63 102.26 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.262 0.553 . . . . 65.329999999999998 110.047 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -112.74 109.7 19.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.272 -0.876 . . . . 71.0 109.16 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -108.66 110.35 21.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.469 -0.567 . . . . 73.319999999999993 109.469 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.75 106.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.109 -0.33 . . . . 70.430000000000007 110.109 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 97' ' ' LEU . 85.4 mt -87.7 -28.84 21.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 110.154 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 28.5 m -140.83 110.92 6.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.48 -0.782 . . . . 74.030000000000001 109.518 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.81 127.0 22.0 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.486 2.124 . . . . 71.120000000000005 111.249 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.11 -174.35 50.32 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 71.120000000000005 112.922 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' OD2' HG22 ' A' ' 37' ' ' VAL . 23.0 t70 -60.82 -43.06 98.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 110.543 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.3 9.74 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.934 -0.575 . . . . 51.130000000000003 114.43 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG22 ' OD2' ' A' ' 35' ' ' ASP . 14.0 m -103.57 -28.0 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.087 0.943 . . . . 73.239999999999995 110.807 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 5.5 p -75.95 88.62 2.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.41 0.624 . . . . 54.219999999999999 109.854 173.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -93.29 114.45 62.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.348 -0.842 . . . . 63.140000000000001 111.068 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HG3' ' HG ' ' A' ' 127' ' ' LEU . 56.1 Cg_endo -70.58 107.77 2.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.412 2.074 . . . . 71.040000000000006 110.974 174.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.08 157.72 15.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 75.109999999999999 110.609 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 157.27 32.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 74.420000000000002 111.057 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.08 76.93 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.004 -0.544 . . . . 65.140000000000001 112.128 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -132.08 141.78 49.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.456 0.303 . . . . 74.430000000000007 110.311 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -71.95 107.61 4.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.736 -0.468 . . . . 61.229999999999997 109.736 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 130' ' ' VAL . 33.6 m -106.42 147.42 11.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 120.887 0.375 . . . . 64.049999999999997 110.903 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.2 m -104.81 108.44 19.93 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.472 -0.786 . . . . 54.210000000000001 109.761 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.651 HG12 HD22 ' A' ' 127' ' ' LEU . 21.3 m -118.78 178.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.482 -0.781 . . . . 41.030000000000001 111.97 -171.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -150.61 137.02 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.866 . . . . 71.409999999999997 109.231 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.638 ' HD1' HG12 ' A' ' 125' ' ' VAL . 56.2 m-85 -126.64 159.4 33.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.71 -0.107 . . . . 71.340000000000003 110.71 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.62 136.35 29.05 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.466 0.479 . . . . 72.430000000000007 109.728 167.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 124.82 7.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.475 -0.393 . . . . 64.230000000000004 112.277 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -141.01 137.46 32.99 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.327 0.584 . . . . 71.310000000000002 110.974 -170.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.19 148.37 39.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 109.744 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 -18.56 37.0 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.799 2.333 . . . . 74.209999999999994 112.457 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -66.56 -31.3 71.93 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.054 -0.521 . . . . 72.299999999999997 110.783 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.43 -21.07 15.21 Favored Glycine 0 C--N 1.327 0.038 0 N-CA-C 109.992 -1.243 . . . . 52.539999999999999 109.992 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -68.87 154.46 41.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.672 -0.764 . . . . 64.140000000000001 110.101 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -142.23 151.77 42.44 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.778 -0.453 . . . . 72.329999999999998 109.778 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.75 -4.54 36.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.714 0.292 . . . . 73.530000000000001 111.422 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -168.26 144.79 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.141 -0.688 . . . . 72.129999999999995 109.141 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.8 p -109.07 85.34 2.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.62 0.724 . . . . 73.409999999999997 110.292 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.1 m -77.83 -18.26 56.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.539 -0.755 . . . . 61.149999999999999 109.401 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -65.05 -32.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.21 -0.904 . . . . 74.420000000000002 109.645 173.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -73.57 -24.26 60.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.342 -0.844 . . . . 52.329999999999998 110.869 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -84.27 -28.64 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 75.439999999999998 110.598 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.25 25.1 59.73 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.086 -0.506 . . . . 63.329999999999998 112.194 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.92 129.15 47.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 122.52 0.328 . . . . 75.340000000000003 110.825 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -87.84 157.05 7.41 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.967 2.444 . . . . 73.209999999999994 112.434 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -134.92 130.13 35.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.888 -0.782 . . . . 71.230000000000004 108.888 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -107.85 138.24 44.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.504 0.192 . . . . 75.030000000000001 110.756 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -157.21 163.55 38.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.267 -0.424 . . . . 73.400000000000006 110.051 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.9 m -82.46 110.79 17.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.192 -0.299 . . . . 75.200000000000003 110.192 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 88' ' ' ALA . 48.1 tp -61.82 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.238 -0.437 . . . . 75.129999999999995 110.223 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.14 12.48 Favored Glycine 0 C--O 1.237 0.286 0 N-CA-C 111.488 -0.645 . . . . 51.530000000000001 111.488 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.57 154.19 38.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 74.430000000000007 110.504 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.61 33.89 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.147 -0.479 . . . . 54.409999999999997 112.67 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.89 -23.6 67.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.022 0.439 . . . . 75.439999999999998 110.641 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.93 174.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.139 -0.689 . . . . 32.009999999999998 109.139 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.6 pt -73.61 140.28 18.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.741 -0.466 . . . . 75.420000000000002 109.741 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 30.3 mmtp -58.45 -16.68 16.1 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.689 0.255 . . . . 73.310000000000002 111.689 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.93 -53.02 46.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.416 -0.897 . . . . 34.43 111.183 172.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.522 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.1 m0 -67.06 -42.1 85.33 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.114 -0.328 . . . . 71.340000000000003 110.114 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.501 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 17.8 t70 -52.59 -55.15 24.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.511 -0.768 . . . . 72.430000000000007 110.671 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -65.6 -40.42 92.65 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.094 -0.503 . . . . 73.310000000000002 110.666 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.69 -53.96 30.24 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.919 -0.582 . . . . 70.400000000000006 112.622 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.94 -30.35 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.544 0.212 . . . . 62.310000000000002 111.369 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -67.2 -30.15 70.01 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.725 0.269 . . . . 72.340000000000003 111.725 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 t -88.46 7.32 33.43 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.001 0.371 . . . . 72.319999999999993 112.001 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 11.9 ptp -121.97 -173.87 2.75 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.168 -0.332 . . . . 71.329999999999998 111.113 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -124.31 175.3 7.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.132 -0.486 . . . . 75.530000000000001 110.732 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.684 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.7 tt -63.33 131.84 49.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 74.120000000000005 110.364 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 8.78 83.7 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.416 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.639 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 14.1 tt0 -102.02 140.92 35.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 71.340000000000003 110.585 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.9 ttpm? -131.79 136.23 47.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.808 -0.442 . . . . 74.540000000000006 109.808 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.13 150.62 35.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.961 0.41 . . . . 55.240000000000002 111.186 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.455 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.1 tt -90.67 109.42 20.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.984 -1.117 . . . . 62.350000000000001 107.984 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HD1' HD13 ' A' ' 100' ' ' ILE . 7.0 t80 -112.0 117.77 33.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 65.010000000000005 110.109 -174.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 31.9 m -77.22 110.54 12.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.401 -0.363 . . . . 71.140000000000001 110.224 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.427 HD13 ' HD1' ' A' ' 98' ' ' PHE . 42.0 mm -90.48 111.6 48.33 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.127 -0.488 . . . . 60.109999999999999 110.488 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HA ' HG23 ' A' ' 120' ' ' THR . 34.3 Cg_exo -59.9 144.46 99.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.396 2.064 . . . . 51.240000000000002 110.908 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.546 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 46.5 p90 -54.56 -36.32 64.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 74.230000000000004 110.882 -176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -62.99 -24.15 67.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 73.140000000000001 111.398 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.34 16.91 24.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.285 -0.416 . . . . 72.140000000000001 110.723 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.69 7.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 75.530000000000001 111.169 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -74.43 -11.03 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.893 -0.594 . . . . 72.409999999999997 111.016 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.89 63.45 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.928 -0.578 . . . . 75.140000000000001 112.485 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 4.7 tm-20 -57.62 -54.81 42.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.072 0.463 . . . . 70.209999999999994 109.996 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -103.67 -24.69 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 72.200000000000003 110.086 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.06 -175.22 52.57 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 112.317 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.799 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m-85 -151.04 -59.47 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.877 0.471 . . . . 75.400000000000006 110.119 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 72.8 Cg_endo -95.26 157.6 1.66 Allowed 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.653 2.235 . . . . 74.049999999999997 112.193 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.82 -17.28 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.852 2.368 . . . . 75.519999999999996 112.472 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.74 -32.53 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 74.310000000000002 110.251 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.651 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 mm -109.14 99.56 36.45 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.05 -0.523 . . . . 64.329999999999998 109.619 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.635 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 36.2 Cg_endo -66.08 152.22 81.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.515 2.144 . . . . 73.409999999999997 112.182 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 34.3 Cg_exo -62.87 137.13 61.02 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.36 2.04 . . . . 61.409999999999997 111.277 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 64.75 37.5 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.63 0.581 . . . . 73.319999999999993 110.501 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -92.98 116.33 28.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.607 -0.724 . . . . 74.120000000000005 110.544 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -74.1 133.96 42.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 71.230000000000004 109.389 173.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -124.87 144.3 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 73.030000000000001 109.307 -172.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.419 ' H ' HD13 ' A' ' 121' ' ' LEU . 88.6 t -100.85 128.01 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 109.914 -0.402 . . . . 74.230000000000004 109.914 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -123.02 120.71 34.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.151 0.501 . . . . 52.100000000000001 110.329 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -82.84 111.05 18.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.614 -0.884 . . . . 64.310000000000002 108.614 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.638 HG12 ' HD1' ' A' ' 50' ' ' TYR . 34.2 m -104.81 150.24 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.029 -0.987 . . . . 41.0 110.614 -173.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.01 128.88 12.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.49 -0.323 . . . . 75.209999999999994 110.439 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -93.43 118.17 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.929 -0.767 . . . . 72.310000000000002 108.929 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.79 -50.33 5.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.428 0.156 . . . . 73.209999999999994 111.141 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.24 0.543 . . . . 55.219999999999999 111.677 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 92' ' ' LEU . 13.3 p . . . . . 0 C--O 1.251 1.167 0 CA-C-N 115.206 -0.906 . . . . 71.349999999999994 108.947 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 . . . . . 0 C--O 1.232 0.139 0 N-CA-C 109.711 -0.477 . . . . 62.340000000000003 109.711 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.8 tp -128.0 118.21 23.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.83 0.348 . . . . 71.530000000000001 110.298 -176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 29' ' ' LYS . 43.2 mt-10 -123.72 146.06 48.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 65.329999999999998 111.001 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -141.02 110.67 6.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 71.0 109.459 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.604 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.9 mptt -108.69 110.4 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 73.319999999999993 109.697 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.5 112.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.015 0.436 . . . . 70.430000000000007 110.139 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.6 mt -92.08 -30.11 16.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.119 -177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 33.6 m -141.37 110.66 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.982 -0.748 . . . . 74.030000000000001 108.982 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.63 135.65 28.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.271 1.981 . . . . 71.120000000000005 112.043 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.94 -165.0 30.65 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.143 -0.551 . . . . 71.120000000000005 111.747 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.24 -20.71 62.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.63 0.215 . . . . 72.409999999999997 111.165 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.22 -30.32 1.15 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.489 -0.386 . . . . 51.130000000000003 113.481 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.4 -32.85 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 73.239999999999995 110.87 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 1.9 p -80.02 108.17 13.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.498 0.666 . . . . 54.219999999999999 110.61 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 41' ' ' GLN . 56.5 pttt -94.43 125.91 50.09 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.105 -0.952 . . . . 63.140000000000001 111.426 -173.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.99 106.17 2.12 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.853 2.368 . . . . 71.040000000000006 110.564 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' OE1' ' HE3' ' A' ' 39' ' ' LYS . 26.1 mt-30 -88.12 146.06 25.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.379 -0.373 . . . . 75.109999999999999 111.242 -176.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.45 156.77 36.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.857 -0.611 . . . . 74.420000000000002 109.892 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.19 16.6 79.65 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.905 -0.664 . . . . 65.140000000000001 111.68 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -132.94 154.86 50.03 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.737 0.415 . . . . 74.430000000000007 109.982 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.718 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -73.17 127.2 31.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 61.229999999999997 109.944 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 130' ' ' VAL . 35.9 m -124.77 150.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 120.818 0.342 . . . . 64.049999999999997 110.642 177.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 m -111.27 110.53 21.06 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.213 -0.903 . . . . 54.210000000000001 110.698 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.737 HG12 HD22 ' A' ' 127' ' ' LEU . 24.8 m -128.66 177.88 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.719 0.771 . . . . 41.030000000000001 112.914 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 8.7 m170 -139.68 152.48 46.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.463 -1.244 . . . . 71.409999999999997 108.933 172.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 83' ' ' TRP . 63.6 m-85 -134.91 142.53 46.57 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.542 -0.54 . . . . 71.340000000000003 109.542 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 36.5 t0 -137.02 143.76 42.9 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.203 -0.295 . . . . 72.430000000000007 110.203 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.55 140.01 15.22 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.338 -0.458 . . . . 64.230000000000004 112.328 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -157.26 149.31 22.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.375 0.607 . . . . 71.310000000000002 111.781 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.87 153.37 63.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.385 -0.825 . . . . 75.120000000000005 109.595 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.11 -20.28 45.32 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.029 2.486 . . . . 74.209999999999994 113.812 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.87 4.16 45.69 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.77 0.319 . . . . 72.299999999999997 111.004 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.37 26.01 37.69 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.184 -0.531 . . . . 52.539999999999999 112.342 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.04 146.77 39.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.807 -0.442 . . . . 64.140000000000001 109.807 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -160.15 157.49 28.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.977 -0.379 . . . . 72.329999999999998 109.977 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -69.21 -42.38 75.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.323 -0.399 . . . . 73.530000000000001 110.706 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.451 ' CG ' HH21 ' A' ' 66' ' ' ARG . 28.0 t70 -170.0 145.71 2.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.725 -0.671 . . . . 72.129999999999995 109.955 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.3 t -82.79 114.8 21.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.624 -0.509 . . . . 73.409999999999997 109.624 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.6 m -86.67 -28.0 23.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 61.149999999999999 111.783 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -69.61 -31.47 69.62 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.142 -0.349 . . . . 74.420000000000002 110.828 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 29.8 p -73.6 -2.92 24.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.285 -0.416 . . . . 52.329999999999998 111.09 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.451 HH21 ' CG ' ' A' ' 61' ' ' ASP . 28.5 mmt180 -75.95 -3.93 38.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.52 -0.309 . . . . 75.439999999999998 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.36 71.66 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.47 -0.395 . . . . 63.329999999999998 113.045 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 55.8 tptt -91.97 106.82 18.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.549 -0.537 . . . . 75.340000000000003 109.549 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.1 Cg_exo -80.86 139.95 12.53 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.176 2.584 . . . . 73.209999999999994 112.1 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -107.62 142.89 36.86 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.793 -0.817 . . . . 71.230000000000004 108.793 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.718 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 50.7 mt-30 -134.63 138.26 44.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.32 -0.252 . . . . 75.030000000000001 110.32 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.32 164.26 34.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.774 -0.193 . . . . 73.400000000000006 110.657 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.5 m -78.53 111.42 14.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.839 -0.43 . . . . 75.200000000000003 109.839 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 88' ' ' ALA . 50.7 tp -61.03 142.61 56.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.41 -0.359 . . . . 75.129999999999995 110.765 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.57 30.51 44.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.192 -0.528 . . . . 51.530000000000001 111.967 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.16 160.7 39.19 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.387 -0.227 . . . . 74.430000000000007 110.387 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.98 42.75 2.12 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 116.39 -0.368 . . . . 54.409999999999997 113.131 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -76.81 -47.43 21.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.973 -0.751 . . . . 75.439999999999998 108.973 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 35.2 m -121.66 175.53 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.222 -0.899 . . . . 32.009999999999998 109.143 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.547 HG13 ' H ' ' A' ' 83' ' ' TRP . 37.2 pt -64.6 144.6 14.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.902 -0.407 . . . . 75.420000000000002 109.902 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 3.9 tmtm? -58.92 -22.52 59.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.308 -0.405 . . . . 73.310000000000002 109.936 -176.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.32 -52.59 51.75 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.921 -0.657 . . . . 34.43 111.793 175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.547 ' H ' HG13 ' A' ' 80' ' ' ILE . 51.3 m0 -67.39 -41.87 84.26 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.127 -0.324 . . . . 71.340000000000003 110.127 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.2 t70 -54.47 -45.68 73.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.622 -0.717 . . . . 72.430000000000007 110.236 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -64.37 -44.72 90.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 73.310000000000002 110.319 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.75 -49.61 61.05 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.733 -0.667 . . . . 70.400000000000006 112.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.6 -30.34 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.49 0.186 . . . . 62.310000000000002 111.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -72.92 -30.23 63.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.617 0.228 . . . . 72.340000000000003 111.617 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.7 t -81.32 -4.15 54.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.723 0.296 . . . . 72.319999999999993 111.696 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 15.2 ptp -112.2 -176.66 2.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.886 0.374 . . . . 71.329999999999998 110.792 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.9 p -121.34 176.2 5.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.458 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -62.64 126.94 29.04 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.981 0.419 . . . . 74.120000000000005 110.71 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.84 65.12 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.648 -0.705 . . . . 72.25 112.772 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 32' ' ' THR . 15.0 tt0 -99.4 143.57 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 71.340000000000003 111.071 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -131.11 120.01 22.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.097 -0.705 . . . . 74.540000000000006 109.097 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.8 147.09 50.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.294 0.569 . . . . 55.240000000000002 111.306 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD22 ' HD3' ' A' ' 29' ' ' LYS . 10.0 tt -90.44 104.96 17.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.676 -1.231 . . . . 62.350000000000001 107.676 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -103.45 118.4 36.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.992 -0.549 . . . . 65.010000000000005 109.731 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -89.06 106.53 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.318 -0.401 . . . . 71.140000000000001 110.0 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 25.6 mm -86.44 113.69 53.83 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.949 -0.569 . . . . 60.109999999999999 111.076 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 120' ' ' THR . 36.3 Cg_endo -66.12 149.93 85.42 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.372 2.048 . . . . 51.240000000000002 110.33 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.495 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 45.9 p90 -54.45 -31.71 56.06 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.356 0.502 . . . . 74.230000000000004 112.356 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.87 -23.78 64.26 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.004 0.372 . . . . 73.140000000000001 112.004 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.03 6.32 46.85 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.556 0.206 . . . . 72.140000000000001 111.556 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.06 -177.71 6.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 75.530000000000001 111.039 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -67.67 -14.3 62.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 72.409999999999997 110.875 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.62 -23.19 35.21 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.405 0.44 . . . . 75.140000000000001 112.63 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 44.9 tt0 -56.76 -44.24 81.57 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.044 0.449 . . . . 70.209999999999994 110.254 174.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 109' ' ' ARG . 20.1 mtp180 -97.92 -18.82 18.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.528 -0.76 . . . . 72.200000000000003 110.42 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 115' ' ' ILE . . . 67.23 -110.22 3.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.761 -0.654 . . . . 74.310000000000002 112.681 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 31.8 m-85 102.92 -71.33 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.639 1.575 . . . . 75.400000000000006 112.418 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.729 ' HG2' ' HB ' ' A' ' 115' ' ' ILE . 41.9 Cg_endo -65.84 149.45 86.63 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 121.439 1.426 . . . . 74.049999999999997 111.748 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 71.5 Cg_exo -51.92 -31.85 44.97 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.103 2.536 . . . . 75.519999999999996 113.23 -175.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 115' ' ' ILE . 27.4 m -83.2 -20.39 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 74.310000000000002 111.586 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 114' ' ' VAL . 49.2 mm -125.15 94.6 43.27 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.486 -0.325 . . . . 64.329999999999998 110.254 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 169.9 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.811 2.341 . . . . 73.409999999999997 111.402 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.58 148.46 63.87 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.127 1.884 . . . . 61.409999999999997 111.694 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.92 16.38 8.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.144 0.578 . . . . 73.319999999999993 111.818 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.39 112.21 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.120000000000005 111.752 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.7 m -88.15 119.59 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.502 -0.925 . . . . 71.230000000000004 108.502 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -124.59 147.97 48.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.649 0.262 . . . . 73.030000000000001 110.512 -167.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.595 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.0 t -98.52 131.85 44.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.428 -0.351 . . . . 74.230000000000004 110.705 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 97.4 m-85 -130.01 121.94 27.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.388 -0.369 . . . . 52.100000000000001 110.561 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 16.8 mt-10 -77.4 113.95 15.72 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.264 -0.643 . . . . 64.310000000000002 109.264 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 132.93 42.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.617 -0.719 . . . . 41.0 109.345 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.6 tt0 -133.32 112.33 11.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 75.209999999999994 110.629 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.749 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -87.62 106.2 17.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.333 -0.618 . . . . 72.310000000000002 109.333 178.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.564 HD21 ' ND1' ' A' ' 49' ' ' HIS . 3.9 mm? -79.24 -50.63 10.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.215 0.531 . . . . 73.209999999999994 109.949 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.572 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . . . -168.35 -176.68 2.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 55.219999999999999 109.683 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 46' ' ' VAL . 31.3 t . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.708 -0.849 . . . . 71.349999999999994 108.708 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 110.247 -0.279 . . . . 62.340000000000003 110.247 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 47.8 tp -145.95 101.72 3.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.193 -0.458 . . . . 71.530000000000001 110.26 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -116.84 122.99 45.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.706 -0.479 . . . . 65.329999999999998 109.706 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' NZ ' ' OG1' ' A' ' 89' ' ' THR . 61.5 pttt -126.39 119.29 26.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.114 0.483 . . . . 71.0 110.13 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.648 -0.705 . . . . 73.319999999999993 110.214 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -61.45 110.6 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.134 0.493 . . . . 70.430000000000007 109.739 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.562 HD23 ' HE3' ' A' ' 95' ' ' LYS . 34.8 tp -96.04 -25.13 16.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.018 -0.537 . . . . 73.129999999999995 110.072 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 57.1 m -149.0 110.77 3.52 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.893 -0.594 . . . . 74.030000000000001 109.725 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.38 133.84 21.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.039 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -95.24 -151.86 28.73 Favored Glycine 0 C--O 1.236 0.254 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 111.823 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' HG1' ' A' ' 38' ' ' THR . 44.1 m-20 -63.92 -36.14 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.933 0.367 . . . . 72.409999999999997 111.306 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.48 -30.03 2.83 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 112.479 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.81 -25.11 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.799 0.333 . . . . 73.239999999999995 111.484 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.444 ' HG1' ' HB2' ' A' ' 35' ' ' ASP . 7.8 p -80.31 96.47 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 54.219999999999999 110.701 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 22.4 pttp -97.89 124.32 48.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.555 . . . . 63.140000000000001 111.651 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -75.12 154.16 41.74 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.902 2.401 . . . . 71.040000000000006 111.401 173.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.63 174.82 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.565 -0.288 . . . . 75.109999999999999 110.689 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.2 144.19 57.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.353 -0.385 . . . . 74.420000000000002 111.153 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.74 16.22 71.08 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.166 -0.47 . . . . 65.140000000000001 112.434 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 27.8 mmmt -109.33 121.8 45.97 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.526 0.331 . . . . 74.430000000000007 111.174 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -74.16 106.1 5.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.15 -0.685 . . . . 61.229999999999997 109.15 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.44 142.14 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.21 0.528 . . . . 64.049999999999997 111.689 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 25.5 m -103.65 108.3 19.52 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.132 -0.94 . . . . 54.210000000000001 109.079 175.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.0 178.15 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.944 -0.571 . . . . 41.030000000000001 111.76 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.494 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.8 t-80 -147.59 139.95 24.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.696 -0.684 . . . . 71.409999999999997 109.366 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.4 m-85 -126.46 149.84 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.37 0.419 . . . . 71.340000000000003 110.543 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 56.9 m-20 -136.11 128.27 29.86 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.607 -0.516 . . . . 72.430000000000007 109.607 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.73 115.52 4.88 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 121.124 -0.56 . . . . 64.230000000000004 112.34 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 26.7 ttp180 -133.32 144.24 49.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 110.951 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -74.34 144.55 81.48 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.962 -0.755 . . . . 75.120000000000005 108.962 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -39.96 -48.74 3.74 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.658 2.905 . . . . 74.209999999999994 114.045 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.81 -41.4 97.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.325 0.491 . . . . 72.299999999999997 112.325 -173.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.84 -24.43 0.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.515 -0.85 . . . . 52.539999999999999 113.108 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -66.71 112.83 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.813 -0.228 . . . . 64.140000000000001 111.174 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.566 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 12.1 pt20 -102.11 144.03 31.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.016 -0.364 . . . . 72.329999999999998 110.016 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -96.44 -26.81 15.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.437 -0.347 . . . . 73.530000000000001 110.606 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -148.36 138.18 22.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.09 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.2 p -124.28 90.2 3.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.11 0.481 . . . . 73.409999999999997 110.589 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -68.05 -18.27 64.63 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 61.149999999999999 110.361 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HG2' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -59.42 -35.27 73.69 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.56 . . . . 74.420000000000002 110.248 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.496 ' N ' ' HG2' ' A' ' 64' ' ' ARG . 8.1 m -64.87 -28.5 69.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.755 -0.657 . . . . 52.329999999999998 110.309 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -96.01 -16.79 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.838 -0.619 . . . . 75.439999999999998 110.373 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.05 35.39 91.93 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.691 -0.564 . . . . 63.329999999999998 111.691 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 69' ' ' PRO . 12.9 tmtt? -85.95 116.75 66.96 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 110.232 -0.284 . . . . 75.340000000000003 110.232 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.451 ' O ' ' HD3' ' A' ' 68' ' ' LYS . 56.7 Cg_endo -94.18 175.06 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.3 2.666 . . . . 73.209999999999994 112.659 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -149.05 128.75 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.381 -0.6 . . . . 71.230000000000004 109.381 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.9 137.09 42.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.562 0.22 . . . . 75.030000000000001 110.891 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 37.7 p90 -154.64 158.19 39.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.749 -0.463 . . . . 73.400000000000006 109.749 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m -87.21 106.65 18.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.76 0.314 . . . . 75.200000000000003 110.816 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.77 111.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 109.774 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.24 -30.67 2.69 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.058 -0.817 . . . . 51.530000000000001 111.058 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.83 158.27 15.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.882 -0.414 . . . . 74.430000000000007 109.882 176.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 43.27 2.35 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.287 -0.483 . . . . 54.409999999999997 113.185 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.24 -23.74 62.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.044 0.45 . . . . 75.439999999999998 110.39 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.63 168.54 22.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.882 -0.599 . . . . 32.009999999999998 110.254 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 104' ' ' LEU . 12.6 pt -75.48 158.36 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 75.420000000000002 110.352 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 7.0 tmtm? -56.01 -37.41 69.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.79 0.329 . . . . 73.310000000000002 110.472 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.21 -46.33 86.11 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.804 -0.713 . . . . 34.43 112.158 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -73.1 -38.65 66.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.477 -0.194 . . . . 71.340000000000003 110.477 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.71 78.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.002 0.43 . . . . 72.430000000000007 110.024 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.35 -43.92 89.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 109.923 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.93 -50.03 52.46 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.85 -0.613 . . . . 70.400000000000006 112.827 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.566 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.8 m -75.38 -33.3 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 62.310000000000002 111.328 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.15 -20.77 55.06 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.065 0.394 . . . . 72.340000000000003 112.065 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 86' ' ' GLY . 7.9 t -86.98 0.99 54.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.892 0.33 . . . . 72.319999999999993 111.892 -176.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.625 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 19.2 ptp -116.22 -171.18 1.94 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.615 0.245 . . . . 71.329999999999998 111.07 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 p -132.05 178.83 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.195 -0.457 . . . . 75.530000000000001 110.941 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.636 HD23 HG12 ' A' ' 130' ' ' VAL . 3.2 tm? -60.86 128.57 37.14 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 120.783 0.325 . . . . 74.120000000000005 110.753 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.74 87.45 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.62 -0.718 . . . . 72.25 112.592 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.1 tt0 -102.66 143.74 31.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.708 0.289 . . . . 71.340000000000003 110.705 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HE3' HD23 ' A' ' 31' ' ' LEU . 37.9 ttpt -136.86 142.48 42.8 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.012 0.434 . . . . 74.540000000000006 110.175 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.94 151.75 48.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.845 -0.616 . . . . 55.240000000000002 110.901 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.0 tp -90.59 105.37 17.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.385 -1.339 . . . . 62.350000000000001 107.385 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 11.3 t80 -110.44 109.65 20.11 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.048 -0.524 . . . . 65.010000000000005 111.086 -167.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.1 m -73.05 113.13 9.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.616 . . . . 71.140000000000001 110.682 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' A' ' 105' ' ' ALA . 35.2 mm -96.75 111.82 58.53 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.363 -0.38 . . . . 60.109999999999999 110.383 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HA ' HG23 ' A' ' 120' ' ' THR . 23.3 Cg_endo -61.85 155.55 53.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.531 2.154 . . . . 51.240000000000002 111.261 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 9.6 p90 -54.37 -42.16 70.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.837 -0.62 . . . . 74.230000000000004 112.265 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.25 -7.6 56.21 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.787 0.291 . . . . 73.140000000000001 111.787 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 80' ' ' ILE . 56.9 mt -102.84 15.3 29.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 72.140000000000001 110.56 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -152.83 175.01 13.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 75.530000000000001 110.616 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -66.28 -15.64 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 72.409999999999997 110.65 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -62.0 -16.68 53.34 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.013 -0.54 . . . . 75.140000000000001 112.636 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 102' ' ' TYR . 3.3 tm-20 -60.56 -55.87 28.22 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.102 0.477 . . . . 70.209999999999994 109.748 176.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.55 -31.44 14.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 72.200000000000003 111.391 -171.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.96 140.64 1.9 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.194 -0.527 . . . . 74.310000000000002 112.441 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.671 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.3 m-85 -137.54 -55.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 122.333 0.253 . . . . 75.400000000000006 110.681 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 80.5 Cg_endo -88.44 139.75 4.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.87 1.713 . . . . 74.049999999999997 111.299 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 72.8 Cg_exo -52.14 -24.88 21.37 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.862 2.374 . . . . 75.519999999999996 113.331 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 115' ' ' ILE . 27.2 m -72.88 -26.7 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.643 -0.253 . . . . 74.310000000000002 111.498 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 114' ' ' VAL . 49.1 mm -113.18 101.92 54.1 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.782 -0.451 . . . . 64.329999999999998 109.782 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.12 163.83 34.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.63 2.22 . . . . 73.409999999999997 111.97 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.3 148.7 84.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.295 1.997 . . . . 61.409999999999997 111.709 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt 67.89 19.58 9.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 73.319999999999993 111.087 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.21 27.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 111.082 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 101' ' ' PRO . 47.1 m -86.96 131.97 33.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.032 -0.729 . . . . 71.230000000000004 109.032 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -132.13 136.88 47.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.811 -0.44 . . . . 73.030000000000001 109.811 -171.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.535 ' N ' HD13 ' A' ' 121' ' ' LEU . 52.1 t -104.38 120.58 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 74.230000000000004 110.208 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 96.2 m-85 -109.31 127.22 54.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.251 -0.431 . . . . 52.100000000000001 110.419 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 29.7 mt-10 -75.15 114.1 13.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.408 -0.96 . . . . 64.310000000000002 108.408 168.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.488 HG23 ' HE3' ' A' ' 90' ' ' MET . 11.4 m -107.55 134.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 41.0 109.964 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.86 133.87 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.635 -0.257 . . . . 75.209999999999994 110.796 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.641 HD11 ' HB ' ' A' ' 130' ' ' VAL . 1.7 tm? -98.52 105.92 18.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.296 -0.631 . . . . 72.310000000000002 109.296 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.7 mm? -85.41 -41.98 14.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.418 -0.355 . . . . 73.209999999999994 111.189 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -146.7 140.52 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.652 0.263 . . . . 55.219999999999999 111.201 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 127' ' ' LEU . 5.0 p . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.428 -0.796 . . . . 71.349999999999994 109.929 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 109.532 -0.544 . . . . 62.340000000000003 109.532 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.64 110.61 5.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.36 . . . . 71.530000000000001 111.65 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.499 ' H ' ' HB ' ' A' ' 99' ' ' THR . 42.9 mm-40 -109.83 113.51 26.3 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.026 -0.731 . . . . 65.329999999999998 109.026 170.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -111.1 101.34 9.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.529 0.681 . . . . 71.0 109.461 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 43.0 tptt -108.96 117.66 34.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.508 -0.769 . . . . 73.319999999999993 110.17 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.99 106.0 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.483 -0.562 . . . . 70.430000000000007 109.483 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.49 HD12 ' HE2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -86.62 -29.66 22.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 73.129999999999995 109.734 -173.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -152.88 110.66 2.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.63 . . . . 74.030000000000001 109.563 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.58 126.7 20.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.876 2.384 . . . . 71.120000000000005 111.978 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.619 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -102.59 -157.63 25.7 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.358 -0.449 . . . . 71.120000000000005 112.6 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.83 -56.64 19.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.601 0.361 . . . . 72.409999999999997 111.26 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.88 -30.05 10.85 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 119.793 -0.449 . . . . 51.130000000000003 114.205 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.21 -9.72 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.102 0.951 . . . . 73.239999999999995 111.494 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.3 m -109.19 111.68 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.874 -0.417 . . . . 54.219999999999999 109.874 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 8.2 mtpm? -106.47 140.08 20.96 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.417 -0.356 . . . . 63.140000000000001 110.786 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.11 160.56 39.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.266 1.977 . . . . 71.040000000000006 110.672 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -141.29 171.46 14.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.633 0.254 . . . . 75.109999999999999 110.738 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.26 156.56 37.08 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.079 -0.51 . . . . 74.420000000000002 111.403 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.9 27.06 67.51 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.009 -0.541 . . . . 65.140000000000001 112.151 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -130.71 128.04 40.06 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.525 -0.176 . . . . 74.430000000000007 110.525 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 17.1 tppt? -73.45 104.91 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.006 -0.739 . . . . 61.229999999999997 109.006 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.3 m -107.26 152.26 8.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.144 0.497 . . . . 64.049999999999997 112.185 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.0 m -100.42 110.17 22.36 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.053 -0.976 . . . . 54.210000000000001 110.393 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' A' ' 72' ' ' PHE . 30.4 m -121.57 178.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.35 -0.841 . . . . 41.030000000000001 111.889 -172.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 4.6 t-160 -144.32 138.25 27.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.003 -0.74 . . . . 71.409999999999997 109.003 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' CD1' HG12 ' A' ' 125' ' ' VAL . 94.5 m-85 -126.64 144.21 50.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.572 -0.285 . . . . 71.340000000000003 110.96 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 58.7 m-20 -136.18 144.66 45.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.931 -0.766 . . . . 72.430000000000007 108.931 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.57 128.34 9.15 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.104 -0.569 . . . . 64.230000000000004 112.65 -173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 13.3 ttm180 -139.61 140.72 37.07 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.56 0.695 . . . . 71.310000000000002 111.343 -175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 60' ' ' PHE . 83.5 m-85 -81.19 157.82 70.39 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.538 -0.755 . . . . 75.120000000000005 109.468 172.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.97 -15.09 36.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.615 2.21 . . . . 74.209999999999994 112.247 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.29 -5.97 58.38 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.079 -0.509 . . . . 72.299999999999997 110.902 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.69 49.34 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.196 -0.526 . . . . 52.539999999999999 112.625 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.72 122.17 19.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 122.296 0.238 . . . . 64.140000000000001 110.885 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 12.8 pt20 -85.23 132.58 34.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.742 -0.466 . . . . 72.329999999999998 109.742 175.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 121' ' ' LEU . 44.8 p90 -89.34 -19.6 25.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.627 0.251 . . . . 73.530000000000001 110.847 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -156.97 144.31 18.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.614 -0.513 . . . . 72.129999999999995 109.614 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.8 p -124.46 98.7 5.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 110.861 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.04 64.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.344 -0.613 . . . . 61.149999999999999 109.344 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.472 HH12 ' CD ' ' A' ' 124' ' ' GLU . 6.9 ptt-85 -60.85 -41.19 95.36 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.603 -0.726 . . . . 74.420000000000002 110.807 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 t -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.978 -0.379 . . . . 52.329999999999998 109.978 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 66' ' ' ARG . 44.6 mtt180 -85.15 -28.85 25.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.172 0.511 . . . . 75.439999999999998 110.059 176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.08 26.27 64.65 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.578 -0.737 . . . . 63.329999999999998 111.712 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.35 116.84 55.91 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 122.234 0.214 . . . . 75.340000000000003 111.309 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.41 -178.63 3.8 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 73.209999999999994 112.074 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -140.86 163.62 32.43 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.951 -0.759 . . . . 71.230000000000004 108.951 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -142.07 138.07 31.47 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.55 0.214 . . . . 75.030000000000001 110.621 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 20.6 p90 -157.29 165.76 34.97 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.964 -0.384 . . . . 73.400000000000006 109.964 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 m -89.15 108.83 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.348 -0.241 . . . . 75.200000000000003 110.348 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.1 135.14 57.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.171 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.55 58.77 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.26 -0.495 . . . . 51.530000000000001 112.405 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.54 171.46 14.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.996 0.427 . . . . 74.430000000000007 110.999 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.12 55.93 4.95 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.745 -0.661 . . . . 54.409999999999997 112.333 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -119.12 -19.01 8.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.614 0.245 . . . . 75.439999999999998 110.495 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -142.77 162.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.497 -0.319 . . . . 32.009999999999998 110.324 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 104' ' ' LEU . 15.8 pt -72.31 151.34 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.958 -0.564 . . . . 75.420000000000002 110.366 174.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 51.3 mmtt -60.47 -15.81 30.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.331 0.493 . . . . 73.310000000000002 112.331 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.69 -60.27 8.78 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.26 -0.972 . . . . 34.43 111.254 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -67.07 -39.58 86.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.101 -0.333 . . . . 71.340000000000003 110.101 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 20.8 t70 -52.14 -54.95 24.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.513 -0.767 . . . . 72.430000000000007 110.625 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -68.21 -36.75 80.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.044 -0.525 . . . . 73.310000000000002 110.507 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -53.43 31.47 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.536 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' MET . 33.4 m -75.59 -30.89 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.734 0.302 . . . . 62.310000000000002 111.091 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.39 -26.23 67.15 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 86' ' ' GLY . 10.9 t -87.99 0.79 55.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.882 0.327 . . . . 72.319999999999993 111.882 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 16.1 ptp -112.4 -174.98 2.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.06 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -121.98 178.98 4.67 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.218 -0.446 . . . . 75.530000000000001 111.072 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -60.56 128.36 36.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.986 -0.552 . . . . 74.120000000000005 110.653 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.409 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 71.26 35.78 63.71 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.577 -0.344 . . . . 72.25 112.427 176.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.619 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 28.6 tt0 -128.02 150.45 49.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.666 0.27 . . . . 71.340000000000003 110.324 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HE2' HD12 ' A' ' 31' ' ' LEU . 6.8 ttpm? -133.26 138.84 46.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 74.540000000000006 110.678 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.9 145.07 41.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.768 -0.651 . . . . 55.240000000000002 110.645 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 8.6 tt -90.25 105.56 17.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.321 -1.362 . . . . 62.350000000000001 107.321 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.56 ' HD2' HD13 ' A' ' 100' ' ' ILE . 17.7 t80 -111.65 114.05 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 65.010000000000005 110.031 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 16.2 m -75.71 106.75 7.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 110.068 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.56 HD13 ' HD2' ' A' ' 98' ' ' PHE . 34.5 mm -80.77 114.31 47.17 Favored Pre-proline 0 C--O 1.243 0.744 0 CA-C-N 116.069 -0.514 . . . . 60.109999999999999 110.568 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.663 ' HA ' HG23 ' A' ' 120' ' ' THR . 21.4 Cg_exo -66.31 149.93 84.84 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.825 2.35 . . . . 51.240000000000002 112.007 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.38 -30.46 52.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.755 -0.657 . . . . 74.230000000000004 111.307 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -65.64 -35.95 82.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.066 -0.516 . . . . 73.140000000000001 111.388 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 80' ' ' ILE . 93.3 mt -100.48 19.96 15.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.140000000000001 111.022 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.09 -178.22 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 75.530000000000001 110.995 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.22 -9.93 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.646 -0.707 . . . . 72.409999999999997 110.424 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.92 40.08 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.856 -0.611 . . . . 75.140000000000001 113.742 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 35.9 tt0 -65.97 -41.36 91.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.652 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.51 -14.07 20.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.052 -0.522 . . . . 72.200000000000003 111.053 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 66.89 -82.07 0.12 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-N 116.033 -0.53 . . . . 74.310000000000002 113.777 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.747 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 62.9 m-85 97.92 -74.25 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.859 1.663 . . . . 75.400000000000006 111.478 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 11.3 Cg_endo -89.05 143.16 4.77 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.058 1.839 . . . . 74.049999999999997 111.856 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.62 -18.41 40.11 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.862 2.375 . . . . 75.519999999999996 112.422 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.68 -37.39 79.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.031 -0.532 . . . . 74.310000000000002 109.948 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.8 mm -106.8 106.48 58.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.573 -0.74 . . . . 64.329999999999998 109.498 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.44 148.6 92.56 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.457 2.105 . . . . 73.409999999999997 112.365 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.36 144.35 67.51 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.551 2.168 . . . . 61.409999999999997 112.235 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 44.7 mtpt 63.59 25.72 14.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.402 -0.817 . . . . 73.319999999999993 111.21 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.49 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 74.120000000000005 111.535 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 101' ' ' PRO . 28.3 m -86.18 131.24 34.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 71.230000000000004 109.072 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -123.82 145.73 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.711 -0.478 . . . . 73.030000000000001 109.711 -170.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.615 ' N ' HD13 ' A' ' 121' ' ' LEU . 97.5 t -98.38 119.8 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.78 0.324 . . . . 74.230000000000004 110.33 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.409 ' CE1' HD12 ' A' ' 121' ' ' LEU . 57.7 m-85 -116.08 118.61 33.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 52.100000000000001 110.166 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 38.2 mt-10 -83.22 106.99 15.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.831 . . . . 64.310000000000002 109.037 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.442 ' O ' ' HE1' ' A' ' 90' ' ' MET . 28.9 m -102.92 145.32 12.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 41.0 110.261 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 43.5 tt0 -143.27 130.12 20.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.542 -0.299 . . . . 75.209999999999994 110.484 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -98.82 105.7 17.88 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.922 -0.77 . . . . 72.310000000000002 108.922 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.89 -48.14 10.33 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.894 0.378 . . . . 73.209999999999994 110.289 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -164.94 -173.68 3.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.656 -0.702 . . . . 55.219999999999999 109.823 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.081 -0.961 . . . . 71.349999999999994 109.762 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.715 ' HB2' HG21 ' A' ' 120' ' ' THR . 71.7 mt-30 . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.899 -0.408 . . . . 62.340000000000003 109.899 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -145.76 112.94 6.15 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.816 0.341 . . . . 71.530000000000001 110.96 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 43.6 mt-10 -136.86 135.36 37.8 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.263 -0.643 . . . . 65.329999999999998 109.263 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -132.91 101.12 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.482 0.658 . . . . 71.0 109.668 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -113.34 110.89 21.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.245 -0.889 . . . . 73.319999999999993 110.378 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.13 111.1 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 70.430000000000007 110.445 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.5 mt -85.4 -24.04 27.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 73.129999999999995 110.327 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.1 m -153.35 110.69 2.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.634 -0.712 . . . . 74.030000000000001 109.462 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.83 126.6 13.45 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 71.120000000000005 111.835 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.19 -145.66 15.24 Favored Glycine 0 C--O 1.237 0.296 0 CA-C-N 115.906 -0.588 . . . . 71.120000000000005 112.114 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.477 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.6 m-20 -66.0 -43.92 86.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.787 0.327 . . . . 72.409999999999997 111.501 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.48 -30.14 2.82 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.228 -0.51 . . . . 51.130000000000003 112.333 -175.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' HB3' ' A' ' 35' ' ' ASP . 33.4 m -89.29 -24.9 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.943 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.4 p -78.03 95.41 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 54.219999999999999 110.524 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -106.41 103.91 48.03 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.577 -0.738 . . . . 63.140000000000001 111.066 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.11 156.62 42.52 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.467 2.111 . . . . 71.040000000000006 111.454 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.76 170.69 14.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.329 . . . . 75.109999999999999 110.74 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.88 156.74 26.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.806 -0.634 . . . . 74.420000000000002 111.047 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.92 25.28 67.29 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 115.889 -0.596 . . . . 65.140000000000001 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -130.01 119.15 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 74.430000000000007 110.748 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -66.34 104.27 1.18 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.159 -0.682 . . . . 61.229999999999997 109.159 172.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.549 HG12 HG23 ' A' ' 130' ' ' VAL . 29.5 m -106.98 155.56 7.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.301 -0.409 . . . . 64.049999999999997 111.342 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -98.91 108.27 20.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.483 -0.781 . . . . 54.210000000000001 110.646 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.508 HG12 HD22 ' A' ' 127' ' ' LEU . 10.5 m -123.43 178.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 41.030000000000001 111.394 -173.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 65.0 t60 -152.29 133.31 14.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 109.566 170.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -126.79 146.19 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.578 -0.897 . . . . 71.340000000000003 108.578 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' PHE . 0.8 OUTLIER -135.86 152.02 50.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.823 -0.436 . . . . 72.430000000000007 109.823 -177.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.05 129.32 9.78 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.381 -0.438 . . . . 64.230000000000004 113.003 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -147.52 145.94 29.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.2 0.524 . . . . 71.310000000000002 110.302 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.413 ' HE1' ' HB2' ' A' ' 60' ' ' PHE . 77.6 m-85 -90.22 148.47 39.29 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.306 -0.406 . . . . 75.120000000000005 110.422 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.77 -13.77 28.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.796 2.331 . . . . 74.209999999999994 111.719 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.16 -25.97 64.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.497 -0.774 . . . . 72.299999999999997 110.348 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.89 -14.78 28.99 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.343 -0.844 . . . . 52.539999999999999 111.489 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -103.11 148.67 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.09 0.556 . . . . 64.140000000000001 110.938 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.71 135.07 54.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.589 -0.522 . . . . 72.329999999999998 109.589 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.413 ' HB2' ' HE1' ' A' ' 54' ' ' PHE . 79.6 t80 -68.76 -62.34 1.43 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.148 -0.478 . . . . 73.530000000000001 110.783 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -137.51 131.31 31.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.92 -0.77 . . . . 72.129999999999995 108.92 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.547 ' OG ' ' HG3' ' A' ' 64' ' ' ARG . 9.7 t -111.02 134.44 52.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.108 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.8 m -75.75 -22.98 55.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.103 -0.499 . . . . 61.149999999999999 111.427 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.547 ' HG3' ' OG ' ' A' ' 62' ' ' SER . 6.7 ppt_? -56.82 -30.67 63.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.654 0.264 . . . . 74.420000000000002 110.861 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 8.9 m -59.14 -26.53 64.81 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.282 -0.417 . . . . 52.329999999999998 110.99 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -96.2 -16.12 21.64 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.113 -0.494 . . . . 75.439999999999998 110.409 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.95 15.78 69.72 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.804 -0.635 . . . . 63.329999999999998 113.51 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.3 ttpp -88.64 118.99 69.95 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-O 120.742 0.306 . . . . 75.340000000000003 111.009 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -89.27 -173.05 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.459 2.773 . . . . 73.209999999999994 111.753 175.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.435 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 81.0 m-85 -137.2 160.31 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 71.230000000000004 109.735 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -139.26 131.31 27.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.848 -0.427 . . . . 75.030000000000001 109.848 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -155.89 156.59 34.89 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.786 -0.45 . . . . 73.400000000000006 109.786 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 86.3 m -79.4 114.54 18.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.14 -0.319 . . . . 75.200000000000003 110.14 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.726 HD11 ' HB2' ' A' ' 88' ' ' ALA . 32.6 tp -56.83 123.13 13.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.744 -0.465 . . . . 75.129999999999995 109.744 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.74 -26.46 24.01 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.886 -0.486 . . . . 51.530000000000001 111.886 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.47 5.07 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.004 0.431 . . . . 74.430000000000007 111.231 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.37 16.52 48.78 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.158 -0.544 . . . . 54.409999999999997 113.186 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -56.25 -39.97 73.42 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 110.181 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 28.3 m -126.43 164.91 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 32.009999999999998 109.177 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 104' ' ' LEU . 14.9 pt -67.75 150.05 11.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.123 0.487 . . . . 75.420000000000002 111.482 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 24.8 mmtm -62.8 -17.42 61.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.787 -0.642 . . . . 73.310000000000002 111.845 -175.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.23 20.73 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.349 -0.929 . . . . 34.43 111.088 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.455 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 18.7 m0 -71.69 -36.54 70.61 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.503 -0.349 . . . . 71.340000000000003 110.216 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.678 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 10.0 t70 -52.82 -55.23 24.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.841 -0.618 . . . . 72.430000000000007 110.39 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.805 ' HA ' HE21 ' A' ' 85' ' ' GLN . 0.0 OUTLIER -72.75 -37.68 67.62 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.156 -0.475 . . . . 73.310000000000002 110.33 -179.098 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.28 -49.79 49.37 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.932 -0.577 . . . . 70.400000000000006 112.038 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.8 p -75.99 -32.29 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.816 0.341 . . . . 62.310000000000002 111.05 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.726 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.52 -29.18 68.95 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.8 t -78.69 4.01 14.88 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.932 0.716 . . . . 72.319999999999993 112.932 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.4 ptp -120.04 -179.47 3.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.203 0.456 . . . . 71.329999999999998 111.442 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.414 HG21 ' HA2' ' A' ' 36' ' ' GLY . 68.7 p -118.88 178.86 4.33 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.963 -0.562 . . . . 75.530000000000001 111.124 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.0 tt -67.24 135.87 54.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.072 0.463 . . . . 74.120000000000005 110.704 -176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.551 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.8 17.25 80.04 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.415 -0.812 . . . . 72.25 111.821 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.84 137.51 51.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 71.340000000000003 110.351 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -123.83 135.31 53.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.625 -0.716 . . . . 74.540000000000006 109.46 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.91 148.75 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.21 0.529 . . . . 55.240000000000002 111.544 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.0 tt -90.76 114.0 26.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.225 -1.028 . . . . 62.350000000000001 108.225 174.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -119.79 116.6 26.23 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.934 0.397 . . . . 65.010000000000005 110.417 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 18.4 m -75.67 106.44 7.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.085 -0.507 . . . . 71.140000000000001 110.304 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.1 mm -83.69 116.72 66.06 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.29 -0.414 . . . . 60.109999999999999 110.624 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.543 ' HA ' HG23 ' A' ' 120' ' ' THR . 52.1 Cg_exo -54.63 146.48 53.84 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.015 2.477 . . . . 51.240000000000002 112.066 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -54.22 -39.62 66.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 112.081 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -69.93 -25.82 63.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.807 0.337 . . . . 73.140000000000001 111.092 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 80' ' ' ILE . 85.7 mt -93.26 15.42 15.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.035 0.445 . . . . 72.140000000000001 110.261 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.19 -170.08 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 75.530000000000001 109.827 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.621 ' HE2' HG13 ' A' ' 115' ' ' ILE . 45.0 p90 -81.35 -7.56 59.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.37 . . . . 72.409999999999997 110.59 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.8 -21.32 65.18 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.836 -0.62 . . . . 75.140000000000001 112.934 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.21 -46.13 79.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.369 0.604 . . . . 70.209999999999994 110.402 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -102.86 -36.31 8.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.949 -1.023 . . . . 72.200000000000003 111.416 -166.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.19 90.58 0.05 OUTLIER Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.178 -0.534 . . . . 74.310000000000002 112.025 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.577 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 95.7 m-85 -82.98 -52.41 0.64 Allowed Pre-proline 0 CA--C 1.537 0.476 0 O-C-N 122.809 -0.23 . . . . 75.400000000000006 110.997 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 96.3 Cg_endo -84.87 143.92 9.57 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.757 1.638 . . . . 74.049999999999997 111.311 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.38 -16.81 30.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.371 . . . . 75.519999999999996 112.631 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.57 -34.74 58.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.074 -0.512 . . . . 74.310000000000002 110.526 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.621 HG13 ' HE2' ' A' ' 106' ' ' TYR . 49.2 mm -103.45 110.39 63.69 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 64.329999999999998 110.327 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.95 155.79 61.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.704 2.269 . . . . 73.409999999999997 111.992 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.34 148.91 88.69 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.239 1.96 . . . . 61.409999999999997 111.283 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 118' ' ' LYS . 9.2 mtpm? 60.93 23.15 13.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.04 0.536 . . . . 73.319999999999993 111.557 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.89 114.97 27.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.759 0.314 . . . . 74.120000000000005 110.474 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 25' ' ' GLN . 98.1 m -73.64 133.11 43.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 71.230000000000004 109.118 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.52 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.1 tm? -123.48 142.62 50.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.246 -0.65 . . . . 73.030000000000001 109.246 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.52 ' N ' HD13 ' A' ' 121' ' ' LEU . 67.4 t -98.27 136.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.001 0.429 . . . . 74.230000000000004 110.24 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 49.7 m-85 -123.28 122.18 37.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 52.100000000000001 110.42 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -80.36 107.23 12.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.28 -1.008 . . . . 64.310000000000002 108.28 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.84 150.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.507 -0.77 . . . . 41.0 111.195 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -150.19 136.33 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.976 -0.557 . . . . 75.209999999999994 110.295 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.5 tm? -96.81 109.53 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.572 -0.899 . . . . 72.310000000000002 108.572 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.71 -43.5 15.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.913 0.387 . . . . 73.209999999999994 110.426 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -171.23 -178.11 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 55.219999999999999 109.82 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.549 HG23 HG12 ' A' ' 46' ' ' VAL . 5.2 p . . . . . 0 C--O 1.249 1.069 0 N-CA-C 109.24 -0.652 . . . . 71.349999999999994 109.24 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 108.898 -0.778 . . . . 62.340000000000003 108.898 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.31 105.29 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.641 0.257 . . . . 71.530000000000001 110.368 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' PHE . 37.7 mt-10 -137.82 122.66 18.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.342 -0.614 . . . . 65.329999999999998 109.342 170.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.595 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -120.44 122.63 41.11 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.26 -0.644 . . . . 71.0 109.26 175.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 35.1 ttmt -116.1 110.12 18.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.073 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.66 104.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 70.430000000000007 110.533 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 ' HE2' ' A' ' 95' ' ' LYS . 35.2 tp -88.37 -22.18 23.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 73.129999999999995 110.026 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 m -149.92 110.93 3.32 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.636 -0.711 . . . . 74.030000000000001 109.745 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.69 119.05 6.06 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.754 2.302 . . . . 71.120000000000005 111.588 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.634 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -86.65 -176.82 49.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.933 -0.651 . . . . 71.120000000000005 112.735 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.83 -33.02 69.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.65 0.262 . . . . 72.409999999999997 111.305 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.26 -30.29 1.63 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 113.511 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -79.37 -38.09 19.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 73.239999999999995 111.048 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 p -66.15 94.0 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.514 . . . . 54.219999999999999 110.715 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -102.09 115.78 64.13 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.479 . . . . 63.140000000000001 110.605 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.95 -173.09 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.684 2.256 . . . . 71.040000000000006 112.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -156.66 164.74 37.81 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.148 -0.478 . . . . 75.109999999999999 110.112 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.98 127.69 33.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.239 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.28 31.63 7.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.772 -0.531 . . . . 65.140000000000001 111.772 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 130.29 49.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.984 -0.376 . . . . 74.430000000000007 109.984 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.11 108.26 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.552 . . . . 61.229999999999997 109.511 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.52 158.68 19.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 116.365 -0.379 . . . . 64.049999999999997 111.128 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 28.8 m -111.92 115.78 29.54 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.956 -0.565 . . . . 54.210000000000001 110.209 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 127' ' ' LEU . 10.3 m -120.99 177.96 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.184 0.516 . . . . 41.030000000000001 111.684 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.407 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.1 t-80 -149.83 139.64 21.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.306 -0.861 . . . . 71.409999999999997 108.712 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -137.72 156.02 48.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.578 -0.283 . . . . 71.340000000000003 110.81 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -152.98 160.53 43.03 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.014 -0.736 . . . . 72.430000000000007 109.014 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 59' ' ' GLN . . . -132.16 151.17 19.78 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.784 -0.722 . . . . 64.230000000000004 113.271 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -148.77 155.05 40.43 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.849 0.459 . . . . 71.310000000000002 109.886 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -87.1 150.17 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 110.407 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.87 -31.77 90.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.908 2.405 . . . . 74.209999999999994 112.954 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.94 -39.95 83.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.472 -0.331 . . . . 72.299999999999997 110.752 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.4 -26.55 1.99 Allowed Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.711 -0.757 . . . . 52.539999999999999 113.429 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -74.79 164.64 26.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.188 0.494 . . . . 64.140000000000001 110.821 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 63.4 tt0 -134.0 141.15 47.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 72.329999999999998 109.911 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -72.23 -54.17 10.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.158 0.504 . . . . 73.530000000000001 110.261 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -151.77 143.97 23.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.648 -0.705 . . . . 72.129999999999995 109.312 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -91.61 90.96 7.81 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.187 0.518 . . . . 73.409999999999997 111.875 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.4 t -73.83 -23.97 59.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.056 -0.52 . . . . 61.149999999999999 110.225 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 4.6 ptm180 -68.7 -34.68 76.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.83 -0.433 . . . . 74.420000000000002 109.83 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -73.51 -36.21 65.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.751 -0.659 . . . . 52.329999999999998 110.937 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -76.6 -28.61 56.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.437 -0.347 . . . . 75.439999999999998 110.615 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.54 37.08 94.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.24 -0.505 . . . . 63.329999999999998 112.714 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -79.48 115.67 55.01 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 110.183 -0.302 . . . . 75.340000000000003 110.183 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 169.17 15.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.732 2.288 . . . . 73.209999999999994 111.754 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.409 ' O ' HG22 ' A' ' 48' ' ' VAL . 77.8 t80 -147.62 115.6 6.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.581 -0.526 . . . . 71.230000000000004 109.581 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -100.11 127.31 46.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.74 -0.467 . . . . 75.030000000000001 109.74 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -153.65 170.03 21.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 73.400000000000006 110.77 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 104.56 14.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 75.200000000000003 109.856 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 88' ' ' ALA . 48.4 tp -59.06 138.91 57.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 75.129999999999995 110.772 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.41 25.91 37.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.061 -0.59 . . . . 51.530000000000001 112.103 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . . . -132.27 178.71 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.22 -0.289 . . . . 74.430000000000007 110.22 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.91 39.47 3.12 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 121.235 -0.507 . . . . 54.409999999999997 112.168 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 76' ' ' ALA . 6.8 mm-40 -74.88 -34.35 62.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.247 0.546 . . . . 75.439999999999998 109.726 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.58 171.65 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.152 -0.931 . . . . 32.009999999999998 109.163 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.7 pt -59.64 141.28 16.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.936 -0.394 . . . . 75.420000000000002 109.936 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 67.2 mmtt -61.59 -16.21 46.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.287 0.477 . . . . 73.310000000000002 112.287 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.05 -52.0 54.98 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.139 -1.029 . . . . 34.43 110.87 171.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -73.77 -43.65 58.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.53 -0.335 . . . . 71.340000000000003 110.381 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.583 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 29.4 t70 -53.5 -54.9 30.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.1 -0.5 . . . . 72.430000000000007 110.442 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.82 -44.6 69.63 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.677 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.21 -47.84 54.61 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.993 -0.548 . . . . 70.400000000000006 112.313 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG22 HD23 ' A' ' 127' ' ' LEU . 8.7 p -75.96 -33.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.8 0.334 . . . . 62.310000000000002 110.775 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.594 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.76 -30.46 70.03 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.946 0.35 . . . . 72.340000000000003 111.946 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 86' ' ' GLY . 9.1 t -82.35 -10.19 59.17 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.419 0.526 . . . . 72.319999999999993 112.419 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.9 ptp -102.97 -170.02 1.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.998 -0.438 . . . . 71.329999999999998 111.001 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 127' ' ' LEU . 56.1 p -133.69 179.03 6.48 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.58 -0.282 . . . . 75.530000000000001 111.726 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.693 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.1 tt -64.19 137.83 58.14 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.235 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 75.12 13.64 82.55 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.651 -0.704 . . . . 72.25 111.908 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.634 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.6 tt0 -111.37 134.13 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 71.340000000000003 110.443 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' HD23 ' A' ' 31' ' ' LEU . 6.1 ttpm? -133.96 130.43 37.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.612 -0.722 . . . . 74.540000000000006 109.765 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.14 143.88 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.031 0.443 . . . . 55.240000000000002 110.966 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.89 111.03 22.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.061 -1.088 . . . . 62.350000000000001 108.061 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 16.9 t80 -112.73 137.99 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 65.010000000000005 110.328 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -89.26 106.68 18.6 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.791 -0.448 . . . . 71.140000000000001 109.791 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.96 113.74 60.66 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 116.38 -0.373 . . . . 60.109999999999999 111.034 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.42 159.35 39.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.795 2.33 . . . . 51.240000000000002 111.908 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -60.02 -26.46 66.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.04 0.385 . . . . 74.230000000000004 112.04 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.656 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 11.2 pt20 -66.1 -18.68 65.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.694 0.283 . . . . 73.140000000000001 111.236 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.656 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 93.9 mt -115.2 14.91 17.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.387 -0.37 . . . . 72.140000000000001 110.948 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.57 175.46 13.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.273 0.559 . . . . 75.530000000000001 111.551 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -72.6 -11.24 60.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.481 -0.781 . . . . 72.409999999999997 110.654 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.18 -15.28 7.09 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.879 -0.601 . . . . 75.140000000000001 113.578 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.6 tt0 -63.59 -55.22 25.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.223 0.535 . . . . 70.209999999999994 110.144 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -97.34 -5.49 36.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.432 -0.804 . . . . 72.200000000000003 110.647 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 64.02 -91.22 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.68 -0.691 . . . . 74.310000000000002 113.618 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.737 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 44.0 m-85 98.94 -65.78 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.793 1.637 . . . . 75.400000000000006 111.562 -172.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 5.1 Cg_exo -75.81 135.55 17.75 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.703 1.602 . . . . 74.049999999999997 111.262 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.5 -14.93 38.04 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.801 2.334 . . . . 75.519999999999996 112.675 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.0 t -75.49 -20.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 110.211 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.26 116.36 64.54 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.845 -0.616 . . . . 64.329999999999998 110.072 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.38 154.07 70.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.619 2.213 . . . . 73.409999999999997 111.946 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.48 126.88 16.97 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.31 2.007 . . . . 61.409999999999997 111.867 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 56.0 mtmt 57.22 49.75 12.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 73.319999999999993 110.713 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.02 148.88 22.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 74.120000000000005 111.348 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.7 m -100.66 131.48 46.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.591 -0.732 . . . . 71.230000000000004 109.698 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.27 161.63 20.09 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.92 0.39 . . . . 73.030000000000001 111.002 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.0 t -98.61 131.51 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.322 -0.621 . . . . 74.230000000000004 109.322 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.95 123.76 23.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 52.100000000000001 111.252 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 48.5 mt-10 -85.76 111.08 19.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.047 -0.723 . . . . 64.310000000000002 109.047 173.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.41 143.72 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 41.0 109.952 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -147.48 133.15 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 75.209999999999994 110.812 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.0 tm? -102.64 113.16 26.3 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.968 -0.752 . . . . 72.310000000000002 108.968 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.03 -44.43 10.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.566 -0.288 . . . . 73.209999999999994 111.103 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -145.55 141.66 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.638 -0.255 . . . . 55.219999999999999 111.121 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.252 1.199 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.224 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 108.786 -0.82 . . . . 62.340000000000003 108.786 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.32 111.56 5.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.861 0.362 . . . . 71.530000000000001 111.036 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -129.35 139.98 51.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.181 -0.463 . . . . 65.329999999999998 109.873 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HB3' ' HD1' ' A' ' 98' ' ' PHE . 24.9 pttm -139.0 111.8 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 71.0 109.549 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.23 117.26 20.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 73.319999999999993 109.175 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.11 136.28 26.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.088 0.47 . . . . 70.430000000000007 110.763 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.4 tp -101.42 -28.18 12.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 73.129999999999995 110.198 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -153.87 112.26 2.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.12 -0.696 . . . . 74.030000000000001 109.12 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.11 134.77 47.49 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.581 2.187 . . . . 71.120000000000005 111.824 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.04 177.81 50.88 Favored Glycine 0 C--O 1.236 0.232 0 C-N-CA 121.271 -0.49 . . . . 71.120000000000005 113.218 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' OD2' HG22 ' A' ' 37' ' ' VAL . 30.6 t70 -64.7 -30.22 71.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.918 0.389 . . . . 72.409999999999997 110.6 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.62 6.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 114.884 0.714 . . . . 51.130000000000003 114.884 168.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.466 HG22 ' OD2' ' A' ' 35' ' ' ASP . 6.4 m -89.75 -23.36 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 117.924 0.862 . . . . 73.239999999999995 112.271 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.601 HG21 ' HB2' ' A' ' 92' ' ' LEU . 34.0 p -62.66 125.57 24.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.698 -0.228 . . . . 54.219999999999999 111.063 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -100.07 126.98 34.67 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 120.933 0.397 . . . . 63.140000000000001 111.29 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -90.24 160.18 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.158 2.572 . . . . 71.040000000000006 111.847 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.623 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 19.8 pt20 -157.41 158.84 36.63 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 110.116 -0.327 . . . . 75.109999999999999 110.116 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -74.16 109.67 7.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.257 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.15 -21.22 3.51 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.738 -0.744 . . . . 65.140000000000001 113.143 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.623 ' HE2' ' HG2' ' A' ' 41' ' ' GLN . 50.9 mtmt -84.35 129.95 34.83 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.042 0.448 . . . . 74.430000000000007 110.607 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.49 111.28 7.53 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.286 -1.005 . . . . 61.229999999999997 108.286 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 130' ' ' VAL . 33.4 m -106.0 143.75 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.982 0.42 . . . . 64.049999999999997 110.91 -174.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -100.35 111.39 23.65 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.27 -0.877 . . . . 54.210000000000001 109.509 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 87' ' ' VAL . 31.0 m -121.5 178.13 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 41.030000000000001 110.614 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 17.1 t-160 -147.27 136.37 22.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.2 -0.667 . . . . 71.409999999999997 109.2 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.485 ' HD1' HG12 ' A' ' 125' ' ' VAL . 78.3 m-85 -126.6 152.37 46.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.769 0.319 . . . . 71.340000000000003 111.086 -176.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -144.95 155.11 43.23 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.73 -0.841 . . . . 72.430000000000007 108.73 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.48 132.34 10.24 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.334 -0.46 . . . . 64.230000000000004 112.899 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ttm-85 -141.58 144.99 34.53 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.366 0.603 . . . . 71.310000000000002 110.902 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.92 147.3 61.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 75.120000000000005 109.555 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.63 -24.81 38.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.135 2.557 . . . . 74.209999999999994 113.491 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -74.33 -34.85 63.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.719 0.295 . . . . 72.299999999999997 110.552 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.78 -12.54 4.51 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 116.117 -0.492 . . . . 52.539999999999999 112.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -75.43 147.06 40.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.228 0.211 . . . . 64.140000000000001 110.568 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.88 127.36 26.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.772 -0.455 . . . . 72.329999999999998 109.772 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -67.54 -36.6 81.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.786 -0.643 . . . . 73.530000000000001 111.574 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -165.6 131.32 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 109.792 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 t -86.18 111.46 20.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.5 . . . . 73.409999999999997 110.728 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 m -79.4 -15.47 57.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 61.149999999999999 111.252 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 14.2 ptp180 -68.0 -32.18 72.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.535 -0.302 . . . . 74.420000000000002 110.764 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 t -67.33 -22.2 65.62 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.096 -0.502 . . . . 52.329999999999998 111.215 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -76.09 -8.97 58.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.706 0.289 . . . . 75.439999999999998 111.151 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.81 8.28 5.52 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 115.263 0.865 . . . . 63.329999999999998 115.263 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -99.3 128.85 30.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 117.669 0.735 . . . . 75.340000000000003 110.065 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -86.74 178.45 3.75 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.801 2.334 . . . . 73.209999999999994 111.912 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -134.45 133.31 40.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.485 -0.561 . . . . 71.230000000000004 109.485 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 96.4 mt-30 -106.19 133.59 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.632 -0.258 . . . . 75.030000000000001 110.368 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 25.3 p90 -152.47 154.96 36.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.584 0.231 . . . . 73.400000000000006 110.415 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.455 ' N ' ' HG3' ' A' ' 78' ' ' GLU . 55.6 m -74.62 110.26 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.551 -0.295 . . . . 75.200000000000003 110.34 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 88' ' ' ALA . 53.0 tp -67.2 136.7 55.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.488 -0.324 . . . . 75.129999999999995 110.478 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.89 80.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.266 -0.493 . . . . 51.530000000000001 112.33 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.61 167.41 11.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.177 -0.305 . . . . 74.430000000000007 110.177 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.92 50.43 3.9 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.337 -0.459 . . . . 54.409999999999997 112.484 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 73' ' ' THR . 6.7 mm-40 -79.68 -46.33 17.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 75.439999999999998 109.968 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.66 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.331 -0.85 . . . . 32.009999999999998 109.839 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.429 HG13 ' H ' ' A' ' 83' ' ' TRP . 30.7 pt -58.54 142.93 13.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.097 0.475 . . . . 75.420000000000002 111.013 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 37.6 mmtm -55.86 -23.22 29.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.814 -0.63 . . . . 73.310000000000002 111.846 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.37 -51.9 56.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.641 -0.79 . . . . 34.43 111.635 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.429 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.2 m0 -70.38 -38.61 74.75 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.267 -0.271 . . . . 71.340000000000003 110.267 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.9 t70 -52.12 -54.66 27.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.117 -0.492 . . . . 72.430000000000007 110.266 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.34 -43.06 95.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.211 -0.45 . . . . 73.310000000000002 110.636 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.66 -48.67 55.65 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.953 -0.567 . . . . 70.400000000000006 112.66 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.538 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.1 m -75.65 -33.83 27.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.927 0.394 . . . . 62.310000000000002 111.176 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -73.81 -13.56 60.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.943 0.349 . . . . 72.340000000000003 111.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -95.58 12.14 30.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 121.267 -0.173 . . . . 72.319999999999993 111.325 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.0 ptp -133.32 -177.19 4.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 111.631 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.5 p -135.93 179.11 6.54 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.7 -0.682 . . . . 75.530000000000001 111.33 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.653 ' HA ' HD12 ' A' ' 127' ' ' LEU . 1.5 tm? -51.45 124.62 12.41 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.968 0.507 . . . . 74.120000000000005 111.104 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 84.81 -1.09 89.09 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.009 -0.541 . . . . 72.25 112.877 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 11.0 tt0 -88.13 143.14 27.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.011 0.434 . . . . 71.340000000000003 110.787 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -142.45 133.51 25.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.531 -0.759 . . . . 74.540000000000006 109.025 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.13 30.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.421 . . . . 55.240000000000002 111.743 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.5 tt -90.86 110.14 21.36 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.475 -0.935 . . . . 62.350000000000001 108.475 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.474 ' HD1' ' HB3' ' A' ' 28' ' ' LYS . 70.3 t80 -122.25 134.31 54.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.144 0.497 . . . . 65.010000000000005 110.888 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.2 m -79.31 120.81 24.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.837 -0.62 . . . . 71.140000000000001 110.264 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.3 mm -99.03 107.24 42.91 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 110.025 -0.361 . . . . 60.109999999999999 110.025 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HA ' HG23 ' A' ' 120' ' ' THR . 28.2 Cg_exo -61.94 145.91 96.62 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.72 2.28 . . . . 51.240000000000002 111.245 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -54.33 -35.49 62.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 111.47 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -64.24 -26.42 68.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.318 -0.401 . . . . 73.140000000000001 111.263 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.02 11.83 37.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.508 -0.315 . . . . 72.140000000000001 111.02 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.16 -176.77 5.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 75.530000000000001 111.018 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.44 -11.81 60.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.693 -0.685 . . . . 72.409999999999997 110.782 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.89 -14.9 59.4 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.843 -0.617 . . . . 75.140000000000001 112.315 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.34 -55.64 30.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.897 -0.408 . . . . 70.209999999999994 109.897 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -86.2 -41.88 14.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.59 . . . . 72.200000000000003 110.758 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.05 143.2 3.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 74.310000000000002 111.608 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.654 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 95.5 m-85 -142.87 -51.69 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 122.84 -0.212 . . . . 75.400000000000006 110.72 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.654 ' HD2' ' H ' ' A' ' 111' ' ' TYR . 89.3 Cg_endo -82.07 138.41 10.18 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.582 1.522 . . . . 74.049999999999997 110.789 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 50.9 Cg_exo -56.26 -21.36 35.84 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 122.868 2.379 . . . . 75.519999999999996 113.349 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 115' ' ' ILE . 35.5 m -75.12 -24.83 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.037 0.446 . . . . 74.310000000000002 110.834 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.647 HG12 HG23 ' A' ' 114' ' ' VAL . 49.0 mm -123.0 88.13 50.9 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 109.173 -0.677 . . . . 64.329999999999998 109.173 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.43 173.59 14.23 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.922 2.415 . . . . 73.409999999999997 112.505 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.42 132.54 24.61 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.576 2.184 . . . . 61.409999999999997 112.84 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 62.43 37.64 13.39 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.437 -0.801 . . . . 73.319999999999993 111.671 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.4 114.74 26.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.120000000000005 110.762 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.9 m -82.3 136.98 34.94 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 71.230000000000004 109.921 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.7 tm? -134.25 145.17 48.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.669 -0.493 . . . . 73.030000000000001 109.669 -172.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 121' ' ' LEU . 61.8 t -99.82 120.91 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.229 . . . . 74.230000000000004 110.398 -176.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -110.83 131.99 54.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.123 0.487 . . . . 52.100000000000001 111.109 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.13 117.08 28.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.855 -0.794 . . . . 64.310000000000002 108.855 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.485 HG12 ' HD1' ' A' ' 50' ' ' TYR . 19.2 m -109.4 149.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.695 . . . . 41.0 110.728 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.0 tt0 -145.03 133.48 21.88 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.837 -0.619 . . . . 75.209999999999994 110.202 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -102.36 116.03 31.78 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 122.702 0.401 . . . . 72.310000000000002 110.192 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.3 mm? -96.75 -37.66 10.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 111.296 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.9 142.26 20.6 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.837 -0.165 . . . . 55.219999999999999 111.016 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 46' ' ' VAL . 3.1 p . . . . . 0 C--O 1.251 1.162 0 CA-C-N 116.49 -0.323 . . . . 71.349999999999994 110.745 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.641 0.258 . . . . 62.340000000000003 110.717 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 tp -145.9 137.0 24.66 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.851 0.358 . . . . 71.530000000000001 111.37 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -141.35 140.63 33.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.944 -0.762 . . . . 65.329999999999998 108.944 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.34 119.85 13.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.848 0.356 . . . . 71.0 110.601 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -112.82 125.59 54.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 73.319999999999993 109.776 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 114.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.562 -0.533 . . . . 70.430000000000007 109.562 176.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.7 mt -99.24 -27.01 13.99 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.58 0.229 . . . . 73.129999999999995 111.5 -174.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 7.4 m -153.66 110.64 2.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 110.247 -0.279 . . . . 74.030000000000001 110.247 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.12 124.15 13.01 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.188 . . . . 71.120000000000005 111.619 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -92.36 -174.13 41.84 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.241 -0.504 . . . . 71.120000000000005 113.098 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -44.66 -57.17 3.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.823 0.849 . . . . 72.409999999999997 112.13 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.1 -30.65 9.44 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.013 -0.613 . . . . 51.130000000000003 114.594 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.5 m -90.34 -22.81 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.175 0.988 . . . . 73.239999999999995 111.007 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.419 HG21 HD13 ' A' ' 92' ' ' LEU . 5.2 p -65.14 142.82 58.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 54.219999999999999 110.541 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.19 101.57 16.24 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 63.140000000000001 110.947 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 141.38 26.72 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 71.040000000000006 111.507 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -131.74 160.42 35.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.073 -0.343 . . . . 75.109999999999999 110.073 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 140.83 50.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.358 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.22 64.98 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 65.140000000000001 112.152 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 143.62 33.28 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.779 0.323 . . . . 74.430000000000007 110.162 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 14.1 tppt? -69.89 126.69 30.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.916 -0.584 . . . . 61.229999999999997 110.027 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 130' ' ' VAL . 27.2 m -117.59 141.96 34.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 120.875 0.369 . . . . 64.049999999999997 110.758 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.4 m -99.87 108.53 20.81 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.369 -0.832 . . . . 54.210000000000001 109.749 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 87' ' ' VAL . 20.9 m -118.26 178.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.27 -0.877 . . . . 41.030000000000001 111.747 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.6 t-160 -155.87 135.97 12.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.393 -0.822 . . . . 71.409999999999997 109.126 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HD1' HG12 ' A' ' 125' ' ' VAL . 61.7 m-85 -126.81 155.51 42.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.479 0.18 . . . . 71.340000000000003 110.857 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 35.4 t70 -136.42 128.19 29.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.994 -0.548 . . . . 72.430000000000007 109.874 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -86.92 100.88 2.61 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.324 -0.465 . . . . 64.230000000000004 112.852 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 53' ' ' ARG . 24.2 ttm-85 -115.95 144.66 43.76 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.927 0.394 . . . . 71.310000000000002 111.126 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -90.67 151.12 43.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 110.085 -0.339 . . . . 75.120000000000005 110.085 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.52 -8.68 21.61 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.892 2.395 . . . . 74.209999999999994 113.473 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.46 -22.11 25.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.69 0.281 . . . . 72.299999999999997 111.162 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.79 10.14 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.313 -0.47 . . . . 52.539999999999999 112.033 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -97.53 162.89 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.345 -0.613 . . . . 64.140000000000001 109.345 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 19.4 pt20 -147.76 146.94 29.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.378 -0.23 . . . . 72.329999999999998 110.378 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -76.82 -34.01 57.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.276 -0.42 . . . . 73.530000000000001 111.714 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.24 131.71 17.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.989 -0.374 . . . . 72.129999999999995 109.989 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.541 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 11.3 p -81.73 85.6 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.223 0.535 . . . . 73.409999999999997 110.197 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.683 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 20.1 m -81.47 -21.66 38.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.786 -0.643 . . . . 61.149999999999999 109.985 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.42 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -66.94 -36.97 83.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.729 -0.669 . . . . 74.420000000000002 109.513 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.6 m -71.54 -21.58 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.468 -0.787 . . . . 52.329999999999998 110.877 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -76.0 -26.32 56.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.233 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.21 31.97 50.26 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.579 -0.737 . . . . 63.329999999999998 113.027 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 39.7 ttmt -79.13 119.8 78.43 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.536 0.168 . . . . 75.340000000000003 110.659 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.3 Cg_endo -82.63 93.92 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.069 2.513 . . . . 73.209999999999994 111.116 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.34 161.4 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.722 -0.672 . . . . 71.230000000000004 109.408 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.32 133.7 33.35 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.292 -0.255 . . . . 75.030000000000001 110.797 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HE1' HG11 ' A' ' 48' ' ' VAL . 26.9 p90 -150.81 158.08 43.71 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.422 -0.353 . . . . 73.400000000000006 110.199 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.5 m -77.42 113.04 14.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.07 -0.344 . . . . 75.200000000000003 110.07 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 88' ' ' ALA . 38.5 tp -60.39 140.41 57.2 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.441 -0.345 . . . . 75.129999999999995 110.878 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.13 -21.61 33.53 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 116.337 -0.392 . . . . 51.530000000000001 112.351 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.66 178.48 8.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 111.022 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.57 24.51 29.05 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.966 -0.561 . . . . 54.409999999999997 112.056 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.35 -41.49 84.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 109.892 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.453 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 34.5 m -123.68 178.23 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 32.009999999999998 109.058 174.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.9 pt -73.4 144.43 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.341 -0.615 . . . . 75.420000000000002 109.341 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.799 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 5.0 mptp? -61.84 -15.79 44.92 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.064 0.394 . . . . 73.310000000000002 112.064 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.96 33.56 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.553 -0.832 . . . . 34.43 111.044 171.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 27.4 m0 -72.33 -36.17 68.77 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 120.851 0.357 . . . . 71.340000000000003 110.238 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.799 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 25.7 t70 -57.62 -55.36 35.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.517 -0.765 . . . . 72.430000000000007 110.747 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -72.51 -38.09 68.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.303 -0.408 . . . . 73.310000000000002 110.15 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.619 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.37 -47.93 66.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.88 -0.6 . . . . 70.400000000000006 112.465 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.2 p -76.05 -35.16 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.773 0.32 . . . . 62.310000000000002 110.862 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.97 -29.27 69.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.679 0.252 . . . . 72.340000000000003 111.679 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 86' ' ' GLY . 6.5 t -79.49 9.11 5.2 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.675 0.62 . . . . 72.319999999999993 112.675 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 17.1 ptp -124.86 -168.4 1.81 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.043 -0.411 . . . . 71.329999999999998 110.896 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -128.92 178.69 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.479 -0.328 . . . . 75.530000000000001 111.404 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 127' ' ' LEU . 9.6 tt -63.28 135.53 57.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 74.120000000000005 111.196 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.65 10.94 85.69 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.907 -0.588 . . . . 72.25 112.633 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.503 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.7 tt0 -106.18 148.81 27.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 71.340000000000003 110.869 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -142.38 137.65 30.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 110.786 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.9 149.78 34.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.02 -0.536 . . . . 55.240000000000002 110.637 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.685 ' HB2' HD11 ' A' ' 31' ' ' LEU . 8.9 tt -90.72 107.51 19.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.494 -0.928 . . . . 62.350000000000001 108.494 175.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -112.0 125.71 54.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 65.010000000000005 110.168 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.6 m -76.2 130.35 38.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 71.140000000000001 110.268 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 43.3 mm -108.14 98.81 28.28 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.364 -0.38 . . . . 60.109999999999999 110.021 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' ILE . 44.7 Cg_endo -68.04 153.97 73.76 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.572 2.181 . . . . 51.240000000000002 111.694 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.31 -23.57 66.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.719 0.637 . . . . 74.230000000000004 112.719 -171.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.55 -16.77 57.08 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.674 0.249 . . . . 73.140000000000001 111.674 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.51 15.58 25.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 72.140000000000001 110.905 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.11 -175.8 5.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 111.322 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -73.79 -6.22 45.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.373 -0.83 . . . . 72.409999999999997 111.005 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -52.8 -25.11 21.74 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.367 0.417 . . . . 75.140000000000001 113.262 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.3 tt0 -61.04 -46.22 91.58 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.909 0.385 . . . . 70.209999999999994 110.74 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -99.63 -46.64 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 72.200000000000003 111.466 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.7 161.65 3.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.58 -0.343 . . . . 74.310000000000002 112.815 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.708 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 87.9 m-85 -135.82 -57.56 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 119.576 -0.25 . . . . 75.400000000000006 110.767 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 9.5 Cg_exo -71.69 142.95 40.82 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.857 1.705 . . . . 74.049999999999997 111.022 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 44.1 Cg_exo -57.36 -19.08 33.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.591 2.194 . . . . 75.519999999999996 112.147 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.461 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 33.9 t -76.09 -24.4 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 110.627 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.06 98.21 18.07 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.148 -0.478 . . . . 64.329999999999998 109.874 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 114' ' ' VAL . 17.9 Cg_exo -67.34 159.9 50.16 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.002 2.468 . . . . 73.409999999999997 112.573 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.81 136.12 44.15 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.588 2.192 . . . . 61.409999999999997 111.43 174.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 62.6 mttp 61.07 34.84 18.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.073 -0.512 . . . . 73.319999999999993 110.871 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.42 122.79 31.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.789 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -73.83 119.11 17.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.625 -0.509 . . . . 71.230000000000004 109.625 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.92 168.78 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.046 0.451 . . . . 73.030000000000001 110.401 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.6 t -133.0 138.21 52.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.426 -0.953 . . . . 74.230000000000004 108.426 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 46.8 m-85 -130.19 122.81 28.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.345 0.593 . . . . 52.100000000000001 110.734 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 31.2 tt0 -76.44 107.03 8.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.559 -1.275 . . . . 64.310000000000002 107.559 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.598 HG12 ' HD1' ' A' ' 50' ' ' TYR . 31.6 m -104.1 144.14 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 41.0 110.4 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 39.2 tt0 -147.54 128.31 14.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 75.209999999999994 110.633 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.5 tm? -98.55 106.17 18.41 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.626 -0.879 . . . . 72.310000000000002 108.626 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.8 mm? -78.57 -48.3 15.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 73.209999999999994 111.002 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.62 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 55.219999999999999 111.195 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.467 HG23 HG12 ' A' ' 46' ' ' VAL . 2.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-N 115.926 -0.579 . . . . 71.349999999999994 110.203 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.252 -0.277 . . . . 62.340000000000003 110.252 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -131.55 102.03 5.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.326 -0.99 . . . . 71.530000000000001 108.326 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.34 125.57 15.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 65.329999999999998 109.224 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -125.48 126.22 44.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 71.0 110.469 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -109.19 121.01 44.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.696 -0.683 . . . . 73.319999999999993 110.232 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.33 103.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.902 -0.407 . . . . 70.430000000000007 109.902 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.41 -19.66 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.42 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 37.9 m -149.57 110.83 3.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.992 -0.549 . . . . 74.030000000000001 109.712 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.75 130.63 23.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 71.120000000000005 111.824 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.17 -153.28 19.88 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.06 -0.518 . . . . 71.120000000000005 112.545 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.73 -36.9 42.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.161 0.505 . . . . 72.409999999999997 110.28 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.569 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.01 -17.72 11.07 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.623 -0.717 . . . . 51.130000000000003 113.329 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 m -89.4 -20.31 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.971 0.36 . . . . 73.239999999999995 111.971 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.4 p -79.95 144.17 33.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.998 0.428 . . . . 54.219999999999999 111.062 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.58 96.24 49.06 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.958 -0.564 . . . . 63.140000000000001 109.784 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 130' ' ' VAL . 51.6 Cg_exo -55.94 145.14 75.39 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.009 2.473 . . . . 71.040000000000006 113.188 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.17 146.0 44.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.971 -0.559 . . . . 75.109999999999999 109.939 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.6 166.14 24.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.728 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.07 7.3 70.46 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.221 -0.514 . . . . 65.140000000000001 112.711 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.95 149.88 40.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.943 0.401 . . . . 74.430000000000007 111.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.662 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -78.06 104.09 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.89 -0.782 . . . . 61.229999999999997 108.89 171.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.33 151.63 8.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.276 0.56 . . . . 64.049999999999997 111.661 -173.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 30.2 m -99.13 108.38 20.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.005 -0.998 . . . . 54.210000000000001 110.015 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.482 HG21 ' CE2' ' A' ' 72' ' ' PHE . 14.7 m -122.57 178.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.924 -0.58 . . . . 41.030000000000001 110.466 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 69' ' ' PRO . 50.0 t-80 -154.22 149.46 27.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.134 -0.691 . . . . 71.409999999999997 109.134 173.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -151.33 152.27 32.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.499 0.19 . . . . 71.340000000000003 110.615 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -135.74 134.59 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.157 -0.682 . . . . 72.430000000000007 109.157 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.23 139.71 15.35 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.281 -0.485 . . . . 64.230000000000004 112.818 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.58 HH21 HG21 ' A' ' 122' ' ' VAL . 11.1 ttp180 -142.03 137.15 30.9 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.092 0.472 . . . . 71.310000000000002 110.432 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -79.95 152.83 74.77 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.731 -0.668 . . . . 75.120000000000005 109.939 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.45 -18.68 32.72 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.666 2.244 . . . . 74.209999999999994 111.774 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.28 -38.87 88.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.392 -0.822 . . . . 72.299999999999997 110.367 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.09 -19.25 5.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.015 -0.538 . . . . 52.539999999999999 112.357 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -86.32 142.93 28.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.6 0.2 . . . . 64.140000000000001 110.571 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.2 mt-30 -86.45 155.25 20.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.604 -0.517 . . . . 72.329999999999998 109.604 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -76.16 -62.02 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.483 -0.562 . . . . 73.530000000000001 109.483 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -145.26 132.99 21.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.634 -0.712 . . . . 72.129999999999995 109.265 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 33.1 t -89.54 85.66 6.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 73.409999999999997 109.85 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 99.9 p -65.25 -26.78 68.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.486 . . . . 61.149999999999999 109.928 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 64' ' ' ARG . 5.3 ptp180 -60.35 -44.29 95.69 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.746 -0.661 . . . . 74.420000000000002 110.477 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -69.81 -23.44 63.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.061 0.458 . . . . 52.329999999999998 110.199 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' SER . 17.4 mtp180 -75.91 -21.85 56.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.294 -0.632 . . . . 75.439999999999998 109.294 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.07 46.53 7.6 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.404 -0.816 . . . . 63.329999999999998 114.128 170.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -145.8 128.98 8.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.101 0.451 . . . . 75.340000000000003 110.477 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 1.4 Cg_endo -84.91 -177.42 2.81 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.24 2.627 . . . . 73.209999999999994 111.914 174.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.4 152.36 48.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.242 -0.651 . . . . 71.230000000000004 109.242 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -134.14 129.58 36.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.356 -0.239 . . . . 75.030000000000001 110.356 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' CE2' HG21 ' A' ' 48' ' ' VAL . 12.6 p90 -154.61 169.86 22.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.715 -0.221 . . . . 73.400000000000006 110.543 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.522 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 21.7 m -80.88 119.09 22.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.421 -0.354 . . . . 75.200000000000003 111.204 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 88' ' ' ALA . 56.8 tp -70.21 137.69 51.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.09 -0.505 . . . . 75.129999999999995 110.347 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.17 24.99 64.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.014 -0.612 . . . . 51.530000000000001 112.422 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.67 172.3 11.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.727 0.299 . . . . 74.430000000000007 110.407 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 15.93 8.4 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.111 -0.495 . . . . 54.409999999999997 113.315 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 73' ' ' THR . 26.6 mm-40 -55.68 -42.99 75.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.269 0.557 . . . . 75.439999999999998 110.314 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.533 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 30.4 m -134.91 176.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 32.009999999999998 109.987 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.9 pt -69.21 150.01 10.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 116.499 -0.318 . . . . 75.420000000000002 110.392 177.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.526 ' HD2' HE21 ' A' ' 85' ' ' GLN . 4.7 tmtm? -58.59 -25.22 62.37 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 110.274 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.62 -52.16 54.21 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.055 -0.593 . . . . 34.43 111.963 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.533 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 49.8 m0 -68.14 -35.12 77.58 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.084 -0.339 . . . . 71.340000000000003 110.084 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.08 -49.37 71.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.105 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.526 HE21 ' HD2' ' A' ' 81' ' ' LYS . 80.3 mt-30 -59.14 -49.18 78.86 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.294 -0.412 . . . . 73.310000000000002 110.237 175.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.24 -50.05 48.05 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.455 -0.793 . . . . 70.400000000000006 113.003 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -75.36 -33.25 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.71 0.291 . . . . 62.310000000000002 111.763 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -77.69 -20.8 53.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.366 0.506 . . . . 72.340000000000003 112.366 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.3 t -85.76 -10.27 55.81 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.171 0.434 . . . . 72.319999999999993 112.171 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.9 ptp -107.19 -176.46 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 111.637 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.569 HG21 ' HA2' ' A' ' 36' ' ' GLY . 17.3 p -118.56 178.83 4.32 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.899 -0.591 . . . . 75.530000000000001 110.89 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.794 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.3 tt -67.28 126.42 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.096 0.474 . . . . 74.120000000000005 110.542 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.404 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 81.62 11.97 82.3 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.707 -0.679 . . . . 72.25 112.531 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 19.1 tt0 -100.5 146.48 27.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.841 0.353 . . . . 71.340000000000003 110.618 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.4 ttpm? -137.45 136.92 38.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.848 -0.614 . . . . 74.540000000000006 109.957 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.82 148.11 46.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.313 -0.403 . . . . 55.240000000000002 110.691 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.5 tt -90.75 105.47 17.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.628 -1.249 . . . . 62.350000000000001 107.628 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.86 126.43 50.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 65.010000000000005 110.268 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.3 m -84.89 106.44 16.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.949 -0.759 . . . . 71.140000000000001 108.949 174.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.98 110.77 40.44 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.435 -0.348 . . . . 60.109999999999999 110.77 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.93 140.87 47.01 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.486 2.124 . . . . 51.240000000000002 111.233 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 46.3 p90 -54.5 -35.06 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 111.781 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 13.8 pt20 -61.83 -20.87 64.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 111.543 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.554 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 95.6 mt -113.45 19.0 17.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.535 -0.302 . . . . 72.140000000000001 110.657 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.8 171.54 14.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.665 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -72.12 -17.34 61.98 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.282 -0.872 . . . . 72.409999999999997 110.587 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.89 -15.97 44.76 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.907 -0.588 . . . . 75.140000000000001 112.366 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 3.6 tm-20 -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.119 -0.326 . . . . 70.209999999999994 110.119 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -78.46 -52.83 7.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.426 -0.583 . . . . 72.200000000000003 109.426 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.97 153.36 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.936 -0.575 . . . . 74.310000000000002 113.008 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.592 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 54.2 m-85 -142.49 -59.84 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 122.574 0.35 . . . . 75.400000000000006 110.651 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 75.6 Cg_endo -84.51 151.18 11.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 121.899 1.733 . . . . 74.049999999999997 111.882 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.9 -21.49 64.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.683 2.255 . . . . 75.519999999999996 112.634 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.641 HG23 HG12 ' A' ' 115' ' ' ILE . 33.8 m -71.91 -22.45 21.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.301 -0.408 . . . . 74.310000000000002 110.724 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.641 HG12 HG23 ' A' ' 114' ' ' VAL . 47.1 mm -121.81 87.68 46.69 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 109.165 -0.68 . . . . 64.329999999999998 109.165 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 35.8 Cg_endo -64.98 156.34 63.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 73.409999999999997 111.785 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.11 135.85 60.2 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.358 2.038 . . . . 61.409999999999997 112.217 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 98.1 mttt 61.83 35.12 16.73 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.778 -0.647 . . . . 73.319999999999993 111.493 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -89.29 125.04 34.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.053 -0.521 . . . . 74.120000000000005 111.562 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.6 m -74.09 132.81 42.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.921 -0.581 . . . . 71.230000000000004 109.442 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.582 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -129.58 150.41 50.92 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.883 -0.414 . . . . 73.030000000000001 109.883 -171.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.582 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.0 t -98.73 131.06 46.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 110.378 -0.23 . . . . 74.230000000000004 110.378 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.456 ' CE2' HD12 ' A' ' 121' ' ' LEU . 56.5 m-85 -130.32 118.76 21.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 52.100000000000001 110.644 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 46.8 mt-10 -77.73 107.8 10.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.759 -0.83 . . . . 64.310000000000002 108.759 171.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.15 147.33 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 123.325 0.391 . . . . 41.0 110.312 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.96 128.92 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 75.209999999999994 110.703 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.9 tm? -96.14 115.91 28.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.85 -43.41 10.05 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.643 0.258 . . . . 73.209999999999994 110.998 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -150.39 135.29 17.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.348 -0.387 . . . . 55.219999999999999 110.388 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.508 HG21 ' HA ' ' A' ' 40' ' ' PRO . 2.9 p . . . . . 0 C--O 1.251 1.149 0 CA-C-N 116.23 -0.441 . . . . 71.349999999999994 111.235 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 109.697 -0.483 . . . . 73.310000000000002 109.697 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.62 97.39 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.139 0.495 . . . . 60.100000000000001 111.691 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -108.14 106.67 16.98 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.814 -1.18 . . . . 74.230000000000004 107.814 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -57.5 102.66 0.1 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.589 -0.732 . . . . 73.230000000000004 111.246 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -67.42 81.92 0.16 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.831 -0.622 . . . . 75.319999999999993 109.74 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -93.05 124.68 37.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.45 -0.574 . . . . 73.329999999999998 109.45 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.549 ' CE1' ' SD ' ' A' ' 9' ' ' MET . 14.1 t-80 -158.26 121.16 3.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.484 -0.325 . . . . 65.319999999999993 110.203 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.75 79.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.236 0.541 . . . . 73.239999999999995 109.663 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.549 ' SD ' ' CE1' ' A' ' 7' ' ' HIS . 11.0 tpt -83.87 -59.65 2.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.655 -0.702 . . . . 52.340000000000003 110.305 -174.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.2 -167.33 29.63 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.79 -0.641 . . . . 72.519999999999996 112.092 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 p -135.73 110.97 8.99 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 110.05 -0.352 . . . . 61.109999999999999 110.05 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.24 -48.58 70.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.546 -0.539 . . . . 72.230000000000004 109.546 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -112.54 114.74 27.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.383 -0.826 . . . . 63.329999999999998 109.128 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.16 -35.19 31.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.232 -0.44 . . . . 33.229999999999997 111.477 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 54.04 56.13 7.44 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.169 -0.678 . . . . 71.120000000000005 109.169 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.7 p 47.37 80.71 0.05 OUTLIER 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.366 -0.834 . . . . 75.230000000000004 110.735 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 0.1 OUTLIER -60.58 141.79 56.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.126 -0.943 . . . . 72.329999999999998 111.133 -177.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.01 -152.79 18.09 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.241 -0.743 . . . . 74.25 111.241 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.2 -11.08 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.535 2.156 . . . . 73.400000000000006 112.382 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.65 -158.37 27.72 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.565 -0.614 . . . . 53.439999999999998 111.565 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.4 m -62.4 131.91 50.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.449 0.299 . . . . 73.519999999999996 110.763 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.1 mmt -68.85 79.03 0.31 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.26 0.553 . . . . 72.150000000000006 110.974 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.4 m -157.87 -161.14 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.244 -0.889 . . . . 71.329999999999998 109.34 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.42 90.14 0.23 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.904 0.383 . . . . 62.109999999999999 110.783 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -92.12 137.77 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 62.340000000000003 109.872 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.3 tp -145.92 102.02 3.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.784 0.326 . . . . 71.530000000000001 111.019 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' H ' ' HB ' ' A' ' 99' ' ' THR . 50.1 mm-40 -113.62 140.68 48.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.99 -0.744 . . . . 65.329999999999998 108.99 172.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 9.1 ptpp? -128.32 111.92 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 71.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -123.41 110.0 14.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 109.878 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 9.9 p -71.37 128.06 34.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.842 0.353 . . . . 70.430000000000007 111.314 -174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 97' ' ' LEU . 3.0 mm? -86.96 -38.08 16.97 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.592 -0.522 . . . . 73.129999999999995 109.592 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.1 m -141.6 112.7 6.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.966 -0.561 . . . . 74.030000000000001 110.187 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.15 146.09 62.81 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.51 2.14 . . . . 71.120000000000005 111.638 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -100.62 -164.64 28.23 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.271 -0.49 . . . . 71.120000000000005 112.717 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.79 -40.89 63.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.092 0.472 . . . . 72.409999999999997 110.996 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 -30.78 2.48 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.734 -0.667 . . . . 51.130000000000003 112.657 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.6 -24.5 8.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.032 0.444 . . . . 73.239999999999995 110.43 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.2 p -75.05 139.58 42.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.552 -0.749 . . . . 54.219999999999999 110.436 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -126.41 113.72 23.29 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.504 -0.316 . . . . 63.140000000000001 110.896 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.64 130.95 14.17 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.429 2.086 . . . . 71.040000000000006 111.451 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.47 149.28 44.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.43 -0.35 . . . . 75.109999999999999 110.815 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.32 164.5 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 111.111 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.24 34.48 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.156 -0.474 . . . . 65.140000000000001 112.73 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -101.44 146.7 27.27 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.430000000000007 111.597 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -77.42 110.85 12.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.299 -0.864 . . . . 61.229999999999997 109.282 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.9 m -106.4 148.76 10.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.945 0.403 . . . . 64.049999999999997 111.662 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.9 m -102.53 108.19 19.4 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-N 115.02 -0.991 . . . . 54.210000000000001 110.515 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.48 HG21 ' HE1' ' A' ' 72' ' ' PHE . 33.1 m -119.21 178.36 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 114.64 -1.164 . . . . 41.030000000000001 111.931 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 13.8 t-160 -157.51 147.32 20.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.199 -1.037 . . . . 71.409999999999997 108.199 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.6 m-85 -132.99 157.39 45.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.822 0.283 . . . . 71.340000000000003 111.383 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.841 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 45.0 m-20 -136.0 122.32 20.52 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.693 -0.685 . . . . 72.430000000000007 109.863 170.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.29 129.79 10.32 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.664 -0.574 . . . . 64.230000000000004 111.664 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -149.0 143.77 26.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 71.310000000000002 110.825 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 147.5 40.59 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.943 -0.391 . . . . 75.120000000000005 109.943 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.32 -22.49 49.66 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.894 2.396 . . . . 74.209999999999994 112.067 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.32 -34.27 74.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.5 -0.773 . . . . 72.299999999999997 110.797 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.59 -38.45 2.19 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.059 -0.816 . . . . 52.539999999999999 111.059 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.95 123.12 16.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.508 -0.346 . . . . 64.140000000000001 110.328 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -75.65 144.19 41.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.506 . . . . 72.329999999999998 110.917 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -72.93 -45.22 59.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.521 -0.548 . . . . 73.530000000000001 109.521 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -166.7 131.3 2.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 72.129999999999995 109.459 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -78.74 85.6 4.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.239 0.542 . . . . 73.409999999999997 109.865 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -72.66 -14.0 61.49 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.438 0.637 . . . . 61.149999999999999 110.086 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.701 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 13.1 ptt-85 -64.46 -35.96 82.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.42 -0.809 . . . . 74.420000000000002 110.678 171.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -69.17 -18.2 63.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.098 0.475 . . . . 52.329999999999998 110.057 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -82.32 -14.2 55.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.989 -0.551 . . . . 75.439999999999998 110.574 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.81 32.82 59.27 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.816 -0.629 . . . . 63.329999999999998 113.578 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -106.47 109.57 63.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.755 0.278 . . . . 75.340000000000003 110.98 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -90.5 125.68 1.18 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.948 2.432 . . . . 73.209999999999994 112.054 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.77 162.63 14.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.33 -0.618 . . . . 71.230000000000004 109.33 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.95 137.35 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.414 -0.178 . . . . 75.030000000000001 110.767 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.48 ' HE1' HG21 ' A' ' 48' ' ' VAL . 35.1 p90 -159.27 155.28 26.66 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.213 -0.195 . . . . 73.400000000000006 110.616 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.6 m -72.09 113.8 9.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.431 -0.35 . . . . 75.200000000000003 110.687 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.489 HD13 HG13 ' A' ' 87' ' ' VAL . 55.8 tp -61.97 133.56 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.7 -0.482 . . . . 75.129999999999995 109.7 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.75 68.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 51.530000000000001 112.803 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.56 167.39 11.96 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 74.430000000000007 110.525 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.91 31.68 3.33 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.475 -0.393 . . . . 54.409999999999997 112.631 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -63.74 -43.54 96.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.377 0.608 . . . . 75.439999999999998 110.593 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.685 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 26.8 m -128.75 177.73 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 32.009999999999998 110.147 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.458 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.3 pt -68.92 152.77 9.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.687 0.279 . . . . 75.420000000000002 110.389 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 5.6 tmtm? -56.25 -29.02 60.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.073 -0.512 . . . . 73.310000000000002 109.94 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.44 -54.43 36.09 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.133 -0.556 . . . . 34.43 112.057 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.685 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 26.0 m0 -68.75 -38.17 79.93 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.52 -0.178 . . . . 71.340000000000003 110.52 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -54.51 -49.3 70.51 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.215 0.531 . . . . 72.430000000000007 110.389 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -65.03 -41.32 95.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.653 -0.703 . . . . 73.310000000000002 110.267 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.49 -53.04 43.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.924 -0.58 . . . . 70.400000000000006 112.492 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.489 HG13 HD13 ' A' ' 74' ' ' LEU . 6.6 p -71.03 -31.81 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.685 0.279 . . . . 62.310000000000002 111.068 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -70.59 -30.66 67.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.635 -0.257 . . . . 72.340000000000003 111.659 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 t -90.15 -15.65 31.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.93 0.344 . . . . 72.319999999999993 111.93 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 87' ' ' VAL . 16.5 ptm -91.01 -175.39 4.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.581 0.229 . . . . 71.329999999999998 110.828 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -126.51 175.23 8.06 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.677 -0.238 . . . . 75.530000000000001 111.14 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.787 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.2 tt -73.84 137.58 43.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.698 0.285 . . . . 74.120000000000005 110.26 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.498 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.25 10.58 85.9 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.652 -0.579 . . . . 72.25 111.652 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.86 149.65 30.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.607 -0.296 . . . . 71.340000000000003 110.63 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . 13.9 ptmt -140.43 133.45 29.35 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.498 -0.556 . . . . 74.540000000000006 109.498 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -131.43 156.71 45.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.693 -0.685 . . . . 55.240000000000002 111.037 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 31' ' ' LEU . 8.7 tt -90.73 107.2 19.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.061 -1.089 . . . . 62.350000000000001 108.061 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -111.46 114.43 27.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.85 -0.426 . . . . 65.010000000000005 109.85 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 22.3 m -76.88 118.44 19.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.5 -0.318 . . . . 71.140000000000001 110.805 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 105' ' ' ALA . 40.0 mm -101.75 110.84 63.05 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 120.675 0.274 . . . . 60.109999999999999 110.414 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.3 Cg_endo -62.46 143.44 93.24 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.634 2.222 . . . . 51.240000000000002 111.889 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -54.26 -32.58 56.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.691 -0.686 . . . . 74.230000000000004 111.982 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.32 -23.34 65.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.074 0.398 . . . . 73.140000000000001 112.074 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.3 mt -96.12 -28.25 14.68 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.671 0.272 . . . . 72.140000000000001 111.549 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.444 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -110.06 -174.34 2.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 75.530000000000001 111.127 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -70.12 -7.44 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.835 -0.621 . . . . 72.409999999999997 111.08 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.33 -28.84 51.52 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 113.089 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 7.6 tm-20 -64.28 -49.85 70.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.365 -0.605 . . . . 70.209999999999994 109.365 175.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -27.32 58.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.491 -0.777 . . . . 72.200000000000003 110.48 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 112' ' ' PRO . . . 80.14 -82.83 1.43 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.616 -0.72 . . . . 74.310000000000002 111.77 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.612 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 58.8 m-85 89.33 -77.77 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.209 1.404 . . . . 75.400000000000006 111.986 -175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 59.4 Cg_endo -89.0 152.67 5.8 Favored 'Trans proline' 0 C--N 1.366 1.482 0 CA-C-N 121.693 1.64 . . . . 74.049999999999997 111.665 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.33 -7.78 13.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.557 2.171 . . . . 75.519999999999996 112.369 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -71.95 -31.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 109.938 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.89 101.92 48.68 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.812 -0.631 . . . . 64.329999999999998 109.899 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 Cg_endo -67.08 119.64 6.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.241 1.961 . . . . 73.409999999999997 111.388 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -36.34 133.96 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.683 2.922 . . . . 61.409999999999997 113.42 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 54.0 mtmt 73.0 31.68 1.45 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.645 0.778 . . . . 73.319999999999993 111.124 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -93.77 123.86 37.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.878 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 101' ' ' PRO . 74.0 m -73.69 127.64 33.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.257 -0.646 . . . . 71.230000000000004 109.257 172.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -120.88 137.09 54.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.547 -0.538 . . . . 73.030000000000001 109.547 -170.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.522 ' N ' HD13 ' A' ' 121' ' ' LEU . 88.7 t -98.51 131.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.691 0.281 . . . . 74.230000000000004 110.424 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.29 123.04 41.22 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.947 -0.39 . . . . 52.100000000000001 109.947 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.841 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 51.0 mt-10 -75.34 115.34 14.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.553 -0.906 . . . . 64.310000000000002 108.553 171.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 m -95.74 137.17 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.653 0.595 . . . . 41.0 109.413 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 36.3 tt0 -136.61 117.71 14.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.589 -0.522 . . . . 75.209999999999994 109.589 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.787 HD12 ' HA ' ' A' ' 92' ' ' LEU . 3.1 tm? -99.87 106.3 18.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.72 -0.845 . . . . 72.310000000000002 108.72 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 49' ' ' HIS . 3.6 mm? -78.2 -45.83 22.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.41 -0.589 . . . . 73.209999999999994 109.41 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -170.81 -173.61 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.528 -0.76 . . . . 55.219999999999999 109.92 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.114 -0.946 . . . . 71.349999999999994 108.669 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.688 0.28 . . . . 73.310000000000002 110.543 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.36 114.63 26.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 60.100000000000001 110.078 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -71.56 95.7 1.45 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.325 0.583 . . . . 74.230000000000004 111.263 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -77.3 93.31 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.614 . . . . 73.230000000000004 109.714 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -137.59 0.95 2.31 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.63 -0.259 . . . . 75.319999999999993 111.667 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -125.27 155.34 40.32 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.884 -0.413 . . . . 73.329999999999998 109.884 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -153.33 141.6 20.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.744 -0.207 . . . . 65.319999999999993 110.716 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -99.13 -24.89 14.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.351 -0.386 . . . . 73.239999999999995 110.888 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.9 tpp -82.47 131.38 35.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.857 0.361 . . . . 52.340000000000003 111.063 -177.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -179.37 18.6 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.073 -0.811 . . . . 72.519999999999996 111.073 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.3 m -75.33 87.47 2.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.037 0.419 . . . . 61.109999999999999 109.942 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tt 56.31 52.39 10.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.012 -0.736 . . . . 72.230000000000004 109.012 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 73.29 -18.7 0.36 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.977 -1.01 . . . . 63.329999999999998 112.097 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.54 160.2 22.63 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.022 0.439 . . . . 33.229999999999997 110.803 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.31 174.07 7.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.803 -0.635 . . . . 71.120000000000005 110.171 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -86.37 166.72 15.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.308 -0.406 . . . . 75.230000000000004 110.569 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -79.58 172.93 13.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.081 -0.509 . . . . 72.329999999999998 109.968 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.44 151.01 39.27 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.029 -0.605 . . . . 74.25 111.735 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.29 152.09 66.38 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.399 2.066 . . . . 73.400000000000006 112.011 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.96 17.09 9.89 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.176 -0.535 . . . . 53.439999999999998 112.166 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -73.11 138.65 45.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.572 0.225 . . . . 73.519999999999996 110.652 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 22' ' ' MET . 23.2 ptm -74.05 95.67 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.993 0.425 . . . . 72.150000000000006 110.433 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 t -176.57 176.27 1.6 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.782 -0.644 . . . . 71.329999999999998 110.005 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.25 111.28 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.464 -0.569 . . . . 62.109999999999999 109.464 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.674 ' H ' ' HB3' ' A' ' 101' ' ' PRO . 8.8 mm-40 -91.89 135.48 33.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.393 -0.595 . . . . 62.340000000000003 109.393 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -144.4 102.41 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.945 0.402 . . . . 71.530000000000001 110.397 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 48.8 mt-10 -142.72 130.59 21.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 65.329999999999998 110.122 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -133.2 101.42 5.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.767 -0.827 . . . . 71.0 108.767 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -108.71 110.33 21.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 73.319999999999993 109.763 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.59 114.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.189 0.518 . . . . 70.430000000000007 110.336 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.7 mt -88.88 -33.02 17.47 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.843 -0.617 . . . . 73.129999999999995 110.117 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 44.7 m -145.49 120.58 5.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.523 -0.762 . . . . 74.030000000000001 109.397 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 146.44 51.99 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.608 2.205 . . . . 71.120000000000005 112.427 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -99.91 -172.06 30.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 112.431 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 78.2 m-20 -63.85 -36.88 85.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.034 0.445 . . . . 72.409999999999997 110.397 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.35 -30.29 2.18 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.774 -0.648 . . . . 51.130000000000003 113.039 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 m -82.25 -35.65 13.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.148 0.499 . . . . 73.239999999999995 110.07 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 12.3 p -84.83 115.57 22.81 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.585 -0.734 . . . . 54.219999999999999 109.476 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 39' ' ' LYS . 8.3 mtmp? -124.39 132.23 24.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 63.140000000000001 111.063 -171.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.18 166.73 20.39 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.549 2.166 . . . . 71.040000000000006 110.997 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -165.21 166.38 18.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.404 -0.221 . . . . 75.109999999999999 110.404 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.39 141.66 52.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.337 -0.392 . . . . 74.420000000000002 110.936 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.59 20.3 41.3 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 116.068 -0.515 . . . . 65.140000000000001 111.877 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -130.61 138.16 49.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.695 0.398 . . . . 74.430000000000007 110.869 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -79.6 106.07 11.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.491 -0.929 . . . . 61.229999999999997 108.491 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.589 HG12 HG13 ' A' ' 130' ' ' VAL . 28.2 m -106.49 146.19 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.365 . . . . 64.049999999999997 111.254 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.1 m -96.35 108.07 20.53 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.613 -0.721 . . . . 54.210000000000001 109.926 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.744 HG12 HD22 ' A' ' 127' ' ' LEU . 18.4 m -124.45 178.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.519 0.676 . . . . 41.030000000000001 111.234 -173.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 64' ' ' ARG . 15.4 t-80 -151.6 140.63 21.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.947 174.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 86.0 m-85 -126.5 144.01 51.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.595 -0.891 . . . . 71.340000000000003 108.595 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 8.9 t70 -136.15 110.71 8.59 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.469 -0.567 . . . . 72.430000000000007 109.469 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.46 137.4 30.88 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.938 -0.574 . . . . 64.230000000000004 112.154 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -148.01 137.16 22.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.002 0.43 . . . . 71.310000000000002 110.519 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 88.9 m-85 -78.53 146.8 70.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 75.120000000000005 110.168 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 30.5 Cg_exo -62.92 -10.39 20.12 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.97 2.446 . . . . 74.209999999999994 113.289 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -87.16 -4.94 59.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.675 0.274 . . . . 72.299999999999997 110.916 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.17 -24.58 15.79 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.742 -0.543 . . . . 52.539999999999999 111.742 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 4.8 ttmp? -59.09 148.63 30.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.204 0.602 . . . . 64.140000000000001 110.896 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -94.88 143.62 26.32 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.025 -0.361 . . . . 72.329999999999998 110.025 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -86.47 -55.66 3.78 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.957 0.408 . . . . 73.530000000000001 110.558 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -138.67 131.41 29.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.348 -0.387 . . . . 72.129999999999995 110.323 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -76.19 85.12 3.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 73.409999999999997 109.95 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.0 p -90.33 -46.91 8.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.441 . . . . 61.149999999999999 109.95 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.479 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.3 ptt180 -60.64 -31.61 70.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.987 -0.551 . . . . 74.420000000000002 110.137 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -70.68 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 52.329999999999998 111.378 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -93.17 -2.27 55.46 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.907 0.384 . . . . 75.439999999999998 110.234 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.18 39.2 69.83 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.71 -0.677 . . . . 63.329999999999998 113.768 174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -141.81 122.63 8.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.796 0.298 . . . . 75.340000000000003 110.582 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.81 177.66 6.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.795 2.33 . . . . 73.209999999999994 111.861 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -135.02 129.92 34.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 71.230000000000004 109.848 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -100.45 141.91 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.293 -0.262 . . . . 75.030000000000001 110.293 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.53 ' HZ ' HG11 ' A' ' 87' ' ' VAL . 11.6 p90 -154.34 158.17 39.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.726 0.298 . . . . 73.400000000000006 110.265 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -83.69 109.43 17.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 110.033 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.72 142.06 56.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.447 -0.342 . . . . 75.129999999999995 110.435 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.21 26.9 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.891 -0.484 . . . . 51.530000000000001 111.891 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.81 168.95 18.51 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 122.696 0.398 . . . . 74.430000000000007 109.966 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.42 28.48 1.48 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.397 -0.43 . . . . 54.409999999999997 113.304 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -69.04 -34.84 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.292 0.568 . . . . 75.439999999999998 109.767 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 83' ' ' TRP . 27.1 m -131.13 165.27 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.233 -0.894 . . . . 32.009999999999998 110.421 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 pt -80.66 164.63 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 75.420000000000002 110.526 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -55.9 -28.54 57.2 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.201 0.445 . . . . 73.310000000000002 112.201 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.52 -59.5 9.74 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 120.432 -0.889 . . . . 34.43 111.681 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.469 ' O ' HG12 ' A' ' 87' ' ' VAL . 27.0 m0 -66.0 -37.02 84.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.665 -0.268 . . . . 71.340000000000003 110.287 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.57 -55.01 39.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.936 -0.575 . . . . 72.430000000000007 110.842 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -65.83 -42.56 90.42 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.453 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.52 -48.68 69.01 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.014 -0.612 . . . . 70.400000000000006 112.682 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG11 ' HZ ' ' A' ' 72' ' ' PHE . 14.2 p -75.21 -32.94 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.826 0.346 . . . . 62.310000000000002 111.077 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.36 68.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.514 -0.312 . . . . 72.340000000000003 111.649 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.8 t -86.23 -4.46 59.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.215 0.45 . . . . 72.319999999999993 112.215 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 19.4 ptm -106.81 176.0 5.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.669 0.271 . . . . 71.329999999999998 110.889 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.1 p -118.65 174.55 6.2 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.764 0.316 . . . . 75.530000000000001 111.306 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.629 HD12 HG23 ' A' ' 130' ' ' VAL . 7.6 tt -73.16 138.34 45.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 111.134 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.495 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.34 34.8 44.52 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.737 -0.665 . . . . 72.25 111.926 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 33.7 tt0 -134.52 153.71 51.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.945 0.402 . . . . 71.340000000000003 111.694 -169.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -131.41 122.36 26.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 74.540000000000006 109.845 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.76 141.57 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 55.240000000000002 110.62 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.7 tt -90.89 113.75 26.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.951 -0.759 . . . . 62.350000000000001 108.951 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -114.37 121.2 42.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.841 0.353 . . . . 65.010000000000005 110.389 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 31.2 m -78.67 116.06 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 71.140000000000001 110.294 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.7 mm -89.87 113.29 56.43 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 116.385 -0.371 . . . . 60.109999999999999 110.853 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.674 ' HB3' ' H ' ' A' ' 25' ' ' GLN . 73.5 Cg_endo -75.75 155.0 39.45 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.547 2.165 . . . . 51.240000000000002 111.556 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -54.17 -30.83 50.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.959 -0.564 . . . . 74.230000000000004 112.075 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.02 -26.8 64.22 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.729 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.4 mt -96.19 11.74 33.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.359 0.124 . . . . 72.140000000000001 111.286 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 -178.2 6.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 75.530000000000001 110.466 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -69.72 -8.27 46.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 72.409999999999997 110.783 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.83 -20.39 32.82 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 116.065 -0.516 . . . . 75.140000000000001 112.817 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -58.17 -51.95 67.58 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.562 -0.533 . . . . 70.209999999999994 109.562 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -84.33 -53.82 5.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.45 -0.795 . . . . 72.200000000000003 110.77 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.96 146.17 12.69 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 116.097 -0.501 . . . . 74.310000000000002 112.158 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -139.06 -55.41 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 122.369 0.268 . . . . 75.400000000000006 110.854 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 13.4 Cg_exo -70.01 128.34 15.66 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.942 1.761 . . . . 74.049999999999997 110.631 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 76.5 Cg_exo -51.58 -27.67 26.29 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.82 2.347 . . . . 75.519999999999996 113.342 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.2 t -73.87 -35.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 74.310000000000002 110.56 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.54 106.17 17.35 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 64.329999999999998 109.549 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 95.3 Cg_endo -79.66 163.38 23.96 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.406 2.071 . . . . 73.409999999999997 112.364 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.11 143.9 91.71 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 122.212 1.941 . . . . 61.409999999999997 111.17 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 65.92 28.19 10.7 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.24 0.338 . . . . 73.319999999999993 111.276 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' PRO . . . -76.34 148.96 37.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.18 0.514 . . . . 74.120000000000005 112.067 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.3 m -108.9 131.33 55.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.439 -0.8 . . . . 71.230000000000004 109.379 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -138.48 147.27 43.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.208 -0.664 . . . . 73.030000000000001 109.208 -175.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.578 ' N ' HD13 ' A' ' 121' ' ' LEU . 94.7 t -105.03 144.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.388 . . . . 74.230000000000004 110.98 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 121' ' ' LEU . 27.8 m-85 -133.01 125.6 30.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.021 0.439 . . . . 52.100000000000001 110.715 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 58.5 mt-10 -76.4 114.85 15.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.23 -0.656 . . . . 64.310000000000002 109.23 170.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.3 m -95.87 133.55 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 41.0 108.765 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 45.5 tt0 -139.02 116.64 11.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.39 -0.368 . . . . 75.209999999999994 110.265 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.744 HD22 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -96.04 111.71 23.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.557 -0.905 . . . . 72.310000000000002 108.557 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.05 -50.82 7.13 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.921 0.391 . . . . 73.209999999999994 110.065 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -167.1 178.82 5.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.388 -0.823 . . . . 55.219999999999999 109.905 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 92' ' ' LEU . 46.6 t . . . . . 0 C--O 1.251 1.142 0 N-CA-C 108.843 -0.799 . . . . 71.349999999999994 108.843 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.727 0.298 . . . . 73.310000000000002 110.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.86 88.58 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.283 -0.417 . . . . 60.100000000000001 110.181 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.26 106.01 0.21 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.033 -0.53 . . . . 74.230000000000004 110.071 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -69.79 127.08 31.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.447 -0.797 . . . . 73.230000000000004 111.742 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -146.78 130.43 16.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.924 -0.58 . . . . 75.319999999999993 110.108 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -73.45 158.99 33.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.529 -0.915 . . . . 73.329999999999998 108.529 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.436 ' HD2' ' SD ' ' A' ' 9' ' ' MET . 85.3 t60 -54.73 99.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 65.319999999999993 110.943 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -62.15 111.71 2.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.861 -0.609 . . . . 73.239999999999995 110.676 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.436 ' SD ' ' HD2' ' A' ' 7' ' ' HIS . 94.8 mmm -85.21 145.49 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 52.340000000000003 109.815 176.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.9 95.43 0.72 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.125 -0.559 . . . . 72.519999999999996 112.218 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -57.32 100.61 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.766 0.317 . . . . 61.109999999999999 110.429 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.3 178.4 3.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 111.568 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.23 105.26 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 63.329999999999998 110.804 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 98.74 5.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.48 -0.563 . . . . 33.229999999999997 109.48 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -81.01 -19.73 43.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.094 -0.503 . . . . 71.120000000000005 110.264 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.6 m -110.48 138.1 47.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.025 -0.534 . . . . 75.230000000000004 109.824 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -83.04 157.93 22.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.931 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.84 165.68 26.81 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.991 -0.549 . . . . 74.25 111.795 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.85 99.19 0.21 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.49 2.126 . . . . 73.400000000000006 112.032 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.11 21.16 9.12 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.005 -0.543 . . . . 53.439999999999998 112.96 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.1 m -67.1 81.4 0.12 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.797 0.332 . . . . 73.519999999999996 110.866 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 58.13 15.44 3.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.807 -0.633 . . . . 72.150000000000006 111.803 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 t -150.16 128.86 12.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 71.329999999999998 109.273 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.46 127.21 31.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 62.109999999999999 111.688 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -95.88 135.46 37.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.635 -0.876 . . . . 62.340000000000003 108.635 172.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.9 tp -119.23 102.04 8.42 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.039 0.447 . . . . 71.530000000000001 111.02 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -114.27 130.1 56.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.74 -0.664 . . . . 65.329999999999998 109.993 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.676 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -140.88 117.18 10.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.549 -0.751 . . . . 71.0 109.209 -175.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.55 118.09 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.481 -0.327 . . . . 73.319999999999993 110.542 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.02 134.0 27.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 70.430000000000007 110.374 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.87 -18.45 13.69 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.409 -0.36 . . . . 73.129999999999995 110.688 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 88.2 m -142.71 110.63 5.7 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.148 -0.316 . . . . 74.030000000000001 110.148 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.23 126.13 10.83 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.766 2.311 . . . . 71.120000000000005 111.053 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.2 -171.29 47.3 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.236 -0.507 . . . . 71.120000000000005 113.177 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -57.61 -34.76 69.63 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.603 0.361 . . . . 72.409999999999997 111.346 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 76.08 -25.59 1.54 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.281 -0.485 . . . . 51.130000000000003 113.474 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 35' ' ' ASP . 34.1 m -75.12 -21.91 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.872 0.368 . . . . 73.239999999999995 111.471 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -81.07 128.92 34.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 54.219999999999999 111.222 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -100.09 110.24 58.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.167 -0.47 . . . . 63.140000000000001 109.988 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.24 134.15 13.99 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 71.040000000000006 111.161 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -127.96 141.72 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 75.109999999999999 110.371 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 162.13 29.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.01 -0.541 . . . . 74.420000000000002 111.776 -176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.95 77.17 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.562 -0.744 . . . . 65.140000000000001 112.981 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -137.4 170.73 15.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 111.719 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -78.64 142.75 36.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 61.229999999999997 111.495 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.15 141.94 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.845 -0.616 . . . . 64.049999999999997 110.112 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.3 m -93.68 108.12 19.9 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 115.764 -0.653 . . . . 54.210000000000001 110.277 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.525 HG12 HD22 ' A' ' 127' ' ' LEU . 20.4 m -123.78 178.33 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.995 -1.002 . . . . 41.030000000000001 111.325 -172.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.589 ' HB3' HD21 ' A' ' 128' ' ' LEU . 8.9 t-80 -157.83 143.35 17.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.391 -0.822 . . . . 71.409999999999997 109.136 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 49.2 p90 -141.49 150.21 41.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.49 0.186 . . . . 71.340000000000003 110.953 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.31 159.19 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.063 -0.517 . . . . 72.430000000000007 110.292 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -109.28 148.44 17.05 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 116.323 -0.399 . . . . 64.230000000000004 112.484 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.54 143.25 17.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.881 -0.414 . . . . 71.310000000000002 109.881 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.91 140.21 27.66 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.411 -0.359 . . . . 75.120000000000005 110.401 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.82 -13.3 21.72 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.721 2.281 . . . . 74.209999999999994 111.432 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.57 -25.71 39.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.044 -0.98 . . . . 72.299999999999997 110.883 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.31 23.73 12.31 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.278 -0.729 . . . . 52.539999999999999 111.278 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -149.16 147.12 28.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.933 -0.395 . . . . 64.140000000000001 109.933 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.05 136.62 53.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.128 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -65.25 -54.28 31.66 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.326 -0.397 . . . . 73.530000000000001 110.002 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.23 160.65 43.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.621 -0.718 . . . . 72.129999999999995 109.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 64' ' ' ARG . 39.5 m -117.41 121.57 41.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.379 -0.373 . . . . 73.409999999999997 110.457 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.6 m -70.35 -29.25 65.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.232 0.539 . . . . 61.149999999999999 109.88 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.527 HH12 ' HD2' ' A' ' 95' ' ' LYS . 8.8 ptm180 -59.85 -31.03 69.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.663 -0.699 . . . . 74.420000000000002 111.336 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.2 m -57.05 -30.25 64.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.451 -0.34 . . . . 52.329999999999998 110.655 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.652 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 5.4 mmp_? -81.09 -10.55 59.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.195 -0.457 . . . . 75.439999999999998 111.158 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.31 48.66 84.16 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.157 -0.474 . . . . 63.329999999999998 112.678 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 20.5 tptm -112.61 115.23 49.31 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 122.826 -0.22 . . . . 75.340000000000003 110.481 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 4.1 Cg_exo -81.26 167.62 17.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.15 2.566 . . . . 73.209999999999994 111.928 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.453 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 97.1 m-85 -136.2 158.97 43.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 71.230000000000004 110.087 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 97.6 mt-30 -143.57 135.87 26.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.874 -0.417 . . . . 75.030000000000001 109.874 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HE1' HG11 ' A' ' 48' ' ' VAL . 11.6 p90 -150.54 160.42 43.8 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 121.057 -0.257 . . . . 73.400000000000006 110.623 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.508 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 15.2 m -85.42 104.66 15.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 75.200000000000003 110.271 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 88' ' ' ALA . 51.0 tp -55.89 137.09 51.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 75.129999999999995 111.046 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.02 -30.45 5.48 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.091 -0.576 . . . . 51.530000000000001 112.626 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.05 178.27 7.65 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.279 . . . . 74.430000000000007 111.095 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.48 53.9 4.78 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.883 -0.487 . . . . 54.409999999999997 111.883 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 73' ' ' THR . 5.7 mm-40 -90.71 -44.93 9.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.043 0.449 . . . . 75.439999999999998 110.552 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.5 m -136.82 177.89 5.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 115.678 -0.692 . . . . 32.009999999999998 110.089 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 104' ' ' LEU . 18.0 pt -68.19 140.97 18.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 109.95 -0.389 . . . . 75.420000000000002 109.95 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.631 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 61.6 mmtt -63.71 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.617 0.599 . . . . 73.310000000000002 112.617 -173.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -56.98 22.26 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.43 -0.89 . . . . 34.43 111.017 171.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -69.15 -40.17 78.36 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.271 -0.27 . . . . 71.340000000000003 110.271 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.631 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 12.4 t70 -51.75 -55.19 21.16 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.746 -0.661 . . . . 72.430000000000007 110.528 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.99 -42.17 70.0 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.077 -0.51 . . . . 73.310000000000002 110.685 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.31 -49.97 48.79 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.045 -0.598 . . . . 70.400000000000006 112.073 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.7 p -75.93 -31.93 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.692 0.282 . . . . 62.310000000000002 110.942 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -59.74 -35.29 74.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.692 0.282 . . . . 72.340000000000003 111.735 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.7 t -87.73 6.56 34.37 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.269 0.47 . . . . 72.319999999999993 112.269 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 13.8 ptp -112.01 177.89 4.5 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.046 -0.408 . . . . 71.329999999999998 110.552 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.523 HG21 ' HA2' ' A' ' 36' ' ' GLY . 42.5 p -121.1 178.82 4.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.852 0.358 . . . . 75.530000000000001 111.708 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -61.99 129.97 43.4 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.703 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.69 17.25 77.8 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.781 -0.645 . . . . 72.25 112.457 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 32' ' ' THR . 14.6 tt0 -106.98 136.35 46.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 71.340000000000003 110.313 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.527 ' HD2' HH12 ' A' ' 64' ' ' ARG . 28.3 ttpp -131.7 126.76 35.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.988 -0.551 . . . . 74.540000000000006 110.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.87 142.12 50.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 55.240000000000002 110.892 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 tt -90.79 117.23 29.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.395 -0.965 . . . . 62.350000000000001 108.395 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -123.37 122.44 38.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.5 . . . . 65.010000000000005 109.649 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 122' ' ' VAL . 54.1 m -81.89 106.51 13.87 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.66 -0.496 . . . . 71.140000000000001 109.66 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 105' ' ' ALA . 27.0 mm -85.64 112.3 43.64 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 115.978 -0.555 . . . . 60.109999999999999 110.236 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.628 ' HA ' HG23 ' A' ' 120' ' ' THR . 38.2 Cg_endo -66.4 159.33 50.81 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.205 1.937 . . . . 51.240000000000002 111.075 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 38.4 p90 -54.41 -31.5 55.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 111.348 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -62.47 -30.04 70.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.515 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 80' ' ' ILE . 88.0 mt -105.38 13.13 30.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.327 -0.397 . . . . 72.140000000000001 111.544 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -147.15 176.17 10.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.075 0.464 . . . . 75.530000000000001 111.435 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -68.47 -14.98 63.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.559 -0.746 . . . . 72.409999999999997 110.617 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.91 -16.42 47.02 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.926 -0.579 . . . . 75.140000000000001 113.045 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 35.0 tt0 -56.2 -55.23 35.66 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.074 0.464 . . . . 70.209999999999994 110.327 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -98.81 -35.18 10.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.831 . . . . 72.200000000000003 110.52 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.67 161.98 10.99 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.805 -0.634 . . . . 74.310000000000002 112.399 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.716 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.7 m-85 -135.39 -57.18 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 122.23 0.212 . . . . 75.400000000000006 110.486 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 68.7 Cg_endo -91.25 142.41 2.99 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.003 1.802 . . . . 74.049999999999997 111.854 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 50.1 Cg_exo -55.05 -18.69 17.88 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.771 2.314 . . . . 75.519999999999996 112.737 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.61 -36.88 77.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.017 -0.538 . . . . 74.310000000000002 110.201 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.4 mm -110.16 99.11 38.3 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 109.304 -0.628 . . . . 64.329999999999998 109.304 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.03 159.79 51.96 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.626 2.217 . . . . 73.409999999999997 112.513 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.71 147.25 89.75 Favored 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.233 1.955 . . . . 61.409999999999997 111.665 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 7.0 mtmp? 69.69 22.85 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.069 0.548 . . . . 73.319999999999993 110.629 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.56 131.62 35.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.114 0.483 . . . . 74.120000000000005 111.31 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.628 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -97.98 127.99 44.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.182 -0.673 . . . . 71.230000000000004 109.182 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -129.44 143.6 50.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.789 -0.448 . . . . 73.030000000000001 109.789 -171.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.57 ' N ' HD13 ' A' ' 121' ' ' LEU . 46.9 t -98.3 131.82 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.117 -0.327 . . . . 74.230000000000004 110.117 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.55 132.17 51.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.656 0.265 . . . . 52.100000000000001 111.153 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 30.9 mt-10 -82.44 112.29 19.24 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.12 -0.696 . . . . 64.310000000000002 109.12 170.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.491 HG23 ' HE1' ' A' ' 90' ' ' MET . 11.1 m -97.06 135.45 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.097 -0.705 . . . . 41.0 109.097 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 95' ' ' LYS . 45.2 tt0 -141.3 121.46 13.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.319 -0.401 . . . . 75.209999999999994 110.427 -172.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -93.54 113.95 26.19 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.613 -0.884 . . . . 72.310000000000002 108.613 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.9 mm? -87.78 -50.72 6.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 120.804 0.335 . . . . 73.209999999999994 110.125 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.22 -173.41 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 55.219999999999999 110.094 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.253 1.276 0 CA-C-O 118.768 -0.634 . . . . 71.349999999999994 109.532 173.562 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.048 -0.353 . . . . 73.310000000000002 110.048 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.94 131.68 1.67 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.278 -0.419 . . . . 60.100000000000001 110.153 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -119.19 95.35 4.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.483 -0.326 . . . . 74.230000000000004 110.309 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -68.89 84.51 0.32 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.743 -0.836 . . . . 73.230000000000004 108.743 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -98.24 160.6 14.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.35 -0.841 . . . . 75.319999999999993 111.454 -171.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -83.81 162.48 20.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 73.329999999999998 110.061 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -96.91 101.57 13.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.281 -0.418 . . . . 65.319999999999993 109.891 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -74.07 141.59 45.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.853 -0.425 . . . . 73.239999999999995 109.853 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp -137.38 -179.91 6.01 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.213 -0.449 . . . . 52.340000000000003 110.4 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.34 124.47 5.31 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.278 -0.729 . . . . 72.519999999999996 111.278 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -77.86 117.42 19.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.825 0.312 . . . . 61.109999999999999 110.367 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.9 mp -54.99 -62.23 1.8 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.385 0.428 . . . . 72.230000000000004 109.858 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -103.15 119.2 38.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 63.329999999999998 109.198 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.11 -177.33 1.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.083 0.468 . . . . 33.229999999999997 111.399 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -64.29 148.21 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.684 -0.689 . . . . 71.120000000000005 110.809 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 p -84.81 13.29 6.0 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.177 0.513 . . . . 75.230000000000004 111.489 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -145.66 140.07 27.05 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.946 -0.57 . . . . 72.329999999999998 109.97 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.86 -143.04 3.56 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.601 -0.6 . . . . 74.25 111.601 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.5 34.94 0.54 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.182 2.588 . . . . 73.400000000000006 112.284 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.71 70.9 2.95 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.31 -0.471 . . . . 53.439999999999998 112.637 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.2 t -152.48 135.35 15.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.252 -0.647 . . . . 73.519999999999996 109.252 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -81.3 -19.94 41.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.691 0.282 . . . . 72.150000000000006 111.158 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -78.93 166.58 22.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.961 0.41 . . . . 71.329999999999998 110.651 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.24 109.88 1.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.676 -0.693 . . . . 62.109999999999999 111.266 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -92.27 135.0 34.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.649 -0.871 . . . . 62.340000000000003 108.649 175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 55.0 tp -145.83 102.8 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.418 0.525 . . . . 71.530000000000001 112.418 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -111.93 132.43 54.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.067 -0.716 . . . . 65.329999999999998 109.067 165.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -129.95 101.27 5.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.508 -0.923 . . . . 71.0 108.508 176.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -123.03 113.74 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 73.319999999999993 110.736 -173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' ALA . 6.5 p -64.38 114.23 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 70.430000000000007 110.863 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.18 -49.75 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.445 -0.576 . . . . 73.129999999999995 109.445 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -112.4 113.54 51.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.369 -0.832 . . . . 74.030000000000001 109.423 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.79 140.86 52.29 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.634 2.223 . . . . 71.120000000000005 112.438 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -98.53 -169.38 31.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.39 -0.433 . . . . 71.120000000000005 112.66 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.42 -46.07 67.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.781 0.324 . . . . 72.409999999999997 110.434 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 95.2 -20.74 47.85 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.093 -0.503 . . . . 51.130000000000003 113.931 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -103.24 -0.86 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 117.687 0.743 . . . . 73.239999999999995 112.634 -172.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.3 p -85.07 142.18 29.73 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.713 0.292 . . . . 54.219999999999999 110.568 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -113.43 119.57 41.6 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.387 -0.369 . . . . 63.140000000000001 110.025 178.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 14.4 Cg_exo -69.56 143.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.571 2.18 . . . . 71.040000000000006 111.582 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -150.54 141.82 23.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.826 0.346 . . . . 75.109999999999999 110.52 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.752 -0.658 . . . . 74.420000000000002 111.71 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.98 19.56 57.37 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.628 -0.715 . . . . 65.140000000000001 113.058 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -138.47 161.73 36.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.077 0.439 . . . . 74.430000000000007 110.813 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.6 tppp? -81.63 117.12 21.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.836 -0.62 . . . . 61.229999999999997 109.636 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG11 HD22 ' A' ' 74' ' ' LEU . 27.5 m -110.35 151.38 12.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 120.901 0.382 . . . . 64.049999999999997 110.539 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -117.01 108.18 15.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.562 -0.745 . . . . 54.210000000000001 110.169 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.01 178.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.589 -0.732 . . . . 41.030000000000001 110.494 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 63.7 t60 -149.24 146.48 27.62 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.09 -0.707 . . . . 71.409999999999997 109.09 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -126.59 152.53 46.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.701 -0.481 . . . . 71.340000000000003 109.701 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.744 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 35.7 m-20 -135.6 112.74 10.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.498 -0.927 . . . . 72.430000000000007 108.498 172.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.95 111.13 3.33 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.936 -0.575 . . . . 64.230000000000004 112.609 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 53' ' ' ARG . 22.3 ttt180 -122.38 137.49 54.84 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.32 0.581 . . . . 71.310000000000002 111.019 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -89.23 151.91 47.17 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 75.120000000000005 109.886 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.64 -17.63 36.27 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.177 2.585 . . . . 74.209999999999994 114.006 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.94 -14.74 53.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.853 0.359 . . . . 72.299999999999997 110.606 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.36 -1.02 37.35 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.219 -0.515 . . . . 52.539999999999999 112.425 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -94.43 157.23 16.11 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.544 -0.539 . . . . 64.140000000000001 109.544 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.73 -0.471 . . . . 72.329999999999998 109.73 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.23 -46.97 66.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.530000000000001 111.324 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.01 131.28 45.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.355 -0.384 . . . . 72.129999999999995 110.959 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 m -104.92 85.63 2.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 73.409999999999997 109.375 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -56.95 -28.86 62.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.059 -0.518 . . . . 61.149999999999999 110.835 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -53.91 -31.76 51.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.749 -0.66 . . . . 74.420000000000002 111.311 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.7 t -59.1 -37.32 76.88 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.886 0.374 . . . . 52.329999999999998 110.728 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -80.29 -11.54 59.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.992 -0.549 . . . . 75.439999999999998 110.564 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.41 18.99 59.42 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.132 -0.485 . . . . 63.329999999999998 112.106 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -82.14 119.13 74.34 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 122.363 0.265 . . . . 75.340000000000003 110.375 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -88.55 162.5 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.046 2.497 . . . . 73.209999999999994 112.352 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -122.69 117.0 24.73 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.37 -0.604 . . . . 71.230000000000004 109.37 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.59 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 92.2 mt-30 -107.06 140.96 39.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.573 -0.285 . . . . 75.030000000000001 110.468 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -156.89 167.6 29.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.479 -0.328 . . . . 73.400000000000006 110.23 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.6 m -82.07 108.93 15.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 110.294 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.436 HD22 HG11 ' A' ' 46' ' ' VAL . 45.1 tp -62.1 111.03 1.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.702 -0.481 . . . . 75.129999999999995 109.702 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.14 -24.56 5.64 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.214 -0.755 . . . . 51.530000000000001 111.214 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.63 145.2 47.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.4 -0.222 . . . . 74.430000000000007 110.4 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.41 43.61 2.33 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.429 -0.35 . . . . 54.409999999999997 113.064 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -82.54 -47.61 11.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 75.439999999999998 110.198 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.7 m -95.06 162.56 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.75 . . . . 32.009999999999998 110.949 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.447 HG12 ' CE3' ' A' ' 83' ' ' TRP . 35.4 pt -80.07 159.02 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.573 -0.528 . . . . 75.420000000000002 109.573 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 55.4 mmtt -60.41 -21.14 61.88 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.418 0.155 . . . . 73.310000000000002 111.418 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.07 -47.97 88.19 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.599 -0.81 . . . . 34.43 111.574 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.447 ' CE3' HG12 ' A' ' 80' ' ' ILE . 18.1 m0 -79.76 -29.28 40.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.589 0.233 . . . . 71.340000000000003 110.401 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 6.6 t70 -58.0 -55.05 39.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.616 0.722 . . . . 72.430000000000007 109.792 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -67.68 -35.86 79.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.496 -0.774 . . . . 73.310000000000002 109.861 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.9 -49.35 58.99 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.766 -0.652 . . . . 70.400000000000006 112.434 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 12.2 p -75.24 -32.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 62.310000000000002 110.274 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -30.08 71.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.33 -0.396 . . . . 72.340000000000003 112.015 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 t -90.4 -14.86 32.09 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.116 0.413 . . . . 72.319999999999993 112.116 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.888 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.8 ptp -93.92 -179.77 5.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.691 0.281 . . . . 71.329999999999998 110.879 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.424 HG21 ' HA2' ' A' ' 36' ' ' GLY . 16.7 p -138.83 178.95 6.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.197 -0.456 . . . . 75.530000000000001 111.213 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -58.81 124.5 20.01 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 122.886 0.474 . . . . 74.120000000000005 110.694 -176.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.68 37.63 57.57 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.398 176.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.629 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.9 tt0 -124.2 126.62 46.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 71.340000000000003 110.975 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 24.5 ttmm -114.9 115.06 26.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.803 -0.635 . . . . 74.540000000000006 109.549 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -113.52 145.42 41.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 110.638 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 28' ' ' LYS . 9.4 tt -90.63 105.4 17.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.04 -1.096 . . . . 62.350000000000001 108.04 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -112.13 126.39 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.337 -0.392 . . . . 65.010000000000005 110.423 -172.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 26' ' ' LEU . 7.9 m -85.12 118.16 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.446 -0.343 . . . . 71.140000000000001 110.639 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.8 mm -99.05 108.57 50.19 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 110.387 -0.227 . . . . 60.109999999999999 110.387 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.99 140.94 39.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.097 2.531 . . . . 51.240000000000002 111.275 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.97 -29.56 57.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.454 -0.339 . . . . 74.230000000000004 111.836 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.2 -30.07 70.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.514 . . . . 73.140000000000001 111.644 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.88 9.06 43.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 72.140000000000001 111.777 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.26 178.95 8.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.145 0.498 . . . . 75.530000000000001 111.658 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -73.61 -2.47 23.07 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.495 -0.775 . . . . 72.409999999999997 111.332 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.31 -14.25 56.35 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 116.189 -0.459 . . . . 75.140000000000001 112.085 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 8.4 tm-20 -66.77 -49.42 65.95 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.413 -0.588 . . . . 70.209999999999994 109.413 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 117' ' ' PRO . 40.4 ttm180 -67.86 -52.08 40.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.876 -0.602 . . . . 72.200000000000003 110.695 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.61 172.29 3.84 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.101 -0.571 . . . . 74.310000000000002 111.952 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 88.5 m-85 -147.17 -63.64 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.782 0.291 . . . . 75.400000000000006 111.298 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 2.3 Cg_endo -84.23 141.36 9.14 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.213 1.942 . . . . 74.049999999999997 111.988 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.63 -21.93 57.89 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.692 2.261 . . . . 75.519999999999996 111.747 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.77 -35.34 63.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.772 -0.649 . . . . 74.310000000000002 110.115 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -125.02 92.95 46.66 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 64.329999999999998 109.218 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -52.02 147.24 27.08 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.038 2.492 . . . . 73.409999999999997 112.673 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 21.1 Cg_endo -59.83 153.43 56.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.727 2.285 . . . . 61.409999999999997 111.435 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 19.4 mtmm 59.1 53.11 5.69 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.393 0.616 . . . . 73.319999999999993 110.431 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.53 132.38 54.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.325 -0.852 . . . . 74.120000000000005 111.123 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.6 m -83.05 130.48 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.38 -0.6 . . . . 71.230000000000004 109.38 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -123.06 143.39 49.99 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.672 -0.492 . . . . 73.030000000000001 109.672 -173.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.576 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.2 t -100.53 116.13 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.832 -0.433 . . . . 74.230000000000004 109.832 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -109.06 116.58 32.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.096 -0.335 . . . . 52.100000000000001 110.096 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.8 mt-10 -78.58 106.86 10.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.181 -1.044 . . . . 64.310000000000002 108.181 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 13.4 m -97.59 149.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.047 -0.979 . . . . 41.0 110.112 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 63.8 tt0 -147.22 131.6 17.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.76 -0.2 . . . . 75.209999999999994 110.795 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.888 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 3.2 tm? -103.08 112.97 26.07 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.865 -0.42 . . . . 72.310000000000002 109.865 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -90.86 -41.48 11.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 110.324 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.43 139.1 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 55.219999999999999 109.932 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 119.37 -0.348 . . . . 71.349999999999994 110.401 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.709 0.29 . . . . 73.310000000000002 110.383 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.89 -70.68 0.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.522 . . . . 60.100000000000001 109.592 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -94.1 54.37 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.969 0.89 . . . . 74.230000000000004 109.037 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -140.0 81.08 1.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.764 -1.107 . . . . 73.230000000000004 108.856 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -92.26 -76.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 75.319999999999993 110.824 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -66.26 142.36 57.71 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.048 -0.524 . . . . 73.329999999999998 110.353 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.548 ' NE2' ' SD ' ' A' ' 9' ' ' MET . 84.0 t60 -145.93 39.54 1.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.193 0.52 . . . . 65.319999999999993 110.406 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -65.4 86.1 0.07 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.013 0.435 . . . . 73.239999999999995 109.959 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.548 ' SD ' ' NE2' ' A' ' 7' ' ' HIS . 16.4 ptm -103.06 4.27 37.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.695 -0.684 . . . . 52.340000000000003 110.108 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.1 -157.54 6.12 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.533 -0.758 . . . . 72.519999999999996 112.401 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.8 t -76.97 167.52 21.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.676 0.751 . . . . 61.109999999999999 111.972 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 12' ' ' LEU . 2.1 pt? -158.11 14.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.357 -1.292 . . . . 72.230000000000004 108.339 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -100.48 171.58 7.65 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.862 -1.063 . . . . 63.329999999999998 110.348 -172.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 55.04 37.67 29.28 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.55 0.531 . . . . 33.229999999999997 110.44 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -66.68 -14.33 62.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.711 -0.677 . . . . 71.120000000000005 111.308 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.3 m -59.82 87.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.368 0.604 . . . . 75.230000000000004 110.214 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.36 -5.89 49.18 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.391 -0.822 . . . . 72.329999999999998 111.668 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.2 171.04 26.67 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.719 -0.552 . . . . 74.25 111.719 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.1 125.26 9.68 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.662 2.241 . . . . 73.400000000000006 112.039 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.39 25.01 9.45 Favored Glycine 0 N--CA 1.453 -0.168 0 N-CA-C 111.615 -0.594 . . . . 53.439999999999998 111.615 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -156.84 176.3 12.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.613 -0.514 . . . . 73.519999999999996 109.613 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.28 58.84 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.221 0.534 . . . . 72.150000000000006 110.11 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -76.7 37.81 0.18 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.603 -0.726 . . . . 71.329999999999998 111.482 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.66 89.04 1.73 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 62.109999999999999 110.015 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -132.28 135.31 46.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.716 -0.675 . . . . 62.340000000000003 109.497 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 5.9 tt -145.7 102.39 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.509 -0.552 . . . . 71.530000000000001 109.509 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -121.73 149.82 42.71 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.981 -0.554 . . . . 65.329999999999998 110.185 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 18.4 ptpt -127.98 103.7 7.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.637 -0.71 . . . . 71.0 109.448 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.64 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 66.8 mttm -109.1 110.39 21.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.825 -0.435 . . . . 73.319999999999993 109.825 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 30' ' ' VAL . 5.8 p -71.87 97.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.486 0.66 . . . . 70.430000000000007 110.134 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.721 HD23 ' HD3' ' A' ' 95' ' ' LYS . 33.9 tp -76.94 -29.2 55.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 109.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 32.1 m -145.51 115.82 4.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 74.030000000000001 109.74 176.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.3 128.74 13.16 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.065 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.69 -159.81 22.05 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.177 -0.535 . . . . 71.120000000000005 112.44 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.46 -37.44 87.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.088 0.471 . . . . 72.409999999999997 110.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.21 -29.84 3.81 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.952 -0.567 . . . . 51.130000000000003 112.134 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.26 -34.12 7.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.737 0.303 . . . . 73.239999999999995 110.711 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 p -71.77 94.07 1.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.295 0.569 . . . . 54.219999999999999 110.983 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -88.06 125.91 62.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.494 -0.775 . . . . 63.140000000000001 110.452 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG3' ' O ' ' A' ' 90' ' ' MET . 86.3 Cg_endo -78.07 176.4 10.02 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.62 2.213 . . . . 71.040000000000006 111.547 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.97 167.25 14.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 109.905 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.43 156.24 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.345 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.71 73.64 Favored Glycine 0 CA--C 1.517 0.206 0 C-N-CA 121.15 -0.548 . . . . 65.140000000000001 112.562 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 4.3 mmmp? -116.19 130.02 56.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.683 0.278 . . . . 74.430000000000007 110.738 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.83 104.01 3.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.68 -0.859 . . . . 61.229999999999997 108.68 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 34.1 m -105.86 142.54 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.157 0.503 . . . . 64.049999999999997 110.951 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.8 m -99.27 120.32 39.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.112 -0.949 . . . . 54.210000000000001 109.27 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.592 HG11 HG21 ' A' ' 87' ' ' VAL . 32.6 m -136.68 177.97 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.569 0.699 . . . . 41.030000000000001 112.454 -172.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 7.3 m170 -137.59 152.62 49.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.504 -1.226 . . . . 71.409999999999997 109.098 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -128.0 142.85 51.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 71.340000000000003 109.534 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.782 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 24.0 m-20 -135.4 119.73 17.87 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.017 -0.734 . . . . 72.430000000000007 109.017 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -82.68 114.32 3.82 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 116.214 -0.448 . . . . 64.230000000000004 112.295 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.522 HH11 HD12 ' A' ' 97' ' ' LEU . 42.1 ttm180 -130.8 148.5 52.59 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.428 0.633 . . . . 71.310000000000002 111.364 -174.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -90.12 156.37 46.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 75.120000000000005 110.224 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.38 2.3 1.26 Allowed 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.946 2.43 . . . . 74.209999999999994 112.861 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.76 -29.9 25.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.236 0.541 . . . . 72.299999999999997 110.517 174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.85 -25.47 8.43 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.706 -0.679 . . . . 52.539999999999999 111.882 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -84.61 157.32 21.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.825 -0.435 . . . . 64.140000000000001 109.825 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 13.9 pt20 -141.84 -175.28 4.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.715 0.293 . . . . 72.329999999999998 110.905 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -86.06 -64.86 1.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.285 -0.416 . . . . 73.530000000000001 110.108 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -144.91 156.66 44.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.009 -0.367 . . . . 72.129999999999995 110.009 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.3 p -87.26 91.53 8.75 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.359 -0.608 . . . . 73.409999999999997 109.359 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.425 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 31.4 m -64.33 -27.39 68.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.829 -0.623 . . . . 61.149999999999999 111.155 -174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.24 69.4 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.434 -0.348 . . . . 74.420000000000002 110.424 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -73.8 -6.23 45.75 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.001 -0.545 . . . . 52.329999999999998 111.593 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 63' ' ' SER . 25.3 mmm180 -75.69 -2.82 31.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.084 0.468 . . . . 75.439999999999998 110.759 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.25 8.57 65.88 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 63.329999999999998 113.953 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HD2' ' HD2' ' A' ' 69' ' ' PRO . 52.5 tptt -122.89 121.58 27.29 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 117.051 0.426 . . . . 75.340000000000003 109.971 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.598 ' HD2' ' HD2' ' A' ' 68' ' ' LYS . 68.1 Cg_endo -85.27 160.06 11.27 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.658 2.239 . . . . 73.209999999999994 112.276 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -114.33 158.14 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.127 -0.694 . . . . 71.230000000000004 109.127 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 85.7 mt-30 -134.77 139.48 45.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.574 0.226 . . . . 75.030000000000001 110.825 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.536 ' HE1' HG21 ' A' ' 48' ' ' VAL . 33.5 p90 -156.16 151.88 27.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.508 -0.553 . . . . 73.400000000000006 109.508 173.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.5 m -73.66 109.03 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.893 0.378 . . . . 75.200000000000003 110.905 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 88' ' ' ALA . 57.2 tp -60.8 135.31 57.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.057 -0.519 . . . . 75.129999999999995 110.209 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.83 -11.52 71.91 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.119 -0.562 . . . . 51.530000000000001 112.135 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.13 160.95 14.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.202 -0.296 . . . . 74.430000000000007 110.202 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.65 2.62 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 121.2 -0.524 . . . . 54.409999999999997 112.756 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -85.75 -25.46 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 75.439999999999998 110.304 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.48 168.21 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.76 -0.655 . . . . 32.009999999999998 109.722 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.4 pt -72.91 154.7 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.997 -0.372 . . . . 75.420000000000002 109.997 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 4.5 tmtm? -60.09 -28.42 67.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.475 -0.33 . . . . 73.310000000000002 110.756 -172.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.88 -54.55 36.55 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.923 -0.656 . . . . 34.43 112.003 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.452 ' O ' HG12 ' A' ' 87' ' ' VAL . 48.2 m0 -66.48 -41.25 89.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.025 -0.361 . . . . 71.340000000000003 110.025 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -52.11 -50.95 60.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.474 -0.785 . . . . 72.430000000000007 110.886 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -66.54 -46.34 76.46 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.347 -0.388 . . . . 73.310000000000002 110.307 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.38 -48.39 54.48 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 115.606 -0.724 . . . . 70.400000000000006 112.834 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.592 HG21 HG11 ' A' ' 48' ' ' VAL . 12.3 p -75.55 -33.2 26.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 62.310000000000002 111.139 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -68.23 -25.95 65.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.706 0.261 . . . . 72.340000000000003 111.706 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 86' ' ' GLY . 11.7 t -89.54 17.58 6.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.89 0.7 . . . . 72.319999999999993 112.89 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 12.3 ptp -125.37 178.15 5.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.901 -0.499 . . . . 71.329999999999998 111.412 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.7 p -116.65 177.31 4.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.294 -0.412 . . . . 75.530000000000001 110.477 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.833 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -69.45 129.71 40.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 110.091 -0.337 . . . . 74.120000000000005 110.091 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 88.82 6.11 73.04 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.326 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' THR . 19.6 tt0 -100.18 133.76 44.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.340000000000003 111.022 -175.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.721 ' HD3' HD23 ' A' ' 31' ' ' LEU . 50.0 tttm -117.67 117.52 29.58 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.82 -0.807 . . . . 74.540000000000006 108.82 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -122.65 137.72 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.216 0.531 . . . . 55.240000000000002 111.275 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 29' ' ' LYS . 7.8 tt -90.78 106.29 18.41 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.972 -1.121 . . . . 62.350000000000001 107.972 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -115.25 124.82 52.34 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.113 -0.329 . . . . 65.010000000000005 110.113 -174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.516 HG23 HG22 ' A' ' 122' ' ' VAL . 4.3 m -80.36 111.75 17.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.219 -0.446 . . . . 71.140000000000001 110.546 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 105' ' ' ALA . 32.6 mm -93.58 113.22 59.71 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.618 -0.264 . . . . 60.109999999999999 110.449 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HA ' HG23 ' A' ' 120' ' ' THR . 43.8 Cg_endo -67.31 151.63 80.41 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.758 2.305 . . . . 51.240000000000002 111.783 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -55.99 -31.79 63.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 111.972 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.559 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 4.1 pt20 -65.52 -27.62 68.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.409 . . . . 73.140000000000001 110.954 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.559 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 91.9 mt -109.07 22.86 15.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.871 -0.604 . . . . 72.140000000000001 110.096 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 100' ' ' ILE . . . -149.18 176.61 10.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.887 -0.597 . . . . 75.530000000000001 111.406 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -76.65 -11.77 59.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.409999999999997 110.282 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.68 -16.69 31.32 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.835 -0.62 . . . . 75.140000000000001 113.377 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.57 -49.32 76.77 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.408 -0.59 . . . . 70.209999999999994 109.408 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -91.92 -26.22 18.54 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.548 -0.751 . . . . 72.200000000000003 110.55 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 82.0 -66.25 3.9 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.745 -0.662 . . . . 74.310000000000002 111.584 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 50.5 m-85 94.56 -74.36 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.324 1.45 . . . . 75.400000000000006 111.567 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 110' ' ' GLY . 95.4 Cg_endo -81.15 139.2 11.69 Favored 'Trans proline' 0 C--N 1.361 1.203 0 CA-C-N 121.332 1.512 . . . . 74.049999999999997 110.84 174.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.11 -11.36 15.43 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.79 2.327 . . . . 75.519999999999996 112.457 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.72 -31.79 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.138 0.494 . . . . 74.310000000000002 110.026 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.9 mm -100.76 120.71 54.98 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.687 -0.688 . . . . 64.329999999999998 109.711 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 58.3 Cg_endo -70.97 151.09 61.89 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.354 2.036 . . . . 73.409999999999997 112.173 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 39.0 Cg_endo -66.43 141.0 59.86 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.294 1.996 . . . . 61.409999999999997 111.739 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 8.6 mtmp? 71.49 26.51 3.21 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.006 -0.543 . . . . 73.319999999999993 111.126 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -84.77 142.53 29.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.024 0.44 . . . . 74.120000000000005 111.365 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 101' ' ' PRO . 91.7 m -95.21 137.34 34.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.695 -0.684 . . . . 71.230000000000004 109.419 176.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -128.57 139.98 52.02 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.78 -0.452 . . . . 73.030000000000001 109.78 -173.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 121' ' ' LEU . 99.3 t -98.54 122.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.715 0.293 . . . . 74.230000000000004 110.32 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -113.6 120.09 39.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.836 0.35 . . . . 52.100000000000001 110.194 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 22.2 mt-10 -81.49 110.99 17.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.641 -0.874 . . . . 64.310000000000002 108.641 169.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.547 HG23 ' HE1' ' A' ' 90' ' ' MET . 4.0 m -99.84 139.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.739 -0.664 . . . . 41.0 109.483 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.4 tt0 -131.79 119.02 20.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.506 -0.316 . . . . 75.209999999999994 110.31 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.833 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -87.76 113.78 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.688 -0.486 . . . . 72.310000000000002 109.688 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.402 HD21 ' ND1' ' A' ' 49' ' ' HIS . 3.7 mm? -91.73 -43.09 9.77 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.364 -0.38 . . . . 73.209999999999994 110.693 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.47 142.13 24.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.542 -0.299 . . . . 55.219999999999999 110.886 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.602 -0.713 . . . . 71.349999999999994 110.411 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.85 0.357 . . . . 73.310000000000002 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.56 134.81 40.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 60.100000000000001 109.823 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 m170 -76.24 75.06 3.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.124 0.488 . . . . 74.230000000000004 111.028 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -129.65 -11.86 4.39 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.821 -0.627 . . . . 73.230000000000004 110.446 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -158.24 127.26 5.63 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.979 -0.555 . . . . 75.319999999999993 109.991 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -164.19 137.33 5.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 110.128 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -144.0 113.12 6.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 65.319999999999993 109.601 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -84.16 128.52 34.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.076 -0.511 . . . . 73.239999999999995 110.44 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ttt -119.41 134.73 55.07 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.516 -0.55 . . . . 52.340000000000003 109.516 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.47 124.29 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.606 -0.598 . . . . 72.519999999999996 111.606 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.64 HG23 ' H ' ' A' ' 13' ' ' GLU . 12.9 t -71.63 -17.0 62.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.534 0.207 . . . . 61.109999999999999 110.849 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.8 mt 66.71 1.69 2.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.112 0.565 . . . . 72.230000000000004 112.332 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.64 ' H ' HG23 ' A' ' 11' ' ' THR . 40.9 mt-10 -97.75 124.27 42.03 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 110.008 -0.367 . . . . 63.329999999999998 110.008 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.0 101.18 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 33.229999999999997 110.728 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -70.96 -30.48 66.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.283 0.563 . . . . 71.120000000000005 109.576 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -129.26 117.36 20.58 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.075 -0.966 . . . . 75.230000000000004 109.398 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -75.5 -43.64 48.07 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.612 -0.267 . . . . 72.329999999999998 110.841 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.16 -130.29 1.24 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.594 -0.812 . . . . 74.25 113.072 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.22 134.26 22.67 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.891 2.394 . . . . 73.400000000000006 113.103 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.16 39.64 1.04 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.765 -0.934 . . . . 53.439999999999998 110.765 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.5 t -101.15 166.36 10.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.814 0.34 . . . . 73.519999999999996 111.024 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.7 ttp -113.94 3.14 15.27 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.439 0.638 . . . . 72.150000000000006 109.601 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -99.45 179.41 4.58 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.635 -0.711 . . . . 71.329999999999998 110.526 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.423 ' HB2' ' NE2' ' A' ' 103' ' ' GLN . . . -90.85 122.77 33.85 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.062 -0.347 . . . . 62.109999999999999 110.062 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -92.18 135.41 34.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.21 -0.45 . . . . 62.340000000000003 110.506 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.0 tp -106.23 101.84 11.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.974 -0.75 . . . . 71.530000000000001 108.974 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -147.67 106.11 3.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.802 -0.636 . . . . 65.329999999999998 110.388 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -136.97 144.91 43.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.932 0.396 . . . . 71.0 110.065 175.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -140.3 113.17 8.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.944 -0.571 . . . . 73.319999999999993 109.543 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.67 128.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.783 0.325 . . . . 70.430000000000007 110.661 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 97' ' ' LEU . 2.7 mm? -91.99 -42.78 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.268 0.556 . . . . 73.129999999999995 109.751 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 110.9 6.92 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.683 -0.689 . . . . 74.030000000000001 110.565 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.62 137.96 44.02 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.583 2.189 . . . . 71.120000000000005 111.698 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.26 -143.68 10.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.082 -0.58 . . . . 71.120000000000005 112.43 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.8 -37.42 81.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 72.409999999999997 110.535 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.84 -30.51 1.29 Allowed Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.704 -0.68 . . . . 51.130000000000003 113.751 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -79.85 -9.86 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 73.239999999999995 111.015 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -87.25 115.84 24.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.824 -0.626 . . . . 54.219999999999999 110.791 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 9.1 mtpm? -92.43 114.44 62.37 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 110.317 -0.253 . . . . 63.140000000000001 110.317 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.21 108.18 1.92 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.754 2.303 . . . . 71.040000000000006 112.183 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -93.26 120.96 34.13 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.036 -0.529 . . . . 75.109999999999999 109.692 173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.36 154.18 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 74.420000000000002 111.021 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.37 -28.08 8.93 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.043 -0.526 . . . . 65.140000000000001 112.023 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -86.04 159.21 19.65 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.159 0.504 . . . . 74.430000000000007 111.264 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -77.89 112.24 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.479 -0.782 . . . . 61.229999999999997 109.101 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.46 152.52 8.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.059 0.456 . . . . 64.049999999999997 111.384 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.2 m -106.5 110.83 23.16 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.072 -0.967 . . . . 54.210000000000001 110.014 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.437 HG21 ' HE1' ' A' ' 72' ' ' PHE . 25.7 m -119.3 178.28 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.336 -0.847 . . . . 41.030000000000001 111.181 -173.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 22.8 t-80 -157.09 142.47 17.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.732 -0.84 . . . . 71.409999999999997 108.732 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.2 m-85 -126.95 153.18 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 71.340000000000003 110.165 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 16.8 t70 -136.67 109.49 7.59 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.539 -0.541 . . . . 72.430000000000007 109.539 174.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.8 147.27 32.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.356 -0.45 . . . . 64.230000000000004 113.587 -172.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 121' ' ' LEU . 25.8 ttm180 -162.14 144.56 11.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.315 0.578 . . . . 71.310000000000002 111.131 -176.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -83.29 147.74 54.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 109.834 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.77 -17.92 61.73 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.373 2.049 . . . . 74.209999999999994 111.533 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.9 -25.74 62.91 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.566 -0.743 . . . . 72.299999999999997 110.461 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.58 -39.94 1.89 Allowed Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.959 -0.564 . . . . 52.539999999999999 111.861 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -56.71 148.44 20.24 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.975 0.51 . . . . 64.140000000000001 111.493 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 19.8 pt20 -130.66 141.53 50.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.245 -0.65 . . . . 72.329999999999998 109.245 172.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -80.12 -38.42 31.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.812 0.301 . . . . 73.530000000000001 111.812 -173.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -152.92 133.64 13.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.318 -0.253 . . . . 72.129999999999995 110.318 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 t -81.07 91.14 6.05 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 73.409999999999997 109.436 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.9 m -67.6 -17.1 64.5 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.676 -0.693 . . . . 61.149999999999999 110.861 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -31.31 62.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.004 -0.544 . . . . 74.420000000000002 110.984 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 t -63.84 -46.22 86.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.769 0.318 . . . . 52.329999999999998 110.616 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 66' ' ' ARG . 5.8 ptt180 -75.87 -12.41 60.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.533 -0.303 . . . . 75.439999999999998 111.411 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.6 36.53 48.27 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.125 -0.488 . . . . 63.329999999999998 113.823 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.1 tppt? -92.21 113.43 59.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 110.163 -0.31 . . . . 75.340000000000003 110.163 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.4 Cg_endo -81.91 150.66 16.24 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.245 2.63 . . . . 73.209999999999994 111.894 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -114.28 160.61 18.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.92 -0.77 . . . . 71.230000000000004 108.92 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -140.62 146.85 38.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.093 -0.336 . . . . 75.030000000000001 110.093 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HE1' HG21 ' A' ' 48' ' ' VAL . 39.8 p90 -166.98 161.59 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 73.400000000000006 110.289 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 m -74.92 112.78 11.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.514 -0.312 . . . . 75.200000000000003 110.206 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 88' ' ' ALA . 47.2 tp -67.81 136.5 54.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.574 -0.285 . . . . 75.129999999999995 110.78 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 40.1 32.66 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.303 -0.475 . . . . 51.530000000000001 111.931 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.68 178.34 8.38 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.39 0.276 . . . . 74.430000000000007 110.31 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.34 46.19 3.59 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 121.036 -0.602 . . . . 54.409999999999997 112.173 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 9.3 mm-40 -85.04 -47.8 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 75.439999999999998 111.051 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.85 178.15 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.674 . . . . 32.009999999999998 109.67 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.97 142.92 15.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.172 0.511 . . . . 75.420000000000002 111.035 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -58.14 -30.61 66.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.478 -0.783 . . . . 73.310000000000002 111.862 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.02 -51.04 59.74 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.884 -0.674 . . . . 34.43 111.616 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -69.14 -47.67 64.45 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.792 -0.204 . . . . 71.340000000000003 110.636 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -54.27 -54.92 33.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.033 0.444 . . . . 72.430000000000007 111.149 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -72.07 -38.3 69.47 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.1 -0.5 . . . . 73.310000000000002 110.501 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.536 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.42 -50.11 57.94 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.935 -0.575 . . . . 70.400000000000006 112.215 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.641 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.1 p -75.72 -31.12 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 62.310000000000002 110.977 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -62.43 -33.49 74.91 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.741 0.305 . . . . 72.340000000000003 111.746 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 86' ' ' GLY . 11.0 t -79.5 7.41 8.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.461 0.541 . . . . 72.319999999999993 112.461 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 7.7 ptm -116.32 -176.51 2.97 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.196 -0.315 . . . . 71.329999999999998 110.456 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 56.9 p -118.21 178.81 4.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.775 0.321 . . . . 75.530000000000001 111.637 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.847 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.3 tt -68.69 135.16 50.91 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 74.120000000000005 110.863 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.433 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 71.96 23.68 77.64 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.633 -0.712 . . . . 72.25 112.299 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -112.46 148.54 34.19 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.859 0.361 . . . . 71.340000000000003 111.271 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -130.09 124.68 33.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.638 -0.71 . . . . 74.540000000000006 110.323 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.21 141.29 39.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 55.240000000000002 110.414 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.579 ' HB2' HD21 ' A' ' 31' ' ' LEU . 9.1 tt -92.19 123.95 35.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.119 -0.697 . . . . 62.350000000000001 109.119 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -130.21 134.51 47.32 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.918 0.389 . . . . 65.010000000000005 110.656 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 51.8 m -83.51 112.68 20.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.004 -0.544 . . . . 71.140000000000001 109.923 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.2 mm -84.84 110.93 31.6 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 116.382 -0.372 . . . . 60.109999999999999 110.607 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 120' ' ' THR . 24.4 Cg_exo -64.22 142.91 81.98 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.117 2.545 . . . . 51.240000000000002 111.565 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.596 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 51.3 p90 -54.39 -39.36 67.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.799 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 13.9 pt20 -70.2 -13.78 62.34 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.376 -0.375 . . . . 73.140000000000001 111.829 -174.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.93 16.55 24.16 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.997 0.427 . . . . 72.140000000000001 110.153 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.05 178.65 9.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.654 -0.703 . . . . 75.530000000000001 111.141 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -60.06 -25.09 65.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.699 -0.682 . . . . 72.409999999999997 110.705 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.73 -19.9 30.15 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.634 -0.712 . . . . 75.140000000000001 113.301 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.596 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 43.2 tt0 -56.16 -47.55 78.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 70.209999999999994 110.169 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -107.6 -15.33 14.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.4 -0.818 . . . . 72.200000000000003 110.907 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.75 -171.78 6.92 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 116.072 -0.513 . . . . 74.310000000000002 112.63 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.765 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 63.7 m-85 -147.53 -61.39 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.614 0.207 . . . . 75.400000000000006 110.677 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 50.9 Cg_endo -93.17 152.02 2.56 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.247 1.964 . . . . 74.049999999999997 112.037 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.63 -19.73 38.79 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.535 2.157 . . . . 75.519999999999996 111.765 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.98 -35.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.929 -0.578 . . . . 74.310000000000002 110.355 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.3 mm -121.25 80.75 36.72 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 108.538 -0.912 . . . . 64.329999999999998 108.538 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.22 169.32 22.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.88 2.387 . . . . 73.409999999999997 112.319 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 71.5 Cg_exo -50.14 148.98 12.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 61.409999999999997 112.228 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.3 mtmt 72.19 17.46 4.99 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.738 0.649 . . . . 73.319999999999993 111.312 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.06 104.42 8.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 111.43 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 101' ' ' PRO . 99.8 m -83.71 134.47 34.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.205 -0.665 . . . . 71.230000000000004 109.205 171.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -136.96 147.02 46.07 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.962 -0.385 . . . . 73.030000000000001 109.962 -170.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.542 ' N ' HD13 ' A' ' 121' ' ' LEU . 60.7 t -98.39 137.33 26.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 110.28 -175.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.44 129.38 31.04 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.54 -0.3 . . . . 52.100000000000001 110.411 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 59.3 mt-10 -75.15 118.57 18.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.756 -0.831 . . . . 64.310000000000002 108.756 167.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.59 136.8 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.834 -0.802 . . . . 41.0 108.834 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 47.8 tt0 -138.59 114.97 10.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.124 -0.489 . . . . 75.209999999999994 109.73 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.6 tm? -97.42 111.84 23.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.252 -0.648 . . . . 72.310000000000002 109.252 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.5 mm? -89.0 -41.26 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.47 -0.332 . . . . 73.209999999999994 110.647 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.77 145.87 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.572 -0.285 . . . . 55.219999999999999 111.038 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.25 1.105 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.059 178.563 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.758 0.313 . . . . 73.310000000000002 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.08 86.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.175 0.512 . . . . 60.100000000000001 111.771 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -99.38 115.27 28.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.187 -0.672 . . . . 74.230000000000004 109.187 173.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -61.78 95.95 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.241 0.543 . . . . 73.230000000000004 109.672 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -76.26 147.94 37.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 75.319999999999993 111.69 -172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -60.7 118.21 6.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.424 -0.807 . . . . 73.329999999999998 109.253 170.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -59.3 110.24 1.04 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.933 0.397 . . . . 65.319999999999993 110.027 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -162.28 147.26 12.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.804 -0.634 . . . . 73.239999999999995 109.516 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm -63.47 91.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.968 0.413 . . . . 52.340000000000003 110.391 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.43 -169.93 46.03 Favored Glycine 0 C--O 1.235 0.213 0 CA-C-N 115.782 -0.645 . . . . 72.519999999999996 112.049 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 t -166.98 174.46 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.033 0.444 . . . . 61.109999999999999 110.649 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.4 mp -90.53 148.4 22.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 109.604 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -61.11 156.28 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 63.329999999999998 111.527 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.27 146.72 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.943 -0.571 . . . . 33.229999999999997 110.101 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.7 101.93 0.16 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.415 0.626 . . . . 71.120000000000005 110.437 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -90.06 17.31 7.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.695 -0.684 . . . . 75.230000000000004 110.87 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -119.39 148.5 43.14 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.49 -0.323 . . . . 72.329999999999998 110.298 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' H ' ' HD2' ' A' ' 19' ' ' PRO . . . -109.32 -61.59 0.53 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.18 -0.464 . . . . 74.25 113.508 -176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 18' ' ' GLY . 71.1 Cg_endo -71.49 24.91 0.23 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.088 2.526 . . . . 73.400000000000006 114.167 -172.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.57 30.58 78.3 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.246 -0.502 . . . . 53.439999999999998 113.234 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -66.4 78.01 0.1 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.698 0.761 . . . . 73.519999999999996 110.462 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.2 ptt? 179.7 -29.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.675 -1.148 . . . . 72.150000000000006 108.856 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.5 m -99.86 175.45 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.563 -0.744 . . . . 71.329999999999998 109.858 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.23 98.07 8.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.664 0.269 . . . . 62.109999999999999 110.598 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -108.0 142.89 37.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 62.340000000000003 110.043 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.88 121.65 35.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.172 -0.677 . . . . 71.530000000000001 109.172 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.724 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 40.3 mt-10 -129.71 108.17 9.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 65.329999999999998 110.344 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 21.1 pttp -109.41 101.53 10.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.353 -0.61 . . . . 71.0 109.353 173.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.724 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 87.0 mttt -118.91 110.4 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.318 . . . . 73.319999999999993 110.415 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.73 119.21 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.051 -0.351 . . . . 70.430000000000007 110.051 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD23 ' HD3' ' A' ' 95' ' ' LYS . 32.7 tp -94.86 -30.99 13.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.267 0.556 . . . . 73.129999999999995 109.977 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 57.3 m -147.14 110.85 4.03 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.494 -0.775 . . . . 74.030000000000001 109.44 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 22.5 Cg_exo -65.48 146.35 84.86 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.037 2.492 . . . . 71.120000000000005 112.64 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.36 -158.67 31.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 71.120000000000005 111.987 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.431 ' HB3' HG22 ' A' ' 37' ' ' VAL . 25.0 m-20 -71.27 -56.78 5.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.283 0.563 . . . . 72.409999999999997 110.582 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 -30.23 3.78 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.403 -0.817 . . . . 51.130000000000003 111.889 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 35' ' ' ASP . 30.3 m -78.54 -32.33 16.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.166 0.508 . . . . 73.239999999999995 110.245 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.547 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 6.0 p -71.15 105.93 3.58 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.341 -0.614 . . . . 54.219999999999999 109.341 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -91.63 109.31 35.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.812 -0.631 . . . . 63.140000000000001 110.928 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 38' ' ' THR . 60.9 Cg_endo -95.85 174.06 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.508 2.805 . . . . 71.040000000000006 111.411 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -153.74 163.0 40.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 110.812 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.27 166.12 23.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.726 -0.67 . . . . 74.420000000000002 111.609 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.04 86.33 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.969 -0.56 . . . . 65.140000000000001 112.443 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -119.2 155.76 31.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.607 0.241 . . . . 74.430000000000007 110.476 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -81.01 113.41 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.322 -0.622 . . . . 61.229999999999997 109.322 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HB ' HD21 ' A' ' 127' ' ' LEU . 33.9 m -106.61 145.89 13.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-O 120.908 0.385 . . . . 64.049999999999997 111.423 -177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.5 m -98.86 108.47 21.16 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.175 -0.921 . . . . 54.210000000000001 110.117 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 m -115.44 178.5 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 124.355 1.034 . . . . 41.030000000000001 111.575 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 11.0 t-160 -152.98 136.55 15.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.989 -1.115 . . . . 71.409999999999997 107.989 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -126.85 151.7 48.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.807 0.299 . . . . 71.340000000000003 111.807 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.706 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 33.5 t70 -138.85 118.54 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.998 -0.547 . . . . 72.430000000000007 110.095 169.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.16 138.93 17.12 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.371 -0.442 . . . . 64.230000000000004 112.624 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.634 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 28.1 ttm180 -157.51 149.26 22.13 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.341 0.591 . . . . 71.310000000000002 111.751 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -87.58 153.83 53.21 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 115.713 -0.676 . . . . 75.120000000000005 109.332 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.64 -20.13 56.43 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.708 2.272 . . . . 74.209999999999994 113.412 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.58 3.54 52.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.558 0.218 . . . . 72.299999999999997 111.26 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.07 -31.73 8.31 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.336 -0.459 . . . . 52.539999999999999 112.143 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.45 145.5 51.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.908 -0.405 . . . . 64.140000000000001 109.908 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.634 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 20.2 pt20 -151.64 147.59 26.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.516 176.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -62.23 -38.4 89.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.764 -0.653 . . . . 73.530000000000001 111.307 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.4 156.56 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.265 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 22.9 t -87.41 86.79 7.27 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.706 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 14.7 m -60.07 -30.11 68.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 61.149999999999999 110.453 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.564 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 34.8 ptt180 -71.32 -44.46 65.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 74.420000000000002 110.972 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -73.52 -4.47 34.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.622 0.248 . . . . 52.329999999999998 111.142 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 62' ' ' SER . 27.2 mmt180 -76.63 -12.71 60.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.575 -0.284 . . . . 75.439999999999998 110.869 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.7 32.08 77.4 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.959 -0.639 . . . . 63.329999999999998 112.282 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.74 104.39 55.31 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-O 120.562 0.22 . . . . 75.340000000000003 110.783 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.86 166.35 19.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.004 2.469 . . . . 73.209999999999994 110.985 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -143.74 131.92 21.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.792 -0.447 . . . . 71.230000000000004 109.792 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 97.4 mt-30 -113.15 131.95 55.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.558 0.218 . . . . 75.030000000000001 110.501 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.574 ' HZ ' HG11 ' A' ' 87' ' ' VAL . 24.5 p90 -154.37 161.13 41.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.462 -0.335 . . . . 73.400000000000006 110.484 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 m -77.32 115.95 17.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.218 -0.447 . . . . 75.200000000000003 110.752 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -63.47 127.91 33.47 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.036 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.93 43.68 7.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.161 -0.542 . . . . 51.530000000000001 112.075 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.69 173.78 14.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.821 0.343 . . . . 74.430000000000007 111.018 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.61 27.64 3.28 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.157 -0.474 . . . . 54.409999999999997 112.678 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 5.6 mm-40 -65.01 -43.78 91.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.227 0.537 . . . . 75.439999999999998 110.279 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.71 178.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.505 -0.77 . . . . 32.009999999999998 110.195 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.482 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.1 pt -62.49 143.59 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 110.01 -0.367 . . . . 75.420000000000002 110.01 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -58.23 -23.97 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.463 -0.335 . . . . 73.310000000000002 110.823 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.73 -50.45 67.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.948 -0.644 . . . . 34.43 111.835 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.482 ' H ' HG13 ' A' ' 80' ' ' ILE . 53.2 m0 -69.05 -42.09 76.75 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.153 -0.314 . . . . 71.340000000000003 110.153 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -54.05 -49.94 67.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.721 -0.672 . . . . 72.430000000000007 110.64 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.42 -41.24 80.67 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 110.501 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.34 -48.65 53.7 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.425 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.574 HG11 ' HZ ' ' A' ' 72' ' ' PHE . 7.1 p -75.68 -36.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 62.310000000000002 110.993 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.36 70.47 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.945 0.35 . . . . 72.340000000000003 111.945 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.3 t -84.56 -20.39 31.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.116 0.413 . . . . 72.319999999999993 112.116 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 18.0 ptp -88.82 -174.47 4.52 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.972 0.415 . . . . 71.329999999999998 111.35 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.3 p -119.42 178.78 4.42 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.679 -0.692 . . . . 75.530000000000001 110.285 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.859 ' HA ' HD12 ' A' ' 127' ' ' LEU . 9.2 tt -72.0 132.94 44.97 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.986 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.93 34.87 46.53 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.383 -0.826 . . . . 72.25 112.252 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -125.95 138.18 53.75 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.965 0.412 . . . . 71.340000000000003 111.627 -171.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.589 ' HD3' HD23 ' A' ' 31' ' ' LEU . 19.2 ttmm -107.6 113.8 27.35 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.446 -0.797 . . . . 74.540000000000006 109.745 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.46 132.59 56.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.42 . . . . 55.240000000000002 110.656 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.53 108.4 19.77 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.873 -1.158 . . . . 62.350000000000001 107.873 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CD1' HD13 ' A' ' 100' ' ' ILE . 12.3 t80 -116.77 123.53 47.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.151 -0.477 . . . . 65.010000000000005 109.956 -174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.9 m -81.17 106.33 13.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.526 -0.546 . . . . 71.140000000000001 109.526 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.439 HD13 ' CD1' ' A' ' 98' ' ' PHE . 47.5 mm -78.25 115.08 48.11 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-N 115.815 -0.63 . . . . 60.109999999999999 110.777 -175.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' A' ' 104' ' ' LEU . 22.0 Cg_exo -64.94 141.3 70.21 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.876 2.384 . . . . 51.240000000000002 110.916 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -58.12 -25.65 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.708 0.633 . . . . 74.230000000000004 112.708 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -75.26 -13.68 60.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.794 0.33 . . . . 73.140000000000001 111.405 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.471 HD12 ' HD2' ' A' ' 101' ' ' PRO . 88.1 mt -102.05 16.94 24.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.776 0.322 . . . . 72.140000000000001 110.382 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -159.79 -174.47 4.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.85 -0.614 . . . . 75.530000000000001 110.516 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -76.0 -5.42 46.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 72.409999999999997 110.358 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.49 -21.98 58.32 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.783 -0.644 . . . . 75.140000000000001 113.407 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 7.4 pt-20 -62.23 -42.61 99.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.902 0.382 . . . . 70.209999999999994 110.782 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 12.5 ttm180 -92.29 -42.51 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.664 . . . . 72.200000000000003 110.399 -176.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.94 141.4 4.14 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.817 -0.629 . . . . 74.310000000000002 111.629 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 49.2 m-85 -137.21 -58.16 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.691 0.246 . . . . 75.400000000000006 110.901 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 8.4 Cg_exo -72.98 147.75 43.99 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 121.974 1.783 . . . . 74.049999999999997 111.185 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.75 -19.2 60.12 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.594 2.196 . . . . 75.519999999999996 112.183 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.601 HG23 HG12 ' A' ' 115' ' ' ILE . 35.1 m -86.31 -17.87 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 74.310000000000002 111.106 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.612 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.2 mm -114.27 102.06 54.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 120.851 0.357 . . . . 64.329999999999998 110.365 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.57 170.62 19.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.665 2.243 . . . . 73.409999999999997 112.056 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.2 144.92 96.25 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.559 2.173 . . . . 61.409999999999997 111.725 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 61.41 26.9 16.6 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.717 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.45 103.12 7.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 74.120000000000005 111.494 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -73.52 122.62 22.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -124.58 144.52 50.11 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.012 -0.366 . . . . 73.030000000000001 110.012 -167.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 121' ' ' LEU . 85.5 t -98.42 133.1 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-O 120.732 0.301 . . . . 74.230000000000004 110.439 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 121' ' ' LEU . 75.8 m-85 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 52.100000000000001 110.531 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 64.4 mt-10 -74.94 106.51 6.48 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.898 -1.149 . . . . 64.310000000000002 107.898 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.23 129.18 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.056 -0.72 . . . . 41.0 109.056 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.4 tt0 -134.77 120.75 19.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.528 -0.305 . . . . 75.209999999999994 110.412 -170.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 92' ' ' LEU . 3.3 tm? -97.21 110.21 22.8 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.368 -0.604 . . . . 72.310000000000002 109.368 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.7 mm? -86.97 -50.54 6.6 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.46 -0.337 . . . . 73.209999999999994 110.641 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.5 -177.03 6.3 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.635 -0.426 . . . . 55.219999999999999 112.133 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.38 -0.827 . . . . 71.349999999999994 109.425 176.684 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.511 0.196 . . . . 73.310000000000002 110.488 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.85 110.27 0.88 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 60.100000000000001 111.516 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -70.93 120.89 17.17 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.934 -0.575 . . . . 74.230000000000004 109.493 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -66.18 100.95 0.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.379 0.609 . . . . 73.230000000000004 110.985 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -91.36 113.24 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.043 -0.981 . . . . 75.319999999999993 109.77 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -74.72 136.96 41.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.931 -0.577 . . . . 73.329999999999998 111.079 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -79.04 128.31 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.346 -0.613 . . . . 65.319999999999993 109.346 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -80.76 39.4 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 -0.288 . . . . 73.239999999999995 110.749 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.3 mtt -117.65 9.0 12.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.053 0.454 . . . . 52.340000000000003 110.208 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.85 153.04 21.34 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.695 -0.684 . . . . 72.519999999999996 112.509 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -91.95 109.69 21.04 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.312 -0.255 . . . . 61.109999999999999 110.312 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.38 97.77 5.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 72.230000000000004 109.962 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -109.61 103.14 11.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.808 -0.633 . . . . 63.329999999999998 109.557 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.18 90.63 3.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 33.229999999999997 111.121 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -86.46 31.26 0.67 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.558 0.694 . . . . 71.120000000000005 109.61 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.1 p -86.1 82.83 7.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.34 -0.845 . . . . 75.230000000000004 111.919 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.17 -71.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.26 -0.427 . . . . 72.329999999999998 110.309 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.93 -170.61 26.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.165 -0.541 . . . . 74.25 111.887 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -62.21 122.33 10.74 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.603 2.202 . . . . 73.400000000000006 112.028 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.72 -179.37 38.73 Favored Glycine 0 C--O 1.235 0.193 0 N-CA-C 111.788 -0.525 . . . . 53.439999999999998 111.788 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 m -72.21 77.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.098 0.475 . . . . 73.519999999999996 111.076 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.6 mmm -107.8 108.95 20.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.881 -0.6 . . . . 72.150000000000006 109.782 176.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.0 m -62.64 -41.26 98.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 71.329999999999998 111.577 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.29 96.75 6.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.929 0.395 . . . . 62.109999999999999 111.462 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -139.26 135.14 33.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.593 -0.731 . . . . 62.340000000000003 109.081 172.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.24 111.8 5.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.207 -0.294 . . . . 71.530000000000001 110.207 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.03 108.29 9.98 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.059 -0.349 . . . . 65.329999999999998 110.059 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -114.36 103.87 11.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.083 -0.71 . . . . 71.0 109.083 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -108.71 110.5 21.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 73.319999999999993 110.028 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 111.69 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 70.430000000000007 110.769 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.86 -42.43 24.26 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.329 -0.989 . . . . 73.129999999999995 108.329 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -149.83 119.93 3.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.222 -0.899 . . . . 74.030000000000001 109.258 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.45 138.31 24.3 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.631 2.221 . . . . 71.120000000000005 112.259 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -89.7 -167.74 42.67 Favored Glycine 0 C--O 1.236 0.244 0 CA-C-N 116.088 -0.505 . . . . 71.120000000000005 112.625 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.64 ' HB3' HG22 ' A' ' 37' ' ' VAL . 72.4 m-20 -56.34 -44.55 80.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.99 0.424 . . . . 72.409999999999997 111.387 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 80.41 -30.65 2.45 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.919 -0.582 . . . . 51.130000000000003 112.093 -175.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' A' ' 35' ' ' ASP . 35.6 m -76.81 -25.52 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.958 0.408 . . . . 73.239999999999995 109.996 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 19.5 p -97.86 89.68 4.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 54.219999999999999 109.748 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' HA ' HG22 ' A' ' 91' ' ' THR . 58.8 mttp -95.91 149.56 36.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 115.748 -0.66 . . . . 63.140000000000001 111.106 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.88 154.49 23.01 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.715 2.277 . . . . 71.040000000000006 111.594 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -133.59 130.06 37.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.109999999999999 110.065 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.56 122.74 17.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.493 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.62 -4.66 32.71 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.356 -0.449 . . . . 65.140000000000001 112.044 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -109.56 165.92 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 74.430000000000007 110.796 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.7 tppp? -67.45 149.09 50.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 61.229999999999997 111.179 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 130' ' ' VAL . 16.9 m -140.14 141.89 32.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.903 -0.59 . . . . 64.049999999999997 109.7 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.9 m -115.09 108.42 16.63 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.514 -0.766 . . . . 54.210000000000001 109.497 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.25 178.21 3.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.818 -0.628 . . . . 41.030000000000001 112.27 -170.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 8.5 t-160 -150.07 147.73 28.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.926 -1.034 . . . . 71.409999999999997 108.329 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.2 153.31 44.85 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 111.365 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 63' ' ' SER . 36.6 t70 -136.27 109.26 7.66 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.663 -0.866 . . . . 72.430000000000007 108.663 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.54 146.97 33.47 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.461 -0.399 . . . . 64.230000000000004 113.121 -173.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' NH2' HH21 ' A' ' 64' ' ' ARG . 22.3 ttm180 -160.16 149.05 17.26 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.006 0.431 . . . . 71.310000000000002 111.176 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -90.54 151.03 43.68 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 116.319 -0.4 . . . . 75.120000000000005 110.313 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.21 -13.08 33.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.792 2.328 . . . . 74.209999999999994 111.819 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.63 -17.44 64.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.589 -0.732 . . . . 72.299999999999997 110.346 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.21 28.84 10.2 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.95 -0.568 . . . . 52.539999999999999 112.374 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -155.21 161.42 41.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.649 -0.501 . . . . 64.140000000000001 109.649 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 9.8 pt20 -142.52 155.83 45.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.684 0.278 . . . . 72.329999999999998 110.535 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.37 -18.63 25.14 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.013 -0.539 . . . . 73.530000000000001 111.467 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -137.38 145.57 43.44 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.015 -0.365 . . . . 72.129999999999995 110.015 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.4 p -102.17 85.61 2.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.422 0.63 . . . . 73.409999999999997 110.173 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.744 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 16.1 m -67.78 -20.68 65.24 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.683 -0.69 . . . . 61.149999999999999 110.317 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.456 HH21 ' NH2' ' A' ' 53' ' ' ARG . 12.8 ptp180 -62.95 -44.38 96.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.403 -0.817 . . . . 74.420000000000002 110.732 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -70.85 -16.62 62.72 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.242 -0.436 . . . . 52.329999999999998 111.213 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.593 ' HD3' ' HA ' ' A' ' 63' ' ' SER . 56.9 mtp180 -82.9 -28.84 29.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 75.439999999999998 109.882 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.52 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.407 -0.815 . . . . 63.329999999999998 114.238 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -91.1 110.21 40.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.938 0.369 . . . . 75.340000000000003 110.299 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.83 168.55 23.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.818 2.345 . . . . 73.209999999999994 112.22 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -147.4 131.24 17.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.748 -0.464 . . . . 71.230000000000004 109.748 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.583 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 90.6 mt-30 -107.69 143.92 35.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.699 -0.228 . . . . 75.030000000000001 110.539 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 39.2 p90 -163.04 170.67 17.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 73.400000000000006 110.254 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.0 m -87.42 117.86 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.43 -0.35 . . . . 75.200000000000003 110.5 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 88' ' ' ALA . 64.4 tp -63.12 138.48 58.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.025 -0.534 . . . . 75.129999999999995 110.812 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 -22.58 37.76 Favored Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 116.141 -0.481 . . . . 51.530000000000001 112.133 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.31 178.47 6.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 74.430000000000007 111.597 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.07 24.39 21.94 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.866 -0.606 . . . . 54.409999999999997 112.278 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 72' ' ' PHE . 10.5 mm-40 -61.45 -45.76 92.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.285 0.564 . . . . 75.439999999999998 110.316 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.445 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 31.2 m -127.26 163.79 29.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.63 -0.713 . . . . 32.009999999999998 109.756 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.7 pt -60.48 141.01 17.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.807 -0.442 . . . . 75.420000000000002 109.807 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.838 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 4.3 mptp? -58.47 -15.54 11.43 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.02 0.378 . . . . 73.310000000000002 112.02 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.1 -56.02 27.57 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.374 -0.917 . . . . 34.43 111.199 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.445 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 43.7 m0 -69.66 -38.72 77.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.002 -0.369 . . . . 71.340000000000003 110.002 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.838 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 24.4 t70 -54.87 -48.97 72.27 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.441 -0.8 . . . . 72.430000000000007 110.822 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 31.2 mm-40 -71.54 -34.59 70.16 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.352 -0.385 . . . . 73.310000000000002 110.111 176.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.51 -48.21 55.63 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.0 -0.545 . . . . 70.400000000000006 112.287 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.579 HG23 HD23 ' A' ' 127' ' ' LEU . 3.5 p -75.63 -36.38 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.775 0.321 . . . . 62.310000000000002 110.801 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -64.73 -20.61 66.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.687 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 86' ' ' GLY . 12.6 t -95.53 10.99 34.63 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.171 0.434 . . . . 72.319999999999993 112.171 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.767 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.2 ptp -127.72 177.3 6.9 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.939 0.399 . . . . 71.329999999999998 111.664 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 39' ' ' LYS . 22.9 p -130.97 178.74 6.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.712 -0.676 . . . . 75.530000000000001 110.725 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.938 ' HA ' HD12 ' A' ' 127' ' ' LEU . 3.8 tt -65.32 130.31 42.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.807 0.336 . . . . 74.120000000000005 110.314 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.524 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 79.7 26.8 55.68 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.687 -0.688 . . . . 72.25 112.107 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.454 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 22.2 tt0 -123.71 141.19 52.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 71.340000000000003 110.534 -176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 125' ' ' VAL . 29.2 ttpp -138.95 135.75 34.69 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.943 -0.571 . . . . 74.540000000000006 109.531 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.58 152.03 39.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.442 . . . . 55.240000000000002 111.693 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.404 ' C ' HD23 ' A' ' 97' ' ' LEU . 7.3 tt -91.18 114.07 26.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.06 -1.089 . . . . 62.350000000000001 108.06 174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' HD1' HD13 ' A' ' 100' ' ' ILE . 7.2 t80 -117.32 121.08 40.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.849 0.356 . . . . 65.010000000000005 110.579 -176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 m -80.92 112.88 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 71.140000000000001 109.76 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.592 HG22 ' HB2' ' A' ' 105' ' ' ALA . 23.7 mm -88.46 110.56 37.61 Favored Pre-proline 0 C--O 1.24 0.555 0 CA-C-N 116.19 -0.459 . . . . 60.109999999999999 110.695 -176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.19 139.96 62.77 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.769 2.313 . . . . 51.240000000000002 111.358 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -55.95 -28.43 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.241 0.46 . . . . 74.230000000000004 112.241 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.36 -37.28 86.67 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.975 0.417 . . . . 73.140000000000001 110.66 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.2 mt -99.4 18.79 16.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.878 -0.601 . . . . 72.140000000000001 109.987 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 80' ' ' ILE . . . -136.61 171.47 14.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.671 . . . . 75.530000000000001 111.24 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.447 ' HB2' ' HE1' ' A' ' 111' ' ' TYR . 44.9 p90 -76.86 -10.08 59.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 72.409999999999997 110.191 174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -25.21 64.06 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.453 -0.794 . . . . 75.140000000000001 112.911 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 2.5 tm-20 -61.35 -54.53 42.55 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.982 -0.747 . . . . 70.209999999999994 108.982 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -64.87 -49.27 71.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.036 -0.984 . . . . 72.200000000000003 111.219 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.89 75.7 0.24 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.057 -0.592 . . . . 74.310000000000002 111.732 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.728 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 74.6 m-85 -59.35 -54.0 60.5 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 111.594 0.22 . . . . 75.400000000000006 111.594 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 76.9 Cg_endo -96.72 148.99 1.06 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.53 2.154 . . . . 74.049999999999997 112.101 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 47.3 Cg_exo -57.39 -20.4 39.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.602 2.201 . . . . 75.519999999999996 112.069 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.58 -28.95 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 110.423 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.93 99.0 36.94 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 109.146 -0.686 . . . . 64.329999999999998 109.146 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 51.3 Cg_exo -54.56 140.64 75.31 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.72 2.28 . . . . 73.409999999999997 112.717 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 39.5 Cg_exo -61.83 142.52 93.82 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.362 2.041 . . . . 61.409999999999997 111.318 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 99.7 mttt 63.48 25.8 14.6 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.017 0.527 . . . . 73.319999999999993 111.612 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.86 135.75 33.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.948 0.404 . . . . 74.120000000000005 111.028 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.4 m -87.41 140.18 29.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 71.230000000000004 109.663 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.97 165.88 12.61 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.487 0.185 . . . . 73.030000000000001 110.619 -174.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -130.38 132.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.812 -0.44 . . . . 74.230000000000004 109.812 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -135.42 125.56 26.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.647 0.261 . . . . 52.100000000000001 110.43 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 30.9 tt0 -84.4 110.04 18.32 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.808 -1.182 . . . . 64.310000000000002 107.808 172.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.471 HG23 ' CE ' ' A' ' 90' ' ' MET . 15.3 m -99.64 141.4 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.546 -0.752 . . . . 41.0 110.907 -175.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 46.1 tt0 -131.29 125.65 33.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.66 -0.7 . . . . 75.209999999999994 110.26 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.938 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.8 tm? -99.94 107.96 20.07 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.798 -0.445 . . . . 72.310000000000002 109.798 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.2 mm? -85.75 -43.01 13.71 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.292 -0.413 . . . . 73.209999999999994 110.448 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.37 169.45 24.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.286 -0.415 . . . . 55.219999999999999 110.363 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 46' ' ' VAL . 30.0 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 tmm? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.937 0.398 . . . . 73.310000000000002 109.952 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.69 171.23 15.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.888 -0.596 . . . . 60.100000000000001 109.96 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -114.32 135.61 53.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.835 0.35 . . . . 74.230000000000004 110.662 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -87.04 76.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.015 -0.735 . . . . 73.230000000000004 109.015 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -109.7 23.4 14.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 75.319999999999993 111.343 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -85.94 -25.65 25.97 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.473 -0.936 . . . . 73.329999999999998 108.473 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 74.24 7.33 4.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.437 -1.256 . . . . 65.319999999999993 113.512 163.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -79.11 88.57 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.354 -0.61 . . . . 73.239999999999995 109.354 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.4 ttm -55.83 -62.04 1.96 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.08 -0.964 . . . . 52.340000000000003 111.59 -176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.4 -45.59 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.887 -0.673 . . . . 72.519999999999996 111.693 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -140.62 136.46 32.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.907 0.384 . . . . 61.109999999999999 110.092 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.2 tp -165.21 -49.68 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.801 -0.814 . . . . 72.230000000000004 108.801 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -86.62 48.51 1.65 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 63.329999999999998 109.485 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.63 63.62 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.57 -0.741 . . . . 33.229999999999997 111.858 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -94.34 110.03 21.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.423 -0.584 . . . . 71.120000000000005 109.423 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.9 m -52.82 117.74 3.16 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.097 -0.502 . . . . 75.230000000000004 111.234 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -67.47 -26.94 66.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.056 -0.52 . . . . 72.329999999999998 110.756 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.67 79.89 1.33 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.116 -0.564 . . . . 74.25 112.856 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.44 -31.62 86.31 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.842 2.361 . . . . 73.400000000000006 112.234 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.86 55.07 4.81 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.795 -0.639 . . . . 53.439999999999998 111.803 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 m -61.29 106.44 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.616 0.246 . . . . 73.519999999999996 110.681 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.8 mtt -76.59 46.56 0.45 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.058 0.456 . . . . 72.150000000000006 111.625 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -152.66 -89.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.326 -0.62 . . . . 71.329999999999998 109.326 175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 174.53 143.69 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.051 -0.522 . . . . 62.109999999999999 110.187 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -129.95 134.96 47.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.487 -0.931 . . . . 62.340000000000003 108.487 171.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.9 tp -138.69 102.28 4.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.865 0.364 . . . . 71.530000000000001 110.16 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.27 164.1 35.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 65.329999999999998 110.229 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -145.65 118.98 8.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 71.0 109.425 173.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -108.91 110.43 21.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.227 -0.657 . . . . 73.319999999999993 109.227 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.64 122.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.894 0.378 . . . . 70.430000000000007 111.316 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 31' ' ' LEU . 2.5 mm? -87.68 -38.89 15.46 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.311 -0.626 . . . . 73.129999999999995 109.311 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -135.4 111.02 10.64 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.324 -0.853 . . . . 74.030000000000001 109.969 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.65 138.65 46.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.495 2.13 . . . . 71.120000000000005 112.228 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.87 -164.78 40.42 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.244 -0.503 . . . . 71.120000000000005 112.103 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' HB2' ' HG1' ' A' ' 38' ' ' THR . 47.1 m-20 -63.71 -25.79 68.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.728 0.299 . . . . 72.409999999999997 110.966 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.95 -30.26 1.81 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.478 -0.392 . . . . 51.130000000000003 113.092 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 m -93.43 -23.47 5.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.729 0.299 . . . . 73.239999999999995 110.892 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.456 ' HG1' ' HB2' ' A' ' 35' ' ' ASP . 7.6 p -76.42 88.47 3.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.165 0.507 . . . . 54.219999999999999 110.705 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -85.88 112.82 47.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.575 -0.739 . . . . 63.140000000000001 111.072 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 114.81 2.5 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.203 2.602 . . . . 71.040000000000006 111.576 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.45 175.13 5.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 110.741 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.25 157.21 36.01 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.355 -0.384 . . . . 74.420000000000002 110.5 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.69 22.74 68.84 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.068 -0.514 . . . . 65.140000000000001 111.964 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -116.66 136.25 53.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.66 0.267 . . . . 74.430000000000007 110.828 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.77 101.63 10.25 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.738 -0.838 . . . . 61.229999999999997 108.738 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.24 142.02 20.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 121.029 0.443 . . . . 64.049999999999997 111.276 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.6 m -105.67 108.47 20.01 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.137 -0.938 . . . . 54.210000000000001 109.301 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.17 172.14 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.164 0.507 . . . . 41.030000000000001 111.021 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 14.5 t-160 -134.03 132.08 39.64 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.186 -1.042 . . . . 71.409999999999997 108.186 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 29.2 p90 -128.37 145.46 51.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.707 0.289 . . . . 71.340000000000003 111.361 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.849 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 26.0 t70 -137.81 119.76 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 72.430000000000007 109.809 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -79.55 127.63 8.09 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.37 -0.443 . . . . 64.230000000000004 112.259 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.648 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 20.4 ttm180 -147.11 151.83 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 111.053 -173.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.31 150.02 42.25 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.839 -0.43 . . . . 75.120000000000005 109.839 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.02 -13.6 28.47 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.518 2.146 . . . . 74.209999999999994 111.656 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -62.98 -32.46 73.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.264 -0.88 . . . . 72.299999999999997 110.532 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.07 -42.04 1.68 Allowed Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.276 -0.73 . . . . 52.539999999999999 111.276 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -79.87 157.87 26.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.774 0.321 . . . . 64.140000000000001 110.522 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.648 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 13.5 pt20 -125.23 165.19 18.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 110.803 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -86.7 -16.74 35.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.733 0.271 . . . . 73.530000000000001 111.733 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.58 153.75 6.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.215 -0.661 . . . . 72.129999999999995 109.215 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.501 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 46.4 m -89.48 97.0 10.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.07 0.462 . . . . 73.409999999999997 110.837 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 50.9 m -93.49 -18.43 22.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.288 0.566 . . . . 61.149999999999999 110.267 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HD2' ' NH2' ' A' ' 53' ' ' ARG . 7.9 ptm180 -68.37 -47.48 67.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.78 -0.645 . . . . 74.420000000000002 111.013 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 p -68.92 -27.86 66.14 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.76 0.314 . . . . 52.329999999999998 111.785 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 62' ' ' SER . 19.8 mtp180 -75.6 -21.52 57.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.416 -0.356 . . . . 75.439999999999998 110.719 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.19 48.09 65.01 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.881 -0.599 . . . . 63.329999999999998 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 68' ' ' LYS . 1.6 tmtp? -95.95 111.76 57.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.814 -0.809 . . . . 75.340000000000003 108.814 175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.64 152.35 7.55 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.802 2.335 . . . . 73.209999999999994 112.635 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -122.18 137.68 54.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.359 -0.608 . . . . 71.230000000000004 109.359 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.39 129.24 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.355 . . . . 75.030000000000001 110.168 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -149.46 160.11 43.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 73.400000000000006 110.554 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.3 m -83.45 104.86 13.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 75.200000000000003 109.937 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.83 131.4 49.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 110.001 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.67 -25.78 26.94 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.145 -0.55 . . . . 51.530000000000001 111.98 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.47 171.19 15.47 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.658 0.266 . . . . 74.430000000000007 110.501 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.54 35.77 2.25 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.233 -0.508 . . . . 54.409999999999997 113.233 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -84.88 -38.74 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.214 0.53 . . . . 75.439999999999998 109.844 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.64 157.95 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.409 -0.814 . . . . 32.009999999999998 109.366 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.8 pt -92.26 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.186 -0.301 . . . . 75.420000000000002 110.186 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 9.5 mmtm -51.62 -19.1 1.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.096 0.776 . . . . 73.310000000000002 113.096 -173.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.07 -63.0 4.91 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.446 -0.883 . . . . 34.43 111.72 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -70.85 -28.42 64.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 71.340000000000003 110.234 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.705 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 16.8 t70 -58.44 -51.66 68.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 72.430000000000007 110.087 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.28 -37.56 87.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.968 -0.382 . . . . 73.310000000000002 109.968 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -51.69 40.78 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.736 -0.666 . . . . 70.400000000000006 112.648 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.2 p -75.65 -31.38 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.038 0.447 . . . . 62.310000000000002 111.086 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.64 -27.76 66.3 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -83.01 -5.48 59.11 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.003 0.371 . . . . 72.319999999999993 112.003 -177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 21.1 ptp -110.45 177.7 4.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.692 0.282 . . . . 71.329999999999998 111.136 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 p -127.66 177.98 6.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.089 -0.505 . . . . 75.530000000000001 110.173 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.7 ' HA ' HD12 ' A' ' 127' ' ' LEU . 5.1 tt -63.88 130.6 44.78 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.541 -176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.514 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 83.71 13.0 76.54 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.63 -0.714 . . . . 72.25 112.405 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -102.63 129.2 49.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.042 0.449 . . . . 71.340000000000003 111.382 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -110.64 116.92 32.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.273 -0.876 . . . . 74.540000000000006 108.893 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.33 142.8 50.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.228 0.537 . . . . 55.240000000000002 111.151 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.2 tt -90.86 109.6 20.82 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.679 -0.859 . . . . 62.350000000000001 108.679 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 28' ' ' LYS . 12.6 t80 -105.17 134.65 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 65.010000000000005 110.511 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.6 m -93.56 112.82 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 71.140000000000001 110.138 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.579 HG21 ' HB2' ' A' ' 105' ' ' ALA . 26.8 mm -103.12 114.0 65.44 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 116.552 -0.295 . . . . 60.109999999999999 110.569 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' HD12 ' A' ' 104' ' ' LEU . 34.3 Cg_exo -59.57 155.1 43.99 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.52 2.147 . . . . 51.240000000000002 111.659 175.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -54.81 -32.18 59.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.936 0.398 . . . . 74.230000000000004 111.111 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -76.22 -10.01 59.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 73.140000000000001 111.795 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.574 HD12 ' HD2' ' A' ' 101' ' ' PRO . 82.3 mt -115.27 19.58 15.48 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.641 0.258 . . . . 72.140000000000001 110.768 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -163.46 -172.24 2.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.029 0.443 . . . . 75.530000000000001 110.776 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -76.39 -3.99 39.94 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.91 -0.586 . . . . 72.409999999999997 110.897 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.59 60.22 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 113.093 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.39 -55.84 9.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.835 0.35 . . . . 70.209999999999994 110.431 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -76.21 -49.81 16.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.813 -0.631 . . . . 72.200000000000003 110.987 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.92 80.41 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.348 -0.453 . . . . 74.310000000000002 112.84 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.539 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.5 m-85 -77.22 -50.67 2.15 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 111.819 0.303 . . . . 75.400000000000006 111.819 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 3.5 Cg_exo -77.48 128.47 9.58 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.233 1.955 . . . . 74.049999999999997 111.51 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.4 -11.9 21.65 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.849 2.366 . . . . 75.519999999999996 113.152 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.406 HG23 HG12 ' A' ' 115' ' ' ILE . 27.6 m -81.4 -17.93 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.992 0.425 . . . . 74.310000000000002 110.684 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 114' ' ' VAL . 49.9 mm -105.32 122.24 43.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.816 -0.629 . . . . 64.329999999999998 109.947 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 55.0 Cg_endo -70.95 130.6 18.12 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.374 2.049 . . . . 73.409999999999997 112.173 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 20.7 Cg_exo -67.26 149.36 81.34 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.822 2.348 . . . . 61.409999999999997 112.044 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm 64.28 27.63 13.83 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.298 0.639 . . . . 73.319999999999993 111.1 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.83 148.9 32.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 74.120000000000005 111.246 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.6 m -82.85 132.31 35.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.718 -0.674 . . . . 71.230000000000004 109.843 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.4 OUTLIER -117.69 139.39 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.785 -0.45 . . . . 73.030000000000001 109.785 -173.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.4 t -106.25 138.81 29.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.536 -0.302 . . . . 74.230000000000004 110.241 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.21 125.24 38.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.074 -0.343 . . . . 52.100000000000001 110.074 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 35.6 tt0 -75.1 106.84 6.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.124 -1.435 . . . . 64.310000000000002 107.124 168.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.9 m -111.71 137.93 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.949 -0.568 . . . . 41.0 109.868 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.9 tt0 -144.02 126.68 16.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.854 -173.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.7 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.3 tm? -79.34 101.69 8.24 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.310000000000002 108.302 176.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -74.94 -49.89 18.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 73.209999999999994 109.549 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.74 156.64 20.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.943 -0.571 . . . . 55.219999999999999 111.027 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.901 -0.591 . . . . 71.349999999999994 109.497 175.565 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 ttp . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.076 -0.342 . . . . 73.310000000000002 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.48 164.6 33.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 60.100000000000001 109.984 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -86.94 140.93 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.921 0.391 . . . . 74.230000000000004 110.628 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -120.11 50.46 1.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.748 -0.834 . . . . 73.230000000000004 108.748 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -71.76 -14.89 62.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.478 -0.783 . . . . 75.319999999999993 110.37 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -107.02 157.54 17.73 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.678 -0.86 . . . . 73.329999999999998 108.678 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -136.65 151.53 49.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.715 0.293 . . . . 65.319999999999993 110.567 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -94.95 142.42 27.5 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.07 -0.514 . . . . 73.239999999999995 111.317 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.96 121.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.185 -0.672 . . . . 52.340000000000003 109.185 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.61 82.6 0.31 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.161 -0.542 . . . . 72.519999999999996 112.62 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.6 m -89.77 104.05 16.65 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.01 -0.367 . . . . 61.109999999999999 110.01 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 tt -83.48 113.93 21.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.023 -0.535 . . . . 72.230000000000004 109.651 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.9 134.7 35.07 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.418 -0.355 . . . . 63.329999999999998 110.119 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -110.93 107.95 17.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 33.229999999999997 110.803 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -81.75 168.83 17.64 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.985 0.421 . . . . 71.120000000000005 110.561 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 p -86.71 151.2 23.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 75.230000000000004 110.671 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 171.77 8.11 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.621 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.62 -157.54 9.1 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.127 -0.488 . . . . 74.25 112.175 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.73 -43.63 12.35 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 73.400000000000006 112.276 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.39 -91.55 0.21 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.93 -0.652 . . . . 53.439999999999998 112.034 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -96.24 151.95 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 73.519999999999996 110.41 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -87.25 -3.69 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.198 -0.455 . . . . 72.150000000000006 110.501 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.6 p -61.8 169.58 2.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.966 -0.561 . . . . 71.329999999999998 111.204 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.44 92.48 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 62.109999999999999 111.426 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -93.02 135.92 33.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.423 -0.955 . . . . 62.340000000000003 108.423 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.3 tp -126.3 102.29 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 71.530000000000001 111.923 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -110.42 113.67 26.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 65.329999999999998 109.654 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -113.82 101.35 9.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.629 -0.878 . . . . 71.0 108.629 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -124.82 118.96 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.644 -0.707 . . . . 73.319999999999993 110.435 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.3 113.08 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.081 -0.509 . . . . 70.430000000000007 109.807 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -76.66 -40.78 48.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.332 -0.618 . . . . 73.129999999999995 109.332 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.3 m -147.08 114.67 4.25 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.606 -0.724 . . . . 74.030000000000001 109.305 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.44 150.3 87.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.713 2.275 . . . . 71.120000000000005 112.611 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -106.46 -135.29 7.97 Favored Glycine 0 C--O 1.237 0.31 0 CA-C-N 115.968 -0.56 . . . . 71.120000000000005 112.005 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 31.6 m-20 -73.4 -50.62 20.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 72.409999999999997 111.251 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.83 -25.18 8.91 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.926 -0.654 . . . . 51.130000000000003 112.172 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 35' ' ' ASP . 33.7 m -98.64 -24.59 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 121.019 0.438 . . . . 73.239999999999995 111.157 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.491 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.8 p -79.1 92.97 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.16 0.505 . . . . 54.219999999999999 110.242 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -88.6 128.59 52.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.738 -0.664 . . . . 63.140000000000001 110.938 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.98 122.93 6.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.487 2.124 . . . . 71.040000000000006 112.048 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -90.44 148.5 22.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.811 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.91 138.16 46.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.073 -0.512 . . . . 74.420000000000002 109.763 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.29 68.51 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 121.182 -0.532 . . . . 65.140000000000001 112.085 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -91.66 134.2 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 74.430000000000007 110.982 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.24 108.34 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.846 -0.798 . . . . 61.229999999999997 108.846 171.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.551 HG12 HG23 ' A' ' 130' ' ' VAL . 27.5 m -106.39 147.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.797 0.332 . . . . 64.049999999999997 110.805 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.1 m -104.62 108.17 19.49 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.787 -0.642 . . . . 54.210000000000001 110.064 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.789 HG12 HD22 ' A' ' 127' ' ' LEU . 15.8 m -125.96 178.23 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.631 -0.713 . . . . 41.030000000000001 110.636 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.81 154.19 36.82 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.84 -0.8 . . . . 71.409999999999997 108.84 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 36.9 p90 -134.06 158.14 44.35 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.429 -0.212 . . . . 71.340000000000003 110.429 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.698 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 1.4 m-20 -134.65 123.37 23.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.131 -0.692 . . . . 72.430000000000007 109.131 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.0 94.46 1.76 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.879 -0.601 . . . . 64.230000000000004 112.908 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.524 ' HA ' ' HB3' ' A' ' 59' ' ' GLN . 19.3 ttm180 -106.25 137.36 44.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.363 0.602 . . . . 71.310000000000002 110.774 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -78.06 154.73 80.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.856 -0.611 . . . . 75.120000000000005 109.789 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.97 -23.71 29.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.767 2.311 . . . . 74.209999999999994 112.05 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.21 -24.24 40.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.379 -0.828 . . . . 72.299999999999997 111.177 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.13 -2.86 56.71 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.63 -0.714 . . . . 52.539999999999999 111.439 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -110.37 156.31 20.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.976 0.51 . . . . 64.140000000000001 110.042 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 26.0 pt20 -141.23 163.56 32.63 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.908 -0.405 . . . . 72.329999999999998 109.908 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.63 -46.63 78.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 111.479 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -170.33 133.21 1.07 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.851 -0.425 . . . . 72.129999999999995 109.851 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 t -69.35 106.67 3.0 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.886 0.374 . . . . 73.409999999999997 110.219 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.3 p -76.46 -26.23 55.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 61.149999999999999 110.776 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -31.39 71.94 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.939 0.4 . . . . 74.420000000000002 110.048 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -60.84 -13.59 16.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.695 . . . . 52.329999999999998 111.225 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -78.36 -16.37 57.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.775 0.321 . . . . 75.439999999999998 111.075 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.5 34.33 73.56 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.159 -0.543 . . . . 63.329999999999998 112.344 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 113.65 14.89 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 110.252 -0.277 . . . . 75.340000000000003 110.252 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -95.61 177.2 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.187 2.592 . . . . 73.209999999999994 113.271 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -125.9 142.23 51.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.581 -0.896 . . . . 71.230000000000004 108.581 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -112.68 135.29 53.59 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.522 -0.177 . . . . 75.030000000000001 110.522 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -150.75 161.12 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.774 -0.454 . . . . 73.400000000000006 109.774 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.484 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 56.9 m -86.09 115.95 23.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.482 0.182 . . . . 75.200000000000003 110.642 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 88' ' ' ALA . 63.6 tp -64.15 138.64 58.55 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.253 -0.431 . . . . 75.129999999999995 110.452 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.38 32.39 31.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.128 -0.558 . . . . 51.530000000000001 111.949 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.15 160.27 43.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.04 -0.355 . . . . 74.430000000000007 110.04 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 29.04 1.51 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.566 -0.349 . . . . 54.409999999999997 113.47 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 73' ' ' THR . 10.9 mm-40 -62.32 -46.65 87.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.502 0.668 . . . . 75.439999999999998 109.568 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.82 178.21 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.729 -1.123 . . . . 32.009999999999998 109.689 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 83' ' ' TRP . 28.1 pt -68.59 145.53 13.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 123.333 0.396 . . . . 75.420000000000002 110.77 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.49 -20.46 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.261 -0.427 . . . . 73.310000000000002 111.579 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.05 21.96 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.505 -0.855 . . . . 34.43 111.535 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.456 ' H ' HG13 ' A' ' 80' ' ' ILE . 47.8 m0 -68.98 -37.91 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.675 0.274 . . . . 71.340000000000003 110.298 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.93 -55.03 35.17 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.885 -0.598 . . . . 72.430000000000007 110.499 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.37 -34.74 70.7 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.025 -0.534 . . . . 73.310000000000002 110.513 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.444 ' O ' HG22 ' A' ' 89' ' ' THR . . . -55.02 -49.83 61.23 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.917 -0.583 . . . . 70.400000000000006 112.138 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 90' ' ' MET . 21.6 m -75.8 -31.88 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.777 0.323 . . . . 62.310000000000002 111.12 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -63.82 -32.0 73.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.609 -0.269 . . . . 72.340000000000003 111.54 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.0 t -82.27 -10.72 59.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.823 0.305 . . . . 72.319999999999993 111.823 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 16.7 ptp -103.59 -172.05 2.04 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.712 0.292 . . . . 71.329999999999998 110.964 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -133.18 179.01 6.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.216 -0.447 . . . . 75.530000000000001 110.805 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 129' ' ' ALA . 3.4 tm? -62.9 138.49 58.56 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.802 0.334 . . . . 74.120000000000005 110.537 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.418 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 72.78 24.65 75.7 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.483 -0.78 . . . . 72.25 112.395 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 21.9 tt0 -121.2 135.32 55.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.08 0.467 . . . . 71.340000000000003 110.792 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -117.87 128.42 54.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.507 -0.77 . . . . 74.540000000000006 109.341 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.13 141.53 44.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.063 0.459 . . . . 55.240000000000002 111.331 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 9.0 tt -90.9 115.63 28.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.633 -0.877 . . . . 62.350000000000001 108.633 174.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' HD1' HD13 ' A' ' 100' ' ' ILE . 21.4 t80 -121.26 122.73 40.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 65.010000000000005 110.107 -175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.593 HG23 HG22 ' A' ' 122' ' ' VAL . 4.2 m -79.59 107.85 12.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.45 . . . . 71.140000000000001 109.784 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.519 HD13 ' HD1' ' A' ' 98' ' ' PHE . 37.2 mm -82.72 110.43 22.46 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 116.222 -0.444 . . . . 60.109999999999999 110.575 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.558 ' HA ' HG23 ' A' ' 120' ' ' THR . 61.3 Cg_endo -72.68 150.29 50.26 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.41 2.073 . . . . 51.240000000000002 111.88 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -54.32 -27.99 39.4 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.679 -0.691 . . . . 74.230000000000004 111.975 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.11 -22.14 49.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.328 -0.396 . . . . 73.140000000000001 111.893 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.9 mt -106.35 22.48 15.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.01 0.434 . . . . 72.140000000000001 110.197 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.455 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -160.53 -174.99 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.824 -0.626 . . . . 75.530000000000001 111.053 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -79.85 -3.37 47.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.548 -0.751 . . . . 72.409999999999997 110.243 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -56.66 -24.6 48.5 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.898 -0.592 . . . . 75.140000000000001 113.465 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 5.9 tm-20 -65.71 -48.36 72.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.555 -0.535 . . . . 70.209999999999994 109.555 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.522 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 1.6 tpm_? -78.38 -56.58 4.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.62 -0.718 . . . . 72.200000000000003 110.974 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.99 162.54 25.86 Favored Glycine 0 CA--C 1.519 0.294 0 N-CA-C 111.485 -0.646 . . . . 74.310000000000002 111.485 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.633 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 89.2 m-85 -143.15 -58.51 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.05 0.425 . . . . 75.400000000000006 110.824 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 71.7 Cg_endo -82.98 140.67 10.19 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.585 1.523 . . . . 74.049999999999997 111.499 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 35.9 Cg_exo -59.43 -5.89 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.819 2.346 . . . . 75.519999999999996 112.983 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 t -81.24 -29.56 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.472 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.7 mm -111.35 109.31 56.46 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.969 -0.56 . . . . 64.329999999999998 110.043 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 22.8 Cg_exo -65.27 149.96 87.93 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.715 2.277 . . . . 73.409999999999997 112.014 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 23.8 Cg_exo -66.41 153.9 76.29 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.74 2.294 . . . . 61.409999999999997 112.039 176.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 47.4 mtmt 59.33 32.91 22.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.05 0.452 . . . . 73.319999999999993 110.759 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.1 116.77 32.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.953 -0.567 . . . . 74.120000000000005 111.12 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -73.79 124.66 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.3 -0.63 . . . . 71.230000000000004 109.3 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.2 tm? -119.11 144.47 46.6 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.097 -0.705 . . . . 73.030000000000001 109.097 -172.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.593 HG22 HG23 ' A' ' 99' ' ' THR . 63.9 t -98.38 111.19 27.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 110.166 -0.309 . . . . 74.230000000000004 110.166 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.457 ' CE2' HD12 ' A' ' 121' ' ' LEU . 40.1 m-85 -108.75 118.4 36.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.281 0.562 . . . . 52.100000000000001 110.855 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.698 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 43.8 mt-10 -75.45 109.04 8.66 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.337 -0.986 . . . . 64.310000000000002 108.337 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG23 ' HE1' ' A' ' 90' ' ' MET . 11.6 m -95.99 149.13 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 123.508 0.505 . . . . 41.0 109.646 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.51 119.64 8.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 110.193 -169.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.789 HD22 HG12 ' A' ' 48' ' ' VAL . 0.3 OUTLIER -90.67 104.35 16.94 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.472 -0.566 . . . . 72.310000000000002 109.472 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.0 -43.9 12.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.801 0.334 . . . . 73.209999999999994 110.752 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.488 ' HA ' HD21 ' A' ' 92' ' ' LEU . . . -159.39 164.34 34.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 55.219999999999999 110.465 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.551 HG23 HG12 ' A' ' 46' ' ' VAL . 2.7 p . . . . . 0 C--O 1.245 0.843 0 N-CA-C 109.771 -0.455 . . . . 71.349999999999994 109.771 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.627 0.251 . . . . 73.310000000000002 110.82 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.53 122.22 27.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.701 0.286 . . . . 60.100000000000001 111.065 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -164.27 142.27 7.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.093 -0.503 . . . . 74.230000000000004 109.728 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -84.11 163.38 19.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 110.476 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -142.59 102.94 4.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.257 0.551 . . . . 75.319999999999993 111.107 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -145.75 150.86 37.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.475 -0.784 . . . . 73.329999999999998 109.712 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -104.79 -55.04 2.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.08 -0.711 . . . . 65.319999999999993 109.08 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -127.66 135.23 49.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.399 -0.818 . . . . 73.239999999999995 110.165 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt -114.52 -41.42 3.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.845 -0.798 . . . . 52.340000000000003 108.845 172.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.09 81.66 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.348 -0.842 . . . . 72.519999999999996 111.278 174.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -79.38 21.13 0.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.034 0.383 . . . . 61.109999999999999 112.034 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 12' ' ' LEU . 2.5 pt? -81.89 1.82 33.34 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.764 0.316 . . . . 72.230000000000004 111.089 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.6 86.25 2.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.002 0.429 . . . . 63.329999999999998 109.855 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.48 165.34 28.86 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.811 -0.631 . . . . 33.229999999999997 110.601 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -96.9 162.86 13.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 71.120000000000005 110.659 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 m -109.65 -34.95 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.176 -0.676 . . . . 75.230000000000004 109.176 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -145.2 158.04 43.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.408 -0.814 . . . . 72.329999999999998 109.092 173.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.03 26.97 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.163 -0.541 . . . . 74.25 112.69 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.12 -19.58 44.86 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.958 2.439 . . . . 73.400000000000006 111.796 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.98 54.35 4.2 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.968 -0.56 . . . . 53.439999999999998 112.433 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -127.77 103.65 7.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.554 -0.536 . . . . 73.519999999999996 109.554 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.1 mpt? -63.49 82.16 0.02 OUTLIER 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.491 0.662 . . . . 72.150000000000006 111.13 -176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m -153.6 179.54 8.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.134 -0.939 . . . . 71.329999999999998 108.77 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.43 85.81 3.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 62.109999999999999 110.358 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -92.24 135.04 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.984 -0.747 . . . . 62.340000000000003 108.984 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.456 ' HA ' ' HB ' ' A' ' 99' ' ' THR . 60.9 tp -146.18 119.62 9.04 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.178 0.436 . . . . 71.530000000000001 112.178 -175.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -101.45 129.52 47.51 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.121 -0.696 . . . . 65.329999999999998 109.121 162.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -125.79 100.71 6.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.745 -1.206 . . . . 71.0 107.745 169.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -119.71 113.29 20.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.945 -0.57 . . . . 73.319999999999993 110.308 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.03 108.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.224 0.535 . . . . 70.430000000000007 110.474 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -82.97 -44.85 14.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.857 -0.61 . . . . 73.129999999999995 109.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.8 m -139.68 110.76 7.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.367 -0.833 . . . . 74.030000000000001 109.45 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.14 133.9 40.2 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.621 2.214 . . . . 71.120000000000005 111.614 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -102.46 -150.69 23.03 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.166 -0.54 . . . . 71.120000000000005 112.795 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.71 -54.73 40.72 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 122.707 0.403 . . . . 72.409999999999997 111.254 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.5 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 75.7 -9.11 17.47 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.212 -0.518 . . . . 51.130000000000003 113.037 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.6 m -103.49 -6.7 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.115 0.483 . . . . 73.239999999999995 110.7 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 92' ' ' LEU . 40.8 p -83.96 120.11 25.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.795 -0.639 . . . . 54.219999999999999 110.681 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -126.66 89.67 51.59 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.728 -0.215 . . . . 63.140000000000001 110.637 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.8 -175.68 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.87 2.38 . . . . 71.040000000000006 111.993 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -146.55 174.94 10.96 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.368 -0.378 . . . . 75.109999999999999 110.268 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 140.36 57.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 111.196 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.12 -1.37 54.67 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.215 -0.516 . . . . 65.140000000000001 112.515 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -92.02 133.08 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 74.430000000000007 110.925 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -83.77 107.83 16.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.851 -0.796 . . . . 61.229999999999997 108.851 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 35.9 m -107.18 147.67 12.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 116.49 -0.323 . . . . 64.049999999999997 111.534 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 m -100.73 108.17 19.95 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.036 -0.983 . . . . 54.210000000000001 110.728 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.822 HG12 HD22 ' A' ' 127' ' ' LEU . 19.7 m -120.36 178.66 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 114.893 -1.048 . . . . 41.030000000000001 111.365 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.658 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 22.4 t-160 -152.8 146.4 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.697 -1.223 . . . . 71.409999999999997 107.697 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 98.5 m-85 -126.97 159.45 34.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.901 0.382 . . . . 71.340000000000003 111.965 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.888 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 5.6 m-20 -135.78 157.35 47.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.951 -1.022 . . . . 72.430000000000007 108.509 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -118.6 128.93 7.92 Favored Glycine 0 N--CA 1.461 0.312 0 C-N-CA 121.039 -0.6 . . . . 64.230000000000004 112.597 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.552 HH21 HG21 ' A' ' 122' ' ' VAL . 16.2 ttp180 -138.32 145.53 41.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.934 0.397 . . . . 71.310000000000002 110.752 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -84.0 155.56 64.19 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 75.120000000000005 109.767 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.33 -17.91 49.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.621 2.214 . . . . 74.209999999999994 112.487 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -68.8 -23.82 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 72.299999999999997 110.598 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.07 -22.53 18.25 Favored Glycine 0 N--CA 1.454 -0.165 0 N-CA-C 111.177 -0.769 . . . . 52.539999999999999 111.177 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -71.77 141.16 49.73 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.726 0.41 . . . . 64.140000000000001 109.949 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 14.6 pt20 -121.2 135.58 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.122 -0.695 . . . . 72.329999999999998 109.122 172.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -69.87 -29.95 67.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.615 -0.266 . . . . 73.530000000000001 111.394 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.09 134.15 7.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 72.129999999999995 110.779 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.459 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 13.7 p -79.14 86.69 4.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.452 -0.573 . . . . 73.409999999999997 109.452 171.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 m -65.42 -12.01 48.21 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.176 0.512 . . . . 61.149999999999999 110.998 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.658 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 8.8 ptp85 -63.56 -31.73 72.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.934 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 t -73.4 -19.14 61.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.831 -0.622 . . . . 52.329999999999998 110.952 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -75.57 -20.56 58.54 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.422 -0.353 . . . . 75.439999999999998 110.06 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.68 48.72 69.64 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.955 -0.566 . . . . 63.329999999999998 113.72 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 64.6 tttp -130.94 124.27 20.53 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.801 -0.444 . . . . 75.340000000000003 109.801 174.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 Cg_endo -83.65 175.13 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.107 2.538 . . . . 73.209999999999994 112.015 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -146.91 128.73 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 71.230000000000004 108.515 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 92.6 mt-30 -106.6 131.54 53.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.464 0.173 . . . . 75.030000000000001 110.654 -177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.86 158.77 43.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.564 -0.289 . . . . 73.400000000000006 110.471 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.1 m -84.32 124.36 31.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 75.200000000000003 110.386 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 tp -59.38 130.3 46.26 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.365 -0.379 . . . . 75.129999999999995 110.383 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.18 39.02 72.63 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.989 -0.55 . . . . 51.530000000000001 112.521 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.81 161.97 31.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.995 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.78 18.51 8.94 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 116.021 -0.536 . . . . 54.409999999999997 113.462 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.83 -19.75 54.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.599 . . . . 75.439999999999998 109.814 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.96 159.71 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.446 -0.797 . . . . 32.009999999999998 109.48 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 83' ' ' TRP . 21.3 pt -70.28 151.09 9.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 116.406 -0.361 . . . . 75.420000000000002 110.102 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -56.68 -26.68 57.16 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.827 -0.434 . . . . 73.310000000000002 109.827 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.27 -52.06 53.84 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.052 -0.594 . . . . 34.43 111.853 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.555 ' H ' HG13 ' A' ' 80' ' ' ILE . 40.8 m0 -69.32 -31.29 69.66 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.325 -0.25 . . . . 71.340000000000003 110.325 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.4 -45.75 80.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.132 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.12 -35.35 76.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 109.789 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 89' ' ' THR . . . -56.46 -47.07 86.22 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.876 -0.602 . . . . 70.400000000000006 112.353 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.627 HG23 HD23 ' A' ' 127' ' ' LEU . 7.1 p -75.05 -34.08 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.809 0.338 . . . . 62.310000000000002 110.622 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.75 70.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.483 -0.326 . . . . 72.340000000000003 111.456 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 86' ' ' GLY . 8.9 t -87.01 3.34 46.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.673 0.273 . . . . 72.319999999999993 111.187 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 15.3 ptm -130.14 175.74 8.66 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 110.81 -177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.5 HG21 ' HA2' ' A' ' 36' ' ' GLY . 59.5 p -127.34 178.68 5.9 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.296 -0.411 . . . . 75.530000000000001 110.789 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.8 tt -69.22 139.38 54.49 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.634 -0.257 . . . . 74.120000000000005 110.395 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.499 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 77.93 12.57 84.29 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.956 -0.565 . . . . 72.25 112.219 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -112.72 153.75 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.321 0.248 . . . . 71.340000000000003 110.643 -172.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -134.09 127.82 32.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.353 -0.61 . . . . 74.540000000000006 109.353 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.07 146.85 41.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 55.240000000000002 110.914 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' GLU . 8.6 tt -90.8 111.67 23.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.531 -0.915 . . . . 62.350000000000001 108.531 176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -117.9 129.0 55.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.802 0.334 . . . . 65.010000000000005 110.147 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 122' ' ' VAL . 27.9 m -84.51 131.12 34.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.655 0.264 . . . . 71.140000000000001 111.138 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.68 103.0 44.83 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-O 120.896 0.379 . . . . 60.109999999999999 110.063 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.616 ' HA ' HG23 ' A' ' 120' ' ' THR . 26.9 Cg_exo -62.67 155.09 61.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.598 2.199 . . . . 51.240000000000002 111.927 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -55.07 -23.38 19.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 111.415 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -75.63 -6.5 50.73 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.241 -0.436 . . . . 73.140000000000001 111.972 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.53 HD12 ' HD2' ' A' ' 101' ' ' PRO . 96.7 mt -127.53 14.46 7.07 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.707 0.262 . . . . 72.140000000000001 111.707 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.34 -175.77 5.01 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.953 0.406 . . . . 75.530000000000001 111.485 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -66.55 -12.33 57.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.515 -0.766 . . . . 72.409999999999997 111.314 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.91 -32.83 19.51 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.35 -0.386 . . . . 75.140000000000001 113.688 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 tp10 -58.08 -49.23 77.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.367 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.26 -47.74 9.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.517 . . . . 72.200000000000003 110.971 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.77 153.44 13.05 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 112.076 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.705 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 76.1 m-85 -144.41 -57.19 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 122.314 0.246 . . . . 75.400000000000006 110.944 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.705 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 6.8 Cg_exo -73.49 143.1 34.01 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.896 1.731 . . . . 74.049999999999997 111.235 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.48 -27.66 41.38 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.821 2.347 . . . . 75.519999999999996 112.786 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 115' ' ' ILE . 33.3 m -78.19 -18.18 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 111.514 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.513 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 49.0 mm -108.19 103.37 50.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.318 -0.401 . . . . 64.329999999999998 110.188 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.52 164.68 31.97 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.568 2.179 . . . . 73.409999999999997 111.668 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.35 142.6 94.98 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.317 2.012 . . . . 61.409999999999997 112.135 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 67.6 mttm 65.97 27.74 10.69 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.937 -0.574 . . . . 73.319999999999993 111.283 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.73 116.84 26.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.835 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.616 HG23 ' HA ' ' A' ' 101' ' ' PRO . 70.6 m -74.04 138.37 44.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.015 -0.539 . . . . 71.230000000000004 109.75 174.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -129.64 138.95 51.5 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.263 -0.643 . . . . 73.030000000000001 109.263 -175.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.552 HG21 HH21 ' A' ' 53' ' ' ARG . 48.1 t -98.6 133.72 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.588 0.232 . . . . 74.230000000000004 110.397 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.54 126.51 44.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.069 0.461 . . . . 52.100000000000001 110.533 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 46.0 mt-10 -78.23 118.36 20.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.953 -0.758 . . . . 64.310000000000002 108.953 173.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -95.97 135.57 29.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.443 -0.577 . . . . 41.0 109.443 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 35.9 tt0 -135.16 106.51 6.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.283 -0.417 . . . . 75.209999999999994 110.113 -175.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.822 HD22 HG12 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -87.03 108.27 18.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.829 -0.804 . . . . 72.310000000000002 108.829 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.24 -50.9 7.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.856 -0.424 . . . . 73.209999999999994 109.856 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -169.9 -173.68 1.63 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.969 -0.56 . . . . 55.219999999999999 110.602 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.243 0.736 0 N-CA-C 109.161 -0.681 . . . . 71.349999999999994 109.161 173.216 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.884 0.373 . . . . 73.310000000000002 110.58 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.67 -81.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.388 -0.824 . . . . 60.100000000000001 112.486 172.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 62.34 10.52 3.94 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.256 -0.429 . . . . 74.230000000000004 110.846 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -92.24 134.22 35.09 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.672 -0.492 . . . . 73.230000000000004 109.672 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -112.41 146.91 37.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.756 -0.461 . . . . 75.319999999999993 109.756 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -74.73 73.04 2.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.205 0.526 . . . . 73.329999999999998 110.311 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -99.54 120.34 39.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.994 -0.548 . . . . 65.319999999999993 109.86 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -125.63 144.86 50.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.906 -0.588 . . . . 73.239999999999995 109.443 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.5 mtp -134.88 120.0 18.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.457 -0.338 . . . . 52.340000000000003 110.67 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.86 49.08 3.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.348 -0.701 . . . . 72.519999999999996 111.348 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.429 ' HB ' ' SD ' ' A' ' 22' ' ' MET . 25.0 m -68.89 138.66 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.658 0.383 . . . . 61.109999999999999 110.851 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 12' ' ' LEU . 2.0 pt? -116.97 -2.97 11.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.306 0.574 . . . . 72.230000000000004 109.805 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -84.82 115.2 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.462 -0.79 . . . . 63.329999999999998 109.997 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.78 79.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 33.229999999999997 111.943 -174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -168.31 115.46 0.69 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.064 -0.517 . . . . 71.120000000000005 110.009 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -150.98 154.11 36.46 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 110.047 -0.353 . . . . 75.230000000000004 110.047 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -74.34 82.32 1.89 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.711 -0.477 . . . . 72.329999999999998 109.711 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.36 143.25 9.25 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 116.071 -0.513 . . . . 74.25 112.002 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 49.1 Cg_endo -68.2 88.22 0.39 Allowed 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.603 2.202 . . . . 73.400000000000006 111.958 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.96 -154.14 22.33 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.832 -0.622 . . . . 53.439999999999998 112.791 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -55.51 -18.24 6.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.95 0.5 . . . . 73.519999999999996 112.138 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.568 ' HB2' HE21 ' A' ' 25' ' ' GLN . 84.9 mmm -67.87 -4.58 13.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.116 0.413 . . . . 72.150000000000006 112.116 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 p 55.87 -75.42 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.733 0.813 . . . . 71.329999999999998 112.827 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' MET . . . -70.88 108.96 4.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.937 0.399 . . . . 62.109999999999999 110.415 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.619 ' HG3' ' HA ' ' A' ' 19' ' ' PRO . 80.0 mm-40 -135.48 163.37 30.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 62.340000000000003 110.638 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -142.51 102.03 3.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 71.530000000000001 110.134 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -124.63 102.26 7.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.262 0.553 . . . . 65.329999999999998 110.047 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -112.74 109.7 19.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.272 -0.876 . . . . 71.0 109.16 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -108.66 110.35 21.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.469 -0.567 . . . . 73.319999999999993 109.469 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.75 106.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.109 -0.33 . . . . 70.430000000000007 110.109 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 97' ' ' LEU . 85.4 mt -87.7 -28.84 21.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 110.154 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 28.5 m -140.83 110.92 6.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.48 -0.782 . . . . 74.030000000000001 109.518 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.81 127.0 22.0 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.486 2.124 . . . . 71.120000000000005 111.249 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -83.11 -174.35 50.32 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 71.120000000000005 112.922 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' OD2' HG22 ' A' ' 37' ' ' VAL . 23.0 t70 -60.82 -43.06 98.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 110.543 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.17 -30.3 9.74 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.934 -0.575 . . . . 51.130000000000003 114.43 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG22 ' OD2' ' A' ' 35' ' ' ASP . 14.0 m -103.57 -28.0 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.087 0.943 . . . . 73.239999999999995 110.807 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 5.5 p -75.95 88.62 2.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.41 0.624 . . . . 54.219999999999999 109.854 173.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -93.29 114.45 62.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.348 -0.842 . . . . 63.140000000000001 111.068 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HG3' ' HG ' ' A' ' 127' ' ' LEU . 56.1 Cg_endo -70.58 107.77 2.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.412 2.074 . . . . 71.040000000000006 110.974 174.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -94.08 157.72 15.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 75.109999999999999 110.609 -176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 157.27 32.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 74.420000000000002 111.057 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.17 22.08 76.93 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.004 -0.544 . . . . 65.140000000000001 112.128 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -132.08 141.78 49.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.456 0.303 . . . . 74.430000000000007 110.311 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -71.95 107.61 4.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.736 -0.468 . . . . 61.229999999999997 109.736 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 130' ' ' VAL . 33.6 m -106.42 147.42 11.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-O 120.887 0.375 . . . . 64.049999999999997 110.903 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.2 m -104.81 108.44 19.93 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.472 -0.786 . . . . 54.210000000000001 109.761 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.651 HG12 HD22 ' A' ' 127' ' ' LEU . 21.3 m -118.78 178.47 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.482 -0.781 . . . . 41.030000000000001 111.97 -171.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -150.61 137.02 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.866 . . . . 71.409999999999997 109.231 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.638 ' HD1' HG12 ' A' ' 125' ' ' VAL . 56.2 m-85 -126.64 159.4 33.72 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.71 -0.107 . . . . 71.340000000000003 110.71 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -142.62 136.35 29.05 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.466 0.479 . . . . 72.430000000000007 109.728 167.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 124.82 7.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.475 -0.393 . . . . 64.230000000000004 112.277 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -141.01 137.46 32.99 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.327 0.584 . . . . 71.310000000000002 110.974 -170.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.19 148.37 39.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 109.744 175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 -18.56 37.0 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.799 2.333 . . . . 74.209999999999994 112.457 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -66.56 -31.3 71.93 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.054 -0.521 . . . . 72.299999999999997 110.783 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.43 -21.07 15.21 Favored Glycine 0 C--N 1.327 0.038 0 N-CA-C 109.992 -1.243 . . . . 52.539999999999999 109.992 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -68.87 154.46 41.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.672 -0.764 . . . . 64.140000000000001 110.101 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -142.23 151.77 42.44 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.778 -0.453 . . . . 72.329999999999998 109.778 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.75 -4.54 36.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.714 0.292 . . . . 73.530000000000001 111.422 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -168.26 144.79 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.141 -0.688 . . . . 72.129999999999995 109.141 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.8 p -109.07 85.34 2.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.62 0.724 . . . . 73.409999999999997 110.292 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.1 m -77.83 -18.26 56.51 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.539 -0.755 . . . . 61.149999999999999 109.401 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -65.05 -32.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.21 -0.904 . . . . 74.420000000000002 109.645 173.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.1 t -73.57 -24.26 60.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.342 -0.844 . . . . 52.329999999999998 110.869 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -84.27 -28.64 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 75.439999999999998 110.598 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.25 25.1 59.73 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.086 -0.506 . . . . 63.329999999999998 112.194 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -89.92 129.15 47.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 122.52 0.328 . . . . 75.340000000000003 110.825 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -87.84 157.05 7.41 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.967 2.444 . . . . 73.209999999999994 112.434 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -134.92 130.13 35.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.888 -0.782 . . . . 71.230000000000004 108.888 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -107.85 138.24 44.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.504 0.192 . . . . 75.030000000000001 110.756 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -157.21 163.55 38.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.267 -0.424 . . . . 73.400000000000006 110.051 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.9 m -82.46 110.79 17.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.192 -0.299 . . . . 75.200000000000003 110.192 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 88' ' ' ALA . 48.1 tp -61.82 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.238 -0.437 . . . . 75.129999999999995 110.223 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.14 12.48 Favored Glycine 0 C--O 1.237 0.286 0 N-CA-C 111.488 -0.645 . . . . 51.530000000000001 111.488 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.57 154.19 38.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 74.430000000000007 110.504 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.9 11.61 33.89 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.147 -0.479 . . . . 54.409999999999997 112.67 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.89 -23.6 67.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.022 0.439 . . . . 75.439999999999998 110.641 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.93 174.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.139 -0.689 . . . . 32.009999999999998 109.139 173.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 83' ' ' TRP . 35.6 pt -73.61 140.28 18.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.741 -0.466 . . . . 75.420000000000002 109.741 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 30.3 mmtp -58.45 -16.68 16.1 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.689 0.255 . . . . 73.310000000000002 111.689 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.93 -53.02 46.28 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.416 -0.897 . . . . 34.43 111.183 172.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.522 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.1 m0 -67.06 -42.1 85.33 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.114 -0.328 . . . . 71.340000000000003 110.114 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.501 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 17.8 t70 -52.59 -55.15 24.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.511 -0.768 . . . . 72.430000000000007 110.671 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -65.6 -40.42 92.65 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.094 -0.503 . . . . 73.310000000000002 110.666 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.69 -53.96 30.24 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.919 -0.582 . . . . 70.400000000000006 112.622 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.94 -30.35 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.544 0.212 . . . . 62.310000000000002 111.369 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -67.2 -30.15 70.01 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.725 0.269 . . . . 72.340000000000003 111.725 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 t -88.46 7.32 33.43 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.001 0.371 . . . . 72.319999999999993 112.001 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 11.9 ptp -121.97 -173.87 2.75 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.168 -0.332 . . . . 71.329999999999998 111.113 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -124.31 175.3 7.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.132 -0.486 . . . . 75.530000000000001 110.732 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.684 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.7 tt -63.33 131.84 49.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 74.120000000000005 110.364 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 8.78 83.7 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.983 -0.553 . . . . 72.25 112.416 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.639 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 14.1 tt0 -102.02 140.92 35.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 71.340000000000003 110.585 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.9 ttpm? -131.79 136.23 47.38 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.808 -0.442 . . . . 74.540000000000006 109.808 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.13 150.62 35.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.961 0.41 . . . . 55.240000000000002 111.186 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.1 tt -90.67 109.42 20.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.984 -1.117 . . . . 62.350000000000001 107.984 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HD1' HD13 ' A' ' 100' ' ' ILE . 7.0 t80 -112.0 117.77 33.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.412 -0.358 . . . . 65.010000000000005 110.109 -174.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 31.9 m -77.22 110.54 12.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.401 -0.363 . . . . 71.140000000000001 110.224 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.427 HD13 ' HD1' ' A' ' 98' ' ' PHE . 42.0 mm -90.48 111.6 48.33 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.127 -0.488 . . . . 60.109999999999999 110.488 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HA ' HG23 ' A' ' 120' ' ' THR . 34.3 Cg_exo -59.9 144.46 99.46 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.396 2.064 . . . . 51.240000000000002 110.908 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.546 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 46.5 p90 -54.56 -36.32 64.22 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 74.230000000000004 110.882 -176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -62.99 -24.15 67.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 73.140000000000001 111.398 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.34 16.91 24.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.285 -0.416 . . . . 72.140000000000001 110.723 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.69 7.78 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 75.530000000000001 111.169 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -74.43 -11.03 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.893 -0.594 . . . . 72.409999999999997 111.016 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.89 63.45 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.928 -0.578 . . . . 75.140000000000001 112.485 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 4.7 tm-20 -57.62 -54.81 42.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.072 0.463 . . . . 70.209999999999994 109.996 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -103.67 -24.69 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 72.200000000000003 110.086 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.06 -175.22 52.57 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.765 -0.652 . . . . 74.310000000000002 112.317 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.799 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 73.8 m-85 -151.04 -59.47 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.877 0.471 . . . . 75.400000000000006 110.119 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 72.8 Cg_endo -95.26 157.6 1.66 Allowed 'Trans proline' 0 C--N 1.361 1.205 0 C-N-CA 122.653 2.235 . . . . 74.049999999999997 112.193 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.82 -17.28 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.852 2.368 . . . . 75.519999999999996 112.472 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.74 -32.53 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 74.310000000000002 110.251 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.651 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 50.7 mm -109.14 99.56 36.45 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.05 -0.523 . . . . 64.329999999999998 109.619 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.635 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 36.2 Cg_endo -66.08 152.22 81.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.515 2.144 . . . . 73.409999999999997 112.182 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 34.3 Cg_exo -62.87 137.13 61.02 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.36 2.04 . . . . 61.409999999999997 111.277 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 64.75 37.5 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.63 0.581 . . . . 73.319999999999993 110.501 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.635 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -92.98 116.33 28.95 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.607 -0.724 . . . . 74.120000000000005 110.544 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 101' ' ' PRO . 86.7 m -74.1 133.96 42.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 71.230000000000004 109.389 173.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -124.87 144.3 50.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 73.030000000000001 109.307 -172.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.419 ' H ' HD13 ' A' ' 121' ' ' LEU . 88.6 t -100.85 128.01 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 109.914 -0.402 . . . . 74.230000000000004 109.914 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -123.02 120.71 34.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.151 0.501 . . . . 52.100000000000001 110.329 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -82.84 111.05 18.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.614 -0.884 . . . . 64.310000000000002 108.614 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.638 HG12 ' HD1' ' A' ' 50' ' ' TYR . 34.2 m -104.81 150.24 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.029 -0.987 . . . . 41.0 110.614 -173.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.01 128.88 12.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.49 -0.323 . . . . 75.209999999999994 110.439 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -93.43 118.17 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.929 -0.767 . . . . 72.310000000000002 108.929 177.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.79 -50.33 5.63 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.428 0.156 . . . . 73.209999999999994 111.141 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.97 168.1 26.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.24 0.543 . . . . 55.219999999999999 111.677 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 92' ' ' LEU . 13.3 p . . . . . 0 C--O 1.251 1.167 0 CA-C-N 115.206 -0.906 . . . . 71.349999999999994 108.947 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.951 -0.389 . . . . 73.310000000000002 109.951 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.99 167.02 30.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.807 0.337 . . . . 60.100000000000001 111.325 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -168.53 115.79 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 74.230000000000004 109.35 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -140.96 114.38 8.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 73.230000000000004 111.232 -173.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -140.08 137.43 34.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.306 -0.628 . . . . 75.319999999999993 109.306 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -128.54 112.24 14.1 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.871 -0.418 . . . . 73.329999999999998 109.871 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -86.34 89.68 7.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.451 -0.34 . . . . 65.319999999999993 111.053 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -157.38 121.75 4.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 73.239999999999995 110.507 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.6 tpt -149.76 121.08 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 52.340000000000003 110.212 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 171.51 48.27 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.958 -0.565 . . . . 72.519999999999996 112.902 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.1 p -128.37 165.12 21.21 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.695 -0.483 . . . . 61.109999999999999 109.695 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.2 mt -132.23 154.16 49.89 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 110.308 -0.256 . . . . 72.230000000000004 110.308 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -80.04 82.77 6.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.218 0.532 . . . . 63.329999999999998 109.739 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.91 123.62 32.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 33.229999999999997 110.534 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -161.98 103.58 1.15 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.501 -0.555 . . . . 71.120000000000005 109.501 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.3 m -150.27 124.73 9.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.474 -0.33 . . . . 75.230000000000004 110.33 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -79.72 83.47 5.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.739 -0.467 . . . . 72.329999999999998 109.739 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.08 -163.17 32.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.145 -0.55 . . . . 74.25 112.552 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HG2' ' HG3' ' A' ' 55' ' ' PRO . 79.6 Cg_exo -50.09 94.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.122 2.548 . . . . 73.400000000000006 112.682 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.71 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 109.876 -1.29 . . . . 53.439999999999998 109.876 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 p -90.45 101.19 13.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.916 -0.772 . . . . 73.519999999999996 108.916 170.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 ptp -65.69 110.56 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.229 0.537 . . . . 72.150000000000006 111.596 -173.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -165.56 175.69 8.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.802 -0.635 . . . . 71.329999999999998 109.804 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.2 75.3 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 62.109999999999999 110.833 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -92.63 135.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 62.340000000000003 109.711 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.8 tp -128.0 118.21 23.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.83 0.348 . . . . 71.530000000000001 110.298 -176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 29' ' ' LYS . 43.2 mt-10 -123.72 146.06 48.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 65.329999999999998 111.001 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -141.02 110.67 6.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 71.0 109.459 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.604 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.9 mptt -108.69 110.4 21.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 73.319999999999993 109.697 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.5 112.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.015 0.436 . . . . 70.430000000000007 110.139 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.6 mt -92.08 -30.11 16.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.119 -177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 33.6 m -141.37 110.66 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.982 -0.748 . . . . 74.030000000000001 108.982 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.63 135.65 28.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.271 1.981 . . . . 71.120000000000005 112.043 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.94 -165.0 30.65 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.143 -0.551 . . . . 71.120000000000005 111.747 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.24 -20.71 62.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.63 0.215 . . . . 72.409999999999997 111.165 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.22 -30.32 1.15 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.489 -0.386 . . . . 51.130000000000003 113.481 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.4 -32.85 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 73.239999999999995 110.87 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 92' ' ' LEU . 1.9 p -80.02 108.17 13.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.498 0.666 . . . . 54.219999999999999 110.61 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HE3' ' OE1' ' A' ' 41' ' ' GLN . 56.5 pttt -94.43 125.91 50.09 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.105 -0.952 . . . . 63.140000000000001 111.426 -173.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.99 106.17 2.12 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.853 2.368 . . . . 71.040000000000006 110.564 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' OE1' ' HE3' ' A' ' 39' ' ' LYS . 26.1 mt-30 -88.12 146.06 25.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.379 -0.373 . . . . 75.109999999999999 111.242 -176.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.45 156.77 36.61 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.857 -0.611 . . . . 74.420000000000002 109.892 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.19 16.6 79.65 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.905 -0.664 . . . . 65.140000000000001 111.68 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -132.94 154.86 50.03 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.737 0.415 . . . . 74.430000000000007 109.982 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.718 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 5.1 tppp? -73.17 127.2 31.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 61.229999999999997 109.944 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 130' ' ' VAL . 35.9 m -124.77 150.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 120.818 0.342 . . . . 64.049999999999997 110.642 177.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.7 m -111.27 110.53 21.06 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.213 -0.903 . . . . 54.210000000000001 110.698 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.737 HG12 HD22 ' A' ' 127' ' ' LEU . 24.8 m -128.66 177.88 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.719 0.771 . . . . 41.030000000000001 112.914 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . 8.7 m170 -139.68 152.48 46.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.463 -1.244 . . . . 71.409999999999997 108.933 172.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 83' ' ' TRP . 63.6 m-85 -134.91 142.53 46.57 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.542 -0.54 . . . . 71.340000000000003 109.542 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 36.5 t0 -137.02 143.76 42.9 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.203 -0.295 . . . . 72.430000000000007 110.203 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.55 140.01 15.22 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.338 -0.458 . . . . 64.230000000000004 112.328 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -157.26 149.31 22.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.375 0.607 . . . . 71.310000000000002 111.781 -175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -83.87 153.37 63.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.385 -0.825 . . . . 75.120000000000005 109.595 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 19.9 Cg_endo -58.11 -20.28 45.32 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.029 2.486 . . . . 74.209999999999994 113.812 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.87 4.16 45.69 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.77 0.319 . . . . 72.299999999999997 111.004 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.37 26.01 37.69 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.184 -0.531 . . . . 52.539999999999999 112.342 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.04 146.77 39.75 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.807 -0.442 . . . . 64.140000000000001 109.807 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -160.15 157.49 28.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.977 -0.379 . . . . 72.329999999999998 109.977 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -69.21 -42.38 75.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.323 -0.399 . . . . 73.530000000000001 110.706 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.451 ' CG ' HH21 ' A' ' 66' ' ' ARG . 28.0 t70 -170.0 145.71 2.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.725 -0.671 . . . . 72.129999999999995 109.955 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.3 t -82.79 114.8 21.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.624 -0.509 . . . . 73.409999999999997 109.624 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.6 m -86.67 -28.0 23.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 61.149999999999999 111.783 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -69.61 -31.47 69.62 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.142 -0.349 . . . . 74.420000000000002 110.828 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 29.8 p -73.6 -2.92 24.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.285 -0.416 . . . . 52.329999999999998 111.09 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.451 HH21 ' CG ' ' A' ' 61' ' ' ASP . 28.5 mmt180 -75.95 -3.93 38.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.52 -0.309 . . . . 75.439999999999998 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.36 71.66 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.47 -0.395 . . . . 63.329999999999998 113.045 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 55.8 tptt -91.97 106.82 18.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.549 -0.537 . . . . 75.340000000000003 109.549 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.1 Cg_exo -80.86 139.95 12.53 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.176 2.584 . . . . 73.209999999999994 112.1 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -107.62 142.89 36.86 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.793 -0.817 . . . . 71.230000000000004 108.793 176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.718 ' HB3' ' HD2' ' A' ' 45' ' ' LYS . 50.7 mt-30 -134.63 138.26 44.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.32 -0.252 . . . . 75.030000000000001 110.32 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.32 164.26 34.96 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.774 -0.193 . . . . 73.400000000000006 110.657 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.5 m -78.53 111.42 14.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.839 -0.43 . . . . 75.200000000000003 109.839 175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 88' ' ' ALA . 50.7 tp -61.03 142.61 56.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.41 -0.359 . . . . 75.129999999999995 110.765 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.57 30.51 44.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.192 -0.528 . . . . 51.530000000000001 111.967 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.16 160.7 39.19 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.387 -0.227 . . . . 74.430000000000007 110.387 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.98 42.75 2.12 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 116.39 -0.368 . . . . 54.409999999999997 113.131 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -76.81 -47.43 21.52 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.973 -0.751 . . . . 75.439999999999998 108.973 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 35.2 m -121.66 175.53 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.222 -0.899 . . . . 32.009999999999998 109.143 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.547 HG13 ' H ' ' A' ' 83' ' ' TRP . 37.2 pt -64.6 144.6 14.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.902 -0.407 . . . . 75.420000000000002 109.902 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 3.9 tmtm? -58.92 -22.52 59.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.308 -0.405 . . . . 73.310000000000002 109.936 -176.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.32 -52.59 51.75 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.921 -0.657 . . . . 34.43 111.793 175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.547 ' H ' HG13 ' A' ' 80' ' ' ILE . 51.3 m0 -67.39 -41.87 84.26 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 110.127 -0.324 . . . . 71.340000000000003 110.127 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.2 t70 -54.47 -45.68 73.23 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.622 -0.717 . . . . 72.430000000000007 110.236 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -64.37 -44.72 90.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.713 -0.676 . . . . 73.310000000000002 110.319 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.75 -49.61 61.05 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.733 -0.667 . . . . 70.400000000000006 112.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -75.6 -30.34 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.49 0.186 . . . . 62.310000000000002 111.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -72.92 -30.23 63.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.617 0.228 . . . . 72.340000000000003 111.617 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.7 t -81.32 -4.15 54.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.723 0.296 . . . . 72.319999999999993 111.696 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 15.2 ptp -112.2 -176.66 2.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.886 0.374 . . . . 71.329999999999998 110.792 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.9 p -121.34 176.2 5.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.458 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.4 tt -62.64 126.94 29.04 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.981 0.419 . . . . 74.120000000000005 110.71 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.84 65.12 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.648 -0.705 . . . . 72.25 112.772 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 32' ' ' THR . 15.0 tt0 -99.4 143.57 29.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 71.340000000000003 111.071 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -131.11 120.01 22.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.097 -0.705 . . . . 74.540000000000006 109.097 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.8 147.09 50.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.294 0.569 . . . . 55.240000000000002 111.306 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD22 ' HD3' ' A' ' 29' ' ' LYS . 10.0 tt -90.44 104.96 17.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.676 -1.231 . . . . 62.350000000000001 107.676 173.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -103.45 118.4 36.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.992 -0.549 . . . . 65.010000000000005 109.731 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.4 m -89.06 106.53 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.318 -0.401 . . . . 71.140000000000001 110.0 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 25.6 mm -86.44 113.69 53.83 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.949 -0.569 . . . . 60.109999999999999 111.076 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 120' ' ' THR . 36.3 Cg_endo -66.12 149.93 85.42 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.372 2.048 . . . . 51.240000000000002 110.33 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.495 ' HB2' ' HA ' ' A' ' 108' ' ' GLU . 45.9 p90 -54.45 -31.71 56.06 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.356 0.502 . . . . 74.230000000000004 112.356 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.87 -23.78 64.26 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.004 0.372 . . . . 73.140000000000001 112.004 -174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.03 6.32 46.85 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.556 0.206 . . . . 72.140000000000001 111.556 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.06 -177.71 6.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 75.530000000000001 111.039 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -67.67 -14.3 62.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 72.409999999999997 110.875 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.62 -23.19 35.21 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.405 0.44 . . . . 75.140000000000001 112.63 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 102' ' ' TYR . 44.9 tt0 -56.76 -44.24 81.57 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.044 0.449 . . . . 70.209999999999994 110.254 174.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 109' ' ' ARG . 20.1 mtp180 -97.92 -18.82 18.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.528 -0.76 . . . . 72.200000000000003 110.42 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 115' ' ' ILE . . . 67.23 -110.22 3.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.761 -0.654 . . . . 74.310000000000002 112.681 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 31.8 m-85 102.92 -71.33 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 125.639 1.575 . . . . 75.400000000000006 112.418 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.729 ' HG2' ' HB ' ' A' ' 115' ' ' ILE . 41.9 Cg_endo -65.84 149.45 86.63 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 121.439 1.426 . . . . 74.049999999999997 111.748 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 71.5 Cg_exo -51.92 -31.85 44.97 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.103 2.536 . . . . 75.519999999999996 113.23 -175.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 115' ' ' ILE . 27.4 m -83.2 -20.39 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 74.310000000000002 111.586 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 114' ' ' VAL . 49.2 mm -125.15 94.6 43.27 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.486 -0.325 . . . . 64.329999999999998 110.254 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 169.9 15.13 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.811 2.341 . . . . 73.409999999999997 111.402 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.58 148.46 63.87 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.127 1.884 . . . . 61.409999999999997 111.694 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.92 16.38 8.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.144 0.578 . . . . 73.319999999999993 111.818 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.39 112.21 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.034 0.445 . . . . 74.120000000000005 111.752 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.7 m -88.15 119.59 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.502 -0.925 . . . . 71.230000000000004 108.502 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -124.59 147.97 48.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.649 0.262 . . . . 73.030000000000001 110.512 -167.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.595 ' N ' HD13 ' A' ' 121' ' ' LEU . 76.0 t -98.52 131.85 44.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.428 -0.351 . . . . 74.230000000000004 110.705 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 97.4 m-85 -130.01 121.94 27.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.388 -0.369 . . . . 52.100000000000001 110.561 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 16.8 mt-10 -77.4 113.95 15.72 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.264 -0.643 . . . . 64.310000000000002 109.264 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 132.93 42.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.617 -0.719 . . . . 41.0 109.345 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 49' ' ' HIS . 35.6 tt0 -133.32 112.33 11.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.383 -0.371 . . . . 75.209999999999994 110.629 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.749 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -87.62 106.2 17.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.333 -0.618 . . . . 72.310000000000002 109.333 178.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.564 HD21 ' ND1' ' A' ' 49' ' ' HIS . 3.9 mm? -79.24 -50.63 10.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.215 0.531 . . . . 73.209999999999994 109.949 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.572 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . . . -168.35 -176.68 2.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 55.219999999999999 109.683 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 46' ' ' VAL . 31.3 t . . . . . 0 C--O 1.25 1.117 0 N-CA-C 108.708 -0.849 . . . . 71.349999999999994 108.708 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.59 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.783 -0.451 . . . . 73.310000000000002 109.783 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.15 3.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.18 -0.464 . . . . 60.100000000000001 110.894 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -80.37 92.82 5.86 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.814 -0.439 . . . . 74.230000000000004 109.814 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -78.84 117.47 19.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.866 -0.606 . . . . 73.230000000000004 110.254 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -80.19 116.65 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 75.319999999999993 110.699 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -175.5 138.37 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.614 -0.513 . . . . 73.329999999999998 109.614 174.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -92.19 178.03 5.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.901 -0.407 . . . . 65.319999999999993 109.901 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -140.88 131.18 25.03 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.262 -0.273 . . . . 73.239999999999995 110.262 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.402 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.8 mpt? -85.61 -19.51 30.91 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.387 -0.37 . . . . 52.340000000000003 110.443 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.49 125.82 14.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.899 -0.592 . . . . 72.519999999999996 112.78 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -105.22 -172.73 2.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.889 -0.411 . . . . 61.109999999999999 109.889 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HG ' ' HG3' ' A' ' 13' ' ' GLU . 53.9 tp -125.69 -69.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.486 -0.561 . . . . 72.230000000000004 109.486 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.482 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 42.7 mt-10 -127.43 165.14 20.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.149 -0.478 . . . . 63.329999999999998 109.771 177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.59 -64.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.365 0.416 . . . . 33.229999999999997 111.464 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -156.14 173.1 17.33 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.224 -0.444 . . . . 71.120000000000005 110.364 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -70.41 134.62 48.01 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.87 -0.418 . . . . 75.230000000000004 109.87 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.27 77.7 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.526 . . . . 72.329999999999998 110.137 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.99 103.9 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.506 -0.77 . . . . 74.25 111.75 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.16 -8.86 19.75 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.647 2.231 . . . . 73.400000000000006 112.426 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 36.1 2.81 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.555 -0.618 . . . . 53.439999999999998 111.555 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 p -78.59 97.67 5.87 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.13 0.491 . . . . 73.519999999999996 110.479 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 22.3 ptm -67.03 87.74 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.473 0.654 . . . . 72.150000000000006 110.656 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 t -157.48 -175.72 5.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.637 -0.71 . . . . 71.329999999999998 109.643 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.31 63.17 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 62.109999999999999 110.458 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -92.42 139.69 30.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.822 -0.627 . . . . 62.340000000000003 110.247 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 47.8 tp -145.95 101.72 3.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.193 -0.458 . . . . 71.530000000000001 110.26 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -116.84 122.99 45.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.706 -0.479 . . . . 65.329999999999998 109.706 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' NZ ' ' OG1' ' A' ' 89' ' ' THR . 61.5 pttt -126.39 119.29 26.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.114 0.483 . . . . 71.0 110.13 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -108.99 110.68 22.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.648 -0.705 . . . . 73.319999999999993 110.214 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -61.45 110.6 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.134 0.493 . . . . 70.430000000000007 109.739 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.562 HD23 ' HE3' ' A' ' 95' ' ' LYS . 34.8 tp -96.04 -25.13 16.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.018 -0.537 . . . . 73.129999999999995 110.072 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 57.1 m -149.0 110.77 3.52 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.893 -0.594 . . . . 74.030000000000001 109.725 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.38 133.84 21.59 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.326 2.017 . . . . 71.120000000000005 112.039 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -95.24 -151.86 28.73 Favored Glycine 0 C--O 1.236 0.254 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 111.823 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB2' ' HG1' ' A' ' 38' ' ' THR . 44.1 m-20 -63.92 -36.14 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.933 0.367 . . . . 72.409999999999997 111.306 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.48 -30.03 2.83 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 112.479 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -91.81 -25.11 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.799 0.333 . . . . 73.239999999999995 111.484 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.444 ' HG1' ' HB2' ' A' ' 35' ' ' ASP . 7.8 p -80.31 96.47 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.409 . . . . 54.219999999999999 110.701 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 22.4 pttp -97.89 124.32 48.29 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.555 . . . . 63.140000000000001 111.651 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -75.12 154.16 41.74 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.902 2.401 . . . . 71.040000000000006 111.401 173.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -154.63 174.82 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.565 -0.288 . . . . 75.109999999999999 110.689 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.2 144.19 57.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.353 -0.385 . . . . 74.420000000000002 111.153 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.74 16.22 71.08 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.166 -0.47 . . . . 65.140000000000001 112.434 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 27.8 mmmt -109.33 121.8 45.97 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.526 0.331 . . . . 74.430000000000007 111.174 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -74.16 106.1 5.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.15 -0.685 . . . . 61.229999999999997 109.15 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.44 142.14 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.21 0.528 . . . . 64.049999999999997 111.689 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 25.5 m -103.65 108.3 19.52 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.132 -0.94 . . . . 54.210000000000001 109.079 175.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.0 178.15 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.944 -0.571 . . . . 41.030000000000001 111.76 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.494 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.8 t-80 -147.59 139.95 24.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.696 -0.684 . . . . 71.409999999999997 109.366 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 85.4 m-85 -126.46 149.84 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.37 0.419 . . . . 71.340000000000003 110.543 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 56.9 m-20 -136.11 128.27 29.86 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.607 -0.516 . . . . 72.430000000000007 109.607 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.73 115.52 4.88 Favored Glycine 0 C--O 1.238 0.344 0 C-N-CA 121.124 -0.56 . . . . 64.230000000000004 112.34 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 59' ' ' GLN . 26.7 ttp180 -133.32 144.24 49.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 110.951 -178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -74.34 144.55 81.48 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 108.962 -0.755 . . . . 75.120000000000005 108.962 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -39.96 -48.74 3.74 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.658 2.905 . . . . 74.209999999999994 114.045 -173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.81 -41.4 97.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.325 0.491 . . . . 72.299999999999997 112.325 -173.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.84 -24.43 0.82 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.515 -0.85 . . . . 52.539999999999999 113.108 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -66.71 112.83 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.813 -0.228 . . . . 64.140000000000001 111.174 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.566 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . 12.1 pt20 -102.11 144.03 31.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.016 -0.364 . . . . 72.329999999999998 110.016 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -96.44 -26.81 15.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.437 -0.347 . . . . 73.530000000000001 110.606 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -148.36 138.18 22.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.09 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.2 p -124.28 90.2 3.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.11 0.481 . . . . 73.409999999999997 110.589 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -68.05 -18.27 64.63 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.186 -0.461 . . . . 61.149999999999999 110.361 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.496 ' HG2' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -59.42 -35.27 73.69 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.56 . . . . 74.420000000000002 110.248 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.496 ' N ' ' HG2' ' A' ' 64' ' ' ARG . 8.1 m -64.87 -28.5 69.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.755 -0.657 . . . . 52.329999999999998 110.309 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -96.01 -16.79 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.838 -0.619 . . . . 75.439999999999998 110.373 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.05 35.39 91.93 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.691 -0.564 . . . . 63.329999999999998 111.691 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 69' ' ' PRO . 12.9 tmtt? -85.95 116.75 66.96 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 110.232 -0.284 . . . . 75.340000000000003 110.232 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.451 ' O ' ' HD3' ' A' ' 68' ' ' LYS . 56.7 Cg_endo -94.18 175.06 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.3 2.666 . . . . 73.209999999999994 112.659 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -149.05 128.75 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.381 -0.6 . . . . 71.230000000000004 109.381 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.9 137.09 42.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.562 0.22 . . . . 75.030000000000001 110.891 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 37.7 p90 -154.64 158.19 39.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.749 -0.463 . . . . 73.400000000000006 109.749 173.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m -87.21 106.65 18.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.76 0.314 . . . . 75.200000000000003 110.816 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.77 111.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 109.774 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.24 -30.67 2.69 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.058 -0.817 . . . . 51.530000000000001 111.058 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.83 158.27 15.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.882 -0.414 . . . . 74.430000000000007 109.882 176.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 43.27 2.35 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.287 -0.483 . . . . 54.409999999999997 113.185 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.24 -23.74 62.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.044 0.45 . . . . 75.439999999999998 110.39 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.63 168.54 22.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.882 -0.599 . . . . 32.009999999999998 110.254 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 104' ' ' LEU . 12.6 pt -75.48 158.36 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 75.420000000000002 110.352 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 7.0 tmtm? -56.01 -37.41 69.11 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.79 0.329 . . . . 73.310000000000002 110.472 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.21 -46.33 86.11 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.804 -0.713 . . . . 34.43 112.158 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -73.1 -38.65 66.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.477 -0.194 . . . . 71.340000000000003 110.477 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -48.71 78.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.002 0.43 . . . . 72.430000000000007 110.024 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.35 -43.92 89.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 109.923 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.93 -50.03 52.46 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.85 -0.613 . . . . 70.400000000000006 112.827 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.566 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.8 m -75.38 -33.3 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.799 0.333 . . . . 62.310000000000002 111.328 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.15 -20.77 55.06 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.065 0.394 . . . . 72.340000000000003 112.065 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 86' ' ' GLY . 7.9 t -86.98 0.99 54.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.892 0.33 . . . . 72.319999999999993 111.892 -176.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.625 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 19.2 ptp -116.22 -171.18 1.94 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.615 0.245 . . . . 71.329999999999998 111.07 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 54.1 p -132.05 178.83 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.195 -0.457 . . . . 75.530000000000001 110.941 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.636 HD23 HG12 ' A' ' 130' ' ' VAL . 3.2 tm? -60.86 128.57 37.14 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 120.783 0.325 . . . . 74.120000000000005 110.753 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.06 7.74 87.45 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.62 -0.718 . . . . 72.25 112.592 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.462 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.1 tt0 -102.66 143.74 31.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.708 0.289 . . . . 71.340000000000003 110.705 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HE3' HD23 ' A' ' 31' ' ' LEU . 37.9 ttpt -136.86 142.48 42.8 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.012 0.434 . . . . 74.540000000000006 110.175 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.94 151.75 48.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.845 -0.616 . . . . 55.240000000000002 110.901 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.0 tp -90.59 105.37 17.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.385 -1.339 . . . . 62.350000000000001 107.385 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 11.3 t80 -110.44 109.65 20.11 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.048 -0.524 . . . . 65.010000000000005 111.086 -167.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.1 m -73.05 113.13 9.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.616 . . . . 71.140000000000001 110.682 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' A' ' 105' ' ' ALA . 35.2 mm -96.75 111.82 58.53 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.363 -0.38 . . . . 60.109999999999999 110.383 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HA ' HG23 ' A' ' 120' ' ' THR . 23.3 Cg_endo -61.85 155.55 53.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.531 2.154 . . . . 51.240000000000002 111.261 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 9.6 p90 -54.37 -42.16 70.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.837 -0.62 . . . . 74.230000000000004 112.265 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.25 -7.6 56.21 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.787 0.291 . . . . 73.140000000000001 111.787 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 80' ' ' ILE . 56.9 mt -102.84 15.3 29.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 72.140000000000001 110.56 178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 100' ' ' ILE . . . -152.83 175.01 13.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 75.530000000000001 110.616 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -66.28 -15.64 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 72.409999999999997 110.65 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -62.0 -16.68 53.34 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.013 -0.54 . . . . 75.140000000000001 112.636 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 102' ' ' TYR . 3.3 tm-20 -60.56 -55.87 28.22 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.102 0.477 . . . . 70.209999999999994 109.748 176.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.55 -31.44 14.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.725 -0.67 . . . . 72.200000000000003 111.391 -171.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 78.96 140.64 1.9 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.194 -0.527 . . . . 74.310000000000002 112.441 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.671 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 96.3 m-85 -137.54 -55.91 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 122.333 0.253 . . . . 75.400000000000006 110.681 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 80.5 Cg_endo -88.44 139.75 4.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.87 1.713 . . . . 74.049999999999997 111.299 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 72.8 Cg_exo -52.14 -24.88 21.37 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.862 2.374 . . . . 75.519999999999996 113.331 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 115' ' ' ILE . 27.2 m -72.88 -26.7 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.643 -0.253 . . . . 74.310000000000002 111.498 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 114' ' ' VAL . 49.1 mm -113.18 101.92 54.1 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.782 -0.451 . . . . 64.329999999999998 109.782 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.12 163.83 34.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.63 2.22 . . . . 73.409999999999997 111.97 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.3 148.7 84.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.295 1.997 . . . . 61.409999999999997 111.709 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt 67.89 19.58 9.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 73.319999999999993 111.087 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.21 27.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 111.082 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 101' ' ' PRO . 47.1 m -86.96 131.97 33.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.032 -0.729 . . . . 71.230000000000004 109.032 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -132.13 136.88 47.43 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.811 -0.44 . . . . 73.030000000000001 109.811 -171.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.535 ' N ' HD13 ' A' ' 121' ' ' LEU . 52.1 t -104.38 120.58 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 74.230000000000004 110.208 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 96.2 m-85 -109.31 127.22 54.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.251 -0.431 . . . . 52.100000000000001 110.419 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 29.7 mt-10 -75.15 114.1 13.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.408 -0.96 . . . . 64.310000000000002 108.408 168.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.488 HG23 ' HE3' ' A' ' 90' ' ' MET . 11.4 m -107.55 134.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 41.0 109.964 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.86 133.87 32.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.635 -0.257 . . . . 75.209999999999994 110.796 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.641 HD11 ' HB ' ' A' ' 130' ' ' VAL . 1.7 tm? -98.52 105.92 18.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.296 -0.631 . . . . 72.310000000000002 109.296 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 49' ' ' HIS . 3.7 mm? -85.41 -41.98 14.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.418 -0.355 . . . . 73.209999999999994 111.189 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -146.7 140.52 25.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.652 0.263 . . . . 55.219999999999999 111.201 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 127' ' ' LEU . 5.0 p . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.428 -0.796 . . . . 71.349999999999994 109.929 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.899 0.38 . . . . 73.310000000000002 110.353 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.69 27.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 60.100000000000001 111.553 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -131.92 128.44 38.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.82 -0.437 . . . . 74.230000000000004 109.82 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -91.43 -25.2 19.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.421 0.629 . . . . 73.230000000000004 109.728 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -124.11 154.27 40.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 75.319999999999993 109.01 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -75.98 156.04 34.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.081 0.467 . . . . 73.329999999999998 111.727 -173.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -87.87 100.48 12.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.725 -0.671 . . . . 65.319999999999993 110.103 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -64.76 -19.38 65.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.846 -0.615 . . . . 73.239999999999995 110.539 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -111.92 139.81 47.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 52.340000000000003 109.21 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.91 161.54 30.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.941 -0.647 . . . . 72.519999999999996 112.864 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.3 t -89.08 13.17 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.283 0.563 . . . . 61.109999999999999 110.259 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.534 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.3 mm? -71.55 135.11 46.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.806 -0.634 . . . . 72.230000000000004 110.629 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.67 -157.92 0.36 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-N 116.04 -0.527 . . . . 63.329999999999998 110.081 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.18 -172.63 3.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.955 -0.566 . . . . 33.229999999999997 109.834 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.34 136.68 37.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 71.120000000000005 109.298 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -96.51 168.81 10.32 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.145 0.498 . . . . 75.230000000000004 111.113 -176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -166.9 99.49 0.55 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.384 -0.826 . . . . 72.329999999999998 108.924 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.26 -179.86 34.38 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.007 -0.616 . . . . 74.25 112.223 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 71.82 3.44 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.891 2.394 . . . . 73.400000000000006 112.028 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.6 113.74 5.49 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.292 -0.723 . . . . 53.439999999999998 111.292 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -72.49 73.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.504 0.668 . . . . 73.519999999999996 111.414 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.2 mtp -118.37 12.13 13.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.546 -0.909 . . . . 72.150000000000006 108.546 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.8 p -165.79 159.41 16.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.677 -1.147 . . . . 71.329999999999998 108.983 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.82 93.41 3.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.339 . . . . 62.109999999999999 110.29 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -92.3 144.59 25.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 62.340000000000003 109.532 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.64 110.61 5.2 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.407 -0.36 . . . . 71.530000000000001 111.65 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.499 ' H ' ' HB ' ' A' ' 99' ' ' THR . 42.9 mm-40 -109.83 113.51 26.3 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.026 -0.731 . . . . 65.329999999999998 109.026 170.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -111.1 101.34 9.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.529 0.681 . . . . 71.0 109.461 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 43.0 tptt -108.96 117.66 34.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.508 -0.769 . . . . 73.319999999999993 110.17 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.99 106.0 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.483 -0.562 . . . . 70.430000000000007 109.483 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.49 HD12 ' HE2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -86.62 -29.66 22.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 73.129999999999995 109.734 -173.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -152.88 110.66 2.7 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.815 -0.63 . . . . 74.030000000000001 109.563 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.58 126.7 20.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.876 2.384 . . . . 71.120000000000005 111.978 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.619 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -102.59 -157.63 25.7 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.358 -0.449 . . . . 71.120000000000005 112.6 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.83 -56.64 19.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.601 0.361 . . . . 72.409999999999997 111.26 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.88 -30.05 10.85 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-O 119.793 -0.449 . . . . 51.130000000000003 114.205 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.7 m -106.21 -9.72 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.102 0.951 . . . . 73.239999999999995 111.494 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.3 m -109.19 111.68 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.874 -0.417 . . . . 54.219999999999999 109.874 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 8.2 mtpm? -106.47 140.08 20.96 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.417 -0.356 . . . . 63.140000000000001 110.786 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.11 160.56 39.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.266 1.977 . . . . 71.040000000000006 110.672 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -141.29 171.46 14.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.633 0.254 . . . . 75.109999999999999 110.738 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.26 156.56 37.08 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.079 -0.51 . . . . 74.420000000000002 111.403 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.9 27.06 67.51 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.009 -0.541 . . . . 65.140000000000001 112.151 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -130.71 128.04 40.06 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.525 -0.176 . . . . 74.430000000000007 110.525 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 17.1 tppt? -73.45 104.91 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.006 -0.739 . . . . 61.229999999999997 109.006 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 32.3 m -107.26 152.26 8.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-O 121.144 0.497 . . . . 64.049999999999997 112.185 -175.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.0 m -100.42 110.17 22.36 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.053 -0.976 . . . . 54.210000000000001 110.393 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' A' ' 72' ' ' PHE . 30.4 m -121.57 178.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.35 -0.841 . . . . 41.030000000000001 111.889 -172.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 4.6 t-160 -144.32 138.25 27.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.003 -0.74 . . . . 71.409999999999997 109.003 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' CD1' HG12 ' A' ' 125' ' ' VAL . 94.5 m-85 -126.64 144.21 50.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.572 -0.285 . . . . 71.340000000000003 110.96 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.563 ' HB2' ' HB2' ' A' ' 124' ' ' GLU . 58.7 m-20 -136.18 144.66 45.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.931 -0.766 . . . . 72.430000000000007 108.931 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.57 128.34 9.15 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.104 -0.569 . . . . 64.230000000000004 112.65 -173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 13.3 ttm180 -139.61 140.72 37.07 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.56 0.695 . . . . 71.310000000000002 111.343 -175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 60' ' ' PHE . 83.5 m-85 -81.19 157.82 70.39 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.538 -0.755 . . . . 75.120000000000005 109.468 172.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.97 -15.09 36.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.615 2.21 . . . . 74.209999999999994 112.247 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.29 -5.97 58.38 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.079 -0.509 . . . . 72.299999999999997 110.902 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.69 49.34 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.196 -0.526 . . . . 52.539999999999999 112.625 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.72 122.17 19.33 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 122.296 0.238 . . . . 64.140000000000001 110.885 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 12.8 pt20 -85.23 132.58 34.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.742 -0.466 . . . . 72.329999999999998 109.742 175.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 121' ' ' LEU . 44.8 p90 -89.34 -19.6 25.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.627 0.251 . . . . 73.530000000000001 110.847 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -156.97 144.31 18.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.614 -0.513 . . . . 72.129999999999995 109.614 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.8 p -124.46 98.7 5.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 110.861 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.04 64.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.344 -0.613 . . . . 61.149999999999999 109.344 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.472 HH12 ' CD ' ' A' ' 124' ' ' GLU . 6.9 ptt-85 -60.85 -41.19 95.36 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.603 -0.726 . . . . 74.420000000000002 110.807 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 t -70.07 -19.4 63.28 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.978 -0.379 . . . . 52.329999999999998 109.978 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 66' ' ' ARG . 44.6 mtt180 -85.15 -28.85 25.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.172 0.511 . . . . 75.439999999999998 110.059 176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.08 26.27 64.65 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.578 -0.737 . . . . 63.329999999999998 111.712 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -108.35 116.84 55.91 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 122.234 0.214 . . . . 75.340000000000003 111.309 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.41 -178.63 3.8 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 73.209999999999994 112.074 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -140.86 163.62 32.43 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.951 -0.759 . . . . 71.230000000000004 108.951 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -142.07 138.07 31.47 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.55 0.214 . . . . 75.030000000000001 110.621 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 20.6 p90 -157.29 165.76 34.97 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.964 -0.384 . . . . 73.400000000000006 109.964 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 m -89.15 108.83 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.348 -0.241 . . . . 75.200000000000003 110.348 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.1 135.14 57.39 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.171 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.55 58.77 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.26 -0.495 . . . . 51.530000000000001 112.405 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.54 171.46 14.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.996 0.427 . . . . 74.430000000000007 110.999 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.12 55.93 4.95 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.745 -0.661 . . . . 54.409999999999997 112.333 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -119.12 -19.01 8.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.614 0.245 . . . . 75.439999999999998 110.495 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -142.77 162.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.497 -0.319 . . . . 32.009999999999998 110.324 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 104' ' ' LEU . 15.8 pt -72.31 151.34 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.958 -0.564 . . . . 75.420000000000002 110.366 174.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 51.3 mmtt -60.47 -15.81 30.49 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.331 0.493 . . . . 73.310000000000002 112.331 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.69 -60.27 8.78 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.26 -0.972 . . . . 34.43 111.254 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -67.07 -39.58 86.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.101 -0.333 . . . . 71.340000000000003 110.101 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 20.8 t70 -52.14 -54.95 24.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.513 -0.767 . . . . 72.430000000000007 110.625 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -68.21 -36.75 80.01 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.044 -0.525 . . . . 73.310000000000002 110.507 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.3 -53.43 31.47 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.773 -0.649 . . . . 70.400000000000006 112.536 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 90' ' ' MET . 33.4 m -75.59 -30.89 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.734 0.302 . . . . 62.310000000000002 111.091 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.39 -26.23 67.15 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.034 0.383 . . . . 72.340000000000003 112.034 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 86' ' ' GLY . 10.9 t -87.99 0.79 55.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.882 0.327 . . . . 72.319999999999993 111.882 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 16.1 ptp -112.4 -174.98 2.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.06 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.0 p -121.98 178.98 4.67 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.218 -0.446 . . . . 75.530000000000001 111.072 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -60.56 128.36 36.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.986 -0.552 . . . . 74.120000000000005 110.653 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 71.26 35.78 63.71 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.577 -0.344 . . . . 72.25 112.427 176.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.619 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 28.6 tt0 -128.02 150.45 49.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.666 0.27 . . . . 71.340000000000003 110.324 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HE2' HD12 ' A' ' 31' ' ' LEU . 6.8 ttpm? -133.26 138.84 46.63 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.958 0.408 . . . . 74.540000000000006 110.678 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.9 145.07 41.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.768 -0.651 . . . . 55.240000000000002 110.645 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 8.6 tt -90.25 105.56 17.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.321 -1.362 . . . . 62.350000000000001 107.321 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.56 ' HD2' HD13 ' A' ' 100' ' ' ILE . 17.7 t80 -111.65 114.05 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 65.010000000000005 110.031 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 27' ' ' GLU . 16.2 m -75.71 106.75 7.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 110.068 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.56 HD13 ' HD2' ' A' ' 98' ' ' PHE . 34.5 mm -80.77 114.31 47.17 Favored Pre-proline 0 C--O 1.243 0.744 0 CA-C-N 116.069 -0.514 . . . . 60.109999999999999 110.568 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.663 ' HA ' HG23 ' A' ' 120' ' ' THR . 21.4 Cg_exo -66.31 149.93 84.84 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.825 2.35 . . . . 51.240000000000002 112.007 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.38 -30.46 52.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.755 -0.657 . . . . 74.230000000000004 111.307 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -65.64 -35.95 82.27 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.066 -0.516 . . . . 73.140000000000001 111.388 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 80' ' ' ILE . 93.3 mt -100.48 19.96 15.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.140000000000001 111.022 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.09 -178.22 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 75.530000000000001 110.995 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.22 -9.93 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.646 -0.707 . . . . 72.409999999999997 110.424 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.92 40.08 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.856 -0.611 . . . . 75.140000000000001 113.742 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 35.9 tt0 -65.97 -41.36 91.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.888 0.375 . . . . 70.209999999999994 110.652 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.51 -14.07 20.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.052 -0.522 . . . . 72.200000000000003 111.053 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 66.89 -82.07 0.12 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-N 116.033 -0.53 . . . . 74.310000000000002 113.777 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.747 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 62.9 m-85 97.92 -74.25 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.859 1.663 . . . . 75.400000000000006 111.478 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 11.3 Cg_endo -89.05 143.16 4.77 Favored 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.058 1.839 . . . . 74.049999999999997 111.856 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.62 -18.41 40.11 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.862 2.375 . . . . 75.519999999999996 112.422 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.68 -37.39 79.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.031 -0.532 . . . . 74.310000000000002 109.948 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 50.8 mm -106.8 106.48 58.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.573 -0.74 . . . . 64.329999999999998 109.498 178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.44 148.6 92.56 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.457 2.105 . . . . 73.409999999999997 112.365 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.36 144.35 67.51 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.551 2.168 . . . . 61.409999999999997 112.235 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 44.7 mtpt 63.59 25.72 14.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.402 -0.817 . . . . 73.319999999999993 111.21 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.49 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 74.120000000000005 111.535 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 101' ' ' PRO . 28.3 m -86.18 131.24 34.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 71.230000000000004 109.072 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -123.82 145.73 48.87 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.711 -0.478 . . . . 73.030000000000001 109.711 -170.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.615 ' N ' HD13 ' A' ' 121' ' ' LEU . 97.5 t -98.38 119.8 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-O 120.78 0.324 . . . . 74.230000000000004 110.33 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.409 ' CE1' HD12 ' A' ' 121' ' ' LEU . 57.7 m-85 -116.08 118.61 33.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 52.100000000000001 110.166 177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 51' ' ' ASP . 38.2 mt-10 -83.22 106.99 15.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.373 -0.831 . . . . 64.310000000000002 109.037 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.442 ' O ' ' HE1' ' A' ' 90' ' ' MET . 28.9 m -102.92 145.32 12.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 41.0 110.261 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 43.5 tt0 -143.27 130.12 20.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.542 -0.299 . . . . 75.209999999999994 110.484 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -98.82 105.7 17.88 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.922 -0.77 . . . . 72.310000000000002 108.922 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.89 -48.14 10.33 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.894 0.378 . . . . 73.209999999999994 110.289 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -164.94 -173.68 3.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.656 -0.702 . . . . 55.219999999999999 109.823 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 2.6 p . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.081 -0.961 . . . . 71.349999999999994 109.762 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 110.062 -0.348 . . . . 73.310000000000002 110.062 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.04 136.09 57.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.204 -0.453 . . . . 60.100000000000001 111.764 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -145.65 135.65 23.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.249 -0.649 . . . . 74.230000000000004 109.249 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -125.62 144.74 50.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 73.230000000000004 111.149 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -117.72 118.37 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 75.319999999999993 109.767 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -127.78 175.09 8.59 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.61 0.243 . . . . 73.329999999999998 111.121 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.6 p80 46.77 31.85 1.57 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.245 1.018 . . . . 65.319999999999993 112.056 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -90.63 82.27 5.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.409 -0.589 . . . . 73.239999999999995 109.409 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtt -127.49 134.63 49.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.712 -0.677 . . . . 52.340000000000003 110.388 -174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.08 118.87 9.94 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.214 -0.755 . . . . 72.519999999999996 111.214 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 p -62.59 95.4 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.838 0.351 . . . . 61.109999999999999 111.401 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.21 102.14 9.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.687 -0.857 . . . . 72.230000000000004 108.687 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.76 93.5 4.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.932 -0.576 . . . . 63.329999999999998 110.022 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.99 118.9 32.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 33.229999999999997 110.917 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -87.61 101.79 13.98 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.18 0.514 . . . . 71.120000000000005 110.146 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 18' ' ' GLY . 39.2 m -148.25 141.44 25.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 75.230000000000004 110.008 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -63.82 -28.91 70.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.878 0.371 . . . . 72.329999999999998 110.602 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.705 ' H ' HG22 ' A' ' 16' ' ' THR . . . 100.75 94.95 2.18 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.615 -0.72 . . . . 74.25 111.337 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD2' ' HA2' ' A' ' 18' ' ' GLY . 16.3 Cg_endo -55.94 90.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.786 2.324 . . . . 73.400000000000006 112.179 -177.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.04 -83.69 0.12 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.513 -0.767 . . . . 53.439999999999998 111.313 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -72.34 83.14 1.05 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.059 0.457 . . . . 73.519999999999996 109.835 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.504 ' HB2' HE21 ' A' ' 25' ' ' GLN . 87.9 mtp -148.01 -160.85 1.22 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 72.150000000000006 109.771 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 p -76.1 -170.8 1.5 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.739 -0.664 . . . . 71.329999999999998 110.188 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.1 109.22 3.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.6 0.238 . . . . 62.109999999999999 110.892 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.715 ' HB2' HG21 ' A' ' 120' ' ' THR . 71.7 mt-30 -92.34 149.92 21.14 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.899 -0.408 . . . . 62.340000000000003 109.899 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -145.76 112.94 6.15 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.816 0.341 . . . . 71.530000000000001 110.96 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 43.6 mt-10 -136.86 135.36 37.8 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.263 -0.643 . . . . 65.329999999999998 109.263 172.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -132.91 101.12 5.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.482 0.658 . . . . 71.0 109.668 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -113.34 110.89 21.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.245 -0.889 . . . . 73.319999999999993 110.378 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.13 111.1 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 70.430000000000007 110.445 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 97' ' ' LEU . 80.5 mt -85.4 -24.04 27.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 73.129999999999995 110.327 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.1 m -153.35 110.69 2.61 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.634 -0.712 . . . . 74.030000000000001 109.462 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.83 126.6 13.45 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.492 2.128 . . . . 71.120000000000005 111.835 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.19 -145.66 15.24 Favored Glycine 0 C--O 1.237 0.296 0 CA-C-N 115.906 -0.588 . . . . 71.120000000000005 112.114 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.477 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.6 m-20 -66.0 -43.92 86.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.787 0.327 . . . . 72.409999999999997 111.501 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.48 -30.14 2.82 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.228 -0.51 . . . . 51.130000000000003 112.333 -175.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' HB3' ' A' ' 35' ' ' ASP . 33.4 m -89.29 -24.9 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 110.943 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 35' ' ' ASP . 14.4 p -78.03 95.41 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.037 -0.529 . . . . 54.219999999999999 110.524 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -106.41 103.91 48.03 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.577 -0.738 . . . . 63.140000000000001 111.066 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.11 156.62 42.52 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.467 2.111 . . . . 71.040000000000006 111.454 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.76 170.69 14.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.792 0.329 . . . . 75.109999999999999 110.74 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.88 156.74 26.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.806 -0.634 . . . . 74.420000000000002 111.047 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.92 25.28 67.29 Favored Glycine 0 C--N 1.329 0.159 0 CA-C-N 115.889 -0.596 . . . . 65.140000000000001 112.267 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -130.01 119.15 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 74.430000000000007 110.748 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -66.34 104.27 1.18 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.159 -0.682 . . . . 61.229999999999997 109.159 172.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.549 HG12 HG23 ' A' ' 130' ' ' VAL . 29.5 m -106.98 155.56 7.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.301 -0.409 . . . . 64.049999999999997 111.342 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -98.91 108.27 20.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.483 -0.781 . . . . 54.210000000000001 110.646 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.508 HG12 HD22 ' A' ' 127' ' ' LEU . 10.5 m -123.43 178.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.572 -0.74 . . . . 41.030000000000001 111.394 -173.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 70' ' ' PHE . 65.0 t60 -152.29 133.31 14.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 71.409999999999997 109.566 170.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -126.79 146.19 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.578 -0.897 . . . . 71.340000000000003 108.578 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' PHE . 0.8 OUTLIER -135.86 152.02 50.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.823 -0.436 . . . . 72.430000000000007 109.823 -177.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.05 129.32 9.78 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.381 -0.438 . . . . 64.230000000000004 113.003 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -147.52 145.94 29.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.2 0.524 . . . . 71.310000000000002 110.302 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.413 ' HE1' ' HB2' ' A' ' 60' ' ' PHE . 77.6 m-85 -90.22 148.47 39.29 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.306 -0.406 . . . . 75.120000000000005 110.422 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.77 -13.77 28.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.796 2.331 . . . . 74.209999999999994 111.719 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.16 -25.97 64.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.497 -0.774 . . . . 72.299999999999997 110.348 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.89 -14.78 28.99 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.343 -0.844 . . . . 52.539999999999999 111.489 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -103.11 148.67 25.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.09 0.556 . . . . 64.140000000000001 110.938 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.71 135.07 54.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.589 -0.522 . . . . 72.329999999999998 109.589 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.413 ' HB2' ' HE1' ' A' ' 54' ' ' PHE . 79.6 t80 -68.76 -62.34 1.43 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.148 -0.478 . . . . 73.530000000000001 110.783 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -137.51 131.31 31.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.92 -0.77 . . . . 72.129999999999995 108.92 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.547 ' OG ' ' HG3' ' A' ' 64' ' ' ARG . 9.7 t -111.02 134.44 52.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.108 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.8 m -75.75 -22.98 55.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.103 -0.499 . . . . 61.149999999999999 111.427 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.547 ' HG3' ' OG ' ' A' ' 62' ' ' SER . 6.7 ppt_? -56.82 -30.67 63.98 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.654 0.264 . . . . 74.420000000000002 110.861 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 64' ' ' ARG . 8.9 m -59.14 -26.53 64.81 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.282 -0.417 . . . . 52.329999999999998 110.99 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -96.2 -16.12 21.64 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.113 -0.494 . . . . 75.439999999999998 110.409 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.95 15.78 69.72 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.804 -0.635 . . . . 63.329999999999998 113.51 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 29.3 ttpp -88.64 118.99 69.95 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-O 120.742 0.306 . . . . 75.340000000000003 111.009 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -89.27 -173.05 0.72 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.459 2.773 . . . . 73.209999999999994 111.753 175.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.435 ' HD2' ' HA ' ' A' ' 49' ' ' HIS . 81.0 m-85 -137.2 160.31 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 71.230000000000004 109.735 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -139.26 131.31 27.94 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.848 -0.427 . . . . 75.030000000000001 109.848 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -155.89 156.59 34.89 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.786 -0.45 . . . . 73.400000000000006 109.786 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 86.3 m -79.4 114.54 18.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.14 -0.319 . . . . 75.200000000000003 110.14 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.726 HD11 ' HB2' ' A' ' 88' ' ' ALA . 32.6 tp -56.83 123.13 13.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.744 -0.465 . . . . 75.129999999999995 109.744 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.74 -26.46 24.01 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.886 -0.486 . . . . 51.530000000000001 111.886 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.47 5.07 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.004 0.431 . . . . 74.430000000000007 111.231 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.37 16.52 48.78 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.158 -0.544 . . . . 54.409999999999997 113.186 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -56.25 -39.97 73.42 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 110.181 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 28.3 m -126.43 164.91 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 32.009999999999998 109.177 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 104' ' ' LEU . 14.9 pt -67.75 150.05 11.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.123 0.487 . . . . 75.420000000000002 111.482 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 24.8 mmtm -62.8 -17.42 61.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.787 -0.642 . . . . 73.310000000000002 111.845 -175.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.87 -57.23 20.73 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.349 -0.929 . . . . 34.43 111.088 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.455 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 18.7 m0 -71.69 -36.54 70.61 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.503 -0.349 . . . . 71.340000000000003 110.216 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.678 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 10.0 t70 -52.82 -55.23 24.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.841 -0.618 . . . . 72.430000000000007 110.39 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.805 ' HA ' HE21 ' A' ' 85' ' ' GLN . 0.0 OUTLIER -72.75 -37.68 67.62 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 116.156 -0.475 . . . . 73.310000000000002 110.33 -179.098 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.28 -49.79 49.37 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.932 -0.577 . . . . 70.400000000000006 112.038 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 90' ' ' MET . 7.8 p -75.99 -32.29 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.816 0.341 . . . . 62.310000000000002 111.05 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.726 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.52 -29.18 68.95 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 86' ' ' GLY . 14.8 t -78.69 4.01 14.88 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.932 0.716 . . . . 72.319999999999993 112.932 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.4 ptp -120.04 -179.47 3.94 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.203 0.456 . . . . 71.329999999999998 111.442 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.414 HG21 ' HA2' ' A' ' 36' ' ' GLY . 68.7 p -118.88 178.86 4.33 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.963 -0.562 . . . . 75.530000000000001 111.124 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.0 tt -67.24 135.87 54.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.072 0.463 . . . . 74.120000000000005 110.704 -176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.551 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 76.8 17.25 80.04 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.415 -0.812 . . . . 72.25 111.821 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -112.84 137.51 51.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 71.340000000000003 110.351 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -123.83 135.31 53.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.625 -0.716 . . . . 74.540000000000006 109.46 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.91 148.75 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.21 0.529 . . . . 55.240000000000002 111.544 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.0 tt -90.76 114.0 26.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.225 -1.028 . . . . 62.350000000000001 108.225 174.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -119.79 116.6 26.23 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.934 0.397 . . . . 65.010000000000005 110.417 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 27' ' ' GLU . 18.4 m -75.67 106.44 7.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.085 -0.507 . . . . 71.140000000000001 110.304 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.1 mm -83.69 116.72 66.06 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 116.29 -0.414 . . . . 60.109999999999999 110.624 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.543 ' HA ' HG23 ' A' ' 120' ' ' THR . 52.1 Cg_exo -54.63 146.48 53.84 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.015 2.477 . . . . 51.240000000000002 112.066 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -54.22 -39.62 66.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 112.081 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -69.93 -25.82 63.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.807 0.337 . . . . 73.140000000000001 111.092 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 80' ' ' ILE . 85.7 mt -93.26 15.42 15.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.035 0.445 . . . . 72.140000000000001 110.261 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.19 -170.08 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 75.530000000000001 109.827 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.621 ' HE2' HG13 ' A' ' 115' ' ' ILE . 45.0 p90 -81.35 -7.56 59.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.385 -0.37 . . . . 72.409999999999997 110.59 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.8 -21.32 65.18 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.836 -0.62 . . . . 75.140000000000001 112.934 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.21 -46.13 79.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.369 0.604 . . . . 70.209999999999994 110.402 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -102.86 -36.31 8.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.949 -1.023 . . . . 72.200000000000003 111.416 -166.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.19 90.58 0.05 OUTLIER Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.178 -0.534 . . . . 74.310000000000002 112.025 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.577 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 95.7 m-85 -82.98 -52.41 0.64 Allowed Pre-proline 0 CA--C 1.537 0.476 0 O-C-N 122.809 -0.23 . . . . 75.400000000000006 110.997 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 96.3 Cg_endo -84.87 143.92 9.57 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.757 1.638 . . . . 74.049999999999997 111.311 174.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.38 -16.81 30.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.371 . . . . 75.519999999999996 112.631 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.57 -34.74 58.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.074 -0.512 . . . . 74.310000000000002 110.526 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.621 HG13 ' HE2' ' A' ' 106' ' ' TYR . 49.2 mm -103.45 110.39 63.69 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.013 -0.54 . . . . 64.329999999999998 110.327 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.95 155.79 61.4 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.704 2.269 . . . . 73.409999999999997 111.992 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.34 148.91 88.69 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.239 1.96 . . . . 61.409999999999997 111.283 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 118' ' ' LYS . 9.2 mtpm? 60.93 23.15 13.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.04 0.536 . . . . 73.319999999999993 111.557 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.89 114.97 27.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.759 0.314 . . . . 74.120000000000005 110.474 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 25' ' ' GLN . 98.1 m -73.64 133.11 43.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 71.230000000000004 109.118 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.52 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.1 tm? -123.48 142.62 50.82 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.246 -0.65 . . . . 73.030000000000001 109.246 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.52 ' N ' HD13 ' A' ' 121' ' ' LEU . 67.4 t -98.27 136.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.001 0.429 . . . . 74.230000000000004 110.24 -174.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 49.7 m-85 -123.28 122.18 37.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 52.100000000000001 110.42 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -80.36 107.23 12.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.28 -1.008 . . . . 64.310000000000002 108.28 174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.84 150.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.507 -0.77 . . . . 41.0 111.195 -174.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -150.19 136.33 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.976 -0.557 . . . . 75.209999999999994 110.295 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.5 tm? -96.81 109.53 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.572 -0.899 . . . . 72.310000000000002 108.572 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.71 -43.5 15.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.913 0.387 . . . . 73.209999999999994 110.426 -175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -171.23 -178.11 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.853 -0.612 . . . . 55.219999999999999 109.82 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.549 HG23 HG12 ' A' ' 46' ' ' VAL . 5.2 p . . . . . 0 C--O 1.249 1.069 0 N-CA-C 109.24 -0.652 . . . . 71.349999999999994 109.24 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.68 0.276 . . . . 73.310000000000002 110.572 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.23 157.0 38.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 60.100000000000001 110.72 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -90.05 96.17 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.526 -0.306 . . . . 74.230000000000004 110.817 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -57.81 122.74 13.6 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.395 -0.594 . . . . 73.230000000000004 109.395 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -76.11 104.26 6.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.934 -0.575 . . . . 75.319999999999993 111.521 -171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -68.6 111.22 4.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.235 -0.654 . . . . 73.329999999999998 109.235 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -69.58 150.75 46.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.056 -0.52 . . . . 65.319999999999993 110.783 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -82.84 -60.57 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.747 -0.464 . . . . 73.239999999999995 109.747 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.6 mtp 49.69 28.91 2.84 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.469 -0.787 . . . . 52.340000000000003 112.083 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.58 -83.48 0.36 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.53 -0.628 . . . . 72.519999999999996 111.53 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 m 62.04 -77.2 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.696 0.398 . . . . 61.109999999999999 110.82 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.4 tp -161.21 10.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.375 0.607 . . . . 72.230000000000004 109.607 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 42.2 mt-10 -86.83 152.84 22.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.704 -0.68 . . . . 63.329999999999998 110.363 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . 74.69 -35.54 0.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.317 0.647 . . . . 33.229999999999997 111.691 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -59.59 138.75 57.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.159 -0.312 . . . . 71.120000000000005 110.159 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -79.94 61.47 3.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 75.230000000000004 111.328 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 176.37 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.485 -0.78 . . . . 72.329999999999998 109.463 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.27 147.18 11.15 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.886 -0.673 . . . . 74.25 112.026 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.26 74.64 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.98 2.454 . . . . 73.400000000000006 111.679 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.62 -112.73 1.34 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.793 -0.64 . . . . 53.439999999999998 111.898 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -84.42 11.19 8.98 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.839 0.311 . . . . 73.519999999999996 111.839 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.544 ' HB2' ' NE2' ' A' ' 25' ' ' GLN . 89.9 mtp -67.92 121.73 16.66 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.398 -0.593 . . . . 72.150000000000006 109.398 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.404 ' HA ' ' CE2' ' A' ' 102' ' ' TYR . 20.4 m -58.58 -61.18 2.79 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.886 0.698 . . . . 71.329999999999998 112.886 -169.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.74 111.7 22.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.909 0.385 . . . . 62.109999999999999 111.119 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 22' ' ' MET . 54.9 mt-30 -126.48 142.35 51.57 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.898 -0.778 . . . . 62.340000000000003 108.898 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.31 105.29 3.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.641 0.257 . . . . 71.530000000000001 110.368 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' PHE . 37.7 mt-10 -137.82 122.66 18.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.342 -0.614 . . . . 65.329999999999998 109.342 170.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.595 ' HD3' ' H ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -120.44 122.63 41.11 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.26 -0.644 . . . . 71.0 109.26 175.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 35.1 ttmt -116.1 110.12 18.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.073 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.66 104.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 70.430000000000007 110.533 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 ' HE2' ' A' ' 95' ' ' LYS . 35.2 tp -88.37 -22.18 23.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 73.129999999999995 110.026 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 m -149.92 110.93 3.32 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.636 -0.711 . . . . 74.030000000000001 109.745 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.69 119.05 6.06 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.754 2.302 . . . . 71.120000000000005 111.588 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.634 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -86.65 -176.82 49.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.933 -0.651 . . . . 71.120000000000005 112.735 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.83 -33.02 69.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.65 0.262 . . . . 72.409999999999997 111.305 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.26 -30.29 1.63 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.234 -0.508 . . . . 51.130000000000003 113.511 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 36.0 m -79.37 -38.09 19.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 117.162 0.481 . . . . 73.239999999999995 111.048 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 p -66.15 94.0 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.514 . . . . 54.219999999999999 110.715 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -102.09 115.78 64.13 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.479 . . . . 63.140000000000001 110.605 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.95 -173.09 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.684 2.256 . . . . 71.040000000000006 112.307 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -156.66 164.74 37.81 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.148 -0.478 . . . . 75.109999999999999 110.112 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.98 127.69 33.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.298 -0.41 . . . . 74.420000000000002 110.239 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.28 31.63 7.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.772 -0.531 . . . . 65.140000000000001 111.772 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.04 130.29 49.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.984 -0.376 . . . . 74.430000000000007 109.984 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -74.11 108.26 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.511 -0.552 . . . . 61.229999999999997 109.511 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.52 158.68 19.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 116.365 -0.379 . . . . 64.049999999999997 111.128 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 28.8 m -111.92 115.78 29.54 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.956 -0.565 . . . . 54.210000000000001 110.209 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 127' ' ' LEU . 10.3 m -120.99 177.96 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.184 0.516 . . . . 41.030000000000001 111.684 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.407 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.1 t-80 -149.83 139.64 21.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.306 -0.861 . . . . 71.409999999999997 108.712 175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -137.72 156.02 48.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.578 -0.283 . . . . 71.340000000000003 110.81 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -152.98 160.53 43.03 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.014 -0.736 . . . . 72.430000000000007 109.014 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 59' ' ' GLN . . . -132.16 151.17 19.78 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.784 -0.722 . . . . 64.230000000000004 113.271 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -148.77 155.05 40.43 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.849 0.459 . . . . 71.310000000000002 109.886 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -87.1 150.17 49.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 75.120000000000005 110.407 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.87 -31.77 90.07 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.908 2.405 . . . . 74.209999999999994 112.954 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.94 -39.95 83.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.472 -0.331 . . . . 72.299999999999997 110.752 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.4 -26.55 1.99 Allowed Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.711 -0.757 . . . . 52.539999999999999 113.429 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -74.79 164.64 26.35 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.188 0.494 . . . . 64.140000000000001 110.821 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 63.4 tt0 -134.0 141.15 47.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 72.329999999999998 109.911 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -72.23 -54.17 10.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.158 0.504 . . . . 73.530000000000001 110.261 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -151.77 143.97 23.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.648 -0.705 . . . . 72.129999999999995 109.312 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.2 p -91.61 90.96 7.81 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.187 0.518 . . . . 73.409999999999997 111.875 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.4 t -73.83 -23.97 59.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.056 -0.52 . . . . 61.149999999999999 110.225 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 4.6 ptm180 -68.7 -34.68 76.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.83 -0.433 . . . . 74.420000000000002 109.83 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.8 t -73.51 -36.21 65.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.751 -0.659 . . . . 52.329999999999998 110.937 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -76.6 -28.61 56.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.437 -0.347 . . . . 75.439999999999998 110.615 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.54 37.08 94.22 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.24 -0.505 . . . . 63.329999999999998 112.714 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -79.48 115.67 55.01 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 110.183 -0.302 . . . . 75.340000000000003 110.183 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 169.17 15.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.732 2.288 . . . . 73.209999999999994 111.754 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.409 ' O ' HG22 ' A' ' 48' ' ' VAL . 77.8 t80 -147.62 115.6 6.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.581 -0.526 . . . . 71.230000000000004 109.581 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -100.11 127.31 46.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.74 -0.467 . . . . 75.030000000000001 109.74 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -153.65 170.03 21.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 73.400000000000006 110.77 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 104.56 14.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 75.200000000000003 109.856 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 88' ' ' ALA . 48.4 tp -59.06 138.91 57.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 75.129999999999995 110.772 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.41 25.91 37.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.061 -0.59 . . . . 51.530000000000001 112.103 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . . . -132.27 178.71 6.6 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.22 -0.289 . . . . 74.430000000000007 110.22 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.91 39.47 3.12 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 121.235 -0.507 . . . . 54.409999999999997 112.168 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 76' ' ' ALA . 6.8 mm-40 -74.88 -34.35 62.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.247 0.546 . . . . 75.439999999999998 109.726 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.58 171.65 11.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.152 -0.931 . . . . 32.009999999999998 109.163 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.7 pt -59.64 141.28 16.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.936 -0.394 . . . . 75.420000000000002 109.936 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 67.2 mmtt -61.59 -16.21 46.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.287 0.477 . . . . 73.310000000000002 112.287 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.05 -52.0 54.98 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.139 -1.029 . . . . 34.43 110.87 171.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -73.77 -43.65 58.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.53 -0.335 . . . . 71.340000000000003 110.381 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.583 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 29.4 t70 -53.5 -54.9 30.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.1 -0.5 . . . . 72.430000000000007 110.442 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.82 -44.6 69.63 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.677 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.21 -47.84 54.61 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.993 -0.548 . . . . 70.400000000000006 112.313 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG22 HD23 ' A' ' 127' ' ' LEU . 8.7 p -75.96 -33.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.8 0.334 . . . . 62.310000000000002 110.775 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.594 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.76 -30.46 70.03 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 111.946 0.35 . . . . 72.340000000000003 111.946 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 86' ' ' GLY . 9.1 t -82.35 -10.19 59.17 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.419 0.526 . . . . 72.319999999999993 112.419 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 14.9 ptp -102.97 -170.02 1.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.998 -0.438 . . . . 71.329999999999998 111.001 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 127' ' ' LEU . 56.1 p -133.69 179.03 6.48 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.58 -0.282 . . . . 75.530000000000001 111.726 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.693 ' HA ' HD12 ' A' ' 127' ' ' LEU . 7.1 tt -64.19 137.83 58.14 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.235 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 75.12 13.64 82.55 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.651 -0.704 . . . . 72.25 111.908 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.634 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.6 tt0 -111.37 134.13 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 71.340000000000003 110.443 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' HD23 ' A' ' 31' ' ' LEU . 6.1 ttpm? -133.96 130.43 37.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.612 -0.722 . . . . 74.540000000000006 109.765 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.14 143.88 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.031 0.443 . . . . 55.240000000000002 110.966 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 tt -90.89 111.03 22.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.061 -1.088 . . . . 62.350000000000001 108.061 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 16.9 t80 -112.73 137.99 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 65.010000000000005 110.328 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -89.26 106.68 18.6 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.791 -0.448 . . . . 71.140000000000001 109.791 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.96 113.74 60.66 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-N 116.38 -0.373 . . . . 60.109999999999999 111.034 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.42 159.35 39.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.795 2.33 . . . . 51.240000000000002 111.908 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 23' ' ' SER . 49.1 p90 -60.02 -26.46 66.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.04 0.385 . . . . 74.230000000000004 112.04 -174.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.656 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 11.2 pt20 -66.1 -18.68 65.5 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.694 0.283 . . . . 73.140000000000001 111.236 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.656 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 93.9 mt -115.2 14.91 17.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.387 -0.37 . . . . 72.140000000000001 110.948 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.57 175.46 13.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.273 0.559 . . . . 75.530000000000001 111.551 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -72.6 -11.24 60.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.481 -0.781 . . . . 72.409999999999997 110.654 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.18 -15.28 7.09 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.879 -0.601 . . . . 75.140000000000001 113.578 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.6 tt0 -63.59 -55.22 25.43 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.223 0.535 . . . . 70.209999999999994 110.144 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -97.34 -5.49 36.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.432 -0.804 . . . . 72.200000000000003 110.647 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 111' ' ' TYR . . . 64.02 -91.22 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.68 -0.691 . . . . 74.310000000000002 113.618 174.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.737 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 44.0 m-85 98.94 -65.78 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.793 1.637 . . . . 75.400000000000006 111.562 -172.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 5.1 Cg_exo -75.81 135.55 17.75 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.703 1.602 . . . . 74.049999999999997 111.262 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.5 -14.93 38.04 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.801 2.334 . . . . 75.519999999999996 112.675 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.0 t -75.49 -20.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 110.211 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.26 116.36 64.54 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.845 -0.616 . . . . 64.329999999999998 110.072 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.38 154.07 70.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.619 2.213 . . . . 73.409999999999997 111.946 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.48 126.88 16.97 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.31 2.007 . . . . 61.409999999999997 111.867 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 56.0 mtmt 57.22 49.75 12.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.103 -0.499 . . . . 73.319999999999993 110.713 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.02 148.88 22.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.504 -0.771 . . . . 74.120000000000005 111.348 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.7 m -100.66 131.48 46.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.591 -0.732 . . . . 71.230000000000004 109.698 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.27 161.63 20.09 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.92 0.39 . . . . 73.030000000000001 111.002 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.0 t -98.61 131.51 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.322 -0.621 . . . . 74.230000000000004 109.322 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.95 123.76 23.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.432 . . . . 52.100000000000001 111.252 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 48.5 mt-10 -85.76 111.08 19.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.047 -0.723 . . . . 64.310000000000002 109.047 173.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.41 143.72 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 41.0 109.952 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -147.48 133.15 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 75.209999999999994 110.812 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.0 tm? -102.64 113.16 26.3 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.968 -0.752 . . . . 72.310000000000002 108.968 177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.03 -44.43 10.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.566 -0.288 . . . . 73.209999999999994 111.103 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -145.55 141.66 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.638 -0.255 . . . . 55.219999999999999 111.121 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.252 1.199 0 N-CA-C 109.248 -0.649 . . . . 71.349999999999994 109.248 177.224 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.066 -0.346 . . . . 73.310000000000002 110.066 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.39 111.85 19.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 60.100000000000001 110.825 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -79.73 97.41 6.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.4 -0.593 . . . . 74.230000000000004 109.4 175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -156.42 127.83 7.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.555 0.217 . . . . 73.230000000000004 111.044 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -97.23 156.53 16.37 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.271 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -109.66 107.83 18.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.244 -1.021 . . . . 73.329999999999998 108.244 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -92.62 126.77 37.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.033 0.444 . . . . 65.319999999999993 111.51 -170.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -128.39 130.56 47.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.764 -0.653 . . . . 73.239999999999995 109.358 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 80.0 mtp -102.54 165.51 11.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.219 0.533 . . . . 52.340000000000003 111.562 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.18 141.75 6.1 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.715 -0.954 . . . . 72.519999999999996 110.715 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.2 m -153.77 133.08 12.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.238 0.519 . . . . 61.109999999999999 110.178 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.57 146.63 50.79 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 72.230000000000004 110.299 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.82 146.27 28.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 63.329999999999998 109.081 173.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.1 156.01 20.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.135 0.493 . . . . 33.229999999999997 111.512 -174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.89 93.89 9.43 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.04 -1.096 . . . . 71.120000000000005 108.04 176.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.6 p -102.83 26.96 7.45 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.688 -0.687 . . . . 75.230000000000004 112.456 -170.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -78.06 77.34 4.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 72.329999999999998 109.915 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.03 58.89 0.39 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.821 -0.627 . . . . 74.25 112.472 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.95 84.7 0.52 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.153 1.902 . . . . 73.400000000000006 110.506 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 46.9 3.3 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.978 -0.849 . . . . 53.439999999999998 110.978 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 p -58.85 -63.95 1.11 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.847 0.356 . . . . 73.519999999999996 110.098 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 86.9 mmm -80.0 144.89 32.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.979 -0.555 . . . . 72.150000000000006 109.961 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.9 t -53.61 -34.45 58.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.26 -0.427 . . . . 71.329999999999998 110.631 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.13 106.1 16.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.99 -0.55 . . . . 62.109999999999999 110.841 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -124.93 135.12 52.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.786 -0.82 . . . . 62.340000000000003 108.786 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -146.32 111.56 5.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.861 0.362 . . . . 71.530000000000001 111.036 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -129.35 139.98 51.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.181 -0.463 . . . . 65.329999999999998 109.873 169.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HB3' ' HD1' ' A' ' 98' ' ' PHE . 24.9 pttm -139.0 111.8 7.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 71.0 109.549 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.23 117.26 20.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.175 -0.676 . . . . 73.319999999999993 109.175 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 p -63.11 136.28 26.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.088 0.47 . . . . 70.430000000000007 110.763 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.4 tp -101.42 -28.18 12.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 73.129999999999995 110.198 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 m -153.87 112.26 2.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.12 -0.696 . . . . 74.030000000000001 109.12 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.11 134.77 47.49 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.581 2.187 . . . . 71.120000000000005 111.824 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.04 177.81 50.88 Favored Glycine 0 C--O 1.236 0.232 0 C-N-CA 121.271 -0.49 . . . . 71.120000000000005 113.218 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' OD2' HG22 ' A' ' 37' ' ' VAL . 30.6 t70 -64.7 -30.22 71.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.918 0.389 . . . . 72.409999999999997 110.6 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.57 -29.62 6.14 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 114.884 0.714 . . . . 51.130000000000003 114.884 168.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.466 HG22 ' OD2' ' A' ' 35' ' ' ASP . 6.4 m -89.75 -23.36 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 117.924 0.862 . . . . 73.239999999999995 112.271 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.601 HG21 ' HB2' ' A' ' 92' ' ' LEU . 34.0 p -62.66 125.57 24.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.698 -0.228 . . . . 54.219999999999999 111.063 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -100.07 126.98 34.67 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 120.933 0.397 . . . . 63.140000000000001 111.29 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -90.24 160.18 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.158 2.572 . . . . 71.040000000000006 111.847 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.623 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 19.8 pt20 -157.41 158.84 36.63 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 110.116 -0.327 . . . . 75.109999999999999 110.116 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -74.16 109.67 7.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.257 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.15 -21.22 3.51 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.738 -0.744 . . . . 65.140000000000001 113.143 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.623 ' HE2' ' HG2' ' A' ' 41' ' ' GLN . 50.9 mtmt -84.35 129.95 34.83 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.042 0.448 . . . . 74.430000000000007 110.607 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -72.49 111.28 7.53 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.286 -1.005 . . . . 61.229999999999997 108.286 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 130' ' ' VAL . 33.4 m -106.0 143.75 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.982 0.42 . . . . 64.049999999999997 110.91 -174.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -100.35 111.39 23.65 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.27 -0.877 . . . . 54.210000000000001 109.509 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 87' ' ' VAL . 31.0 m -121.5 178.13 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 41.030000000000001 110.614 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 126' ' ' GLU . 17.1 t-160 -147.27 136.37 22.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.2 -0.667 . . . . 71.409999999999997 109.2 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.485 ' HD1' HG12 ' A' ' 125' ' ' VAL . 78.3 m-85 -126.6 152.37 46.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.769 0.319 . . . . 71.340000000000003 111.086 -176.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -144.95 155.11 43.23 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.73 -0.841 . . . . 72.430000000000007 108.73 166.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.48 132.34 10.24 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.334 -0.46 . . . . 64.230000000000004 112.899 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ttm-85 -141.58 144.99 34.53 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.366 0.603 . . . . 71.310000000000002 110.902 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -80.92 147.3 61.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 75.120000000000005 109.555 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.63 -24.81 38.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.135 2.557 . . . . 74.209999999999994 113.491 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -74.33 -34.85 63.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.719 0.295 . . . . 72.299999999999997 110.552 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.78 -12.54 4.51 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 116.117 -0.492 . . . . 52.539999999999999 112.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -75.43 147.06 40.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.228 0.211 . . . . 64.140000000000001 110.568 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.88 127.36 26.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.772 -0.455 . . . . 72.329999999999998 109.772 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -67.54 -36.6 81.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.786 -0.643 . . . . 73.530000000000001 111.574 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -165.6 131.32 2.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 109.792 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 t -86.18 111.46 20.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.5 . . . . 73.409999999999997 110.728 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 m -79.4 -15.47 57.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 61.149999999999999 111.252 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 14.2 ptp180 -68.0 -32.18 72.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.535 -0.302 . . . . 74.420000000000002 110.764 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 t -67.33 -22.2 65.62 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.096 -0.502 . . . . 52.329999999999998 111.215 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.0 mtm-85 -76.09 -8.97 58.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.706 0.289 . . . . 75.439999999999998 111.151 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.81 8.28 5.52 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 115.263 0.865 . . . . 63.329999999999998 115.263 169.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -99.3 128.85 30.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 117.669 0.735 . . . . 75.340000000000003 110.065 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -86.74 178.45 3.75 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.801 2.334 . . . . 73.209999999999994 111.912 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -134.45 133.31 40.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.485 -0.561 . . . . 71.230000000000004 109.485 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 96.4 mt-30 -106.19 133.59 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.632 -0.258 . . . . 75.030000000000001 110.368 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HZ ' HG21 ' A' ' 87' ' ' VAL . 25.3 p90 -152.47 154.96 36.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.584 0.231 . . . . 73.400000000000006 110.415 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.455 ' N ' ' HG3' ' A' ' 78' ' ' GLU . 55.6 m -74.62 110.26 8.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.551 -0.295 . . . . 75.200000000000003 110.34 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 88' ' ' ALA . 53.0 tp -67.2 136.7 55.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.488 -0.324 . . . . 75.129999999999995 110.478 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.89 80.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.266 -0.493 . . . . 51.530000000000001 112.33 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.61 167.41 11.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.177 -0.305 . . . . 74.430000000000007 110.177 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.92 50.43 3.9 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.337 -0.459 . . . . 54.409999999999997 112.484 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 73' ' ' THR . 6.7 mm-40 -79.68 -46.33 17.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 75.439999999999998 109.968 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.66 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.331 -0.85 . . . . 32.009999999999998 109.839 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.429 HG13 ' H ' ' A' ' 83' ' ' TRP . 30.7 pt -58.54 142.93 13.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.097 0.475 . . . . 75.420000000000002 111.013 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 37.6 mmtm -55.86 -23.22 29.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.814 -0.63 . . . . 73.310000000000002 111.846 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.37 -51.9 56.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.641 -0.79 . . . . 34.43 111.635 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.429 ' H ' HG13 ' A' ' 80' ' ' ILE . 54.2 m0 -70.38 -38.61 74.75 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.267 -0.271 . . . . 71.340000000000003 110.267 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 11.9 t70 -52.12 -54.66 27.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.117 -0.492 . . . . 72.430000000000007 110.266 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -64.34 -43.06 95.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.211 -0.45 . . . . 73.310000000000002 110.636 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 89' ' ' THR . . . -52.66 -48.67 55.65 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.953 -0.567 . . . . 70.400000000000006 112.66 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.538 HG21 ' HZ ' ' A' ' 72' ' ' PHE . 18.1 m -75.65 -33.83 27.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.927 0.394 . . . . 62.310000000000002 111.176 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.54 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -73.81 -13.56 60.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.943 0.349 . . . . 72.340000000000003 111.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 86' ' ' GLY . 15.1 t -95.58 12.14 30.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 121.267 -0.173 . . . . 72.319999999999993 111.325 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 127' ' ' LEU . 8.0 ptp -133.32 -177.19 4.41 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.032 0.444 . . . . 71.329999999999998 111.631 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.5 p -135.93 179.11 6.54 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.7 -0.682 . . . . 75.530000000000001 111.33 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.653 ' HA ' HD12 ' A' ' 127' ' ' LEU . 1.5 tm? -51.45 124.62 12.41 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.968 0.507 . . . . 74.120000000000005 111.104 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 92' ' ' LEU . . . 84.81 -1.09 89.09 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.009 -0.541 . . . . 72.25 112.877 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.638 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 11.0 tt0 -88.13 143.14 27.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.011 0.434 . . . . 71.340000000000003 110.787 -174.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -142.45 133.51 25.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.531 -0.759 . . . . 74.540000000000006 109.025 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.13 30.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.421 . . . . 55.240000000000002 111.743 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.5 tt -90.86 110.14 21.36 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.475 -0.935 . . . . 62.350000000000001 108.475 175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.474 ' HD1' ' HB3' ' A' ' 28' ' ' LYS . 70.3 t80 -122.25 134.31 54.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.144 0.497 . . . . 65.010000000000005 110.888 -174.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.2 m -79.31 120.81 24.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.837 -0.62 . . . . 71.140000000000001 110.264 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.3 mm -99.03 107.24 42.91 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 110.025 -0.361 . . . . 60.109999999999999 110.025 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HA ' HG23 ' A' ' 120' ' ' THR . 28.2 Cg_exo -61.94 145.91 96.62 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.72 2.28 . . . . 51.240000000000002 111.245 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -54.33 -35.49 62.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 111.47 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -64.24 -26.42 68.49 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.318 -0.401 . . . . 73.140000000000001 111.263 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.02 11.83 37.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.508 -0.315 . . . . 72.140000000000001 111.02 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.16 -176.77 5.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.013 0.435 . . . . 75.530000000000001 111.018 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.44 -11.81 60.33 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.693 -0.685 . . . . 72.409999999999997 110.782 176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -64.89 -14.9 59.4 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.843 -0.617 . . . . 75.140000000000001 112.315 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.34 -55.64 30.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.897 -0.408 . . . . 70.209999999999994 109.897 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -86.2 -41.88 14.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.901 -0.59 . . . . 72.200000000000003 110.758 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.05 143.2 3.03 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 74.310000000000002 111.608 -175.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.654 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 95.5 m-85 -142.87 -51.69 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 122.84 -0.212 . . . . 75.400000000000006 110.72 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.654 ' HD2' ' H ' ' A' ' 111' ' ' TYR . 89.3 Cg_endo -82.07 138.41 10.18 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.582 1.522 . . . . 74.049999999999997 110.789 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 50.9 Cg_exo -56.26 -21.36 35.84 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 122.868 2.379 . . . . 75.519999999999996 113.349 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.647 HG23 HG12 ' A' ' 115' ' ' ILE . 35.5 m -75.12 -24.83 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.037 0.446 . . . . 74.310000000000002 110.834 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.647 HG12 HG23 ' A' ' 114' ' ' VAL . 49.0 mm -123.0 88.13 50.9 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 109.173 -0.677 . . . . 64.329999999999998 109.173 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.43 173.59 14.23 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.922 2.415 . . . . 73.409999999999997 112.505 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.42 132.54 24.61 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.576 2.184 . . . . 61.409999999999997 112.84 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt 62.43 37.64 13.39 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.437 -0.801 . . . . 73.319999999999993 111.671 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.4 114.74 26.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.120000000000005 110.762 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 101' ' ' PRO . 52.9 m -82.3 136.98 34.94 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.944 -0.571 . . . . 71.230000000000004 109.921 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 122' ' ' VAL . 1.7 tm? -134.25 145.17 48.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.669 -0.493 . . . . 73.030000000000001 109.669 -172.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 121' ' ' LEU . 61.8 t -99.82 120.91 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.229 . . . . 74.230000000000004 110.398 -176.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -110.83 131.99 54.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.123 0.487 . . . . 52.100000000000001 111.109 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.13 117.08 28.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.855 -0.794 . . . . 64.310000000000002 108.855 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.485 HG12 ' HD1' ' A' ' 50' ' ' TYR . 19.2 m -109.4 149.6 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.695 . . . . 41.0 110.728 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 42.0 tt0 -145.03 133.48 21.88 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.837 -0.619 . . . . 75.209999999999994 110.202 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 92' ' ' LEU . 1.9 tm? -102.36 116.03 31.78 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 122.702 0.401 . . . . 72.310000000000002 110.192 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.3 mm? -96.75 -37.66 10.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 111.296 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.9 142.26 20.6 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.837 -0.165 . . . . 55.219999999999999 111.016 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 46' ' ' VAL . 3.1 p . . . . . 0 C--O 1.251 1.162 0 CA-C-N 116.49 -0.323 . . . . 71.349999999999994 110.745 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.812 0.339 . . . . 73.310000000000002 110.69 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.67 76.45 7.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 60.100000000000001 110.516 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -81.03 40.61 0.55 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.326 0.584 . . . . 74.230000000000004 110.69 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -162.06 90.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -73.98 103.3 4.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.258 0.552 . . . . 75.319999999999993 111.749 -171.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.06 145.71 48.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.198 -0.91 . . . . 73.329999999999998 110.426 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -77.23 153.46 34.0 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.825 0.345 . . . . 65.319999999999993 111.24 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -134.17 -10.07 2.59 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.893 -0.594 . . . . 73.239999999999995 110.634 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -98.52 101.39 12.81 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.362 -0.381 . . . . 52.340000000000003 110.274 -176.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.25 126.46 0.93 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.657 -0.577 . . . . 72.519999999999996 111.657 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.9 p 50.33 25.61 1.93 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.154 0.582 . . . . 61.109999999999999 112.096 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.4 tp -83.23 -30.43 27.71 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.558 0.694 . . . . 72.230000000000004 109.413 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.26 -164.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.003 -0.998 . . . . 63.329999999999998 109.896 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.4 -79.75 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.675 0.274 . . . . 33.229999999999997 111.247 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -105.6 174.39 5.9 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.929 0.395 . . . . 71.120000000000005 110.991 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 m -138.39 97.19 3.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.531 -0.914 . . . . 75.230000000000004 108.531 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -74.84 105.26 5.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 72.329999999999998 110.842 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.91 -55.14 32.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.886 -0.597 . . . . 74.25 112.651 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 25' ' ' GLN . 78.0 Cg_exo -52.51 110.18 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 73.400000000000006 112.913 176.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.9 163.56 30.77 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.868 -0.605 . . . . 53.439999999999998 111.672 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 t -74.4 -70.88 0.37 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.812 0.306 . . . . 73.519999999999996 110.984 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -85.75 -19.49 30.71 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.764 0.316 . . . . 72.150000000000006 111.08 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 p -79.22 131.53 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 71.329999999999998 110.29 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.29 104.37 0.25 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.992 0.425 . . . . 62.109999999999999 111.079 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -92.43 135.42 34.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 62.340000000000003 110.717 -178.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 tp -145.9 137.0 24.66 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.851 0.358 . . . . 71.530000000000001 111.37 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -141.35 140.63 33.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.944 -0.762 . . . . 65.329999999999998 108.944 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -140.34 119.85 13.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.848 0.356 . . . . 71.0 110.601 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -112.82 125.59 54.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.061 -0.518 . . . . 73.319999999999993 109.776 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 114.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 109.562 -0.533 . . . . 70.430000000000007 109.562 176.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 97' ' ' LEU . 79.7 mt -99.24 -27.01 13.99 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.58 0.229 . . . . 73.129999999999995 111.5 -174.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 7.4 m -153.66 110.64 2.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 110.247 -0.279 . . . . 74.030000000000001 110.247 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.12 124.15 13.01 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.188 . . . . 71.120000000000005 111.619 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -92.36 -174.13 41.84 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.241 -0.504 . . . . 71.120000000000005 113.098 -177.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -44.66 -57.17 3.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.823 0.849 . . . . 72.409999999999997 112.13 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.1 -30.65 9.44 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.013 -0.613 . . . . 51.130000000000003 114.594 172.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.5 m -90.34 -22.81 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.175 0.988 . . . . 73.239999999999995 111.007 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.419 HG21 HD13 ' A' ' 92' ' ' LEU . 5.2 p -65.14 142.82 58.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 54.219999999999999 110.541 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.19 101.57 16.24 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.872 0.368 . . . . 63.140000000000001 110.947 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.95 141.38 26.72 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 71.040000000000006 111.507 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -131.74 160.42 35.57 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.073 -0.343 . . . . 75.109999999999999 110.073 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 140.83 50.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.358 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.22 64.98 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 65.140000000000001 112.152 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 143.62 33.28 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.779 0.323 . . . . 74.430000000000007 110.162 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 14.1 tppt? -69.89 126.69 30.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.916 -0.584 . . . . 61.229999999999997 110.027 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 130' ' ' VAL . 27.2 m -117.59 141.96 34.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 120.875 0.369 . . . . 64.049999999999997 110.758 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.4 m -99.87 108.53 20.81 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.369 -0.832 . . . . 54.210000000000001 109.749 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 87' ' ' VAL . 20.9 m -118.26 178.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.27 -0.877 . . . . 41.030000000000001 111.747 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 64' ' ' ARG . 10.6 t-160 -155.87 135.97 12.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.393 -0.822 . . . . 71.409999999999997 109.126 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HD1' HG12 ' A' ' 125' ' ' VAL . 61.7 m-85 -126.81 155.51 42.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.479 0.18 . . . . 71.340000000000003 110.857 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 124' ' ' GLU . 35.4 t70 -136.42 128.19 29.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.994 -0.548 . . . . 72.430000000000007 109.874 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 59' ' ' GLN . . . -86.92 100.88 2.61 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.324 -0.465 . . . . 64.230000000000004 112.852 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 53' ' ' ARG . 24.2 ttm-85 -115.95 144.66 43.76 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.927 0.394 . . . . 71.310000000000002 111.126 -174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -90.67 151.12 43.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 110.085 -0.339 . . . . 75.120000000000005 110.085 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.52 -8.68 21.61 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.892 2.395 . . . . 74.209999999999994 113.473 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.46 -22.11 25.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.69 0.281 . . . . 72.299999999999997 111.162 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.79 10.14 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 121.313 -0.47 . . . . 52.539999999999999 112.033 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -97.53 162.89 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.345 -0.613 . . . . 64.140000000000001 109.345 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 19.4 pt20 -147.76 146.94 29.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.378 -0.23 . . . . 72.329999999999998 110.378 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -76.82 -34.01 57.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.276 -0.42 . . . . 73.530000000000001 111.714 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -147.24 131.71 17.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.989 -0.374 . . . . 72.129999999999995 109.989 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.541 ' HA ' ' NE2' ' A' ' 59' ' ' GLN . 11.3 p -81.73 85.6 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.223 0.535 . . . . 73.409999999999997 110.197 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.683 ' HB2' ' HA ' ' A' ' 51' ' ' ASP . 20.1 m -81.47 -21.66 38.61 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.786 -0.643 . . . . 61.149999999999999 109.985 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.42 ' HA ' ' CE1' ' A' ' 49' ' ' HIS . 0.1 OUTLIER -66.94 -36.97 83.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.729 -0.669 . . . . 74.420000000000002 109.513 177.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.6 m -71.54 -21.58 61.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.468 -0.787 . . . . 52.329999999999998 110.877 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -76.0 -26.32 56.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.233 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.21 31.97 50.26 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.579 -0.737 . . . . 63.329999999999998 113.027 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 39.7 ttmt -79.13 119.8 78.43 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.536 0.168 . . . . 75.340000000000003 110.659 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 2.3 Cg_endo -82.63 93.92 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.069 2.513 . . . . 73.209999999999994 111.116 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -76.34 161.4 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.722 -0.672 . . . . 71.230000000000004 109.408 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.32 133.7 33.35 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.292 -0.255 . . . . 75.030000000000001 110.797 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HE1' HG11 ' A' ' 48' ' ' VAL . 26.9 p90 -150.81 158.08 43.71 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.422 -0.353 . . . . 73.400000000000006 110.199 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.5 m -77.42 113.04 14.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.07 -0.344 . . . . 75.200000000000003 110.07 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 88' ' ' ALA . 38.5 tp -60.39 140.41 57.2 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.441 -0.345 . . . . 75.129999999999995 110.878 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.13 -21.61 33.53 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 116.337 -0.392 . . . . 51.530000000000001 112.351 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.66 178.48 8.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 111.022 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.57 24.51 29.05 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.966 -0.561 . . . . 54.409999999999997 112.056 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.35 -41.49 84.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 109.892 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.453 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 34.5 m -123.68 178.23 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.327 -0.852 . . . . 32.009999999999998 109.058 174.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.9 pt -73.4 144.43 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.341 -0.615 . . . . 75.420000000000002 109.341 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.799 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 5.0 mptp? -61.84 -15.79 44.92 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.064 0.394 . . . . 73.310000000000002 112.064 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.64 -54.96 33.56 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.553 -0.832 . . . . 34.43 111.044 171.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 27.4 m0 -72.33 -36.17 68.77 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-O 120.851 0.357 . . . . 71.340000000000003 110.238 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.799 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 25.7 t70 -57.62 -55.36 35.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.517 -0.765 . . . . 72.430000000000007 110.747 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -72.51 -38.09 68.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.303 -0.408 . . . . 73.310000000000002 110.15 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.619 ' O ' HG22 ' A' ' 89' ' ' THR . . . -54.37 -47.93 66.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.88 -0.6 . . . . 70.400000000000006 112.465 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 90' ' ' MET . 9.2 p -76.05 -35.16 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.773 0.32 . . . . 62.310000000000002 110.862 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -60.97 -29.27 69.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.679 0.252 . . . . 72.340000000000003 111.679 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 86' ' ' GLY . 6.5 t -79.49 9.11 5.2 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.675 0.62 . . . . 72.319999999999993 112.675 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 17.1 ptp -124.86 -168.4 1.81 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.043 -0.411 . . . . 71.329999999999998 110.896 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -128.92 178.69 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.479 -0.328 . . . . 75.530000000000001 111.404 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 127' ' ' LEU . 9.6 tt -63.28 135.53 57.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 74.120000000000005 111.196 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.65 10.94 85.69 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.907 -0.588 . . . . 72.25 112.633 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.503 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 18.7 tt0 -106.18 148.81 27.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.695 0.283 . . . . 71.340000000000003 110.869 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -142.38 137.65 30.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 110.786 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.9 149.78 34.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.02 -0.536 . . . . 55.240000000000002 110.637 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.685 ' HB2' HD11 ' A' ' 31' ' ' LEU . 8.9 tt -90.72 107.51 19.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.494 -0.928 . . . . 62.350000000000001 108.494 175.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -112.0 125.71 54.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 65.010000000000005 110.168 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.6 m -76.2 130.35 38.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.353 . . . . 71.140000000000001 110.268 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 43.3 mm -108.14 98.81 28.28 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.364 -0.38 . . . . 60.109999999999999 110.021 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' ILE . 44.7 Cg_endo -68.04 153.97 73.76 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.572 2.181 . . . . 51.240000000000002 111.694 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.31 -23.57 66.82 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.719 0.637 . . . . 74.230000000000004 112.719 -171.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.55 -16.77 57.08 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.674 0.249 . . . . 73.140000000000001 111.674 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.51 15.58 25.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.755 0.312 . . . . 72.140000000000001 110.905 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.11 -175.8 5.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 111.322 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -73.79 -6.22 45.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.373 -0.83 . . . . 72.409999999999997 111.005 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -52.8 -25.11 21.74 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.367 0.417 . . . . 75.140000000000001 113.262 -176.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 39.3 tt0 -61.04 -46.22 91.58 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.909 0.385 . . . . 70.209999999999994 110.74 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -99.63 -46.64 5.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 72.200000000000003 111.466 -173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.7 161.65 3.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.58 -0.343 . . . . 74.310000000000002 112.815 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.708 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 87.9 m-85 -135.82 -57.56 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 119.576 -0.25 . . . . 75.400000000000006 110.767 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 9.5 Cg_exo -71.69 142.95 40.82 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.857 1.705 . . . . 74.049999999999997 111.022 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 44.1 Cg_exo -57.36 -19.08 33.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.591 2.194 . . . . 75.519999999999996 112.147 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.461 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 33.9 t -76.09 -24.4 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 110.627 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.06 98.21 18.07 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.148 -0.478 . . . . 64.329999999999998 109.874 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 114' ' ' VAL . 17.9 Cg_exo -67.34 159.9 50.16 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.002 2.468 . . . . 73.409999999999997 112.573 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.81 136.12 44.15 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.588 2.192 . . . . 61.409999999999997 111.43 174.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 62.6 mttp 61.07 34.84 18.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.073 -0.512 . . . . 73.319999999999993 110.871 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.42 122.79 31.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.789 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -73.83 119.11 17.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.625 -0.509 . . . . 71.230000000000004 109.625 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.92 168.78 8.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.046 0.451 . . . . 73.030000000000001 110.401 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.6 t -133.0 138.21 52.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.426 -0.953 . . . . 74.230000000000004 108.426 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 46.8 m-85 -130.19 122.81 28.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.345 0.593 . . . . 52.100000000000001 110.734 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 31.2 tt0 -76.44 107.03 8.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.559 -1.275 . . . . 64.310000000000002 107.559 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.598 HG12 ' HD1' ' A' ' 50' ' ' TYR . 31.6 m -104.1 144.14 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 41.0 110.4 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 39.2 tt0 -147.54 128.31 14.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 75.209999999999994 110.633 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.5 tm? -98.55 106.17 18.41 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.626 -0.879 . . . . 72.310000000000002 108.626 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.8 mm? -78.57 -48.3 15.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 73.209999999999994 111.002 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.14 166.62 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 55.219999999999999 111.195 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.467 HG23 HG12 ' A' ' 46' ' ' VAL . 2.8 p . . . . . 0 C--O 1.25 1.111 0 CA-C-N 115.926 -0.579 . . . . 71.349999999999994 110.203 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.192 -0.299 . . . . 73.310000000000002 110.192 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.41 5.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 60.100000000000001 110.491 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -72.72 -42.5 64.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.419 . . . . 74.230000000000004 110.032 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -75.83 116.72 16.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.566 -0.902 . . . . 73.230000000000004 108.566 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -59.98 94.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.636 . . . . 75.319999999999993 111.62 -169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -73.3 70.55 1.19 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.56 -0.533 . . . . 73.329999999999998 109.56 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -95.22 128.72 42.28 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.941 -0.763 . . . . 65.319999999999993 108.941 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -131.84 134.78 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.757 0.313 . . . . 73.239999999999995 110.558 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.21 174.28 13.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.328 -0.619 . . . . 52.340000000000003 109.328 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.65 -129.07 2.4 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.058 -0.591 . . . . 72.519999999999996 111.656 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.9 p -73.89 81.11 1.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.938 0.369 . . . . 61.109999999999999 110.177 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.6 mt 60.84 20.17 10.39 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.808 -0.633 . . . . 72.230000000000004 110.539 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.88 18.81 2.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.822 -0.626 . . . . 63.329999999999998 110.813 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.63 106.88 16.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 33.229999999999997 110.854 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 69.97 -5.29 1.29 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.755 -0.657 . . . . 71.120000000000005 112.105 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 p -77.39 87.42 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 75.230000000000004 110.67 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -140.87 13.17 2.27 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.684 -0.689 . . . . 72.329999999999998 110.584 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 22' ' ' MET . . . 112.12 88.17 1.75 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.097 -0.501 . . . . 74.25 112.224 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.15 122.49 5.74 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.73 2.287 . . . . 73.400000000000006 112.471 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.19 -127.27 8.13 Favored Glycine 0 C--O 1.237 0.29 0 C-N-CA 121.138 -0.553 . . . . 53.439999999999998 112.711 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 m -74.35 79.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.923 0.392 . . . . 73.519999999999996 110.83 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.467 ' HG3' ' HA3' ' A' ' 18' ' ' GLY . 24.8 mmt -142.29 -48.29 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.152 -0.476 . . . . 72.150000000000006 110.027 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -156.62 -179.51 8.26 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.647 -0.706 . . . . 71.329999999999998 109.573 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.4 95.36 6.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 62.109999999999999 110.453 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -92.42 135.32 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.508 . . . . 62.340000000000003 110.252 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -131.55 102.03 5.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.326 -0.99 . . . . 71.530000000000001 108.326 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.34 125.57 15.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 65.329999999999998 109.224 -176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -125.48 126.22 44.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 71.0 110.469 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -109.19 121.01 44.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.696 -0.683 . . . . 73.319999999999993 110.232 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.33 103.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.902 -0.407 . . . . 70.430000000000007 109.902 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.41 -19.66 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.42 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 37.9 m -149.57 110.83 3.39 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.992 -0.549 . . . . 74.030000000000001 109.712 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.75 130.63 23.76 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.272 1.981 . . . . 71.120000000000005 111.824 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 94' ' ' GLU . . . -85.17 -153.28 19.88 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.06 -0.518 . . . . 71.120000000000005 112.545 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.73 -36.9 42.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.161 0.505 . . . . 72.409999999999997 110.28 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' HA2' HG21 ' A' ' 91' ' ' THR . . . 81.01 -17.72 11.07 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.623 -0.717 . . . . 51.130000000000003 113.329 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.8 m -89.4 -20.31 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 111.971 0.36 . . . . 73.239999999999995 111.971 -173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.4 p -79.95 144.17 33.55 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.998 0.428 . . . . 54.219999999999999 111.062 176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.58 96.24 49.06 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.958 -0.564 . . . . 63.140000000000001 109.784 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 130' ' ' VAL . 51.6 Cg_exo -55.94 145.14 75.39 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.009 2.473 . . . . 71.040000000000006 113.188 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.17 146.0 44.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.971 -0.559 . . . . 75.109999999999999 109.939 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.6 166.14 24.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.728 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.07 7.3 70.46 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.221 -0.514 . . . . 65.140000000000001 112.711 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -117.95 149.88 40.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.943 0.401 . . . . 74.430000000000007 111.038 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.662 ' HB2' ' HZ3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -78.06 104.09 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.89 -0.782 . . . . 61.229999999999997 108.89 171.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.5 m -106.33 151.63 8.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.276 0.56 . . . . 64.049999999999997 111.661 -173.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 129' ' ' ALA . 30.2 m -99.13 108.38 20.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.005 -0.998 . . . . 54.210000000000001 110.015 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.482 HG21 ' CE2' ' A' ' 72' ' ' PHE . 14.7 m -122.57 178.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.924 -0.58 . . . . 41.030000000000001 110.466 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 69' ' ' PRO . 50.0 t-80 -154.22 149.46 27.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.134 -0.691 . . . . 71.409999999999997 109.134 173.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 38.7 p90 -151.33 152.27 32.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.499 0.19 . . . . 71.340000000000003 110.615 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -135.74 134.59 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.157 -0.682 . . . . 72.430000000000007 109.157 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.23 139.71 15.35 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.281 -0.485 . . . . 64.230000000000004 112.818 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.58 HH21 HG21 ' A' ' 122' ' ' VAL . 11.1 ttp180 -142.03 137.15 30.9 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.092 0.472 . . . . 71.310000000000002 110.432 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -79.95 152.83 74.77 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.731 -0.668 . . . . 75.120000000000005 109.939 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.45 -18.68 32.72 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.666 2.244 . . . . 74.209999999999994 111.774 176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.28 -38.87 88.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.392 -0.822 . . . . 72.299999999999997 110.367 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.09 -19.25 5.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.015 -0.538 . . . . 52.539999999999999 112.357 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -86.32 142.93 28.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.6 0.2 . . . . 64.140000000000001 110.571 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.2 mt-30 -86.45 155.25 20.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.604 -0.517 . . . . 72.329999999999998 109.604 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -76.16 -62.02 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.483 -0.562 . . . . 73.530000000000001 109.483 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -145.26 132.99 21.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.634 -0.712 . . . . 72.129999999999995 109.265 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 33.1 t -89.54 85.66 6.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 73.409999999999997 109.85 -178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 99.9 p -65.25 -26.78 68.25 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.486 . . . . 61.149999999999999 109.928 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 64' ' ' ARG . 5.3 ptp180 -60.35 -44.29 95.69 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.746 -0.661 . . . . 74.420000000000002 110.477 175.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -69.81 -23.44 63.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.061 0.458 . . . . 52.329999999999998 110.199 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' SER . 17.4 mtp180 -75.91 -21.85 56.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.294 -0.632 . . . . 75.439999999999998 109.294 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.07 46.53 7.6 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.404 -0.816 . . . . 63.329999999999998 114.128 170.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -145.8 128.98 8.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.101 0.451 . . . . 75.340000000000003 110.477 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HA ' ' HD2' ' A' ' 49' ' ' HIS . 1.4 Cg_endo -84.91 -177.42 2.81 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.24 2.627 . . . . 73.209999999999994 111.914 174.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -128.4 152.36 48.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.242 -0.651 . . . . 71.230000000000004 109.242 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -134.14 129.58 36.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.356 -0.239 . . . . 75.030000000000001 110.356 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' CE2' HG21 ' A' ' 48' ' ' VAL . 12.6 p90 -154.61 169.86 22.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.715 -0.221 . . . . 73.400000000000006 110.543 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.522 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 21.7 m -80.88 119.09 22.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.421 -0.354 . . . . 75.200000000000003 111.204 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 88' ' ' ALA . 56.8 tp -70.21 137.69 51.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.09 -0.505 . . . . 75.129999999999995 110.347 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.17 24.99 64.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.014 -0.612 . . . . 51.530000000000001 112.422 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.67 172.3 11.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.727 0.299 . . . . 74.430000000000007 110.407 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 15.93 8.4 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.111 -0.495 . . . . 54.409999999999997 113.315 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 73' ' ' THR . 26.6 mm-40 -55.68 -42.99 75.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.269 0.557 . . . . 75.439999999999998 110.314 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.533 ' HB ' ' HE3' ' A' ' 83' ' ' TRP . 30.4 m -134.91 176.88 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 32.009999999999998 109.987 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.532 HG13 ' H ' ' A' ' 83' ' ' TRP . 32.9 pt -69.21 150.01 10.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 116.499 -0.318 . . . . 75.420000000000002 110.392 177.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.526 ' HD2' HE21 ' A' ' 85' ' ' GLN . 4.7 tmtm? -58.59 -25.22 62.37 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 110.274 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -60.62 -52.16 54.21 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.055 -0.593 . . . . 34.43 111.963 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.533 ' HE3' ' HB ' ' A' ' 79' ' ' VAL . 49.8 m0 -68.14 -35.12 77.58 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.084 -0.339 . . . . 71.340000000000003 110.084 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.08 -49.37 71.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.105 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.526 HE21 ' HD2' ' A' ' 81' ' ' LYS . 80.3 mt-30 -59.14 -49.18 78.86 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.294 -0.412 . . . . 73.310000000000002 110.237 175.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.24 -50.05 48.05 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.455 -0.793 . . . . 70.400000000000006 113.003 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -75.36 -33.25 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.71 0.291 . . . . 62.310000000000002 111.763 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -77.69 -20.8 53.02 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.366 0.506 . . . . 72.340000000000003 112.366 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.3 t -85.76 -10.27 55.81 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.171 0.434 . . . . 72.319999999999993 112.171 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 15.9 ptp -107.19 -176.46 3.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.742 0.306 . . . . 71.329999999999998 111.637 -175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.569 HG21 ' HA2' ' A' ' 36' ' ' GLY . 17.3 p -118.56 178.83 4.32 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.899 -0.591 . . . . 75.530000000000001 110.89 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.794 ' HA ' HD12 ' A' ' 127' ' ' LEU . 6.3 tt -67.28 126.42 29.2 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.096 0.474 . . . . 74.120000000000005 110.542 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.404 ' N ' HD23 ' A' ' 92' ' ' LEU . . . 81.62 11.97 82.3 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.707 -0.679 . . . . 72.25 112.531 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 19.1 tt0 -100.5 146.48 27.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.841 0.353 . . . . 71.340000000000003 110.618 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 6.4 ttpm? -137.45 136.92 38.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.848 -0.614 . . . . 74.540000000000006 109.957 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.82 148.11 46.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.313 -0.403 . . . . 55.240000000000002 110.691 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.5 tt -90.75 105.47 17.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.628 -1.249 . . . . 62.350000000000001 107.628 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.86 126.43 50.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 65.010000000000005 110.268 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.3 m -84.89 106.44 16.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.949 -0.759 . . . . 71.140000000000001 108.949 174.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.98 110.77 40.44 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.435 -0.348 . . . . 60.109999999999999 110.77 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.93 140.87 47.01 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.486 2.124 . . . . 51.240000000000002 111.233 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.491 ' O ' ' HB2' ' A' ' 108' ' ' GLU . 46.3 p90 -54.5 -35.06 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 111.781 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HG3' ' HG ' ' A' ' 104' ' ' LEU . 13.8 pt20 -61.83 -20.87 64.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 111.543 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.554 ' HG ' ' HG3' ' A' ' 103' ' ' GLN . 95.6 mt -113.45 19.0 17.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.535 -0.302 . . . . 72.140000000000001 110.657 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.8 171.54 14.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.665 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -72.12 -17.34 61.98 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.282 -0.872 . . . . 72.409999999999997 110.587 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.89 -15.97 44.76 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.907 -0.588 . . . . 75.140000000000001 112.366 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 3.6 tm-20 -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.119 -0.326 . . . . 70.209999999999994 110.119 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -78.46 -52.83 7.96 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.426 -0.583 . . . . 72.200000000000003 109.426 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.97 153.36 2.87 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.936 -0.575 . . . . 74.310000000000002 113.008 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.592 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 54.2 m-85 -142.49 -59.84 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 122.574 0.35 . . . . 75.400000000000006 110.651 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 111' ' ' TYR . 75.6 Cg_endo -84.51 151.18 11.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 121.899 1.733 . . . . 74.049999999999997 111.882 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.9 -21.49 64.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.683 2.255 . . . . 75.519999999999996 112.634 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.641 HG23 HG12 ' A' ' 115' ' ' ILE . 33.8 m -71.91 -22.45 21.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.301 -0.408 . . . . 74.310000000000002 110.724 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.641 HG12 HG23 ' A' ' 114' ' ' VAL . 47.1 mm -121.81 87.68 46.69 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 109.165 -0.68 . . . . 64.329999999999998 109.165 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 119' ' ' ALA . 35.8 Cg_endo -64.98 156.34 63.07 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 73.409999999999997 111.785 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.11 135.85 60.2 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.358 2.038 . . . . 61.409999999999997 112.217 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 98.1 mttt 61.83 35.12 16.73 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.778 -0.647 . . . . 73.319999999999993 111.493 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . . . -89.29 125.04 34.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.053 -0.521 . . . . 74.120000000000005 111.562 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.6 m -74.09 132.81 42.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.921 -0.581 . . . . 71.230000000000004 109.442 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.582 HD13 ' N ' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -129.58 150.41 50.92 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.883 -0.414 . . . . 73.030000000000001 109.883 -171.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.582 ' N ' HD13 ' A' ' 121' ' ' LEU . 90.0 t -98.73 131.06 46.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 110.378 -0.23 . . . . 74.230000000000004 110.378 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.456 ' CE2' HD12 ' A' ' 121' ' ' LEU . 56.5 m-85 -130.32 118.76 21.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 52.100000000000001 110.644 177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 46.8 mt-10 -77.73 107.8 10.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.759 -0.83 . . . . 64.310000000000002 108.759 171.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.15 147.33 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 123.325 0.391 . . . . 41.0 110.312 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.96 128.92 11.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.714 0.292 . . . . 75.209999999999994 110.703 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 92' ' ' LEU . 2.9 tm? -96.14 115.91 28.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.85 -43.41 10.05 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.643 0.258 . . . . 73.209999999999994 110.998 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 47' ' ' THR . . . -150.39 135.29 17.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.348 -0.387 . . . . 55.219999999999999 110.388 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.508 HG21 ' HA ' ' A' ' 40' ' ' PRO . 2.9 p . . . . . 0 C--O 1.251 1.149 0 CA-C-N 116.23 -0.441 . . . . 71.349999999999994 111.235 -177.307 . . . . . . . . 1 1 . 1 stop_ save_